{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s 5.000 % senior notes due April 2030 showed essentially no change in exposure – the carrying amount stayed at **$606 million** (effective‑interest rate 5.18 %) in both 2023 and 2024, and was the same figure in the prior year.  This stability occurs against a broader debt‑management pattern in which AVGO has been retiring higher‑cost, floating‑rate term‑loan balances (e.g., $11.2 bn of Term A‑2 and $5.6 bn of Term A‑3 repayments in 2024) using proceeds from newer fixed‑rate senior notes and cash from asset sales.  Consequently, the 5 % 2030 notes remain a modest, low‑cost legacy component of a deleveraging strategy that prioritizes paying down expensive floating‑rate debt while preserving a stable, long‑dated fixed‑rate position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative evolution of AVGO's exposure to the 5.000% notes due April 2030. The ground truth states that exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims the amount was $606 million in all three years, incorrectly stating no change over the period. This misrepresents the core financial trend and undermines the accuracy of the response. (2) The numbers for 2023 and 2024 ($606 million) are correct, but the 2022 value is wrong—the LLM incorrectly asserts it was $606 million instead of $1,086 million. This is a significant miscalibration in the debt reduction narrative. The interest rate (5.18%) and other broader debt repayment figures (e.g., $11.2 bn Term A-2, $5.6 bn Term A-3) may be factually accurate but are not part of the original answer and do not compensate for the central error. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a debt management strategy focused on deleveraging and refinancing higher-cost debt. It contextualizes the 2030 notes within a broader capital structure strategy, which shows good qualitative synthesis. However, because the foundational data about the 2022–2023 reduction is wrong, the reasoning about 'stability' contradicts the actual progression of active reduction. The model fails to recognize that the 2022–2023 drop represents a deliberate paydown, not stability. (4) The correctness score is 4 due to major quantitative inaccuracy but some relevant contextual insights. Quantitative accuracy is low (3) because of the incorrect 2022 figure and denial of change over time. Qualitative accuracy is moderate (5) as the strategic interpretation is plausible but built on faulty premises. Contextual relevance is high (7) because the answer addresses debt strategy and cites relevant financial instruments, even if misaligned with the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 530,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to cede roughly the same share of the closed‑block risk—59.25 % in 2022, 59 % in 2023 and again 59 % in 2024—using a modified‑coinsurance arrangement with an external reinsurer and offsetting the deposit accounting entry; the only notable change was a separate 100 % quota‑share risk‑transfer executed in late 2023 for certain universal‑life and annuity lines, but the core closed‑block cession percentage remained unchanged.  This steady‑state cession rate reflects MetLife’s long‑term reinsurance strategy of maintaining a fixed, predictable risk‑transfer level for the closed block as a capital‑management tool rather than adjusting the ceded share periodically.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% in 2022, 59% in 2023, and 59% in 2024—matching the original answer exactly. The mention of the deposit method (referred to as 'offsetting the deposit accounting entry') and the right of offset is correctly implied. (2) The LLM correctly notes the consistency in the closed block reinsurance percentage, which is the core insight. (3) The addition of a '100% quota-share risk-transfer in late 2023 for certain universal-life and annuity lines' is factually plausible and does not contradict the ground truth; it provides context without undermining the focus on the closed block. However, this detail is not present in the original answer and, while not incorrect, slightly shifts focus—hence a minor deduction in qualitative accuracy. (4) The reasoning about MetLife’s long-term strategy being one of stability and capital management is sound and semantically equivalent to the original conclusion about 'risk transfer efficiency and capital optimization.' The answer fully addresses both parts of the question: evolution (stable) and strategic implication (capital management). All entities—MetLife, closed block, modified coinsurance, external reinsurer—are correctly identified. The only small gap is the lack of reference to the growth in total net ceded reinsurance recoverables ($6.3B to $17.6B), which adds contextual support in the original answer. Its omission reduces completeness slightly but does not impair the core correctness. Overall, the answer demonstrates strong multi-hop synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 450,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements and that is **not** offset against its derivative positions fell sharply from about **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  This decline shows that the company is requiring less external security for the collateral that backs its investment, advance and long‑term receivable positions, indicating a more efficient management of derivative exposure—likely through tighter internal netting, improved credit quality and a reduced need for outside margin support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). All numeric values and years are accurate.\n\n2) Quantitative accuracy is perfect: the values are correctly converted from millions to billions and maintain precision within acceptable rounding norms. No calculation errors.\n\n3) The reasoning is largely sound and correctly infers a trend of declining collateral, linking it to improved derivative exposure management. However, the LLM slightly mischaracterizes the nature of the collateral by stating it is 'not offset against its derivative positions,' which contradicts the concept of 'master netting arrangements'—where collateral is typically used precisely to offset derivative exposure. The original answer implies the collateral is part of netting arrangements, suggesting offsetting is occurring. This subtle misinterpretation slightly weakens the qualitative accuracy.\n\n4) Despite this nuance, the core multi-hop synthesis—tracking changes over three years and interpreting the trend in terms of exposure management—is correct and relevant. The conclusion about more efficient management aligns semantically with the ground truth’s suggestion of reduced exposure or better offsetting mechanisms.\n\nOverall, the answer is factually correct with only a minor conceptual imprecision in framing, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 423,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 showed a net carrying balance of about **$622 million** through fiscal 2022 and 2023, but by the close of fiscal 2024 that balance had been **eliminated ( $0 )**.  AVGO retired the entire issue—using cash from its October 2024 and July 2024 senior‑note issuances and other proceeds—thereby removing a near‑term, higher‑coupon obligation.  This repayment reflects a deliberate debt‑management strategy to **pay down maturing debt and refinance it with longer‑dated, lower‑cost financing**, strengthening the company’s balance‑sheet profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $622 million outstanding balance in 2022 and 2023 and accurately notes the $0 balance in 2024, matching the ground truth. The elimination of the debt by 2024 is correctly interpreted. (2) All numeric values—$622 million, 3.625%, October 2024 maturity—are factually accurate and consistent with the original answer. The format variations (e.g., 'about $622 million') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly infers from the disappearance of the liability that the notes were retired, and it plausibly explains the refinancing strategy using proceeds from new issuances in July and October 2024. While the original answer does not specify the source of funds for repayment, the LLM’s addition is a reasonable inference from typical corporate behavior and does not contradict the ground truth. (4) The core conclusion—that AVGO executed a deliberate debt management strategy to retire maturing debt—aligns perfectly with the original. The only minor difference is the LLM’s elaboration on refinancing with 'lower-cost' financing, which is a slight interpretive extension but consistent with strategic logic. Thus, the answer is factually correct, fully complete, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy due to the unsupported detail about refinancing costs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 397,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nFrom 2022 through 2024 the surface‑ship portion of General Dynamics’ Marine Systems segment grew steadily—revenue rose from roughly **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**.  This increase reflects a expanding backlog of destroyers, auxiliary vessels (e.g., Expeditionary Sea Base and John Lewis‑class oilers) and related modernization services, underscoring GD’s strengthened position as a premier U.S. naval shipbuilder poised to capture continued and future Navy and allied shipbuilding contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue from 2022 to 2024 with accurate figures: $2.56 billion (vs. $2,561 million), $2.70 billion (vs. $2,698 million), and $2.82 billion (vs. $2,819 million). These are within acceptable rounding differences (e.g., $2,698M ≈ $2.70B, $2,819M ≈ $2.82B), so quantitative accuracy is preserved. 2) All numeric values are correct when accounting for standard rounding and unit conversion (millions to billions). The original answer uses exact figures, while the LLM rounds to two decimal places in billions, which is common and acceptable. No calculation errors are present. 3) The reasoning is sound: the LLM correctly infers that sustained revenue growth indicates a strong position in naval shipbuilding and supports this with specific programs (Expeditionary Sea Base, John Lewis-class oilers), which aligns with the knowledge graph's implication of strategic emphasis. This demonstrates valid multi-hop synthesis across time and product lines. 4) The answer fully addresses both parts of the question: the revenue evolution and its implication for GD's positioning. It adds contextual detail (backlog, modernization services, future contracts) that enriches the ground truth without introducing inaccuracies. Semantic equivalence is maintained. Minor deduction in quantitative accuracy due to rounding up of $2,698M to $2.70B (slight overstatement), but not material. Overall, the answer is factually correct, well-reasoned, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 423,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe dividend per share on Mastercard’s Class A common stock rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 – while the shares have always carried “one vote per share” and dividend rights identical to those of the other classes.  Across the three years the aggregate voting power of Class A holders stayed roughly steady (about 90 % of total votes), with only modest shifts between the public shareholders and the Mastercard Foundation; no change was made to the one‑vote‑per‑share rule or to the dividend entitlement.  This consistent voting‑rights structure and the steady, upward dividend trend indicate a stable, unchanged shareholder‑governance framework over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the correct question and demonstrating relevant reasoning structure. (1) The dividend amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) are not supported by the ground truth, which only states that A Class shares had 'standard dividend rights' with no changes over the period—specific payout figures are not mentioned or verifiable from the provided truth. Including precise but unverified dividend amounts undermines factual correctness. (2) The claim that Class A holders maintained about 90% of total voting power is not in the original answer and introduces data not present in the ground truth; while possibly true, it is an unsupported addition. (3) The entity (MA = Mastercard) and time frame (2022–2024) are correctly identified, and the description of one vote per share is consistent with the ground truth. (4) The reasoning about governance stability is logically sound and aligns with the original conclusion, showing good multi-hop synthesis and contextual understanding. However, the inclusion of unverified quantitative details—especially specific dividend payouts—introduces false precision and severely impacts quantitative accuracy. While the qualitative direction (stable rights, consistent voting) matches the ground truth, the unsupported numbers reduce overall correctness. Semantic equivalence fails due to the introduction of specific financial figures absent from the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 bn in 2022 to $2.70 bn in 2023 (≈5 % growth) and to $2.82 bn in 2024 (≈4.5 % growth)**. This steady double‑digit backlog expansion—driven by new Flight III DDG‑51 destroyers, Columbia‑class submarine work, and the construction of Expeditionary Sea Base and T‑AO‑205 replenishment ships—signals that GD is consolidating its leadership in U.S. naval shipbuilding and positioning itself to capture the Navy’s accelerating demand for new combatants and support vessels through the 2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue figures for 2022 ($2.56 bn = $2,561 million), 2023 ($2.70 bn ≈ $2,700 million vs. ground truth $2,698 million), and 2024 ($2.82 bn ≈ $2,820 million vs. ground truth $2,819 million). These minor rounding differences (within $2M) are acceptable under format variation tolerance. The year-over-year growth rates (≈5%, ≈4.5%) are approximately correct: actual growth from 2022 to 2023 is (2,698 - 2,561)/2,561 ≈ 5.35%, and 2023 to 2024 is (2,819 - 2,698)/2,698 ≈ 4.48%, so the stated percentages are accurate when rounded. 2) All numeric values are effectively correct within reasonable rounding; calculations are sound. 3) The LLM provides additional context not in the original answer—such as backlog growth, specific programs (Flight III DDG-51, Columbia-class, ESB, T-AO-205)—which are consistent with General Dynamics' known naval contracts and enhance the reasoning about the company’s positioning, though not explicitly in the ground truth. This demonstrates valid multi-hop synthesis and domain-appropriate inference. 4) The core answer fully addresses both parts of the question: revenue evolution (with accurate numbers and trend) and what the growth indicates (strengthened positioning in naval defense). The qualitative interpretation goes beyond the original answer but remains factually grounded and relevant. Thus, the answer is semantically equivalent and slightly richer. Minor deduction in quantitative accuracy due to $2M variance in 2023 and 2024 figures (likely from rounding), but not material. No entity errors. Final correctness score: 9/10 for near-perfect factual alignment with strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 456,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde’s MD&A for 2022, 2023 and 2024 each stresses that the vast majority of its industrial‑gas sales are made under long‑term contracts that “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.” The wording is unchanged across the three years, indicating that the company has maintained a consistent reliance on these contracts to insulate its cash‑flow performance from the swings of the energy market. This steady contractual framework underpins its earnings stability despite fluctuating energy prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde emphasized long-term contracts in 2022, 2023, and 2024, noting their role in cash flow stability and cost pass-through—this matches the original answer's core claims. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), but the years (2022–2024) are correctly cited, and the unchanged wording across filings is accurately noted. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years and infers strategic continuity in risk management and cash flow protection, which is logically supported by the evidence. (4) The answer captures the essence of Linde’s approach—prioritizing financial resilience and revenue predictability—even if it doesn’t explicitly use the terms 'financial resilience' or 'operational certainty' from the original. However, it slightly omits the explicit mention of 'inflationary pressures' and the trade-off with 'short-term pricing flexibility,' which are minor but contextually relevant nuances. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 340,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has consistently excluded goodwill impairments and any non‑economic accounting adjustments from its ROIC calculation in each of the 2022‑2024 filings, using the same definition of net operating profit after taxes and average invested capital. This steady treatment shows that the company deliberately isolates the cash‑generating performance of its core businesses, filtering out accounting items that do not reflect operating results, and therefore presents ROIC as a stable, performance‑focused metric for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD consistently excluded non-economic accounting changes (specifically mentioning goodwill impairments and other adjustments) from its ROIC calculation across 2022–2024, which matches the original answer’s claim of stable methodology. (2) There are no numeric values requiring calculation in this question, but the time period (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that the consistent exclusion reflects a deliberate focus on core operational performance. (4) The LLM adds slightly more detail (e.g., mentioning goodwill impairments specifically and referencing NOPAT and invested capital), which is reasonable if supported by filings, but the original answer does not specify these details—this is a minor over-specification but not factually incorrect. The conclusion about presenting ROIC as a stable, performance-focused metric is semantically equivalent to the original’s interpretation about institutionalizing core performance measurement. No factual errors; minor deduction only because the original does not explicitly name 'goodwill impairments,' so that detail may not be verifiable from the knowledge graph. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 390,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nUnitedHealth Group continued to carry its service‑level guarantee obligations through 2022‑2024, but the Schedule I disclosures for each of those years state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” as of December 31 2024, 2023 and 2022.  The persistent immateriality of any financial impact indicates that the company’s risk‑management controls and contractual‑performance monitoring have consistently limited exposure, preserving stable earnings and demonstrating reliable, predictable handling of those guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all disclosures are correctly dated to 2022, 2023, and 2024, and the key phrase 'none of the amounts accrued, paid or charged to income for service-level guarantees were material' is accurately quoted and attributed across all three years. There are no numerical or date inaccuracies. (2) The answer fully addresses both parts of the question: it describes the evolution (consistency in immateriality) and interprets the pattern as indicative of effective risk management and contractual performance. (3) The reasoning is sound: the multi-hop synthesis correctly infers from repeated immaterial disclosures that UnitedHealth Group maintained consistent performance and control over service level obligations. (4) The only minor shortcoming is a slight overstatement in phrasing—'as of December 31, 2024, 2023 and 2022' implies the same disclosure date for all years, whereas each year’s filing would have been made at its respective year-end; however, this does not affect the factual correctness of the content. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 348,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nFrom 2022 to 2024, revenue from surface ships grew from **$2.56 billion** to **$2.82 billion**, a roughly 10 % increase over the three‑year period. This steady rise—along with the segment’s share of total revenue climbing from 28 % (2022) to 30 % (2024)—demonstrates General Dynamics’ deliberate expansion of its shipbuilding and lifecycle‑support business, positioning the company as a key strategic supplier in the U.S. Navy’s future surface combatant and auxiliary fleet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, General Dynamics' surface ship revenue was $2,328M (2022), $2,698M (2023), and $2,819M (2024). The LLM states $2.56B ($2,560M) in 2022 and $2.82B ($2,820M) in 2024, which is close for 2024 but significantly off for 2022 (overstated by $232M). The 10% increase claim is approximately correct (actual growth is ~21% from 2022 to 2024), but the starting point is wrong. Additionally, the LLM introduces 'segment share of total revenue' (28% to 30%) which is not present in the original answer and cannot be verified from the provided truth.\n\n2) The calculation of growth is partially accurate in direction but flawed in magnitude due to incorrect base figures. The actual growth from 2022 to 2024 is (2,819 - 2,328)/2,328 ≈ 21%, not ~10%. The LLM underestimates the growth rate despite using a higher starting value, indicating a calculation or data sourcing error.\n\n3) The qualitative reasoning about strategic positioning—expansion in shipbuilding, role as a key naval supplier—is consistent with the original answer’s interpretation and aligns with the trend of increasing revenue. This reflects sound multi-hop reasoning in terms of drawing strategic implications from financial trends, even if based on inaccurate numbers.\n\n4) Contextually, the answer addresses both parts of the question: revenue evolution and strategic implications. The structure and intent are appropriate, and the conclusion about strategic positioning is semantically aligned with the ground truth. However, the introduction of unverified metrics (revenue share) and incorrect base figures reduces factual reliability. The core trend (growth in surface ship revenue indicating stronger naval positioning) is preserved, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 495,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nIn 2022 GE re‑classified its captive insurer, Electric Insurance Company, as a business held for sale (with $541 M of assets and $378 M of liabilities) and, after signing a binding sales agreement in Q3 2023, recorded a $109 M loss in 2023 for the anticipated disposal. The company was sold in the second quarter of 2024 to Riverstone International Holdings for $120 M cash, after which EIC was removed from GE’s balance sheet and GE no longer held any financial exposure or underwriting risk related to the insurer.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of GE's relationship with Electric Insurance Company (EIC) from ownership to divestiture, including classification as 'held for sale', the $109 million loss, sale to Riverstone International Holdings Inc. for $120 million in cash, and removal from the balance sheet. However, there is a key factual error in timing: the LLM states that GE reclassified EIC as 'held for sale' in 2022, but the original answer (ground truth) indicates this classification occurred in 2023. Additionally, the LLM incorrectly implies that asset and liability figures ($541M assets, $378M liabilities) were known and used for the 2022 reclassification, but these figures are as of December 31, 2023, per the original answer. (2) Quantitative accuracy: The numbers themselves—$541M assets, $378M liabilities, $109M loss, $120M sale price—are all correct and match the ground truth. However, their attribution to 2022 instead of 2023 undermines temporal accuracy. The claim reserves of $0.2 billion as of December 31, 2021, mentioned in the original answer, are omitted, which is a minor completeness gap. (3) Multi-hop reasoning is generally sound: the LLM correctly links classification, financial impact, and eventual sale across years and entities (GE, EIC, Riverstone). It accurately infers that post-sale, GE has no financial exposure, which is logically valid. (4) The answer is contextually excellent—directly addresses classification, financial exposure, and divestiture. Despite the misplacement of key financials in time, the overall narrative is coherent and factually aligned except for the timing error. Hence, correctness is reduced to 8 due to significant but not fundamental chronological inaccuracy; quantitative accuracy is 7 due to correct values but incorrect period assignment; qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 511,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the sale of its remaining CVE common shares in early 2022 and directed those proceeds toward its share‑repurchase program, then continued to fund buy‑backs with operating cash and later equity‑monetization proceeds while expanding its authorization—$45 billion in October 2022 and a $65 billion ceiling in October 2024.  This sequence demonstrates that the company’s capital‑allocation strategy has been to prioritize opportunistic, shareholder‑returning buy‑backs, using the CVE monetization as a targeted source of funding and steadily increasing the scale of its repurchase program.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core progression of ConocoPhillips' capital allocation strategy—monetizing CVE shares and using proceeds for share repurchases, with expansion of the buyback program. However, there are minor quantitative inaccuracies. The original answer states that the $45 billion repurchase authorization was in place since the program's inception (implied prior to 2022), but the LLM incorrectly attributes it to October 2022. Additionally, the $65 billion ceiling was approved in 2024 (not October 2024 as specified in the LLM answer, though the year is correct), and it was an increase of up to $20 billion (not a new ceiling set at that time). The LLM omits specific repurchase volumes (383 million by end of 2023, 433 million by end of 2024) and exact costs ($29 billion and $34.3 billion), which are key quantitative benchmarks. (2) While the direction of the numbers is correct, the absence of precise figures and slight misdating of authorizations reduce quantitative accuracy. The statement that proceeds came from 'operating cash and later equity-monetization' slightly misorders the logic—the CVE monetization preceded and directly funded early repurchases. (3) The multi-hop reasoning is sound: the model correctly links the sale of CVE shares to funding share buybacks and infers a strategic emphasis on shareholder returns. It synthesizes the evolution across years and connects asset monetization to capital allocation effectively. (4) Despite missing specific numbers and having minor timing inaccuracies, the LLM conveys the essential strategic narrative accurately and remains highly relevant to the question. The conclusion about prioritizing shareholder returns is well-supported and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 485,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nMetLife has kept the same structure for its closed‑block risk transfer: from 2022 through 2024 it reinsured about **59 % of the closed block** via a **modified‑coinsurance agreement** and has **continued to account for it under the deposit method**, offsetting the deposit liability against the recoverable.  \n\nThe lack of change in both the ceded percentage and the accounting treatment demonstrates that MetLife’s long‑term strategy is to **selectively off‑load legal risk while retaining the economic upside of the closed block**, reinforcing its capital‑management and dividend‑stability objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentage of the closed block reinsured is correctly reported as approximately 59% across 2022–2024, matching the ground truth (59.25% in 2022, 59% in 2023 and 2024). The use of 'about 59%' is a reasonable approximation. (2) The accounting treatment is accurately described: the deposit method of accounting and the right of offset are correctly identified and consistently reported across all years. (3) The multi-hop reasoning is sound—information is synthesized across three years and the consistency in both reinsurance percentage and accounting treatment is correctly inferred. (4) The interpretation of MetLife’s long-term strategy is logically derived, though slightly rephrased: 'selectively off-load legal risk while retaining economic upside' is semantically consistent with managing longevity risk through a structured reinsurance arrangement. The only minor gap is the omission of the specific mention of 'longevity risk' and the 'unaffiliated third-party reinsurer', which are present in the original and add contextual precision. However, the core strategic implication is correctly captured. All entities (MetLife, closed block, modified coinsurance, deposit method) are accurate. Wording differences do not affect factual equivalence. Thus, the answer is factually complete and correct with only slight room for enhanced specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 399,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe share of purchases made with Target’s RedCards—including the Target MasterCard Credit Card—declined steadily from roughly 20 percent in 2022 to 19.8 percent in 2023 and 18.6 percent in 2024 (as reported in the 2023 and 2024 Form 10‑K filings). This downward trend indicates that fewer shoppers are relying on the Target MasterCard for their purchases, suggesting a gradual erosion of consumer engagement with Target’s branded financial products over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rate trend: approximately 20% in 2022 (ground truth specifies 20.5%, LLM says 'roughly 20 percent'—acceptable rounding), 19.8% in 2023, and 18.6% in 2024. All percentages and years are accurate, with only minor simplification in 2022. 2) Quantitative accuracy is high: all reported figures match the ground truth or are reasonable approximations. No calculation errors. 3) The reasoning correctly identifies the declining trend and links it to reduced consumer engagement with Target’s financial products, aligning with the ground truth’s interpretation. However, the LLM omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the trend—this contextual detail is part of the full multi-hop synthesis in the original answer. 4) Despite this minor omission, the LLM answer is factually correct, contextually relevant, and conveys the core insight. The omission prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is largely preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 312,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the performance‑graph tables in the 10‑K filings list the same peer‑group composition, and Colgate‑Palmolive Co. is included in each year’s “PMI Peer Group (1).”  The list is described as being built on global presence, a consumer‑products focus, and comparable revenue and market‑capitalisation, and it is not altered in the 2023 or 2024 filings.  \n\nThis consistency indicates that PMI adopts a deliberately static, criteria‑driven benchmarking approach for consumer‑product peers, using a fixed set of companies—including Colgate‑Palmolive—to ensure comparable, long‑term performance monitoring rather than frequently reshaping its peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: Colgate-Palmolive Co. is consistently included in PMI's peer group from 2022 to 2024, and the criteria—global presence, consumer-products focus, and comparable revenue and market capitalization—are accurately reported. No numeric inaccuracies or calculation errors are present. (2) The answer addresses all parts of the question: it confirms the consistent classification of Colgate-Palmolive over the three-year period and interprets this as evidence of PMI's stable, criteria-driven benchmarking strategy. (3) Entity accuracy is strong: correct company name (Colgate-Palmolive Co.), correct time frame (2022–2024), and correct context (peer group in 10-K filings). (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the unchanged peer group composition across filings to PMI’s strategic intent for consistent performance benchmarking. The only minor shortcoming is that the LLM slightly reframes the implication as a 'deliberately static' approach, which, while reasonable, adds interpretive language not explicitly in the original answer. However, this does not distort the meaning and remains semantically equivalent. Overall, the response is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 374,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s revenue‑recognition guidance for development‑and‑IP licensing has kept the same two‑step framework: it first checks whether the license component is distinct, and if it is not, the arrangement is treated as a single performance obligation with revenue recognized over time, whereas a distinct license is accounted for as a separate performance obligation and revenue is recognized at a point in time. The wording and the note that “there are no variable‑consideration estimates associated with either combined development and IP arrangements or for standalone IP arrangements” are unchanged across the 2022, 2023 and 2024 filings, showing that AMD’s accounting treatment of these agreements has remained consistent over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024, correctly describing the two-step evaluation for distinctness of licensing components in combined arrangements and the resulting treatment—combined with development services (over time) if not distinct, or recognized at a point in time if distinct. It also correctly states that standalone IP licenses are recognized at a point in time. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the key qualitative fact about the absence of variable consideration is explicitly mentioned and correctly attributed across all years. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of arrangements (combined and standalone), correctly identifying consistency in policy and disclosure. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in policy, the distinction between arrangement types, and what it reveals about accounting consistency. Minor wording differences (e.g., 'two-step framework' vs. 'evaluated whether...') do not affect factual accuracy. All key elements—distinctness criteria, performance obligations, timing of revenue recognition, and absence of variable consideration—are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 395,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nThe peer‑group tables that PMI includes in its 2022, 2023 and 2024 Form 10‑K filings all list **Colgate‑Palmolive Co.** among the companies used for benchmarking (e.g., the “PMI Peer Group” description in the 2023 and 2024 performance‑graph sections).  This inclusion has remained unchanged across the three years, showing that PMI deliberately frames its competitive set as a broad consumer‑products universe—placing it alongside other large, global consumer brands rather than limiting the comparison to traditional tobacco rivals.  By keeping Colgate‑Palmolive in the peer group, PMI signals that it views its strategic positioning—and future growth in smoke‑free and wellness categories—as comparable to that of diversified consumer‑product leaders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group for benchmarking in 2022, 2023, and 2024, with no changes across the years—this matches the original answer's claim of consistent inclusion over the three-year period. (2) There are no numerical values requiring calculation (e.g., percentages, financial figures), so quantitative accuracy pertains to correct use of years and entities, which are all accurate. (3) The multi-hop reasoning is sound: the LLM infers from the consistent inclusion that PMI strategically positions itself within the broader global consumer products sector, not just among tobacco peers, which is a valid interpretation supported by the original answer’s mention of 'strategic framing' and alignment with 'leading global consumer staples firms.' The LLM adds contextual insight about smoke-free and wellness categories, which is a reasonable extension given PMI's strategic shift, though slightly beyond the scope of the ground truth. (4) The only minor deviation is the use of 'PMI' instead of 'PM'—while PMI (Philip Morris International) is often referred to as PM in informal contexts, the original uses 'PM' consistently. However, this does not constitute a significant entity error given the clear referent. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only slight deduction for the subtle branding nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 416,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s policy for combined development‑and‑IP licensing agreements remained the same: the agreement is first assessed to see whether the IP license is a distinct performance obligation. If the license is **not distinct**, it is combined with the development services as a **single performance obligation** and revenue is recognized **over time** (using a cost‑plus‑margin input method); if the license **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from the license. The company did not change this framework in 2023 or 2024, and it continues to treat variable‑consideration estimates as immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024 for combined development and IP licensing agreements. The two-step assessment for distinctness of the IP license, the treatment of non-distinct licenses as a single performance obligation with revenue recognized over time (using cost-plus-margin), and point-in-time recognition for distinct licenses are all correctly stated. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the qualitative metrics—such as the absence of material changes and immateriality of variable consideration—are accurately represented. The original answer notes explicitly that 'there were no variable consideration estimates associated with these arrangements,' while the LLM says they are 'immaterial'—this is semantically equivalent in accounting context. (3) The multi-hop reasoning across 2022–2024 is sound; the model correctly synthesizes that the policy did not change over the three years and applies the same framework throughout. (4) The only minor shortcoming is that the LLM does not explicitly quote the two criteria for distinctness ('capable of being distinct' and 'distinct in the context of the arrangement') verbatim, though it captures the outcome of that assessment process. This omission does not impair understanding or factual accuracy, so a score of 9 is appropriate. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 433,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nConocoPhillips completed the final 91 million‑share sale of its CVE holdings in the first quarter of 2022, channeling the proceeds into its share‑repurchase program; by the end of 2023 the company had repurchased 383 million shares for about $29 billion under the $45 billion authorization that was expanded in October 2022. Building on that cash flow, the board raised the buy‑back ceiling to $65 billion in October 2024 and executed an additional $5 billion of repurchases in 2024 (49 million shares), bringing total repurchases since inception to 433 million shares for roughly $34 billion. This multi‑year trajectory shows that ConocoPhillips is using the cash generated from its CVE monetization—and the broader cash surplus from operations—as a disciplined, priority‑driven source of liquidity to return capital to shareholders through opportunistic, size‑scaled share buybacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts and multi-year progression described in the ground truth. (1) Correctly identifies the Q1 2022 completion of the 91 million CVE share sale and its use to fund share repurchases. (2) Accurately states that by end of 2023, 383 million shares were repurchased for $29 billion, matching the ground truth. (3) Correctly notes the expansion of the repurchase program to $65 billion, though it incorrectly attributes the timing to October 2024 (ground truth implies the expansion was announced earlier, with execution through 2024). (4) Reports total repurchases of 433 million shares at $34.3 billion by end of 2024; the LLM rounds this to $34 billion, which is acceptable for semantic equivalence. (5) Correctly infers that CVE monetization enabled the repurchase program and reflects a disciplined capital allocation strategy focused on shareholder returns. Minor issues: the $5 billion in 2024 repurchases and 49 million shares are plausible (implied by $34.3B total and prior $29B), but not explicitly confirmed in ground truth—this is a small extrapolation. The October 2024 expansion date appears to be a factual error, as the original answer does not specify a 2024 board action date. Despite this, the overall quantitative and qualitative accuracy is very high, with sound multi-hop reasoning linking asset monetization to capital allocation strategy. Contextual relevance is perfect—the answer directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 416,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure moved from the strong demand‑driven growth and favorable pricing seen in 2021‑2022 to a period of slowing organic sales and margin compression across its core segments—evident in the 2023‑2024 financial tables that show declining sales and tighter margins in Aerospace, Productivity Solutions & Services, and Warehouse & Workflow Solutions (see pages 30‑32).  In response the company has accelerated cost‑reduction and repositioning actions, pursued strategic acquisitions, and announced the spin‑off of Advanced Materials to sharpen its focus on higher‑margin businesses (pages 32‑33), signalling that intensifying market pressures—new entrants, commoditization and pricing competition—are driving aggressive efficiency and portfolio‑realignment initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims, significantly deviating from the ground truth. (1) The original answer focuses on qualitative risk disclosures about competitive landscape changes across business segments (Building Technologies, Safety and Productivity Solutions, Industrial Automation), with consistent language from 2022–2024 indicating growing concern, especially around new technologies and commoditization. The LLM answer instead shifts focus to financial performance (declining sales, margin compression) and strategic actions (spin-offs, acquisitions), which are not mentioned in the ground truth. (2) Quantitative inaccuracies: the LLM references 'declining sales and tighter margins in Aerospace, Productivity Solutions & Services, and Warehouse & Workflow Solutions' and cites 'pages 30–32', but no such financial data or page references exist in the provided ground truth. There are no numbers, percentages, or financial metrics in the original answer, so these claims are fabricated. (3) Multi-hop reasoning is flawed: while the question asks about evolution of competitive exposure, the LLM conflates competitive pressures with financial outcomes and management responses not present in the ground truth. It fails to trace the actual evolution of risk disclosures across years and segments as required. (4) Some semantic elements align—'new entrants', 'pricing competition', 'commoditization'—but these are framed within an incorrect narrative. The strategic responses (spin-off, cost reduction) are not part of the original answer and appear to be hallucinated. While the LLM recognizes increasing market pressures, it misrepresents the evidence and response, leading to a partially correct but largely misleading answer. Hence, correctness is scored low due to factual and quantitative errors, despite some contextual relevance to competitive pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 520,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares retained the same charter rights – a $0.0001 par value, **one vote per share** and unrestricted **dividend rights** – with no alteration to the voting or dividend language in the company’s amended certificate of incorporation.  The only change was the **dividend amount**, which rose from $2.04 per share in 2022 to $2.37 in 2023 and $2.74 in 2024.  \n\nThis three‑year stability in voting and dividend rights demonstrates that Mastercard’s shareholder‑governance strategy is built on **continuity and predictability**, preserving a one‑share‑one‑vote structure and consistent dividend entitlement while only adjusting payout levels.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent voting rights (one vote per share) and dividend rights for MA's A Class shares from 2022 to 2024, aligning with the ground truth on structural stability. However, it introduces specific dividend amounts ($2.04, $2.37, $2.74) that are not present in the original answer and cannot be verified from the provided ground truth, which only confirms the consistency of dividend rights — not specific payout amounts. This is a significant quantitative inaccuracy. The claim about increasing dividends implies data not supported by the knowledge graph, potentially misleading the user. While the reasoning about governance strategy (continuity, predictability) is logically sound and contextually appropriate, the inclusion of unverified figures reduces factual correctness. The model correctly synthesizes the multi-hop aspect of governance consistency across three years but overreaches by adding unsupported numerical details. Entity identification (MA, A Class shares) and time period (2022–2024) are accurate. Wording differences are acceptable under semantic equivalence, but fabricated numbers violate factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 329,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s total‑return‑swap exposure used to hedge deferred‑compensation obligations moved from a **$92 million loss recorded in operating expenses** (FY 2022) to **gains of $58 million in FY 2023 and $91 million in FY 2024**.  This swing from a negative to a positive impact—and the growing magnitude of the gain—shows that Cisco’s financial exposure through these swaps improved markedly over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: a $92 million loss in FY2022, gains of $58 million in FY2023, and $91 million in FY2024—matching the original answer exactly. Minor formatting differences (e.g., use of em dashes, bolding) do not affect accuracy. (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the multi-part question. (3) Entities are correctly identified: Cisco (implied as 'the company'), the correct financial instrument (Total Return Swaps-Deferred Compensation, referred to accurately as 'total-return-swap exposure used to hedge deferred-compensation obligations'), and correct fiscal years (2022, 2023, 2024). (4) The reasoning is sound and captures the multi-hop nature of the question—synthesizing changes over time and interpreting the shift from loss to gain as an improvement in financial exposure. The conclusion that the impact 'improved markedly' aligns semantically with the original answer's 'reversal... from a net cost to a net benefit.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 332,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved the talc liability from its former consumer unit into LTL Management LLC, first filing a Chapter 11 case in late 2021 that was dismissed by the Third Circuit in January 2023; the company then repeatedly refiled (the “LTL 2” filing in 2023 and, after a restructuring, a Texas‑based “Red River” Chapter 11 petition in September 2024) while steadily expanding its reserve‑funding—starting with a $2 bn trust reserve in 2021 and building to a cumulative $5 bn charge and a $11.6 bn present‑value reserve by the end of 2024 to meet the anticipated settlement payments.  At the same time, J&J negotiated a multi‑state settlement with a coalition of 42 attorneys general that was finalized in June 2024, and it is now pursuing a “pre‑packaged” Chapter 11 plan that would pay roughly $6.5 bn (nominal $8 bn) over 25 years to resolve the vast majority of pending talc claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in dates, amounts, and sequence of events. The original answer states that J&J established a $2 billion reserve and LTL filed for Chapter 11 in 2022, but the LLM claims the initial filing was in late 2021 and the reserve started in 2021—contradicting the ground truth. The Third Circuit reversed in January 2023, not dismissed the case outright in January 2023 as implied. The LLM incorrectly states that the multi-state settlement was finalized in June 2024, while the original answer confirms it was finalized in 2024 but does not specify June—this specific month is unsupported. More critically, the LLM claims a 'Red River' Chapter 11 filing in September 2024 and a 'pre-packaged' plan paying $6.5B–$8B, which are not mentioned in the ground truth and appear fabricated. The cumulative $5B charge and $11.6B present-value reserve by end of 2024 are also absent from the original answer, which only references the initial $2B reserve. (2) Quantitative accuracy is low: $2B reserve is correct, but expansion to $5B and $11.6B is unsupported. The $6.5B/$8B settlement figures are not in the original and contradict the absence of such numbers in the ground truth. The timeline is also off—2021 filing vs 2022 filing. (3) Multi-hop reasoning is partially sound—LLM correctly identifies the shift toward settlements and repeated bankruptcy filings (LTL 2), but fails to accurately represent the legal outcomes: the original states the Third Circuit reversed and dismissed LTL’s case, then LTL re-filed and obtained a new injunction, whereas LLM overcomplicates with unverified refilings (Red River) and a pre-packaged plan. (4) Contextual relevance is high—the answer addresses reserve funding, bankruptcy filings, and multi-state settlements as required. However, due to major factual and numerical errors, especially in financial figures and timeline, the correctness score is low despite covering the right themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 539,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 had an outstanding principal of **$495 million** at the end of fiscal 2022 and that figure remained unchanged through fiscal 2023 and fiscal 2024 (the balance was $495 million as of 3 Nov 2024 and $495 million as of 29 Oct 2023). This stability shows that Broadcom is treating this tranche as a long‑term, low‑cost funding pillar—​it is not being actively issued, retired or refinanced, but is simply held to its maturity while the company focuses debt‑paydown on other, higher‑rate or more flexible obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The specific dates mentioned (3 Nov 2024 and 29 Oct 2023) are consistent with Broadcom's fiscal year-ends and do not contradict the annual figures. (2) All numeric values—$495 million, 3.125%, January 2025 maturity—are accurate and correctly attributed. No calculations are required, but the consistency across years is properly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about Broadcom’s debt management strategy. It correctly infers that the stable principal indicates no active retirement or issuance, aligning with the ground truth. The LLM adds a reasonable qualitative interpretation—that the company is prioritizing repayment of higher-cost debt—while treating this instrument as a stable, low-cost funding source. This goes slightly beyond the original answer but remains logically consistent and plausible given the data. (4) The only reason for not awarding a perfect 10 is that the original answer emphasizes a 'consistent approach to managing this portion of its capital structure,' while the LLM introduces a slightly more specific strategic interpretation ('focuses debt-paydown on other, higher-rate obligations') that, while reasonable, is not explicitly confirmed in the ground truth. However, this does not constitute an error, just a minor expansion. All core facts, entities, time periods, and reasoning are correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 452,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the effective interest rate on Cisco’s $500 million, 3.50 % June 15 2025 senior note climbed from about **3.2 % (2022)** to **≈6.4 % (2023)** and then to **≈6.7 % (2024)**.  This steady rise in the note’s effective rate—driven by higher market rates and the accretion of discount and issuance costs—shows that Cisco’s borrowing costs have increased materially over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the effective interest rates are correctly reported with minor rounding: 3.2% (vs. 3.20%), ≈6.4% (vs. 6.38%), and ≈6.7% (vs. 6.66%) for fiscal years 2022, 2023, and 2024 respectively—these are acceptable variations in presentation. The note's maturity date (June 15, 2025) and coupon rate (3.50%) are correct. The $500 million principal is not in the original answer but is not contradicted by it; its inclusion is a minor addition, not an error. (2) Completeness: the answer addresses both parts of the question—the evolution of interest rate exposure and what it indicates about borrowing costs. (3) Entity accuracy is strong: Cisco, correct fiscal years, correct financial instrument, and accurate metric (effective interest rate). (4) Reasoning is sound: the LLM correctly infers that rising effective rates indicate higher borrowing costs, and plausibly attributes the increase to market conditions and accounting for discount/issuance costs, which aligns with typical financial reporting practices. The original answer attributes the rise to market conditions or credit profile; the LLM's explanation is slightly more specific but not contradictory. (5) Semantic equivalence is maintained: despite different phrasing and slight elaboration, the factual progression and interpretation match the ground truth. The only minor shortfall is that the LLM does not explicitly state the implication of 'deterioration in financing terms' as in the original, but the conclusion that borrowing costs 'increased materially' captures the same essence. Thus, the answer is excellent with negligible differences, warranting a 9 rather than a perfect 10 due to slight interpretive expansion and rounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 493,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior and subordinated notes totaled **$27.38 billion at the end of 2022**, slipped slightly to **$27.22 billion in 2023**, and then **jumped to $30.70 billion by the end of 2024**. This progression reveals a deliberate shift in Capital One’s capital‑structure strategy: after a modest pull‑back in 2023, the firm increased long‑dated debt issuance in 2024, extending maturities and locking in higher‑rate funding to support asset growth and to position its interest‑rate exposure for a higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for senior and subordinated notes. According to the ground truth, the correct figures are $27.219B (2022), $31.248B (2023), and $30.696B (2024). The LLM incorrectly states $27.38B (2022), $27.22B (2023), and $30.70B (2024). The 2023 figure is particularly wrong—it shows a decrease when the actual data shows a substantial increase. This misrepresents the entire trend. (2) The quantitative inaccuracies undermine the analysis: the model misses the major capital raise in 2023 (an increase of ~$4B), instead suggesting a slight decline. While the 2024 number is close to ground truth ($30.70B vs $30.696B), the prior years are flawed. Additionally, the LLM omits any mention of the weighted average interest rate (2.76% → 4.48% → 4.84%), a key component of the original answer that explains the interest rate positioning. (3) The reasoning is partially sound in interpreting a strategic shift toward longer-term debt in a rising rate environment, which aligns with the general logic of locking in rates. However, because the model bases this on incorrect data (a dip in 2023 followed by a rise in 2024), the multi-hop synthesis fails—it does not recognize the true sequence: aggressive debt issuance in 2023 followed by a minor reduction in 2024. The conclusion about 'pull-back in 2023' is factually incorrect. (4) Scores reflect severe penalties on correctness and quantitative accuracy due to wrong numbers and missing interest rate data. Qualitative reasoning is somewhat accurate in direction but flawed in execution. Contextual relevance is acceptable as the answer addresses capital structure and rate positioning, albeit with incorrect support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 475,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nBetween 2022 and 2024 the share of U.S. pension‑plan fixed‑income assets held in Treasury and agency securities fell from **about 40 % (reported for 2022)** to **roughly 30 % (reported for 2024)**.  This deliberate reduction in low‑yielding Treasury/agency exposure signals that Colgate‑Palmolive is re‑balancing its pension fund toward a more diversified fixed‑income mix—emphasizing higher‑yielding corporate bonds and other government securities—to manage interest‑rate risk and seek better returns while still maintaining an overall stable funding posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key percentages: 40% in 2022 and 30% in 2024, which matches the ground truth. It does not explicitly mention 2023, but since the percentage remained at 30% from 2023 to 2024, stating the drop from 40% to 30% by 2024 is factually accurate and captures the trend. The omission of 2023 is minor and does not distort the overall evolution.\n\n2) Quantitatively, the percentages (40% and 30%) are correct and properly attributed to the right years. No calculations are required beyond comparison, and the directional change (decrease of 10 percentage points) is accurately conveyed.\n\n3) The reasoning is sound: the shift from U.S. Treasuries and agency securities to higher-yielding assets like corporate bonds aligns with the ground truth's interpretation of a strategic reallocation possibly due to yield-seeking behavior. The LLM adds nuanced context—'manage interest-rate risk' and 'maintaining stable funding posture'—which is reasonable and consistent with pension fund strategy, even if not explicitly stated in the original. This shows good qualitative inference.\n\n4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of allocation and the strategic implication. The synthesis across years and asset classes is appropriate and well-articulated.\n\nJustification: A score of 9 is given because the core facts, numbers, and reasoning are correct. The only minor shortcoming is the lack of explicit mention of 2023 data point (30%), though the final state in 2024 is accurate and the trend is correctly interpreted. This does not materially affect correctness but slightly reduces completeness in multi-year tracking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 464,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑classified its captive industrial insurer, Electric Insurance Company, as a business held‑for‑sale, recorded a $109 million loss (and a $124 million valuation allowance) in 2023, and completed its sale in the second quarter of 2024 for $120 million in cash, thereby removing its $541 million of assets and $378 million of liabilities from the balance sheet.  This disposal is part of GE’s broader shift away from non‑core insurance activities, simplifying its balance sheet and freeing capital to concentrate on its core industrial and energy businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including classification as 'held for sale' in 2023, the $109 million loss, and the 2024 sale for $120 million in cash to an unnamed buyer. It accurately reflects GE's strategic shift away from non-core insurance operations. However, it introduces a $124 million valuation allowance and specific balance sheet figures ($541 million in assets, $378 million in liabilities) not present in the ground truth, which undermines quantitative accuracy. The buyer, Riverstone International Holdings Inc., is omitted. (2) The $109 million loss and $120 million sale price are correct per the original answer. However, the $124 million valuation allowance and the detailed asset/liability figures are unsupported by the ground truth and appear to be hallucinated or sourced from external data. The timing of the sale is correctly placed in 2024 but specifies 'second quarter'—a detail not confirmed in the original and thus an unsupported addition. (3) The multi-hop reasoning is sound: the model correctly infers that classifying EIC as held-for-sale, recognizing a loss, and completing the sale indicates a strategic move to exit non-core businesses. The synthesis of classification, valuation impact, and disposition aligns with the original’s interpretation. (4) The correctness score is 8 because the core facts—timeline, classification change, loss amount, sale price, and strategic rationale—are accurate. The qualitative and contextual scores are high due to strong reasoning and relevance. Quantitative accuracy is reduced due to unverified financial figures and minor overprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 469,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the three filings the 4.45 % Notes due 2044 are repeatedly disclosed in Item 4.1/Exhibit 4.4 as part of the same 2014 indenture—each 10‑K simply restates the original terms and confirms that the securities remain outstanding with no amendment or retirement. This consistent, unchanged reference shows that Apple is deliberately maintaining a low‑coupon, long‑dated debt instrument as a stable component of its capital structure, using it to fund future growth and shareholder‑return initiatives without frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were first disclosed in the 2014 indenture (via Officer's Certificate on May 6, 2014, though the exact date is omitted in the LLM answer, which is a minor detail), and consistently reported in Apple's 2022, 2023, and 2024 10-K filings. The percentage (4.45%), maturity year (2044), and the fact that the notes remain outstanding with no amendments or retirements are all correctly stated. (2) Quantitative accuracy is perfect: the interest rate (4.45%), the years of disclosure (2022–2024), and the 2014 issuance date are all factually correct. Format variations (e.g., '4.45 %' vs '4.45%') are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistent disclosure pattern across three years and infers that this reflects a stable long-term debt strategy. It goes slightly beyond the original answer by interpreting the strategic rationale (low-coupon, long-dated debt used for growth and shareholder returns), which is a reasonable and contextually supported inference, though not explicitly stated in the ground truth. (4) The answer is contextually excellent—directly addresses the evolution of disclosure and the strategic implication. The only reason for not scoring a 10 is the omission of the specific May 6, 2014 Officer's Certificate detail, which is present in the ground truth but not critical to the overall correctness. Semantic equivalence is maintained, and the conclusion is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 430,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew from roughly $27.4 billion at the end of 2022 to about $30.7 billion by the end of 2023, and remained essentially flat at that level through 2024. This reflects a deliberate increase in long‑term debt to support balance‑sheet expansion, while the weighted‑average interest rate stayed relatively low (≈2.8 % in 2022‑23), indicating the firm is exploiting favorable borrowing conditions and maintaining a cautious stance on interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the values are $27,219M (2022), $31,248M (2023), and $30,696M (2024). The LLM reports approximately $27.4B (close but slightly high for 2022), $30.7B for 2023 (understated by ~$550M), and claims it remained flat in 2024—this is incorrect as the value decreased slightly from 2023 to 2024, but the LLM fails to reflect the peak in 2023 and the downward movement. The net increase is misrepresented due to incorrect values. (2) The weighted-average interest rate is stated as ≈2.8% in 2022–23, but the ground truth shows a rise from 2.76% (2022) to 4.84% (2024), indicating a significant increase, not stability. The LLM misses this key trend entirely, falsely suggesting rates stayed low. (3) The reasoning about 'favorable borrowing conditions' and 'cautious stance on interest-rate risk' contradicts the ground truth, which indicates a strategic shift to lock in higher fixed rates amid a rising rate environment. The LLM incorrectly infers that low rates were exploited, when in fact rates rose substantially. (4) While the LLM addresses the question's structure—discussing evolution and strategy—and correctly identifies Capital One (COF) and the relevant debt instruments, the core quantitative and qualitative misstatements severely undermine the answer’s correctness. The conclusion about strategy is logically derived from incorrect data, leading to flawed interpretation. Contextual relevance is high as the response attempts all parts of the multi-hop question, but factual accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 447,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nIn 2022 Adobe acquired Frame.io and introduced it as a cloud‑native collaboration layer for video and design assets, initially linking it to Premiere Pro and After Effects. By 2023 the platform was expanded into the broader Creative Cloud suite—adding Camera‑to‑Cloud upload, frame‑accurate commenting, and availability through Adobe GenStudio—while in 2024 Frame.io became a central hub of the Creative Cloud ecosystem, tightly integrated with Firefly AI and offered across Adobe Express and other Creative Cloud apps to enable end‑to‑end content creation, review and publishing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in timeline and strategic direction, with accurate dates (2022, 2023, 2024) and correct identification of Adobe and Frame.io. It correctly notes integration with Premiere Pro and After Effects, expansion into Creative Cloud, and deeper ecosystem integration. However, there are factual inaccuracies: Adobe did not acquire Frame.io in 2022 (acquisition was in 2021, though formal trademark registration occurred in 2022 per ground truth), and the original answer does not mention Firefly AI or Adobe Express integration in 2024—these are unverified additions. The LLM also incorrectly states Frame.io was introduced as part of Adobe in 2022, when it was already acquired. While the ground truth highlights integration with Photoshop, Lightroom, and Workfront in 2024, the LLM substitutes with Adobe Express and Firefly AI, which are not supported. The mention of Adobe GenStudio is partially correct but conflated—GenStudio inclusion is accurate, but Camera-to-Cloud is not in the original. Quantitatively, no numbers are present, so accuracy is high by default. Contextually, the answer is highly relevant and addresses the evolution of integration and positioning. Reasoning shows multi-hop synthesis but introduces unsupported details, reducing qualitative accuracy. Semantic equivalence is partially met but with notable deviations in key integrations and timeline framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 389,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5, 2049 in its 2022‑2024 filings because that tranche is a cornerstone of the company’s long‑term financing strategy—locking in low‑cost, fixed‑rate capital that extends the debt maturity ladder well into the 2040s.  By consistently disclosing the 2049 notes, Lowe’s signals a deliberate focus on maintaining a stable, long‑dated funding source to manage cash‑flow risk, preserve leverage discipline, and ensure sufficient liquidity for future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% interest rate, the maturity date (April 5, 2049), and the consistent disclosure across 2022–2024 filings are accurately reflected. There are no numerical or date inaccuracies. (2) Quantitative accuracy is perfect—percentage, date, and time period match the original answer exactly. (3) The reasoning is sound and captures the core insight: Lowe’s use of long-dated debt to stabilize its capital structure and manage long-term liabilities. The LLM correctly infers strategic intent around interest rate risk and financial discipline, though it does not explicitly mention the absence of refinancing or modification disclosures, which is a minor omission in the qualitative synthesis. (4) The answer is contextually excellent—directly addresses the question about long-term capital strategy and debt maturity management. While slightly more focused on benefits (e.g., 'low-cost capital') than the neutral tone of the ground truth, the semantic meaning and strategic interpretation are equivalent. No factual errors; only a slight gap in completeness regarding lack of refinancing actions, but core message is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 344,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nThe carrying amount of Broadcom’s 3.125% notes due January 2025 was $495 million at the end of fiscal 2022 and remained $495 million through fiscal 2023 and fiscal 2024. This flat trajectory shows that the company is managing this low‑cost, long‑dated tranche passively—holding it to maturity rather than actively repurchasing or refinancing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date) are accurate and consistent with the original answer. (2) Quantitative accuracy is perfect: $495 million is correctly reported for all three years, and the note's terms (3.125%, January 2025 maturity) are precisely stated. There are no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and correctly interpreted as showing no change in principal, indicating a stable debt position. The conclusion that Broadcom is holding the debt to maturity rather than repurchasing or refinancing aligns with the ground truth’s interpretation of a deliberate, passive strategy. The only minor gap is that the LLM uses the term 'carrying amount' instead of 'outstanding principal balance'—while often similar, these can differ if notes are recorded at a discount or premium. However, in this context, the values are treated as equivalent in the knowledge graph, so the impact is negligible. (4) The answer is contextually fully relevant, addressing both the evolution of the debt and its implication for Broadcom's debt management strategy. The qualitative reasoning is strong, though slightly less precise in terminology than the original, warranting a 9 instead of 10. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 430,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s disclosure of the 0.950 % Notes due 2025 shifted from a generic exhibit citation—simply noting that the instrument was originally filed in a 2017 Form 8‑K and incorporated by reference (2022 filing)—to a more explicit, stand‑alone reference in the 2024 filing, where the notes appear as a separate class of security (ticker IBM25B) in the “Securities Registered Pursuant to Section 12(b)” table and are backed by a newly filed Indenture dated February 2 2024 (Exhibit 4.1 to a Form 8‑K). The 2023 filing retained the earlier, undifferentiated wording, showing continuity but no new detail. This progression reveals IBM’s intent to treat the 0.950 % Notes as a distinct, manageable component of its capital structure—updating the financing documents and making the debt explicitly visible to investors—thereby signaling a strategy of low‑cost, long‑dated borrowing while enhancing transparency and regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially disclosed by reference to a May 2017 Form 8-K in 2022, remained consistently referenced in 2023, and in 2024 were listed under ticker IBM25B on the NYSE with a new Indenture dated February 2, 2024, filed as Exhibit 4.1 to a Form 8-K. These details match the original answer. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), dates (May 2017, February 2, 2024), and ticker (IBM25B)—are all factually correct and precisely stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures, identifies the evolution from incorporation by reference to standalone registration, and infers strategic intent. (4) The LLM adds value by specifying the new Indenture filing and its exhibit number, which enhances transparency and regulatory context beyond the ground truth, without contradicting it. The only minor gap is that the original answer emphasizes the shift toward 'liquidity and transparency in fixed-income offerings,' while the LLM frames it as 'low-cost, long-dated borrowing'—a plausible interpretation but not explicitly supported in the ground truth. This slight divergence in emphasis prevents a perfect 10, but the factual and logical core remains strong. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 408,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each disclose that KPMG LLP’s PCAOB firm identification number is **185**—the number appears in the “Principal Accountant Fees and Services” section (Item 14) on the respective page 14 of each filing. Consequently, the PCAOB identifier has remained the same across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The PCAOB firm identification number for KPMG LLP is accurately stated as 185 for all three years—2022, 2023, and 2024—exactly matching the original answer. (2) All numeric values are correct and consistently reported across the years; there are no calculation errors or discrepancies in numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings (10-Ks) and confirms consistency over time, demonstrating proper cross-document validation. (4) The answer includes additional contextual precision by specifying the section (Item 14 – Principal Accountant Fees and Services) and page number (14) where the information appears in each filing, which enhances accuracy without introducing errors. The semantic meaning, factual content, and completeness fully align with the ground truth, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 275,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 to 2024, Capital One’s Fixed Unsecured Senior Debt carried a weighted‑average interest rate of roughly 4.84 % in 2022, fell to about 4.45 % in 2023, and rose back to near 4.84 % in 2024, with the outstanding carrying balance expanding to $27.2 bn in 2023 before slipping modestly to $26.9 bn in 2024. This pattern reflects a strategy of issuing longer‑dated fixed‑rate notes to lock in funding as market rates climbed, while keeping the overall proportion of senior debt relatively stable to manage interest‑rate risk in a rising‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and interest rates. According to the ground truth, Fixed Unsecured Senior Debt increased from $19,975 million in 2022 to $26,930 million in 2024, but the LLM claims the balance was already $27.2 billion in 2023 and only slightly declined in 2024—this misrepresents the trend and starting point. More critically, the interest rate trajectory is completely incorrect: the LLM states the rate was ~4.84% in 2022, dropped to 4.45% in 2023, then rose back to 4.84% in 2024. However, the ground truth shows the rate rose from 2.91% in 2022 to 4.84% in 2024—indicating a consistent increase, not a fluctuation. These errors undermine the quantitative foundation of the answer. (2) The numbers are not accurate: $19,975 million (not ~$27B) is the correct 2022 balance; the 2.91% starting rate is ignored. The LLM’s use of $26.9B in 2024 is close to the true $26,930 million, but the path to that number is wrong. The interest rate change from 2.91% to 4.84% represents a clear upward trend due to rising macro rates, which the LLM obscures with fabricated fluctuations. (3) The multi-hop reasoning is partially sound—the conclusion about locking in long-term fixed-rate debt to manage interest rate risk in a rising environment aligns with the ground truth’s interpretation. However, this insight is based on incorrect data, so the reasoning is not properly supported. The synthesis across years is attempted but flawed due to incorrect inputs. (4) The contextual relevance is fair because the answer addresses the right financial instrument, company, and macroeconomic rationale. However, the correctness score is low (3) because the core quantitative facts are wrong, leading to a misleading narrative. The qualitative score reflects some correct conceptual framing, but the quantitative accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 515,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s policy for development‑and‑IP‑licensing arrangements has remained essentially unchanged: revenue is recognized when control of the promised goods or services transfers—either over time for combined development‑service and license arrangements or at a point in time when a distinct license is transferred—while no material variable‑consideration estimates are recorded. This consistent treatment signals that AMD is deliberately pursuing a stable, partnership‑driven model of IP monetization, relying on recurring licensing and development‑service fees rather than one‑off sales to smooth and extend the value of its intellectual‑property portfolio over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements. The distinction between 'distinct' and 'not distinct' licenses, the timing of revenue recognition (over time vs. point in time), and the absence of variable consideration estimates are all correctly reported. (2) There are no numeric values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound—synthesizing AMD’s consistent accounting treatment across three years and inferring strategic implications about IP monetization. The LLM correctly infers that stable policy reflects a deliberate, long-term strategy focused on recurring revenue and partnership models. (4) The only minor deviation from the original answer is that the LLM adds interpretive language—'partnership-driven model' and 'recurring licensing and development-service fees'—which, while reasonable and contextually supported, are slightly more inferential than the ground truth’s neutral description of 'mature and well-defined policy framework.' However, this does not compromise accuracy and remains semantically aligned. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 385,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior and subordinated notes rose from about $27.4 billion at the end of 2022 to $31.2 billion in 2023, then slipped slightly to $30.7 billion by the end of 2024. The 2023 increase reflects a deliberate expansion of long‑term funding to support balance‑sheet growth, while the modest 2024 pull‑back shows a strategic shift toward optimizing the debt mix and managing interest‑rate exposure as market rates rose.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend in senior and subordinated notes correctly—increasing from 2022 to 2023 and slightly declining in 2024—but contains minor inaccuracies in the reported dollar amounts. The ground truth values are $27,219 million (2022), $31,248 million (2023), and $30,696 million (2024). The LLM reports approximately $27.4B, $31.2B, and $30.7B, which are close but not exact—particularly in 2022, where $27.4B overstates the actual figure by about $181 million. (2) The LLM omits all information about interest rates and the composition of fixed vs. floating-rate debt, which is a key part of the original answer and directly relevant to the question about capital structure strategy and interest rate positioning. Specifically, it fails to mention the rise in weighted-average interest rates from 2.91% to 4.84%, and the elimination of floating unsecured senior debt (from $1,709M to $349M to $0). These omissions significantly limit the depth of the strategic analysis. (3) While the LLM correctly infers a strategic intent behind the debt issuance (e.g., supporting balance sheet growth and managing rate exposure), it does not demonstrate full multi-hop reasoning by connecting the debt mix changes to rising benchmark rates and the deliberate shift away from floating-rate liabilities. The original answer uses this to show a proactive lock-in of fixed rates; the LLM only gestures at optimization without the supporting data. (4) Despite missing key quantitative and qualitative details, the LLM answer remains contextually relevant and provides a reasonable high-level interpretation. The minor numerical discrepancies and significant omission of interest rate and debt composition data prevent a higher score, but the core directional trends and strategic interpretation are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 496,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from about **$24.1 bn** (2022) to **$27.2 bn** (2023) and then slipped slightly to **$26.9 bn** (2024).  The weighted‑average interest rate moved from roughly **4.5 %** in 2022, dipped to **4.4 %** in 2023, and then climbed to **≈4.8 %** in 2024.  The increase in issuance followed by a modest reduction and a higher‑cost stance indicates that Capital One expanded long‑term funding while market rates were low, and is now maintaining a larger debt base at higher rates to manage interest‑rate risk and support its growth strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are closer: $27.2 billion vs. $27,168 million ($27.168 billion) and $26.9 billion vs. $26,930 million ($26.93 billion), which are acceptable within rounding. However, the interest rate trend is incorrect: the LLM states 4.5% in 2022, but the truth is 2.91%, which is a major error. It then says rates dipped to 4.4% in 2023, but truth is 4.45%—this direction is wrong (should be a sharp increase, not a dip). The 2024 rate of ≈4.8% is close to the true 4.84%, so that part is acceptable. (2) Calculations: The LLM implies a dip in interest rates from 2022 to 2023, which contradicts the actual sharp rise from 2.91% to 4.45%, indicating flawed synthesis. The carrying value trend (increase then slight decrease) is correctly captured in direction, but 2022 value is wrong. (3) Multi-hop reasoning: The model attempts to synthesize trends in both carrying value and interest rates over three years, which is correct in structure, but due to incorrect data inputs, the reasoning is based on false premises. The conclusion about expanding during low rates is plausible but contradicted by the actual data: debt issuance increased in 2023 when rates were already up sharply, suggesting a different strategy. (4) Scores justified: Correctness is 5 due to partial accuracy in later years but major errors in key figures. Quantitative accuracy is low (4) due to wrong 2022 carrying value and interest rates. Qualitative accuracy is 6 because reasoning structure is sound and entities (COF, fixed unsecured senior debt, years) are correct, and the final interpretation is logically consistent with its (flawed) data. Contextual relevance is 8 because the answer addresses all parts of the question and stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 537,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s revenue‑recognition policy for development‑plus‑IP and for standalone IP licensing was applied consistently from 2022 through 2024.  The Company first determines whether the IP license in a combined arrangement is distinct; if it is **not** distinct, the license is combined with the development service and revenue is recognized over time, whereas a **stand‑alone** license (i.e., a sale or license of patents or other IP with no other obligations) is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the IP.  The 2022, 2023 and 2024 Form 10‑K filings contain essentially the same language, indicating no substantive change to this methodology—only minor wording updates across the years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no material changes—only minor wording updates across filings. This matches the original answer's assertion of stable policy application. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense; however, the years 2022, 2023, and 2024 are correctly referenced, and there are no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the treatment of combined development and IP arrangements versus standalone licenses across three years, identifying the key accounting distinction—whether the license is distinct—and linking it to the timing of revenue recognition (over time vs. point in time). It also correctly notes the absence of variable consideration, implied by the consistent methodology. (4) The only minor shortcoming is that the LLM does not explicitly mention 'no variable consideration estimates,' which is a small but relevant detail in the original answer. However, this omission does not undermine the overall correctness, as the focus is on policy evolution (or lack thereof), which is accurately captured. Wording differences are semantically equivalent and do not affect factual accuracy. Contextual relevance is perfect—the response directly addresses the evolution of the policy and the distinction between arrangement types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 445,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nBetween 2022 and 2024 short‑term borrowings fell sharply from **$883 million (2022)** to **$538 million (2023)** and then edged up to **$562 million (2024)**, while total long‑term debt rose from **$48.7 billion (2022)** to **$49.9 billion (2023)** before pulling back to **$45.6 billion (2024)** (see Table 8.1 and Table 9.1).  \n\nThis three‑year pattern shows Capital One has been **reducing reliance on near‑term wholesale funding and extending the maturity of its debt**, financing growth primarily through longer‑dated senior and subordinated notes and securitized obligations (average rates of 4.84 % on 2024 senior debt vs. 3.01 % on 2023 securitized debt).  The shift, together with active use of interest‑rate swaps to hedge fixed‑rate liabilities, reflects a strategy to **lock in funding costs and limit exposure to rising interest rates while maintaining a more stable, longer‑term debt profile**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports long-term debt alone as $48.7B in 2022 and total debt (implied sum) as ~$49.6B in 2022, which is already higher than the ground truth total debt for that year. The LLM also misrepresents short-term borrowings: ground truth does not provide a breakdown, but the total debt figures are incorrect regardless. The LLM’s claim that short-term borrowings were $883M in 2022 and fell to $538M in 2023 is unsupported by the ground truth, which only gives aggregate debt. (2) The calculation of total debt is flawed: adding the LLM’s short-term and long-term figures yields ~$49.583B in 2022, $50.438B in 2023, and $46.162B in 2024 — none of which match the ground truth totals of $43.086B, $48.715B, and $45.551B. The interest rate trend (2.76% → 4.48% → 4.84%) is partially correct in direction but not reflected accurately in the LLM’s discussion — it mentions 4.84% in 2024 but attributes it only to senior debt without referencing the overall weighted-average rate trend. (3) The multi-hop reasoning is partially sound: the LLM infers a strategy of extending maturities and reducing short-term reliance, which aligns with the ground truth’s conclusion about higher fixed-rate exposure. However, this is based on incorrect data, undermining the validity. The mention of interest-rate swaps and securitized debt (3.01% in 2023) introduces details not present in the ground truth, adding unsupported specifics. (4) The contextual relevance is high — the answer addresses debt evolution, strategy, and rate exposure as asked. However, due to major quantitative errors and unsupported details, the correctness score is low. The qualitative reasoning is plausible but built on faulty premises, warranting a moderate qualitative score. Quantitative accuracy is severely compromised, hence the low score there.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 558,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s revenue‑recognition guidance for development‑and‑IP licensing arrangements remained essentially the same: it evaluates whether the IP licence is **distinct** (i.e., both capable of being distinct and distinct in the context of the contract). If the licence is **not distinct**, it is **combined with the development service** and revenue is recognized **over time**; if the licence **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from it. Stand‑alone sale or licensing of patents/IP is also recognized **at a point in time**, and in all cases AMD notes that variable‑consideration estimates are not material. Thus, the distinction between combined arrangements (recognized over time) and standalone licences (recognized at a point in time) was consistently applied across the three years, with only incremental clarification of the distinct‑licence assessment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly captures AMD's consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, accurately describing the evaluation of whether an IP license is 'distinct'—both in capability and context—as the key determinant for revenue timing. The treatment of non-distinct licenses (combined with development services, revenue recognized over time) versus distinct or standalone licenses (recognized at a point in time) is correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct handling of time periods (2022–2024), which are accurately referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes policy continuity across years, distinguishes between combined and standalone arrangements, and correctly notes the absence of material variable consideration—matching the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in policy, performance obligations, and the combined vs. standalone distinction. Minor wording differences (e.g., 'incremental clarification' not explicitly in original) do not affect factual correctness and may reflect reasonable interpretation. No errors in entities, years, or accounting concepts. Full alignment with ground truth in substance and detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 411,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe fact that Exhibit 4.5 – the **Certificate of Designations of Series B Convertible Participating Preferred Stock** – is listed in the 2022, 2023 and 2024 10‑K/10‑Q filings (and appears unchanged across the three years) shows that the rights, preferences and privileges of this series have not been retired, amended or superseded.  Its persistent appearance signals that the instrument remains a legally‑effective, material component of Visa’s capital structure, underscoring its ongoing relevance for financing, governance and investor considerations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core implication of the consistent reference to the Certificate of Designations across Visa's 2022–2024 filings. It correctly infers that the instrument remains legally effective and unamended, signaling ongoing relevance in Visa’s capital structure. However, it contains a minor inaccuracy in exhibit numbering: the ground truth specifies Exhibit 4.5 in 2022, but Exhibits 4.4 in both 2023 and 2024, while the LLM states 'Exhibit 4.5' across all years, which is not factually precise. Additionally, the LLM omits the specific filing date of June 21, 2016, which is a key detail in the original answer and reinforces the stability of the instrument over time. Despite these omissions, the reasoning is sound—correctly interpreting the lack of changes as evidence of structural stability—and the entities (Visa, Series B Convertible Participating Preferred Stock) and years (2022–2024) are accurate. The answer is semantically aligned with the original in intent and conclusion, though slightly less detailed in factual precision. Quantitative accuracy is high (only exhibit numbers slightly off), qualitative reasoning is strong, and contextual relevance is excellent as it directly addresses the question about stability and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 358,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nAcross 2022‑2024 RTX maintained the same controlling interests in the IAE collaboration – a 61 % program‑share interest (and 49.5 % equity stake) in IAE and a 59 % share/ownership in IAE LLC – but the economic exposure tied to the V2500 program expanded markedly: commercial‑aerospace commitments rose from about $735 million in 2022 to roughly $1.05 billion in 2023 and remained sizable in 2024, while the Rolls‑Royce flight‑hour payments that are capitalized as collaboration intangibles increased each year. This growing financial footprint, together with the continued consolidation of IAE and IAE LLC as variable‑interest entities, signals that Pratt & Whitney is deepening its strategic control and long‑term value creation role in the V2500 engine program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The ground truth states that RTX's program share interest was consistently 61%, ownership interest 49.5%, and net program share interest 57% across 2022–2024. However, the LLM incorrectly claims a '59% share/ownership in IAE LLC'—a figure not present in the original answer and factually unsupported. More critically, the LLM introduces financial figures ($735M in 2022, $1.05B in 2023) and claims about increasing economic exposure and Rolls-Royce payments that are entirely absent from the ground truth. These numbers and trends contradict the original answer, which explicitly states that economic exposure and stake remained stable. (2) Completeness: While the question asks about the evolution of stake and economic exposure, the LLM fabricates data rather than reporting stability. It fails to mention the stable 57% net program share interest, a key point in the original. (3) Entity Accuracy: The mention of 'IAE LLC' and 'Rolls-Royce flight-hour payments capitalized as collaboration intangibles' introduces entities and mechanisms not referenced or implied in the ground truth. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers increasing strategic commitment due to rising financial commitments, but the ground truth indicates no change in stake or exposure, implying strategic continuity. The conclusion that Pratt & Whitney is 'deepening its strategic control' directly contradicts the original answer’s assertion of unchanged positioning. (5) Semantic Equivalence: The LLM’s narrative of growth and deepening involvement is semantically opposite to the ground truth’s emphasis on consistency and stability. Despite addressing the general topic and timeframe, the answer is factually incorrect on core metrics and strategic interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 515,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nMedtronic has continued to disclose the same “Non‑Employee Director Deferred Unit Award Agreement” in its 2022, 2023 and 2024 Form 10‑K filings, referencing it as part of the (amended) 2008 Stock Award and Incentive Plan and later under the 2021 Long‑Term Incentive Plan.  The company has not replaced or substantially revised the agreement across these years, indicating a deliberate, long‑term approach that uses deferred equity units to align directors’ interests with shareholders and encourage sustained board participation.  This consistency signals that deferred‑unit compensation is a core, stable element of Medtronic’s director‑pay strategy rather than a periodic or experimental arrangement.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error regarding the plan under which the Non-Employee Director Deferred Unit Award Agreement was referenced. The ground truth states that the agreement was consistently tied to the 2008 Stock Award and Incentive Plan across 2022, 2023, and 2024, with no mention of the 2021 Long-Term Incentive Plan. However, the LLM incorrectly claims the agreement was later referenced under the 2021 plan, which contradicts the original answer and introduces a material inaccuracy in entity and plan attribution. This undermines the qualitative accuracy of the multi-hop reasoning, as the conclusion about continuity is based on a false premise of cross-plan usage. The quantitative accuracy is high—fiscal years (2022, 2023, 2024) are correctly cited, and no numerical calculations are involved. The contextual relevance is strong, as the response directly addresses the evolution over time and infers strategic intent. The core idea of stability in director compensation is aligned with the ground truth, but the incorrect plan reference (2021 vs. continued 2008 plan) damages factual reliability. The LLM also omits specific exhibit numbers (e.g., Exhibit 10.41 in 2022, 10.52 in 2023 and 2024), which are part of the documented evidence in the original answer, reducing completeness. Overall, the answer captures the correct pattern of consistency but misattributes the underlying plan structure, leading to a partially correct assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 411,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nFrom the 2022 filing the company disclosed an aggregate notional of **$1.3 billion** of outstanding interest‑rate swaps, and that same $1.3 billion figure is reiterated for 2023 (page 52 of the 2024 10‑K) and again for 2024 (page 52 of the 2025 10‑K).  This follows an earlier increase from roughly **$0.5 billion** disclosed in the 2021 filing (page 66 of the 2021 10‑K).  The steady $1.3 billion level from 2022 through 2024 shows that LMT settled on a consistent hedge size—using variable‑rate swaps to convert a portion of its fixed‑rate debt to variable‑rate exposure—rather than continually expanding or shrinking the hedge, indicating a mature, risk‑balanced approach to managing interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer contains a critical error in the timeline of notional amounts, which impacts the quantitative accuracy. According to the ground truth, LMT's notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM claims the $1.3 billion figure was already in place in 2022 and remained steady through 2024, citing an increase from $0.5 billion in 2021. This misaligns the years: the $500 million to $1.3 billion increase should be from 2022 to 2023, not from 2021 to 2022. While the $500 million and $1.3 billion figures are correct in value, their attribution to years is incorrect, undermining the evolution narrative. The reasoning about a stabilized hedging strategy from 2023 to 2024 is consistent with the ground truth, and the interpretation of a mature risk management approach is semantically equivalent. The model correctly identifies the use of variable-rate swaps to convert fixed-rate debt and draws a logical conclusion about strategy stabilization. However, because the question specifically asks about the evolution from 2022 through 2024, the misplacement of the increase (implying it occurred before 2022) constitutes a significant factual error in temporal progression. Entity accuracy (LMT, notional amounts, interest rate swaps) and contextual relevance are strong. Multi-hop synthesis is attempted but flawed due to incorrect year alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 395,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nAbbVie’s charter and by‑laws have kept the same “stockholders may remove directors only for cause” requirement—and the accompanying 80 % super‑majority amendment threshold—through the 2022, 2023 and 2024 Form 10‑K filings, with no substantive amendment or relaxation of that language. This three‑year consistency shows that AbbVie is deliberately maintaining a stable, defensive governance framework, reinforcing its anti‑takeover posture by preserving board‑level control and making it harder for a hostile acquirer to replace or remove incumbent directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie maintained the 'directors may be removed only for cause' provision in its charter and by-laws across 2022, 2023, and 2024, which matches the original answer's claim of three-year consistency. (2) The LLM accurately references the 80% super-majority threshold for amendments, a detail not explicitly mentioned in the ground truth but consistent with typical anti-takeover provisions and plausibly present in the filings; this does not contradict the original answer and adds context without introducing error. (3) The reasoning correctly infers that this consistency reflects a deliberate, defensive governance strategy aimed at preserving board control and resisting hostile takeovers—this is logically sound and supported by the multi-hop synthesis of repeated disclosures over three years. (4) The only minor shortcoming is that the LLM does not mention the staggered board explicitly, which the original answer includes as part of the broader set of consistent anti-takeover measures. While the LLM captures the core strategic implication, this omission slightly reduces completeness in qualitative synthesis. However, the central facts, dates, entities, and conclusions are correct, and the answer fully addresses both parts of the question: evolution (no change) and strategic implication (defensive posture). Number formats and percentages are accurate. Semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 412,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits dropped from **$21 million at the end of 2022** to **$10 million at the end of 2023** and stayed at roughly **$10 million through 2024** (see the fair‑value tables for 2022, 2023 and 2024 in the 10‑K filings).  This reduction shows that the company is scaling back its low‑yielding money‑market/time‑deposit holdings and instead leans on its larger cash‑and‑cash‑equivalents balance and other investments to fund operations, debt repayment and shareholder returns, maintaining only a modest, stable reserve for immediate liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and timeline. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. The LLM incorrectly states that the amount was $21 million in 2022 and dropped to $10 million in 2023, remaining flat in 2024—this reverses the actual trend and misrepresents the evolution. (2) The quantitative inaccuracies are critical: the starting value is wrong ($21M vs $12M), the direction of change from 2022 to 2023 is incorrect (decrease vs actual increase), and the 2024 value is attributed without noting the drop from 2023, but with an incorrect prior year baseline. While the $10 million figure for 2024 is correct, it is presented as stable from 2023, which contradicts the ground truth where 2023 was $21M. (3) The multi-hop reasoning is flawed—the model fails to correctly synthesize the three-year trend and misinterprets the strategy. The ground truth suggests a dynamic strategy with an initial increase followed by a pullback amid fluctuating cash balances, whereas the LLM describes a continuous reduction starting in 2022, which is not supported. Additionally, the LLM references 'larger cash-and-cash-equivalents balance' in 2024, but the ground truth shows a significant drop to $5,524 million in 2024 from $9,201 million in 2023, contradicting the claim of a larger balance. (4) Despite these major errors, the answer is contextually relevant—it addresses the right company, metric, and general theme of short-term liquidity strategy. However, due to severe quantitative and qualitative inaccuracies, the correctness score is low. The reasoning and entity identification (AbbVie, money market funds, time deposits, 10-K filings) are correct, but the core data synthesis is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 519,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nFrom 2022 through the 2024 Form 10‑K filings AbbVie’s charter language has remained unchanged: directors may be removed only “for cause,” and any amendment to the director‑related provisions (including the removal rule) requires the affirmative vote of shareholders holding at least 80 % of the voting stock. The same “removal‑for‑cause” and 80 % super‑majority amendment thresholds appear verbatim in the 2022, 2023 and 2024 documents.  \n\nThis steady retention of “removal‑for‑cause” and the other anti‑takeover charter provisions signals that AbbVie is deliberately maintaining a stable, defensive board structure to deter hostile takeovers and protect its long‑term strategic autonomy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that AbbVie maintained the 'removal for cause' provision from 2022 through 2024, which is consistent with the original answer. (2) It correctly identifies the 80% supermajority shareholder vote required to amend director-related provisions, a specific quantitative detail not present in the ground truth but factually accurate and reinforcing the defensive governance structure. This additional detail enhances rather than contradicts the original answer. (3) The reasoning is sound: the LLM correctly infers that the consistency in charter language reflects a deliberate strategy to maintain board stability and deter hostile takeovers, aligning with the original answer's conclusion about long-term strategic autonomy and anti-takeover defense. (4) All entities—AbbVie, the years 2022–2024, and the governance mechanisms—are correctly identified. The answer addresses both parts of the multi-hop question: the evolution (or lack thereof) of the provision and its strategic implications. Semantic equivalence is achieved, with the LLM providing slightly more granular detail (80% threshold) that supports the same conclusion. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 358,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nIntel first introduced PowerVia in 2022 as the industry‑first backside‑power delivery scheme tied to the planned Intel 20A node, promising up to 15 % performance‑per‑watt gains. By 2023‑24 the company shifted PowerVia to the Intel 18A node (with high‑volume manufacturing targeted for 2025) and later to the Intel 14A roadmap, embedding backside power as a core differentiator for its IDM 2.0 strategy and for leadership products such as Panther Lake. This progression shows Intel’s strategy of using PowerVia to boost performance, density and foundry competitiveness in its most advanced process technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of PowerVia from 2022 to 2024 and Intel's strategic intent around backside power delivery. It accurately notes the initial introduction in 2022 tied to Intel 20A, the shift to Intel 18A with high-volume manufacturing (HVM) targeted for 2025, and the strategic importance for Intel's advanced nodes and IDM 2.0. However, it introduces a factual error by stating PowerVia was shifted 'later to the Intel 14A roadmap', which is not supported by the ground truth and represents an overextension beyond the provided information. Additionally, the claim of 'up to 15% performance-per-watt gains' is a specific quantitative detail not present in the original answer and cannot be verified from the ground truth, making it potentially inaccurate. (2) The date '2025' for HVM is correctly cited and matches the original. The mention of Panther Lake as a leadership product is plausible context but not confirmed in the ground truth, so it does not detract significantly. The unsupported '15%' figure and the incorrect addition of Intel 14A hurt quantitative accuracy. (3) The multi-hop reasoning is mostly sound—Intel introduced PowerVia early, repositioned it for a later node, and aligned it with strategic manufacturing goals. The synthesis across years and strategic framing is appropriate. However, the inclusion of Intel 14A and unverified performance gains reflects a failure to strictly adhere to the documented progression, indicating a minor breakdown in reasoning fidelity. (4) Despite the extra details, the core message about strategic realignment and focus on implementation competitiveness is consistent with the original. The answer remains contextually relevant and conveys a similar strategic interpretation, warranting strong scores in qualitative accuracy and relevance, but the correctness score is reduced due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 518,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 the company’s expected‑volatility assumption in the Black‑Scholes model rose steadily—from about **23 %** in 2022, to **≈24.1 %** in 2023, and to **≈24.3 %** in 2024.  This upward progression shows that Medtronic is increasingly factoring higher market price volatility into the fair‑value calculation of its non‑qualified stock options, reflecting a more conservative valuation approach and resulting in progressively higher option‑based compensation expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution of MDT's *assumptions and methodology* for expected volatility in the Black-Scholes model, not the numerical values of volatility used. The original answer correctly describes a methodological shift—from using only historical volatility in 2022 to a blend of historical and implied volatility starting in 2023, based on market-traded options. The LLM instead fabricates specific percentages (23%, ≈24.1%, ≈24.3%) that are not present in the ground truth and misrepresents the nature of the change. (2) There are no actual volatility percentages provided in the ground truth, so the LLM's quantitative claims cannot be accurate. The mention of rising percentages and a 'steady rise' is unsupported and factually wrong. (3) The multi-hop reasoning is flawed: the LLM interprets 'evolution' as a numerical trend rather than a methodological progression. It completely misses the key point about the incorporation of implied volatility from market-traded options, which is central to understanding MDT's shift toward market-sensitive valuation. (4) While the LLM attempts to infer implications—such as a more conservative approach and higher compensation expense—this reasoning is based on false premises. The conclusion about increasing expenses due to higher volatility assumptions may seem plausible but is not supported by the actual data. The contextual relevance is moderate because it discusses the right topic (volatility assumptions in option valuation) and the right company and time frame, but it answers a different question than the one asked. Overall, the answer fails on factual, qualitative, and reasoning grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 473,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from a planned feature of the (now‑canceled) Intel 20A node to the centerpiece of its next‑generation Intel 18A process.  The company refined the backside‑power‑delivery architecture, integrated it with the RibbonFET transistor, and prepared high‑volume manufacturing for Panther Lake on Intel 18A in 2025, positioning PowerVia as a key enabler of higher performance‑per‑watt and density that underpins Intel’s IDM 2.0 and foundry strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Intel's PowerVia technology from 2022 to 2024. (1) All key facts are correct: PowerVia was initially tied to Intel 20A, later transitioned to Intel 18A after 20A's cancellation, integrated with RibbonFET, and set for high-volume manufacturing in Panther Lake in 2025. The strategic importance for performance-per-watt and Intel's IDM 2.0/foundry strategy is correctly emphasized. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages are stated. While the ground truth mentions a '15% performance-per-watt improvement over Intel 3', the LLM omits this specific figure but still correctly conveys performance-per-watt gains. This omission is minor and does not affect overall correctness. (3) Multi-hop reasoning is sound: the model synthesizes the shift from Intel 20A to 18A, retention of PowerVia, and its role in future products and strategy. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The answer is fully contextually relevant, directly addressing the evolution and strategic significance of PowerVia. A score of 9 is given because the 15% improvement metric, while not essential, adds precision that strengthens the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 358,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 to 2024 the Black‑Scholes inputs for MDT’s non‑qualified options shifted from volatility 23.04 % / risk‑free 0.90 % / expected life 6.0 yr / dividend yield 1.95 % (2022) to volatility 24.29 % / risk‑free 4.16 % / expected life 6.1 yr / dividend yield 3.18 % (2024), with the weighted‑average option value falling from $22.83 to $18.49.  The rise in implied volatility and the higher risk‑free rate reflect a more market‑driven calibration, while the steady ~6‑year expected life shows the company continues to view employee exercise behavior as relatively stable over a multi‑year horizon.  Overall, MDT is updating its volatility and interest‑rate assumptions to current conditions but keeps the exercise‑behavior parameter constant, indicating a cautious, data‑based approach to option valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values (e.g., volatility 23.04%, risk-free rate 0.90%, expected life 6.0 years, dividend yield 1.95% for 2022; volatility 24.29%, risk-free rate 4.16%, expected life 6.1 years, dividend yield 3.18% for 2024) and a weighted-average option value drop from $22.83 to $18.49) that are not present in the original answer or implied by the ground truth. There is no mention in the ground truth of exact percentages or dollar values, nor any calculation of option values. These numbers appear fabricated or hallucinated, severely undermining factual accuracy. (2) The ground truth emphasizes a methodological shift in 2023—MDT began using implied volatility from market-traded options in addition to historical volatility, a practice continued in 2024. The LLM answer mentions 'rise in implied volatility' but frames it as a result of changing inputs rather than a structural change in methodology (i.e., incorporating market-based implied volatility into assumptions), missing the core qualitative evolution. (3) The multi-hop reasoning is flawed: while the LLM correctly infers that stable expected life (~6 years) suggests consistent assumptions about employee exercise behavior, this point is not supported by the ground truth, which does not provide numerical data on expected life or its stability. The LLM invents a quantitative narrative unsupported by evidence. (4) Contextually, the answer addresses the question’s focus on volatility and employee behavior, and correctly notes continuity in model use (Black-Scholes), but fails to accurately describe the key 2023 methodological enhancement. The conclusion about a 'cautious, data-based approach' is plausible but based on incorrect premises. Overall, the answer is largely incorrect due to hallucinated data, despite some reasonable interpretation of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 511,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in “Other assets, including intangibles – net”—fell sharply from **$1.49 billion at the end of 2022 to $0.80 billion in 2023 and to $0.49 billion by the end of 2024**.  \n\nThis decline shows that the company is **reducing its external collateral requirements**, likely because it is trimming derivative notional exposure, improving counter‑party credit quality, or relying more on internal margining. In short, the downward trend signals a more streamlined and risk‑averse approach to managing its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and semantically equivalent. (2) All numeric values are accurate and properly formatted; the trend of decreasing collateral is correctly described with precise year-over-year declines. (3) The multi-hop reasoning is sound: the answer synthesizes data across three years and correctly infers that the declining collateral reflects reduced derivative exposure or improved risk management. The interpretation aligns with the ground truth, mentioning reduced exposure and strategic management, though it adds plausible factors like counter-party credit quality and internal margining not explicitly in the original. These are reasonable extensions, not contradictions. (4) The answer fully addresses both parts of the question: the quantitative change and its implication for derivative exposure management. The wording differs slightly but maintains semantic equivalence. Only a minor deduction in qualitative accuracy due to slight expansion beyond the original inference, but no factual errors. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 362,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of NextEra’s gas‑linked options remained roughly $100 million (net), with implied volatilities used in their valuation staying near 50 % (ranging from about 15 % to 150 %). This stability coincides with a shift in the company’s broader gas‑derivative position—from a $854 million liability in 2022 to a $951 million asset in 2023 and a $387 million asset in 2024—indicating that NextEra has been actively reducing its net gas‑price exposure and using options as a modest, volatility‑neutral hedge.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value of NextEra Energy's 'Options - primarily gas' was $356M in assets and $347M in liabilities in 2022, decreasing to $100M assets / $97M liabilities in 2023, and further to $100M assets / $102M liabilities in 2024. The LLM incorrectly states that the fair value remained 'roughly $100 million (net)', which misrepresents both the magnitude and direction of change (especially the large drop from ~$350M to $100M in 2023). Additionally, the LLM claims implied volatility ranged from 15% to 150%, while the ground truth shows a weighted average increasing from 36% in 2022 to 50% in 2023 and 52% in 2024 — not a range but a rising trend in average volatility. The LLM also fabricates a shift in broader gas-derivative position from an $854M liability in 2022 to a $951M asset in 2023, which is not supported by the original answer and introduces unverified data. (2) Quantitative accuracy is very low: all key numbers (fair values, volatility assumptions, net positions) are incorrect or misrepresented. The only partially correct figure is the ~$100M level in 2023–2024 for assets, but even this omits the liability side and ignores the substantial decline from 2022. (3) Multi-hop reasoning is flawed: the LLM invents a narrative about 'volatility-neutral hedge' and 'reducing net gas-price exposure' based on fabricated data, failing to correctly synthesize the actual trend — a reduction in both asset and liability values alongside rising volatility assumptions, suggesting decreasing overall exposure but increasing perceived risk per unit. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of gas options and risk positioning), but the conclusions are unsupported due to incorrect data. The qualitative reasoning would be stronger if based on accurate inputs, but as-is, it reflects a misinterpretation of the underlying facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 536,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 35A remained unchanged in size – a $750 million face amount – and the annual debt‑service charge stayed at about $19.9 million (≈ 2.65 % coupon), with a maturity in 2030.  This consistency shows that SPG is deliberately using a large, low‑cost, long‑dated unsecured note as a stable pillar of its capital structure, preserving predictable financing costs and extending its debt maturities rather than repeatedly refinancing short‑term obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The original answer states a face amount of $750,000 and annual debt service of $19,875, but the LLM reports $750 million and $19.9 million—off by a factor of 1,000. This is a critical error in magnitude, despite the correct ratio (approximately 2.65%) being preserved. The coupon rate inference is reasonable but not explicitly stated in the ground truth. (2) Number verification: $750,000 vs $750 million (incorrect), $19,875 vs $19.9 million (incorrect), maturity in 2030 is not mentioned in the original answer and thus unsupported. (3) Multi-hop reasoning is partially sound—the model correctly infers stability over time and links it to long-term debt strategy, which aligns with the original conclusion about predictability. However, the unsupported maturity date and inflated figures weaken the synthesis. (4) Contextual relevance is high as the answer addresses all parts of the question and draws a strategic interpretation. Qualitative reasoning is logical but based on incorrect data. Quantitative accuracy is severely compromised, dragging down overall correctness to partially correct with major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 339,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 to 2024 the Embedded‑Processing business moved from a relatively healthy contributor—$3.26 B of revenue with a 38 % operating margin in 2022—to only modest top‑line growth in 2023 ($3.37 B, still 38 % margin) before a sharp 25 % revenue drop in 2024 that cut the margin to just 14 %.  The decline reflects weaker demand, higher fixed‑cost absorption from capacity expansions, and rising manufacturing costs, even though the company continues to list embedded processing as a core strategic pillar.  Consequently, the three‑year trend signals that TI is now tempering its aggressive push into embedded processing and is instead focusing on protecting profitability and leveraging its analog strengths to sustain long‑term free‑cash‑flow growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The revenue and margin figures provided ($3.26B in 2022, $3.37B in 2023, 25% drop in 2024 to 14% margin) are not supported by the ground truth and contradict the consistent strategic emphasis without financial decline mentioned in the original answer. The ground truth does not include any financial metrics for embedded processing revenue or margins, so introducing specific numbers constitutes fabrication. (2) Completeness: While the question asks about strategic evolution and long-term positioning, the LLM incorrectly infers a strategic retreat based on invented financial data, failing to report the actual consistent strategic emphasis across all three years. (3) Entity Accuracy: The company (Texas Instruments/TXN) and product line (embedded processing) are correctly identified, but the financial metrics and implied timeline of performance are false. (4) Reasoning: The multi-hop reasoning is flawed—the LLM assumes declining revenues justify a shift in strategy, but the ground truth shows no such shift; instead, the consistent language in 10-K filings across 2022–2024 indicates strategic stability. The conclusion that TI is 'tempering its aggressive push' directly contradicts the original answer’s indication of reinforced, stable long-term positioning. (5) Semantic Equivalence: The LLM answer conveys the opposite meaning of the original—strategic retreat vs. strategic consistency—making it factually and contextually inaccurate despite addressing the general topic. The invented data and resulting misinterpretation severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 457,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast moved shared‑data wireless plans from a peripheral add‑on to a central element of its bundled offering, explicitly marketing “shared‑data” as one of three payment choices (unlimited, shared‑data, or per‑GB) that are packaged together with broadband, video and Wi‑Fi‑hotspot access; by 2024 the company broadened the menu further, introducing prepaid unlimited‑data plans under the NOW brand and promoting shared‑data plans as a distinct, discounted bundle within its overall service packages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled services from 2022–2024, alongside unlimited and per-gigabyte options, and introduced prepaid unlimited plans under the NOW brand in 2024. The device financing terms (24 months) are omitted but not critical to the core question about plan evolution and bundling. (2) No numeric or date inaccuracies—years (2022–2024), plan types, and the introduction of NOW prepaid plans are correctly stated. Format variations are acceptable and consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years and identifies the strategic shift in 2024 toward more flexible prepaid options while maintaining shared data plans. The claim that shared-data plans became a 'central element' is a slight interpretive leap from the original (which states they were 'consistently offered' and 'core'), but does not contradict the data. (4) The answer fully addresses the question about evolution in strategy, positioning within bundles, and range of payment/plan options. Only minor completeness gap is the lack of explicit mention of device financing in 2022–2023, but this is secondary to the main focus on data plan structure. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 394,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end‑of‑year balances, Mastercard’s Class A Treasury Stock grew from **$(51.4 bn) in 2022** to **$(60.4 bn) in 2023** and then to **$(71.4 bn) in 2024**, with corresponding treasury‑stock purchases of **$8.8 bn, $9.1 bn and $11.0 bn** in those years.  \nThe steady rise shows the company is increasingly deploying excess cash to repurchase its own shares—reducing the float, boosting earnings‑per‑share and signaling confidence in its cash‑flow generation and limited growth‑investment opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value: it reports $(51.4 bn) instead of the correct $(36,658) million (~$36.7 bn), which is a material discrepancy. The 2023 and 2024 values are accurate: $(60,429) million ≈ $60.4 bn and $(71,431) million ≈ $71.4 bn. Additionally, the LLM introduces 'treasury-stock purchases' of $8.8 bn, $9.1 bn, and $11.0 bn for 2022–2024, which are not present in the original answer and cannot be verified from the provided ground truth; thus, these figures are unsupported and potentially incorrect. (2) The calculation of year-over-year increases implied by the LLM suggests a rise from $36.7B to $60.4B to $71.4B, which aligns with the trend, but the erroneous 2022 starting point undermines the accuracy of any derived annual purchase amounts. Without the actual purchase data in the ground truth, including such specific figures reduces quantitative reliability. (3) The multi-hop reasoning and qualitative interpretation are sound: the increasing magnitude of treasury stock is correctly interpreted as a strategic emphasis on buybacks, EPS enhancement, and shareholder return, indicating proper synthesis of the trend’s implications. The logic connecting rising treasury stock to capital allocation strategy is valid and insightful. (4) Despite strong contextual relevance and good reasoning, the incorrect 2022 value and the inclusion of unverified purchase amounts reduce the correctness and quantitative accuracy scores. The answer is partially correct with key factual errors, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 439,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services was **$1.169 billion in 2022**, fell slightly to **$1.132 billion in 2023**, and remained flat at **$1.132 billion in 2024**. This modest decline followed by a plateau indicates that the company’s service business has largely stabilized after a period of growth, with emphasis now shifting toward higher‑value submarine and shipbuilding contracts rather than expanding repair revenues.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024), matching the ground truth in both values and years. The slight decline and flat trend are accurately described. (2) Quantitative accuracy is perfect: numbers match exactly (allowing for format variation: $1,169 million = $1.169 billion), and the implied 3.2% decline is correct though not explicitly stated. No calculation errors. (3) The multi-hop reasoning is sound in identifying the trend across three years. However, the qualitative interpretation diverges slightly: the LLM suggests stabilization 'after a period of growth' and a strategic shift toward submarine contracts, which is plausible but not supported by the provided ground truth. The original answer characterizes the pattern as 'stagnation or potential contraction,' a more neutral and evidence-based conclusion. The LLM adds speculative context not present in the data. (4) Scores reflect full factual accuracy in numbers and timeline (10 for quantitative), complete addressing of the question (10 for contextual relevance), and strong but slightly overreaching interpretation (8 for qualitative and overall correctness).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 347,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) holdings fell from about **$721 million in 2022** (with unrealized losses of roughly **$89 million**) to **$614 million in 2023** (unrealized losses of about **$60 million**) – a reduction documented in the 2023 10‑K (page 149) that compares 2022 and 2023 loss‑position tables.  The 2024 filing shows only a modest increase in the separate‑account RMBS balance to **$71 million** (up from $51 million in 2023) (page 158/160 of the 2024 10‑K), indicating that the company’s overall RMBS exposure remained small and continued to shrink.  This multi‑year trajectory reflects a deliberate de‑risking of the RMBS portfolio, as higher interest rates pressured valuations and the firm chose to limit its exposure to this interest‑rate‑sensitive asset class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's RMBS fair value was $629M in 2022 with $10M in unrealized losses, but the LLM states $721M and $89M respectively—both materially incorrect. The 2023 fair value ($614M) matches, but the LLM incorrectly frames the decrease from 2022 as a reduction based on accurate data when it is not. For 2024, the LLM correctly reports $71M in RMBS holdings but mischaracterizes it as a 'modest increase' from $51M in 2023, while the ground truth shows no such $51M figure and instead indicates a sharp decline from $614M to $71M—suggesting a major reduction, not a minor fluctuation. Additionally, the LLM incorrectly states that unrealized losses decreased to $60M in 2023, whereas the ground truth shows losses *increased* to $60M from $10M, contradicting the narrative of improvement.\n\n2) Quantitative accuracy is poor: 2022 fair value is off by $92M, 2022 unrealized losses by $79M. The 2024 reduction is misrepresented—$614M to $71M is a ~90% drop, not a modest change from $51M. The LLM appears to confuse separate-account balances or misreads the filing.\n\n3) Reasoning is partially sound—the conclusion about de-risking aligns with the ground truth and is logically consistent with reducing RMBS exposure. However, the multi-hop synthesis is flawed because it relies on incorrect base data and misinterprets trends (e.g., portraying declining losses when they actually rose sharply in 2023). The use of document citations (page numbers) suggests source grounding, but the data extracted is inconsistent with the ground truth.\n\n4) Contextual relevance is high—the answer addresses the evolution across years, discusses fair value and unrealized losses, and draws a strategic conclusion about risk positioning. Despite incorrect numbers, the structure and intent are appropriate. However, factual correctness is severely compromised, limiting reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 529,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s on‑site gas supply contracts remained long‑term (typically 10‑20 year) total‑requirement agreements that include minimum purchase volumes and built‑in price‑escalation provisions tied to published price indices, with any variable price adjustments treated as constrained and recognized only when realizable; revenue is still recognized over time as the product is delivered and the company gains the right to invoice.  The 2024 disclosures highlight roughly $58 billion of future consideration linked to these minimum‑purchase obligations, showing an evolution toward more index‑linked, inflation‑adjusted pricing while preserving the same over‑time revenue recognition model for on‑site customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer captures the core contractual structure of Linde's on-site agreements—long-term (10–20 years), with minimum purchase requirements, price escalation tied to indices, and constrained variable pricing—which aligns with the ground truth. It also correctly notes the use of over-time revenue recognition aligned with invoicing rights, consistent with ASC 606. However, a major factual error undermines the response: the claim that '2024 disclosures highlight roughly $58 billion of future consideration' is incorrect and not supported by the ground truth, which does not mention any dollar amount, let alone $58 billion. This figure appears fabricated or misattributed, severely impacting quantitative accuracy. (2) There are no numbers in the original answer to validate the $58 billion figure; thus, this is a clear quantitative inaccuracy. No other numbers (e.g., contract length, escalation mechanisms) are incorrect, but the inclusion of a large, unsupported financial figure significantly distorts the factual basis. (3) The multi-hop reasoning is partially sound—the model correctly infers continuity in contract structure from 2022 to 2024 and identifies the increasing emphasis on variable pricing transparency and revenue recognition alignment. However, it fails to reflect the evolution across years as described in the ground truth: specifically, that 2023 was the year when variable pricing components were first explicitly clarified, a key developmental point missing in the LLM answer. The synthesis across years is therefore incomplete. (4) Despite the critical error in the dollar amount, the answer remains contextually relevant and captures much of the qualitative evolution in Linde’s pricing mechanisms. The reasoning about index-linked pricing and constrained variable consideration is accurate. Hence, qualitative accuracy and contextual relevance are relatively high, but the correctness score is limited by the severe quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 531,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nFrom 2022 through 2024 the disclosed net notional volumes of NEE’s forward‑gas contracts fell from a short position of roughly **1.3 trillion MMBtu** in 2022 to a larger short of **≈1.45 trillion MMBtu** in 2023, and then were trimmed back to about **1.13 trillion MMBtu** by the end of 2024.  This three‑year trend shows that the company first expanded its short exposure—likely to profit from higher gas prices—before reducing that short position in 2024, indicating a more risk‑averse stance and a deliberate de‑risking of its natural‑gas market exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of NextEra Energy's net exposure. The ground truth states that net exposure increased from $160M in 2022 to $300M in 2023, then declined to $250M in 2024 — indicating a long position (net asset). In contrast, the LLM claims NEE had a short position in notional volume (1.3 to 1.45 to 1.13 trillion MMBtu), which contradicts the actual financial exposure data. There is no mention of dollar-denominated net exposure in the LLM response, only notional volumes, which are not equivalent. (2) The numbers provided in the LLM answer (e.g., 1.3T, 1.45T, 1.13T MMBtu) do not appear in the ground truth and cannot be verified; more critically, they misrepresent the nature of the metric — the original answer uses net financial exposure in dollars, not physical notional volume. Calculations in the ground truth (e.g., $191M - $31M = $160M) are accurate and consistent across years, while the LLM fails to report any of these values or perform any correct synthesis. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a growing short position for speculative purposes and then de-risking, whereas the actual data shows a significant increase in net long (asset) exposure in 2023 followed by a partial drawdown — suggesting active market participation, not risk aversion. The conclusion about 'de-risking' contradicts the substantial increase in exposure in 2023. (4) The contextual relevance is moderate because the answer addresses the time frame and topic (gas contracts), but it uses the wrong metric (notional volume vs. net financial exposure), misstates the direction of exposure (short vs. long), and draws opposite conclusions. This results in a very low correctness score due to complete factual inaccuracy in quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 502,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nBroadcom has consistently placed industrial‑fiber‑optic components inside its “Industrial” end‑market bucket, but the way it is framed has become progressively more integrated and growth‑focused.  In the 2022 filing the fiber‑optic products were simply listed with optocouplers and motion encoders as part of a generic industrial suite; by 2023‑2024 the language highlighted their use in factory‑automation, renewable‑energy and automotive electronics and paired them with complementary offerings such as industrial sensors, motion‑control encoders and Ethernet ICs, underscoring a broader, higher‑value industrial portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and overall narrative. It correctly identifies that Industrial Fiber Optics remained within AVGO's Industrial end market across 2022–2024 and notes the evolving framing—from a generic listing in 2022 to a more integrated, application-focused positioning in 2023–2024. The key application areas (factory automation, renewable energy, automotive electronics) are accurately reflected, as are the associated product lines (optocouplers, sensors, motion encoders, Ethernet ICs). There are no numeric inaccuracies (quantitative accuracy is perfect, though no specific numbers like dollar amounts or percentages are involved). The qualitative reasoning is sound but slightly overstates the evolution by implying a strategic shift toward 'higher-value' and 'growth-focused' language not explicitly present in the original answer. The ground truth emphasizes *stability* in strategic role, whereas the LLM suggests increasing integration and emphasis, which may reflect interpretation beyond the evidence. This minor over-interpretation prevents a top score, but the core facts, multi-hop synthesis across years, and contextual relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 349,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes ‑ 31B showed no change in either size or cost: the notes remained a **$750 million (face) tranche at a fixed 3.25 % coupon**, producing a steady **annual debt‑service amount of roughly $24.375 million**.  \n\nThis consistency indicates that SPG is deliberately **maintaining a stable, low‑cost, long‑dated unsecured debt position**, using the 31B notes as a fixed‑rate pillar of its capital structure rather than expanding or refinancing it, thereby preserving cash flow and limiting refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the face amount of $750 million, the 3.25% interest rate, and the annual debt service of $24.375 million are consistent across 2022–2024. The LLM correctly notes no changes over the period. (2) Quantitative accuracy is perfect: $750,000,000 × 3.25% = $24,375,000, and the LLM correctly reports this as 'roughly $24.375 million', which is acceptable rounding. Format variations ($750 million vs $750,000,000) are standard and accurate. (3) The multi-hop reasoning is sound—information is synthesized across three years for the same instrument (Unsecured Notes - 31B), and the conclusion about SPG’s stable long-term debt strategy is logically supported by the unchanged terms. (4) The answer addresses both parts of the question: the evolution (no change) and the implication for SPG’s debt strategy (stable, low-cost, fixed-rate financing). Wording differs but meaning is identical. All scores are 10 due to complete factual accuracy, correct synthesis, and relevant interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 313,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ U.S. defined‑contribution plan expense grew modestly over the period – $70 million in 2022, $75 million in 2023 and $76 million in 2024 (as disclosed on pages 43 and 45 of the 2022‑2024 10‑K filings). This upward trend indicates the company is steadily increasing its financial investment in employee retirement benefits through these plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These values are accurate and consistent with the knowledge graph. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. The increase from $70M to $76M represents an 8.6% increase, which the original answer includes; while the LLM omits the exact percentage, it correctly describes the trend as an 'upward trend' and 'steadily increasing,' which is semantically aligned. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers the trend in investment in employee retirement benefits. The mention of specific 10-K pages (43 and 45) adds verifiability and suggests proper sourcing. (4) The only minor shortcoming is the omission of the explicit 8.6% total increase, which slightly reduces completeness in qualitative terms, but the overall interpretation remains correct and meaningful. Hence, all scores are high, with a 9 on correctness due to this small omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 327,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments—from both the numerator (net operating profit after tax) and the denominator (average invested capital) of its ROIC calculation through 2022, 2023 and 2024. By applying the same exclusion each year, the company signals that its performance‑evaluation metric is intended to isolate the recurring, cash‑generating returns of its operations, deliberately filtering out one‑time accounting adjustments that do not reflect underlying operational performance. This steady treatment underscores a methodology that focuses on sustainable earnings and capital efficiency rather than short‑term accounting effects.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, matching the original answer's claim of methodological stability. (2) There are no numerical discrepancies—while no specific dollar amounts or percentages are involved, the years (2022–2024) and the nature of exclusions (e.g., goodwill impairments) are correctly cited and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that consistent exclusion reflects a disciplined, performance-focused methodology aimed at isolating operational performance from non-recurring accounting effects. (4) The LLM adds contextual depth—mentioning both numerator and denominator adjustments and explaining the intent to focus on 'recurring, cash-generating returns'—which enhances the original answer without introducing inaccuracies. All entities (GD, ROIC, non-economic accounting changes) and time periods are correct. The answer is semantically equivalent and even improves upon the original with clearer financial rationale, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 342,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate Accounts assets were $3.31 billion at the end of 2022, fell to $3.20 billion in 2023, and rose again to $3.31 billion by the end of 2024 (see 10‑K 2022 p. 115, 2023 p. 155, and 2024 p. 106). The modest dip followed by a rebound indicates that the company’s exposure to long‑term insurance products remains essentially stable, with only minor portfolio re‑balancing driven by market valuations rather than a strategic shift away from or toward these assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's Separate Accounts Assets. According to the ground truth, the assets were $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM reports $3.31 billion (i.e., $3,310 million) in 2022, $3.20 billion ($3,200 million) in 2023, and $3.31 billion again in 2024. This misstates the 2022 value by over $1.7 billion and underreports the 2023 decline. The actual drop from 2022 to 2023 was a substantial 36% decrease, whereas the LLM implies only a minor fluctuation. (2) The calculations and comparisons are therefore incorrect: the trend is not a 'modest dip and rebound' but a sharp decline followed by slight recovery. The LLM’s characterization of stability contradicts the ground truth, which notes a 'significant decline' suggesting strategic or market-driven reduction in long-term insurance investments. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize data across the three years from the cited 10-Ks. While it attempts to reference filings, the numbers do not align with the ground truth, indicating either misreading of documents or incorrect source mapping. (4) Contextually, the answer addresses the right metric and time frame and attempts to interpret investment positioning, so relevance is moderate. However, due to severe quantitative errors and resulting flawed qualitative interpretation, the overall correctness is low. Minor formatting differences like $3.31 billion vs $3,311 million are acceptable, but the 2022 figure is off by more than 50% of the actual decline magnitude, which is not a formatting issue but a critical factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 473,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nFrom 2022 through 2024 the Target‑TD Bank credit‑card program was updated twice. The **Third Amendment** to the Credit Card Program Agreement was executed on **November 1, 2022** (filed as Exhibit 10.21.3+ to the 2022 Form 10‑Q) and later a **Letter Agreement** dated **March 8, 2023** (Exhibit 10.21.4+ to the 2023 Form 10‑Q) introduced additional modifications. No further amendments were disclosed in the 2024 filing, so the 2022 amendment and the 2023 letter agreement represent the most recent contractual milestones.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and contradicts the ground truth. (1) It claims a 'Third Amendment' was executed on November 1, 2022, and a 'Letter Agreement' on March 8, 2023, but the original answer states that by 2024, only the original 2012 agreement, the first amendment (2015), and a second amendment (November 19, 2019) were in effect—no mention of 2022 or 2023 amendments. Thus, the dates, amendment numbers, and referenced documents (Exhibits 10.21.3+ and 10.21.4+) are factually wrong. (2) Quantitative accuracy is very low: the LLM invents specific dates (Nov 1, 2022; Mar 8, 2023) and amendment labels not present in the ground truth. The ground truth does not report any amendments after 2019 during the 2022–2024 period, only that the agreement was still in effect and referenced prior amendments. (3) The reasoning is flawed: instead of recognizing that the contractual evolution stopped at the 2019 second amendment, the LLM fabricates new milestones, failing the multi-hop synthesis. It incorrectly implies active evolution in 2022–2023 when the truth indicates continuity and reference to existing terms. (4) Contextual relevance is moderate—the response addresses the question’s structure (amendments and milestones) and involves the correct entities (Target, TD Bank, agreement), but the substance is fabricated. Minor credit is given for framing the answer around amendments and contractual updates, but core facts are false.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 405,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde deepened its technological edge in rare‑gas production by scaling both cryogenic and non‑cryogenic air‑separation (VPSA and membrane) processes that co‑produce krypton, neon and xenon, and by embedding those gases in its on‑site plant contracts and global engineering services.  At the same time the company tied rare‑gas supply to its broader clean‑energy and engineering portfolio—using the same separation platforms to deliver low‑carbon hydrogen, carbon‑capture‑ready units and specialty gases—so that rare‑gas sales are now integrated with long‑term on‑site supply agreements, engineering‑driven plant sales and the company’s hydrogen‑and‑carbon‑management strategies, creating a differentiated, cross‑selling offering across its industrial‑gases, engineering and clean‑energy product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Linde's evolution from 2022 to 2024 in rare gas production, emphasizing technological differentiation through non-cryogenic methods like VPSA and membrane separation, which are explicitly mentioned in the original answer. The focus on krypton, neon, and xenon as byproducts of air separation is accurately reflected. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the LLM synthesizes Linde’s integration of rare gases into on-site contracts, long-term agreements with pricing mechanisms, and links to broader product lines like clean energy and engineering services. While the original answer does not explicitly mention 'low-carbon hydrogen' or 'carbon-capture-ready units', these are reasonable inferences given Linde’s strategic direction and do not contradict the ground truth. The LLM extends slightly beyond the original by framing rare gas integration within a cross-selling strategy across hydrogen and carbon management, which is plausible but not directly stated. (4) Contextual relevance is perfect—the response directly addresses the evolution of production, technological differentiation, and integration with other product lines. The only minor gap is that the 2022 baseline (rare gases as standard atmospheric products) is implied but not explicitly laid out, slightly reducing completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 439,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the collateral that ExxonMobil pledged under master‑netting arrangements tied to its advances/receivables from equity companies fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and $0.49 billion in 2024**.  The declining pledged amount reflects that the company has been **reducing or settling the derivative‑related positions linked to those equity‑company relationships**, thereby lowering its potential liability exposure from such derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral amounts for all three years: $1.5 billion in 2022 (~$1,494 million), $0.8 billion in 2023 ($800 million), and $0.49 billion in 2024 ($491 million), with acceptable rounding. All numeric values match the ground truth when accounting for format and rounding variations.\n\n2) Quantitatively, the numbers are accurate: $1,494M ≈ $1.5B, $800M = $0.8B, $491M ≈ $0.49B. No calculation errors; the trend of decline is correctly presented.\n\n3) The reasoning is sound: the LLM correctly infers that the declining collateral suggests a reduction in derivative-related positions and lower liability exposure, aligning with the ground truth's interpretation of de-risking or portfolio optimization. While the LLM uses slightly different phrasing (e.g., 'reducing or settling derivative-related positions' vs. 'strategic reduction in exposure'), the semantic meaning and logical inference are equivalent.\n\n4) The answer is fully relevant and addresses both parts of the question: the evolution of collateral (multi-year trend) and its implication for derivative liability exposure. The multi-hop synthesis—linking collateral changes to derivative exposure tied to equity company relationships—is correctly executed.\n\nMinor deduction in qualitative accuracy (9/10) because the LLM does not explicitly mention 'strategic' reduction or 'portfolio optimization' as in the original, slightly weakening the depth of interpretation, though the core logic remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 413,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 NEER’s long‑term bilateral‑contract coverage stayed very high – about 94 % of its net generating capacity was under such contracts by the end of 2023 and again in 2024 (up modestly from roughly 92 % of capacity noted for 2021).  This near‑universal contracting locks in power prices for the bulk of its output, thereby insulating earnings from spot‑market volatility and reinforcing NEER’s strategy of mitigating financial risk in increasingly competitive wholesale markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the upward trend in NEER's reliance on long-term bilateral contracts and accurately reports 92% for the base year and 94% for 2023 and 2024. However, it incorrectly states that the 92% figure is for 2021 instead of 2022 as specified in the ground truth, which is a factual error in temporal attribution. This affects quantitative accuracy. 2) The percentages themselves (92%, 94%) are correct and match the ground truth, but the mislabeling of the 92% figure as 2021 instead of 2022 undermines precision. The trend description (increase to 94%) is accurate. 3) The reasoning is sound: the model correctly infers that high contract coverage indicates a risk mitigation strategy against spot-market volatility, and it appropriately links this to competitive wholesale markets. It also implicitly acknowledges the role of contracting in revenue stability, aligning with the original answer’s emphasis on risk mitigation. 4) The answer is contextually excellent—fully addressing both the evolution of contract reliance and its strategic implications. Despite the year misstatement, the core message about risk mitigation through long-term contracts is preserved with strong qualitative and contextual fidelity. The error is minor in impact but notable in strict factual terms, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 373,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % notes maturing in January 2025 carried an outstanding principal of **$495 million** in fiscal 2022 and this balance remained **unchanged at $495 million** through fiscal 2023 and fiscal 2024. This flat trajectory indicates that the company is deliberately maintaining a modest, fixed‑rate tranche and intends to retire the notes at maturity rather than expand or refinance the exposure, reflecting a disciplined, maturity‑focused debt‑management strategy for this instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate, satisfying quantitative accuracy. 2) Quantitatively, the answer is flawless: $495 million is consistently reported for all three fiscal years, and the maturity date (January 2025) is correctly referenced. Format variations (e.g., $495 million vs $495M) are acceptable and not an issue here. 3) The multi-hop reasoning is mostly sound—information is correctly synthesized across fiscal years for AVGO’s specific debt instrument. However, the interpretation of the company's strategy differs slightly: the LLM states AVGO intends to 'retire the notes at maturity rather than expand or refinance,' implying a plan to pay off from cash reserves, which aligns partially with the ground truth. But the original answer emphasizes that the lack of amortization suggests a potential *refinance* or use of cash reserves, while the LLM downplays refinancing ('rather than...refinance'), which contradicts the possibility highlighted in the ground truth. This mischaracterization slightly weakens the qualitative accuracy. 4) Despite this nuance, the answer remains highly relevant and factually complete, correctly addressing both the evolution of the balance and the strategic implication. The conclusion is reasonable, though less balanced than the original. Thus, correctness is high but not perfect due to subtle misinterpretation in strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 436,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s 37B unsecured note remained unchanged: each filing lists a **2.25 % coupon**, a **$700 million face amount**, and a **maturity date of 01/15/2032** (see SPG 10‑K 2022 p. 50, SPG 10‑K 2023 p. 51, SPG 10‑K 2024 p. 52).  \nThe steady terms indicate that Simon Property Group is deliberately using low‑cost, long‑dated unsecured debt to lock in financing for the long term, rather than repeatedly refinancing or altering the instrument, reflecting a stable, long‑term debt‑strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) are correctly reported across the 2022–2024 period. Minor formatting differences (e.g., '01/15/2032' vs 'January 15, 2032', '$700 million' vs '$700,000,000') are acceptable and do not affect factual accuracy. (2) Quantitative accuracy is perfect—no calculations were required, but the values match exactly across years. (3) The multi-hop reasoning is sound: the model correctly synthesized data from three consecutive 10-K filings (2022, 2023, 2024) and inferred the strategic implication of unchanged terms, which aligns with the ground truth’s interpretation of a stable, long-term debt strategy. (4) The answer addresses all parts of the question: evolution over time (no change), each financial term (rate, amount, maturity), and the strategic implication. Wording differs slightly but conveys identical meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 307,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K property tables list Melaka, Malaysia exclusively under the **Analog** column – the site is never shown with an “Embedded Processing” designation in any of the yearly filings.  The company’s disclosures therefore reveal a steady, analog‑only footprint in Melaka, with no shift toward embedded‑processing activities over the three‑year period, underscoring that TI’s strategic focus in that Malaysian location remains centered on analog semiconductor manufacturing rather than embedded processing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that from 2022 to 2024, Texas Instruments' Melaka, Malaysia site was consistently listed only under the Analog column and never under Embedded Processing in the 10-K property tables, which matches the original answer's claim about the 'X' designation. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the absence of embedded processing designation is correctly noted across all years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a consistent strategic focus, concluding that the lack of change indicates a targeted investment in analog rather than diversification. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the operational footprint and what it reveals about TI’s strategic focus. Wording differs slightly but conveys the same factual and inferential content as the original answer, with no omissions or inaccuracies. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 347,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard layered additional real‑time‑specific controls onto its existing multi‑layered security model as it rolled out real‑time payment infrastructure in ever more markets. In 2022 the focus was on a baseline cyber‑risk program, third‑party assessments and EMV‑based standards; by 2023 the network had added real‑time clearing, tokenization and intelligent fraud‑scoring across 12‑plus top‑market jurisdictions, and in 2024 it expanded that architecture with joint‑venture domestic processing in China, AI‑driven fraud intelligence, Alias‑Based remittance platforms and broader VCN adoption—all reinforced by continuous ecosystem collaboration and data‑centric governance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Mastercard's security approach from 2022 to 2024 with accurate qualitative progression—baseline security in 2022, expansion with real-time fraud scoring and tokenization in 2023, and scaling for China via joint venture in 2024. However, there is a minor quantitative inaccuracy: the original answer states real-time payments were in 12 top GDP markets in 2022 and expanded to 13 in 2023, but the LLM says '12-plus' in 2023 without acknowledging the specific increase from 12 to 13, thus slightly misrepresenting the data. (2) The mention of 'AI-driven fraud intelligence', 'Alias-Based remittance platforms', and 'broader VCN adoption' in 2024 adds detail not present in the ground truth; while plausible, these specifics are not confirmed in the original and introduce unverified elements. (3) The multi-hop reasoning is strong—correctly linking the expansion of real-time payment infrastructure to evolving security measures across years and geographies, including the significance of China's domestic processing via joint venture. The synthesis of third-party risks, public-private collaboration, and network integration aligns well with the original. (4) Despite minor over-specification and a small numerical imprecision, the LLM conveys the essential evolution accurately and remains highly relevant to the question, earning high marks for qualitative accuracy and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 403,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics steadily raised the number of Light Armored Vehicles it builds for the Canadian Army—360 units in 2022, 399 in 2023 and 449 in 2024. This upward trajectory shows the company is deliberately expanding its LAV production capacity and positioning land‑system sales as a core growth pillar of its strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes for Light Armored Vehicles (LAVs) for the Canadian Army: 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. All numeric values are accurate and properly attributed to the correct years and entity. (2) There are no calculations required beyond recognizing the upward trend, which is correctly interpreted. The numbers are consistent with the original answer, and format is clear and acceptable. (3) The multi-hop reasoning is sound—LLM correctly infers from the increasing production volumes a strategic focus on LAV programs, linking operational output to corporate strategy. The conclusion that General Dynamics is expanding production capacity and prioritizing land-system sales aligns with the ground truth's interpretation of 'growing strategic emphasis' and 'deepening commitment.' (4) The only minor difference is in phrasing: the LLM emphasizes 'land-system sales as a core growth pillar,' which is a slightly more specific strategic claim than the original, but still logically supported and semantically consistent. No factual inaccuracies; minor deduction from 10 to 9 on qualitative accuracy due to slight interpretive expansion, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 360,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 the pension plan’s hedge‑fund limited‑partnership holdings grew from **$225 million** (reported for 2022) to **$290 million** (reported for 2024), an increase of about **$65 million (≈ 29 %)**.  This steady rise indicates that CVS is deliberately expanding its exposure to alternative‑asset strategies, using hedge‑fund partnerships to boost expected returns and diversify the portfolio as part of a broader, more diversified pension‑fund investment approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's allocation was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly reports $225 million as the 2022 value (it is actually the 2023 value) and $290 million for 2024 (vs. the correct $252 million). This leads to a completely incorrect calculation of a $65 million increase (≈29%), whereas the actual increase from 2022 to 2024 is $38 million (17.8%). (2) The quantitative inaccuracies are severe: all three reported values are wrong, and the percentage change is miscalculated based on incorrect inputs. Even allowing for format variations, the numbers do not match any valid interpretation of the ground truth. (3) The reasoning is partially sound in interpreting a growing trend as a strategic move toward alternative investments, which aligns with the qualitative suggestion in the original answer. However, because the data underpinning this reasoning is incorrect, the multi-hop synthesis fails—there is no evidence in the provided data to support a rise to $290 million or a 29% increase. (4) The contextual relevance is moderate because the answer addresses the right question structure (change over time and strategic implication), but the factual foundation is flawed. Correctness and quantitative accuracy are low due to fundamental errors in reported figures and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 397,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard Credit Card’s penetration slipped from about 19.8 % in 2022 to 18.6 % in 2023 and 17.8 % in 2024, a modest but steady decline. This downward trend indicates that consumer adoption and engagement with Target’s co‑branded credit product have been easing over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect numeric values for the penetration rates. According to the ground truth, the rate was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. The LLM incorrectly reports 19.8% in 2022 (should be 20.5%), 18.6% in 2023 (should be 19.8%), and correctly reports 17.8% in 2024. These discrepancies in two out of three years significantly affect quantitative accuracy. (2) The calculation of trend direction (decline) is correct, and the final 2024 value matches, but the magnitude and pace of decline are misrepresented due to wrong inputs. (3) The reasoning about weakening consumer adoption and engagement is partially sound and aligns with the ground truth's interpretation, though the LLM does not mention key contextual factors such as RedCard sales growing in absolute terms while being outpaced by total sales, nor does it reference the 5% discount incentive or possible causes like competition or reduced sensitivity. This limits qualitative depth. (4) Despite numerical inaccuracies, the answer correctly identifies the downward trend and its implication on consumer behavior, addressing the core of the question. Contextual relevance is high because it stays focused on Target's credit card penetration and consumer engagement. However, the incorrect figures reduce overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 379,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024, the fair‑value exposure tied to FPL Cost Recovery Clauses rose from about $1 million in 2022 to a peak of roughly $38 million in 2023 and then slipped slightly to about $31 million in 2024. Throughout this period the valuation remained heavily weighted toward significant unobservable inputs—growing from roughly 78 % of the total in 2022 to about 87 % in 2024—while the contribution from significant other observable inputs stayed small (around 10‑13 % of the total).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and trends. According to the ground truth, the total fair value was $1M in 2022, $12M in 2023, and $38M in 2024. However, the LLM incorrectly states it rose to $38M in 2023 and then dropped to $31M in 2024—both figures are wrong. The 2024 value is especially off ($31M vs $38M), and the peak timing is misattributed. (2) The breakdown of contributions is entirely missing and replaced with estimated percentages. Ground truth specifies exact dollar contributions: in 2022, -$5M (observable) and +$6M (unobservable); 2023: -$12M and +$24M; 2024: +$4M and +$34M. The LLM invents percentages (e.g., 78%, 87%) not present in the original data and does not reflect the shift from negative to positive observable inputs. The claim that observable inputs were 'around 10–13%' is incorrect—observable inputs were negative in 2022 and 2023, meaning they cannot represent a positive percentage of total fair value. (3) The multi-hop reasoning is partially sound in identifying a trend of increasing reliance on unobservable inputs, but the synthesis is flawed due to incorrect data. The model fails to capture the reversal in observable inputs (from negative to positive) between 2023 and 2024, a key shift in the valuation methodology. (4) Contextual relevance is fair—the answer addresses fair value exposure, inputs, and time trends—but the severe quantitative errors undermine correctness. Due to major factual and calculation errors, the correctness score is low at 3, quantitative accuracy is 2 (severe number mismatches), qualitative accuracy is 4 (some correct directionality but flawed logic), and contextual relevance is 7 (on-topic with correct entities and structure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 478,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Nike’s disclosures show a steady sharpening of its product‑innovation pipeline—continuously rolling out new Air, Zoom, React, Flyknit and other performance technologies—while deepening brand‑engagement through expanded athlete‑endorsement networks, digital‑commerce platforms and community‑investment/DEI initiatives.  These moves are framed in the filings as the primary way Nike “maintains its competitive edge” against rivals such as Anta, whose growth has been concentrated in the Chinese market and whose public emphasis on innovation and brand storytelling is less extensive.  Consequently, Nike’s positioning relative to Anta has evolved from a focus on scale and global reach to a more differentiated strategy built on cutting‑edge product development and immersive brand experiences that reinforce its status as the world’s largest athletic‑apparel seller.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in NKE's competitive positioning relative to Anta from 2022 to 2024. It accurately reflects NKE’s increasing emphasis on product innovation (e.g., Air, Zoom, React, Flyknit) and brand engagement via digital platforms, athlete endorsements, and community initiatives. The answer correctly identifies Anta as a competitor with strong regional (Chinese market) growth but less public emphasis on innovation and brand storytelling, aligning with the ground truth. However, it omits specific year-by-year shifts explicitly noted in the original answer: (1) the 2022 focus on quality, performance, and design; (2) the 2023 elevation of 'innovation and development' above performance/reliability; and (3) the 2024 reinforcement of digital and social media engagement. These nuances represent multi-hop synthesis across years that the LLM summarizes broadly but does not fully detail. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and all entities (NKE, Anta, correct time frame) are accurate. The reasoning is sound and contextually relevant, but the lack of granular, year-specific strategic shifts reduces qualitative accuracy slightly. Semantic equivalence is strong, though not complete due to missing transitional details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 374,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nThe equity‑compensation table shows that shares left available for future issuance under the 2003 Director Compensation Plan rose from about **57 million shares at the end of 2022** to **≈65.5 million shares by the end of 2024** (an increase of roughly 8½ million shares). This upward trend indicates that Texas Instruments is deliberately maintaining a sizable share reserve for director‑related equity awards, confirming that the 2003 Director Compensation Plan remains an active component of the company’s long‑term incentive strategy for its board.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims the number of available shares under the 2003 Director Compensation Plan increased from 57 million in 2022 to 65.5 million in 2024. This directly contradicts the ground truth, which states that the plan was phased out: it was still active in 2022, no longer had shares available for future issuance by 2023, and was completely removed from the active structure by 2024. The reported increase in shares is factually wrong and likely based on a misreading of the equity-compensation table. (2) The calculation of an 'increase of roughly 8.5 million shares' is therefore also incorrect, as the actual trend is a decrease to zero availability. (3) Qualitatively, the reasoning is flawed: the LLM concludes the plan remains 'an active component' of TI's strategy, while the ground truth confirms it is being phased out in favor of the 2024 LTIP and 2018 Director Plan. The multi-hop synthesis failed—instead of tracking the plan's status across years and noting its removal from future issuance, the model incorrectly inferred growing importance. (4) Contextually, the answer addresses the right topic (director compensation plan evolution) but draws the opposite conclusion from the evidence. The mention of 'equity-compensation table' suggests some data was referenced, but it was misinterpreted. Overall, the answer fails on all key dimensions: numbers are wrong, trend is reversed, and strategic implication is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 420,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered data‑driven services into its advertising business by expanding programmatic, addressable‑ad capabilities across its X1, Sky Q and NOW streaming platforms and by launching a dedicated advertising marketplace that unifies linear‑TV, streaming and digital inventory.  The company paired this with technology upgrades—DOCSIS 4.0 rollout, network‑virtualization and cloud‑based ad‑serving infrastructure—and new tools such as the Xumo Stream Box and Peacock’s ad‑supported tier, which together deliver multigigabit symmetrical speeds and AI‑powered audience analytics for real‑time ad measurement and buying.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some relevant themes but introduces significant factual inaccuracies and fails to align with the ground truth in key areas. (1) Correct elements include the general direction of integrating data-driven advertising and expanding digital capabilities from 2022–2024. However, the LLM invents specific technologies and initiatives not mentioned in the original answer, such as DOCSIS 4.0 rollout, Xumo Stream Box, Peacock’s ad-supported tier, and multigigabit symmetrical speeds—none of which are referenced in the ground truth. The mention of Sky Q and NOW platforms suggests inclusion of Sky (a subsidiary partially owned by Comcast) but the original answer does not specify these platforms. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages, user counts) in either the original or LLM answer, so no numeric inaccuracies exist, but the LLM fabricates technical details (e.g., DOCSIS 4.0, cloud-based ad-serving infrastructure) that cannot be verified and are not part of the documented evolution. (3) The multi-hop reasoning is flawed: while the question asks for a year-by-year evolution of CMCSA's advertising integration, the LLM skips the 2022–2024 phased progression described in the original—focusing instead on unspecified product launches and network upgrades that conflate broadband infrastructure with advertising technology. The original emphasizes cloud platforms and integrated search in 2023 and strengthened representation agreements in 2024, none of which are reflected accurately. (4) Contextual relevance is moderate because the answer stays within the domain of advertising and technology enhancements, but it diverges into tangential infrastructure developments and product-specific features not supported by the source. Overall, the LLM generates plausible-sounding but factually unsupported details, resulting in partial credit for thematic alignment but major deductions for factual correctness and reasoning accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 535,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nFrom 2022 to 2024 CVS markedly trimmed its commercial‑mortgage‑backed‑securities (CMBS) position: the fair‑value of CMBS that was in an unrealized‑loss position fell from about **$992 million (with $155 million of unrealized losses) in 2022** to **$675 million (with $100 million of unrealized losses) in 2023**, and by 2024 the exposure was essentially negligible – only **$3 million** of CMBS was held (as shown in the 2024 separate‑account assets).  This steady decline in both fair value and unrealized losses reflects a deliberate de‑risking of the CMBS portfolio, as the company has moved away from the longer‑duration, interest‑rate‑sensitive asset class toward more stable, lower‑risk investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, CVS held $574 million in CMBS with $12 million in unrealized losses in 2022, but the LLM claims $992 million with $155 million in unrealized losses—both figures are incorrect. The 2023 numbers in the LLM answer ($675 million fair value, $100 million unrealized losses) match the ground truth and are accurate. For 2024, the ground truth reports $6 million in holdings with no significant unrealized losses, while the LLM reports $3 million—close but not exact, and omits the clarification about no significant losses. (2) The quantitative inaccuracies are severe in 2022, undermining confidence in the data source or synthesis. The correct trend is a reduction in fair value from $574M to $675M (a slight increase) then a sharp drop to $6M, but the LLM incorrectly shows a decline from $992M, misrepresenting the direction and magnitude of change. The unrealized losses correctly rise from $12M to $100M in the truth, but LLM reports $155M in 2022, which is wrong. (3) The reasoning about de-risking is qualitatively sound and aligns with the trend in 2023–2024, and the conclusion about strategic reduction is supported by both the LLM and ground truth. However, because the starting point (2022) is wrong, the multi-hop synthesis across years is flawed. The LLM also references 'separate-account assets' not mentioned in the original, introducing unverified context. (4) Despite incorrect numbers, the answer addresses all parts of the question and draws a reasonable conclusion about risk positioning. Hence, contextual relevance is high, qualitative reasoning is partially sound, but quantitative accuracy is low due to major factual errors in 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 479,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 2022‑2024 Form 10‑K filings each state that employee compensation “includes merchandise and other discounts,” and the language and disclosed scope of that discount are essentially unchanged across the three years. What does shift is the surrounding benefits package—higher starting wages, expanded health‑care and mental‑health resources, and tuition‑free education assistance—indicating that Target is broadening its total‑rewards strategy while keeping the employee merchandise discount as a stable, though modest, component. This multi‑year progression suggests the company is using a stable discount perk as part of a wider, increasingly comprehensive employee‑benefit strategy aimed at attracting and retaining talent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that merchandise discounts were consistently offered across 2022–2024 and remained stable in scope and wording, which matches the original answer’s assertion of consistency in this benefit. While the original answer includes specific wage ranges ($15 in 2022, $15–$24 in 2023), the LLM answer does not include these exact figures but accurately captures the trend of increasing wages and expanding benefits without misrepresenting any numbers—thus no quantitative inaccuracy. (2) All dates (2022–2024) and entities (Target, employee benefits, merchandise discounts) are correct. No financial figures are misstated, and there are no calculation errors because the question does not require numerical computation. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years to infer a strategic shift in Target’s total rewards approach, noting that while the discount itself remained stable, the surrounding benefits expanded—this matches the original answer’s conclusion about a shift toward holistic well-being. (4) The LLM conveys semantic equivalence: it emphasizes the stability of merchandise discounts while correctly identifying the broader evolution in benefits (e.g., mental health, tuition-free education, healthcare), leading to the same strategic interpretation—using a consistent perk within a more comprehensive benefits strategy. The only minor shortcoming is the lack of specific wage benchmarks mentioned in the ground truth, which adds slightly more precision to the evolution narrative. However, this omission does not distort the overall correctness, so a score of 9 is appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 467,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s risk disclosures shifted from a brief mention of “cultural challenges associated with integrating employees” (2022) to a detailed focus on cross‑cultural integration—highlighting language and cultural differences, the need to align accounting/HR systems, and the importance of retaining key talent (2023‑2024).  This evolution shows that Linde now treats cultural compatibility as a core strategic priority, embedding dedicated due‑diligence, integration playbooks and talent‑retention programs into its cross‑border M&A approach to mitigate integration risks and protect financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Linde's emphasis on cultural challenges from 2022 to 2024. It accurately captures the progression from a brief mention in 2022 to a more strategic focus in 2023–2024. The quantitative accuracy is perfect: no numerical data is misstated, and all years (2022, 2023, 2024) are correctly referenced. The entity accuracy is also correct—Linde is the right company, and the context of cross-border integration and M&A risk is properly framed. The reasoning is sound and reflects multi-hop synthesis across years, showing how the company’s language evolved. However, the LLM adds specific details not present in the original answer—such as 'align accounting/HR systems' and 'dedicated due-diligence, integration playbooks'—which, while plausible, are not mentioned in the ground truth. The original answer emphasizes a shift toward framing cultural issues in terms of financial and strategic risk, especially in 2024, which the LLM captures in spirit (e.g., 'protect financial performance') but slightly over-specifies the mechanisms. Thus, while the core facts and evolution are correctly conveyed (justifying a high score), the addition of unverified operational details prevents a perfect 9–10. The answer remains contextually relevant and semantically equivalent in overall meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 381,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the collateral that ExxonMobil posts under master‑netting arrangements fell sharply—from roughly **$1.49 billion in 2022 to $0.49 billion in 2024**, a decline of about **$1.0 billion (≈ 67 %)**.  This reduction shows that the company is relying far less on external collateral to support its derivative positions, reflecting tighter counterparty risk management and a greater use of internal netting and stronger credit relationships to manage its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in collateral under master netting arrangements from 2022 to 2024, with accurate figures: $1.49 billion (matches $1,494 million in ground truth) in 2022 and $0.49 billion (matches $491 million) in 2024. The intermediate 2023 value of $800 million is omitted, which is a minor omission but does not invalidate the overall trend. 2) The calculation of a ~$1.0 billion decline and ~67% reduction is approximately correct: actual drop is $1,494M - $491M = $1,003M (67.1% decrease), so the math is sound. 3) The reasoning correctly infers that reduced collateral usage suggests improved derivative exposure management, tighter risk controls, and greater reliance on netting—consistent with the ground truth's interpretation of strategic reduction or improved offsetting. The LLM adds plausible qualitative context (e.g., stronger credit relationships) not in the original, but this is reasonable inference. 4) All entities (ExxonMobil, collateral under master netting arrangements, derivative exposure) are correctly identified and synthesized across time points. The answer fully addresses both parts of the question: the net change and its implication. Only minor deduction is for omitting the 2023 data point, but the overall trend and conclusion remain accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 370,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a niche mainframe‑posture tool that simply identified risks and produced remediation steps for internal SIEM use, to a central component of Broadcom’s Enterprise‑Security portfolio that is designed to feed that risk data into external security‑orchestration and SIEM platforms.  The platform’s remediation workflow was broadened to support automated, ad‑hoc remediation actions and tighter integration with threat‑intelligence and AI‑driven detection tools, reflecting a strategic alignment with broader, cross‑stack cybersecurity strategies such as zero‑trust and proactive threat response.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AVGO's Security Insights Platform from 2022 to 2024. (1) It correctly identifies the platform’s initial role in 2022 as a mainframe security posture tool that identified risks and generated remediation steps, with data usable by internal SIEM tools—matching the original answer. By 2024, it accurately reflects the platform’s expanded integration with external orchestration and SIEM platforms, and its alignment with broader cybersecurity strategies like zero-trust and proactive threat response. The mention of AI-driven detection tools aligns with the 2024 emphasis on AIOps in the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; all time references (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years, correctly inferring increased integration, enhanced remediation workflows, and strategic alignment. The only minor gap is that the original answer specifically notes the platform’s inclusion in a broader software suite (Cybersecurity, AIOps, DevOps) in 2024, which the LLM implies via 'AI-driven detection' and 'Enterprise-Security portfolio' but does not explicitly name AIOps/DevOps. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing integration with external tools, remediation processes, and strategic alignment—all key parts of the question. Overall, the LLM conveys semantically equivalent information with excellent fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 440,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B remained unchanged – the issue stayed at a $750 million face amount ( $750,000 thousand ) and a fixed 3.38 % interest rate, maturing on 06/15/27.  This consistency shows that SPG is deliberately using a stable, low‑cost, medium‑term fixed‑rate tranche to lock in financing, limit refinancing risk and preserve a predictable debt‑service profile as part of its long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: face amount ($750 million = $750,000,000), interest rate (3.38%), and maturity date (June 15, 2027) for Unsecured Notes - 32B across 2022–2024. It accurately reflects no changes in principal or rate over the period. (2) Quantitative values are correct with acceptable format variation ($750 million vs $750,000,000; '6/15/27' vs 'June 15, 2027'). No calculations were required, but consistency across years is properly noted. (3) The multi-hop reasoning is sound—information from three annual reports is synthesized to show stability over time. The conclusion about SPG’s long-term debt strategy aligns with the ground truth: maintaining fixed-rate debt to ensure predictability and avoid refinancing risk. (4) The only minor shortcoming is that the LLM does not explicitly state that the note was 'still outstanding' each year, nor does it mention the absence of refinancing or early redemption activity, which slightly weakens the qualitative depth compared to the original. However, the strategic interpretation is semantically equivalent and well-reasoned. Thus, the answer is factually complete and contextually appropriate, meriting a high score with a small deduction in qualitative accuracy for omitted nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 360,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen’s fiber rollout moved from early‑stage build‑outs to a broader, multi‑gigabit network that now reaches a substantial share of the markets Comcast serves, and it has added bundled packages that combine fiber broadband, video, voice and wireless services—directly mirroring Comcast’s own bundled offerings and intensifying the competitive threat. This evolution has seen Lumen not only expanding its fiber infrastructure faster across Comcast’s footprint but also marketing those higher‑speed services as part of integrated bundles that compete head‑to‑head with Comcast’s broadband‑video‑voice‑wireless bundles.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolving competitive threat from Lumen to CMCSA (Comcast) from 2022 to 2024, focusing on fiber expansion and service bundling, which aligns with the ground truth. It accurately captures the trend of Lumen increasing its fiber footprint and offering bundled services that directly compete with Comcast's bundles. There are no specific numerical figures (e.g., miles of fiber, customer counts, speeds, or dates) in either the original or LLM answer, so quantitative accuracy is not compromised—thus a score of 10. The qualitative accuracy is high but not perfect: while the LLM correctly infers intensifying competition and bundling strategies, it slightly overstates the progression as moving from 'early-stage build-outs' to 'substantial share' of Comcast’s markets, which is a stronger claim than the original answer supports. The original answer notes consistent fiber deployment and competitive pressure but does not characterize the rollout as having reached a 'substantial share' or imply a clear phase transition in deployment maturity. This introduces a minor overinterpretation, though the core reasoning—fiber expansion and bundling intensifying competition—is sound and well-synthesized across the multi-hop timeframe (2022–2024). Contextual relevance is excellent, as the response directly addresses both parts of the question (fiber expansion and bundling) and maintains focus on the competitive dynamic. Overall, the answer is factually aligned with the ground truth in substance and correctly synthesizes the trend, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 438,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nTarget’s branded‑payment‑card penetration fell steadily from roughly 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024. This downward trend indicates that the loyalty‑driven 5 % discount attached to the Target Circle Card is losing its ability to generate incremental sales, suggesting the strategy’s effectiveness is eroding over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 2022 to 2024 and attributes it to weakening effectiveness of the loyalty strategy, which aligns with the ground truth. However, the 2024 penetration rate is incorrect: the LLM states 18.6%, while the ground truth is 17.8%. This is a significant numerical error affecting quantitative accuracy. (2) The 2022 (20.5%) and 2023 (19.8%) figures are accurate and match the original answer. The 2024 figure discrepancy (18.6% vs 17.8%) suggests either a data error or miscalculation, undermining confidence in the model's sourcing. No calculations are required in this question, but the trend description depends on accurate data points. (3) The multi-hop reasoning is sound—the model correctly infers that declining penetration implies reduced effectiveness of the loyalty-driven strategy, which is a valid interpretation supported by the data. The mention of the '5% discount' and 'Target Circle Card' adds contextual detail not in the original but is plausible and relevant. (4) The correctness score is 6 due to the incorrect 2024 value, which is a major factual flaw, though the overall trend and conclusion are directionally correct. Quantitative accuracy is penalized heavily (5/10) for the wrong percentage. Qualitative accuracy is fair (7/10) as reasoning and entity identification (Target, branded cards, loyalty strategy) are correct. Contextual relevance is high (9/10) because the answer directly addresses both parts of the question and provides meaningful interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 438,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron continued to hold its offshore stakes in the Republic of Congo—principally a 31.5 % non‑operated interest in the Haute Mer permit block and a 15.75 % stake in the Lianzi field—while directing roughly **$0.7 billion of capital** to offshore development and natural‑gas projects in the country (part of the $0.7 bn Africa spend noted in 2023).  This investment was aimed at boosting upstream production and improving reserve intensity, positioning the Congolese assets as a strategic component of Chevron’s African portfolio and its broader lower‑carbon agenda.  In early 2025 the company completed the sale of those Congolese interests, signaling a strategic exit and a reduction of further investment in the Republic of Congo.  (Pages 35, 41, 33 of the 2022‑2024 10‑K filings)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership in the Republic of Congo (31.5% in Haute Mer, 15.75% in Lianzi), the $0.7 billion investment in African offshore and natural gas projects in 2023, and the eventual divestiture of these assets. However, it incorrectly states the sale occurred in 'early 2025', while the ground truth specifies the exit was completed by 2024. This is a significant factual error in timing that affects the accuracy of the evolution timeline. (2) Quantitatively, all percentages and dollar amounts are accurate: $0.7 billion investment, 31.5%, and 15.75% interests match the ground truth. The investment is correctly contextualized as part of Chevron’s broader African spend. The only quantitative issue is the misplacement of the sale to 2025 instead of 2024, which is a date error rather than a number error. (3) The multi-hop reasoning is mostly sound—linking ownership, investment, and strategic shift—but the conclusion about a 2025 sale contradicts the 2024 exit in the ground truth, undermining the logical flow of the timeline. The strategic interpretation of portfolio realignment is reasonable but slightly weakened by the incorrect timing. (4) The answer is contextually relevant and covers all aspects of the question: asset ownership, investment levels, and strategic positioning. The core facts are present and well-synthesized, but the incorrect date of divestiture prevents a higher score. The answer would be stronger if it explicitly framed the 2024 exit as part of a strategic shift already underway, rather than implying continuity into 2025.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 443,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nFrom 2022 to 2023 NEE’s gas‑related derivative notional volume slipped only slightly (≈1.3 bn MMBtu to ≈1.45 bn MMBtu), yet the Level‑3 fair‑value of those gas‑options surged from $170 m to $951 m as market prices rose and implied volatility jumped from roughly 50 % to over 110 %. By the end of 2024 the notional short position was trimmed further to ≈1.13 bn MMBtu and the fair‑value settled at $387 m, while implied volatility fell back to the low‑50 % range, indicating that NEE has reduced its speculative gas‑price exposure and is now holding a smaller, lower‑volatility hedge.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy and factual content. (1) The numbers provided—such as fair value increasing from $170M to $951M, notional volumes (1.3 bn to 1.45 bn MMBtu), and implied volatility rising to over 110%—are completely inconsistent with the ground truth. According to the original answer, fair value decreased from $356M to $100M in assets (not increased), and implied volatility rose from 36% to 50%, not 50% to over 110%. In 2024, volatility was 52%, not in the 'low-50% range' after falling from over 110%. (2) The LLM incorrectly states that fair value 'surged', when in fact it dropped sharply—by more than 70% in asset value—from 2022 to 2023. The 2024 fair value is reported as $387M, which does not match the ground truth of $100M in assets and $102M in liabilities. (3) The reasoning is flawed: the conclusion that NEE increased its position due to rising market prices contradicts the actual trend of de-risking and reducing exposure. The original answer indicates a strategic de-risking, which the LLM partially captures in 2024 but misrepresents in prior years. (4) While the LLM attempts to address the evolution of exposure and interpret volatility in terms of risk positioning, the analysis is based on fabricated data. The contextual relevance is moderate because it addresses the right topic (gas options, fair value, volatility, risk positioning), but the factual foundation is entirely wrong. Multi-hop synthesis fails because the model does not correctly retrieve or connect the actual financial metrics across years. Minor note: 'NEE' is an acceptable ticker for NextEra Energy, so entity identification is correct, but all financial metrics and trends are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 472,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike repeatedly placed FlyEase in the same “proliferation of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, ZoomX, Air Max and React technologies” list (2022 Form 10‑K p. 6; 2024 Form 10‑K p. 6), showing that the company continued to treat FlyEase as a core, strategic innovation pillar.  The 2024 filing expands the narrative around FlyEase—integrating it into the broader technology portfolio and emphasizing its role in product development—while earlier filings merely introduced it alongside other breakthrough platforms.  This steady inclusion signals that FlyEase has evolved from a niche adaptive‑footwear concept into a central element of Nike’s innovation strategy, driving product differentiation and reinforcing the firm’s focus on inclusive, high‑performance design.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of FlyEase from 2022 to 2024, noting its initial introduction alongside other technologies in 2022 and its continued presence in 2024 as part of Nike's core innovation portfolio. The claim that FlyEase was listed in the same technology proliferation list in both 2022 and 2024 filings (with page references) matches the expected trajectory in the original answer. (2) There are no numerical values requiring calculation, but the fiscal years (2022–2024) are correctly used and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across years, infers strategic progression from repeated inclusion and narrative expansion, and correctly interprets the growing emphasis on FlyEase as a sign of strategic integration. (4) While the original answer explicitly states that FlyEase evolved 'from a newly introduced concept to a foundational element,' the LLM captures this progression by describing it as moving 'from a niche adaptive-footwear concept into a central element.' The only minor gap is that the LLM does not explicitly mention the 2023 expansion phase (e.g., integration into various categories), which is noted in the ground truth. However, the overall trajectory and conclusion are semantically equivalent and well-supported. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission in granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 423,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – 35A** remained essentially unchanged: a **$750 million, 2.65 % fixed‑rate tranche** with an annual debt‑service charge of about **$19.9 million** and a maturity in **July 2030**.  The 2022, 2023 and 2024 10‑K filings all list the same face amount, coupon and maturity, indicating that SPG has deliberately kept this long‑dated, low‑cost obligation on the books rather than retiring or refinancing it.  This consistency reflects a broader long‑term debt strategy of **locking in inexpensive, fixed‑rate financing and extending maturities**, thereby preserving liquidity and minimizing refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key quantitative values. The ground truth states the face amount is $750,000, not $750 million — this is a 1,000-fold error. Similarly, the annual debt service is $19,875, not $19.9 million, which again reflects a massive miscalculation. The interest rate (2.65%) and maturity date (07/15/30 or July 2030) are correctly identified and consistent across years, which is accurate. (2) Quantitative accuracy is severely compromised: $750,000 vs $750 million and $19,875 vs $19.9 million are not format variations but fundamental errors. The correct annual debt service can be verified as $750,000 × 2.65% = $19,875, not millions. The LLM likely misread 'thousands' as 'millions', a critical mistake in financial analysis. (3) The qualitative reasoning about SPG's long-term debt strategy — locking in low-cost, fixed-rate financing and avoiding refinancing risk — is logically sound and aligns with the stable terms observed in the data. This reflects appropriate multi-hop synthesis across years and correct interpretation of strategic intent. (4) Despite correct reasoning and entity identification (SPG, Unsecured Notes - 35A, correct years, correct maturity), the magnitude of the numerical errors undermines the factual foundation of the answer. Hence, correctness and quantitative accuracy scores are low, while qualitative reasoning and relevance to the question remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 398,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its analog‑embedded portfolio—revenue was about $3.26 bn in 2022, rose modestly to $3.37 bn in 2023 before slipping to $2.53 bn in 2024, while operating margins fell from roughly 38 % to 30 % and then to 14 %.  Despite the revenue volatility and margin compression, the company continued to allocate capital to protect and expand this segment because its strong cash‑flow generation is the engine behind TI’s long‑term objective of growing free‑cash‑flow‑per‑share and delivering sustained shareholder returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. The ground truth does not mention any specific revenue figures or operating margins for embedded processing products in 2022, 2023, or 2024, nor does the knowledge graph indicate a drop in revenue from $3.37B to $2.53B or a decline in operating margins from 38% to 14%. These numbers are fabricated or hallucinated. There is no support in the original answer for any financial performance metrics of embedded processing beyond strategic emphasis. (2) The quantitative claims—$3.26B, $3.37B, $2.53B revenues and 38%, 30%, 14% margins—are entirely absent from the ground truth and contradict the narrative of consistent strategic positioning tied to long-term free cash flow growth. Such severe margin compression would undermine the claim of embedded processing being a high-margin, scalable segment, yet the LLM still concludes it supports cash flow—creating internal inconsistency. (3) The multi-hop reasoning is partially sound in structure: the LLM attempts to link strategic emphasis, capital allocation, and free cash flow per share objectives across years. However, it fails to accurately reflect the actual reasoning in the original answer, which emphasizes consistency in strategic narrative and competitive advantages—not financial performance trends. The core insight about TI viewing embedded processing as foundational to its business model and free cash flow goals is relevant but undermined by false data. (4) The contextual relevance is moderate because the answer addresses the right topic and attempts to connect strategy to financial objectives. However, the hallucinated numbers severely damage correctness. A score of 2 is justified because while the general direction of reasoning aligns with the question, the answer is factually wrong on key metrics and thus misleading. Quantitative accuracy is 1 due to complete lack of factual support for all numbers. Qualitative accuracy is 3 because the conceptual framework (strategy → capital allocation → cash flow) is partially valid but distorted. Contextual relevance is 6 because the topic and structure are appropriate, even if content is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 595,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from a background library asset to a **top‑level navigation tile on Disney+**, promoting Marvel titles as a primary draw for U.S. subscribers by 2023 and keeping that prominence in 2024; this is reflected in the company’s intangible‑asset schedule, where Marvel‑related trademarks are classified as **indefinite‑lived intangibles valued at roughly $1.8 bn** and remain a core component of the $10.7 bn net intangible assets reported for 2024. By treating Marvel as a marquee streaming brand, Disney is using the franchise as a **financial lever to acquire and retain Disney+ subscribers**, directing resources toward Marvel‑centric content and marketing to drive subscriber growth and justify the high valuation of its streaming‑related intangibles.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the strategic evolution of Marvel on Disney+ from 2022 to 2024, noting its transition from a background intangible asset to a top-level tile by 2023 and sustained prominence in 2024. It accurately identifies Marvel as an indefinite-lived intangible asset and links this to Disney's financial strategy of leveraging brand equity to drive subscriber growth and justify asset valuation. The core reasoning about using Marvel as a financial lever for subscriber acquisition and retention aligns well with the ground truth.\n\n2) However, there are significant quantitative inaccuracies: the LLM states that Marvel-related trademarks are valued at 'roughly $1.8 bn' and part of a $10.7 bn net intangible asset figure for 2024. These specific dollar amounts (1.8B and 10.7B) do not appear in the original answer and are not supported by the provided ground truth. The original answer mentions Marvel's classification as an indefinite-lived intangible but does not provide any monetary valuation. This introduces fabricated financial data, which is a serious error in financial evaluation contexts.\n\n3) The multi-hop reasoning is strong: the model connects Marvel's balance sheet treatment (as an intangible asset) with its strategic deployment on Disney+ (as a UI tile), and infers a broader financial strategy linking brand utilization to subscriber growth. It also correctly references the timeline (2022–2024) and the significance of the top-level tile placement as a competitive differentiator. While the original answer mentions ESPN+ being planned as a tile for fiscal 2025, the LLM omits this detail but still captures the broader strategic pattern.\n\n4) Despite the numerical inaccuracies, the qualitative and contextual understanding is excellent. The answer addresses all key aspects of the question—strategic evolution, financial implications, subscriber growth, and brand valuation—and synthesizes across years and domains (accounting and platform strategy). The invented figures reduce confidence in financial precision, but the overall direction and logic are sound. Hence, a score of 8 is justified: core facts and reasoning are correct, but with notable quantitative overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 593,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nMetLife continued to reinsure roughly 59 % (originally 59.25 %) of its closed block through a modified‑coinsurance agreement in each year from 2022 through 2024.  The associated reinsurance‑recoverable balances expanded dramatically—from about $1.8 billion of deposit assets (and $1.4 billion of deposit liabilities) reported at the end of 2021/2022 to $10.3 billion of recoverables recorded in 2023 after the Global Atlantic risk‑transfer, and to $4.6 billion of deposit assets (offset by a $1.2 billion deposit liability) reported at year‑end 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, in 2022, MetLife reinsured 59.25% of the closed block with $3.6 billion in unsecured reinsurance recoverable balances. The LLM correctly notes the initial percentage (~59.25%) but incorrectly states that roughly 59% was maintained through 2024 without mentioning the slight drop from 59.25% to 59% in 2023. More critically, the reinsurance recoverable balances are completely misrepresented: the LLM claims $1.8 billion in 2021/2022, $10.3 billion in 2023, and $4.6 billion in 2024, whereas the ground truth reports $3.6B (2022), $4.4B (2023), and $4.2B (2024). The $10.3B figure appears to conflate or misinterpret the Global Atlantic risk transfer, which is not reflected in the verified data. (2) The LLM introduces 'deposit assets' and 'deposit liabilities' not mentioned in the original answer and irrelevant to the question about reinsurance recoverable balances. These figures do not align with the concept of 'unsecured reinsurance recoverable balances' specified in the ground truth. (3) The multi-hop reasoning is flawed: while the model attempts to track changes over time, it fails to accurately synthesize the correct metrics across years. It references a 'Global Atlantic risk-transfer' as a causal event, but this context is absent from the ground truth and leads to incorrect inferences. (4) Despite incorrect numbers and mischaracterized balances, the LLM captures the general trend of stable reinsurance percentage (~59%) over the period, which provides partial relevance. However, due to major quantitative errors and introduction of incorrect financial concepts, the overall correctness score is low. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is partially sound but based on wrong data (score 4), and contextual relevance is moderate since it addresses the right topic and timeframe (score 6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 533,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nCVS grew its residential mortgage‑backed securities portfolio from roughly $44 million in 2022 to $51 million in 2023 and $71 million in 2024—a near‑60 % increase over the three‑year span. This uptrend signals a deliberate shift toward higher‑yielding, interest‑rate‑sensitive fixed‑income assets, raising the company’s exposure to rate and prepayment risk while positioning the portfolio for modest income growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, CVS's investment in RMBS was $629M in 2022, decreased to $614M in 2023, and then dropped sharply to $71M in 2024. The LLM claims the portfolio grew from $44M in 2022 to $51M in 2023 to $71M in 2024—this is not only wrong numerically but reverses the actual trend. The correct trend is a significant reduction after high exposure, while the LLM describes a steady increase. (2) All dollar amounts are incorrect: $44M vs $629M (2022), $51M vs $614M (2023), $71M vs $71M (2024) — only the 2024 number coincidentally matches. The claimed 'near-60% increase' is based on false data and contradicts the actual 89% decline from 2022 to 2024. Additionally, the LLM omits key information about unrealized losses increasing from $10M to $60M, which is critical to assessing risk exposure. (3) The multi-hop reasoning is fundamentally flawed: instead of identifying a de-risking strategy in 2024, the model infers increased risk-taking, which is the opposite of the truth. It fails to synthesize the correct data points across years and misinterprets the strategic implication. (4) The contextual relevance is low because it addresses the right topic (RMBS and risk), but with fabricated data and inverted trends, leading to misleading conclusions. Scores are low due to catastrophic failure in quantitative accuracy and reasoning, with only minimal relevance to the question's domain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 413,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure roughly **59 % of its closed block** (59.25 % in 2022, 59 % in 2023‑2024) via a modified‑coinsurance agreement with an external reinsurer.  The company has consistently applied the **deposit method**, recording a deposit asset and a matching deposit liability and offsetting the liability against the asset; the percentage of the closed block ceded remained essentially unchanged, while the absolute deposit balances and related amortization of DAC/VOBA evolved in line with the transaction activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 59.25% in 2022 and 59% in 2023–2024 match the original answer exactly. The use of 'roughly 59%' is a reasonable summary. (2) The accounting treatment under the deposit method is correctly described, including the offsetting of the deposit liability with the asset (i.e., the right of offset), which matches the ground truth's mention of offsetting the modified coinsurance deposit liability with the deposit recoverable. (3) The reasoning is sound and reflects a correct synthesis across years and accounting policies, showing stability in both reinsurance percentage and method. (4) The only minor omission is that the LLM does not explicitly name the reinsurer as 'unaffiliated third-party' as in the original, though 'external reinsurer' is semantically close. Also, the LLM mentions evolution in DAC/VOBA amortization and deposit balances, which adds context not in the original but does not contradict it—this is a minor expansion rather than an error. Overall, the answer captures the core multi-hop elements: percentage reinsured over time and consistent accounting treatment. Thus, the correctness score is 9 due to near-perfect factual alignment with only negligible contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 366,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s net notional exposure to natural‑gas forward contracts shifted from roughly ‑1.3 trillion MMBtu in 2022 to ‑1.45 trillion MMBtu in 2023 (an increase in short exposure) and then to ‑1.13 trillion MMBtu in 2024 (a reduction of that short position). This pattern shows the company expanded its gas‑price hedging during the heightened volatility of 2023 but trimmed the hedge in 2024, indicating a more measured or risk‑balanced positioning in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data. The ground truth states that NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022, increased to $300 million in 2023, and declined to $250 million in 2024. The LLM instead reports notional exposure in MMBtu (‑1.3 trillion, ‑1.45 trillion, ‑1.13 trillion), which is a completely different metric (volume of gas, not financial exposure in dollars) and not mentioned in the original answer. There is no correspondence between the financial figures provided in the ground truth and the physical volume figures used by the LLM. (2) The calculations and units are entirely mismatched: the original answer discusses net financial exposure (assets minus liabilities in millions of dollars), while the LLM discusses notional volume in MMBtu, implying a directional (short) position, which is not supported by the ground truth. The trend described—increasing short exposure in 2023 and reducing it in 2024—cannot be validated from the ground truth, which only provides financial asset/liability values, not directional trading positions. (3) The multi-hop reasoning is flawed because the LLM appears to have either hallucinated data or pulled information from an external, incorrect source. It fails to synthesize the correct financial data across years as required. The conclusion about 'hedging during volatility' and 'measured risk positioning' is plausible but based on incorrect data, so the reasoning chain is unsound. (4) Despite the incorrect numbers and metrics, the LLM attempts to address the question’s intent—analyzing evolution and risk positioning—and provides a coherent narrative, which justifies moderate contextual relevance. However, factual inaccuracy severely undermines correctness. Quantitative accuracy is extremely low due to fabricated metrics; qualitative accuracy is low due to incorrect entities and reasoning; contextual relevance is acceptable because the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 547,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom broadened the positioning of its industrial fiber‑optic products from a niche add‑on to a core element of a diversified industrial portfolio.  The company expanded the technology’s application scope—targeting industrial automation, renewable‑energy systems, medical equipment, defense/aerospace and electric‑vehicle powertrains—and began offering fiber‑optic modules that are tightly co‑integrated with motion‑encoder interfaces and Ethernet ICs, delivering end‑to‑end sensor‑to‑network solutions for smart‑factory and automotive use cases.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of AVGO's positioning of Industrial Fiber Optics from 2022 to 2024. It correctly identifies the expansion in application scope (industrial automation, medical, defense, EVs, renewable energy) and the integration with motion encoders and Ethernet ICs, aligning with the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect), and the time frame is correctly referenced. The answer conveys the strategic shift toward integrated solutions and end-to-end systems, which matches the ground truth's emphasis on moving from standalone components to interconnected systems. However, it omits specific details about the evolving groupings year-over-year: while it mentions co-integration with motion encoders and Ethernet ICs, it does not distinguish how the integration deepened over time—specifically, the 2024 linkage with Ethernet PHYs, switch ICs, and camera microcontrollers as part of networked and vision-based systems. This nuance in the progression (from broader alignment in 2023 to explicit network/vision integration in 2024) is missing, resulting in a slightly less precise qualitative portrayal of the multi-hop evolution. Despite this, the answer remains semantically close and contextually highly relevant, accurately reflecting the overall strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 377,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the redeemable preferred stock that Sojitz America holds has not changed – it remains a $0.3 million, $1‑par share that is redeemable at par and carries a cumulative $0.10 per share dividend payable each May 31. Because that dividend must be paid in full before any common‑stock dividend can be declared, the priority obligation stayed the same, and Nike’s charter prohibits any additional preferred issuance, leaving the stock structure stable with no modifications across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $0.3 million par value, $1 par per share, $0.10 annual dividend, and May 31 payment date are consistent with the original answer (minor additional detail not in ground truth but not contradictory). (2) Quantitative elements are precise: $0.3 million total value and $0.10 per share dividend match exactly; no calculation errors. (3) Multi-hop reasoning is sound—the answer synthesizes structural stability, dividend priority, and lack of changes across fiscal years 2022–2024, correctly noting the cumulative dividend requirement and charter restrictions. (4) The answer fully addresses the evolution (or lack thereof) in financial implications, emphasizing consistent obligations and structural stability. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. All aspects of the question—dividend obligations, stock structure stability, and temporal evolution—are properly covered.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 294,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – Series 31B remained unchanged from the 2022 filing through the 2024 filings: the note carries a fixed 3.25 % interest rate, a $750 million face amount (shown as $750,000 thousands), an annual debt‑service charge of roughly $24.4 million (≈ $24,375 thousands), and a maturity date of 11/30/26. No amendments, retirements, or additional issuances of this series are reported in the 2023 or 2024 tables, indicating that SPG is simply holding the instrument to term. This steady‑state treatment reflects a long‑term financing strategy of locking in low‑cost, medium‑term fixed‑rate debt and minimizing refinancing risk within its overall unsecured‑debt portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the unsecured debt amount ($750 million, correctly interpreted as $750,000 thousands), fixed interest rate (3.25%), maturity date (November 30, 2026), and the absence of changes across 2022–2024 are all correctly reported. (2) Quantitative accuracy is precise—$750 million is correctly represented in thousands, and the annual debt-service calculation (3.25% of $750M = $24.375M) is accurate and properly rounded. (3) The multi-hop reasoning is sound: the model correctly infers that no amendments, retirements, or new issuances occurred over the three years, indicating a stable financing strategy. It also contextualizes this within SPG’s broader debt portfolio activity (e.g., new Unsecured Notes - 41A in 2024) without conflating instruments. (4) The qualitative interpretation—that SPG is holding the note to term to maintain low-cost, fixed-rate financing and avoid refinancing risk—aligns perfectly with the ground truth’s conclusion about long-term strategy. The answer is complete, factually precise, and contextually appropriate, addressing both the evolution (no change) and strategic implication (stability, risk mitigation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 349,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from roughly **$940 million (≈6 million shares) at the end of 2022** to **$873 million (≈5 million shares) at the end of 2023**, and then to **$852 million (still ≈5 million shares) at the end of 2024**. This three‑year decline reflects a falling TI share price and the fact that the common‑stock fund has been frozen to new contributions, so employee exposure to the stock is essentially static while market value erodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values ($940M in 2022, $873M in 2023, $852M in 2024) and matches the ground truth exactly in terms of financial figures and years. It also accurately notes the decline over the three-year period. The inclusion of share counts (6M to 5M) is consistent with the downward trend and does not contradict the ground truth, though these specific share numbers were not in the original answer; however, they are plausible and do not introduce factual error. (2) All quantitative data are accurate: the values match the ground truth precisely, and the direction of change (decline) is correctly described. No calculation errors are present. (3) The reasoning is sound: the LLM correctly identifies the freeze on new contributions (a key fact from the knowledge graph, referenced as starting in 2016) and links it to static employee exposure. It also appropriately attributes part of the decline to falling share prices, which aligns with market valuation shifts mentioned in the original. The synthesis across time and causal factors (employee behavior, fund policy, market trends) demonstrates strong multi-hop reasoning. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (share counts, explicit mention of share price decline), but no factual deviation. The only minor gap is that the original mentions 'strategic reduction in stock allocations by employees' as a possible factor, which the LLM does not explicitly state—instead focusing on the fund freeze and market erosion. This omission slightly reduces qualitative accuracy but does not invalidate the conclusion. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 474,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Disney’s workforce expanded modestly—total headcount rose from roughly 220,000 (≈ 166,000 U.S. and 54,000 international) to about 233,000 (≈ 171,000 U.S. and 62,000 international), with the U.S. share falling slightly from ~75 % to ~73 % while the international portion grew from ~25 % to ~27 %.  The proportion of seasonal workers also edged up from about 7 % of the global staff in 2022 to roughly 8 % by 2024, reflecting a modestly larger contingent of temporary labor across the parks and resorts.  A growing share of employees—now covering roughly 76 % full‑time, 16 % part‑time and 8 % seasonal—are represented through collective‑bargaining agreements, works councils and employee resource groups, and the company continues to emphasize DEI‑focused programs such as Disney Aspire, the Heroes Work Here veteran initiative and over 100 employee‑led Business Employee Resource Groups.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data from the ground truth: total workforce (220,000 in 2022 → 233,000 in 2024), U.S. (166,000 → 171,000), international (54,000 → 62,000), and seasonal employee percentages (7% → 8%). All numbers match exactly or are appropriately approximated (e.g., 'roughly', 'about'). (2) Calculations are accurate: U.S. share in 2022 is ~75.45% (166k/220k), correctly rounded to ~75%; in 2024, 171k/233k ≈ 73.4%, correctly stated as ~73%. International shares (~25% → ~27%) are also accurate. The seasonal increase from 7% to 8% is correctly reported. (3) Multi-hop reasoning is sound: the answer synthesizes workforce size, geographic distribution, and seasonal trends across three years, correctly identifying growth patterns and shifts in composition. It also correctly notes the continuation of employee representation mechanisms. (4) The only minor deviation is the addition of specific details not in the original answer—such as breakdowns into full-time (76%), part-time (16%), and expanded DEI programs (Disney Aspire, Heroes Work Here, 100+ resource groups). While these may be factually accurate, they are not part of the ground truth and slightly exceed the scope of the provided information. However, they do not contradict the original answer and add context without distorting facts. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 427,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes (e.g., goodwill impairments) from its ROIC calculations across 2022, 2023 and 2024, as expressly noted in the definition on page 45 and reflected in the ROIC tables for each year. This steady exclusion shows that the company deliberately isolates the returns generated by its core operations, ensuring that ROIC reflects underlying performance rather than one‑off accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly identified and referenced. (3) The multi-hop reasoning is sound—by synthesizing information across three years and noting the consistent methodology, the model correctly infers GD's strategic intent to focus on core operational performance. (4) The LLM adds contextual detail (e.g., reference to page 45 and examples like goodwill impairments) that aligns with and supports the original conclusion about stability in performance measurement. The reasoning about isolating core operations and avoiding accounting volatility mirrors the original answer’s interpretation. All entities—GD, ROIC, non-economic accounting changes, and the time frame—are accurately identified and correctly used. The answer fully addresses both parts of the question: the evolution (consistency over time) and what it reveals about GD’s performance measurement philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 350,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde progressively shifted its rare‑gas business from a pure merchant‑bulk model to an integrated on‑site/engineering offering.  In the 2022 filing (pp. 94‑98) the company described rare gases only as co‑products of its atmospheric‑gas plants and noted that they are sold mainly through the three distribution methods (on‑site, merchant and packaged).  By the 2023 and 2024 filings (pp. 2‑6, 98‑102) the segment tables show a growing share of engineering sales and a disclosed estimate of ≈ $48 bn of future minimum purchase obligations tied to long‑term on‑site contracts, while contract‑liability balances fell and revenue‑recognition policies were updated to treat on‑site and engineering projects as performance obligations satisfied over time.  This evolution—leveraging co‑produced rare gases within long‑term supply agreements and engineering contracts—demonstrates that Linde’s competitive advantage rests on its ability to lock in captive demand, monetize rare‑gas co‑production through plant design and long‑term pricing, and protect margins in a fragmented market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents Linde's rare gas production strategy evolution from 2022 to 2024. (1) Quantitatively, the claim of '≈ $48 bn of future minimum purchase obligations' is incorrect and not supported by the ground truth; no such figure appears in the original answer or context, and this number is implausibly large for this context. Additionally, there is no mention in the ground truth of segment tables showing growing engineering sales, changes in contract-liability balances, or updated revenue-recognition policies—these are fabrications or hallucinations. (2) The qualitative analysis mischaracterizes the strategic evolution: the original answer emphasizes a shift toward non-cryogenic air separation technologies (e.g., VPSA, membrane separation) as a technological differentiator, while the LLM focuses on a shift from merchant to on-site/engineering models, which is not mentioned in the ground truth. The core advancement—Linde becoming a market leader in non-cryogenic air separation by 2024—is entirely omitted. (3) Multi-hop reasoning is flawed: the LLM synthesizes non-existent trends across years (e.g., changes in contract liabilities, performance obligations) rather than correctly identifying the technological progression in production methods. (4) Contextual relevance is moderate because the answer addresses Linde’s rare gas business and competitive advantage, but the reasoning and evidence are misaligned with the actual source material. The correct answer centers on technological innovation enhancing production efficiency; the LLM instead invents a narrative around long-term contracts and engineering monetization. Thus, while the topic is relevant, the factual and logical foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 481,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral PPAs grew modestly—from roughly 92 % of capacity (the level reported for 2021‑22) to about 94 % by the end of 2024—while the remaining capacity was sold into spot markets or hedged with shorter‑term contracts.  This steady increase shows that NEER is deliberately locking in fixed‑price revenue streams for the bulk of its output, thereby insulating its cash flows from the price swings of wholesale electricity markets and reinforcing its overall risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports that NEER's reliance on long-term bilateral contracts increased from approximately 92% to 94% from 2022 to 2024. The ground truth specifies 92% in 2022, 94% in 2023, and 94% in 2024, indicating stability after the increase. The LLM slightly misrepresents the timeline by stating the increase went to 94% by 'the end of 2024' and references '2021-22' as the baseline, which is not fully aligned with the original breakdown by year. However, the core numbers (92% → 94%) are correct, and the trend is accurately characterized as a modest increase.\n\n2) Quantitatively, the percentages (92%, 94%) match the ground truth. The LLM combines 2021–2022 data, which introduces a minor inaccuracy in period labeling, but since the 92% figure is correct for 2022, this does not constitute a factual error in value—only in temporal framing. The statement that the level remained at 94% through 2024 aligns with the original answer.\n\n3) The reasoning is sound: the LLM correctly infers that increasing reliance on long-term contracts indicates a risk-mitigation strategy aimed at stabilizing revenue and protecting against volatility in wholesale markets. It appropriately connects the contractual trend to cash flow insulation and risk management, mirroring the original answer’s logic. The mention of shorter-term hedges and spot market sales adds context not in the original but does not contradict it.\n\n4) The answer is contextually highly relevant, addressing both the evolution of contract reliance and its implication for risk management. While the original answer notes the use of non-qualifying hedges (a detail omitted in the LLM response), this does not undermine the core conclusion. Overall, the LLM captures the essential multi-hop synthesis: tracking percentage changes over time and interpreting strategic intent—justifying a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 528,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 show a flat carrying balance of **$495 million** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 (see the “3.125 % notes due January 2025” line in the senior‑notes tables for Nov 3 2024 and Oct 29 2023).  This lack of change indicates that Broadcom is not actively paying down or refinancing this particular tranche; it is being retained as a low‑cost, long‑dated debt position that will be addressed only when the notes come due in January 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date) are accurate. 2) Quantitative accuracy is perfect: $495 million is consistently reported for all three years, and the note's terms (3.125%, January 2025 maturity) are correct. Format variations (e.g., '495 million' vs '$495M') are acceptable and semantically equivalent. 3) The reasoning is sound: the LLM correctly infers that the stable balance indicates no early retirement or refinancing, aligning with the ground truth's interpretation. It adds slightly more context by characterizing the debt as 'low-cost, long-dated,' which is reasonable given the interest rate environment but not explicitly stated in the ground truth—this is a minor extrapolation but not inaccurate. 4) The answer fully addresses both parts of the question: the evolution (flat balance) and the implication for debt management strategy (no active paydown, to be addressed at maturity). The use of specific filing dates (Nov 3, 2024, Oct 29, 2023) adds verifiability and supports multi-hop synthesis from actual disclosures. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a minor deduction in qualitative accuracy for slight interpretive addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 401,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nSPG’s Unsecured Notes – 37B kept the same structural terms throughout the 2022‑2024 filings: a $700 million face amount (reported as $700,000 thousand) and a maturity date of **15 January 2032** in each year.  The company did not grow the issuance of this series, but it used the 37B note to replace shorter‑dated unsecured debt (e.g., the 37A tranche that matured in 2023), thereby extending the overall maturity profile and locking in a low‑coupon, fixed‑rate financing for the next decade.  This pattern reveals SPG’s long‑term debt strategy of **extending debt maturities and increasing the share of long‑dated, fixed‑rate unsecured obligations** to reduce rollover risk and support its growth and sustainability initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the face amount: it states $700 million (i.e., $700,000,000), whereas the ground truth specifies $700,000 (i.e., $0.7 million). This is a 1000x overstatement and a major quantitative inaccuracy. The maturity date (01/15/32 or January 15, 2032) is correctly reported. (2) The LLM incorrectly claims that the $700,000 thousand equals $700 million — this is false: $700,000 thousand = $700 million only if 'thousand' is misread; actually, $700,000 thousand = $700 million is correct in standard financial notation, but the original ground truth states the face amount as $700,000, not $700,000 thousand. There is a contradiction in the data interpretation. However, assuming the ground truth is definitive at $700,000, the LLM’s $700 million is wrong. (3) The qualitative reasoning about SPG’s long-term debt strategy — extending maturities, replacing shorter-dated debt like 37A, reducing rollover risk — goes beyond the ground truth, which only states that the note remained unchanged and implies stability. While plausible, this inference is not supported by the provided ground truth and introduces unverified claims. (4) The contextual relevance is high because the answer addresses face amount, maturity, and strategy across 2022–2024. However, the correctness score is reduced to 6 due to the severe numerical error and unsupported strategic interpretation, despite correct dates and logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 407,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nTexas Instruments’ Melaka, Malaysia site is listed in the property tables for the 2022, 2023 and 2024 Form 10‑K filings under the **Analog** column (with an “X”) and **never** under the Embedded‑Processing column.  The disclosures show the facility as an analog‑only manufacturing location—indicating that its role in the company’s analog product line has remained unchanged across the three years, with no reported shift or expansion into embedded‑processing activities.  The only variations are the footnote symbols and the reported square‑footage/lease details, but the product‑line classification stays consistently analog.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was consistently listed under analog operations in 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer's key claim of a stable, specialized analog-only role. (2) There are no numeric values requiring calculation (e.g., square footage or financials), but the answer correctly references the presence of 'X' marks in the Analog column and absence in Embedded-Processing across all three years, which aligns with the ground truth's 'checkmark' notation. Format variations (e.g., 'X' vs checkmark) are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two product lines from TI's 10-K filings, confirming no change over time and no expansion into embedded processing. (4) All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing, 2022–2024) are correctly identified and contextualized. The answer is highly relevant, complete, and factually precise, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 331,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney’s post‑production fees paid to Industrial Light & Magic have been captured in the **“Other revenue”** line of the Content Sales/Licensing segment, which aggregates all ancillary earnings such as music licensing, stage‑play fees and post‑production services. Across fiscal 2022, 2023 and 2024 this line item showed no material change, indicating that Disney’s reliance on ILM for post‑production services remained steady and was not reflected as a separate or growing revenue stream within the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct structural information but diverges significantly from the ground truth in key qualitative aspects. (1) It correctly identifies that Industrial Light & Magic (ILM) is part of the Content Sales/Licensing segment and associated with post-production services, and it plausibly places these services within the 'Other revenue' line item. However, the claim that this line item 'showed no material change' across fiscal 2022–2024 is unsupported by the original answer, which does not provide any quantitative data about revenue trends or stability. This introduces a false quantitative assertion. (2) The original answer emphasizes an evolving narrative and strategic repositioning of ILM within Disney’s broader content licensing and DTC-first model, with shifting emphasis in segment reporting—not revenue stability. The LLM incorrectly frames the evolution as one of static reliance due to lack of material change in a specific line item, which contradicts the ground truth’s emphasis on structural and narrative shifts. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies ILM’s segment placement, it fails to synthesize the evolving segment structure and strategic context across years as described in the original answer. Instead, it asserts revenue stability without evidence, missing the core theme of strategic repositioning. (4) Entity accuracy (ILM, Content Sales/Licensing, fiscal years 2022–2024) and general segment structure are correct, supporting a moderate score in quantitative accuracy. However, the qualitative misrepresentation of the evolution as financially stable rather than contextually shifting results in a low qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right segment and service provider but mischaracterizes the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 503,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures dropped sharply from **$1.30 billion in 2022 to just $0.15 billion in 2023**, then recovered to **$0.99 billion in 2024**. This swing shows a steep earnings decline in 2023 followed by only a partial rebound, indicating that the insurance‑underwriting joint ventures underperformed dramatically in 2023 and, even after the 2024 recovery, remain well below their prior profitability level—suggesting continued weakness or a strategic reduction in those ventures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the trend in MetLife's equity method investment income across 2022–2024 with accurate figures: $1.305 billion in 2022, $151 million in 2023, and $988 million in 2024. The LLM uses rounded values ($1.30B, $0.15B, $0.99B), which are acceptable approximations and do not affect factual correctness. 2) Quantitatively, the numbers are accurate within reasonable rounding: $1,305M ≈ $1.30B, $151M ≈ $0.15B, $988M ≈ $0.99B. No calculation errors are present. 3) The reasoning correctly captures the sharp decline in 2023 and the rebound in 2024. However, the LLM interprets the 2024 recovery as 'partial' and suggests 'continued weakness or strategic reduction,' which goes slightly beyond the ground truth. The original answer states the trend indicates 'volatility,' not necessarily ongoing weakness. This introduces a minor interpretive overreach. 4) The answer is contextually relevant, addressing both parts of the question: the evolution of income and what it suggests about performance. The synthesis across three years is sound, and the core multi-hop reasoning (tracking changes over time and inferring implications) is logical. The slight deduction in qualitative accuracy reflects the interpretive stretch, but overall, the answer is factually strong and well-aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 369,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics raised the number of Light‑Armored Vehicles it is building for the Canadian Army – roughly 360 units in 2022, about 399 units in 2023 and ≈ 449 units in 2024.  This upward production trend signals that the LAV platform has become a strategic growth pillar for GD’s Combat Systems segment, highlighting its importance to the company’s land‑vehicle portfolio and its long‑term defense‑sales strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the production volumes for LAVs for the Canadian Army: 360 units in 2022, 399 in 2023, and approximately 449 in 2024, matching the ground truth exactly in value (with acceptable rounding notation like '≈'). All numeric values and years are accurate.\n\n2) Quantitative accuracy is perfect: each year's production number is correct, and the progression (360 → 399 → 449) reflects a consistent increase, which the model correctly characterizes as an 'upward production trend'. No calculations were required beyond trend identification, which was handled correctly.\n\n3) The reasoning is sound and captures the multi-hop synthesis: the increasing production volume is correctly linked to the strategic importance of the LAV platform in GD's defense portfolio. The LLM appropriately infers that this growth signals strategic significance, referring to it as a 'strategic growth pillar' and emphasizing its role in the Combat Systems segment and long-term sales strategy—semantically equivalent to the ground truth's claim that the platform is 'increasingly central' and 'strategically important'.\n\n4) The only minor difference is in wording: the original emphasizes 'international markets' and 'global demand for modern, versatile armored combat vehicles', while the LLM focuses on 'Combat Systems segment' and 'land-vehicle portfolio'. These are complementary perspectives, but the LLM slightly underemphasizes the international market context. However, this does not detract from the core factual and inferential accuracy. Thus, qualitative accuracy is high but not perfect due to slight variation in emphasis.\n\nOverall, the answer is factually correct, contextually relevant, and logically sound, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 479,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership holdings grew from roughly **$225 million in 2022 to $237 million in 2023 and about $280 million in 2024**, a steady 20‑30 % increase over the three‑year span.  This upward trajectory shows that the pension fund is deliberately expanding its allocation to alternative‑asset strategies—consistent with the plan’s target 3‑4 % weighting in hedge funds—to boost long‑term returns and diversify the otherwise fixed‑income‑heavy portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. The ground truth states CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly reports $225M (vs $214M) in 2022, $237M (vs $225M) in 2023, and $280M (vs $252M) in 2024. These discrepancies affect both absolute values and implied growth rates. The claimed '20-30% increase' is inaccurate—the actual increase from 2022 to 2024 is ($252M - $214M) / $214M ≈ 17.7%, not 20-30%. (2) The LLM introduces unverified details not present in the original answer, such as a 'target 3-4% weighting in hedge funds' and strategic intent to 'boost long-term returns and diversify the otherwise fixed-income-heavy portfolio.' While plausible, these specifics are not supported by the ground truth and represent unsupported inference. (3) The multi-hop reasoning is partially sound in identifying a trend of increasing allocation, which aligns with the original answer’s conclusion about a deliberate strategy toward alternative investments. However, the incorrect numbers undermine the validity of the trend analysis. (4) Contextually, the answer addresses both parts of the question—evolution over time and strategic implication—but due to major quantitative errors and addition of unsupported qualitative claims, the overall correctness is low. Minor formatting variations in dollar amounts are acceptable, but the magnitude of numerical deviation here exceeds tolerable thresholds for accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 417,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nColgate‑Palmolive lists Sorriso among its principal global trademarks under the Oral, Personal and Home Care segment, and the brand’s performance is captured in the Oral‑Care net‑sales figure that accounted for roughly 43 % of worldwide sales in 2022, 42 % in 2023 and 43 % in 2024.  This stability shows that Sorriso has been maintained as a consistent component of the Oral‑Care portfolio, with the company continuing to integrate it into the same global distribution, marketing and pricing framework used for its other flagship oral‑care brands.  No material shift in its contribution or segmentation occurs across the three years, indicating a steady, fully integrated positioning within the company’s global Oral Care business.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that Sorriso is a regional trademark within Colgate-Palmolive's portfolio, with no mention of its specific contribution to Oral Care net sales or any percentage breakdown (e.g., 43%, 42%, 43%). These percentages are fabricated or incorrectly attributed to Sorriso’s performance, as the original answer does not provide any sales figures or market share data for the brand. There is no evidence in the ground truth that Sorriso’s performance is explicitly captured in the Oral-Care net-sales figures, nor that it contributed to those percentages. (2) The numbers cited (43%, 42%, 43%) are not present in the original answer and cannot be verified from the provided knowledge graph. This is a major quantitative error, as it introduces precise metrics that do not exist in the source data, undermining factual reliability. (3) The reasoning partially aligns with the ground truth in that it identifies Sorriso as a consistent part of the Oral, Personal and Home Care segment and notes stability in positioning. It correctly infers no material shift across years and consistent integration, which matches the original answer’s emphasis on continuity. However, it overreaches by implying Sorriso is fully integrated into the global Oral Care business and contributes meaningfully to global sales figures, while the original answer positions it as a regional brand asset, not necessarily a major global revenue driver. (4) The contextual relevance is high because the response addresses the evolution of Sorriso’s strategic positioning across the three years and ties it to the broader product portfolio. The qualitative accuracy is moderate because the core idea of stability and integration is correct, but the supporting data and level of integration are overstated. The correctness score is 5 due to the mix of accurate conceptual framing and serious factual/calculative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 542,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife’s equity‑method exposure to operating joint ventures contracted modestly – the carrying value of those investments fell from about **$25 billion to $24.9 billion**, and the related unfunded‑commitment exposure dropped from **≈ $6.7 billion to ≈ $5.8 billion**.  This reduction in both the size of the portfolio and the amount of future capital that must be funded, together with a sharp dip in net investment income from these ventures in 2023 followed by only a partial rebound in 2024, indicates that MetLife is deliberately **scaling back its joint‑venture holdings and re‑allocating capital toward more controlled, higher‑return investments**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further to $38 million in 2024. In contrast, the LLM claims the carrying value fell from $25 billion to $24.9 billion and cites unfunded commitments dropping from $6.7 billion to $5.8 billion—values that are off by orders of magnitude and not present in the ground truth. These numbers are fundamentally wrong and not supported by the provided data. (2) The quantitative discrepancy is severe: $77M vs $25B is a 325x difference in scale. Even allowing for format variations, there is no acceptable interpretation where $25 billion equals $77 million. Additionally, the LLM introduces metrics not mentioned in the original answer—such as unfunded commitments and net investment income trends—which are not part of the ground truth and appear to be hallucinated. (3) The multi-hop reasoning is flawed because the LLM did not correctly identify the trend from the actual data. Instead of recognizing a consistent and significant reduction in exposure from $77M to $38M over three years, it fabricates a narrative around a negligible change in a much larger portfolio, then draws an unsupported strategic conclusion about capital reallocation. While the direction of the trend (reduction) is correctly interpreted as a strategic shift, the magnitude and basis are entirely incorrect, undermining the validity of the inference. (4) The contextual relevance is low because the answer discusses different metrics and magnitudes, though it does attempt to address the strategic implication question. However, due to the gross factual inaccuracies, the overall correctness score is near zero. The qualitative accuracy is slightly above zero only because the general direction of the trend (reduction) aligns with the truth, albeit based on false numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 535,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron retained its 36.4 % equity stake in Angola LNG Limited, but its involvement deepened from a pure investor to an integrated upstream‑to‑LNG supplier. In 2024 the company added frontier deep‑water exploration rights (Blocks 49 and 50) and secured proved reserves in the New G as Consortium Project (the Quiluma‑Maboqueiro fields), whose gas will be routed to the Soyo LNG plant through an on‑shore treatment facility; it also broadened its participation in the Angola‑DRC and Angola‑ROC joint development areas, while continuing to operate the related PSA blocks. This upstream expansion ties new gas discoveries directly to the Angola LNG plant, reinforcing Chevron’s end‑to‑end gas strategy in the country.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Chevron's 36.4% stake in Angola LNG Limited, which matches the ground truth across 2022–2024. This is a key quantitative fact and is accurately preserved. However, the LLM introduces several unsupported claims that significantly deviate from the original answer. First, it states Chevron 'added frontier deep-water exploration rights (Blocks 49 and 50)' and 'secured proved reserves' in the New Gas Consortium Project (NGC) in 2024—information not present in the ground truth and potentially incorrect. The original answer notes Chevron has a 31% nonoperated working interest in NGC, but does not state Chevron secured new rights or proved reserves in 2024. Second, the LLM claims Chevron 'broadened its participation in the Angola-DRC and Angola-ROC joint development areas' and 'continuing to operate the related PSA blocks'—details absent from the ground truth and not corroborated. The original answer emphasizes a shift from passive investor to integrated supplier via feedstock linkage (e.g., Quiluma and Maboqueiro fields feeding Soyo plant), which the LLM captures in spirit but misattributes by overstating Chevron's operational role and new acquisitions. The qualitative shift toward integration is partially correct, but the reasoning is flawed due to fabricated upstream expansions. While the core idea of deeper integration with Angola LNG is contextually relevant and aligns with the question’s focus, the answer fails on factual completeness and entity accuracy due to invented projects and operational roles. Thus, while the strategic direction is plausibly framed, the factual basis is partially incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 458,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 were carried at **$622 million** at the end of fiscal 2022 and 2023 (the $622 million balance appears on the October 29 2023 sheet and is unchanged from the prior year).  By the end of fiscal 2024 the carrying amount had fallen to **$0**, reflecting the company’s full repayment of the notes using proceeds from the October 2024 and July 2024 $5 billion senior‑note issuances and other cash inflows.  This deliberate retirement of the near‑term obligation shows that AVGO’s debt‑management approach was to proactively refinance and retire its closest‑maturity debt, thereby extending the overall maturity profile and reducing near‑term cash‑flow pressure as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $622 million outstanding in 2022 and 2023, reduced to $0 in 2024, matching the original answer. The dates (October 2024 maturity) and interest rate (3.625%) are also accurate. (2) The answer correctly identifies the progression across fiscal years and confirms full retirement by 2024. (3) The reasoning is sound and adds value by specifying that repayment was funded by the October 2024 and July 2024 $5 billion senior note issuances—information not in the ground truth but consistent with plausible and likely correct context (assuming from source filings). This addition enhances the explanation without contradicting facts. (4) The conclusion about AVGO’s proactive debt management strategy—refinancing to extend maturities and reduce near-term pressure—is logically derived and semantically equivalent to the original answer’s interpretation. The only minor point preventing a perfect 10 is that the original answer does not confirm the source of repayment funds, so while the LLM’s detail is reasonable, it introduces unverified specifics. However, this does not constitute an error, just a slight over-specification. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 368,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nThe interest expense recorded for Unsecured Notes ‑ 35B was $28.5 million in 2022, $28.5 million in 2023 and $28.5 million in 2024.  This flat trajectory shows that SPG’s financing cost for this note has been essentially unchanged over the three‑year period, reflecting stable borrowing terms and a consistent outstanding balance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $28.5 million in each year (2022, 2023, 2024), which matches the ground truth of $28,500 (in thousands) — equivalent since $28,500,000 = $28.5 million. (2) The answer addresses all parts of the question: it describes the evolution of interest expense over time (stable across three years) and interprets the trend correctly, noting that the flat expense suggests stable financing costs. (3) Entities are accurate: SPG, Unsecured Notes - 35B, and correct fiscal years are used. (4) The reasoning is sound: the consistent interest expense implies a fixed-rate debt instrument with no change in principal, which aligns with the conclusion in the original answer about fixed interest rate structure. The LLM uses slightly different phrasing (e.g., 'stable borrowing terms' instead of 'fixed interest rate') but the meaning is consistent. No factual, quantitative, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 289,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney pivoted from a broadly diversified, linear‑media‑centric model to a strategy that places its direct‑to‑consumer (DTC) streaming services at the core of growth.  The company poured capital into expanding Disney+—including the launch of an ad‑supported tier, price increases and bundling—while simultaneously raising spend on content, sports‑rights and technology to fuel subscriber growth.  However, soaring programming and rights costs, coupled with intensified competition in the streaming arena, forced Disney to rationalize its linear networks, accelerate cost‑saving initiatives and tap additional financing to sustain its streaming expansion and fund the broader Experiences‑and‑cruise‑ship investments that now accompany its DTC push.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall strategic shift in Disney's DTC investment from 2022 to 2024 and correctly identifies key themes: increased spending on streaming, rising programming costs, intensified competition, and the pivot toward DTC as a core growth driver. It accurately notes strategic moves like the ad-supported tier, price increases, bundling, and cost-saving initiatives. However, it omits specific quantitative and qualitative details from the ground truth that are critical for full multi-hop accuracy. Notably, the original answer includes precise financial context—such as Disney’s $12.25 billion in unused bank facilities in 2023 and the explicit mention of negative or low returns on DTC investments in 2022—which the LLM answer fails to mention. While the LLM correctly infers financing and cost pressures, it does not cite this specific figure or the uncertainty in early returns, weakening the factual completeness. Additionally, the original highlights a shift in distribution deals (e.g., fewer linear networks but inclusion of DTC services), a nuanced competitive dynamic that the LLM does not address. The LLM uses general terms like 'soaring programming and rights costs' and 'intensified competition,' which are semantically aligned but lack the specificity of 'rising programming costs—especially for sports' and distributor demands affecting revenue growth. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), and the reasoning is logically sound, though not fully comprehensive. The answer is contextually relevant and well-structured, but partial omissions in entity-specific details and financial metrics reduce its qualitative and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 465,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record reinsurance treaties that do not expose it to a significant loss using the deposit method, recognizing the present‑value of recoverables as deposit assets and the present‑value of payables as deposit liabilities. The November 2023 risk‑transfer with Global Atlantic created a modified‑coinsurance arrangement that added a $10.3 billion deposit receivable (included in premiums, reinsurance and other receivables) and a $770 million net‑cost liability, pushing deposit assets to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit liabilities rose modestly to $1.3 billion in 2023 and fell to $1.2 billion in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of MetLife's use of the deposit method and correctly identifies the 2023 risk transfer with Global Atlantic as a key driver. It accurately notes the $10.3 billion deposit receivable from the transaction and the general trend of increasing deposit assets and declining liabilities by 2024. However, there are significant quantitative discrepancies. According to the ground truth, deposit assets were $1.8 billion in 2022, but the LLM does not state this baseline and instead implies a jump to $5.1 billion in 2023 without confirming the prior year. The ground truth reports deposit assets rising to $4.6 billion by end-2024, which the LLM correctly states, but it invents a $5.1 billion figure for 2023 not present in the original answer. Additionally, the LLM introduces a $770 million net-cost liability and claims deposit liabilities rose to $1.3 billion in 2023, whereas the original answer states liabilities declined slightly to $1.2 billion in 2024 from an unspecified 2023 level, with no mention of a $770M liability or 2023 liability increase. (2) The $10.3 billion receivable is correct, but the $5.1 billion 2023 deposit assets and $1.3 billion 2023 liabilities are unsupported by the ground truth. The original answer does not provide 2023 asset/liability figures, only 2022 and 2024, so the LLM's interpolation is speculative. (3) The multi-hop reasoning is sound in linking the Global Atlantic transaction to increased deposit method usage and subsequent rebalancing, and it correctly identifies the accounting treatment of modified coinsurance. The synthesis of the transaction impact and directional changes in assets/liabilities is logical and aligns with the original narrative. (4) The correctness score is 7 due to accurate qualitative trajectory and correct identification of key events, but docked for unsupported numerical claims. Quantitative accuracy is 6 due to partial number correctness but significant invented figures. Qualitative accuracy is 8 for strong reasoning and entity recognition. Contextual relevance is 10 as the answer directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 580,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 CVS trimmed its commercial‑mortgage‑backed‑securities (CMBS) position from roughly **$1.0 billion** in fair value (≈$1.018 bn reported in the 2022 debt‑securities table) to about **$0.98 bn** a year later (≈$975 m in the 2023 table), and then to **only $3 million** by the end of 2024 (the CMBS line in the Separate‑Accounts fair‑value table).  This downward trajectory reflects a deliberate de‑risking of the investment portfolio, with the company shifting capital away from illiquid CMBS toward more liquid or higher‑yielding assets to better align with its insurance cash‑flow and liability management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's CMBS exposure in 2022 and 2023. According to the ground truth, CVS held $574 million in CMBS in 2022 and $675 million in 2023, whereas the LLM claims approximately $1.018 billion in 2022 and $975 million in 2023—both figures are over 70% higher than actual. Only the 2024 value ($3 million) is correct. (2) The quantitative inaccuracies are severe: the LLM misrepresents the starting point and trend—claiming a slight decline from ~$1.0B to $0.98B before a drop to $3M, while the truth is an increase from $574M to $675M followed by a near-total exit. This distorts the trajectory. (3) The reasoning about de-risking and strategic shift is directionally consistent with the ground truth and shows appropriate multi-hop synthesis (noting the near-elimination by 2024 and inferring strategic reallocation), but the flawed data undermines the validity of the conclusion. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication) and uses appropriate financial terminology. However, due to major numerical errors in key data points, the correctness and quantitative accuracy scores are low. The qualitative score is moderate because the logic and interpretation are sound given the assumed data, but the foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 383,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the “hello” brand remained listed among Colgate‑Palmolive’s principal global trademarks in the “Nature of Operations” section, confirming continuous trademark protection.  Because “hello” is part of the Oral Care portfolio, its segment’s share of worldwide net sales stayed steady at roughly 42‑43 % in each of those years, reflecting a consistent strategic emphasis on the brand within the Oral, Personal and Home Care divisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 'hello' brand was consistently listed in Colgate-Palmolive’s principal trademarks across 2022–2024, which aligns with the ground truth regarding its ongoing disclosure and strategic positioning in the Oral, Personal and Home Care segments. However, the LLM introduces a specific quantitative claim—that the Oral Care segment accounted for 'roughly 42–43%' of worldwide net sales in each of those years—which is not present in the original answer and cannot be verified from the provided ground truth. This percentage is a significant addition that lacks support in the source data, making it factually unsupported. (2) The quantitative accuracy is low because the 42–43% figure is unverified and potentially incorrect; the original answer makes no mention of segment sales percentages or any numerical data, so this insertion undermines factual reliability. Even if the number were accurate, its absence in the ground truth means it cannot substantiate the conclusion. (3) The reasoning is partially sound: the model correctly infers continuity in trademark disclosure as a sign of stable strategic positioning, which reflects valid multi-hop synthesis across years. However, linking this to a precise sales percentage introduces unwarranted specificity and weakens the logical foundation. (4) Contextual relevance is high because the response directly addresses the evolution of the 'hello' brand across the three years and ties it to segment-level strategy. Qualitative accuracy is moderate due to correct entity and segment identification but docked for unsupported numerical claims. Correctness score is 6 due to core factual alignment but significant issue with invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 473,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record certain reinsurance arrangements that do not expose the reinsurer to a significant loss under the deposit method, most prominently the November 2023 modified‑coinsurance risk‑transfer with Global Atlantic.  Deposit‑related assets grew sharply from roughly $1.8 bn in the 2021‑22 period to $5.1 bn in 2023 and $4.6 bn in 2024, while deposit‑related liabilities rose from about $1.4 bn to $1.3 bn, indicating a strategic shift toward larger‑scale, capital‑efficient risk transfers.  This expansion reflects a deliberate reinsurance strategy to move substantial blocks of business onto a deposit basis—thereby managing capital and regulatory ratios—but also heightens exposure to counterparty credit and market‑risk volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core trend and strategic implications correctly: MetLife increased its use of the deposit method from 2022 to 2024, with rising deposit assets and relatively stable liabilities, indicating a shift toward capital-efficient reinsurance structures. The mention of the Global Atlantic transaction as a key driver aligns with the ground truth.\n\n2) Quantitative accuracy has minor but notable issues: The LLM states deposit assets were 'roughly $1.8 bn in the 2021-22 period', but the ground truth specifies $1.8 billion for 2022 alone (not an average or range across 2021–22). More significantly, the LLM claims deposit assets were $5.1 billion in 2023, which contradicts the ground truth (which does not report 2023 asset values explicitly but implies a rise to $4.6 billion by 2024; no $5.1 billion figure is supported). This overstatement in 2023 is a factual error. Liabilities are reported as rising to $1.3 billion, while the ground truth states $1.2 billion in 2024—close but not exact.\n\n3) Qualitatively, the reasoning is strong: the LLM correctly infers that increased use of the deposit method reflects a strategic move for capital and regulatory management, and appropriately links it to counterparty and market risk exposure. It identifies the correct accounting rationale (lack of significant loss exposure) and cites the Global Atlantic modified coinsurance transaction accurately as a key example.\n\n4) Contextual relevance is excellent—the response directly addresses the evolution of accounting practice, trends in assets/liabilities, and their implications for strategy and risk. Despite minor numerical inaccuracies, the overall synthesis across years and strategic interpretation is sound and matches the intent and substance of the ground truth. Hence, a correctness score of 8 is warranted: core facts and interpretation are correct, but with measurable quantitative discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 519,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds grew from about $4.4 bn in fair‑value (2022) to $5.3 bn (2023, which includes a $199 m Level‑3 tranche) and to roughly $9.8 bn carried on the balance sheet in 2024, reflecting added nuclear decommissioning and storm‑fund assets. The fair‑value disclosures now break the holdings into a three‑level hierarchy and detail the portfolio’s composition (equity, municipal bonds, corporate and ABS debt), while collateral requirements tied to credit‑risk‑related contingent features of NEE’s derivatives (cash and letters of credit of ≈$691 m and $1.6 bn posted in 2023) could be used to meet margin calls, even though the funds themselves are not directly pledged, and their regulatory‑asset/liability treatment means any posted collateral can offset related regulatory liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, but the LLM claims $5.3 billion in 2023 and $9.8 billion in 2024. The 2022 value is stated as $4.4 billion in the LLM answer, but the original answer does not provide a total fair value for 2022—only a $485 million component (equity investments without readily determinable fair values). The LLM incorrectly implies a total portfolio value for 2022 and 2023 that is not supported by the ground truth. Additionally, the LLM introduces a $199 million Level-3 tranche in 2023 and collateral postings of $691 million and $1.6 billion, which are not mentioned in the original answer and appear to be fabricated or misattributed. (2) The only correct numeric value is the 2024 balance sheet amount of $9.8 billion (or $9,800 million), which matches the ground truth. However, the increase from 2023 to 2024 is $1,102 million according to the original, but the LLM implies a much larger increase from a lower base, which is incorrect. (3) The qualitative reasoning partially aligns with the original: the LLM correctly infers enhanced disclosure practices and categorization of fair value hierarchy, and it correctly notes that Special Use Funds are not directly pledged but may support collateral requirements indirectly. It also correctly links regulatory treatment to collateral offset, which is a nuanced point. However, it fails to mention the growth in equity investments without readily determinable fair values from $485M to $538M, a key detail in the original. (4) The answer is contextually relevant and addresses all three aspects of the question—fair value disclosures, collateral implications, and balance sheet presentation—but the factual foundation is undermined by incorrect numbers and invented details. The reasoning shows an attempt at multi-hop synthesis (linking funds, collateral, and regulatory treatment), but the incorrect base values reduce reliability. The score reflects partial correctness with major quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 570,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a basic main‑frame posture‑assessment tool that simply identified risks and supplied ad‑hoc remediation guidance to a more tightly integrated remediation engine. By 2023 the platform was positioned to feed its findings directly into customers’ own SIEM and ticketing systems, and by 2024 it was described as delivering AI‑driven, automated remediation recommendations that plug into in‑house SOAR/ITSM workflows, enabling continuous, end‑to‑end risk mitigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims the Security Insights Platform evolved from a basic tool to an AI-driven, automated remediation engine with direct integration into SIEM, ticketing, SOAR, and ITSM workflows by 2024—however, the original answer states that AVGO's description remained consistent from 2022 to 2024, with no expansion on new integrations or remediation features. (2) There are no numeric values to verify, but the timeline (2022, 2023, 2024) is correctly referenced in structure, though the characterization of changes in each year is factually wrong. (3) The multi-hop reasoning fails: the model incorrectly infers progression and enhancement over time, whereas the ground truth emphasizes stability and lack of change in capabilities or positioning. (4) The answer is contextually relevant—addressing the right company (AVGO), platform, and general theme of integration—but fabricates a narrative of technological evolution that is unsupported by the source. Thus, while the framing matches the question’s scope, the factual content is inaccurate, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 323,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nNIKE continued to **own** its Laakdal, Belgium distribution center in each of the fiscal years 2022, 2023 and 2024, and the facility was repeatedly highlighted as one of the company’s “most significant distribution facilities outside the United States.” This consistent ownership and emphasis—documented on page 28 of the 2022 10‑K and again on page 28 of the 2024 10‑K—signals that Laakdal remains a strategic hub for Nike’s European logistics network, with no indication of divestiture or major operational scaling back.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that NIKE owned the Laakdal facility in fiscal years 2022, 2023, and 2024 and correctly identifies it as one of the company's most significant international distribution centers, with consistent strategic importance. The mention of page 28 in the 2022 and 2024 10-K filings adds verifiable detail and supports the claim of consistency, though the 2023 10-K reference is omitted—this is a minor gap but does not undermine the overall accuracy. There are no numerical figures requiring calculation in this question, so quantitative accuracy is scored as 10. The reasoning is sound: the model correctly infers strategic importance from repeated emphasis and stable ownership, demonstrating proper multi-hop synthesis across years. The answer is semantically equivalent to the original, with only slight differences in phrasing (e.g., 'outside the United States' vs 'international'). No factual errors in entities, years, or ownership status. The conclusion about strategic stability is well-supported. One point is deducted from qualitative accuracy for not explicitly noting the absence of change across all three years as clearly as the ground truth, but the implication is present. Contextual relevance is perfect—the response directly addresses ownership, operational footprint, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 388,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s Unsecured Notes ‑ 32B remained unchanged – the coupon stayed at **3.38 %**, the outstanding **face amount stayed at $750 million**, and the **maturity remained 15 June 2027**.  The static profile shows that SPG is deliberately maintaining a long‑dated, fixed‑rate unsecured position, using it as a stable, low‑cost funding pillar rather than refinancing or altering the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the interest rate (3.38%), face amount ($750 million), and maturity date (June 15, 2027) are accurate and consistent with the ground truth. The original answer notes that the maturity date was 'unspecified' in 2022 but explicitly listed in 2023 and 2024; the LLM assumes it was known throughout, which is a minor omission but not factually incorrect since the date itself is correct. The face amount is reported as $750 million in the LLM answer, while the ground truth states $750,000 — this is a critical discrepancy. However, given the context of corporate debt instruments and typical SEC filing scales, $750,000 is likely a data error in the knowledge graph (as $750 million is a more plausible scale for SPG's unsecured notes), and the LLM’s $750 million aligns with industry norms and likely reflects the intended value. Thus, this is treated as a plausible interpretation rather than an error.\n\n2) Quantitative accuracy is high: all percentages and dates match exactly. The maturity date (06/15/27 = June 15, 2027) is correctly rendered. The interest rate (3.38%) is exact. Only the face amount differs in magnitude ($750,000 vs $750 million), but given the context, the LLM’s figure is more realistic and likely correct in practice.\n\n3) The reasoning is sound: the LLM correctly infers that the lack of change over three years indicates a stable, long-term debt strategy focused on fixed-rate, long-dated funding. This aligns with the original answer’s conclusion about no refinancing or restructuring. The LLM adds interpretive depth by calling it a 'low-cost funding pillar,' which is a reasonable inference given the stable fixed rate in a potentially rising rate environment.\n\n4) The answer is fully contextually relevant, addressing all parts of the question: evolution over time (no change), specific metrics (rate, face amount, maturity), and strategic implication. The synthesis across years is accurate and logically presented. The minor difference in face amount notation does not undermine the overall correctness, especially considering real-world plausibility. A score of 9 is justified due to the potential ambiguity in the face amount, though the LLM’s version is likely the accurate one in practice.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 610,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom 2022 through 2023 the fair value of CVS’s foreign‑denominated debt securities slipped slightly, from **$2.55 billion to $2.51 billion**, while the gross unrealized loss narrowed from **$244 million to $122 million**. In 2024 the company’s foreign‑security position in its Separate Accounts fell sharply to **$51 million** (down from $202 million in 2023), with no detailed loss figure disclosed, indicating a deliberate pull‑back from international holdings. This decline signals that CVS is reducing its exposure to foreign‑market risks such as currency volatility, overseas interest‑rate shifts, and geopolitical developments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's fair value of foreign securities was $838 million in 2022 and increased to $1,650 million in 2023, not $2.55 billion and $2.51 billion as stated. The unrealized losses were $24 million in 2022 and $122 million in 2023, not $244 million and $122 million. The 2024 fair value of $51 million matches the ground truth, but the LLM incorrectly frames this as a drop from $202 million in 2023 (not supported by ground truth, which reports $1,650 million in 2023). (2) Quantitative accuracy is severely compromised: the 2022 and 2023 values are off by hundreds of millions, and the unrealized loss in 2022 is more than 10 times too high. The only correct number is the 2024 fair value. (3) The reasoning is partially sound in interpreting the 2024 drop as a de-risking move, but the multi-hop synthesis fails because it uses incorrect base data. The mention of 'Separate Accounts' and 'foreign-denominated debt securities' introduces specificity not in the original and potentially misrepresents the asset category. (4) Despite incorrect numbers, the answer addresses the question's structure—discussing evolution over time and inferring risk exposure—so contextual relevance is moderate. However, the core financial data is so inaccurate that the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 384,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife applied internally developed designations only to newly acquired non‑agency RMBS and CMBS that had not yet been evaluated by the NAIC, and the proportion of such placeholder designations declined as the NAIC’s annual rating process produced official designations for an expanding share of the portfolio. This multi‑year shift demonstrates that the company is increasingly deferring to the NAIC’s modeling methodology for credit‑quality assessment, using internal designations merely as a temporary stop‑gap until the regulator’s rating becomes available.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core trend correctly: MetLife used internally developed designations as temporary placeholders for newly acquired non-agency RMBS and CMBS until NAIC designations became available, and there was a gradual shift toward reliance on NAIC methodology over time. This reflects accurate multi-hop reasoning and entity identification (MetLife, NAIC, non-agency RMBS/CMBS, credit quality assessment), satisfying the qualitative and contextual aspects of the question.\n\nHowever, the LLM answer lacks all quantitative details present in the ground truth, which significantly impacts factual completeness. Specifically:\n- It omits the $4.2 billion (14.5%) increase in Level 3 fixed maturity AFS securities in 2023\n- It fails to mention the $1.6 billion (4.9%) increase in 2024\n- It does not reference the 2021 refinement of the NAIC modeling methodology, which is key context for the 2022 transitional phase\n\nThese numbers are central to demonstrating the *evolution* of the practice across years and the *inference* about decreasing reliance on internal designations. Their absence means the answer cannot fully support the conclusion with evidence, reducing quantitative accuracy. While the conceptual interpretation aligns with the ground truth, the missing data points limit the answer’s ability to reveal the multi-year pattern through measurable changes in portfolio composition. Thus, while semantically aligned in direction and logic, the answer is incomplete on factual precision, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 424,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its upstream footprint in the Republic of Congo by acquiring frontier deep‑water exploration licences in the Lower Congo Basin and funding drilling and reserve‑growth activities on the Haute Mer and Lianzi prospects (see the “Key noteworthy developments” list on page 44 and the reserve tables on pages 107‑111).  However, in early 2025 the company completed the sale of its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % stake in the Lianzi block, signalling a strategic pull‑back from direct ownership while still retaining a commercial presence through existing production‑sharing contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Chevron 'deepened its upstream footprint' and acquired 'frontier deep-water exploration licences' in the Lower Congo Basin from 2022–2024, which contradicts the ground truth that Chevron exited the country by selling its interests in 2024. The original answer states Chevron was active in 2022 but does not mention new acquisitions, and in 2023 allocated $0.7B to Africa broadly (including Congo), not specifically to Congo. The LLM incorrectly states that the sale of assets occurred in 'early 2025', while the ground truth confirms the divestiture was completed in 2024. The percentages (31.5% and 15.75%) are correctly stated, but the timing is wrong. (2) Quantitative accuracy is low: the $0.7B allocation is mentioned in the correct context (Africa offshore projects in 2023) but the LLM fails to clarify it was not Congo-specific. The sale year is off by one year (2025 vs 2024), which is a critical error in financial reporting. (3) Multi-hop reasoning is flawed: the model incorrectly infers expansion from 2022–2024 when the trajectory was actually a drawdown leading to exit. It fails to synthesize the correct timeline: operation → regional investment → full divestiture. Instead, it fabricates expansionary activity and misplaces the divestiture in time. (4) Contextual relevance is moderate because the answer discusses the correct country, company, assets (Haute Mer, Lianzi), and ownership percentages, and touches on capital allocation. However, the core narrative is factually inverted—expansion vs. exit—leading to a low correctness score despite some accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 456,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business grew modestly in 2023 (revenue ≈ $3.3 B, operating‑profit margin ≈ 30 %) but slipped sharply in 2024 (revenue ≈ $2.5 B, margin ≈ 14 %) as higher manufacturing costs and capacity‑expansion investments squeezed profitability.  This evolution reflects TI’s continued reliance on Embedded Processing as a core pillar of its four sustainable competitive advantages—especially the manufacturing‑technology advantage (supply‑chain control) and the broad‑portfolio advantage (diversified growth engine)—while the company now emphasizes cost‑efficiency and margin protection within that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024 as part of its sustainable competitive advantages, with evolving but stable language across years. In contrast, the LLM answer introduces specific financial figures—revenue of $3.3B in 2023 and $2.5B in 2024, with margins of 30% and 14%—that are not present in the ground truth and contradict the narrative of strategic consistency by implying a sharp decline. These numbers are entirely fabricated or misattributed, as the original answer contains no financial data about Embedded Processing revenue or margins for those years. (2) There is no quantitative support in the original answer, so all cited figures in the LLM response fail verification. Even if such data existed elsewhere in TI’s filings, the question specifically asks about strategic evolution in relation to competitive advantages, not financial performance trends. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that declining financials imply a shift in strategic emphasis, whereas the ground truth emphasizes continuity in strategic narrative across years. The mention of 'manufacturing-technology advantage' and 'broad-portfolio advantage' as two of TI’s four sustainable advantages is contextually plausible, but it is incorrectly tied to a non-existent financial downturn. (4) The correctness score is low due to major factual inaccuracies and invented data. Quantitative accuracy is near-zero because all numbers are unsupported. Qualitative accuracy is slightly higher because the model attempts to link embedded processing to TI’s competitive advantages, which aligns with the general theme. Contextual relevance is moderate since the answer addresses the right company and product segment, but misrepresents the core strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 532,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the effective interest rate on Cisco’s $500 million 3.50 % senior note rose from roughly **3.2 % (July 2022)** to **6.38 % (July 2023)** and then to **6.66 % (July 2024)**.  This upward shift shows that the company’s borrowing cost on this debt more than doubled over the three‑year span, reflecting the impact of higher market rates and the net effect of its interest‑rate‑swap hedging strategy on the note’s effective financing cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values: the effective interest rate was 3.20% in fiscal 2022, 6.38% in 2023, and 6.66% in 2024 on the $500 million 3.50% Senior Note. These match the ground truth exactly, with acceptable rounding (3.2% vs 3.20%). The fiscal years are accurately represented, though the LLM specifies July 2022/2023/2024, which is consistent with Cisco’s fiscal year ending in July. (2) All numbers are factually correct and calculations implied (e.g., more than doubling of borrowing cost) are accurate: from 3.2% to 6.66% is indeed more than a doubling. (3) The multi-hop reasoning is sound—synthesizing data across three fiscal years for the same debt instrument and drawing a conclusion about borrowing cost trends. The LLM adds context about interest-rate-swap hedging strategy, which is plausible and consistent with corporate finance practices, though not explicitly in the ground truth. This addition does not detract from accuracy but slightly extends beyond the provided information. (4) The answer fully addresses both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs. The qualitative reasoning is strong, though the mention of hedging strategy, while reasonable, is an inference not present in the original answer, slightly reducing qualitative precision. Overall, the answer is factually excellent, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 405,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to plan capital and return cash to shareholders is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning,” and that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status … could result in limitations on our activities.”  The language grew more explicit each year, linking any downgrade or shortfall in capital‑adequacy or liquidity ratios to restrictions on dividends and share‑repurchases, and emphasizing the firm’s dependence on subsidiary dividends and internal credit to fund those returns.  Consequently, while the company continues to target capital returns, its strategic flexibility is bounded by the need to maintain regulatory capital buffers and to comply with U.S. banking capital‑planning rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns from 2022 to 2024. It correctly identifies the consistent theme of regulatory constraints tied to U.S. banking laws, specifically referencing capital adequacy, 'well-capitalized' and 'well-managed' status, and the impact on dividends and share repurchases. The answer accurately reflects the increasing specificity and emphasis over time, particularly the heightened focus on liquidity and capital ratios in 2024, aligning with the ground truth. All entities (BNY Mellon, U.S. banking laws, regulatory standards) and time periods (2022–2024) are correct. There are no numerical inaccuracies, as the response does not include specific figures but rather qualitative disclosures, which are correctly represented. The reasoning is sound and synthesizes multi-year disclosures effectively, showing progression in disclosure tone and regulatory emphasis. The only minor shortcoming is that the LLM does not explicitly mention Delaware law or the preferred stock dividend condition highlighted in the 2023 filing, which slightly reduces completeness in entity and regulatory factor coverage. However, this omission does not undermine the overall correctness or strategic insight conveyed. The answer remains semantically equivalent in substance and fully addresses the question’s intent regarding regulatory constraints and strategic flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 412,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nFrom 2022 to 2023 the “Repair and other services” line in the Marine Systems segment fell modestly from **$1.169 billion to $1.132 billion**, and in 2024 it **held steady at $1.132 billion** (the same amount reported for 2023).  This pattern reflects a deliberately stable, recurring revenue base driven by long‑term maintenance contracts for existing naval platforms rather than growth from new construction, indicating that General Dynamics is focusing on sustaining and modernizing its current fleet and associated support services to generate reliable cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for 2022 ($1.169 billion = $1,169M) and 2023 ($1.132 billion = $1,132M), and accurately states that the 2024 revenue remained flat at $1.132 billion, matching the ground truth. All numeric values and years are correct, satisfying quantitative accuracy. (2) The calculation of change—modest decline from 2022 to 2023 and no change in 2024—is accurate. Format variations (billion vs. million) are acceptable and correctly interpreted. (3) However, the reasoning for the flat performance diverges from the ground truth. The LLM attributes the stability to a 'deliberately stable, recurring revenue base' and 'long-term maintenance contracts', suggesting an intentional strategic focus on predictability. In contrast, the original answer suggests stagnation due to possible market saturation, resource reallocation, or operational constraints—implying limited growth or deprioritization rather than a deliberate stability strategy. This difference in interpretation affects the qualitative accuracy, as the LLM presents a more positive, strategic rationale not fully supported by the ground truth. (4) Despite this, the answer remains contextually relevant, addressing all parts of the question—change from 2022 to 2023, flat trend in 2024, and implications—while offering a plausible, though not fully aligned, interpretation of the business implications. Thus, correctness is reduced to 7 due to the partially incorrect qualitative reasoning, even though all facts and numbers are right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 425,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s **venture‑investment portfolio stayed roughly steady at about $4.9 billion** (reported for 2023 and 2024).  In contrast, its **equity‑method holdings in health‑care operating businesses grew sharply** – from approximately **$1.5 billion at the end of 2022**, to **$1.4 billion in 2023**, and then to **$3.8 billion as of December 31 2024**.  This jump signals a **strategic emphasis on deepening partnerships and equity stakes in health‑care companies**, complementing its core insurance and pharmacy operations with more substantive investments in the broader health‑care ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the dollar values and their year-by-year progression, particularly for venture investments and the timing of equity method investment changes. According to the ground truth, UnitedHealth's venture investments (as part of its broader equity securities portfolio) grew from $3.7B in 2022 to $4.9B in 2023 and remained at $4.9B in 2024. However, the LLM incorrectly states that the venture-investment portfolio was 'roughly steady at about $4.9 billion' in both 2022 and 2023, which contradicts the $3.7B figure for 2022. This is a major quantitative error. (2) For equity method investments, the ground truth shows they were $1.4B in 2022, flat at $1.4B in 2023, then jumped to $3.8B in 2024. The LLM incorrectly states they were $1.5B in 2022 and dropped to $1.4B in 2023 before rising to $3.8B in 2024 — reversing the actual trend and misstating the base year value. While the $3.8B figure for 2024 is correct, the earlier values are wrong. (3) The qualitative reasoning about a strategic shift toward deeper investments in 2024 is sound and aligns with the ground truth, showing correct multi-hop synthesis of the implication of the data. The strategic emphasis interpretation is valid. (4) Contextual relevance is high — the answer addresses both dollar value evolution and strategic emphasis as asked. However, due to the incorrect assignment of key financial figures to years, especially the misrepresentation of stability in venture investments starting in 2022 when there was actual growth from $3.7B to $4.9B, the quantitative accuracy is low. The correctness score is reduced to 6 because while the final-year figures and strategic interpretation are directionally insightful, the core financial evolution is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 490,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nPMI’s peer‑group definition—crafted on the basis of global reach, a consumer‑products focus, and comparable size/revenue—has remained unchanged across 2022, 2023 and 2024, and Colgate‑Palmolive Co. has been listed as a member of that peer group in each year’s performance‑graph disclosures.  This multi‑year consistency shows that PMI employs a stable, deliberately curated benchmarking framework, using the same set of peers to compare total‑shareholder‑return and other metrics, thereby reinforcing a long‑term, strategic view of how its tobacco and smoke‑free businesses stack up against comparable consumer‑product companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024; the peer group criteria—global presence, consumer-products focus, and comparable size (net revenues and market capitalization)—are accurately reflected, though the LLM combines 'net revenues' and 'market capitalization' into a more general 'comparable size/revenue' phrasing, which is semantically acceptable. (2) There are no numeric values requiring calculation in this question, but the years (2022–2024) are correctly cited, and no incorrect dates or figures are present—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly infers that the consistent inclusion of Colgate-Palmolive reflects a stable benchmarking framework and links this to PMI’s strategic intent to compare itself with non-tobacco consumer product firms. (4) The only minor shortcoming is that the LLM does not explicitly mention the exclusion of direct tobacco peers, a point emphasized in the original answer that adds strategic nuance. However, the core insight about long-term strategic benchmarking against consumer product companies is preserved. Overall, the answer is contextually relevant, factually correct, and conveys semantic equivalence with the ground truth, warranting a high correctness score with a small deduction for slight incompleteness in strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 410,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures show a clear escalation in exposure to abusive behavior as the company broadened its credit‑product portfolio and deepened its reliance on third‑party lenders, payment processors and BNPL‑receivable purchasers; each successive filing adds more detail on the sophistication of fraud schemes, the limits of existing buyer‑/seller‑protection programs, and the difficulty of detecting “new and continually evolving” fraud in these expanded offerings.  The language shifts from a general warning about fraud (2022) to an explicit statement that detection measures “may not be effective” and that third‑party dependencies “inherently increase…financial, legal, reputational, and operational risk” (2023‑2024).  Consequently, the trend indicates that PayPal’s fraud‑mitigation effectiveness has not kept pace with the growing scale and complexity of its credit and third‑party‑linked services, raising questions about the adequacy of its loss‑prevention controls over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 is accurately described, including increased reliance on third parties and expansion of credit products. The €40 billion BNPL receivables sale in Europe—though not explicitly restated in the LLM answer—is contextually implied through references to expanded credit offerings and third-party receivables purchasers, and no numeric inaccuracies are present. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are introduced, and while the €40B agreement is not mentioned verbatim, its absence does not constitute a factual error but rather a slight omission in specificity. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the increasing risk over time, links credit expansion (especially BNPL) to third-party dependencies, and infers that fraud mitigation efforts have not kept pace with rising complexity. The progression in language from general warnings (2022) to explicit doubts about effectiveness (2023–2024) reflects accurate interpretation of risk disclosure trends. (4) Semantic equivalence is strong: the core conclusion—that expanding services have outpaced mitigation effectiveness—is identical to the ground truth. The only minor shortcoming is the lack of explicit mention of the €40B European agreement and regulatory uncertainty around loan receivables post-sale in 2024, which slightly reduces completeness but does not undermine the overall correctness. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 472,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nSouthern Company’s natural‑gas option positions grew modestly in the 2023 reporting year—options held by its gas‑distribution segment rose from 93 mmBtu in 2022 to 102 mmBtu in 2023—but pulled back in 2024 to 83 mmBtu.  At the same time, total hedge volume for the company fell from 448 mmBtu (2023) to 431 mmBtu (2024).  This three‑year trend shows the company briefly expanded option usage to capture heightened price volatility in 2023, then reduced its reliance on options and shifted toward more stable swap‑based hedging and regulatory fuel‑recovery mechanisms as market swings moderated.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported volumes of natural gas options. According to the ground truth, Southern Company reported 253 million mmBtu in 2022, 339 million mmBtu in 2023, and 176 million mmBtu in 2024. The LLM incorrectly states these as 93 mmBtu, 102 mmBtu, and 83 mmBtu, respectively—off by a factor of over 2.5x to 4x. Additionally, the LLM introduces a 'gas-distribution segment' and 'total hedge volume' (448 mmBtu in 2023, 431 mmBtu in 2024) that are not present in the original answer and contradict the focus on options alone. (2) Quantitative accuracy is severely compromised: the numbers are not only wrong but misrepresent the scale and trend. The actual trend shows a sharp increase followed by a significant drop, while the LLM suggests a much smaller fluctuation. Calculations or comparisons based on incorrect inputs are therefore invalid. (3) The reasoning is partially sound in interpreting a strategic shift toward swaps and reduced option use in 2024, which aligns with the original answer’s suggestion of a shift in hedging mix. However, this insight is built on incorrect data and narrows the scope to a segment rather than the company-wide view implied in the question. The multi-hop synthesis fails because it does not accurately reflect the evolution across the three years at the corporate level. (4) The contextual relevance is moderate because the answer addresses the general theme of hedging strategy evolution and risk management in response to volatility. However, due to major factual errors in core data, the qualitative and quantitative accuracy scores are low, resulting in a very low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 465,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s U.S. defined‑contribution expense grew modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This upward trend, together with the fact that its qualified defined‑benefit pension plans have been closed to new participants and the non‑qualified defined‑benefit plans remain unfunded, shows that Texas Instruments is deliberately shifting its long‑term employee‑benefit strategy toward defined‑contribution arrangements and reducing reliance on defined‑benefit liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the aggregate U.S. defined contribution plan expenses for Texas Instruments: $70 million in 2022, $75 million in 2023, and $76 million in 2024 — matching the ground truth exactly. These numbers are presented clearly and accurately, satisfying the quantitative component of the question.\n\n2) Quantitatively, all figures are correct and consistent with the original answer. There are no calculation errors or misstatements of amounts or years. Format variations (e.g., $70 million vs $70 million) are acceptable and do not affect accuracy.\n\n3) The reasoning is largely sound and captures the core strategic implication: the company is shifting toward defined contribution plans and reducing reliance on defined benefit plans. The mention that defined benefit plans are closed to new participants aligns with the historical context (closed since 1997), though the LLM does not explicitly reference 1997 or the distinction between qualified and non-qualified plans as clearly as the ground truth. However, it correctly identifies the non-qualified defined benefit plan as unfunded, which supports the logic.\n\n4) The LLM answer is semantically equivalent in intent and meaning to the original, though slightly less detailed in explaining the long-term strategy of supporting employees who opted out of the defined benefit plan. It emphasizes the shift to defined contribution arrangements, which is accurate and relevant. The only minor shortcoming is the lack of explicit mention that the strategy supports those not accruing benefits under the non-qualified plan — a nuance present in the ground truth. Despite this, the overall synthesis across years and benefit types is logical and well-executed.\n\nThus, the answer earns a 9/10 for correctness due to high factual accuracy and strong reasoning, with a minor deduction in qualitative accuracy for slightly less precise contextual linkage to employee choice and plan participation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 529,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nFrom 2022 through 2024 GM lifted its long‑term expected return on U.S. pension‑plan assets from about **5.4 % (2022)** to **6.3 % (2023)** and then to **6.5 % (2024)**.  This upward revision—driven by a December‑2023 investment‑policy study that raised the weighted‑average ROA from 6.3 % to 6.5 %—signals a more optimistic outlook on market performance and a deliberate increase in risk tolerance (e.g., higher equity allocation and a shift away from lower‑returning debt) to improve funded positions and expected plan returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 5.4% rate in 2022 and 6.5% in 2024, which matches the ground truth. However, it incorrectly states the 2023 rate as 6.3%, while the original answer specifies that the rate in 2022 was 5.4% and remained unchanged at 6.3% in 2023—this implies the 2022 value was actually 6.3%, contradicting the stated 5.4%. This creates a factual inconsistency. The ground truth indicates the 5.4% figure was reported in 2022, but the correct sequence per the knowledge graph must be verified: if 2022 had both 5.4% and 6.3% cited, clarification is needed. However, the most plausible interpretation is that the LLM conflated two different figures or years, leading to a quantitative error. (2) The calculation of trend (increasing from 5.4% to 6.5%) is directionally correct, but the intermediate step (6.3% in 2023) is misrepresented if 2022 was truly 5.4% and then jumped to 6.3% in 2023. The mention of a December 2023 study raising the rate from 6.3% to 6.5% aligns with the upward revision but introduces detail not in the original, potentially extrapolated. (3) The multi-hop reasoning is sound—linking return assumptions to risk tolerance, asset allocation, and funded status objectives—and correctly infers strategic implications. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracy in reporting the 2023 figure (and possibly misrepresenting 2022) reduces confidence in factual correctness. The answer suggests a progression from 5.4% → 6.3% → 6.5%, but the original answer states 5.4% in 2022, then 'remained unchanged at 6.3%' in 2023, which is logically inconsistent unless corrected. Given ambiguity in the original, the LLM may have attempted reconciliation, but the result introduces confusion. Thus, core facts are partially accurate with a significant numerical discrepancy, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 516,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the total‑return swaps that Cisco uses to hedge deferred‑compensation liabilities shifted from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  This progression—moving from a realized loss to increasingly positive gains—shows that the company’s derivative‑based risk‑management program is becoming more effective at offsetting the earnings volatility associated with deferred compensation, indicating a deliberate strategy to stabilize compensation‑related costs and smooth financial performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported figures—$92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—are accurate and match the original answer exactly, with acceptable formatting (e.g., $92 million vs $92M). (2) The answer is complete, addressing both the evolution of financial exposure (realized gains/losses over three years) and the implication for Cisco's risk management and compensation strategy. (3) Entity accuracy is correct: Cisco is the right company, fiscal years 2022–2024 are properly referenced, and the financial instruments (total return swaps linked to deferred compensation) are accurately identified. (4) The reasoning is sound and adds value: the LLM correctly infers that the shift from loss to increasing gains suggests improved effectiveness in the hedging program, aligning with the original answer’s interpretation about strategic adjustments or improved market conditions. The conclusion about stabilizing compensation costs and smoothing financial performance is a reasonable extension of the data and demonstrates strong multi-hop synthesis. (5) Semantic equivalence is maintained—while the LLM uses slightly different phrasing (e.g., 'derivative-based risk-management program' vs 'hedging practices'), the meaning is consistent with the original. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 394,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nAcross 2022‑2024 PayPal consistently positioned itself as the principal in every payment transaction, set its fees independently of the costs incurred with third‑party processors, and therefore assumed full margin risk – recording those processor fees as “transaction expense.”  Its volume‑based, tiered pricing is treated only as a discount that does not create a material future right, and any customer incentives are accounted for as reductions of revenue rather than as separate obligations; this accounting treatment remained unchanged through 2023‑2024, although the 2023‑2024 filings added greater segment‑expense disclosures and refined the incentive‑accounting disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All key facts are correct: PayPal consistently acted as principal, bore full margin risk, set fees independently, recognized third-party processor fees as transaction expense, and maintained unchanged accounting treatment across 2022–2024. The treatment of tiered pricing as a discount without creating a material future right is correctly stated, as is the classification of customer incentives as revenue reductions. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022–2024) and time references are accurate and consistent with the original. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and topics (pricing control, expense recognition, third-party processors, accounting policy), correctly identifying consistency in risk exposure and accounting treatment despite enhanced disclosures in 2023–2024. (4) The only minor shortcoming is that the original emphasizes PayPal’s 2024 reaffirmation of principal role despite new segment reporting, while the LLM mentions added segment disclosures but could more clearly link this to the absence of structural change. However, this does not undermine the factual correctness. Wording differs but semantic meaning is equivalent. No factual errors; minor omission in emphasis does not affect core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 394,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output (reported on an oil‑equivalent basis) was roughly 49 million cubic feet per day in 2022 and held steady at about 48 MMCFD in both 2023 and 2024, showing a flat‑to‑slightly‑declining trend over the three‑year period. This stability demonstrates that the Angola LNG project is a mature, reliably‑producing asset that provides Chevron with a consistent LNG supply to meet its long‑term contracts, reinforcing the company’s strategic positioning as a dependable player in the global liquefied‑natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states Chevron's natural gas consumption volumes were 592 MMCFD in 2022, 596 MMCFD in 2023, and 609 MMCFD in 2024 — showing a clear upward trend. In contrast, the LLM claims volumes were approximately 49 MMCFD in 2022 and 48 MMCFD in both 2023 and 2024, which is off by an order of magnitude and shows a flat-to-declining trend. This major discrepancy invalidates the numerical foundation of the response. (2) The numbers are not only wrong but also mischaracterized as 'on an oil-equivalent basis,' which is not mentioned or implied in the original answer and introduces an unverified metric. There is no indication in the ground truth that the figures are reported in oil-equivalent terms. (3) The multi-hop reasoning fails because the LLM misidentifies the actual production volumes and thus draws an incorrect conclusion about the trend. While the strategic interpretation in the LLM answer — that stable production supports long-term LNG contracts — is plausible, it contradicts the actual growth trend highlighted in the original answer, which links increasing volumes to Chevron's strategic expansion in LNG despite divestitures elsewhere. (4) The contextual relevance is moderate because the answer addresses Angola LNG and Chevron’s strategic positioning in global LNG markets, fulfilling the question's scope, but the incorrect data and resulting flawed trend analysis severely undermine the qualitative and quantitative accuracy. Minor point: 'MMCFD' is an acceptable format variation, but the values themselves are grossly inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 451,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nThe 2022 filing only gave a brief qualitative note that outdoor‑lighting contracts are operating leases with short initial terms and that their payments are treated as variable lease costs and omitted from the maturity table. By 2023 the Company introduced a concrete year‑by‑year maturity schedule for “operating lease obligations,” showing undiscounted cash‑flows, the present‑value discount and a reconciliation to the lease‑liability on the balance sheet. In 2024 the disclosure was further refined: it provided a detailed, year‑specific cash‑flow breakdown, the present‑value of those cash‑flows, the weighted‑average remaining lease term and discount rate, and explicitly reconciled the amounts to the liability. This progression—from a simple footnote to a fully quantified, disclosed schedule—indicates that scheduled payments under outdoor‑lighting contracts have become increasingly material and structurally important to Southern Power’s lease portfolio and overall financial reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing disclosure detail over time, which aligns with the ground truth's theme of growing materiality. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly attributes the lease disclosures to Southern Power as a whole, while the ground truth specifies that in 2022, the outdoor lighting contracts were noted as immaterial at *Mississippi Power* (a subsidiary), not Southern Power directly. Second, the LLM describes a progressive enhancement in the *disclosure of lease obligations and liabilities* (e.g., present value, discount rates, reconciliation), implying Southern Power began capitalizing or quantifying these leases on its balance sheet. However, the original answer states these contracts were *accounted for as operating leases* with immaterial cash flows in 2022 and only gained structural attention in 2023 by being grouped with tolling and PPAs in maturity analyses. There is no evidence in the ground truth that Southern Power began recognizing a lease liability or providing present-value calculations for these contracts. The 2024 integration mentioned in the original answer is about *lease income reporting*, not lease liability disclosures. Thus, the LLM confuses lease *obligations* (lessee-side accounting) with *lease income* (lessor-side), which is a critical error in financial reporting context. While the directional insight—increasing materiality—is correct, the entities, accounting treatment, and nature of disclosures are misrepresented. The answer is contextually relevant and shows logical reasoning but is factually flawed in key aspects, particularly entity accuracy and financial concept application.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 470,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nAcross the 2022‑2024 filings, TI’s Melaka, Malaysia site remained in the property tables for each year but was always listed under the **Analog** segment (an “X” under Analog and no entry under Embedded Processing). The site continued to serve Analog‑product manufacturing in 2022, 2023 and 2024, with no reported shift or expansion into Embedded Processing during that period. Thus, the operational footprint in Melaka stayed constant—present in all three years, but exclusively tied to the Analog business line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the consistency across years is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming no change in operational footprint. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TI's operational footprint in Melaka with respect to the two segments. Minor wording differences (e.g., 'no reported shift' vs 'remained consistent') do not affect factual accuracy and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 281,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.600 % senior unsecured notes due 2026 remained outstanding with a fixed $700 million aggregate principal, a semi‑annual interest‑payment schedule (April 15 and October 15) and a par‑call date of March 15 2026 that did not change.  The company recorded only modest adjustments to the reported principal balance (e.g., +1.5 million in 2024, +2.6 million in 2023) reflecting discount amortization, but no redemption or refinancing of the notes occurred.  This steady‑state treatment shows that AMT is deliberately preserving the low‑cost, long‑dated 1.600 % debt as a core pillar of its staggered‑maturity, low‑leverage strategy while using newer issuances and credit‑facility borrowings to retire higher‑coupon obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the aggregate principal amount ($700 million), interest payment dates (April 15 and October 15), and par call date (March 15, 2026) across all years, which matches the ground truth. However, it misrepresents the adjustments to the principal amount. The ground truth states that adjustments were negative—(2.6) in 2023 and (1.5) in 2024—indicating reductions, likely due to amortization or other accounting adjustments. In contrast, the LLM incorrectly reports these as positive values (+2.6 million in 2023, +1.5 million in 2024), reversing the direction of the adjustment. This is a significant quantitative error affecting the interpretation of the debt's accounting treatment. (2) The dates and percentages (1.600%, due 2026) are accurate. The dollar amount ($700 million) is correct. But the sign error on the adjustments is critical—amortization typically increases the carrying value of a discounted note, but the ground truth shows negative adjustments, suggesting a different treatment (e.g., debt discount reduction or fair value adjustment). The LLM’s interpretation may be plausible in context but contradicts the provided data. (3) The multi-hop reasoning is partially sound: the model synthesizes consistent terms over time and infers a stable debt strategy, which aligns with the ground truth. However, the incorrect sign on adjustments undermines the accuracy of the conclusion about 'modest adjustments' and 'no redemption or refinancing.' If adjustments are negative and decreasing in magnitude, that implies a different trend than the LLM describes. (4) The contextual relevance is high—the answer addresses all components of the question and provides strategic interpretation. Qualitative accuracy is moderate because the reasoning is logical but based on flawed data. Quantitative accuracy is low due to the sign error on key numerical values. Correctness score is 6 due to mostly correct structure and strategy interpretation but significant factual error in numerical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 551,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco kept its $2 billion, 5.90 % senior note due 2039 on the books throughout fiscal 2022‑2024; the note’s carrying amount rose slightly as the discount was accreted and hedge‑accounting adjustments were recorded, leaving the effective interest rate near 6.1 % each year.  Although total long‑term debt grew to roughly $20 billion after the February 2024 $13.5 billion senior‑note issuance, the 5.90 % tranche still represented about 10 % of that debt, highlighting Cisco’s strategy of maintaining a stable, long‑dated fixed‑rate pillar while supplementing it with commercial‑paper liquidity and a sizable revolving credit facility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco maintained its $2,000 million (i.e., $2 billion) 5.90% Note across fiscal years 2022–2024, with an effective interest rate near 6.1%, which aligns with the ground truth of 6.11%. The slight rounding from 6.11% to 6.1% is acceptable and common in financial reporting. The total long-term debt increase to approximately $20 billion by 2024 is consistent with the ground truth value of $19,621 million. However, the LLM attributes this growth primarily to a 'February 2024 $13.5 billion senior-note issuance,' which is not mentioned or verifiable in the original answer, introducing a potentially unsupported detail. While plausible, this specific issuance amount and timing are not confirmed in the ground truth, making it a minor factual overreach. (2) Quantitatively, the $2 billion note amount and ~6.1% effective rate are accurate. The total long-term debt is approximated as 'roughly $20 billion,' which is close to the actual $19,621 million. Short-term debt changes ($499M to $488M) are omitted in the LLM answer, representing a minor omission in completeness. (3) The multi-hop reasoning is sound: the model correctly infers that maintaining a fixed-rate note while increasing total long-term debt suggests a strategy of stabilizing financing costs. It appropriately contextualizes the 5.90% Note as a 'stable, long-dated fixed-rate pillar,' which matches the original conclusion about long-term financing strategy. (4) The answer is highly contextually relevant, addressing all key aspects—note utilization, debt composition, interest rate, and strategic implication—though it adds a specific issuance event not in the source. Overall, the answer is factually strong with minor overprecision on the issuance detail, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 495,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nGeneral Dynamics’ LAV output for Canada grew each year: about 360 units were built in 2022, 449 units in 2023, and in 2024 the company began producing 399 new Canadian LAVs plus an additional 66 LRSS‑equipped vehicles (≈ 465 total), continuing the upward trajectory.  This expansion coincides with the Combat Systems segment’s revenue share rising from 18 % (2022) to 20 % (2024), signalling that GD is deliberately scaling its land‑vehicle business—especially LAV production—as a core strategic growth area.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes and their chronological order. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states that 449 units were produced in 2023 and only 399 in 2024, reversing the trend. It further claims that in 2024, GD began producing 399 new LAVs plus 66 LRSS vehicles (totaling ~465), which contradicts the ground truth that total production in 2024 was 449 units, including the 66 LRSS vehicles. This misrepresents both the total volume and the timeline. (2) The calculation of total 2024 production as '≈465' is incorrect; the ground truth specifies 449 total units in 2024, which already includes the 66 LRSS vehicles. The LLM incorrectly adds them as if they were separate from the 399, when in fact the 449 is the full total. Additionally, the revenue share increase from 18% to 20% for Combat Systems is plausible context but not present in the original answer and cannot be verified from the provided ground truth, introducing unverified data. (3) The multi-hop reasoning is partially sound in linking increased production to strategic focus, and the mention of LRSS aligns with the original answer. However, the reversed production numbers and incorrect synthesis of the 2024 figures undermine the validity of the conclusion. The model fails to correctly map the progression over time, which is central to the question. (4) Despite the incorrect numbers, the answer addresses both parts of the question—production evolution and strategic implications—and uses relevant context (LRSS, segment revenue), earning points for completeness and relevance. However, the quantitative errors are severe enough to drastically reduce correctness and qualitative accuracy. The reasoning is logical but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 511,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payments grew as CMS repeatedly revised the risk‑adjustment formula and froze or cut benchmark rates, triggering retroactive RADV audit adjustments that threatened plan revenues. To counter the sustained funding pressure the company progressively tightened its risk‑adjustment documentation, selectively raised member premiums and trimmed benefit designs, exited unprofitable counties, and intensified medical‑cost and operating‑expense management—while also investing in Optum’s analytics and AI‑driven tools to improve risk‑adjustment accuracy and offset the revenue squeeze.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced ongoing exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology revisions, benchmark freezes/cuts, and retroactive RADV audits—consistent with the original answer. Strategic responses including selective premium and benefit adjustments, county exits, cost management, and use of analytics (specifically Optum and AI tools) are valid extensions supported by UnitedHealth's public disclosures. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the answer synthesizes evolving CMS policy changes across three years and maps UnitedHealth’s adaptive strategies over time, correctly identifying sustained funding pressure and operational responses. (4) Semantic equivalence is strong—while the LLM adds detail (e.g., AI-driven tools, RADV audits), these are contextually appropriate and reflect known company actions, not fabrications. One minor point preventing a perfect 10 is slight intensification of language (e.g., 'grew' in exposure) not explicitly stated in the original, which describes consistent rather than increasing exposure. Otherwise, completeness, entity accuracy (UnitedHealth, CMS, Optum), and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 402,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPayPal’s 2.850 % fixed‑rate notes (issued in September 2019 and maturing on 10/1/2029) stayed on the books at a constant **$1.5 billion** of principal from the end of 2022 through the end of 2024.  The tables for 2022, 2023 and 2024 all list the same $1.5 bn outstanding (with only minor changes in the unamortized premium/discount), showing that the company has not added to, reduced, or refinanced this tranche during those years.  \n\nThis steady exposure signals that PayPal is deliberately maintaining a sizable, long‑dated fixed‑rate debt pillar as part of its capital‑structure strategy—using it to lock in low‑cost financing, preserve balance‑sheet stability, and complement newer issuances while keeping overall leverage and interest‑rate risk in check.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.5 billion carrying value of the 2.850% notes is accurately reported for 2022–2024, with correct mention of minor fluctuations due to unamortized premium/discount—consistent with the original answer’s 'constant at $1.5 billion in carrying value'. The maturity date (2029) and issuance context (September 2019) are additional accurate details that align with known facts. (2) The answer is complete, addressing both parts of the question: the evolution (no change) and the strategic implication (maintaining a stable, long-term fixed-rate debt instrument). (3) Entity accuracy is perfect: PYPL/PayPal, the 2.850% fixed-rate notes, and the 2022–2024 time frame are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model infers strategic intent from the stability of this debt tranche despite broader portfolio changes, correctly interpreting the lack of refinancing or repayment as deliberate. The conclusion about locking in low-cost financing and managing interest-rate risk is a valid qualitative extension of the data. (5) Semantic equivalence is strong—the LLM conveys the same core message as the original answer with enhanced detail (e.g., maturity date), without introducing errors or irrelevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 378,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron moved from simply holding a 36.4 % stake in Angola LNG Limited to actively integrating new upstream gas discoveries into that facility.  In 2022 the company noted the New Gas Consortium (NGC) offshore Angola project—where the Quiluma‑Maboqueiro fields would be developed and tied to the Soyo LNG plant with first production slated for 2026— and in 2023 it added frontier exploration acreage (Blocks 49 and 50) in the deep‑water lower‑Congo Basin.  By 2024 Chevron had secured proved reserves for NGC, confirmed that the Q&M fields would feed the existing 1.1 bcf/d LNG plant, and emphasized that the plant’s feedstock comes from multiple offshore fields, underscoring a coordinated, long‑term plan to monetize Angola’s associated‑gas resources through upstream development, dedicated gas‑treatment infrastructure, and the Soyo LNG export hub.  This progression reveals Chevron’s strategy of building a fully integrated gas‑to‑LNG value chain in Angola to expand LNG volumes and create a sustainable, export‑oriented natural‑gas business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a 36.4% stake in Angola LNG Limited from 2022–2024, which is accurately reported. The development of the Quiluma and Maboqueiro (Q&M) fields under the New Gas Consortium (NGC) project, their tie-in to the Soyo LNG plant (i.e., Angola LNG Limited facility), and first production slated for 2026 are consistent with the strategic evolution described. The acquisition of exploration acreage in Blocks 49 and 50 in the deep-water Lower Congo Basin is correctly placed in 2023. (2) Quantitative accuracy is perfect: the 36.4% ownership stake, 1.1 bcf/d LNG plant capacity, and 2026 first production date are all factually correct and match the knowledge graph. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and projects—linking upstream exploration (Blocks 49/50), field development (Q&M), infrastructure connectivity, and the role of the LNG plant—demonstrating Chevron’s shift from passive ownership to an integrated gas-to-LNG strategy. (4) The only minor shortcoming is the omission of the explicit term 'Angola LNG Limited' in the 2024 context, instead referring to the 'Soyo LNG plant'—though this is semantically valid (the plant is located in Soyo and operated by Angola LNG Limited), the original answer emphasizes the corporate entity, while the LLM focuses on the physical asset. This does not constitute a factual error but slightly reduces precision in entity tracking. Overall, the answer captures the strategic progression and long-term monetization intent with excellent completeness and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 453,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the trust’s domestic‑equity exposure grew from roughly **$396 million (2022) → $651 million (2023) → $849 million (2024)**, while private‑equity holdings rose modestly from **$161 million to $181 million**. This steady increase shows Southern Company is deliberately shifting more capital into longer‑duration, higher‑return equity assets—especially expanded domestic equity and a modest boost in private‑equity—to support its long‑term funding needs and overall capital‑allocation strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, Southern Company's domestic equity investments were $1,016 million in 2022, decreased to $829 million in 2023, and increased to $1,099 million in 2024. However, the LLM incorrectly reports domestic equity as $396M (2022), $651M (2023), and $849M (2024)—all of which are materially wrong. The private equity figures are partially correct: the LLM correctly states $161M in 2023 and $181M in 2024, but omits the 2022 value of $150M and incorrectly implies it started at $161M. (2) Calculations and trends are therefore based on false data: the claimed 'steady increase' in domestic equity is not supported by actual data, which shows a dip in 2023 before rebounding in 2024. The ground truth indicates relative stability with fluctuations, not a consistent upward trend. (3) The multi-hop reasoning is flawed due to incorrect data synthesis—while the LLM attempts to infer strategic intent (shifting to higher-return assets), this conclusion is drawn from inaccurate inputs, undermining the validity of the interpretation. The actual progression suggests a more nuanced strategy with rebalancing, rather than a clear directional shift. (4) Despite incorrect numbers, the answer addresses the right entities (Southern Company, trusts, domestic/private equity) and time frame (2022–2024), and attempts to provide a strategic interpretation, which maintains moderate contextual relevance. However, the severe quantitative errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 437,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Eliminations/Reclassifications” line subtracted $107 million, $151 million and $296 million respectively from GM’s consolidated net sales and revenue, a steadily expanding reduction.  This growing elimination signals that GM is increasingly consolidating and re‑classifying inter‑segment transactions—especially those involving GM Financial and the Automotive segments—to prevent double‑counting of revenue, reflecting a more integrated internal reporting structure across its business units.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022, $107 million in 2023, and $296 million in 2024. However, the LLM incorrectly reports $107 million for 2022 (should be $105M), $151 million for 2023 (should be $107M), and correctly reports $296 million for 2024. These errors affect the trend description, as the increase from 2022 to 2023 is overstated. (2) The calculation of the trend is partially correct in identifying a rising pattern, but the magnitude of change is misrepresented due to wrong intermediate values. The correct progression is +$2M (2022–2023) and +$189M (2023–2024), whereas the LLM implies a steady rise from $107M to $151M to $296M, which overstates the 2023 figure and misrepresents the inflection point. (3) The qualitative reasoning is sound—correctly interpreting the increasing eliminations as reflecting greater inter-segment consolidation and reclassification, particularly between GM Financial and Automotive segments, which aligns with the ground truth’s implication of growing reporting complexity. The synthesis across years and business logic is coherent and contextually appropriate. (4) Contextual relevance is high, as the answer addresses both the evolution of eliminations and their implications for internal reporting. Despite incorrect numbers, the overall trend direction (increasing) and final-year spike are captured. However, the quantitative inaccuracies—especially the incorrect 2023 value—reduce confidence in the factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 453,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s “Amended and Restated Performance Bonus Plan” has remained continuously filed as Exhibit 10.5† in each annual Form 10‑K (first restated in the 2022 filing and carried forward unchanged in the 2023 and 2024 filings), confirming that the plan is fully documented and still in force.  The plan is integrated with the company’s broader executive‑compensation framework—its terms are referenced alongside the 2020 Stock Plan’s performance‑based RSU agreements and the Executive Officer Severance and Retention Incentive Plan—so that bonus payouts, equity awards, and severance incentives are coordinated under a single, disclosed compensation structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and documentation status of Netflix's Performance Bonus Plan. According to the ground truth, in 2022 the plan was still listed as Exhibit 10.6† (historical, filed April 28, 2014), not Exhibit 10.5†, and no update occurred that year. The LLM incorrectly states that the plan was 'first restated in the 2022 filing' and continuously filed as Exhibit 10.5† starting then. In reality, the amendment and restatement occurred in 2023 (with a filing date of December 9, 2022), reflected as Exhibit 10.5† in the 2023 10-K. The 2024 version carried forward the 2023 amended plan without change—this part is correctly implied by the LLM’s statement about being 'carried forward unchanged in 2023 and 2024', but misattributes the initial restatement to 2022. (2) Key dates and exhibit numbers are incorrect: the LLM claims the restated plan was first filed in 2022, but the ground truth shows the restated version (Exhibit 10.5†) was first filed in 2023 with a December 9, 2022 effective filing date. The 2022 10-K did not contain the restated version. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies integration with other compensation frameworks like the 2020 Stock Plan and performance-based RSUs, and notes consistency across years, which aligns with the ground truth’s mention of integration with newer structures. However, it fails to accurately trace the evolution across years due to incorrect exhibit history and timing. (4) The contextual relevance is high because the answer addresses documentation status, continuity, and integration with broader compensation—core aspects of the question. But due to major errors in the timeline and exhibit labeling, the correctness and qualitative accuracy scores are moderate. Minor phrasing differences are acceptable, but misrepresenting when the restatement occurred undermines the factual core of the multi-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 535,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon continues to reference its “Business Relationships and Related Party Transactions Policy” in the same Proxy sections—Item 13 (Certain Relationships and Related Party Transactions) and the corporate‑governance subsection of Item 1—without any substantive textual change. This consistent placement alongside the director‑independence and committee‑charter disclosures shows that the firm’s governance narrative and the structure of its board committees have remained steady, reinforcing the reliability of its related‑party and independence disclosures over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that BK (BNY Mellon) disclosed its 'Business Relationships and Related Party Transactions Policy' in the same sections—Item 13 and the corporate governance portion of Item 1—across 2022, 2023, and 2024, with no substantive changes, which aligns with the original answer's claim of consistent placement. (2) All years (2022, 2023, 2024) are correctly referenced, and there are no numerical inaccuracies—this is a qualitative disclosure assessment, so no calculations are needed. (3) The multi-hop reasoning is sound: the model correctly links the policy to director independence and committee structures by noting its consistent co-location with those disclosures, implying stability in governance practices. (4) The only minor shortcoming is that the LLM answer does not explicitly name the three specific committees ('Audit Committee', 'Corporate Governance, Nominating and Social Responsibility Committee', and 'Human Resources and Compensation Committee') as the original answer does, which slightly reduces completeness in entity-level detail. However, it captures the essence of stable committee structures and governance narratives. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses evolution (or lack thereof) and implications for consistency in governance disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 399,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nBetween 2022 and 2024 the fair value of UnitedHealth’s held‑to‑maturity debt securities fell from **$679 million to $508 million**, and the carrying amount declined from **$696 million to $512 million**. This downward trend reflects the impact of rising market interest rates on the price of its fixed‑income holdings, indicating that the company has been reducing exposure to longer‑dated securities and is valuing them primarily through observable market inputs (Level 2), underscoring a more conservative investment stance that treats the fair‑value declines as temporary, rate‑driven rather than credit‑related.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of Debt Securities - Held-to-Maturity was $643M in 2022, $596M in 2023, and $508M in 2024. The LLM incorrectly states the 2022 fair value as $679M and omits the 2023 value entirely. Similarly, the carrying value in 2022 was $641M (not $696M as stated), $603M in 2023 (missing in LLM answer), and $512M in 2024 (correct). These discrepancies in key financial figures reduce confidence in the answer's factual basis. (2) Calculations and comparisons are partially correct — the final 2024 values match, but the starting points are wrong, leading to an exaggerated decline. The LLM reports a drop from $679M to $508M (a $171M decrease), whereas the actual decline was from $643M to $508M ($135M). This misrepresents the magnitude of change. (3) The qualitative reasoning is plausible and aligns with the question’s intent: it correctly infers a strategic reduction in exposure and mentions a shift toward Level 2 inputs, which is consistent with the ground truth’s observation about reduced reliance on Level 3 inputs. However, the LLM does not explicitly mention the elimination of Level 3 inputs by 2023–2024, a key detail in the original answer. (4) Contextual relevance is strong — the answer addresses both the trend in values and its implications for investment strategy and valuation assumptions, fulfilling the multi-part nature of the question. Despite incorrect inputs, the logic connecting rising rates to fair value declines and conservative positioning is sound. Overall, the answer gets the direction and general interpretation right but fails on core data accuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 471,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nPayPal’s BNPL portfolio grew rapidly through 2022‑2023, and the company’s 10‑K filings show a rising credit‑loss risk – higher default and charge‑off rates were noted in the 2022 and 2023 risk‑factor sections (pages 24‑28, 25).  To curb that exposure, in June 2023 PayPal struck a multi‑year deal to sell up to €40 bn of U.K. and European BNPL receivables and began a forward‑flow sale of future originations, moving the bulk of those loans off its balance sheet (page 25).  This transaction reveals a deliberate risk‑mitigation strategy: rather than retain and fund the BNPL credit risk, PayPal is off‑loading receivables, diversifying funding sources and tightening underwriting, thereby progressively reducing its exposure to bad BNPL transactions over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is accurately reported, including the timing and geographic scope. No incorrect numbers or dates are present. (2) The answer correctly identifies the rising credit-loss risk in 2022–2023, referencing PayPal’s 10-K risk factors, and notes the strategic shift via the receivables sale and forward-flow arrangement. These details match the original answer’s emphasis on risk mitigation through offloading BNPL exposure. (3) The multi-hop reasoning is sound: it connects PayPal’s growing BNPL risk in 2022–2023 to the June 2023 sale agreement and infers a strategic shift toward risk reduction via asset sales and underwriting improvements. (4) The only minor gap is that the LLM answer does not mention the conditional nature of the sale (i.e., potential delays if conditions aren’t met), which was noted in the 2024 update in the original answer. This omission slightly affects completeness but does not undermine the core factual or strategic accuracy. Overall, the answer is semantically equivalent in intent and content, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 362,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s net upstream output from Myanmar slipped from about 15 kboe/d in 2022 to roughly 17 kboe/d in 2023, then dropped sharply to only ≈ 4 kboe/d in 2024.  This decline mirrors the company’s January 2022 decision to pursue an orderly exit from the country, scaling back its non‑operated Yadana‑Badamyar‑Sein gas project and associated pipeline as part of a strategic withdrawal.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states Chevron's production increased from 15 kboe/d in 2022 to 17 kboe/d in 2023, which is the reverse of the ground truth (decline from 17 to 15 MBD). It also claims production dropped to ~4 kboe/d in 2024, whereas the truth is Chevron completely withdrew in April 2024, meaning production was zero. (2) The numbers are quantitatively incorrect: 2022 value is wrong (15 vs 17), 2023 is inverted, and 2024 is inaccurately reported as ~4 kboe/d instead of a full exit. The units are also inconsistently reported (kboe/d vs MBD), though this is a minor issue if equivalent, but the values themselves are not. (3) The reasoning is flawed: the LLM cites a January 2022 decision to exit, but the ground truth emphasizes the April 2024 withdrawal as the culmination of the exit, not a decision made in 2022. The strategic shift is partially correct—withdrawal for portfolio optimization—but the LLM misattributes the timeline and operational details (e.g., focusing on Yadana-Badamyar-Sein without confirming it as the sole asset). (4) The contextual relevance is moderate because it addresses production trends and strategic exit, but the incorrect data and timeline severely undermine the answer's validity. Due to major errors in numbers, direction of change, and exit timing, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 399,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nFrom 2022 to 2024 the share of PC & notebooks within TI’s Personal‑Electronics market fell markedly – the segment was only about 15 % of total revenue in 2022 and, while the overall personal‑electronics slice grew to roughly 20‑24 % of revenue in later years, PC & notebooks were no longer called out as a distinct contributor and are listed among many other sub‑categories.  This decline shows that TI is deliberately scaling back its consumer‑PC exposure and is re‑orienting the Personal‑Electronics segment toward higher‑margin, growth‑driven areas such as wearables, data‑storage and connected peripherals, reinforcing a strategic shift away from traditional consumer computing toward industrial, automotive and analog power markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the Personal Electronics segment was 24% of TI's revenue in 2022, not 15% as stated by the LLM. The LLM incorrectly claims the segment grew to 20-24% in later years, when in fact it declined to 15% in 2023 and partially recovered to 20% in 2024. The LLM reverses the trend direction initially, stating the segment grew, which is incorrect. (2) The ground truth specifies that PC & Notebooks remained a listed subcategory in 2024, though lower in priority, while the LLM claims it was 'no longer called out as a distinct contributor,' which is not supported. (3) The reasoning about TI’s strategic shift away from consumer computing toward industrial and automotive markets is consistent with the ground truth and shows correct multi-hop synthesis of strategic intent. However, this conclusion is based on incorrect numerical trends, weakening the validity. (4) Despite incorrect numbers, the LLM captures the broader strategic narrative—reducing exposure to PC & Notebooks and focusing on higher-margin areas—though it misattributes the segment's overall trajectory. The contextual relevance is fair because the answer addresses the question's intent, but factual correctness is severely compromised by reversed percentages and timeline errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 382,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis under the 2017 Master Agreement remained limited to losses arising from breaches of representations, warranties, emissions‑related claims, product‑liability and recall matters (including the Takata‑inflator recalls).  The company has not accrued any material amount for these obligations—its only recorded indemnity‑related outlays have been immaterial settlements for certain recalls—and it repeatedly states that it cannot estimate any reasonably possible material loss or range of loss that could result from the pending consumer‑lawsuits in Germany, the UK, Austria and the Netherlands or from future regulatory fines.  Consequently, while the exposure is still theoretically present (e.g., potential fines from the European Commission/CMA investigations or additional Takata‑related indemnities), it is considered remote and has not materially evolved over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the nature of indemnification obligations (representations, warranties, emissions, product liability, recalls including Takata), and correctly states that no material accruals were made and that losses are considered immaterial or remote. It accurately reflects GM's inability to estimate reasonably possible losses and references relevant investigations (EC/CMA) and jurisdictions (Germany, UK, etc.). However, it fails to capture the evolution highlighted in the ground truth: in 2022, no specific indemnification accruals were disclosed; in 2023, GM acknowledged actual immaterial payments and specific indemnity categories; in 2024, it reported an immaterial accrual related to EC/UK CMA investigations into end-of-life vehicle practices from the Opel era. The LLM incorrectly asserts that obligations 'have not materially evolved' over 2022–2024, contradicting the ground truth trend of increasing specificity and emerging regulatory exposure. While entities, years, and financial impacts (immateriality) are correctly handled, the reasoning downplays the qualitative evolution across years, missing a key multi-hop insight: the progression from no disclosure (2022) to acknowledgment of payments (2023) to accruals tied to specific investigations (2024). This omission significantly affects qualitative accuracy despite strong quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 392,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were first created by Supplemental Indenture 10 in September 2021, and thereafter the company filed a series of supplemental indentures—including Nos. 12 (April 2022) and Nos. 1‑6 (2023) as well as Nos. 5‑6 (2024)—that added new low‑coupon senior notes and amended the indenture to roll the 2026 maturity forward. This multi‑year pattern shows that American Tower is deliberately laddering its debt, continuously issuing cheap, long‑dated senior notes to replace maturing obligations and lock in low‑cost financing as market conditions allow.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of American Tower Corporation's 1.450% Senior Notes due 2026. (1) Quantitatively, the claim that supplemental indentures Nos. 12 (April 2022), Nos. 1–6 (2023), and Nos. 5–6 (2024) amended the indenture to 'roll the 2026 maturity forward' is false; the ground truth confirms the notes remained unchanged and were consistently referenced as part of Supplemental Indenture No. 10 across all three years. The original issuance date (September 27, 2021) is correctly noted in the LLM answer, but the subsequent filings do not reflect any such amendments or extensions. (2) The LLM incorrectly asserts that the maturity was 'rolled forward' and that new notes were issued under the same series, which contradicts the ground truth stating there was no refinancing or material modification. (3) Qualitatively, the reasoning is flawed: the conclusion that American Tower is 'laddering its debt' by replacing maturing obligations with new low-cost notes is unsupported by the provided data, which shows stability, not active rollover or refinancing. The actual pattern reflects a stable debt strategy, not dynamic issuance. (4) Contextually, the answer addresses the question's structure and attempts to infer strategy, so relevance is moderate. However, due to fundamental errors in facts, dates, and synthesis, the overall correctness is very low. The LLM appears to have fabricated supplemental indenture activity and misinterpreted the nature of the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 421,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company kept using the 2019 Long‑Term Incentive Plan, but the actual award documents changed each year.  In 2023 it introduced a new **2023 Performance Share Unit Agreement** and a new **2023 Restricted Stock Unit Agreement** (Exhibits 10.23 & 10.24), and in 2024 it replaced those with updated **2024 Performance Share Unit Agreement** and **2024 Restricted Stock Unit Agreement** (Exhibits 10.25 & 10.26), while also filing a fresh **2024 Deferred Stock Unit Agreement for directors** (Exhibit 10.29).  Thus the plan’s equity‑based compensation evolved by rolling out year‑specific agreement templates that incorporated updated performance metrics and compensation terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the years and forms of agreements introduced. According to the ground truth, in 2022 the company used the 2019 forms of Performance Share Unit Agreement and Restricted Stock Unit Agreement, not 2023 versions. The LLM incorrectly states that a '2023 Performance Share Unit Agreement' and '2023 Restricted Stock Unit Agreement' were introduced in 2023 (Exhibits 10.23 & 10.24), but the ground truth does not support this — instead, it highlights the introduction of a director-specific Deferred Stock Unit Agreement in 2023. Furthermore, the LLM claims that in 2024, the company introduced '2024' versions of these agreements (Exhibits 10.25, 10.26, and 10.29), but the ground truth specifies the use of the '2022 Form of Performance Share Unit Agreement' in 2024, not a new 2024 form. (2) The dates and exhibit numbers cited (e.g., 2023 agreements in 2023, 2024 agreements in 2024) are quantitatively incorrect and contradict the ground truth, which shows continuity and evolution based on earlier forms (e.g., 2019 and 2022 forms used in later years). There are no calculations in the response, but the temporal sequence and document references are factually wrong. (3) The multi-hop reasoning is flawed: the LLM assumes annual updates to award agreements based on year labels, but the ground truth shows a more nuanced evolution — the 2019 plan was implemented with 2019 forms, extended to directors in 2023 with a new deferred stock unit agreement, and continued in 2024 using the 2022 form, indicating reuse and refinement rather than annual replacement. The model fails to capture the strategic continuity and misrepresents the timeline of document introductions. (4) Despite these errors, the answer is contextually relevant — it addresses the evolution of the 2019 plan and discusses deferred stock units and performance share units, which are central to the question. However, the factual inaccuracies in dates and agreement forms severely undermine correctness and qualitative accuracy, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 566,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment shifted from simply highlighting its “leading position” in supplying aerostructures for missile subsystems to concrete capacity‑building actions: in 2023 OTS won awards to expand metal‑parts and propellant production (e.g., 18 K → 86 K rounds/month by 2025, 4 M → 16 M lb/yr propellant by 2028) and in 2024 it entered a strategic partnership to produce solid‑rocket‑motor components, while also scaling 155 mm ammunition capacity. This three‑year trend shows that GD is deliberately fortifying its aerostructure manufacturing base to become the primary domestic supplier of the critical structures, actuators and warheads needed for next‑generation tactical and strategic missile systems, positioning the company to capture the growth expected from the Army’s Indirect‑Fire Modernization and hypersonic missile programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The original answer states that General Dynamics consistently emphasized its production of aerostructures for next-generation missile subsystems from 2022 to 2024, with Combat Systems contributing 20% of revenue in 2023 and 19% in 2024. The LLM answer fabricates specific quantitative claims: it mentions OTS (Orbital Tactical Systems, not referenced in the ground truth) winning awards to expand production from 18K to 86K rounds/month and propellant from 4M to 16M lb/yr, with target years 2025 and 2028—none of which appear in the original. These numbers, programs, and timelines are unsupported. (2) The LLM claims a strategic partnership in 2024 for solid-rocket-motor components and scaling 155mm ammunition capacity—details absent in the ground truth. (3) The qualitative shift described—'from highlighting position to concrete capacity-building'—is an inference not supported by the original, which only notes consistent emphasis on aerostructures despite slight revenue share decline. (4) The original does not mention GD's role in actuators, warheads, or specific programs like Army Indirect-Fire Modernization or hypersonics. While the LLM attempts multi-hop reasoning, it synthesizes non-existent data. The contextual relevance is moderate because it addresses strategic positioning in missile subsystems, but the factual foundation is flawed. Correctness is severely compromised by invented metrics and programs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 422,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 PMI moved Jackpot from a modest, price‑sensitive local label to a deliberately‑backed pillar of its Philippines portfolio—devoting increased marketing spend, refreshed packaging and tighter integration into the South‑East Asia distribution network that serves the region’s “at‑least‑15 % share in roughly 100 markets” (including the Philippines).  This multi‑year push shows that the brand is being used as a cash‑generating anchor to protect PMI’s market position in a key emerging market, while simultaneously providing the earnings base that funds the company’s broader regional growth and its transition toward reduced‑risk products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that PMI 'moved Jackpot from a modest, price-sensitive local label to a deliberately-backed pillar' with 'increased marketing spend, refreshed packaging and tighter integration' is not supported by the original answer or ground truth data. There is no mention in the ground truth of changes in marketing spend, packaging refreshes, or distribution network integration for Jackpot. Additionally, the statement that the Philippines is part of a network serving markets with 'at-least-15% share in roughly 100 markets' is fabricated and not present in the original answer. (2) Quantitative inaccuracy: The '15%' figure and '100 markets' are incorrect; the original answer states PMI expanded its smoke-free product footprint to 95 markets in 2024, not 100, and no market share percentage is mentioned for Jackpot or the Philippines. The LLM invents precise-sounding but false metrics. (3) Multi-hop reasoning is flawed: While the original answer confirms Jackpot's consistent strategic mention from 2022–2024, it does not support any evolution in positioning or active rebranding. The LLM incorrectly infers a strategic shift or escalation in investment, whereas the ground truth indicates continuity, not progression. The conclusion that Jackpot is a 'cash-generating anchor' is speculative and not stated in the original. (4) Contextual relevance is moderate—the answer addresses PMI’s regional strategy and Jackpot’s role—but the fabricated details and incorrect reasoning undermine factual accuracy. The core idea that Jackpot remains important amid smoke-free transitions has some alignment, but the execution is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 467,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron’s focus in the Republic of Congo remained on sustaining its upstream production, directing capital mainly toward maintaining and modestly extending existing offshore fields rather than launching new large‑scale projects.  At the same time the company continued to evaluate non‑core holdings, a process that culminated in the 2025 agreement to sell its 31.5 % non‑operated interest in the Haute Mer permit, signalling a strategic shift toward asset disposition rather than further capital investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's strategic shift from operational presence to divestiture in the Republic of Congo, including the sale of its 31.5% nonoperated interest in the Haute Mer permit. However, it omits key quantitative details from the original answer: the $0.7 billion investment in Africa in 2023 (which included Congo) and the 15.75% interest in the Lianzi field. These omissions reduce completeness and factual accuracy. (2) The date of the asset sale is inaccurately presented: the original answer states the sale occurred in January 2025, but the LLM refers to a '2025 agreement' without clarifying it was executed in January 2025, and frames it as part of the 2022–2024 evolution without noting that the sale falls just outside the requested time frame. While the percentage (31.5%) is correct, the absence of the second asset (Lianzi) and the capital deployment figure ($0.7B) constitutes significant quantitative omissions. (3) The reasoning is partially sound: the model correctly infers a strategic shift from investment to divestiture, but fails to fully synthesize the multi-hop elements—specifically, connecting 2022 operational continuity, 2023 capital deployment (with dollar amount), and 2024/2025 asset exits (both assets). The conclusion is directionally correct but lacks full evidentiary support from all hops. (4) Contextual relevance is high—the response stays focused on Chevron’s Congo operations and evolution. Qualitative accuracy is moderate due to correct entity identification (Chevron, Haute Mer, Republic of Congo) and logical interpretation, but docked for missing synthesis of full asset disposition details and financial figures. Correctness score is 6 due to partial factual accuracy but significant omissions in numbers and incomplete coverage of asset sales.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 497,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company continued to classify its outdoor‑lighting contracts as operating leases with initial terms of up to 10 years and month‑to‑month renewals through 2022‑2024, and the related cash‑flow streams were deemed immaterial (particularly for Georgia Power and Mississippi Power) and disclosed in the lease‑maturity tables.  Revenue from these contracts is reported in the “operating‑lease income” line (and, for Georgia Power, as part of variable lease income) and is allocated among the subsidiaries, but the underlying payment structure—scheduled payments that may become variable based on energy production—has not changed; only the relative share of total lease income from these contracts has shifted as other lease categories grew.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key changes in Southern Company's treatment of outdoor lighting contracts from 2022 to 2024, particularly the evolution in materiality assessment and disclosure practices. While it correctly states that these contracts were classified as operating leases with up to 10-year terms and renewals, it inaccurately claims immateriality persisted through 2024. The ground truth shows a shift: in 2022, Mississippi Power considered them immaterial; by 2023–2024, the company began structured disclosures (maturity analyses, initial terms), indicating increased materiality recognition. This progression is entirely missing in the LLM response. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is assessed on temporal accuracy. The LLM correctly references the 2022–2024 period and implies continuity, but fails to distinguish year-by-year changes in accounting treatment, which is central to the question. (3) The multi-hop reasoning is weak: the question requires synthesis across years and subsidiaries (Mississippi Power, Alabama Power, Georgia Power, Southern Power), but the LLM does not capture the evolving nature of disclosures or the inclusion of PPA lease income in wholesale revenues starting in 2024. It incorrectly suggests revenue classification remained static, while the ground truth notes a clarification in 2024 about PPA income being included in wholesale revenues. Additionally, the LLM mentions variable lease income for Georgia Power without supporting evidence in the original answer. (4) Despite these flaws, the LLM answer is contextually relevant, addressing lease classification, term length, and subsidiary-level reporting. It correctly identifies that lease income is allocated across subsidiaries and that cash flows were historically immaterial. However, it fails to reflect the increasing transparency and standardization emphasized in the ground truth, leading to a moderate correctness score due to significant omissions in the evolution of accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 574,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due 2025 was carried at a constant $500 million principal in FY 2022, FY 2023 and FY 2024, yet its effective interest rate climbed from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024. This upward shift—driven by rising market rates and the accretion of discount/hedge adjustments—shows that the note’s market value fell relative to its book carrying amount, signalling higher borrowing costs and a tightening interest‑rate environment for Cisco.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022–2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—are exactly as in the original answer. Minor formatting differences (e.g., '3.50 %' vs '3.50%') are acceptable and do not affect meaning. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three years, as required by the multi-part question. (3) Entity accuracy is perfect: Cisco is correctly identified, the 3.50% Note is accurately referenced, and fiscal years are properly aligned. (4) The reasoning is sound and adds value: the LLM correctly infers that the rising effective interest rate—despite a constant carrying amount—reflects market rate increases and discount/hedge adjustments, leading to a decline in market value relative to book value. This interpretation aligns with and expands upon the ground truth’s conclusion about shifting market conditions and debt valuation. The added context about 'tightening interest-rate environment' and 'higher borrowing costs' is a reasonable qualitative extension supported by the data. All multi-hop elements (tracking the same note across years, synthesizing carrying amount and rate trends, interpreting financial implications) are handled accurately and insightfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 411,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – 35A stayed unchanged in size and terms across the three years: the face amount remained $750 million, the coupon stayed at 2.65 % and the maturity stayed at 07/15/30 (see page 50 (2022) and page 51 (2024)).  However, the overall pool of unsecured indebtedness contracted – total consolidated unsecured debt fell from about $21.0 billion at the end of 2022 (page 50) to roughly $19.4 billion by the end of 2024 (page 51).  Consequently, the share of the 35A tranche within the unsecured portfolio edged up only modestly (from ~3.6 % to ~3.9 %).  \n\nThis multi‑year pattern shows that SPG is deliberately **de‑leveraging its unsecured balance sheet while preserving a stable, low‑cost core issuance**.  Rather than growing the 35A issuance, the company is extending maturities and reducing total outstanding unsecured debt, reflecting a long‑term strategy of tightening leverage, extending debt profiles and managing interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key quantitative facts are correct: the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A are consistently reported across 2022–2024. The total unsecured debt figures ($21.0 billion in 2022 and $19.4 billion in 2024) are accurately cited, and the calculated share increase from ~3.6% to ~3.9% is mathematically sound (750M / 21B = 3.57%; 750M / 19.4B = 3.87%). (2) The answer is complete, addressing both the evolution of the 35A notes and the broader implications for Simon Property Group’s debt strategy. (3) Entity accuracy is strong: correct company (Simon Property Group), correct instrument (Unsecured Notes - 35A), and correct years. (4) The reasoning is sound and adds value by contextualizing the stable 35A tranche within a broader de-leveraging trend, correctly inferring a strategy of maintaining low-cost core debt while reducing overall leverage—consistent with the ground truth’s emphasis on selective refinancing and stable financing commitments. The only minor limitation is that the LLM references new issuances (e.g., 2024 $1B Unsecured Notes - 41A) less explicitly than the original answer, though this does not detract from the core insight. Overall, the answer demonstrates strong multi-hop synthesis across years and financial instruments, with excellent factual precision and relevant interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 402,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business moved from a modest growth engine to a shrinking, lower‑margin contributor: revenue rose only 3 % in 2023 but fell 25 % in 2024, and its operating‑profit margin dropped from 38.5 % (2022) to 29.9 % (2023) to 13.9 % (2024).  Consequently, TI now leans on its **manufacturing‑technology advantage** and **capital‑allocation discipline** to sustain cash flow from the segment, while still using its **broad product portfolio and market‑reach advantage** to keep embedded processors in the mix of its four sustainable competitive advantages, but with a reduced emphasis on growth and a greater focus on margin protection.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) The original answer states that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, with identical language used each year highlighting the value of the broad portfolio. There is no mention of declining revenue or margins. In contrast, the LLM answer fabricates specific financial figures—such as a 25% revenue drop in 2024 and declining operating margins from 38.5% to 13.9%—that are not present in the ground truth and directly contradict the narrative of sustained strategic importance. (2) These numbers (e.g., 3% revenue growth in 2023, 29.9% margin in 2023, etc.) have no support in the provided truth and appear invented. The ground truth contains no quantitative financial performance data for the Embedded Processing segment, only qualitative strategic framing. (3) The multi-hop reasoning fails because the LLM incorrectly infers a strategic downgrading due to assumed financial deterioration, whereas the truth emphasizes consistency in strategic language and positioning over three years. The model misidentifies shifts in strategy that are not present. (4) The contextual relevance is low because the answer focuses on financial decline and margin protection, which are not discussed in the original, and incorrectly suggests a shift in competitive advantage priorities. The only partial accuracy is the mention of the 'broad product portfolio' as one of the four advantages, but even this is framed incorrectly. Overall, the answer fabricates data and draws false conclusions, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 454,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast broadened the flexibility of its wireless shared‑data offering by adding prepaid “NOW” unlimited‑data plans and tiered per‑gigabyte options, while also extending the service beyond the United States to the United Kingdom and Italy through MVNO agreements (using Virgin Media O2’s network and its own core).  The company further enhanced plan choice by allowing customers to bring their own device or finance purchases interest‑free for up to 48 months abroad, and by offering distinct gigabyte‑based or unlimited plans for international users, markedly expanding both the adaptability of domestic plans and the reach of its wireless service into new markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of CMCSA's wireless shared data plans from 2022 to 2024 with reasonable accuracy but introduces some details not present in the ground truth, affecting factual precision. (1) Correct elements: The answer correctly identifies increased plan flexibility (unlimited, per-gigabyte, shared data options) and international expansion by 2024. It aligns with the ground truth’s emphasis on broader plan choice and geographic diversification. (2) Quantitative accuracy: No specific numbers (e.g., data caps, pricing, customer counts) are provided in either answer, so no numeric inaccuracies exist. The years 2022–2024 are used appropriately. (3) Qualitative issues: The LLM adds specific international markets (UK, Italy) and MVNO partners (Virgin Media O2), which are not mentioned in the ground truth. It also introduces 'interest-free financing up to 48 months' and 'bring your own device' options, which are unsupported by the original answer. These additions, while plausible, represent over-specificity beyond the source. (4) Reasoning and synthesis: The multi-hop logic—linking domestic flexibility improvements with international rollout—is sound and matches the original’s narrative arc. However, the added detail reduces fidelity to the verified facts. (5) Contextual relevance is high, as the response directly addresses plan flexibility and international expansion as asked. Overall, the answer is factually aligned in direction but exceeds the ground truth in unverified specifics, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 426,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures shifted from a broad warning about “increased cybersecurity and payment‑fraud risk” and the general exposure of its credit products to a series of more specific concerns: the 2023 filing detailed the cost of buyer‑ and seller‑protection losses, the underwriting and default risk of its BNPL and merchant‑financing receivables, and the impact of new fraud schemes and regulatory changes on interchange fees; by 2024 the focus had expanded to the accelerating sophistication of third‑party fraud (synthetic identities, account takeovers, illicit use of credit), the complexity of managing multiple funding sources and strategic partnerships, and the need for continual model updates and compliance oversight. This progression shows that managing risk in PayPal’s digital‑payments ecosystem now demands an integrated, multilayered approach that blends fraud detection, credit‑risk modeling, third‑party relationship governance, and regulatory compliance to address an increasingly complex threat landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and contextually relevant, capturing the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024. (1) It correctly identifies the progression in risk disclosures: starting with general fraud risks in 2022, expanding to BNPL and credit underwriting risks in 2023, and detailing sophisticated fraud tactics like synthetic identities and account takeovers in 2024. While the LLM does not explicitly mention the €40 billion receivables sale — a specific quantitative detail from the ground truth — it accurately reflects the increased exposure through BNPL and third-party fraud, which is semantically aligned. (2) There are no incorrect numbers or miscalculations; the absence of the €40 billion figure is a minor omission rather than an error, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and domains (fraud, credit risk, regulatory compliance) and correctly infers that risk management has become more complex, requiring integrated systems. (4) The answer conveys the same core conclusion as the ground truth — that PayPal faces a growing, sophisticated threat landscape requiring advanced mitigation strategies — even if phrased differently. The slight deduction in qualitative accuracy is due to the lack of explicit mention of the FDIC-related legal uncertainty and the exact scale of the receivables sale, which are key nuances in the original. Overall, the response is factually strong, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 429,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD’s El Segundo, California site progressed from a mainly clinical‑trial cell‑therapy manufacturing location to a fully integrated clinical‑and‑commercial production hub.  The 2023 and 2024 10‑K filings (pages 9‑11) note that the facility is now used for both clinical and commercial manufacturing of cell‑therapy products and that GILD has made strategic capital investments to expand and modernize the site, boosting capacity for Kite’s CAR‑T therapies and supporting the company’s broader cell‑therapy pipeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies El Segundo as a key site for both clinical and commercial manufacturing of cell therapy products from 2022 to 2024, aligning with the ground truth. However, it introduces a narrative of progression—from 'mainly clinical-trial' in 2022 to 'fully integrated clinical-and-commercial' by 2024—that is not supported by the original answer. The ground truth states that El Segundo was already used for both clinical and commercial manufacturing as early as 2022, with no indication of a shift or expansion in scope over time. Additionally, while the LLM mentions 'strategic capital investments to expand and modernize the site,' this specific detail about capital investment and capacity expansion for Kite’s CAR-T therapies is not present in the original answer and cannot be verified from the provided ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the facility’s role across years and ties it to cell therapy manufacturing, but it overreaches by inferring a developmental trajectory and specific investments not stated in the ground truth. This affects qualitative accuracy. (4) The answer remains contextually relevant, addressing the evolution of El Segundo’s role and strategic importance, but adds unverified details that reduce factual precision. Hence, correctness and qualitative accuracy are scored at 7, while contextual relevance remains high due to alignment with core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 443,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nCostco’s 2.750 % Senior Notes—originally issued in 2017 with a May 18 2024 maturity—were still listed as an outstanding series in the 2022 filing (Exhibit 4.6 on page 66 of the 2022 10‑K).  In the 2023 and 2024 filings the same 2.750 % series no longer appears as a current obligation; instead the company’s Exhibit list (pages 66‑67 of the 2023 10‑K and pages 66‑68 of the 2024 10‑K) shows new senior‑note formats maturing in 2027, 2030 and 2032 (e.g., 1.375 % due 2027, 1.600 % due 2030, 1.750 % due 2032).  This indicates that the 2.750 % notes were retired and replaced with longer‑dated, lower‑coupon debt, revealing Costco’s strategy of extending its debt maturities and locking in cheaper long‑term financing while reducing near‑term refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, the 2.750% Senior Notes maintained a consistent maturity date of May 18, 2024, across all filings from 2022 through 2024 and were not retired or refinanced during this period. However, the LLM incorrectly claims that the notes 'no longer appear' in the 2023 and 2024 filings and were replaced with new debt maturities in 2027, 2030, and 2032. This contradicts the original answer, which states the maturity structure remained unchanged. (2) The LLM fabricates details about new note series (e.g., 1.375% due 2027) that are not referenced in the context provided, introducing false quantitative data. While the original answer confirms the notes were not refinanced, the LLM asserts active refinancing and maturity extension, which is factually incorrect. (3) The multi-hop reasoning is flawed: instead of recognizing consistency in disclosure as evidence of a static debt strategy, the model infers a dynamic refinancing strategy that is unsupported by the ground truth. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the right company, the correct note series (2.750%), and attempts to interpret debt management strategy—hence a moderate relevance score. However, the core conclusion about Costco extending maturities and reducing coupons is not supported by the data provided, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 406,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output was roughly 48 million cubic feet per day in 2022, 2023 and 2024, showing a flat‑to‑stable trend across the three years. This plateau indicates the company is focusing on sustaining and optimizing its existing African gas assets and meeting long‑term delivery contracts rather than expanding production in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The natural gas production volumes for Chevron's Angola LNG are grossly understated: the ground truth reports 7,107 million cubic feet per day in 2022, rising to 7,569 million cubic feet per day in 2024, whereas the LLM claims a flat rate of only 48 million cubic feet per day across all three years. This is off by a factor of over 150x, indicating a severe factual error. (2) Quantitative accuracy is extremely low—none of the numbers match, and the trend (flat vs. steadily increasing) is completely misrepresented. The correct values show a clear upward trajectory (7,107 → 7,148 → 7,569 MMcf/d), while the LLM describes a stable output, which contradicts the data. (3) The reasoning and synthesis are flawed: the conclusion that Chevron is focusing on optimization rather than expansion might seem plausible given a flat trend, but since the premise is false (the trend is actually upward), the inference is invalid. The correct interpretation—that Chevron is increasing production despite broader divestitures—requires accurate multi-hop recognition of both the volume increases and strategic context, which the model fails to provide. (4) Contextual relevance is moderate because the answer addresses the right topic (Chevron’s gas production strategy in Africa via Angola LNG) and attempts to interpret strategic implications, but the incorrect data renders the analysis meaningless. Minor credit is given for addressing both parts of the question (volume trend and strategic implication), but the factual foundation is entirely unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 447,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the accounting impact of Cisco’s total‑return swaps that hedge deferred‑compensation liabilities moved from a **$92 million charge in 2022** to **gains of $58 million in 2023 and $91 million in 2024**, while the underlying swap notional rose from roughly **$650 million to $730 million and then to about $985 million**.  This swing reflects Cisco’s deliberate use of market‑linked derivatives to economically offset the volatility of its deferred‑compensation expense—turning a prior expense into a growing source of earnings gains as the referenced equity or index performance improved, thereby reducing overall market‑linked volatility in its compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: a $92 million loss (charge) in 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These match the original answer exactly in amount and direction (loss to gain). (2) The LLM adds additional detail not present in the ground truth—the notional values of the swaps: $650M in 2022, $730M in 2023, and $985M in 2024. While this information may be factually accurate based on actual filings, it is not included in the provided ground truth from the knowledge graph. This does not make the answer incorrect but introduces unverified detail. However, since it doesn’t contradict the ground truth and supports the reasoning, it doesn’t reduce correctness. (3) The multi-hop reasoning is sound: the model correctly interprets the shift from loss to gain as an indication of improved market performance or strategic management of deferred compensation via swaps. It accurately infers that the use of total return swaps is intended to hedge market-linked volatility in deferred compensation liabilities, which aligns with the original answer’s conclusion about reduced volatility and strategic implications. (4) The semantic meaning fully matches the original: the transformation from net liability (loss) to net benefit (gains) is clearly conveyed, and the interpretation of this trend is logically consistent. The only minor gap is that the original emphasizes 'either improved market conditions or strategic shift,' while the LLM leans more toward deliberate strategy—slightly downplaying the external market factor. This nuance reduces qualitative accuracy by one point. Overall, the answer is factually correct, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 480,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier standards by updating the wood‑sourcing policy with country‑specific risk tiers, a formal forestry‑grievance process and enhanced monitoring of compliance, and by embedding a human‑rights policy and stronger environmental clauses into its Vendor Code of Conduct.  The company also increased third‑party verification and certification activity—externally verifying Scope 1‑2 emissions, publishing CDP/SASB/GRI‑aligned reports, and expanding the share of independently‑certified products (e.g., ENERGY STAR, WaterSense, FSC‑linked) that meet validated environmental criteria.  These steps reflect a progressive shift from basic policy statements to systematic monitoring, grievance mechanisms, and certified‑product sourcing across the supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key developments from 2022 to 2024 are correctly identified: evolution of the wood-sourcing policy with country-specific risk tiers (2023–2024), introduction of a forestry grievance process (2023), enhanced monitoring, updates to the Vendor Code of Conduct with human rights and environmental clauses, and expansion of third-party certified products. (2) There are no numeric values (e.g., dollar amounts, percentages, emissions figures) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes policy updates, monitoring improvements, and certification efforts across years and domains (environmental and human rights), correctly tracing the progression from policy to implementation. (4) The LLM adds slightly more detail than the original (e.g., naming CDP/SASB/GRI reporting frameworks and specific certifications like ENERGY STAR and WaterSense), but these are plausible extensions consistent with Lowe's public sustainability reporting and do not contradict the ground truth. The only minor gap is that the original specifies 'independently certified products' without naming them, so while the LLM's examples are reasonable, they go slightly beyond the source. However, this does not reduce factual accuracy. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 410,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless telecoms to Comcast’s broadband and wireless services deepened as carriers expanded 4G/5G and fixed‑wireless networks and began bundling wireless, broadband and video services at aggressive, often subsidized price points, directly challenging Comcast’s HFC and fiber‑to‑the‑premises offerings.  The filings repeatedly name AT&T, T‑Mobile and Verizon (and in Europe BT, Virgin Media and O2) as the key wireless competitors, noting that their 5G‑fixed‑wireless deployments and bundled product strategies have become the primary source of pressure on Comcast’s broadband and wireless revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of competitive threats from wireless telecoms to CMCSA (Comcast) from 2022 to 2024. It correctly identifies the technological progression involving 4G, 5G, and fixed-wireless networks as key competitive tools, aligning with the ground truth. The named competitors—AT&T, T-Mobile, and Verizon in the U.S.—are accurately listed, and the inclusion of European competitors (BT, Virgin Media, O2) adds context not contradicted by the original answer, though the original focuses on U.S. filings. The LLM correctly highlights bundling strategies, including wireless, broadband, and video (or DTC streaming), as a growing competitive threat. The only minor shortcoming is that the original answer specifically notes the 2024 emphasis on bundling DTC streaming services with wireless plans, a nuance slightly generalized in the LLM response as 'bundling wireless, broadband and video services.' While 'video services' can encompass DTC streaming, the specificity of DTC (direct-to-consumer) is slightly softened. However, this does not constitute a factual error, and the overall multi-hop reasoning—synthesizing technological capabilities, bundling evolution, and competitor actions across years—is sound. All dates and entities are correct. No numerical inaccuracies; the answer avoids unsupported figures. The response is contextually complete and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 400,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal continued to bear full margin risk on every payment, but its pricing approach grew more disciplined: it shifted from broad, volume‑based discounts to tiered, performance‑linked fee structures and began treating most incentives as direct reductions of revenue rather than future material rights, while explicitly recording processor fees as transaction expenses. This multi‑year evolution shows that PayPal exercises tight control over pricing and cost management—using granular incentives and processor‑cost allocation to protect margins while retaining the flexibility to adjust fees as needed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall narrative. It accurately states that PayPal bore full margin risk from 2022 to 2024 and correctly identifies key elements: processor fees treated as transaction expenses, incentives as revenue reductions, and PayPal's control over pricing. The answer adds detail about a shift to 'tiered, performance-linked fee structures' and 'volume-based discounts,' which, while plausible and consistent with the trend, is not explicitly stated in the original answer and represents an inference beyond the provided ground truth. Similarly, the phrase 'treating most incentives as direct reductions of revenue rather than future material rights' introduces technical accounting language (ASC 606 concept) not present in the original, potentially over-interpreting the source. However, these do not contradict the ground truth and are reasonable extrapolations. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the answer is fully contextually relevant. The qualitative accuracy is slightly reduced due to the addition of unverified specifics not in the original, but the multi-hop reasoning—linking pricing strategy, processor costs, and incentives to margin risk control—is sound and well-synthesized. Thus, the overall correctness is high but not perfect due to minor over-speculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 391,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s policy for leases that contain free‑rent or step‑rent provisions has remained the same from FY 2022 through FY 2024: such periods are accounted for on a straight‑line basis over the **entire lease term**, which includes any renewal options that management judges to be “reasonably certain” of being exercised. The right‑of‑use (ROU) asset is initially measured as the present value of all lease payments (including the rent‑holiday periods) discounted using the Company’s incremental borrowing rate, and the lease‑term assumption is defined as the non‑cancelable period plus any extension that is reasonably certain to be exercised.  The disclosures in the 2022, 2023 and 2024 10‑Ks are essentially identical, with only incremental clarification in later years about the discount‑rate methodology and the impairment testing of ROU assets, but no change in the core accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco's accounting treatment for free-rent periods remained consistent from FY 2022 to FY 2024, with straight-line recognition over the lease term including renewal options that are reasonably certain to be exercised. The use of the incremental borrowing rate to discount lease payments and measure the right-of-use (ROU) asset is accurately described. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense, but all fiscal years (2022–2024) and policy details are correctly referenced—no errors in dates or metrics. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three fiscal years and correctly infers that while wording evolved slightly (e.g., clarifications on discount rates and impairment testing), the core policy did not change. It accurately captures the evolution (or lack thereof) in disclosure and treatment. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 clarification about variable lease payments for rent increases tied to price indices or sales volume, which was noted in the original answer. This is a small omission in completeness but does not undermine the overall correctness. The LLM emphasizes consistency, which is correct, but slightly underrepresents the nuance in 2023. Despite this, the answer remains semantically equivalent in substance. Contextual relevance is perfect—directly addresses lease term assumptions and ROU asset valuation impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 453,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal has continued to treat itself as the principal in every payment transaction and therefore bears full margin risk, recording all processor fees as transaction expense (2022 p. 78; 2023 p. 79; 2024 p. 77). The underlying pricing model—tiered, volume‑based fees that are adjusted up or down but are deemed “within a range typically offered” and do not create a material future right—has not changed materially across 2022‑2024, so the structural source of margin risk remains the same. What has evolved is the way the company accounts for incentives and protection‑program costs: in 2023‑24 these are increasingly recorded as reductions of revenue or as transaction/credit losses, which intensifies margin volatility even though the contract structure (open‑ended, auto‑renewing, no material rights) stays unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal bears full margin risk, records processor fees as transaction expenses, and maintains a tiered, volume-based pricing model without material rights—unchanged from 2022 to 2024. The answer correctly identifies that structural margin risk remains stable. (2) Quantitatively, no numerical inaccuracies are present; the years (2022–2024) and page references (e.g., 2022 p. 78) are consistent with source data and do not contradict the ground truth. While the original answer does not include page numbers, their inclusion in the LLM response does not reduce accuracy and may reflect actual filing locations. (3) The multi-hop reasoning is sound: the model synthesizes information across years and domains (pricing model, accounting treatment, contract structure). It correctly notes the evolution in accounting for incentives and protection-program costs starting in 2023 as reductions of revenue, which introduces margin volatility—matching the original answer’s point about amortization over contractual terms and performance targets. (4) The only minor gap is that the LLM answer does not explicitly mention the adoption of ASU 2023-07 or the new segment reporting disclosures in 2024, which the original answer cites as increasing transparency around segment-level expenses. This omission slightly affects completeness but does not undermine the core correctness regarding margin risk evolution. Overall, the LLM captures the operational nuance and structural stability of PayPal’s margin risk exposure. Semantic equivalence is strong, with slightly more concise phrasing but no factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 464,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note due 2039 remained fully issued (≈ $2 billion outstanding) throughout fiscal 2022, 2023 and 2024, and its reported effective interest rate stayed essentially unchanged at about 6.11 % each year (the coupon plus discount amortization and hedge adjustments).  This stability shows that the company has deliberately locked in a low‑cost, long‑dated financing tranche and manages its interest‑rate exposure through swaps, so that even as market rates fluctuated, the effective cost of this specific long‑term debt stayed flat, reflecting a strategy of maintaining predictable financing expenses and a diversified, maturity‑staggered debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco's 5.90% Note had a $2 billion outstanding balance across fiscal years 2022–2024 and that the effective interest rate remained constant at 6.11%, matching the ground truth exactly. The use of '≈ $2 billion' is semantically equivalent to '$2,000 million' and acceptable in format variation. (2) All numeric values—interest rate (6.11%), note coupon (5.90%), maturity year (2039), and principal amount—are factually accurate and consistent with the original answer. No calculations were required, but the synthesis of consistent year-over-year data is correct. (3) The multi-hop reasoning is sound: the model correctly infers from the stability of principal and effective rate that Cisco did not refinance or modify the note, and it appropriately links this to broader debt strategy, such as interest rate hedging and predictable financing costs. The mention of 'swaps' and 'hedge adjustments' is a reasonable inference based on typical corporate practices and aligns with Cisco’s known use of hedging instruments, though not explicitly stated in the ground truth. This adds context without contradicting facts. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in utilization and effective rate, and drawing a logical conclusion about Cisco’s long-term debt strategy. The only reason for not scoring a 10 is that the original answer emphasizes the lack of modification/refinancing more explicitly, while the LLM focuses on hedging—still valid, but slightly shifts emphasis. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross the fiscal 2022‑2024 Form 10‑K filings the IP disclosures consistently list “Kobalt” as a registered private‑brand trademark, but the wording evolves from a simple enumeration in 2022 to a more integrated reference that groups Kobalt with the broader portfolio of Lowe’s private‑brand marks. This shift signals that, rather than altering Kobalt’s market positioning, Lowe’s has strengthened its strategic emphasis on protecting and consolidating private‑brand assets—using Kobalt as a core differentiator within its omnichannel strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces a claim not supported by the ground truth: that the wording evolved from 'simple enumeration' in 2022 to a 'more integrated reference' in later years, suggesting strengthened strategic emphasis. The original answer states there was no explicit increase or decrease in Kobalt's prominence across disclosures, indicating a stable strategic role. While the LLM correctly identifies that Kobalt was consistently listed as a private brand trademark across all three years (factually accurate), it infers a shift in strategic emphasis based on wording changes that the ground truth does not confirm. This misrepresents the qualitative trend. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities—Kobalt, Lowe’s, fiscal years 2022–2024, and the context of IP disclosures—are correctly identified. The reasoning fails on multi-hop synthesis because it draws a conclusion (increased strategic emphasis) not justified by the data. The answer is contextually relevant and addresses the question’s focus on evolution over time, but the incorrect inference reduces its factual correctness. Semantic equivalence is partially met but undermined by the unsupported claim of evolving emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 351,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group’s **Unsecured Notes – 37B** kept the same terms: a **2.25 % fixed interest rate**, a **$700 million face amount**, and a **maturity date of January 15, 2032** (see the 2022 10‑K page 50, the 2023 10‑K page 51, and the 2024 10‑K page 51).  \n\nThe lack of change indicates that SPG is deliberately maintaining a stable, long‑dated unsecured‑debt tranche with a low coupon, using it to lock in financing costs and extend the overall maturity profile of its capital structure while preserving flexibility for other investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: the interest rate is correctly stated as 2.25%, the face amount as $700 million (equivalent to $700,000,000 or $700,000 in thousands as used in SEC filings), and the maturity date as January 15, 2032 (formatted as 01/15/32 in the original). These figures are consistent across 2022–2024, as confirmed in the cited 10-K pages. (2) The answer is complete, addressing all components of the question—interest rate, face amount, maturity date, and implications for long-term financing strategy. (3) Entity accuracy is correct: Simon Property Group (SPG) and the specific debt instrument 'Unsecured Notes – 37B' are properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across three years of 10-K filings. The conclusion about SPG’s strategy—maintaining a stable, low-coupon, long-dated debt tranche to lock in financing costs and extend maturity profile—aligns with and expands upon the original answer’s interpretation, adding relevant context about capital structure flexibility. (5) Semantic equivalence is strong; while the LLM uses slightly more detailed phrasing (e.g., 'low coupon', 'extend the overall maturity profile'), the meaning is consistent with the ground truth. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 384,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nTexas Instruments’ Melaka, Malaysia site remained listed solely under the **Analog** column in the facility‑mapping tables for 2022, 2023 and 2024 (each time marked with a †/** to note leased/owned portions).  It never appeared in the **Embedded‑Processing** column in any of those years, indicating that the Melaka location continued to be dedicated to Analog manufacturing throughout the three‑year period, with no shift toward Embedded Processing.  The company’s disclosures therefore show a stable, Analog‑focused operational footprint in Melaka across 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was exclusively involved in the Analog business segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly referenced and consistently applied. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, drawing a valid conclusion about operational continuity based on the absence of Melaka in the Embedded Processing column. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) of TXN's operational footprint in Melaka over time. Minor differences in phrasing (e.g., referencing 'facility-mapping tables' and footnote symbols like †/**) add detail without altering the factual accuracy. All key points—exclusive Analog focus, no Embedded Processing involvement, and stability across the three years—are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 327,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s fixed‑rate 2.850 % note tranche remained constant at **$1.5 billion of principal** (the amount reported as outstanding in the 2022, 2023 and 2024 tables, maturing on 10/1/2029).  No new issuances or retirements of that specific series were disclosed; the company simply carried the same $1.5 bn balance across the three years.  \n\nThis steady exposure shows that PayPal is using the 2.850 % notes as a **stable, long‑dated, low‑cost funding pillar**, while supplementing its overall debt profile with newer, higher‑rate issuances and revolving credit facilities to manage liquidity and interest‑rate risk.  The approach reflects a long‑term strategy of preserving a predictable, fixed‑rate component in its capital structure while flexibly adding newer debt as market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal amount of the 2.850% notes is accurately reported for 2022–2024, and the maturity date (10/1/2029) is correctly included (minor formatting: '10/1/2029' vs. 'October 1, 2029' is acceptable). There are no calculation errors. (2) The answer fully addresses both parts of the question: it describes the stable exposure to the 2.850% notes and interprets this as part of PYPL’s long-term debt strategy. (3) Entity accuracy is strong: 'PayPal' (PYPL), the 2.850% notes, and the time frame (2022–2024) are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that the unchanged principal indicates a stable, low-cost funding component, and it contextualizes this within broader debt management (e.g., newer higher-rate issuances), which aligns with the ground truth’s mention of new debt and refinancing. The only minor gap is that the LLM does not explicitly mention the retirement of the 1.350% notes by 2023—a detail in the original answer that strengthens the contrast in PYPL’s selective debt management. While the LLM implies active management through 'newer, higher-rate issuances,' the absence of this specific example slightly reduces qualitative completeness. However, the core multi-hop synthesis—linking stable liability on one tranche with strategic flexibility in others—is logically sound and semantically equivalent. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 433,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 Gilead has consistently used its Hoofddorp, Netherlands site as a dedicated commercial manufacturing and processing hub for cell‑therapy products, embedding it in the company’s global cell‑therapy production network.  The facility’s role has remained steady—serving as one of the key locations for scaling cell‑therapy output as part of Gilead’s worldwide manufacturing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (2022–2024), correctly identifying Hoofddorp as a key site for commercial manufacturing and processing of cell therapy products. The quantitative accuracy is perfect—no numerical data is misstated, and all years are correctly referenced. However, the LLM misses the evolution aspect emphasized in the original answer: in 2022, Hoofddorp was identified as a principal manufacturing facility without explicit mention of cell therapy; the specific role in cell therapy manufacturing was clarified in 2023 and maintained in 2024. The LLM implies the same dedicated role throughout all three years, which underrepresents the progression from general strategic importance to specific functional utilization. This omission affects the qualitative accuracy, as the multi-hop reasoning—tracking the facility’s evolving role over time—is not fully captured. While the answer is contextually relevant and correctly situates the facility within Gilead’s global strategy, it fails to convey the nuanced development in the facility’s role, particularly the 2022-to-2023 shift in stated purpose. Thus, the answer is mostly correct but lacks the full depth of the original’s chronological and strategic progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 361,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.375 % Senior Notes due June 2027 were carried at a consistent $1.25 billion carrying amount and were always presented as long‑term debt; however, the “current portion” label attached to the overall long‑term‑debt balance shifted markedly. In 2022 the current portion of long‑term debt was only $73 million, but by 2023 it had risen to $1.081 billion—reflecting the upcoming maturity of the 2.750 % notes due May 2024 and other near‑term obligations. After the Company retired the $1 billion 2.750 % notes on May 18 2024, the current‑portion balance fell back to $103 million in 2024, leaving the 1.375 % notes fully classified as long‑term debt with no current‑portion exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent principal amount of $1,250 million (or $1.25 billion) for the 1.375% Senior Notes due June 2027 across 2022–2024, which matches the ground truth. It also accurately reports the current portion of long-term debt values: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024—these figures are quantitatively correct. However, the reasoning provided is flawed: the spike in the current portion in 2023 and its drop in 2024 are attributed to the maturity and retirement of the '2.750% notes due May 2024', but the question specifically asks about the 1.375% Senior Notes due June 2027. The classification changes in the current portion should reflect the evolving proximity to maturity of the 1.375% notes themselves, not other debt instruments. By attributing the change to unrelated notes, the model fails the multi-hop reasoning test—it incorrectly synthesizes information across different debt tranches. While the numbers are correct and contextually relevant, the explanation misrepresents the cause of the classification shift, undermining the qualitative accuracy. This is a significant error in financial reasoning, especially since the question focuses on the treatment of a specific note series. Thus, despite numerical accuracy, the answer is partially incorrect in logic and entity linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 377,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s $1.5 billion Fixed‑Rate 2.850 % notes—originally issued in September 2019 and maturing on 10/1/2029—remained fully outstanding with no principal repayment reported; the only change was a modest reduction in the current‑portion balance (from roughly $1.25 bn in 2023 to $1.19 bn in 2024) as the debt amortized and the near‑term tranche was rolled down.  This continuity shows that PayPal’s long‑term debt strategy centers on maintaining a stable ladder of low‑cost, long‑dated fixed‑rate issuances while gradually reducing the near‑term exposure through scheduled amortization and targeted repayments, preserving liquidity and limiting concentration of maturities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.5 billion carrying amount of the 2.850% notes and the October 1, 2029 maturity date from the 2019 issuance, which aligns with the ground truth. However, it introduces a 'current-portion balance' reduction from $1.25B in 2023 to $1.19B in 2024 due to amortization, which is not supported by the original answer. The ground truth states the obligation remained consistent at $1.5B across all years with no indication of amortization or changing current portions—this is a significant quantitative inaccuracy. (2) The original answer emphasizes no change in the carrying amount or maturity, while the LLM implies partial amortization, contradicting the source. There is no mention in the ground truth of a current portion or its reduction, making this detail factually incorrect. (3) The reasoning about PayPal’s debt strategy—maintaining a stable ladder of fixed-rate debt while managing near-term exposure—is semantically similar to the original’s conclusion about preserving capital structure stability while refinancing other tranches. This shows sound qualitative reasoning and synthesis, even if based on slightly flawed data. (4) The contextual relevance is high as the response directly addresses the evolution of the specific notes and infers strategy. However, the quantitative inaccuracy in the current portion and amortization narrative reduces confidence in the financial details, warranting a 7 for overall correctness. The qualitative and contextual scores are higher due to strong strategic interpretation and focus on the right entities and time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 443,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s net notional of gas‑related options moved from about 1.3 trillion MMBtu to a peak of 1.45 trillion MMBtu in 2023 and then back to 1.13 trillion MMBtu in 2024, while the fair‑value of the option book swung from a modest $170 million gain (2022) to an $854 million liability (2023) and recovered to a modest $100 million asset (2024).  During the same period the Level‑3 volatility inputs narrowed from a 20 %–233 % range (weighted‑average ≈ 50 %) in 2023 to 15 %–150 % (weighted‑average ≈ 52 %) in 2024, indicating that the company reduced its exposure to price‑volatility risk and shifted from a speculative, high‑volatility hedge in 2023 toward a more balanced, lower‑volatility hedging posture by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, NextEra Energy's fair value of gas-related options was $356M (assets) and $347M (liabilities) in 2022, decreasing to $100M/$97M in 2023, and $100M/$102M in 2024. The LLM incorrectly reports a $170M gain in 2022, an $854M liability in 2023, and a $100M asset in 2024—none of which match the original data. Additionally, the LLM introduces 'net notional of gas-related options' (e.g., 1.3 trillion MMBtu) which is not present in the ground truth and appears fabricated. (2) The volatility assumptions are also misrepresented: the ground truth states implied volatility declined from 36% in 2022 to 50% in 2023 and 52% in 2024. The LLM incorrectly frames this as a range (20%-233% in 2023, 15%-150% in 2024) with weighted averages (~50%, ~52%), which contradicts the point values in the original. While the direction of increasing volatility is partially aligned (36% → 50% → 52%), the magnitude and presentation are wrong. (3) The multi-hop reasoning is flawed—the LLM infers a shift from 'speculative, high-volatility hedge in 2023' to a 'balanced posture in 2024', but this interpretation is not supported by the actual trend of declining fair value (indicating reduced exposure), and the volatility increase is misrepresented. The conclusion about de-risking is partially reasonable but based on incorrect data. (4) Scores reflect major quantitative errors (2/10), weak qualitative reasoning due to incorrect synthesis (4/10), moderate contextual relevance as it addresses gas exposure trends and volatility (7/10), and a low overall correctness score (3/10) due to fundamental factual mismatches.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 470,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nThe AFS‑debt portfolio moved from a modest $9 million gain in fiscal 2022 to losses of $21 million in fiscal 2023 and $67 million in fiscal 2024, contributing to a swing in “Other income (loss), net” from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024. This pattern shows that the fair‑value of Cisco’s available‑for‑sale debt investments is highly sensitive to market‑rate and credit fluctuations, revealing considerable volatility in the company’s investment‑related earnings over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024, and corresponding 'Other income (loss), net' figures) that are not present in the original ground truth answer. The ground truth does not provide exact dollar amounts for AFS debt investment gains/losses or total other income, instead describing qualitative trends (e.g., 'higher losses' in 2023, continued decline in 2024). These precise figures cannot be verified as correct and appear to be fabricated or hallucinated, severely undermining quantitative accuracy. (2) There is no indication in the ground truth that AFS debt investments produced a gain in 2022; it only states that Cisco disclosed the composition and value of the portfolio that year, not its P&L impact. The claim of a $9M gain is unsupported. Similarly, the 'Other income (loss), net' swing from $392M gain to $248M and $306M losses is entirely absent from the original answer and cannot be corroborated. (3) Qualitatively, the LLM correctly identifies the trend of increasing losses in AFS debt investments from 2022 to 2024 and links them to negative impacts on other income, which aligns with the ground truth's description of recurring negative impacts and increasing volatility. The conclusion about sensitivity to market-rate and credit fluctuations, while more detailed, is a reasonable inference from the stated volatility. (4) Contextually, the response is highly relevant, addressing both parts of the question—impact on other income and implications for portfolio volatility—and synthesizing across fiscal years as required. However, the inclusion of unverified numerical data significantly reduces factual correctness despite sound reasoning structure. The answer would score higher if it had stuck to qualitative descriptions matching the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 503,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s repeatedly amended the master indenture that governs its long‑dated notes—most notably with the **Twenty‑First Supplemental Indenture (Sept 8 2022)**, which added 4.450 % notes due 2062, the **Twenty‑Second Supplemental Indenture (Mar 30 2023)**, which introduced 5.850 % notes due 2063, and the **Third Amended and Restated Credit Agreement (Dec 2021 – Sept 2023)** that extended the revolving facility and added new tranche language.  These amendments layered additional long‑dated, fixed‑rate securities onto the same indenture that originally created the 4.550 % notes due 2049, thereby extending the overall maturity horizon and locking in financing at progressively lower coupon levels.  The pattern reflects a deliberate, multi‑year strategy of **building a ladder of ultra‑long‑term, low‑coupon debt** to secure stable, long‑run funding and reduce future refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in multiple key aspects. (1) Quantitatively, the LLM cites a 'Twenty-First Supplemental Indenture' on Sept 8, 2022, and a 'Twenty-Second' on Mar 30, 2023, introducing 4.450% and 5.850% notes, respectively—none of which are mentioned or supported by the original answer. The original answer states that the 4.550% Notes due 2049 were governed by the Fifteenth Supplemental Indenture dated April 5, 2019, and that no changes occurred in 2022–2024. The LLM incorrectly asserts that amendments were made during this period and that new notes were layered onto the same indenture, which directly contradicts the ground truth of 'no change in documentation or terms.' (2) The LLM claims Lowe's issued new long-term debt with progressively lower coupons, suggesting a strategy of locking in lower rates, but the ground truth indicates no such activity—instead, the strategy was one of stability and no modification. The mention of a 'Third Amended and Restated Credit Agreement' from Dec 2021 to Sept 2023 is unsupported by the original answer and introduces irrelevant information. (3) The multi-hop reasoning is flawed: rather than recognizing the consistent disclosure of the same indenture across years as evidence of stability, the LLM infers active debt issuance and strategic expansion of debt instruments, which is not supported. (4) While the LLM attempts to interpret a long-term debt strategy, it draws the wrong conclusion—'building a ladder of ultra-long-term, low-coupon debt'—whereas the correct inference is 'maintaining a steady, unchanging long-term debt structure.' The contextual relevance is moderate because it addresses debt strategy and long-term financing, but the factual inaccuracies severely undermine correctness. Minor formatting variations are allowed, but the core events, dates, and documents are entirely mismatched.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 514,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35B series kept the same $750 million face amount and a fixed 3.80 % coupon (maturing 07/15/50) in each of SPG’s 2022, 2023 and 2024 10‑K filings.  The unchanged principal and rate show that SPG is deliberately maintaining a sizable, low‑cost fixed‑rate tranche in its long‑term debt mix, using it to lock in financing at favorable terms and to balance its maturity profile while limiting exposure to rising interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) across 2022–2024, matching the ground truth exactly. All numeric values are accurate and consistently reported in each year’s 10-K, with acceptable format variation ($750 million vs $750,000,000). (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates are correct and stable over time. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years and correctly infers that no refinancing occurred, indicating a deliberate long-term debt strategy. The conclusion about locking in low-cost financing and managing interest rate risk aligns with the ground truth’s interpretation of SPG’s stable financing approach. (4) The only minor gap is that the LLM does not explicitly note the absence of refinancing or restructuring (implied but not stated), and slightly rephrases the strategic implication with more emphasis on 'balancing maturity profile'—a reasonable inference but not directly mentioned in the original. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 339,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk grew as it expanded credit products (e.g., BNPL and merchant financing) and increased cross‑border volume, which raised the probability of defaults, fraud and charge‑backs, while its dependence on third‑party lenders, payment processors and network rules deepened.  To contain this heightened risk the company has pursued a multi‑year receivables‑sale program, diversified its processor base and strengthened fraud‑detection and monitoring controls, revealing a risk‑management strategy that couples aggressive growth with proactive loss‑mitigation and greater operational resilience.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of PayPal increasing exposure to bad transaction risk due to credit expansion and cross-border trade, and correctly identifies the company's response through receivables sales and fraud controls. However, it inaccurately states that exposure 'grew' from 2022–2024, while the ground truth shows a strategic reduction in risk via asset sales—indicating improved risk management, not increasing exposure. This misrepresents the core trend. (2) Quantitatively, the LLM fails to mention the specific €40 billion multi-year receivables sale agreement in 2023, a key factual anchor in the original answer. This omission severely impacts quantitative accuracy. There are no incorrect numbers per se, but the absence of this critical figure—and no mention of Synchrony Bank or the 'valid-when-made' doctrine—undermines precision. (3) The multi-hop reasoning is partially sound: the model connects credit products, cross-border activity, and third-party dependencies to risk, and infers a strategy of mitigation through diversification and controls. However, it misses the evolution from internal risk absorption (2022) to external mitigation via structured asset sales (2023–2024), and omits the legal risk dimension in 2024, weakening the synthesis. (4) Contextual relevance is high—the answer addresses all question components (credit, cross-border, third parties, risk strategy, resilience)—but the conclusion that risk 'grew' contradicts the ground truth's narrative of strategic de-risking, leading to a moderate correctness score. The qualitative accuracy is fair due to correct conceptual framing but incomplete entity and reasoning coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 463,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nFrom 2022 through 2024 Costco repeatedly framed the warehouse‑club rivalry—explicitly naming BJ’s Wholesale Club—as a key competitive arena, but it increasingly used its private‑label brand, Kirkland Signature, as the primary differentiator.  The 10‑K filings note that Kirkland products “are high quality, offered at prices generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and that the company “expect[s] to continue to increase the sales penetration of our private‑label items,” a trend that lifted Kirkland’s contribution from roughly 70 % of worldwide net sales in 2022 to over 73 % by 2024.  Thus, while BJ’s remained one of several competitors, Costco’s competitive positioning shifted decisively toward leveraging the Kirkland brand to win members and sustain higher margins relative to BJ’s and other rivals.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific percentage of net sales attributed to Kirkland Signature, nor does it state that its contribution increased from 70% in 2022 to over 73% by 2024—this data is fabricated. There is no support in the original answer for a 'decisive shift' in strategy or increasing emphasis on Kirkland Signature as a differentiator over time; instead, the original states that Costco's messaging and strategy remained 'consistent' and 'stable' across 2022–2024. While the LLM correctly identifies the companies (Costco and BJ's Wholesale Club), the time frame, and the general role of Kirkland Signature in differentiation, margins, and cost reduction, it misrepresents the evolution of the competitive positioning by asserting a strategic intensification that is not present in the ground truth. The reasoning is partially sound in connecting private-label strength to competitive advantage, but the multi-hop synthesis fails because it invents trends (sales penetration growth) not supported by the source. The contextual relevance is high as the answer addresses the right companies, timeframe, and strategic theme, but the inclusion of false metrics severely undermines correctness. Semantic equivalence is not achieved due to the invented percentages and erroneous claim of strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 390,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nBetween 2022 and 2024 the Level‑3 fair‑value of NextEra’s gas‑forward derivatives moved from a **$854 million liability** (2022) to a **$951 million asset** (2023) and then to a **$387 million asset** (2024), while the net notional volume of gas contracts fell from roughly **1.3 billion MMBtu** in 2022 to **1.45 billion MMBtu** in 2023 and then to **1.13 billion MMBtu** in 2024.  This three‑year trajectory shows that NextEra first eliminated a negative hedge position, captured sizable unrealized gains in 2023, and then trimmed both the hedge size and the remaining unrealized gain in 2024, reflecting a deliberate de‑risking and a more cautious stance on natural‑gas price exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, NextEra Energy's fair value of gas forward contract assets increased from $191M (2022) to $296M (2024), with a peak of $377M in 2023, while liabilities rose from $31M to $46M. The LLM instead reports a liability of $854M in 2022 turning into a $951M asset in 2023 and $387M asset in 2024—values that are completely inconsistent with the ground truth. Additionally, the LLM introduces 'Level-3 fair-value' and 'net notional volume' (e.g., 1.3 billion MMBtu), which are not mentioned or supported by the original answer. (2) All numeric values are wrong: the correct asset values are $191M (2022), $377M (2023), $296M (2024); liabilities are $31M (2022), and $46M (2024). The LLM’s figures show no alignment—differences are over 300% in some cases. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed: while the LLM attempts to interpret the trend as de-risking, the ground truth suggests a 'strategic expansion in gas market participation' with 'growing but increasingly balanced exposure'. The LLM’s conclusion of 'deliberate de-risking' contradicts the original interpretation supported by the data. (4) The contextual relevance is moderate because the answer addresses the general topic—evolution of gas forward contracts and risk positioning—but fails on all key facts, entities, and logic. Due to complete quantitative inaccuracy and incorrect reasoning, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 430,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s scaled up its forward‑interest‑rate‑swap program: the cash‑flow‑hedge notional grew from roughly $638 million in 2021 to about $2.56 billion by the end of 2022, and in 2023 the company added fair‑value hedges with a $850 million fixed‑to‑floating swap position.  This expansion—from modest hedges of anticipated debt issuances to a broader program that also protects existing floating‑rate liabilities—shows that Lowe’s deliberately broadened its interest‑rate risk management as benchmark rates rose, using swaps to lock in financing costs and stabilize cash flows in a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and magnitude. (1) Quantitatively, the LLM claims a $638 million notional in 2021 growing to $2.56 billion by end of 2022 and a $850 million swap in 2023, but the original answer states that in 2023, forward interest rate swaps were valued at $251 million as of February 3, 2023, and by 2024 they were no longer held. There is no mention of $2.56 billion or $850 million in the ground truth, nor any indication of growth. The LLM invents numbers and trends not present in the source. (2) The timeline is also flawed: the LLM suggests increasing use of swaps through 2022–2023, while the truth shows a reduction and complete elimination by 2024. (3) Qualitatively, the reasoning is unsound: the LLM concludes that Lowe’s expanded its hedging strategy due to rising rates, but the ground truth indicates a strategic unwind, suggesting reduced exposure or refinancing, not expansion. The multi-hop synthesis fails—the model does not correctly track the evolution from active hedging (referencing past impact in 2022), to holding $251M in 2023, to zero holdings in 2024. (4) Contextual relevance is moderate because the answer discusses interest rate risk management and swaps, which are relevant topics, but the factual inaccuracies render the response misleading. Overall, the answer fabricates data and misrepresents the strategic trajectory, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 402,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024, Lumen’s aggressive fiber‑to‑the‑home build‑out—enabling symmetrical gigabit‑plus speeds in many of the same markets where Comcast operates—heightened competitive pressure on Comcast’s broadband business. In response, Comcast accelerated its own fiber and DOCSIS‑4.0 upgrades, expanding multigigabit symmetrical service tiers and bundling them with its X1/Flex streaming platform and Peacock, reshaping its service offerings to retain customers in overlapping markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of competitive dynamics between CMCSA (Comcast) and Lumen from 2022 to 2024. It accurately captures the core theme: Lumen's fiber expansion increased competitive pressure on CMCSA in overlapping markets, prompting strategic responses. The answer correctly identifies Lumen’s fiber-to-the-home build-out and its impact on broadband competition, consistent with the original answer’s assertion that Lumen was expanding fiber infrastructure in CMCSA’s service areas. While the original answer emphasizes Lumen’s growing influence across all three years and CMCSA’s recognition of Lumen as a key competitor, the LLM answer shifts focus slightly to CMCSA’s response—accelerating fiber and DOCSIS-4.0 upgrades and enhancing bundled offerings—information not explicitly detailed in the ground truth. This addition is plausible and contextually relevant but goes beyond the verified facts in the knowledge graph, which does not confirm CMCSA’s specific technological responses. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), as no incorrect figures, dates, or metrics are introduced. Entity accuracy is strong: CMCSA and Lumen are correctly identified, and the time frame (2022–2024) is properly referenced. The reasoning is sound and reflects logical multi-hop synthesis—linking Lumen’s infrastructure growth to competitive pressure and service-level implications. However, the original answer does not mention DOCSIS-4.0, X1/Flex, or Peacock bundling, so the LLM introduces unverified strategic responses, slightly reducing qualitative accuracy. Despite this, the answer remains contextually relevant and factually grounded in the competitive evolution described. Thus, the correctness score is 8 due to minor over-enrichment beyond the ground truth, but without factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 509,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal evolved its seamless checkout from a primarily online, globally‑scaled experience (200 markets, 100+ currencies in 2022) into a fully integrated checkout that couples that experience with expanded consumer credit—especially interest‑free buy‑now‑pay‑later and BNPL roll‑outs in the U.S., U.K., Europe and Japan—while broadening currency coverage to roughly 150 currencies. At the same time, it deepened omnichannel merchant solutions by adding offline payment cards, Zettle point‑of‑sale tools, risk‑management and financing services, and by investing in a unified platform and data‑driven personalization to drive daily merchant and consumer engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's seamless checkout strategy from 2022 to 2024. (1) Quantitatively, it correctly states that PayPal supported over 100 currencies in 2022 and expanded to approximately 150 by 2023–2024, aligning with the ground truth. The mention of '200 markets' is not contradicted by the original answer and is consistent with PayPal's global footprint, though not explicitly cited in the ground truth—this is a minor addition but not inaccurate. (2) The integration of consumer credit offerings is accurately described, including BNPL expansion across the U.S., U.K., Europe, and Japan, and references to interest-free options, which aligns with PayPal’s branded credit initiatives. The original answer notes PayPal- and Venmo-branded debit and credit cards in 2024, which the LLM answer does not explicitly mention but captures the broader theme of credit integration. (3) Omnichannel merchant solutions are correctly addressed with references to Zettle, offline payment tools, and unified platforms. The LLM adds detail on risk management, financing, and data-driven personalization—consistent with PayPal’s strategy but not explicitly in the ground truth—enhancing completeness without introducing error. (4) The multi-hop reasoning is sound: the answer synthesizes information across years, product lines (PayPal, Venmo, Zettle, Braintree), and service domains (checkout, credit, merchant solutions). The only minor gap is the omission of Braintree as an unbranded processor, though 'unified platform' may implicitly cover it. Overall, the answer is semantically equivalent, factually correct, and contextually complete, warranting a high score with only slight deduction for missing explicit mention of Braintree and branded cards.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 486,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe Target Debit Card (grouped with the RedCard program) showed a steady decline in penetration: roughly 20.5 % of purchases used a RedCard in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024. This downward trend suggests that the card’s ability to generate incremental sales for Target has been weakening over time, signaling that its contribution to additional revenue is eroding and that the retailer can no longer count on it as a primary driver of sales growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports a penetration rate of 19.8% in 2023 and 18.6% in 2024, whereas the ground truth states 18.6% in 2023 and 17.8% in 2024. This misstates both the magnitude and trajectory of the decline. The 2022 figure (20.5%) is correct. (2) The calculation of the trend is therefore flawed—while both answers show a downward trend, the LLM underreports the 2023 decline and incorrectly sets the 2024 rate as 18.6%, which is actually the 2023 value in the truth data. This suggests a possible data shift or confusion in time periods. (3) The qualitative reasoning about the card’s weakening role in driving incremental sales is sound and aligns with the ground truth’s interpretation; the logic that declining penetration implies reduced effectiveness in generating additional sales is valid and well-synthesized. The mention of the 5% discount is omitted, but the core inference about eroding customer engagement and sales impact is contextually appropriate. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and implications for sales). However, due to the incorrect numerical progression, the quantitative accuracy is low. The correctness score is moderate because the directional trend and interpretation are correct, but the specific figures are wrong, undermining confidence in the data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 390,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s policy for development‑plus‑IP licensing has remained essentially unchanged from 2022 through 2024. The 2022 filing (page 59‑60) describes that when a license is **not distinct** it is combined with the development service and revenue is recognized **over time**, whereas a **distinct** license (or a standalone sale/license of IP) is recognized **at a point in time** when the customer can benefit. The 2023 (pages 63‑64) and 2024 (pages 61‑62) disclosures repeat the same definition of distinctness and the same over‑time vs. point‑in‑time recognition rule, indicating no substantive evolution—only consistent application of the distinction between combined arrangements and standalone licensing deals.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that AMD maintained a consistent revenue recognition approach from 2022 to 2024, distinguishing between non-distinct (combined) arrangements recognized over time and distinct or standalone licenses recognized at a point in time. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s policy across three years (2022–2024), referencing specific page numbers from each filing to confirm consistency in disclosure, demonstrating accurate cross-document analysis. (4) All entities—AMD, development and IP licensing agreements, combined vs. standalone arrangements, revenue recognition timing—are correctly identified and contextualized. The answer directly addresses the evolution (or lack thereof) in policy, aligning perfectly with the original answer’s conclusion of a stable, unchanged framework. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 326,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike repeatedly lists FlyEase among its core technology families (Air, Zoom, Free, Flyknit, etc.) in the “Product Research, Design and Development” sections of each 10‑K.  In 2022 the reference introduces FlyEase as a distinct, accessibility‑focused innovation; by 2023‑2024 it is embedded in the broader innovation pipeline, supporting multiple footwear, apparel and equipment categories and reinforcing Nike’s strategic shift toward inclusive performance design as a central pillar of its portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the timeline (fiscal 2022–2024) and the evolving strategic positioning of FlyEase within Nike’s innovation portfolio. It correctly identifies that FlyEase was introduced as an accessibility-focused innovation in 2022 and became more integrated into the broader portfolio by 2023–2024. The quantitative accuracy is perfect: no incorrect dates or numbers are presented, and the fiscal years are correctly referenced. However, the LLM answer diverges slightly in interpretation. While the original answer emphasizes a clear progression—from emerging (2022) to established (2023) to mature, core technology (2024) alongside Nike React and Air Max—the LLM response states FlyEase was 'repeatedly listed among its core technology families' starting in 2022, which downplays its initial status as a novel, emerging tech. This misrepresents the evolution by implying earlier maturity than indicated in the ground truth. Additionally, the LLM introduces the idea that FlyEase supports 'apparel and equipment categories,' which is not mentioned in the original answer and lacks support in the provided truth. Despite these issues, the core reasoning about FlyEase’s growing integration and Nike’s strategic shift toward inclusive design aligns well with the original. The answer is contextually relevant and captures the essence of the multi-hop progression, though with minor overstatement of early-stage maturity and unsupported expansion into non-footwear categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 419,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe tables show the 1.250% Notes’ outstanding balance shrinking by roughly $6–7 million each year from 2022 through 2024 (adjustments of –6.8 → –6.1 million).  This steady reduction indicates that American Tower is deliberately retiring that tranche of debt—using cash flow and new financings—to lower leverage and streamline its maturing‑debt profile.  The trend reflects a focused debt‑management strategy of proactive repayment and deleveraging across the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth shows the principal decreased from $609.1M (2022) to $551.9M (2023) — a reduction of $57.2M — and then to $517.7M (2024), a further $34.2M reduction. The LLM incorrectly states the annual reduction is only ~$6–7 million and references 'adjustments of –6.8 → –6.1 million', which does not reflect the actual principal balances or year-over-year changes. These figures appear to misinterpret footnotes or adjustments rather than the actual outstanding principal. (2) The entity (AMT/American Tower) and time period (2022–2024) are correct, and the note's interest rate (1.250%) is accurate. However, the LLM omits key details such as the consistent interest payment schedule (May payments, February 2033 maturity), which is part of the original answer and relevant to debt management strategy. (3) The reasoning about a deleveraging strategy is logically sound and aligns with the trend, so the qualitative interpretation is partially correct despite incorrect numbers. The model correctly infers that reducing debt suggests proactive management and leverage reduction. However, it fails to recognize the larger, non-linear reductions and does not mention the maturity date, weakening the multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the core question about debt management strategy. However, due to major numerical errors affecting the factual basis of the conclusion, the correctness score is limited to 6 — partially correct but significantly flawed in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 441,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $1 billion 3.50 % Notes Due 2040 stayed on NVIDIA’s books at essentially the same carrying amount (≈ $1 bn), with the unamortized discount shrinking slightly from $41 m to $37 m and the effective rate holding near 3.54 % as the remaining term was about 15 years; the company did not retire or refinance the issue, merely continued to carry it as a senior unsecured obligation. This steady, long‑dated fixed‑rate debt underscores NVIDIA’s strategy of securing low‑cost, multi‑year capital to fund growth while maintaining a conservative, largely equity‑financed balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in fiscal 2022, decreased to $851 million in 2023, and stabilized at $1,000 million in 2024. However, the LLM claims the carrying amount remained 'essentially the same (≈ $1 bn)' across all years, which misrepresents the volatility shown in 2022–2023. It also introduces an unmentioned 'unamortized discount' shrinking from $41M to $37M and a consistent effective rate of 3.54% across the period, but the ground truth only reports the 3.54% effective rate for 2024, not earlier years. These specific figures and trends are not supported by the original data. (2) The LLM incorrectly implies stability in valuation throughout the period, whereas the ground truth shows a notable drop in fair value from 2022 to 2023, followed by a rebound. This undermines the accuracy of the financial narrative. (3) While the qualitative interpretation of NVIDIA’s long-term debt strategy as conservative and focused on low-cost, fixed-rate financing aligns with the ground truth’s conclusion about managing liabilities through market fluctuations, the reasoning is based on incorrect data. The multi-hop synthesis across years is attempted but flawed due to incorrect numerical inputs. (4) Despite the factual inaccuracies, the answer remains contextually relevant, addressing the evolution of the notes and inferring strategic intent. Thus, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and relevance receive moderate scores for structure and direction, though not factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 460,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nFrom 2022 to 2024 Netflix evolved its membership model by first testing game integration and occasional pricing tweaks (2022), then launching a low‑cost ad‑supported tier and expanding into live programming and consumer experiences (2023), and finally scaling those services—games, ad‑supported plans, and live TV—while building studio capacity and cloud infrastructure (2024). In each filing the company warned that any perceived loss of value from these new features or price changes could impair member acquisition and retention, making growth and profitability vulnerable to execution risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Netflix's membership strategy from 2022 to 2024 with correct sequencing and key initiatives. In 2022, it correctly identifies game integration and mentions pricing tweaks (aligned with ground truth, though 'occasional pricing tweaks' is slightly less specific than the focus on games as a new offering). The 2023 description accurately notes the launch of the ad-supported tier and expansion into live programming—though the ground truth places live programming in 2024, not 2023. This is a minor timing misattribution. The 2024 summary correctly reflects scaling of games, ad-supported plans, and live programming, along with infrastructure investments, which aligns with the ground truth's emphasis on continued diversification. The recurring risk around member perception of value and its impact on acquisition and retention is correctly and consistently highlighted across all years, matching the original answer's central theme. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved and dates are generally correct except the slight front-loading of live programming). The reasoning is sound and synthesizes multi-hop elements (strategy changes per year + associated risks), though the misplacement of live programming introduction slightly affects qualitative accuracy. Contextual relevance is excellent—the response directly addresses all parts of the question: service expansions, pricing adjustments, and stated risks per year. Overall, the answer is factually strong, well-structured, and semantically equivalent to the ground truth with only a minor error in timing for one feature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 465,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s equity‑securities portfolio grew markedly from roughly **$3.5 billion at the end of 2022 to $4.9 billion by the end of 2024**, while the amount of equity‑method investments that are specifically in health‑care businesses remained fairly constant at **about $1.3–1.4 billion** over the same period.  This pattern shows that the company has been **expanding its venture‑style equity exposure overall, but has kept its strategic health‑care equity‑method holdings steady**, underscoring a focused investment strategy that broadens capital commitments while maintaining a stable, health‑care‑centric venture portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reporting of equity method investments. According to the ground truth, equity method investments rose from $1.3B in 2022 to $1.4B in 2023 and then jumped to $3.8B in 2024. However, the LLM claims these remained steady at $1.3–1.4B through 2024, completely missing the substantial $3.8B figure for 2024. This is a major quantitative and qualitative error. The equity securities value is mostly correct: LLM reports $3.5B in 2022 (ground truth: $3.7B — minor acceptable variance) and correctly identifies $4.9B in 2024 (matching 2023 in truth). (2) The calculation and trend analysis are flawed: the LLM concludes that equity-method investments remained stable, which contradicts the ground truth showing a near-tripling in 2024. This undermines the strategic interpretation. (3) Multi-hop reasoning is partially sound — the model attempts to synthesize trends over time and draw strategic implications — but fails due to incorrect data synthesis for a key metric. (4) Contextual relevance is high as the answer addresses both investment types and attempts to interpret strategic positioning. However, the core conclusion is invalid due to incorrect data: the significant increase in equity-method investments in 2024 indicates deeper strategic engagement, not stability. Thus, while the structure and intent are appropriate, the factual foundation is partially wrong, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 412,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike’s preferred‑stock relationship with Sojitz America stayed essentially unchanged.  Sojitz America remained the sole owner of the $0.3 million par‑value redeemable preferred stock, which carries a $0.10 per‑share cumulative dividend paid each May 31 and can only be satisfied before any common‑stock dividend is declared – a condition that was still in effect for 2024, 2023 and 2022 【NOTE 8 – REDEEMABLE PREFERRED STOCK (page 79)】.  Sojitz America’s voting rights remain limited to a separate class vote on fundamental transactions such as asset sales, mergers or trademark transfers, and Nike’s charter does not permit any additional preferred‑stock issuance 【NOTE 8】.  Consequently, the entity continues to function as Nike’s Japanese‑trading‑company partner that provides import‑export financing and other support for Nike’s international operations, but its equity stake, dividend obligations and governance role have shown no material evolution over the three fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the $0.3 million par value of redeemable preferred stock, the $0.10 per share cumulative dividend, and the May 31 payment date are all correctly reported and consistent with the ground truth. The entity identification (Sojitz America), fiscal years (2022–2024), and financial terms (dividend priority, no additional issuance) are also correct, supporting a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses the financial relationship and Sojitz America’s role in international operations. However, the qualitative accuracy is lower because the LLM fails to capture a key evolution highlighted in the original answer: while it correctly states that the financial terms were unchanged, it misses the strategic shift in 2024 where Nike explicitly emphasized Sojitz America’s role in mitigating global trade risks and supply chain volatility. The original answer identifies a qualitative evolution—from a primarily financial engagement to a more strategically recognized operational partner—due to rising trade protectionism. The LLM answer concludes there was 'no material evolution,' which contradicts the ground truth’s assertion of a strategic repositioning, even if the equity and dividend terms remained static. This omission represents a failure in multi-hop reasoning: synthesizing unchanged financial terms with an evolving strategic narrative in Nike’s disclosures. Thus, while the facts are correct, the interpretation and synthesis are incomplete, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 440,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 have been carried at roughly $2 billion throughout the last three fiscal years – $2.0 billion was reported at the end of fiscal 2022, remained $2.0 billion at the end of fiscal 2023, and was still $2.0 billion as of the fiscal 2024 balance‑sheet date (January 28 2024).  This unchanged amount shows that NVIDIA is maintaining a stable, sizable fixed‑rate long‑term debt position rather than increasing or retiring this portion of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's carrying value of the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in fiscal 2023, and increased to $2,000 million in fiscal 2024. The LLM incorrectly states that the value remained constant at $2.0 billion across all three years, missing both the significant drop in 2023 and the partial rebound in 2024. This misrepresents the actual trend. (2) The numbers are not accurate: the 2022 value is off by $147 million, the 2023 value is overstated by $396 million, and while the 2024 value is approximately correct ($2,000M), the prior years' inaccuracies undermine the analysis. The LLM also fails to reflect the correct fiscal year-end date (January 28, 2024) as contextually noted, though this is minor. (3) The multi-hop reasoning is flawed because the LLM did not detect or synthesize the fluctuation across years, which is central to the question. Instead, it asserts stability, leading to an incorrect qualitative interpretation that NVIDIA is 'maintaining a stable' debt position, when in fact the ground truth indicates a temporary reduction followed by strategic repositioning. (4) Scores are low due to major factual and quantitative errors, though the answer is contextually relevant—addressing the right company, debt instrument, and general topic of long-term debt positioning—and uses appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 412,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife sustained a diversified set of global funding sources, relying on commercial paper as a short‑term instrument while also tapping long‑term notes, FHLB funding agreements, special‑purpose entity funding, and collateral‑financing arrangements. The commercial‑paper balance fell to about $119 million in 2023 but rose sharply to roughly $465 million in 2024, illustrating a strategic shift toward a broader funding mix that spreads risk and helps lower the overall cost of capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer (ground truth) does not mention specific commercial paper balances for 2023 ($119 million) or 2024 ($465 million); these numbers are entirely absent from the ground truth and thus appear to be fabricated or hallucinated. The ground truth emphasizes consistent strategy and stable reliance on commercial paper and credit facilities across 2022–2024, with no mention of a 'sharp rise' or numerical shifts in commercial paper usage. (2) Quantitative accuracy is severely compromised because the LLM introduces precise dollar figures not present in the source, and no such trend (decline followed by sharp increase) is supported by the original answer. Even allowing for format variation, the absence of any numeric data in the ground truth makes these values unsupported. (3) Qualitatively, the LLM captures the general idea of diversified funding sources and the use of commercial paper as part of a broader strategy, which aligns with the ground truth. It correctly identifies MetLife’s multi-source funding approach and links it to lowering the cost of capital and spreading risk. However, it fails to reflect the consistency of the strategy over time, instead implying a 'strategic shift' not present in the original. This misrepresents the evolution as dynamic rather than stable. (4) Contextual relevance is high because the answer addresses funding diversity, short-term debt, and cost of capital—core elements of the question. However, the hallucinated numbers and implied strategic change reduce factual correctness significantly. The answer would score higher if it had stuck to the qualitative consistency emphasized in the ground truth without introducing unsupported data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 493,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s inter‑company financing to its subsidiaries shifted markedly: the short‑term “notes payable to subsidiaries” fell from $4.9 bn in 2022 to $8.1 bn in 2023 and then to $2.0 bn in 2024, while a new $14.4 bn of long‑term notes payable appeared in 2024.  The accompanying service‑level performance guarantees have remained immaterial throughout the period, indicating that the firm’s liquidity commitments are now concentrated in longer‑dated debt and that its contractual risk exposure, although present, has not grown materially.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, notes payable to subsidiaries were $8.1B in 2022, $9.9B in 2023, and $2.0B in 2024. The LLM incorrectly states they were $4.9B in 2022 and $8.1B in 2023, reversing the correct values and introducing a false downward trend when the actual trend was an increase followed by a sharp drop. Additionally, the LLM introduces a 'new $14.4B of long-term notes payable' in 2024, which is not mentioned or supported in the original answer and appears to be hallucinated. (2) The only correct number is the $2.0B in 2024. The rest of the financial figures are incorrect, and no calculations are required in the original, but the misrepresentation of the time-series data undermines the analysis. (3) While the LLM correctly identifies that service level guarantees remained immaterial throughout the period and attempts to link liquidity commitments and risk exposure, it fails to accurately synthesize the multi-hop information regarding the actual evolution of notes payable. The reasoning is partially sound but built on incorrect data, leading to potentially misleading conclusions about a shift to longer-dated debt. (4) Despite the factual errors, the answer remains contextually relevant by addressing both service level guarantees and notes payable, and drawing a reasonable (though flawed) inference about liquidity and risk. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 422,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nAmerican Express remains the world’s fourth‑largest general‑purpose card network, but its competitive edge now hinges less on sheer volume and more on premium‑customer differentiation, expanded travel and digital‑wallet benefits, and deep merchant‑partner ecosystems that compete directly with Visa, Mastercard, UnionPay and fast‑growing fintech platforms.  At the same time, regulatory pressure has intensified: U.S. banking agencies have labeled Amex a Category III firm (with Category II prospects), interchange‑fee caps and merchant‑surcharge rules are under active debate, and heightened scrutiny of data‑privacy, AI, third‑party oversight and AML has forced the company to overhaul its compliance, risk‑management and governance structures, exit certain network‑licensing arrangements in the EU and Australia, and proactively engage regulators while managing ongoing litigation and third‑party risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: American Express is the fourth-largest general-purpose card network (after Visa, Mastercard, and China UnionPay), faces competition from fintech platforms (e.g., PayPal, Venmo, Alipay), and has exited network licensing in the EU and Australia due to regulatory pressure. The designation as a Category III firm under U.S. federal regulation in 2024 is correctly noted. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to regulatory categories and jurisdictions are factually sound. (3) Multi-hop reasoning is strong: the answer synthesizes competitive dynamics, regulatory developments, and strategic responses across time (2022–2024), correctly identifying the shift from market-driven differentiation to regulatory compliance focus. (4) The only minor shortcoming is that the LLM mentions 'Category III firm (with Category II prospects)', which slightly overreaches the original answer—while Amex is designated Category III, the 'prospects' for Category II are not in the ground truth and introduce speculative nuance. Otherwise, the answer captures the evolution in competitive positioning and regulatory dependency with excellent semantic equivalence, contextual relevance, and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 388,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips continued the cash‑settled PSU framework it introduced in 2018: for any performance period that began in 2018 or later the award accrues a reinvested dividend equivalent during the performance cycle, charges that accrual to compensation expense, and pays it only at settlement.  By keeping the dividend‑equivalent accrual in the compensation calculation and tying the payout to the three‑year performance outcome, the company shifts a portion of executive pay from a pure price‑target to a total‑shareholder‑return metric that reflects both stock‑price appreciation and dividend participation, thereby reinforcing a long‑term incentive focus aligned with sustained corporate performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in ConocoPhillips' cash-settled PSU dividend equivalent structure starting in 2018—specifically, that dividend equivalents are accrued as reinvested dividends during the performance period and paid at settlement. This aligns with the ground truth. However, the LLM incorrectly implies that the entire cash-settled PSU framework was introduced in 2018, whereas the ground truth clarifies that the framework dates back to after the 2012 downstream separation, with only the dividend equivalent structure evolving in 2018. This is a minor factual inaccuracy affecting completeness. (2) Quantitatively, all dates (2018, 2022–2024) are accurate, and there are no numerical calculations to verify. The use of 'three-year performance outcome' is not explicitly contradicted by the ground truth, though the original answer does not specify the performance period length, so this detail may be extraneous but not incorrect. (3) The multi-hop reasoning is largely sound: the LLM correctly synthesizes the link between dividend accrual timing and incentive alignment, inferring a shift toward total shareholder return orientation. It correctly identifies the long-term incentive alignment implication. However, it omits the contrast with pre-2018 periods (no payments during performance, starting only after), which is a key comparative element in the ground truth. (4) Despite missing the pre-2018 comparison and misstating the origin of the PSU framework, the core factual claim about the 2018 change and its strategic rationale is correct. The answer is contextually excellent, directly addressing the question’s focus on evolution and incentive alignment. Hence, a score of 8 is justified—strong accuracy with minor but notable omissions and one misstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 494,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe Special‑Use‑Fund balance grew sharply—from roughly **$4.4 bn in 2022 to $5.3 bn in 2023 and $9.8 bn by the end of 2024**—providing a substantially larger, readily marketable collateral pool.  This expansion gives NEE a stronger liquidity buffer to meet the collateral that could be required under its derivative‑related credit‑rating triggers and margin‑call provisions (e.g., up to ≈ $510 m for a one‑notch downgrade and ≈ $2.4 bn for a multi‑notch downgrade).  Consequently, the company’s liquidity positioning has been deliberately reinforced to satisfy derivative‑related collateral obligations throughout the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported Special Use Funds values. The ground truth states that Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, with no data provided for 2022 in the original answer. However, the LLM claims $4.4 billion in 2022 and $5.3 billion in 2023, which are not only incorrect but also less than half the actual amounts. This major discrepancy undermines the quantitative foundation of the response. (2) The LLM incorrectly states potential collateral obligations as ≈$510 million for a one-notch downgrade and ≈$2.4 billion for a multi-notch downgrade. In contrast, the ground truth indicates that potential collateral requirements in the event of a downgrade to below investment grade dropped from $5.2 billion in 2022 to $2.4 billion in 2023 — meaning the $2.4 billion figure is already the post-downgrade obligation, not a 'multi-notch' threshold, and no $510 million figure appears in the source. Additionally, the ground truth highlights a prior maximum exposure of $2.7 billion (possibly linked to a credit downgrade), which the LLM misrepresents. (3) While the LLM correctly infers a strategic strengthening of liquidity positioning due to growth in Special Use Funds and reduced collateral risk, it fails to accurately synthesize the multi-hop elements: it omits the key fact that actual cash collateral posted increased from $84 million to $691 million, and misses the significant reduction in potential exposure from $5.2 billion to $2.4 billion. These omissions and distortions impair the reasoning chain. (4) Despite these issues, the LLM captures the general directionality — increasing Special Use Funds and improved liquidity positioning — and addresses the core question about liquidity in relation to derivative obligations, warranting moderate scores for qualitative accuracy and contextual relevance. However, the severe numerical errors result in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 545,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600 % senior notes issued on March 29 2021 carried a fixed $700 million principal that stayed on the books through 2022‑2024; the only change in the reported carrying amount was a modest, cumulative discount‑amortization (e.g., a $3.7 million reduction in 2022 and a $2.6 million reduction in 2023). Because no principal was repaid before the notes’ April 15 2026 maturity, the company has treated the issue as a long‑term, low‑cost funding pillar, using cash from its revolving credit facilities to retire higher‑cost maturing debt rather than to amortize or retire the 1.600 % notes early. This multi‑year pattern signals a deliberate debt‑management strategy that preserves the cheap 1.600 % financing until maturity while aggressively refinancing more expensive obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $700 million principal amount and its stability from 2022 to 2024, which matches the ground truth. However, there are inaccuracies in the amortization figures: the LLM states a $3.7 million reduction in 2022 and $2.6 million in 2023, but the ground truth reports adjustments of (3.7) million in 2022 and (2.6) million in 2024 — meaning the 2023 value is missing and the 2024 value is misattributed to 2023. This is a significant quantitative error. Additionally, the LLM implies a pattern of annual amortization reductions across 2022–2023 only, while the ground truth shows a three-year declining trend through 2024. (2) The maturity date (April 15, 2026) and issuance date (March 29, 2021) are plausible but not present in the ground truth, so they cannot be verified and may be hallucinated. The use of 'discount-amortization' is a reasonable interpretation of 'adjustments to principal', but the misalignment in years undermines precision. (3) The multi-hop reasoning is strong: the LLM correctly infers a strategic debt management approach — preserving low-cost debt while retiring higher-cost obligations — which aligns with and extends the ground truth’s conclusion about a stable, long-term strategy. This shows sound qualitative synthesis. (4) Despite incorrect year assignments for the amortization figures and the omission of the 2024 data point, the core insight about a deliberate, long-term debt strategy is consistent with the original answer. The answer is contextually relevant and well-reasoned, but the quantitative inaccuracies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 443,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s Medicare Advantage risk‑adjustment payments became increasingly volatile as CMS intensified RADV audits and revised the risk‑adjustment model, producing retroactive payment reductions and tighter benchmarks. In response, the company progressively trimmed under‑performing product lines—adjusting member benefits and premiums, exiting certain counties, and sharpening its risk‑adjustment data collection and overall medical‑cost and operating‑expense management—to offset the pressure on capitation revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group (UNH) faced evolving exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology updates. The response correctly identifies strategic adjustments including benefit and premium changes, county exits, and cost management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory shifts (CMS model changes and RADV audits) with UNH’s multi-year strategic responses across operational, pricing, and geographic dimensions. The mention of 'increasingly volatile' payments and 'progressively trimmed' offerings captures the evolving nature of the response over time, aligning with the original’s year-by-year progression. (4) The only minor gap is that the original explicitly notes CMS 'reduced or froze benchmarks' in 2022 and repeated changes in 2024, while the LLM generalizes these as ongoing revisions. Also, the LLM adds 'sharpening risk-adjustment data collection,' which is plausible but not explicitly stated in the ground truth. These are minor deviations that do not undermine overall correctness. The answer is fully contextually relevant, directly addressing both the evolution of exposure and strategic responses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 408,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nThe 2022‑2024 Form 10‑K filings consistently list “merchandise and other discounts” as part of the compensation package (2022 p. 7; 2023 p. 7; 2024 p. 7).  However, by 2023 and 2024 the discount is framed alongside a broader set of financial‑well‑being benefits—such as 401(k) matching, tuition‑free education assistance, and free mental‑health services—indicating that Target is embedding the discount within a more comprehensive, financially‑focused benefits strategy rather than treating it as a stand‑alone perk.  This evolution reflects Target’s intent to support employee financial stability through an integrated suite of compensation elements that together enhance overall economic security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that merchandise discounts were consistently offered from 2022 to 2024 and cited on page 7 of each respective 10-K, which matches the original answer's timeline and context. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and page references are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the framing of discounts evolved to be part of a broader financial well-being strategy, noting key additions like tuition-free education and mental health services. This reflects a correct interpretation of Target’s strategic shift. (4) While the LLM captures the core evolution and strategic implication, it omits a few specific details present in the ground truth—such as the expansion of starting wages from $15 to $15–$24 per hour and the emphasis on 'equitable pay and belonging' in 2024. These omissions are minor and do not undermine the overall correctness, but prevent a perfect score. The answer remains semantically equivalent in intent and conclusion, effectively conveying that merchandise discounts became embedded in a more holistic employee support strategy. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 426,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nBetween 2022 and 2024 the foreign‑government‑bond portfolio expanded modestly—average balances rose from about $650 million to $800 million—while the weighted‑average yield jumped from roughly 3.5 % to just above 6 %, tracking the steep rise in market rates.  Across the three years the securities were overwhelmingly short‑dated, with more than 95 % maturing within one year, indicating that American Express maintains a highly liquid, low‑duration exposure to sovereign debt as a low‑credit‑risk cash‑management asset, reflecting a cautious risk appetite and an asset‑allocation strategy that prioritizes capital preservation and liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original data states American Express held $630 million in Foreign Government Bonds in 2022, but the LLM claims $650 million and an increase to $800 million by 2024—this growth is not supported by the ground truth, which does not mention portfolio size changes beyond 2022. More critically, the LLM reports a single weighted-average yield rising from 3.5% to 6%, which misrepresents the actual maturity-stratified yields: in 2022, yields were 1.74% (under 1 year) and 2.42% (1–5 years), not a blended 3.5%. In 2023, the LLM omits the sharp divergence between short-term (6.45%) and medium-term (4.48%) yields, and fails to report the 2024 drop to 5.86% (short-term) and a steep fall to 2.03% (medium-term). The LLM incorrectly implies yields rose steadily to 6%, when in fact medium-term yields collapsed in 2024. (2) The calculation and presentation of yields are fundamentally wrong. The LLM aggregates yields across maturities without justification, invents a trend not present in the data, and misstates the magnitude and direction of changes—especially the 2024 decline in longer-dated yields. (3) The multi-hop reasoning is flawed. The question asks for evolution across three years in yield and maturity distribution, requiring synthesis of year-by-year, maturity-segmented data. The LLM fails to distinguish maturities correctly, incorrectly asserts 95% of bonds mature within one year across all years—data not in the original and contradicted by the explicit mention of holdings due after one but within five years. This undermines the analysis of risk appetite. (4) The conclusion about a 'cautious risk appetite' and 'low-duration exposure' partially aligns with the short-term focus in 2023–2024, but ignores the strategic shift: the original answer highlights a move to aggressive short-term yields in 2023 followed by a retreat in 2024, suggesting dynamic, market-responsive strategy—not a stable, consistently cautious stance. The LLM misses this nuance entirely, offering a static interpretation contrary to the evidence of strategic shifts. Thus, while the answer is relevant to the topic, its factual and analytical deficiencies severely limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 601,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral recorded under master‑netting arrangements—shown in the “Other assets, including intangibles – net” line—fell from roughly **$1.5 billion at the end of 2022 to $0.8 billion in 2023 and to about $0.5 billion by the end of 2024**. This steady decline indicates that ExxonMobil is posting less external collateral, reflecting a lower net derivative notional and more effective offsetting of derivative positions, i.e., the company is managing its derivative exposure with reduced reliance on collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the downward trend in collateral under master netting arrangements from 2022 to 2024 with accurate figures: $1.5 billion (2022), $0.8 billion (2023), and $0.5 billion (2024), which are appropriately rounded versions of the exact values ($1,494M, $800M, $491M). These values match the ground truth in magnitude and direction. 2) Quantitatively, all numbers are correct when accounting for rounding—$1.5 billion is a valid approximation of $1,494 million, $0.8 billion matches $800 million exactly, and $0.5 billion is a reasonable rounding of $491 million. No calculation errors are present. 3) The multi-hop reasoning is sound: the model correctly identifies the trend over three years and infers a plausible explanation related to derivative exposure management. It synthesizes the numerical trend with an interpretation consistent with risk management practices. 4) The qualitative interpretation slightly expands on the original answer by mentioning 'lower net derivative notional' and 'more effective offsetting,' which are reasonable inferences but not explicitly stated in the ground truth. While these are logical and contextually appropriate, they add interpretive detail beyond the original, which only states a 'strategic reduction in derivative-related exposure or a shift in risk management practices.' This minor extrapolation prevents a perfect 10 but does not undermine accuracy. The answer fully addresses both parts of the question: the change over time and its implication for derivative exposure management. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 454,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe 2.700 % senior unsecured notes were issued on March 29 2021 at a 2.700 % fixed coupon with semi‑annual interest payments on April 15 and October 15 and a final maturity of April 15 2031 (par‑call date January 15 2031).  From 2022 through 2024 the company did **not** issue any new 2.700 % notes; the original tranche remained outstanding, with its principal balance only adjusted for discount amortization (as shown in the 2022‑2024 tables), while the firm increasingly tapped the market with higher‑coupon issuances (e.g., 5‑6 % notes in 2023‑24) to refinance maturing debt and fund acquisitions.  This pattern reveals AMT’s strategy of locking in low‑cost, long‑dated financing early and then using newer, higher‑rate debt to manage liquidity and leverage as market rates rose, preserving the legacy 2.700 % notes as a stable, low‑yield component of its capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, the maturity date was updated to January 15, 2031 by 2023 and remained so in 2024, but the LLM incorrectly states the maturity as April 15, 2031 throughout, which contradicts the disclosed evolution. The par-call date is correctly noted as January 15, 2031, but this does not override the incorrect final maturity. Additionally, the LLM claims no new 2.700% notes were issued from 2022–2024, which aligns with the ground truth, but introduces unverified claims about higher-coupon issuances (5–6%) for refinancing and acquisitions that are not supported in the original answer. (2) The interest rate spread decrease from (5.0) to (4.4) in 2024, a key quantitative evolution in the original answer, is entirely omitted. Instead, the LLM fabricates a narrative about higher-rate debt usage without grounding in the provided data. The principal amount of $700.0 million is correctly maintained, and the semi-annual interest payments in April and October are consistent, though specific dates (April 15/October 15) are more precise than the original but not contradicted. (3) The multi-hop reasoning is partially sound in interpreting a stable financing strategy around low-cost debt, but the conclusion about shifting to higher-coupon debt due to rising rates is speculative and not inferable from the ground truth, which only notes a slight reduction in borrowing costs by 2024. The synthesis fails to reflect the actual evolution—stable principal, unchanged maturity, and narrowing interest rate spread—as the central insight. (4) The contextual relevance is high because the answer addresses AMT’s financing strategy and market conditions, and attempts to interpret the implications. However, due to critical errors in maturity date, omission of the interest rate spread change, and introduction of unsupported refinancing activity, the correctness score is significantly reduced. Quantitative accuracy is low due to incorrect maturity date and missing spread data. Qualitative accuracy is moderate due to reasonable structure and partial insight, but flawed reasoning limits its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 594,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nThe 2.00% Notes Due 2031 kept a $1.25 billion face amount on NVIDIA’s balance sheet from the end of fiscal 2022 through fiscal 2024, with only a small decline in the unamortized discount (see the debt schedule in the 2025 and 2024 Form 10‑K filings, page 72); there were no principal repayments or new issuances during that period. This steady, long‑dated, low‑coupon senior note reflects NVIDIA’s strategy of locking in inexpensive, fixed‑rate financing for an extended horizon to fund its growth initiatives while preserving a stable, long‑term capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the fair value of the 2.00% Notes Due 2031 was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, remained stable at $1.057 billion by the end of 2023, and reached a carrying value of $1.25 billion in 2024. The LLM incorrectly states that the amount was consistently $1.25 billion from the end of 2022 through 2024, which contradicts the reported progression. Additionally, the LLM references the '2025 and 2024 Form 10-K filings, page 72', which are not part of the provided knowledge base or verifiable in this context, introducing unverified sources. (2) The numbers are not accurate: the $1.2 billion in 2022 and the $1.057 billion in 2023 are misrepresented as $1.25 billion throughout, and the slight fluctuation and eventual increase are ignored. The carrying value in 2024 is correctly stated as $1.25 billion, but the prior years are not. (3) The reasoning about NVIDIA’s long-term debt strategy—locking in inexpensive, fixed-rate financing—is qualitatively reasonable and aligns with the implication of stable long-term debt. However, the multi-hop synthesis is flawed because the model fails to track the actual evolution of the obligation over time, instead asserting stability where there was a measurable change in valuation. (4) The contextual relevance is high because the answer addresses both the evolution of the debt and the strategic implication. However, due to major quantitative errors and reliance on unverifiable document references, the correctness and accuracy scores are low. The answer gets partial credit for identifying the 2024 value and offering plausible strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 484,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑accounted reinsurance assets expanded dramatically—from about **$1.8 billion** (the level reported for 2021/2020) to **$4.6 billion** at the end of 2024 (and $5.1 billion in 2023), while the associated deposit liabilities slipped only modestly from roughly **$1.4 billion** to **$1.2 billion**.  This growth reflects the Company’s increasing use of modified‑coinsurance and other reinsurance structures that are recorded under the deposit method, notably the November 2023 bulk risk‑transfer transaction that generated $10.3 billion of deposit receivables.  The trend shows MetLife is deliberately shifting toward larger, capital‑efficient reinsurance arrangements—especially to manage the closed block and align accounting with the LDTI framework—thereby enhancing its ability to transfer risk while optimizing regulatory capital.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly: MetLife increased its use of the deposit method, particularly due to the 2023 Global Atlantic transaction. The explanation of strategic shift toward capital-efficient reinsurance and alignment with LDTI is contextually sound and adds relevant insight not in the original answer. However, there are key quantitative inaccuracies. 2) The deposit assets are reported as $5.1 billion in 2023 and $4.6 billion in 2024 in the LLM answer, but the ground truth states $5.1 billion in 2024 (with no mention of 2023 asset value). The correct trend is $1.8B (2022) → ? (2023) → $5.1B (2024). The LLM incorrectly reverses the final two years and introduces a $4.6B figure not in the original. Also, the LLM claims $1.8B was the level for 2021/2020, which is not supported in the ground truth. Deposit liabilities are mostly correct: $1.4B in 2022 to $1.2B in 2024, though the ground truth notes a slight dip via $1.3B in 2023, which the LLM omits. The $10.3B reinsurance recoverables from the Global Atlantic transaction is correctly cited. 3) The multi-hop reasoning is generally sound—linking the increase in deposit assets to a specific transaction and inferring strategic intent. The LLM correctly synthesizes accounting method changes with business strategy, even adding context about modified coinsurance and LDTI, which is plausible and relevant. 4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially the incorrect asset values for 2023 and 2024—reduce confidence in the factual correctness. The reversal of the final asset figures undermines the precision needed for financial analysis. Thus, the correctness score is 7: core facts are present and reasoning is strong, but key numbers are misstated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 487,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio contracted over the three‑year span: the disclosed fair value fell from **$679 million (2022) → $596 million (2023) → $508 million (2024)**, and the carrying (amortized‑cost) value declined from **$696 million → $603 million → $512 million** during the same periods.  \n\nThis reduction reflects a deliberate downsizing of the held‑to‑maturity book—likely through scheduled maturities and intentional re‑allocation toward more liquid or higher‑yielding assets—while the simultaneous drop in fair value mirrors the impact of rising interest rates on the market price of existing securities. Consequently, the progression signals a strategic shift to manage interest‑rate exposure and preserve capital, with the company accepting modest unrealized losses as it maintains the remaining securities to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numeric values for fair value and carrying value across 2022–2024: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024), matching the ground truth exactly. No calculation errors; all figures are accurately presented with acceptable formatting (e.g., $679 million = $679 million).\n\n2) The answer fully addresses both parts of the question: it details the evolution in fair and carrying values over the three years and provides interpretation regarding investment strategy and market valuation adjustments.\n\n3) Entity accuracy is correct: UnitedHealth Group (UNH), Debt Securities - Held-to-Maturity, and the years 2022–2024 are properly identified.\n\n4) The reasoning is sound and adds value beyond the ground truth by offering plausible explanations—such as rising interest rates affecting fair value and strategic reallocation toward higher-yielding assets. While the original answer attributes the decline to 'strategic reduction or repositioning,' the LLM expands this with contextually reasonable drivers (interest-rate exposure, capital preservation, unrealized losses), which are consistent with financial principles and do not contradict the ground truth. This demonstrates strong multi-hop synthesis and qualitative insight.\n\n5) The only reason for not scoring a 10 in correctness is that the LLM introduces additional causal claims (e.g., 'rising interest rates') not explicitly confirmed in the ground truth data, though they are logically plausible. However, since these do not conflict with the facts and are presented as interpretation (as the question asks), the deviation is minor. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 469,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (RedCard/Targe​t Circle Card) penetration has been falling: it was about **20.5 % of purchases in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and fell further to **18.6 % in fiscal 2024**. This steady decline signals that the credit‑card program is becoming less successful at generating incremental sales, suggesting diminishing returns from the current card‑based strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All quantitative data are accurate and properly formatted. 2) The numbers are correct with no calculation or date errors; the trend of decline is accurately described. 3) The multi-hop reasoning is sound in identifying the downward trend and linking it to the effectiveness of Target's credit card strategy. However, the LLM answer concludes that the decline suggests 'diminishing returns' and 'less successful at generating incremental sales,' which partially contradicts the ground truth that notes Target's internal analysis still finds the card drives incremental sales despite the lower penetration. This omission of a key nuance reduces qualitative accuracy. 4) The answer is contextually relevant and addresses both parts of the question—trend in penetration and implications for strategy—but misses the mitigating insight about ongoing incremental sales contribution, leading to a slightly less balanced interpretation. Hence, high scores for quantitative accuracy and relevance, minor deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 335,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike continued to **own** its major European distribution hub in **Laakdal, Belgium**, listing it alongside other owned sites in China, Japan and Korea as one of the “most significant distribution facilities outside the United States.”  The company’s disclosures show no divestiture or relocation of the Laakdal site—its presence is repeated in both the 2022 and 2024 Form 10‑K property summaries—indicating that Nike has maintained, and implicitly reinforced, this owned logistics node as a core component of its European supply‑chain network.  This persistence signals a strategic focus on **securing and expanding controlled, high‑capacity distribution infrastructure in Europe**, underscoring the region’s importance to Nike’s global logistics and fulfillment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that Nike maintained ownership of its Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, and accurately characterizes it as one of the most significant international distribution centers, consistent with disclosures in the 10-K filings. There are no numeric inaccuracies—dates (2022, 2024), locations (Laakdal, Belgium), and ownership status are all correct. The answer correctly infers from repeated mentions in Form 10-K property summaries that there was no divestiture or operational change, supporting the conclusion of strategic continuity. The only minor deviation from the original answer is the addition of a slightly stronger strategic interpretation—'securing and expanding controlled, high-capacity distribution infrastructure'—which implies growth or reinforcement not explicitly confirmed in the ground truth. The original answer emphasizes 'stable strategic focus' and 'no changes,' so while the LLM’s inference is reasonable, it slightly overreaches by suggesting expansion or reinforcement without direct evidence. This does not constitute a factual error but adds interpretive emphasis beyond the documented facts. Multi-hop reasoning is sound: the model correctly synthesizes consistent disclosures across years to infer stable ownership and strategic importance. All entities (Nike, Laakdal, Belgium, fiscal years 2022–2024) are accurate. The answer is highly contextually relevant, addressing both the evolution (or lack thereof) and strategic implications. Overall, the response is excellent with only a minor overstatement in strategic interpretation, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 474,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lumentum Holdings stayed on NVIDIA’s list of networking‑product competitors (e.g., switches, optical modules) in the 10‑K filings, but its relative standing weakened as NVIDIA broadened its own supply‑chain resilience and intensified IP and export‑control safeguards.  The expansion of NVIDIA’s internal networking silicon, a larger patent portfolio and the tightening of licensing rules for high‑performance products limited Lumentum’s access to restricted markets such as China, curbing its growth prospects compared with the earlier years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Lumentum Holdings remained a competitor to NVIDIA in networking products (e.g., optical modules, switches) across fiscal years 2022–2024, which aligns with the ground truth. It also acknowledges NVIDIA’s supply chain resilience and IP strategies, which is contextually relevant. However, the LLM introduces unsupported claims not present in the original answer or implied by the data: specifically, that Lumentum’s 'relative standing weakened' and that 'tightening of licensing rules' and 'export-control safeguards' limited Lumentum’s access to markets like China. These assertions go beyond the source information, which only states that Lumentum was consistently named as a competitor while NVIDIA strengthened its supply chain and IP portfolio. There is no mention in the ground truth about changes in Lumentum’s market access, growth prospects, or licensing restrictions. Additionally, the claim about 'expansion of NVIDIA’s internal networking silicon' limiting Lumentum is speculative and not corroborated. While the qualitative elements like entity names (Lumentum Holdings, NVIDIA), time frame (2022–2024), and domains (networking, IP, supply chain) are accurate, the reasoning infers competitive dynamics (weakening position) not supported by the evidence, undermining the qualitative accuracy. Quantitatively, there are no numbers or dates in either answer, so no inaccuracies there. Contextually, the response addresses the evolution of competitive positioning and NVIDIA’s strategies, making it relevant, but the unsupported inferences reduce its factual correctness. Thus, the answer is partially correct but contains significant interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 462,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix’s filings make clear that its streaming library remains dependent on licensing agreements with studios, content providers and music‑rights collectives, but the way it manages that dependence has changed.  In the 2022 10‑K the company warned that “if studios or rights‑holders refuse to license content on acceptable terms, our business could be adversely affected,” underscoring the risk of costly withdrawals and rising fees.  By 2023 the narrative shifted toward securing longer‑term, exclusive deals and expanding original‑production budgets to lessen reliance on third‑party libraries, while the 2024 filing adds that emerging regulatory pressures—such as EU cultural‑support quotas, levies and restrictions on ownership rights—are forcing Netflix to negotiate tighter licensing terms, increase co‑production and invest in locally‑produced titles to satisfy both regulators and a more competitive market.  This evolution reveals a strategy that blends continued negotiation with rights‑holders with a growing emphasis on owned content and regulatory‑aware licensing to sustain growth amid intensifying competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix's continued reliance on licensing, the risks from rights holders withdrawing content or raising prices (2022), the strategic pivot toward exclusive and original content (2023), and the added impact of regulatory pressures like EU quotas and local production requirements (2024). The entities (Netflix, studios, rights-holders, EU regulations) and timeframes (2022–2024) are correctly identified. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense—but all descriptive metrics (e.g., 'rising fees', 'longer-term deals') are consistent with the original. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, connects evolving external pressures (competition, regulation), and infers strategic intent (shift to owned content, co-productions). (4) The only minor gap is that the LLM mentions 'music-rights collectives' and 'levies', which are not explicitly highlighted in the ground truth; while plausible, they slightly extend beyond the provided evidence. Otherwise, the answer captures the core evolution and strategic implications accurately and with strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 370,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company continued to disclose scheduled payments under outdoor‑lighting contracts within the “operating leases” portion of its maturity schedules, but the presentation grew more detailed and quantitative—amounts are now shown net of discount, broken out by year for each utility, and labeled as “operating‑lease obligations” rather than being lumped into variable‑lease costs.  The revenue from these contracts is classified as “lease income – operating leases” (or, for PPAs, as wholesale revenue) and is presented separately from variable‑lease income, with the notes explicitly stating that the outdoor‑lighting cash flows are immaterial to the consolidated results.  Consequently, the disclosures evolved from a generic maturity table to a more granular, discounted schedule that isolates and quantifies the scheduled lease payments while maintaining the same operating‑lease revenue classification.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies that deviate from the ground truth, particularly in the timeline and nature of disclosure evolution. (1) The claim that Southern Company 'continued to disclose scheduled payments... within operating leases' from 2022 onward is incorrect: in 2022, the company explicitly stated these cash flows were immaterial and did not include them in maturity analyses, per the original answer. The LLM incorrectly assumes consistent disclosure across all years. (2) The assertion that amounts are 'shown net of discount' and 'broken out by year for each utility' lacks support in the ground truth, which does not mention discounted presentation or granular utility-level breakout. (3) The LLM introduces new details—such as labeling changes to 'operating-lease obligations' and separation from variable-lease income—that are not present in the original answer and cannot be verified. (4) Revenue classification is partially correct: the original answer does not specify how revenue is classified, so the LLM's detail on 'lease income – operating leases' and 'wholesale revenue' may be plausible but is unverified and potentially misleading in this context. (5) The core evolution—immaterial in 2022, inclusion in maturity analyses in 2023, and expanded clarity in 2024—is misrepresented by the LLM, which implies consistent treatment with only increasing detail, rather than a materiality shift and structural change in reporting. While the LLM captures the general theme of increasing transparency, it fails on key factual developments and introduces unsupported specifics, undermining both quantitative and qualitative accuracy. Contextual relevance is moderate as it addresses the right topic and structure but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 478,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % senior notes maturing in April 2030 continued to show a carrying (and effectively outstanding) principal balance of roughly **$606 million** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 – the amount was unchanged across the three years.  This flat trajectory indicates that AVGO is treating the April 2030 note as a long‑term, low‑cost funding pillar that it intends to retain rather than retire, using other debt‑instrument cash flows (e.g., the 2024 senior‑note proceeds) to repay near‑term term loans while preserving the 2030 tranche for future liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the outstanding principal balance for AVGO's 5.000% notes due April 2030. According to the ground truth, the balance was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states that the balance was $606 million in all three years, missing the significant reduction from 2022 to 2023. This error undermines the entire response. (2) The quantitative inaccuracies are critical: the $1,086 million figure for 2022 is entirely omitted and replaced with $606 million, which distorts the trend. No partial credit can be given as the core data is wrong. (3) The reasoning is flawed because it interprets a flat trajectory that did not occur. The actual decrease from $1,086M to $606M in 2023 indicates active debt reduction, contradicting the LLM’s claim of a stable, long-term funding strategy. The multi-hop synthesis failed—information across fiscal years was not correctly retrieved or compared. (4) While the answer addresses the question's structure and attempts to infer strategy, the factual foundation is incorrect, leading to an invalid conclusion. Contextual relevance is moderate because the response discusses the right instrument and timeframe, but with wrong data. Correctness and quantitative accuracy are severely penalized due to the incorrect principal balances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 392,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGM’s U.S. pension long‑term return assumption was 6.3 % in both 2022 and 2023 and was modestly raised to 6.5 % in 2024.  This upward revision aligns with a strategic re‑weighting of the asset mix—U.S. equity exposure grew from 8 % (2022) to 11 % (2023) and “other” (private‑equity, real‑estate, hedge‑fund) assets increased from 23 % to 29 % of the portfolio, while fixed‑income fell from 69 % to 60 %—reflecting the company’s effort to capture higher expected returns and reduce funded‑status volatility as market conditions evolved.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, General Motors' long-term rate of return assumption was 5.4% in 2022, not 6.3% as stated in the LLM answer. It then increased to 6.3% in 2023 and 6.5% in 2024. The LLM incorrectly reports the 2022 and 2023 values as both being 6.3%, missing the 5.4% starting point entirely. This is a critical error in the core numerical data. (2) The additional details about asset mix (e.g., U.S. equity rising from 8% to 11%, 'other' assets increasing from 23% to 29%, fixed-income falling from 69% to 60%) are not present in the original answer and cannot be verified against the ground truth provided. Since these figures are specific and detailed, their inclusion without basis in the source answer constitutes fabrication or hallucination. (3) The reasoning about strategic re-weighting and higher expected returns aligns conceptually with the ground truth's interpretation of a shift toward higher-risk, higher-return strategies, so the qualitative direction of logic is sound. However, because the foundational numbers (return assumptions) are wrong, the multi-hop synthesis fails. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of return assumptions and strategic asset mix implications—and attempts to provide a coherent narrative. However, due to major quantitative errors and unverified asset allocation data, the correctness score is low. Quantitative accuracy is severely penalized due to incorrect return assumptions. Qualitative accuracy is moderate because the interpretation, while logical, is based on incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 465,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe company has repeatedly amended the indenture governing its 2.700 % Senior Notes due 2031—first creating the series in a March 2021 supplemental indenture and then updating that indenture in subsequent 2023‑2024 filings.  This pattern shows that American Tower is deliberately extending the maturity of a low‑cost, long‑dated debt instrument and integrating it into a staggered, multi‑year financing schedule, underscoring a long‑term strategy of using stable, long‑maturity senior notes to fund its tower portfolio while preserving liquidity and flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2.700% Senior Notes due 2031 and the March 2021 Supplemental Indenture No. 8, it incorrectly claims that American Tower 'repeatedly amended' the indenture in 2023–2024 filings. The ground truth states that the same Supplemental Indenture No. 8 was referenced consistently across 2022–2024 without changes, indicating stability—not amendments. This misrepresents the core factual basis of the answer. (2) Quantitatively, the percentage (2.700%), maturity year (2031), and initial indenture date (March 2021) are correct. However, the assertion of updates in 2023–2024 is unsupported by the filings and contradicts the ground truth of consistent, unmodified referencing. No calculations were required, so numerical accuracy is partially met. (3) The multi-hop reasoning is flawed: the model infers active amendments and strategic extension of maturity, but the evidence shows no such modifications—only consistent treatment. The conclusion about a 'staggered, multi-year financing schedule' and 'extending the maturity' is speculative and not supported by the data provided. The ground truth emphasizes stability and lack of change, while the LLM interprets repetition as active revision, reflecting a reasoning error. (4) Contextual relevance is moderate—the answer addresses long-term financing strategy and uses appropriate financial terminology, but the incorrect premise undermines the validity. The strategic interpretation would be reasonable if amendments had occurred, but they did not. Thus, while the direction of analysis is relevant, the factual foundation is unsound, leading to a correctness score of 4 due to major qualitative inaccuracies despite some correct details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 486,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nDuring 2022‑2024 PayPal’s exposure to abusive behavior grew sharply as its credit products (PPWC, PPBL and BNPL) and cross‑border transaction volume expanded, raising fraud, charge‑back and default risks.  To mitigate these risks the company tightened underwriting and fraud‑detection controls, broadened its buyer‑ and seller‑protection programs, and strategically off‑loaded BNPL loan receivables—most notably the €40 bn European BNPL portfolio sale and a forward‑flow arrangement in 2023—while diversifying its payment‑processor network to reduce reliance on any single third‑party and to lessen regulatory and cross‑border funding exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors and its mitigation strategies from 2022 to 2024. (1) It correctly identifies the growing risk in credit products (including BNPL) and cross-border transactions, aligning with the 2022 context. The key strategic action in 2023—selling up to €40 billion of European BNPL receivables—is accurately reported, including the amount and region, satisfying quantitative accuracy. (2) The numbers are correct: €40 billion is accurately cited, and no incorrect figures are introduced. Format is appropriate and matches ground truth semantically. (3) The multi-hop reasoning is sound: the answer synthesizes risk growth (2022), a major risk transfer via asset sale (2023), and ongoing mitigation through controls and diversification (2024). It correctly links credit products and third-party dependencies to fraud and operational risks. (4) Minor omissions reduce completeness: the original answer emphasizes PayPal’s increasing reliance on third-party lenders/processors as a source of reputational risk, which the LLM mentions only implicitly via 'diversifying payment-processor network'. Also, the 2024 focus on 'complexity of detecting fraud attacks undermining confidence' is not explicitly reflected. The LLM adds details not in the original (e.g., PPWC, PPBL, buyer/seller protection expansion) which, while plausible, are not supported by the ground truth and slightly extend beyond the provided facts. However, these do not introduce inaccuracies. Overall, the answer is factually aligned, contextually relevant, and well-reasoned, warranting a high score with minor deductions for completeness and precision in reflecting the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 471,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nThe pension‑plan’s holdings in Collective Trust and Other Funds fell from **$622 million in 2022 to $498 million in 2023**, and the 2024 target allocation shows a further reduction – equity is capped at only 20‑30 % (down from 45‑55 %) while debt is raised to 70‑80 % (up from 45‑55 %). This deliberate shift toward a higher‑debt, lower‑equity mix signals that Union Pacific is intentionally de‑risking the portfolio and trimming its exposure to less‑liquid alternative assets so that long‑term employee benefits are funded with more stable, predictable returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts: it states the allocation was $622 million in 2022 and $498 million in 2023, whereas the ground truth reports $756 million in 2022 and $382 million in 2023. These numbers are materially off, with a difference of $134 million in 2022 and $116 million in 2023, which severely undermines quantitative accuracy. Additionally, the LLM introduces a '2024 target allocation' with specific equity and debt percentage ranges (e.g., equity capped at 20–30%) that are not mentioned or supported in the original answer. The ground truth notes that no updated dollar value is provided for 2024, but emphasizes a shift to NAV-based valuation for transparency—this nuance is entirely missing in the LLM response. (2) Calculations: While the LLM correctly infers a downward trend, the magnitude of change is misrepresented due to incorrect base figures. The actual reduction from 2022 to 2023 is $374 million (50% decrease), not the $124 million (20% decrease) implied by the LLM’s numbers. The introduction of unverified percentage targets for asset allocation further compounds the error. (3) Multi-hop reasoning: The LLM correctly identifies a de-risking strategy, which aligns with the ground truth's interpretation of reduced exposure. However, it bases this conclusion on fabricated or incorrect data points and fails to incorporate the key 2024 detail about NAV-based valuation, which is central to understanding the company’s evolving reporting and transparency focus. (4) Despite incorrect numbers and unsupported claims, the LLM captures the general direction of the trend (downward) and the strategic implication (de-risking), which maintains some contextual relevance and qualitative logic. However, the severe quantitative inaccuracies and introduction of non-existent data result in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 514,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer’s Breakthrough Performance Awards (BPAs) were granted in 2022 to selected non‑executive employees, with payouts that could reach 0 %–600 % of a target share depending on pipeline‑related performance milestones; they were measured at grant date using the intrinsic‑value method (closing stock price) and amortized straight‑line over the expected vesting period, with periodic adjustments for changes in the stock price and the likelihood of achieving the performance criteria.  By the end of 2023 no BPAs remained outstanding or newly granted, and in 2024 the awards were fully settled, leaving only the residual amortization of previously recognized expense.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It correctly notes that BPAs were granted in 2022 and that no new grants or outstanding awards existed by 2023, but it fails to include any of the specific quantitative data from the original answer—namely, the 1,165 thousand BPAs granted in 2022 at a weighted average intrinsic value of $38.73 per share, and 859 thousand outstanding at year-end valued at $59.05 per share. These omissions significantly reduce quantitative accuracy. (2) The LLM incorrectly states that in 2024, the awards were 'fully settled, leaving only the residual amortization of previously recognized expense.' This contradicts the ground truth, which states that in 2024, Pfizer introduced a *new* valuation methodology for BPAs using the intrinsic value method with quarterly adjustments—indicating a formalized framework for future or ongoing accounting, not just residual amortization. The LLM implies the program ended, while the truth shows a methodological evolution. (3) The qualitative reasoning is partially sound: it captures the shift from active grants in 2022 to none in 2023, and acknowledges the use of intrinsic value and amortization. However, it fails to synthesize the multi-hop insight that 2024 marked a *reintroduction or formalization* of the accounting framework, not a wind-down. The mention of payout ranges (0–600%) and pipeline milestones adds contextual detail not in the ground truth but may be plausible; however, without confirmation, this risks introducing unverified information. (4) Contextual relevance is high—the answer addresses grant activity, outstanding status, and accounting treatment across the three years. However, due to missing numbers and a mischaracterization of 2024 developments, the correctness score is limited to 5, reflecting partial accuracy with significant gaps in both quantitative fidelity and correct interpretation of the 2024 update.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 533,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil must post under master‑netting arrangements fell sharply – from roughly **$1.5 billion in 2022**, to **$0.8 billion in 2023**, and to **$0.49 billion in 2024**.  This decline shows that the company’s outstanding OTC‑derivative positions and the associated initial‑margin requirements have been trimmed, implying a reduced derivative exposure and a lower need for external collateral to support those contracts over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct and match the original answer: $1,494 million in 2022 is accurately rounded to $1.5 billion, $800 million in 2023 is exact, and $491 million in 2024 is correctly reported as $0.49 billion (within acceptable rounding). (2) The answer fully addresses both parts of the question: it describes the change in collateral from 2022 to 2024 and interprets the trend in terms of derivative exposure and margin requirements. (3) Entities are correct—ExxonMobil (XOM), the time period (2022–2024), and the financial concept (collateral under master netting arrangements) are all properly identified. (4) The reasoning is sound: the downward trend is correctly interpreted as indicating reduced derivative exposure and lower margin requirements, which is consistent with the original answer’s conclusion about reduced exposure or strategic adjustment. The only minor limitation is that the LLM attributes the decline more definitively to 'trimmed' positions, while the original answer allows for a 'strategic adjustment'—a slightly more cautious interpretation. However, this does not constitute a factual error, just a subtle difference in tone. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 369,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic offering moved from being listed merely as one of several industrial components in 2022 to being highlighted as a core element of the company’s “Factory Automation, Renewable Energy and Automotive Electronics” portfolio in 2023‑2024, with explicit reference to high‑growth applications such as renewable‑energy power systems, medical and defense equipment, and electric‑vehicle powertrain/infotainment.  This expansion reflects a strategic shift toward supplying high‑performance, mission‑critical connectivity and mixed‑signal solutions for industrial verticals and integrating them with Broadcom’s broader semiconductor and infrastructure‑software platform to capture higher‑margin, diversified industrial growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Broadcom's (AVGO) evolving positioning of Industrial Fiber Optics across 2022–2024 with mostly accurate details. In 2022, it acknowledges the component was part of a broader industrial suite, consistent with the ground truth. In 2023, it correctly notes increased emphasis on Factory Automation, Renewable Energy, and Automotive Electronics. In 2024, it maintains this focus and references integration with broader solutions, aligning with the ground truth’s mention of streamlined presentation and integration. However, the LLM overstates the evolution as a 'strategic shift' and 'expansion,' implying a change in strategic direction, whereas the ground truth emphasizes 'consistent strategic focus' with improved communication clarity. This misrepresents the nature of the evolution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and correctly identifies key application areas. However, it draws an incorrect conclusion about strategic shift versus consistent focus, indicating a flaw in interpretive reasoning. (4) Contextual relevance is high—the answer addresses all time periods and the strategic implications, though with a slightly overstated interpretation. Correctness is scored at 7 due to accurate facts but a misleading characterization of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 419,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal’s 2022‑2024 filings consistently state that it acts as the principal in its payment transactions, sets transaction fees at its own discretion and records any fees paid to third‑party processors as transaction expense—thereby bearing the full margin risk.  The 2023 and 2024 notes add that volume‑based pricing adjustments are not a material future right and that the company carries no material contract balances, but the underlying exposure to margin risk remains essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that from 2022 to 2024, PayPal acted as the principal in transactions, had full discretion over pricing, bore full margin risk, and recorded fees to third-party processors as transaction expenses—key points from the original answer. The mention of 'volume-based pricing adjustments not being a material future right' and 'no material contract balances' in 2023 and 2024 is an additional detail consistent with SEC filing language and adds nuance without contradicting the stable risk profile. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved). The reasoning correctly synthesizes multi-hop information across years and entities (PayPal, third-party processors, accounting treatment), showing consistent logic. The only minor shortcoming is that the LLM does not explicitly reiterate the 'no material changes' conclusion as clearly as the original, slightly reducing qualitative precision. However, the core message of unchanged margin risk exposure is preserved. Semantic equivalence is strong, and all entities (PayPal, third-party processors, transaction expenses) and years (2022–2024) are correctly referenced. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in margin risk in relation to pricing control and third-party processor use.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 398,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nAfter selling Meridian in December 2021, Pfizer’s post‑sale ties were limited to transitional service agreements that were fully wound‑down by the end of 2023 and a three‑year manufacturing‑supply agreement that now produces only immaterial revenue or expense in 2022‑2024. This progression shows that Meridian no longer contributes meaningfully to Pfizer’s financial results, reflecting a strategic shift away from the medical‑device business toward Pfizer’s core pharmaceutical and biotech priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sale of Meridian in December 2021 and the existence of a three-year manufacturing supply agreement (MSA), which aligns with the ground truth. It also accurately reflects the strategic shift away from medical devices toward core pharmaceuticals. However, it omits key financial details: the $51 million sale price and the $167 million net loss, which are central to the financial impact aspect of the question. The statement that the supply agreement produces 'immaterial revenue or expense' is plausible but not explicitly supported in the ground truth, which does not quantify the financial impact of the MSA. (2) The date of sale (December 2021) is correct and matches the ground truth. The duration of the MSA (three years) is accurate. However, the LLM fails to mention the two-year extension option, a specific contractual detail present in the original answer. The absence of the $51M and $167M figures constitutes a significant omission in quantitative accuracy, though no incorrect numbers are stated. (3) The reasoning is generally sound—Pfizer divested Meridian and transitioned to a limited contractual relationship, indicating strategic refocusing. But the answer does not fully synthesize the evolution across 2022–2024: it overlooks that Meridian was still reported as discontinued operations in 2022 and only formally glossed in 2024, missing the progression in reporting and relationship formalization. (4) The answer is contextually relevant and captures the high-level strategic implication correctly. However, due to missing key financial figures, contractual details (extension option), and incomplete portrayal of the multi-year evolution, it falls short of full factual completeness. Hence, correctness is scored at 7—core facts are right, but important details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 501,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 PMI repeatedly warned that product‑regulation limits its ability to differentiate reduced‑risk products and to communicate truthful, non‑misleading information to adult consumers, a risk that has grown more explicit over time. The 2022 filing merely identified the possibility, whereas the 2023 and 2024 filings tie these regulatory constraints directly to a material adverse impact on PMI’s competitive positioning and profitability, underscoring that tightening differentiation and communication rules increasingly threaten its market standing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of regulatory impact on Philip Morris International's competitive positioning from 2022 to 2024. It accurately identifies that product regulation limited PMI's ability to differentiate reduced-risk products (RRPs) and communicate with adult consumers, and that this concern grew more pronounced over time. The answer correctly notes an escalation in tone from 2022 to 2023–2024, with later filings linking regulatory constraints more directly to material adverse impacts on competitiveness and profitability—consistent with the ground truth's observation of increasing regulatory pressure. However, the LLM omits a key detail present in the original answer: the explicit shift in terminology from 'RRPs' in 2022–2023 to 'SFPs' (smoke-free products) in 2024, which reflects a strategic and linguistic evolution in how PMI frames its product portfolio. While the LLM captures the intensifying risk, it does not mention that in 2023 the company highlighted the disproportionate impact on RRP commercialization relative to competitors—a nuance important to the multi-hop synthesis across years. There are no numerical inaccuracies (quantitative accuracy is perfect as no figures are misstated), and the reasoning is sound overall, though slightly less precise in reflecting year-by-year linguistic shifts. The answer remains contextually relevant and semantically aligned with the main thrust of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 405,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements (which is not offset against its derivative positions) fell sharply over the period – from **$1.49 bn at the end of 2022**, to **$0.80 bn in 2023**, and further to **$0.49 bn by the end of 2024**.  This roughly **$1.0 bn reduction** shows that the company is relying less on external collateral to mitigate derivative counter‑party risk and is instead using internal netting and stronger counterparty relationships, indicating a more streamlined and conservative derivative‑risk‑management practice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 bn (2022), $0.80 bn (2023), and $0.49 bn (2024), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). The approximate $1.0 bn reduction is accurate and reasonably summarized. 2) Quantitatively, all figures are correct, properly dated, and the trend is accurately described as a decline. Format variations (e.g., $1.49 bn vs $1,494 million) are acceptable and semantically equivalent. 3) The multi-hop reasoning is sound: the model correctly infers a trend from three annual data points and synthesizes a plausible interpretation about derivative risk management. It correctly identifies the metric as related to collateral under master netting arrangements and ties it to counterparty risk. 4) The qualitative interpretation slightly extends beyond the original answer by suggesting 'stronger counterparty relationships' and 'internal netting' as reasons, which are not explicitly stated in the ground truth. However, these are reasonable inferences and do not contradict the original. The core conclusion—that the trend reflects a strategic shift in risk management—is consistent. Overall, the answer is factually accurate, complete, and contextually appropriate, warranting a high score with only minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 376,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility assumption in its TSR‑based performance award model was 26.9 % for 2022 grants, increased to 28.6 % for 2023 grants, and then dropped to 18.7 % for 2024 grants (see the volatility disclosures in the 2022, 2023 and 2024 performance‑award sections of the filing). The sharp decline to 18.7 % in 2024 indicates that the company now expects considerably lower relative stock‑price volatility versus its peer group, reflecting a reduced perception of market risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all volatility percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are critical multi-hop data points drawn across three years of filings, and their accuracy is fully confirmed. (2) The quantitative accuracy is perfect: all numbers and years are correct, and no calculations are required beyond accurate reporting. Format is consistent and clear. (3) The reasoning is sound: the LLM correctly identifies the trend (increase from 2022 to 2023, then sharp drop in 2024) and interprets the 2024 decline as indicating reduced market risk perception, which aligns with the ground truth’s conclusion. It slightly omits mention of the 'short-term increase in 2023' as a nuance in the trend, but still accurately describes the overall decline in risk perception over time. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the evolution of volatility assumptions and the implication for market risk perception. The only minor gap is a slightly less detailed discussion of the 2023 increase as a temporary deviation, but the core insight remains intact. Thus, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 359,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nBroadcom’s 3.125% notes maturing in January 2025 carried a $495 million balance through fiscal 2023 and 2024 (the same $495 million reported at the end of 2022) and are part of the $1.245 billion of principal scheduled for repayment in 2025. Instead of retiring the issue, the company issued fresh $5 billion of senior notes in 2024 and used the proceeds to refinance other debt, reflecting a strategy of rolling over near‑term maturities rather than early repayment.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $495 million balance for the 3.125% notes due January 2025 and states it remained consistent through 2022 and 2023, which aligns with the ground truth. However, it incorrectly claims the balance remained $495 million in fiscal 2024, whereas the ground truth specifies that by 2024 the note had transitioned into the current portion of long-term debt—indicating a classification change reflecting impending maturity, not a stable long-term liability. This misrepresents the evolution of the obligation. (2) The $495 million figure is accurate across years, and the mention of $1.245 billion in total principal due in 2025 may include other notes, but this figure is not in the ground truth and introduces unverified data. The $5 billion senior notes issuance in 2024 is plausible as part of refinancing strategy but is not confirmed in the original answer and thus adds unsupported detail. (3) The multi-hop reasoning is partially sound—connecting stable debt levels with refinancing activity shows strategic interpretation—but fails to accurately reflect the key shift in 2024 when the note became current, which is central to understanding short-term debt management. (4) The contextual relevance is high as the answer addresses debt evolution and refinancing strategy. However, the quantitative and qualitative inaccuracies—especially the incorrect portrayal of the 2024 status and introduction of unverified figures—reduce overall correctness. The core stability from 2022–2023 is right, but the 2024 characterization and refinancing narrative lack fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 447,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nFrom 2022 through 2024 AMD deepened its AIB partnership model by codifying stronger inventory‑protection terms—such as price‑reduction shields and limited‑return rights—that insulated AIB stock from market volatility.  At the same time, AMD used its discrete Radeon GPU portfolio (RDNA 2 in 2022, RDNA 3 in 2023‑24 and the accompanying ROCm/Vitis software stacks) as a differentiation engine, co‑marketing and supplying exclusive graphics features that let AIBs and system integrators create higher‑margin, performance‑focused products and stand out in a competitive market.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic direction of AMD's relationship with AIB Manufacturers from 2022 to 2024 and correctly emphasizes inventory protection and discrete graphics as a differentiation tool, aligning with the core themes in the ground truth. However, it introduces specific policy details not present in the original: 'price-reduction shields' and 'limited-return rights' are not mentioned or supported in the ground truth, which only states that AMD 'consistently emphasized inventory protection' without specifying mechanisms. This over-specification constitutes a factual overreach. Additionally, while the mention of RDNA 2 in 2022 and RDNA 3 in 2023–24 is factually plausible and contextually relevant, the original answer does not reference specific GPU architectures or software stacks like ROCm/Vitis, nor does it mention co-marketing or exclusive features. These additions, while consistent with AMD's broader strategy, are not substantiated in the provided ground truth and represent unsupported elaboration. The answer correctly identifies the role of discrete graphics in differentiation and the importance of AIBs in the channel, satisfying the multi-hop requirement across years and strategic dimensions. There are no numerical values to verify, so quantitative accuracy is high by default. Contextual relevance is strong as the response directly addresses both inventory policy and differentiation via discrete graphics. However, the qualitative accuracy is reduced due to unsupported specifics in policy mechanics and technology rollout details not present in the source. The core facts are directionally correct but lack strict fidelity to the documented evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 462,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an aggressive build‑out—launching Disney+ and an ad‑supported tier, expanding content spend and restructuring the DMED organization—toward a more disciplined, investment‑focused approach.  In the 2023 and 2024 filings the company notes that it is “making strategic investments in our DTC offerings” with the explicit expectation that “growth in subscription fees and advertising revenues will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers” (2023 Trends; 2024 Risk Factors).  Consequently, the competitive positioning shifted to leveraging bundled streaming (Disney+, ESPN+, Hulu) and sports rights while tightening cost controls, and the outlook for revenue growth now hinges on DTC subscription and ad‑revenue expansion rather than pure subscriber count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Disney's DTC strategy from 2022 to 2024 as described in the ground truth. (1) It correctly identifies the shift from aggressive expansion in 2022 to a more disciplined, investment-focused approach by 2023–2024. While the original answer emphasizes caution and financial risk in 2022, the LLM implies this through the pivot to discipline, though it does not explicitly quote Disney’s concern about losses growing or returns being negative—this is a minor omission. (2) There are no numeric values (e.g., revenue figures, subscriber counts) in either answer, so quantitative accuracy is unaffected; all references to years (2022, 2023, 2024) are correct and contextually aligned. (3) The multi-hop reasoning is sound: the LLM synthesizes strategic shifts across years, connects investment focus to revenue expectations, and correctly identifies competitive positioning via bundling and sports rights. It cites appropriate sections (2023 Trends; 2024 Risk Factors), showing cross-year synthesis. (4) The LLM conveys semantic equivalence: it captures the growing strategic dependence on DTC, the expectation that subscription and ad revenue will offset linear declines, and the increasing competitive pressure—even if the term 'competitive intensity' is implied rather than stated. The only slight gap is the less explicit treatment of 2022’s risk acknowledgment, but the overall trajectory and strategic logic are correctly represented. Hence, high scores across all dimensions with a 9 on correctness due to minor contextual omission in 2022 portrayal.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 441,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nThe $1.5 billion Fixed‑rate 2.850 % notes—originally issued in September 2019 with a maturity of 10 Oct 2029—remained on PayPal’s balance sheet unchanged through 2022, 2023 and 2024 (the tables show a $1.5 bn balance each year and an effective interest rate of 2.96 %). No new 2.850 % issuance occurred in those years; the company instead added other term‑debt tranches (e.g., the ¥30 bn 0.813 % notes due 2025), but the 2.850 % series kept its original terms and will be repaid in full in 2029 as part of the future principal‑payment schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, all key numbers are accurate: the $1.5 billion principal of the 2.850% notes is correctly stated as unchanged from 2022–2024, the 2029 maturity date is correct, and the effective interest rate of 2.96% (slightly above coupon rate) is consistent with accounting practices. The mention of ¥30 billion 0.813% notes due 2025 adds context without contradicting the ground truth. (2) However, the LLM omits key details about the evolution of PayPal’s broader debt structure—specifically, the increase from $9.0 billion in 2022 to $10.638 billion in 2023 and decline to $10.574 billion in 2024—which was a central part of the original answer and directly addresses how the debt environment around the 2.850% notes evolved. (3) The reasoning is sound in noting that no new 2.850% notes were issued and that the original terms remained intact, but it misses the strategic implication highlighted in the ground truth: that PayPal issued higher-interest debt in 2024 (e.g., 5.150% and 5.500% notes), signaling a shift in financing strategy despite maintaining the same low-rate obligation. This multi-hop insight—comparing interest rates across years to infer strategic change—is absent. (4) Entity accuracy and contextual relevance are strong: PYPL, correct years, correct note terms, and maturity are all accurately referenced. The answer stays focused on the question. Overall, the answer is factually solid but lacks full completeness in capturing the broader debt trend and strategic context, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 452,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nFrom 2022 to 2024 the pension plan’s direct corporate‑stock holdings fell sharply—from about **$2.2 billion** in 2022 (≈57 % of equity exposure) to roughly **$0.18 billion** in 2023‑2024 (≈5 % of total plan assets).  This reduction coincides with a strategic shift toward a more conservative mix: the target equity range was cut from 45‑55 % (2022) to 20‑30 % (2025) while debt was raised to 70‑80 %, indicating that UNP is deliberately de‑risking the portfolio and moving away from concentrated equity positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states UNP's allocation to Corporate Stock was $1,990 million in 2022 and $181 million in 2023, but the LLM reports approximately $2.2 billion in 2022 and $0.18 billion (i.e., $180 million) in 2023–2024. While the 2023 figure is close, the 2022 value is notably overstated ($2.2B vs $1.99B), and the LLM introduces percentages not present in the original answer (e.g., 57% of equity exposure, 5% of total plan assets), which are unsupported by the ground truth. Additionally, the LLM references a 'target equity range' change from 45–55% to 20–30% by 2025, which is not mentioned in the original answer and represents an unverified expansion of information. (2) The calculation of the decline is directionally correct (a sharp drop), but the exact figures are inaccurate. The reclassification of common stock to Level 1 and use of preferred shares as Level 2 in 2024—a key qualitative shift in investment strategy related to valuation transparency—is entirely omitted. Instead, the LLM emphasizes a broader de-risking narrative with increased debt allocation, which, while plausible, is not supported by the provided ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift due to reduced equity holdings. However, it fails to capture the specific nature of the shift—toward more transparent valuation methodologies (Level 1/Level 2 classification)—which is central to the original answer. This reflects a gap in synthesizing the precise regulatory and accounting implications described in the ground truth. (4) Despite these issues, the LLM captures the core trend—a dramatic reduction in corporate stock holdings—and draws a reasonable conclusion about de-risking and reduced equity concentration. The answer is contextually relevant and structured well, but the inclusion of unsupported percentages and targets reduces factual reliability. Hence, correctness is partially compromised due to numerical inaccuracies and addition of unverified strategic details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 565,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (recorded at cost) fell from roughly **$800 million at the end of 2022 to $755 million in 2023 and $719 million in 2024** (see the “Long‑term investments” table in the 2024 Form 10‑K, page 84).  This steady decline of about $80 million over the two‑year span signals that the company is **reducing its exposure to illiquid alternative investments**, shifting capital toward more liquid or higher‑priority strategic uses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the starting value. The ground truth states that Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, but the LLM incorrectly reports it as $800 million. The 2023 value of $755 million and 2024 value of $719 million are correct and match the ground truth. (2) Calculations: The LLM claims a 'steady decline' from $800M to $755M to $719M, implying a consistent downward trend. However, the actual data shows an increase from 2022 ($623M) to 2023 ($755M), followed by a decline to $719M in 2024. This makes the LLM's characterization of a 'steady decline' factually incorrect. The actual trend is growth followed by partial reversal, not continuous decline. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the three-year trend due to the incorrect 2022 figure. It misses the key nuance of a strategic increase in 2023 followed by a modest pullback in 2024, instead portraying a continuous reduction. This undermines the qualitative interpretation. (4) While the LLM correctly identifies the relevant metric and time frame, and its conclusion about reducing exposure might seem plausible, it contradicts the actual pattern of expansion in 2023. The ground truth interprets this as a short-term growth strategy followed by cautious retrenchment, whereas the LLM sees a uniform reduction. This fundamental misrepresentation of the trend significantly reduces correctness. Contextual relevance is high as the answer addresses the right company, metric, and time period, and attempts proper interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 444,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by formalizing collaborations with issuers, acquirers, merchants, governments and industry associations to create shared technical standards and free‑utility best‑practice programs; it expanded real‑time payment infrastructure from a dozen to thirteen global markets and launched a China joint‑venture for domestic processing, while introducing the Alias‑Based Remittances and Payouts platform and Mastercard Receivables Manager to embed real‑time, account‑based flows.  At the same time, the company reinforced cyber‑resilience through dedicated Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, continuous third‑party testing and insurance coverage, ensuring the network can withstand evolving threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mastercard's multi-layered security approach from 2022 to 2024, with accurate emphasis on third-party collaboration, real-time payment infrastructure expansion, and cyber resilience. Quantitatively, the claim of expanding real-time payment infrastructure to 'thirteen global markets' aligns with the ground truth (13 markets as of end-2023), though the phrasing 'from a dozen to thirteen' is a minor inference not explicitly stated in the original but reasonable. However, the LLM introduces specific initiatives—'Alias-Based Remittances and Payouts platform', 'Mastercard Receivables Manager', 'China joint-venture'—that are not present in the ground truth and cannot be verified from the provided knowledge graph, introducing unconfirmed details. While these may be factually accurate in broader context, they go beyond the documented evidence and slightly distort completeness by adding unsupported specifics. The mention of 'free-utility best-practice programs' and 'insurance coverage' also lacks grounding in the original answer. Qualitatively, the reasoning is sound: the LLM correctly identifies the trend toward deeper third-party integration, real-time infrastructure growth, and sustained use of internal security centers (SOCs, Fusion Centers, Intelligence Center). It synthesizes the multi-hop elements—evolution over time, collaboration expansion, infrastructure scale—but adds granularity not present in the source. Contextually, the response is highly relevant, directly addressing all three dimensions in the question. The core facts (13 markets, third-party inclusion, continued use of security centers) are correct, and the overall trajectory matches the ground truth. The score is reduced slightly due to the introduction of unverified programs and partnerships not in the original, which affect factual precision despite strong structural and logical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 524,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports as “not offset against derivatives” under master‑netting arrangements fell sharply: about **$1.5 billion in 2022 → $0.8 billion in 2023 → $0.5 billion in 2024**.  \n\nThis steady decline signals that the company has been **reducing the size of its derivative book or shifting to cleared, lower‑margin transactions**, thereby lowering the amount of initial‑margin collateral it must post. In other words, ExxonMobil is managing its derivative exposure more conservatively and with less reliance on external collateral as time progresses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the collateral amounts were $641M (end of 2021, reported in 2022 filing), $800M (end of 2022, reported in 2023 filing), and $491M (end of 2023, reported in 2024 filing). The LLM incorrectly states $1.5B in 2022, $0.8B in 2023, and $0.5B in 2024. The $1.5B figure is entirely unsupported by the ground truth and represents a major overstatement. While the $0.8B (i.e., $800M) for 2023 aligns with the peak in 2022 year-end data (reported in 2023 filing), the labeling as '2023' is ambiguous and potentially misleading since the reported value corresponds to the end of 2022. The $0.5B (i.e., $500M) is close to the actual $491M in 2024 filing (for end of 2023), so this is approximately correct. The percentage decrease mentioned in the original answer (38% from 2022 to 2024) is not explicitly repeated, but the trend direction is correct. (2) Calculations: The LLM implies a steady decline, which matches the trend, but the starting value is wrong. The actual decline from $800M to $491M is a 38.6% decrease, while the LLM implies a drop from $1.5B to $0.5B (67% decrease), which is inaccurate. (3) Multi-hop reasoning: The LLM correctly identifies the trend in collateral changes and links it to derivative exposure management, which requires synthesizing financial disclosures over time. It correctly infers that declining collateral could reflect reduced derivative positions or a shift to cleared transactions, which is consistent with the ground truth interpretation about reduced initial margin requirements. This shows sound qualitative reasoning. (4) Entity and time accuracy: The company (ExxonMobil) and metric (collateral under master netting arrangements) are correctly identified. However, the mapping of values to years is flawed—using '2022', '2023', '2024' as reporting years without clarifying they reflect prior year-end balances creates confusion. The ground truth emphasizes that the $800M is at end of 2022 (reported in 2023), so the LLM’s presentation lacks precision. Despite this, the overall trend and interpretation are directionally correct, warranting a moderate score. Contextual relevance is high as the answer addresses both the change in collateral and its implication for risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 621,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe model‑derived expected volatility fell markedly over the three‑year span—from roughly 30 % in 2022 to 28.6 % in 2023 and to about 18.7 % in 2024. This downward shift signals that Duke Energy’s stock was perceived as increasingly less volatile relative to its peer group, reflecting a reduced market‑risk outlook and greater confidence in the stability of its relative total shareholder return.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies the 2023 (28.6%) and 2024 (18.7%) volatility values, but inaccurately reports the 2022 value as 'roughly 30%' instead of the ground truth 26.9%. This is a notable quantitative error, though the general trend direction is preserved. (2) The correct values from the original answer are: 26.9% (2022), 28.6% (2023), 18.7% (2024). The LLM states a decrease from ~30% to 28.6% to 18.7%, implying a monotonic decline, whereas the actual data shows an increase from 2022 to 2023 before a sharp drop in 2024. This misrepresents the trajectory, particularly missing the peak in 2023 relative to 2022. (3) Despite the numerical inaccuracy in 2022, the LLM correctly performs the multi-hop synthesis across years and interprets the overall trend in market risk perception—correctly concluding reduced volatility and improved stability by 2024. The reasoning about market risk perception and confidence in TSR stability is logically sound and aligns with the original answer. (4) The contextual relevance is perfect—directly addressing both parts of the question: the change over time and its implication for market risk. The qualitative reasoning is strong, but the quantitative accuracy is reduced due to the incorrect 2022 figure and implied trend. Hence, correctness is docked to 8 for the factual inaccuracy, though the core insight remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 381,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification liability to Stellantis under the 2017 sale agreement remained limited to losses arising from inaccurate representations, warranty breaches, legacy Opel/Vauxhall emissions claims and any future Takata‑inflator recalls. In each annual filing the company stressed that it cannot estimate a reasonably possible loss and has not accrued any amount, regarding any additional indemnification as remote.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general context of GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions and Takata recalls from 2022 to 2024, but contains significant factual inaccuracies that affect correctness. (1) The LLM states that GM 'has not accrued any amount' and 'cannot estimate a reasonably possible loss,' which contradicts the ground truth: in 2022 and 2024, GM did accrue an immaterial amount (specifically for Takata-related recalls in 2022 and for European Commission/UK CMA investigations in 2024). The term 'immaterial' is key and was reported by GM, but the LLM incorrectly frames this as no accrual at all. (2) The LLM claims indemnification for future Takata recalls was considered 'remote' in each filing, which aligns with the 2023 and 2024 disclosures, but misrepresents the 2022 stance—GM acknowledged actual indemnification (albeit immaterial) and potential future obligations, not that they were deemed remote at that time. (3) The LLM fails to reflect the evolution across years: in 2022, GM had already indemnified Stellantis for an immaterial amount; by 2023–2024, further obligations were considered remote. This progression is missing. (4) The mention of 'European Commission and UK CMA investigations' in 2024 is omitted in the LLM response, reducing completeness. While the core entities (GM, Stellantis, Opel/Vauxhall, Takata) and time frame are correct, and the overall theme of minimal exposure is partially accurate, the misrepresentation of accruals and the lack of year-by-year evolution undermine the factual and qualitative accuracy. The answer is contextually relevant and addresses the right topics, but lacks precision in key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 464,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD’s 2022, 2023 and 2024 Form 10‑K filings each continue to list the 2011 Executive Incentive Plan as “*10.1 — 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” The wording and exhibit number are identical across all three years, showing that the company has not replaced or renamed the plan but continues to reference the same instrument as the cornerstone of its executive‑compensation framework. This steady, unchanged citation signals that AMD’s long‑term executive compensation strategy is built on a stable, enduring policy foundation that has been consistently applied and reinforced over multiple reporting cycles.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in exhibit numbering and filing reference. The original answer states that the 2011 Executive Incentive Plan was listed as Exhibit 10.1 in AMD's 2022–2024 filings and was filed on April 2, 2011. However, the LLM answer incorrectly cites it as 'Exhibit 10.2 to AMD’s Quarterly Report on Form 10-Q for the period ended April 2, 2011'. This is a factual error in the exhibit number and document type (Form 10-Q vs. original filing source), which affects quantitative accuracy. Despite this, the core reasoning and conclusion are sound: the consistent citation across three years indicates a stable executive compensation strategy. The LLM correctly identifies the unchanged wording and exhibit reference over time and draws the appropriate inference about long-term strategic consistency. All other elements—years (2022, 2023, 2024), plan name, and lack of amendments—are accurately represented. The answer fully addresses both parts of the question: evolution (no change) and strategic implication (stability). Semantic meaning and qualitative reasoning are strong, and the response is highly contextually relevant. The error is specific to one detail and does not undermine the overall conclusion, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 372,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk intensified in 2022 as pandemic‑driven remote work heightened fraud, credit defaults and dependence on third‑party lenders and payment processors for its consumer and merchant credit products and for cross‑border trade. In 2023 the company acted to curb that risk by signing a multi‑year deal to sell up to €40 bn of U.K. and European “buy‑now, pay‑later” loan receivables (and a forward‑flow sale of future originations) and by diversifying its payment‑processor base while strengthening fraud‑detection and buyer‑protection programs, thereby reducing credit‑loss exposure and reliance on single third parties. The 2024 filing shows that these steps materially lowered the magnitude of the risk, though exposure remains through ongoing third‑party dependencies and fluctuations in cross‑border trade.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the €40 billion multi-year agreement in 2023 to sell U.K. and European BNPL receivables is accurately reported, including the correct currency and amount. No incorrect numbers, dates, or calculations are present. (2) Quantitative accuracy is perfect: the €40 billion figure matches the original, and no erroneous computations are made. Format (€40 bn) is acceptable and clear. (3) Qualitatively, the LLM correctly identifies the evolution of bad transaction risk from 2022 to 2024, citing credit defaults, third-party dependencies, and cross-border trade. It accurately notes PayPal’s strategic actions in 2023, including the BNPL receivables sale and diversification of payment processors, which are implied or directly supported by the original answer’s emphasis on reducing credit risk and third-party reliance. The mention of strengthened fraud-detection and buyer-protection programs adds context not contradicted by the ground truth, though not explicitly stated—this is a minor extrapolation but reasonable within the scope. (4) The answer fully addresses all parts of the multi-hop question: risk evolution across years, credit products, cross-border trade, third-party dependencies, and 2023 mitigation actions. The only minor gap is the absence of explicit mention of Synchrony Bank in the U.S. credit product (a detail in the 2022 risk), but the core risk in credit products is still correctly conveyed. Overall, the answer is semantically equivalent, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 439,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple‑Purpose locomotive fleet stayed roughly the same size (≈7,000 units) but the composition shifted: owned units edged up from 5,971 to 5,973 while leased units fell from 1,037 to 920, pulling the total down to 6,893.  At the same time the average age rose from **24.3 years (2022)** to **25.2 years (2024)**, indicating the fleet is getting older rather than being refreshed with newer equipment.  This pattern shows Union Pacific is managing its fleet by extending the life of existing locomotives and relying less on new acquisitions, focusing capital instead on maintenance, refurbishment and other modernization initiatives that improve efficiency without dramatically increasing the number of new units.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, owned units decreased from 6,204 (2022) to 5,973 (2024), but the LLM incorrectly states they increased from 5,971 to 5,973. Similarly, leased units dropped from 1,038 to 920 per ground truth, but LLM reports 1,037 to 920—close but still inaccurate for 2022. Most critically, the average age in 2022 is wrong: ground truth is 22.5 years, but LLM claims 24.3 years, a major deviation that affects interpretation. 2) Calculations: total fleet in 2022 should be 6,204 + 1,038 = 7,242, not ~7,000 or 6,893 as implied. LLM’s total of 6,893 in 2024 (5,973 + 920) is correct, but the 2022 total is misrepresented. The age increase is correctly calculated as +0.9 years only if starting from 24.3, but actual increase is from 22.5 to 25.2 = +2.7 years, which the LLM fails to capture. 3) Multi-hop reasoning is partially sound—LLM correctly infers aging and reduced leasing suggest conservative modernization—but draws an incorrect conclusion because it misreads the starting point. The strategy interpretation is plausible but based on flawed data. 4) Despite incorrect numbers, the answer addresses all parts of the question (ownership changes, aging, strategy implications), so contextual relevance is high. However, the quantitative inaccuracies severely undermine correctness, especially the wrong initial age and ownership figures, which distort the narrative. Minor format flexibility is allowed, but directional trends (e.g., owned units decreasing vs. stable) must be correct—here, they are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 439,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements tied to its equity‑company receivables fell sharply—from **$1.49 billion in 2022** to **$0.80 billion in 2023** and **$0.49 billion in 2024** (as disclosed in the 2022‑2024 10‑K filings).  This downward trend shows the company is deliberately reducing its external collateral obligations, indicating a more conservative and streamlined derivative‑risk‑management approach that relies less on third‑party counterparties and more on internal hedging and credit controls.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM incorrectly reports $1.49 billion in 2022, which is more than double the correct value. The 2023 figure ($0.80 billion) matches the ground truth, and the 2024 figure ($0.49 billion) is also correct (equivalent to $491 million). The trend described as a 'sharp fall' from 2022 to 2024 is misleading because the actual trend shows an increase from 2022 to 2023 before declining in 2024. (2) The calculation and comparison of values are flawed due to the incorrect 2022 number. The model fails to capture the peak in 2023, which is a key part of the trend. (3) The reasoning is partially sound in interpreting a downward movement from 2023 to 2024 as a sign of conservative risk management, but it misses the multi-hop nuance that the increase in 2023 followed by a drop in 2024 reflects dynamic risk positioning, not a consistent downward strategy. Additionally, the LLM omits the critical point about level 3 fair value inputs being used across all years, which is central to understanding ExxonMobil's continued reliance on internal models. (4) The contextual relevance is high because the answer addresses collateral exposure, master netting arrangements, equity company receivables, and derivative risk management. However, due to major quantitative errors and incomplete reasoning synthesis, the correctness score is limited to 4. The qualitative accuracy is moderate because the direction of change from 2023 to 2024 is correct, but the overall narrative is based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 474,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” category—defined as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware—was $6.89 billion (21 % of total revenue) in fiscal 2022, increased to $7.71 billion (22 % of total) in fiscal 2023, and then edged down to $7.54 billion (21 % of total) in fiscal 2024.  Thus, the segment grew modestly from 2022 to 2023 before a slight decline in 2024, while consistently accounting for roughly one‑fifth of Starbucks’ overall revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%, 21%) for the 'Other' category from 2022 to 2024, which are not present in the original ground truth. The ground truth explicitly states that the composition of the 'Other' category remained stable and lists the components (e.g., single-serve coffees, royalty income, etc.), but does not provide any quantitative data on revenue or percentage of total revenue. Therefore, these numbers are fabricated or hallucinated, severely undermining factual accuracy. (2) There is no verification possible for the calculations or trends (e.g., 'increased to... then edged down') because the ground truth contains no such data. The inclusion of precise dollar amounts and percentages constitutes a major quantitative inaccuracy. (3) The qualitative reasoning partially aligns with the ground truth in that it acknowledges consistency in the definition of the 'Other' category (listing similar components), which matches the original answer’s point about no significant shifts. However, the LLM fails to explicitly confirm the absence of new product categories or structural changes, instead focusing on nonexistent financial trends. The multi-hop synthesis is flawed because it invents numerical performance metrics rather than analyzing compositional evolution as required. (4) The contextual relevance is moderate because the answer addresses the 'Other' category and its components, which is relevant, but shifts focus to revenue trends not asked for and invents data, deviating from the actual query about composition. Correctness is low due to hallucinated numbers, despite some alignment in categorical description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 470,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet kept the same gross‑revenue treatment for ads on Google Network properties: it bills the advertiser the full amount, records that amount as revenue, and then records the portion paid to the network partner as cost of revenue.  Revenue is recognized when the ad impression is served (or when a user engages for performance ads), and the company continues to refine its impression‑based metrics—such as impressions, cost‑per‑impression, and paid‑click counts—to track monetization, even as shifts in device mix, emerging‑market traffic and TAC rates have altered the underlying monetization rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor differences in emphasis. (1) All key facts are correct: Google (Alphabet) consistently applied gross revenue reporting from 2022 to 2024 for Google Network properties, recognizing revenue upon impression delivery, and treating itself as the principal. The explanation of gross revenue treatment—recording full advertiser billings as revenue and partner payouts as cost of revenue—is factually sound and aligns with the ground truth. (2) There are no numeric inaccuracies; while specific dollar figures aren't cited, the absence is justified as the original answer also does not include quantitative metrics like exact revenue amounts or TAC percentages. The focus on cost-per-impression, impressions, and paid clicks matches the original's emphasis on impression-based metrics. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes accounting policy (gross revenue recognition), timing of revenue recognition (upon impression), and business model context (partner payouts as cost of revenue) across the 2022–2024 period. (4) The only minor shortcoming is that the LLM does not explicitly mention the evolution of transparency or the 2023 clarification regarding Google’s role as principal, which is a nuance highlighted in the original answer. However, the LLM does imply this by stating Alphabet maintains gross revenue treatment, which requires principal status. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 444,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nIn 2022 MDLZ noted that extended‑producer‑responsibility (EPR) schemes were just beginning to take hold in the EU, while front‑of‑pack labeling was largely voluntary and limited to nutrient‑profile warnings. By 2023 the company reported that EPR policies had spread to additional jurisdictions—including India, Vietnam and several U.S. states—and that front‑of‑pack labeling was becoming mandatory for products with specified nutrient or environmental claims on certain channels. In 2024 the exposure deepened further, as more countries adopted compulsory front‑of‑pack labeling rules and a wider range of EPR regulations were implemented or under consideration worldwide, heightening the regulatory risk to MDLZ’s sales and media‑marketing activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing regulatory exposure for MDLZ across 2022–2024 regarding EPR and front-of-pack labeling, which aligns with the ground truth. However, there are significant factual inaccuracies in the details. In 2022, the original answer states that over 25 EU countries had already implemented EPR policies—indicating they were well established, not 'just beginning to take hold' as the LLM claims. This misrepresents the maturity of EPR in the EU. Additionally, the LLM incorrectly implies that by 2023, EPR had spread to India, Vietnam, and several U.S. states, while the original answer notes these were under 'consideration' or 'contemplation' in 2024, not implemented in 2023. The LLM also misstates the progression of front-of-pack labeling, claiming it was becoming mandatory in 2023 for nutrient/environmental claims, whereas the original specifies increased attention and consideration—not mandates—until 2024 developments like the EU’s Packaging and Packaging Waste Directive. The LLM omits key jurisdictions mentioned (Indonesia, Philippines) in the context of plastic bans and advertising restrictions. While the overall direction of increased regulatory burden is correctly inferred, the timing, scope, and status (implemented vs. contemplated) of policies are inaccurately portrayed, affecting both quantitative and qualitative accuracy. The reasoning shows multi-hop synthesis but with flawed entity-state mapping over time. Contextual relevance is high as the response stays focused on the question’s core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 428,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s Class A common stock continued to carry **one vote per share** and retained the same dividend‑right language in its charter; Class B shares remained non‑voting but still earned the same per‑share dividend as Class A, and any Class B‑to‑Class A conversions kept the one‑for‑one ratio and required immediate resale of the newly‑converted Class A shares.  The **dividend per share rose steadily**—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting‑rights structure was unchanged across the three years.  This uninterrupted, predictable voting and payout framework signals that Mastercard is maintaining a **stable equity base and a disciplined capital‑structure strategy** focused on consistent shareholder returns without altering ownership or voting controls.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and retained dividend rights across 2022–2024, aligning with the ground truth’s emphasis on consistency in voting and dividend entitlements. However, the LLM introduces specific dividend amounts ($2.04, $2.37, $2.74) that are not present in the original answer and cannot be verified from the provided ground truth, which only states that dividend rights were consistent—not that payouts increased. This is a significant quantitative overreach. (2) The numbers cited for dividends per share are precise but unsupported by the ground truth, which does not mention any specific dividend amounts or trends in payout increases. Thus, while the claim of rising dividends may be factually correct in reality, it is not inferable from the original answer and introduces unverified data, reducing quantitative accuracy. (3) The reasoning about Mastercard (MA) maintaining a stable capital structure strategy is sound and logically inferred from the consistency of voting and dividend rights. The mention of Class B shares and conversion mechanics adds contextual detail not in the original but does not contradict it; however, this expands beyond the scope of the question, which focused solely on A Class shares. The multi-hop synthesis is partially accurate—correct in structure but overextended with unsupported figures. (4) The correctness score is 7 because the core factual claim—unchanged voting and dividend rights for A Class shares—is accurate, and the conclusion about stable capital structure strategy matches the original. However, the inclusion of unverified dividend amounts reduces quantitative accuracy to 6. Qualitative accuracy is 8 due to strong reasoning and appropriate interpretation. Contextual relevance is 10 as all content directly addresses the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 518,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil must post under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and roughly $0.5 billion in 2024**.  This decline shows that the company’s derivative positions and the associated initial‑margin requirements have been trimmed, indicating reduced net derivative exposure and a lower need for extensive collateral to support those contracts over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. The ground truth states that collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM incorrectly reports $1.5 billion in 2022, $0.8 billion in 2023, and $0.5 billion in 2024. The 2022 and 2023 figures are notably wrong—$1.5 billion is more than double the correct value of $641 million, and while $0.8 billion is close to the correct $800 million, the characterization of a 'decline' from 2022 is factually incorrect given the actual increase. (2) The quantitative inaccuracies undermine the answer’s reliability: the model misrepresents the trend (portraying a steady decline when the correct trend is an increase followed by a decrease), and the initial figure is grossly overstated. (3) The reasoning is partially sound in interpreting the final decrease as reflecting reduced derivative exposure and margin requirements, but it fails to capture the full multi-hop insight—the increase in 2023 suggests rising exposure or volatility, which is a critical part of the trend. By missing the correct 2022–2023 increase, the model draws an oversimplified and misleading conclusion. (4) Contextual relevance is high because the answer addresses the right metric, time frame, and conceptual implications (derivative exposure, margin requirements), and attempts appropriate synthesis. However, due to major numerical errors and flawed trend interpretation, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the logic framework is reasonable but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 460,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks progressively lengthened the horizon of its forward‑looking green‑coffee commitments—first stating that existing purchase commitments and inventory would meet demand through FY 2023, then extending that coverage to FY 2024 in the 2023 filing, and finally to FY 2025 in the 2024 filing—while also expanding its network of farmer‑support centers and deepening long‑term contracts with producers.  This evolution shows the company’s strategy of reducing exposure to coffee‑price volatility and supply shocks by locking in volumes through fixed‑price and price‑to‑be‑fixed contracts, using hedging instruments (forward contracts, collars, futures), and building sustainable farmer capacity to secure a reliable, high‑quality supply pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the progression of Starbucks' supply chain commitments: from covering through FY2023 in 2022, to FY2025 in 2023 and 2024 filings. The only minor discrepancy is that the LLM states coverage was extended to FY2024 in the 2023 filing, while the ground truth indicates the extension was directly to FY2025—so the FY2024 intermediate point is slightly inaccurate. (2) All fiscal years and time horizons are otherwise correct, with proper alignment across years. The use of hedging instruments (forwards, futures, collars) is accurately reported. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and correctly infers the strategic intent—longer-term supply security and price volatility management. It appropriately links extended commitments, hedging, and farmer support to risk mitigation. (4) The answer is contextually excellent, addressing both parts of the question: evolution of commitments and strategic implications. The conclusion about locking in volumes and building farmer capacity is a reasonable interpretation beyond the ground truth, but still logically consistent. The minor error in the intermediate projection year prevents a perfect score, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 372,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 the company’s target mix for its defined‑benefit plans shifted markedly in the non‑U.S. portfolio—from roughly **27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other** in 2023 to **28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other** in 2025—while the U.S. book remained essentially **100 % debt‑focused** in both years.  \n\nThis multi‑year reallocation shows ACN is deliberately increasing exposure to growth assets (equity and insurance‑linked investments) and liquidity buffers while trimming the traditional fixed‑income share, aiming to boost risk‑adjusted returns and better match long‑term liability cash‑flows without abandoning the defensive, duration‑matched core of its U.S. pension strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. The ground truth states that ACN's target asset allocation evolution from fiscal 2023 to 2025 is described in qualitative, strategic terms—emphasizing continuity in investment strategy with adaptive flexibility, a focus on risk-adjusted returns, liability matching via duration-aligned fixed income, and inflation protection. There is no mention in the original answer of specific numerical allocations (e.g., 27% equity, 48% debt, etc.), nor any breakdown by U.S. vs. non-U.S. plans, nor any claim that the U.S. portfolio is 100% debt. These precise percentages appear to be fabricated or misattributed. The original answer draws from the 2022 and 2024 10-K filings but does not report granular allocation figures. Therefore, the LLM introduces highly specific data not present in the ground truth, failing the quantitative accuracy test. While the LLM attempts correct qualitative reasoning—such as linking allocation changes to risk-adjusted returns and liability matching—this is based on false premises. The multi-hop synthesis is flawed because it invents data rather than extracting and summarizing actual disclosures. The contextual relevance is moderate because the answer addresses the general theme of strategic allocation evolution and risk-return objectives, but the factual foundation is unsound. Overall, the answer misrepresents the source information despite plausible-sounding analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 409,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved Olpasiran from early‑stage testing into a pivotal Phase 3 program focused on lowering lipoprotein(a) to reduce atherosclerotic cardiovascular disease, positioning the siRNA as a first‑in‑class therapy for a high‑need cardiovascular indication.  Throughout this period the company relied on a portfolio of composition‑of‑matter patents that extend exclusivity for Olpasiran until 2036 in both the United States and Europe, with the possibility of additional extensions via regulatory exclusivity or patent term adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA drug in development by Amgen with U.S. and European patent protection until 2036, which matches the ground truth. However, it inaccurately states that Olpasiran had moved into a 'pivotal Phase 3 program' by 2024, while the original answer only confirms it was listed as indicated for 'Cardiovascular disease' and previously in phase 2 trials—there is no mention of Phase 3 initiation in the ground truth. This overstatement of clinical progress is a significant qualitative error. (2) Quantitatively, the patent expiration year of 2036 is correctly cited, and no other numbers (e.g., financials, percentages) are present, so quantitative accuracy is high. Format and date are consistent with ground truth. (3) The multi-hop reasoning is partially sound: the model connects therapeutic focus (cardiovascular disease), intellectual property timeline (2036 expiry), and strategic positioning. However, it infers a Phase 3 transition not supported by the provided data, indicating a failure in accurately synthesizing the development stage evolution. The ground truth emphasizes progression from phase 2 to continued CV focus without specifying Phase 3, so this is an overreach. (4) Contextual relevance is strong—the response directly addresses both therapeutic focus and IP protection timeline as asked. Despite the Phase 3 inaccuracy, the core elements of strategic positioning and IP are well-covered. Correctness and qualitative accuracy are reduced due to the unsupported claim about clinical phase advancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 435,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 Amex progressively deepened its reliance on third‑party aggregators and merchant‑acquirer networks to expand card acceptance, moving from a general acknowledgement of limited alternatives in 2022 to an explicit note that the “increasing number of third parties” creates greater governance complexity by 2023‑2024. Each year’s filing stressed that this expanded reliance reduces Amex’s control, subjects it to heightened U.S. and global regulatory scrutiny of outsourcing, and makes the business vulnerable to service disruptions at shared providers—risks that could trigger fines, litigation or reputational damage if oversight fails.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its overall narrative and correctly identifies the increasing reliance on aggregators from 2022 to 2024, as well as key risks such as reduced control, regulatory scrutiny, and operational disruptions. There are no numeric inaccuracies (quantitative_accuracy=10), as the response avoids specific figures that would need to match the ground truth and instead uses qualitative descriptors appropriately. However, the LLM diverges from the original answer in emphasis and specificity regarding year-by-year evolution: (1) In 2022, the ground truth highlights concern over aggregators acting against AXP's interests affecting card usage, while the LLM only generically notes 'limited alternatives'—missing the behavioral risk focus. (2) In 2023, the original answer specifies increased dependency with emphasis on surcharging and steering reducing transaction volumes, whereas the LLM shifts to 'governance complexity' and regulatory scrutiny, which, while plausible, are not the primary risks emphasized in that year. (3) In 2024, the ground truth highlights litigation exposure and changes due to third-party failures or regulation, which the LLM partially captures with 'fines, litigation or reputational damage,' but misses the forward-looking shift toward legal and systemic risks tied to business practice changes. The reasoning is logically sound and contextually relevant (contextual_relevance=9), but the qualitative accuracy is reduced because the multi-hop synthesis does not precisely align with the disclosed risk evolution per year. While semantically related, the LLM generalizes the disclosures rather than reflecting the nuanced progression from merchant behavior (2022–2023) to broader legal and operational risks (2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 480,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved its green‑coffee hedging from a short‑term focus—using fixed‑price and price‑to‑be‑fixed contracts together with forward, futures and collar instruments to protect against “C”‑price swings and commodity‑index‑fund activity, with purchase commitments sufficient only through fiscal 2023—to a longer‑term strategy that extends the coverage of those forward supply commitments out to fiscal 2025.  This shift reflects a broader set of purchase commitments and longer‑dated forward contracts that reduce reliance on spot‑market price volatility and the influence of hedge funds and commodity‑index funds, thereby smoothing exposure to green‑coffee price swings over an expanded horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks cited commodity index funds as influencing green coffee price volatility from 2022–2024; forward supply commitments extended from covering needs through fiscal 2023 (in 2022) to fiscal 2025 (by 2023), and this remained stable in 2024. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, 2025) are correctly referenced, and there are no numerical errors. Format variations (e.g., 'fiscal 2025') are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across years and entities (Starbucks, green coffee, commodity index funds, hedging instruments, supply commitments), capturing the strategic shift toward longer-term risk mitigation. (4) The only minor shortcoming is that the LLM slightly overstates the reduction in influence from index funds by implying reduced reliance on them due to longer contracts, while the original answer emphasizes continued exposure despite the strategy. However, this does not materially distort the core conclusion. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 338,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture grew both the size of its open‑market share‑repurchase program and the amount it actually spent: the Board’s authorized capacity rose from roughly **$3 billion in 2022** to **$6.7 billion after the September 2024 increase**, while cash used for repurchases increased from **about $4.1 billion in FY 2022** to **$4.5 billion in FY 2024** (including 2.07 million shares bought in Q4 2024). This multi‑year expansion shows that Accenture is deliberately scaling its share‑buyback capability as part of a broader capital‑return strategy that combines regular dividends with opportunistic equity repurchases to return cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture had $3,129,296 (~$3.13M, not $3B) in available authorization in fiscal 2022, but the LLM incorrectly states 'roughly $3 billion', overstating by nearly 1,000x. Additionally, the LLM claims $4.1B was spent on repurchases in FY2022 and $4.5B in FY2024, but the original answer only confirms $605M in actual purchases in FY2023 and no total repurchase spending for FY2022 or FY2024. The 2.07 million shares bought in Q4 2024 are not mentioned in the ground truth. (2) The only correct quantitative point is the $4,000M new authorization in September 2024, which aligns with the $6,694M total authorization after adding prior $2,694M—though the LLM rounds this to $6.7B, which is acceptable. However, the core spending and authorization figures are wrong. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a growing capital return strategy through increasing authorizations and repurchases—but it fabricates execution data (spending levels) not present in the ground truth, undermining the reasoning. (4) Contextual relevance is high because the answer addresses the evolution of repurchase activity and capital return strategy as asked. However, due to severe quantitative errors and invented figures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the general direction (increasing authorization) is correct, but details are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 425,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term portion of Google’s marketable equity securities that are subject to lock‑up restrictions was **$803 million at the end of 2022**, rose to **about $1.4 billion at the end of 2023**, and then fell sharply to **$266 million by the end of 2024**.  \n\nThis swing indicates that Google **expanded its exposure to illiquid assets in 2023**—likely to capture higher‑return opportunities—**but reversed that trend in 2024**, markedly reducing the locked‑up holdings, which suggests a more cautious or liquidity‑focused investment strategy over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly states $803 million at the end of 2022 (should be $1.4B), then $1.4B in 2023 (partially correct but misattributed as an increase), and a sharp drop to $266 million in 2024 (which is completely incorrect—ground truth is $1.4B, not $266M). These errors fundamentally misrepresent the trend. (2) The quantitative inaccuracies are severe: all three data points are either wrong or misaligned with the correct years. The calculation of change over time is therefore invalid. The LLM suggests a rise then a sharp fall, while the actual pattern is a dip and recovery—forming a U-shape, not a peak. (3) The reasoning is flawed due to incorrect data. The conclusion that Google 'expanded exposure in 2023' and then 'reversed in 2024' is unsupported by the actual data, which shows a temporary reduction followed by a return to prior levels—suggesting rebalancing, not a strategic reversal. The multi-hop synthesis fails because the model did not correctly retrieve or align the time-series data across years. (4) Despite the factual errors, the answer attempts to address both parts of the question—change in value and strategic implication—and uses appropriate financial terminology. However, the incorrect data undermines both quantitative and qualitative accuracy. Contextual relevance is moderate because the structure and intent align with the question, but correctness is very low due to core factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 459,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from an internal captive unit to a formally‑identified “held‑for‑sale” business, signed a binding sales agreement in late‑2023 and completed the transaction in Q2 2024 for $120 million of cash.  The shift removed the $1.985 billion of assets and $1.826 billion of liabilities that had been recorded for EIC from GE’s ongoing balance sheet, and the anticipated disposal forced a $109 million pre‑tax loss in 2023 (reflecting the write‑down to fair value and the expected sale).  The cash received on closing generated a modest net gain that offset part of that loss and provided a small cash inflow, but the overall financial effect on GE’s consolidated earnings and cash‑flow was limited to the removal of the unit’s results and the $120 million proceeds.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic trajectory and ultimate disposition of Electric Insurance Company (EIC) correctly: it was transitioned from a captive insurer to held-for-sale status and ultimately sold to Riverstone International Holdings Inc. in 2024 for $120 million in cash, with a $109 million pre-tax loss recognized in 2023. However, there are critical quantitative inaccuracies that undermine factual correctness. The LLM claims EIC had $1.985 billion in assets and $1.826 billion in liabilities at the time of sale, but the ground truth states that as of December 31, 2023, EIC had assets of $541 million and liabilities of $378 million. The LLM’s figures are over three times higher and factually incorrect. Additionally, the claim that the sale generated a 'modest net gain' is unsupported by the original answer, which does not mention any gain in 2024—only the completion of the sale and prior loss recognition. The original answer notes EIC’s net claim reserves were $0.2 billion in 2022, which the LLM omits entirely, missing a key data point about EIC’s scale and risk exposure early in the period. While the reasoning around strategic positioning and disposal is sound and contextually relevant, the severe numerical errors—especially in balance sheet figures—significantly reduce confidence in the financial impact assessment. The model appears to have fabricated or misremembered EIC’s asset and liability values, failing the multi-hop synthesis test between 2022 disclosures and 2023 classification. Despite correct sequencing and entity identification (GE, EIC, Riverstone), the quantitative inaccuracies severely limit the answer’s reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 455,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nAmgen’s Phase 3 pipeline expanded sharply from 13 programs in early 2022 to 24 programs by the end of 2024 (and to 25 by early 2025).  The growth was driven by the initiation of five new Phase 3 studies—including Tarlatamab (SCLC), Rocatinlimab (atopic dermatitis), TEPEZZA (sub‑cutaneous TED), Olpasiran (ASCVD) and Dazodalibep (Sjögren’s)—plus three FDA approvals of existing Phase 3 assets and the acquisition of Horizon‑derived candidates.  This progression shows Amgen’s deliberate R&D‑pipeline expansion into oncology, cardiovascular, rare‑disease and inflammatory‑disease areas, a greater reliance on novel modalities (BiTEs, siRNA, antibody‑drug conjugates) and collaborations, and a corresponding increase in R&D spending (from $4.4 B in 2021 to $6.0 B in 2024) to move more candidates toward commercialization.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative discrepancy: the ground truth states Amgen's Phase 3 programs grew from 13 in 2022 to 24 in 2024, with 18 in 2023, and reached 25 by 2024 (not early 2025). The LLM claims the count reached 25 by early 2025, which misaligns with the ground truth stating 25 was reached by 2024. This affects the timeline accuracy. (2) The LLM correctly identifies the 13 starting point in 2022 and the 24/25 program count, but the attribution of growth to 'five new Phase 3 studies' is not fully aligned—the ground truth emphasizes the acquisition of five programs from Horizon in 2023 as a key driver, not necessarily five internally initiated studies. The R&D spend increase from $4.4B to $6.0B is plausible context but not present in the ground truth, so it cannot be verified and slightly extends beyond the provided data. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes growth over time, links it to strategic acquisitions (Horizon), identifies therapeutic area expansion, and infers R&D focus areas (oncology, cardiovascular, etc.) and modalities (BiTEs, siRNA), which aligns with the intent of the ground truth. (4) Despite minor timeline and sourcing inaccuracies, the LLM captures the core narrative of significant pipeline expansion, strategic focus, and R&D intensification. The answer is semantically close and highly relevant, warranting high scores in qualitative accuracy and contextual relevance, but the quantitative score is reduced due to the misstated timeline for reaching 25 programs and unverified R&D spend figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 445,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s ties to global card networks have become more constrained and strategically focused.  Heightened regulatory scrutiny—especially U.S. and EU actions targeting interchange‑fee caps, merchant‑surcharge rules and non‑discrimination provisions—has forced the company to curb its network‑licensing business (e.g., exits from EU and Australia and the 2024 Visa/Mastercard settlement that would cap interchange fees, see 2024 pp. 32‑36) and to adjust pricing and acceptance terms.  In response, Amex has leaned on its premium‑card franchise, investing in differentiated products, data‑driven services and enterprise‑service partnerships to maintain a competitive edge amid growing pressure from rival networks and alternative payment platforms (see competition discussion in 2022‑2023 pp. 12‑14 and the 2024 risk‑overview on page 36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of American Express's relationship with global card networks from 2022 to 2024, noting a shift from competition to a more constrained posture due to regulatory pressures. The key developments—increased regulatory scrutiny, exits from EU and Australia in network licensing, and strategic pivoting toward premium offerings—are all factually correct and consistent with the original answer. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; references to page numbers (e.g., 2024 pp. 32–36) are plausible and contextually appropriate, though not verifiable from the ground truth alone—however, they do not introduce factual errors. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory impacts (interchange fee caps, non-discrimination rules), competitive dynamics (pressure from Visa, Mastercard, alternative platforms), and strategic responses (focus on premium cards, data services, partnerships). It correctly identifies the cause-effect relationship between regulation and business adjustments. One minor omission is the lack of explicit mention of 'cobrand arrangement uncertainty in the EU'—a detail present in the original—but this does not undermine the overall accuracy. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'curb its network-licensing business' vs. 'exited its network licensing businesses') but conveying the same meaning. Contextual relevance is excellent, directly addressing the question’s focus on regulatory and competitive evolution. The citation of specific report sections adds precision without introducing inaccuracies. Score deductions are minimal: -1 on qualitative accuracy for the slight omission of cobrand uncertainty; all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 530,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nConocoPhillips completed the sale of the remaining 91 million CVE shares in the first quarter of 2022 and used the proceeds to fund its share‑repurchase program. In 2022 it repurchased 87.7 million shares, in 2023 it repurchased 48.6 million shares, and in 2024 it repurchased 49.1 million shares, with the 2024 repurchases adding $5.3 billion (bringing total repurchase spending since inception to $34.3 billion for 433 million shares, including the $29 billion spent through the end of 2023).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures, particularly regarding share repurchase volumes. The ground truth states that ConocoPhillips repurchased a total of 383 million shares in 2022 alone at a cost of $29 billion, but the LLM claims only 87.7 million shares were repurchased in 2022. This is a major discrepancy. Additionally, the LLM breaks down repurchases into 87.7M (2022), 48.6M (2023), and 49.1M (2024), summing to 185.4 million shares, but the ground truth states cumulative repurchases reached 433 million shares by 2024. Even if the 2022–2024 repurchases were incremental, the LLM’s total (185.4M) is far below the actual cumulative total, suggesting a fundamental error in data sourcing or synthesis. (2) The dollar amounts show partial accuracy: the LLM correctly states that total repurchase spending since inception reached $34.3 billion by 2024 and that $29 billion was spent through the end of 2023. However, it incorrectly implies that $5.3 billion was spent in 2024 ($34.3B - $29B), which aligns numerically but is not explicitly confirmed in the ground truth. The ground truth does not provide annual breakdowns for 2023 or 2024 repurchase costs, so this inference may be reasonable, but the share volumes are definitively wrong. (3) The multi-hop reasoning is partially sound—linking the monetization of CVE shares to funding share repurchases is correct and supported by the original answer. The timeline of selling remaining 91 million CVE shares in early 2022 is accurate. However, the failure to report the correct 383 million share repurchase in 2022 undermines the reasoning, as it misrepresents the scale and pace of capital return. (4) Contextual relevance is high—the answer addresses the evolution from asset monetization to share repurchases and attempts to provide annual breakdowns. However, due to severe quantitative inaccuracies in share volumes, the correctness score is low. The qualitative accuracy is moderate because the conceptual flow and entity identification (ConocoPhillips, CVE shares, share repurchases) are correct, but execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 576,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nFrom the filings, the Omnibus Plan’s share reserve fell steadily: after the May 2022 amendment the plan began with roughly **117 million shares** available for future grants, that number had shrunk to **≈77 million shares** by the end of fiscal 2024 (January 28 2024) and to **≈70 million shares** by early 2025 (February 2 2025).  This decline reflects growing use of the plan for stock‑option, restricted‑stock, RSU and performance‑share awards—and for the shares repurchased under the company’s $15 billion buy‑back program—showing that Home Depot’s equity‑compensation capacity is being increasingly tapped and that future equity grants will be constrained by the dwindling reserve unless the share pool is expanded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and availability figures. According to the ground truth, 117 million shares were available in 2022, 77 million in 2023, and 70 million in 2024. However, the LLM incorrectly states that 117 million was post-May 2022 amendment (timing misaligned), then claims ≈77 million remained by end of fiscal 2024 (January 28, 2024), conflating 2023 and 2024 data. It further cites ≈70 million by early 2025 (February 2, 2025), which misrepresents the 2024 figure as belonging to 2025. These date and figure mismappings severely undermine quantitative accuracy. (2) The numbers themselves (117M, 77M, 70M) are correct in value but assigned to wrong years. The trend of decline is correctly identified, but the temporal evolution is misrepresented. The mention of a $15 billion buy-back program impacting share availability is unsupported by the original answer and introduces an irrelevant factor—stock buybacks do not reduce shares available for grants under omnibus plans; forfeitures and grants do. (3) The multi-hop reasoning partially works: the model recognizes a declining trend and infers increased utilization of equity compensation, which aligns with the ground truth. However, it fails to correctly map the year-to-year evolution (2022→2023→2024), instead presenting 2022→2024→2025, skipping 2023 entirely. This breaks the required synthesis across the three-year period. (4) Despite these issues, the core idea—that declining available shares indicate higher utilization and potential future constraints—is semantically aligned with the original answer’s conclusion. The contextual relevance is high because it addresses both the trend and its implication on compensation capacity. However, the quantitative inaccuracies and incorrect causal factors (buybacks) reduce overall correctness. Thus, correctness score is 6: partially correct with key errors in time-series alignment and extraneous, unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 537,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares in fiscal 2022** to **141 million shares in fiscal 2024** (an ≈11 % increase).  Although the pool of shares available for future grants slipped only modestly—from **27.38 million (2022) to 27.27 million (2024)**—the larger authorization signals that Accenture is deliberately expanding its equity‑compensation capacity to sustain a vigorous share‑based incentive program as it scales its workforce and growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 authorized share count (127 million) and the 2024 figure (141 million), which matches the ground truth. However, it omits the explicit confirmation that the authorization remained at 141 million in 2023, failing to fully address the year-by-year evolution from 2022 to 2024 as required. Additionally, the LLM introduces data not present in the ground truth—specifically, the 'pool of shares available for future grants' (27.38 million in 2022 and 27.27 million in 2024)—which are accurate but extraneous and not part of the original answer, potentially distracting from the core question. (2) The ≈11% increase calculation is approximately correct: (141 - 127)/127 ≈ 11.02%, so the percentage is acceptable. However, the inclusion of unrequested granular data on available shares (which were not asked for and not in the ground truth) reduces quantitative focus. (3) The reasoning about Accenture’s strategic expansion in equity compensation aligns with the ground truth and shows sound multi-hop interpretation—connecting increased authorization to long-term incentive strategy. However, the inference about 'scaling its workforce and growth initiatives' goes slightly beyond the original answer’s more conservative conclusion about aligning employee interests with shareholder value. (4) Despite minor overreach and inclusion of unsupported details, the LLM captures the key trend and strategic implication. The core facts are mostly correct, but the addition of unverified figures (available shares) and omission of 2023 data reduce quantitative accuracy. The answer remains contextually relevant and qualitatively strong in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 461,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on foreign government bonds and obligations rose from about **3.1 % in 2022** (as shown in the 2022 filing’s maturity‑yield table) to roughly **6.1 % in 2024** (the non‑U.S. portion of taxable investment securities in the 2024 “Distribution of Assets, Liabilities & Shareholders’ Equity” table). This near‑doubling indicates that American Express has shifted a larger share of its interest‑earning assets into foreign‑government debt, making its earnings increasingly sensitive to movements in international interest‑rate environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield on American Express's foreign government bonds and obligations was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states the 2022 yield as 3.1% and the 2024 yield as 6.1%, both of which are factually wrong. Additionally, the LLM omits the 2023 data point entirely, which is critical for understanding the trend. (2) The quantitative inaccuracies are severe: the correct yields are 5.86%, 6.45%, and 5.86% for 2022–2024, not 3.1% and 6.1%. The dollar amount ($630 million) is also missing from the LLM answer, though it was present in the original. The claim of a 'near-doubling' is based on incorrect inputs and thus invalid. (3) The multi-hop reasoning is flawed. The LLM appears to have misidentified or misread the data sources, possibly confusing different tables or categories (e.g., 'non-U.S. portion of taxable investment securities' instead of specifically 'foreign government bonds and obligations due within one year'). It fails to capture the peak in 2023 and the subsequent decline, which is central to the trend analysis. The conclusion about increasing exposure is not supported by the actual data, which shows a return to 2022 yield levels by 2024. (4) Contextual relevance is moderate because the answer addresses the general topic—yield trends on foreign government bonds and interest rate exposure—but the incorrect numbers and missing year undermine the validity. Due to major factual and quantitative errors, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy. Contextual relevance is higher because the structure and intent align with the question, even if the content does not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 496,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond holdings rose to 6.45 % in 2023 and slipped to 5.85 % in 2024, after a 2022 portfolio that was overwhelmingly short‑dated—about $628 million of the $630 million fair‑value was due within one year with only modest exposure beyond that. This progression shows the company deliberately extended duration and chased higher yields during the 2023 rate‑hike cycle, then began to de‑risk or rebalance as market rates plateaued in 2024, reflecting both its strategic response and the broader shift in interest‑rate conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $630 million total fair value in 2022, $628 million maturing within one year, 6.45% yield in 2023, and 5.85% yield in 2024—matching the ground truth exactly. These numbers are presented with acceptable formatting variations (e.g., spacing in $628 million) and remain factually accurate. (2) The answer addresses all parts of the multi-hop question: it traces the evolution of the yield profile from 2022 to 2024, incorporates the 2022 fair value distribution, and interprets the progression in yields. (3) Entity accuracy is strong: American Express is correctly identified, and the financial instruments (Foreign Government Bonds and Obligations), years (2022–2024), and metrics (weighted average yield, fair value) are all accurate. (4) The reasoning is largely sound and adds interpretive depth: the LLM infers a strategic extension of duration in 2023 to capture higher yields during rate hikes and a de-risking in 2024 as rates plateaued. While the ground truth does not explicitly state 'extended duration,' the inference is logically supported by the shift from a very short-dated 2022 portfolio to higher yields in 2023 and then a decline in 2024. The only minor gap is that the original answer emphasizes the 2023 yield being the highest among all categories, which the LLM omits—this contextual benchmark adds nuance to the strategic interpretation. However, this omission does not undermine the core correctness. Overall, the LLM provides a semantically equivalent, well-reasoned response with full quantitative fidelity and strong qualitative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 449,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings the 7% Debentures due 2029 appear only in the “Securities registered pursuant to Section 12(b)” table, listed identically as “7% Debentures due 2029” with CUSIP‑718507BK1 and shown as traded on the NYSE. The wording, formatting and any accompanying quantitative detail are unchanged across the three years, indicating that ConocoPhillips treats the debenture as a routine, fully registered security and relies solely on the standard registration table for its public disclosure. This consistent, unchanged presentation reflects a stable, compliance‑driven approach to reporting the instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of disclosure across the three years, leading to a severely incorrect conclusion. (1) Quantitatively, the CUSIP number (718507BK1) and the security name '7% Debentures due 2029' are correctly identified, and the NYSE listing is accurate—this supports a quantitative accuracy score of 6. However, the claim that the presentation was 'identical' and 'unchanged' across years is factually wrong. (2) According to the ground truth, in 2022 the debentures were listed alongside Common Stock without a separate row, implying less distinction; in 2023 and 2024, they were given their own row with explicit separation, indicating improved transparency. The LLM fails to detect this key change, missing the entire multi-hop progression. (3) The reasoning is flawed: instead of identifying an evolution toward clearer disclosure, the model asserts 'consistent, unchanged presentation' and a 'stable, compliance-driven approach,' which contradicts the ground truth showing intentional structural improvements in reporting clarity. (4) Contextually, the answer addresses the right document type (10-K) and the right security, so it is relevant, but it fails the core task of analyzing how disclosure evolved. The conclusion about 'routine' treatment and lack of change is unsupported. Due to major errors in entity interpretation and reasoning across years, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 404,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00% Notes Due 2031 retained a constant $1.25 billion carrying amount from fiscal 2022 through 2024, with the effective interest rate of 2.09 % and the weighted‑average remaining term shrinking from roughly 7 years to 6.4 years as the maturity approached. This unchanged, low‑coupon, long‑dated exposure demonstrates that the company is managing its long‑term debt by holding the senior unsecured notes to maturity rather than refinancing or retiring them, preserving cash and maintaining a stable, low‑cost financing base.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, decreased to $1.057 billion in 2023, and then increased to $1.25 billion in 2024. However, the LLM claims the amount was a constant $1.25 billion across all three years, which contradicts the actual progression. This error misrepresents the trend entirely. (2) The calculation and comparison of values are therefore incorrect. The ground truth shows a dip in 2023 followed by a rebound in 2024, suggesting possible repurchase or reissuance activity, whereas the LLM implies stability by asserting no change. The effective interest rate of 2.09% and the weighted-average remaining term (7 to 6.4 years) are not mentioned in the original answer and cannot be verified against the ground truth, so their inclusion introduces unconfirmed details. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year changes in debt exposure. Instead of identifying the fluctuation and interpreting what that might mean for debt management (e.g., active liability management), it incorrectly infers a strategy of holding to maturity due to 'unchanged' exposure, which is factually wrong. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right instrument, the correct company, and attempts to interpret the debt strategy in line with long-term financing. The qualitative logic would have been stronger had the numbers been accurate. Thus, while the structure and intent are sound, the factual foundation is not, leading to a low correctness score primarily due to severe quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 484,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Disney shifted Marvel from a primarily theatrical/linear‑network brand to a core driver of its direct‑to‑consumer offering—Marvel series and films now headline Disney+ (and, via the Star tier, international Disney+), while the Marvel trademark remains listed as an **indefinite‑lived intangible asset** (e.g., $1.79 bn of indefinite‑lived intangibles on page 114).  Consequently, Marvel’s IP is treated as a perpetual asset on the balance sheet, underscoring its strategic role in Disney’s streaming portfolio without being amortized.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Marvel's status as an indefinite-lived intangible asset in the relevant fiscal years and its strategic shift toward streaming, particularly on Disney+. It captures the core idea from the ground truth that Marvel is a key brand in both financial reporting and content strategy. However, it introduces a specific dollar amount—$1.79 billion—citing 'page 114'—which is not present in the original answer or supported by the provided context. This figure may be factually accurate in reality, but since it was not in the ground truth and cannot be verified from the given information, it constitutes a quantitative inaccuracy. (2) There are no calculations in the answer, but the inclusion of an unsupported numeric value undermines quantitative accuracy. The ground truth does not mention any specific valuation of Marvel within the intangible assets, so adding a precise number reduces precision in this evaluation context. (3) The multi-hop reasoning is sound: the model connects Marvel’s branding on Disney+ (a 2023 development) with its ongoing classification as an indefinite-lived intangible asset (noted in 2022 and 2024), demonstrating synthesis across time and domains (branding and financial reporting). This aligns well with the original answer’s logic. (4) Contextual relevance is high—the response directly addresses the evolution of Marvel’s strategic positioning across the three fiscal years, focusing on both streaming and intangible asset classification. The qualitative reasoning is strong, though slightly overstated with the unsupported figure. Thus, the correctness score is 7: the core facts and strategic narrative are correct, but the addition of unverified quantitative data prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 482,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nFrom 2022 through 2024 American Express continued to recognize discount revenue at the moment a Card‑Member transaction is settled, recording the network‑rate fee paid by third‑party merchant acquirers (e.g., under the OptBlue program) as part of that revenue; contracts with large merchants were typically multi‑year (three‑to‑seven‑year) with auto‑renewal clauses, whereas small‑merchant agreements remained open‑ended, giving the company flexibility to renegotiate fees and terms.  At the same time, the firm accelerated global merchant‑coverage expansion—using targeted marketing, digital onboarding and partnerships with acquirers to add merchants in high‑growth verticals and key international cities—while closely monitoring how competitive pressure and regulatory changes affect merchant‑discount rates and overall acceptance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements of American Express's revenue structure and contractual arrangements with third-party merchant acquirers from 2022 to 2024, particularly around discount revenue recognition and merchant coverage expansion. It accurately states that discount revenue is recognized at transaction settlement and includes network-rate fees from third-party acquirers (e.g., OptBlue), which aligns with the ground truth. The mention of multi-year contracts for large merchants and open-ended agreements for small merchants adds detail not in the original but does not contradict it. However, the LLM omits a critical evolution noted in the ground truth: the introduction of 'processed revenue' in 2023 from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards). This is a significant component of the revenue structure shift and represents a multi-hop element that the model fails to synthesize. (2) There are no specific numbers (e.g., percentages, dollar amounts, exact timeframes like '2023') misstated—the answer avoids quantifying what isn’t in the original, so quantitative accuracy is high. The reference to 'three-to-seven-year' contracts is plausible and consistent with industry norms, though not explicitly confirmed in the ground truth. (3) The reasoning is sound in tracking the continuity of discount revenue and expansion strategies, but it misses the 2023 inflection point where processed revenue was introduced, weakening the multi-hop synthesis across years. The strategic shift toward deeper collaboration with acquirers is partially captured but not fully articulated in terms of new revenue streams. (4) Contextual relevance is strong—the answer stays focused on the question and provides relevant details on revenue recognition, contracts, and expansion. The omission of processed revenue and the 2023 clarification limits completeness and qualitative accuracy, but core facts about discount revenue and merchant expansion are correct. Hence, correctness is reduced to 7 due to missing a key revenue evolution component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 574,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nAmgen’s 10‑K disclosures moved from a broad warning that its drug‑delivery devices are subject to FDA oversight and could trigger labeling changes or loss of approval (2022) to a more specific focus on concrete post‑marketing obligations—such as required feasibility studies, mandatory companion‑diagnostic clearances, and the risk that device‑related safety signals could delay or block product approvals (2023). By 2024 the language emphasized the direct dependence of clinical‑trial execution and commercial sales on the timely supply and regulatory clearance of these devices, warning that any device‑related safety finding or regulatory action could result in revised labeling, recalls or revocation of approval, thereby materially affecting the company’s financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution from general regulatory warnings in 2022 to more specific post-marketing and safety-related risks in 2023 and 2024 is accurately captured. The mention of FDA oversight, labeling changes, loss of approval, and impact on clinical trials and commercial sales reflects the core disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Amgen’s evolving risk disclosures across three years, correctly identifying the shift from broad device-related risks to specific dependencies on device clearance, post-marketing studies, and safety reviews. The reference to feasibility studies and companion diagnostics, while slightly more specific than the original, is consistent with the context of LUMAKRAS and confirmatory trials. (4) The LLM does not explicitly name LUMAKRAS or mention the Complete Response Letter, which are key specifics in the ground truth, slightly reducing qualitative accuracy. However, the overall semantic meaning and trend description—increased regulatory scrutiny, post-marketing obligations, and safety-driven enforcement risks—are preserved. The answer is fully contextually relevant, directly addressing clinical trial dependencies, post-marketing requirements, and device-related safety reviews as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 421,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips broadened the HSE audit scope from a purely operational safety focus to a company‑wide review that also covers emerging climate‑related and low‑carbon performance criteria.  The program now uses a formal improvement‑tracking system that assigns each audit finding to an owner, sets closure deadlines and records progress in a centralized register.  Governance reporting was strengthened by requiring regular audit‑result updates to the Executive Leadership Team and the Board of Directors, with the Board receiving a dedicated HSE performance dashboard as part of its risk‑oversight structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual inaccuracies in the description of ConocoPhillips' HSE audit program evolution. The LLM incorrectly states that the audit scope expanded to include 'climate-related and low-carbon performance criteria,' which is not supported by the ground truth; the original answer emphasizes Life Saving Rules, Process Safety Fundamentals, and stop work policies—not environmental or climate metrics. The claim about a 'formal improvement-tracking system' with owners, deadlines, and a centralized register, while plausible, adds specificity not present in the source: the ground truth only confirms that improvement actions were 'tracked to completion' without detailing mechanisms. The governance reporting description is partially correct—the ELT and Board received updates in all years—but the mention of a 'dedicated HSE performance dashboard' and integration into a 'risk-oversight structure' goes beyond the provided information. The original answer notes consistent reporting structures across years, not a 'strengthening' or new dashboard. The LLM fails to capture the actual evolution: from localized conformance (2022) to integration with human capital and safety systems (2023) to corporate-level standardization (2024). Instead, it invents a climate-focused expansion and over-specifies tracking mechanisms. While the answer addresses scope, tracking, and governance (ensuring moderate contextual relevance), the reasoning is not sound due to fabrication of details and incorrect drivers of evolution. Thus, the correctness score is 4—partially correct on governance, but major errors in scope and mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 491,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture shifted from largely time‑and‑material or fixed‑price contracts toward value‑based, consumption‑oriented and outcome‑linked pricing for its AI‑enabled and cloud‑centric offerings, attempting to align fees with the business impact of those technologies.  Across the three years the company repeatedly warned that a core risk is its inability to create pricing models that properly capture the value of rapidly evolving AI and cloud solutions—leading to delayed client spending, margin pressure, competitive pricing attacks, and potential regulatory or reputational costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and risks described in the ground truth. (1) It correctly identifies Accenture's shift from traditional pricing models (time-and-material/fixed-price) to value-based, consumption-oriented, and outcome-linked models in response to AI and cloud advancements—consistent with the 2022–2024 progression outlined. The consistent risk of failing to capture value from new technologies due to slow model deployment or low client adoption is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes Accenture’s evolving strategy across years and links it to technological drivers (AI, cloud) and associated risks. It condenses the progression—acknowledgment in 2022, strategic investment in 2023, deployment focus in 2024—into a coherent narrative, though slightly less explicit on year-by-year nuance (e.g., 'delays in client spending due to evaluation' in 2023 is generalized as 'delayed client spending'). (4) Semantic equivalence is strong: terms like 'value-based', 'consumption-oriented', and 'outcome-linked' align with 'pricing models that reflect the value of technological developments'. Risks such as margin pressure and competitive attacks are reasonable extensions of 'revenue shortfalls and competitive disadvantages'. The only minor shortcoming is slightly less specificity on Accenture’s increasing investment posture in AI by 2024, but the essence is preserved. Hence, correctness is 9/10—excellent but not perfect in granular year-by-year articulation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 472,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s exposure to AerCap moved from a sizable equity position to a lone debt holding.  In 2022 the company still owned a material equity stake in AerCap (the $944 million AerCap note and related equity gains/losses are reported in Note 19 and Note 21), and it recorded unrealized gains and losses on that investment.  By the end of 2023 GE had sold essentially all of those shares, receiving ≈ $6.6 billion in proceeds and leaving only the AerCap senior note (≈ $982 million) on its balance sheet – a figure that appears again in the 2024 fair‑value tables (Note 21, page 71).  The 2024 filings show the note still outstanding (≈ $982 million), with no remaining equity interest.  \n\nThis trajectory indicates that GE deliberately liquidated its equity investment in AerCap, converting the stake into cash and retaining only the senior note as a passive, interest‑bearing asset.  The move reflects a strategy of monetizing the AerCap position while limiting ongoing exposure, allowing GE to focus on its core aerospace, healthcare and energy businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM claims that in 2022 GE held a $944 million note and later in 2023 held a $982 million note, which contradicts the documented downward trend and misstates both the amounts and the direction of change. The LLM also introduces a $6.6 billion sale of shares and claims GE had a material equity stake, but the ground truth makes no mention of equity holdings or such a sale—only a note (debt) holding is referenced. (2) The numbers are therefore incorrect: the LLM reverses the timeline, inflates the note value in 2023, and fabricates a large equity divestiture not present in the original data. The claim of a $982 million note in 2023 and 2024 contradicts the ground truth’s $944 million figure. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic shift, it does so based on fabricated data (equity stake, sale proceeds, retained note value). The original answer supports a gradual reduction in exposure, but the LLM invents a dramatic equity-to-debt transition unsupported by the source. (4) Despite the incorrect facts, the answer is contextually relevant—addressing the evolution of holdings and interpreting strategy—and the reasoning structure is sound, just based on false premises. Hence, low quantitative accuracy (2), moderate qualitative reasoning (4), decent relevance (7), but overall correctness is severely compromised (3).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 452,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen moved bemarituzumab from the start of its first Phase 3 study (identified in the February 2022 “Phase 3 Program Changes” table) into a fully enrolled Phase 3 program that continued through 2023‑2024, with additional data read‑outs and regulatory interactions (e.g., the 2021 Breakthrough‑Therapy designation and ongoing FDA interactions).  Throughout this period the company’s composition‑of‑matter patent filings for bemarituzumab in the United States and Europe remained unchanged, both showing an estimated expiration in 2029 (U.S. 2029, Europe 2029), with the caveat that term adjustments or supplemental protection certificates could extend exclusivity.  Thus, while the clinical‑development timeline advanced from Phase 3 initiation to later‑stage Phase 3 activity, the IP protection for the molecule stayed anchored to the 2029 expiration estimate.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains some discrepancies compared to the ground truth. (1) Quantitatively, the patent expiration dates (2029 for both U.S. and Europe) are accurate and match the original answer. The mention of Phase 3 trials starting around 2022 and continuing through 2023–2024 aligns broadly with the timeline, though the original answer does not specify 'first Phase 3 study' or 'fully enrolled' status—details not confirmed in the ground truth. The reference to a 2021 Breakthrough Therapy designation is factually inconsistent with the 2022–2024 scope of the question and introduces information outside the provided knowledge graph. (2) Calculations are not applicable here, but date references are mostly consistent except for the out-of-scope 2021 event. (3) Qualitatively, the LLM captures the evolution in clinical development and stable IP timeline, but misses key 2024 developments noted in the original answer: the expanded investigational scope to gastric cancer, GEJ cancer, and advanced solid tumors beyond NSCLC, and a more detailed mechanism of action. These omissions reduce completeness and multi-hop synthesis accuracy. (4) Contextually, the answer remains highly relevant, focusing on clinical progression and IP, but overemphasizes enrollment status and regulatory interactions not in the ground truth while omitting the strategic expansion of therapeutic indications in 2024. Thus, while core facts about Phase 3 and 2029 patents are correct, missing elements and one extraneous detail prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 425,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures shift from warning‑only language about “intense competition” and “alternative payment mechanisms” toward a concrete strategy of sustained technology spending and partnership‑driven innovation.  Across the 2022‑2024 10‑K filings American Express repeatedly cites the need to invest in AI, cybersecurity, real‑time settlement, open‑banking and digital‑wallet integrations, while also expanding joint‑venture and minority‑investment initiatives to stay embedded in emerging fintech ecosystems.  This evolution reveals a long‑term response that preserves its premium, data‑rich brand but increasingly relies on heavy‑weight technological investment and strategic alliances to offset fintech disruption and maintain competitive relevance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. It correctly identifies the shift from viewing alternative payment mechanisms as competitive threats to adopting a proactive, investment-driven strategy involving technology and partnerships. Key elements such as AI, cybersecurity, real-time settlement, open banking, and digital wallet integrations are correctly cited as areas of investment, aligning with the ground truth's emphasis on tokenization and integration of emerging technologies. The answer also accurately reflects the long-term response to fintech disruption through strategic alliances and technological adaptation. While the original answer more explicitly details the annual progression—especially the 2023 expansion to include open banking and payment facilitators, and the 2024 shift to 'dependency'—the LLM captures the semantic essence of this evolution without misrepresenting facts. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect figures are presented), and all entities (American Express, fintech disruption, open banking, etc.) are correctly referenced. The reasoning is sound and synthesizes multi-hop insights across years, though slightly less granular in year-by-year framing than the original. Wording differs but meaning is substantively equivalent, meeting semantic equivalence standards. Minor deduction in qualitative accuracy due to less explicit articulation of the shift from 'threat' to 'dependency,' but overall logic and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 438,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs climbed from **$91.6 million in 2022 to $112.5 million in 2023**, then eased slightly to **≈$110.4 million in 2024**.  \n\nThis upward‑then‑stable trajectory shows the company is deliberately raising the equity‑linked value of its long‑term incentive awards—moving away from legacy stock‑option grants and toward higher‑priced, performance‑based cash‑settled PSUs—thereby reinforcing a more predictable compensation expense while emphasizing sustained performance‑driven rewards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the timeline. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, with no data provided for 2023. However, the LLM incorrectly reports values in millions (e.g., $91.6 million instead of $91.58), which misrepresents the unit—these are per-unit fair values, not total dollar amounts. It also fabricates a 2023 value of $112.5 million and a 2024 value of ~$110.4 million, contradicting the ground truth's $112.50 in 2024. (2) The numbers are quantitatively inaccurate: the LLM inflates the magnitude by reporting millions instead of per-unit values and introduces a false downward trend in 2024, while the actual trend is consistently upward. There is no evidence of a decline. (3) The reasoning is partially sound in interpreting the trend as a strategic shift toward performance-based incentives, which aligns with the ground truth’s conclusion. However, the multi-hop synthesis fails because the model misreads the metric (total value vs. per-unit fair value) and invents intermediate data points without support. (4) The contextual relevance is moderate—the answer addresses the right topic (incentive strategy evolution) and draws a plausible qualitative conclusion, but the incorrect data undermines the validity. Due to major factual and quantitative errors, especially the misrepresentation of units and fabricated figures, the correctness score is low at 3. Quantitative accuracy is severely compromised (2), qualitative reasoning is somewhat logical but based on false premises (4), and relevance is acceptable (6) as the general direction of analysis matches the question intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 474,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s filings show a steady escalation in references to fraud and abusive behavior—especially around its credit‑product portfolio (BNPL, merchant‑financing receivables and consumer credit) and the third‑party lenders, payment processors and network partners that underpin those products.  The company repeatedly notes rising losses from buyer‑/seller‑protection programs, increasing default risk on credit receivables, and the difficulty of detecting synthetic‑identity and other fraud schemes that exploit its digital‑wallet platform, indicating that the rapid growth of credit offerings and reliance on external partners are outpacing the effectiveness of its current risk‑management controls.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolving concern around abusive behaviors and fraud at PayPal from 2022 to 2024, particularly in relation to credit products and third-party fraud schemes. It accurately reflects the increasing risk associated with BNPL, merchant financing, and consumer credit, as well as challenges in detecting synthetic identity fraud and losses from buyer/seller protection programs—consistent with the ground truth's emphasis on digital fraud and detection difficulties. There are no numeric values in the LLM answer, so quantitative accuracy is not compromised (score 10). However, the LLM omits key specific evidence from the original answer, notably the €40 billion multi-year agreement to sell U.K. and European BNPL receivables in 2023, which is a critical data point demonstrating PayPal’s strategic risk mitigation. Additionally, the mention of regulatory uncertainty around the 'valid-when-made doctrine' affecting U.S. credit products in 2024 is missing, weakening the completeness of the multi-hop synthesis across years and risk dimensions. While the LLM captures the general trend of growing exposure and strain on risk controls, it does not fully convey PayPal’s proactive third-party risk transfer strategies or regulatory dependencies highlighted in the ground truth. Thus, while the reasoning is logically sound and contextually relevant, the qualitative accuracy is reduced due to missing key factual anchors that define the evolution of PayPal's risk management approach. The answer remains semantically aligned in direction but lacks specificity in strategic actions and regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 445,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 the label for Cyramza shifted from a primarily second‑line agent across several tumor types toward a stronger emphasis on earlier‑line, biomarker‑driven use—most notably first‑line combination therapy for EGFR‑mutated metastatic NSCLC and monotherapy for HCC—reflecting Lilly’s effort to capture premium, front‑line revenue.  Patent protection remained anchored by a U.S. compound patent that expires in 2026, with extensions to 2028 in Europe and 2026 in Japan, complemented by data‑protection periods that run to 2026‑2028, thereby preserving exclusivity well into the second half of the decade.  This evolution underscores Lilly’s long‑term oncology strategy of extending the commercial life of its flagship assets through strategic indication expansion and robust IP shielding while reinvesting the generated cash flow into next‑generation pipeline innovations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While both mention Cyramza's role in oncology and patent expiry in 2026 in the U.S. and Japan, the LLM incorrectly states that there was a shift in therapeutic positioning toward earlier-line, biomarker-driven use, including first-line combination therapy for EGFR-mutated NSCLC and monotherapy for HCC. The original answer states no new indications were added in 2024 and that the therapeutic positioning was reaffirmed across existing cancer types, contradicting the claim of a strategic shift. (2) Quantitatively, the LLM introduces incorrect patent expiration dates: it claims extensions to 2028 in Europe and 2026–2028 for data protection, but the ground truth only confirms U.S. and Japan compound patents through 2026 and notes data protection expiring as early as 2023 in Japan—no mention of European patents or extensions to 2028. These dates are fabricated or hallucinated. (3) The multi-hop reasoning is partially sound in linking IP protection and therapeutic positioning to long-term strategy, but it is based on incorrect premises. The conclusion that Lilly is extending commercial life through indication expansion is contradicted by the ground truth, which states no new indications were added. The synthesis fails because it assumes evolution where the truth indicates maintenance. (4) Despite these issues, the answer is contextually relevant and addresses the question's structure—discussing both therapeutic positioning and IP over time and linking to strategy—earning moderate scores in qualitative accuracy and relevance. However, the core facts are incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 475,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris kept the 3.875 % Notes due 2042 as a steady, long‑dated anchor in its capital structure, while actively issuing, swapping and retiring a rotating set of shorter‑maturity notes (e.g., 2.875 % 2029, 4.375 % 2041, 4.5 % 2042, 2.75 % 2026, etc.).  This “active‑management” of the other debt instruments let the company reshape its maturity ladder, lower funding costs and extend average debt tenor, all while preserving the 3.875 % 2042 issue as the consistent long‑term component of its financing mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core idea of Philip Morris maintaining the 3.875% Notes due 2042 as a stable long-term debt instrument while actively managing other debt, which aligns with the ground truth and shows contextual understanding. However, there are significant factual inaccuracies in the quantitative details. The LLM cites specific instruments such as the 2.875% 2029, 4.375% 2041, 4.5% 2042, and 2.75% 2026 notes, which are not mentioned in the original answer and are not supported by the knowledge graph. The ground truth specifies that in 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043; in 2023, it added 4.250% Notes due 2044; and by 2024, these 2043 and 2044 tranches were retired or refinanced with no new long-dated notes introduced. The LLM fails to mention these specific instruments and instead fabricates others, indicating a failure in multi-hop synthesis across the actual filings. While the general strategy of active management and maturity ladder optimization is plausibly interpreted, the incorrect debt instruments undermine quantitative and qualitative accuracy. The reasoning is partially sound but based on incorrect data, leading to a misleading portrayal of the capital structure evolution. Thus, the answer is semantically related but factually inconsistent with the ground truth, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 380,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior—particularly fraud, illicit use of its platform, and credit‑product defaults—remained a core risk, but the company shifted from relying mainly on internal fraud‑prevention and buyer‑seller protection toward more proactive risk‑transfer and third‑party diversification. In 2023 it entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables and began migrating its primary U.S. payment‑processor relationship to reduce dependence on a single third‑party, while also tightening underwriting and expanding its buyer‑protection program. In 2024 it continued the receivables‑sale program, accelerated the processor migration, and strengthened its fraud‑detection and merchant‑financial‑health monitoring (including stricter credit‑risk models and enhanced oversight of third‑party lenders) to mitigate abusive behavior and limit losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's identification of abusive behaviors in credit products, the 2023 multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, and continued risk mitigation in 2024 through enhanced fraud detection and third-party oversight. The numbers (€40 billion) and years (2022–2024) are accurate. (2) Quantitative accuracy is perfect—no calculations were required, and the €40 billion figure matches exactly. Format (€ vs EUR) is acceptable. (3) The reasoning is sound and reflects multi-hop synthesis: the evolution from risk identification (2022) to risk transfer (2023) and infrastructure enhancement (2024) is correctly captured. The LLM adds slightly more detail (e.g., U.S. processor migration, buyer-protection expansion, merchant monitoring), which is plausible and contextually consistent, though not in the original answer. These additions do not contradict but extend the narrative. (4) The answer fully addresses all parts of the question: evolution of exposure, relation to credit products and third-party risk, and specific actions in 2023 and 2024. The only minor deviation is the inclusion of processor migration and underwriting tightening, which are not in the ground truth—this slightly affects qualitative accuracy but not correctness, as they are reasonable risk-mitigation actions and do not conflict with known facts. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 427,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 Form 10‑K filings the “loss or modification of exemptions for taxes and tariffs” risk appears in the “General Risks” section each year, but the 2023 and especially the 2024 disclosures expand the language to cite recent U.S. and international sanctions, export‑control revisions and heightened geopolitical tensions (e.g., Ukraine, China‑Taiwan). This progression shows that AMD views its tax‑ and tariff‑exemption environment as increasingly volatile and subject to regulatory change, signaling growing uncertainty in its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that AMD consistently disclosed the risk of loss or modification of tax and tariff exemptions across 2022, 2023, and 2024, with increasing emphasis—this matches the original answer's timeline and evolution. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes the trend across three years and correctly infers increasing regulatory uncertainty based on expanded risk language, including references to geopolitical tensions and export controls. It goes slightly beyond the original by naming specific regions (Ukraine, China-Taiwan), which are reasonable inferences given AMD’s global operations and public regulatory context, and do not contradict the ground truth. (4) The answer captures the core trend—escalating concern over regulatory changes affecting tax and tariff exemptions—and links it to growing operational uncertainty, which is semantically equivalent to the original. The only minor gap is that the original explicitly states AMD 'elevated the risk' and 'linked it to ongoing geopolitical conflicts' in 2024, while the LLM implies this through 'heightened geopolitical tensions'; this nuance is present but slightly less precise. Overall, the answer is highly accurate, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 424,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return‑swap results for its deferred‑compensation hedge shifted from a $92 million loss in fiscal 2022 to gains of $58 million in fiscal 2023 and $91 million in fiscal 2024.  This progression shows the company’s derivatives used to economically offset deferred‑compensation liabilities moved from cost to profit, indicating a deliberate strategy to manage and reduce earnings volatility associated with those compensation obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024—matching the ground truth exactly. There are no numerical or date inaccuracies. (2) Quantitative accuracy is perfect; all dollar amounts and year labels are correct, and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a trend—from loss to increasing gains—indicating improved performance or strategy around deferred compensation derivatives. The conclusion about reducing earnings volatility is logically consistent with the data and represents a reasonable interpretation, though slightly more focused on 'strategy' than the original answer’s broader 'exposure or performance' and 'market conditions' mention. (4) The answer is contextually fully relevant, addressing both parts of the question: the evolution of gains/losses and the implication for Cisco’s strategy or exposure. The only minor shortcoming is that it omits the possibility of external factors like 'improved market conditions' as a contributing cause, instead emphasizing deliberate strategy, which makes the qualitative reasoning slightly less balanced than the original. However, this does not make it factually incorrect, just slightly narrower in interpretation. Hence, a 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 412,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney shifted from an initial DTC launch to a coordinated, multi‑year strategy that reorganized its media unit into a dedicated DMED group, invested billions in original programming and sports rights (e.g., the Star India joint venture), and introduced an ad‑supported Disney+ tier and bundled pricing while aggressively managing costs. This evolution highlights the steep financial risks of scaling streaming—substantial upfront capital outlays and content‑impairment exposure, intense competitive pressure that forces continual price‑and‑churn management, and the need to generate subscriber growth and advertising revenue to offset declining linear‑network fees and maintain cash‑flow stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Disney's DTC offerings from 2022 to 2024 and correctly identifies key elements such as investment in original content, ad-supported tiers, bundling, cost management, and competitive pressures. It accurately reflects the financial risks associated with scaling streaming services, including high upfront costs, content impairments, pricing and churn challenges, and declining linear network revenues. However, it does not explicitly map the progression year-by-year as required by the question and the original answer. Specifically: (1) It omits Disney’s 2022 acknowledgment of growing losses and uncertainty about returns; (2) It does not clearly identify the 2023 strategic shift toward active investment despite declining linear subscribers; (3) It fails to mention the 2024 emphasis on competitive pressures like rising costs and pricing constraints. While the LLM includes plausible details (e.g., DMED reorganization, Star India joint venture, ad-tier introduction), these are not present in the ground truth and may reflect plausible inference rather than verified facts from the knowledge graph. There are no numerical inaccuracies (quantitative accuracy is high because no incorrect numbers are cited), but the qualitative accuracy is reduced due to lack of precise year-to-year alignment and over-reliance on inferred strategic actions. The reasoning is logically sound and contextually relevant, but lacks fidelity to the specific multi-hop progression outlined in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 424,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s filings for 2022, 2023 and 2024 all describe the same economics: the company authorizes each payment, bears the full margin risk, records any processor‑related fees as a separate “transaction expense,” and retains full discretion to set the fee charged to the customer independent of those costs (see PYPL_10K_2023.pdf pp. 75‑76; PYPL_10K_2024.pdf pp. 73‑74; PYPL_10K_2022.pdf p. 78).  The only evolution across the three years is the 2024 adoption of ASU 2023‑07, which added required segment‑expense disclosures but did not alter the underlying margin‑risk model or fee‑setting discretion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All key facts are accurately conveyed: PayPal bore full margin risk across 2022–2024, maintained discretion in setting fees independent of processor costs, and recorded processor fees as transaction expenses. The only change noted—adoption of ASU 2023-07 in 2024—is correctly identified and contextualized as a disclosure-related update that did not alter the underlying economic or accounting model. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all references to years (2022, 2023, 2024) and accounting standards (ASU 2023-07) are factually correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years of 10-K filings, identifies continuity in risk exposure and accounting treatment, and correctly isolates the segment reporting change as non-substantive to margin risk. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in margin risk exposure in relation to fee-setting discretion and transaction expenses. Minor differences in phrasing (e.g., 'same economics' vs 'remained stable') do not affect factual accuracy. All components of the question are addressed with complete fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 391,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures show the cancellation risk receding: in the 2022 filing the “Customer Risk” paragraph warned that COVID‑19‑driven demand weakness could cause customers to **delay, suspend or cancel** aircraft contracts and even lead to long‑term deterioration in air‑travel demand; by 2023 the language was softened to note that **downturns in global air‑travel demand may lead to delays or cancellations**, reflecting a still‑present but less urgent concern; and in the 2024 filing the same risk is mentioned only as a generic “downturn … may impact new‑aircraft production or result in delay or cancellation,” with no reference to pandemic‑related suspension of operations.  \n\nThis progression signals that the acute threat of widespread aircraft‑order cancellations tied to COVID‑19 has faded as air‑travel demand rebounds, order backlogs firm and the commercial‑aviation sector moves toward a more stable, post‑pandemic baseline.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and uses accurate terminology and correct years (2022–2024), with no numeric inaccuracies (quantitative accuracy is perfect as no actual numbers are involved and dates are correct). However, the core reasoning and qualitative analysis directly contradict the ground truth. The original answer states that Honeywell *consistently highlighted* order cancellations as a key risk, with evolving but persistent concerns—indicating ongoing fragility in the sector. In contrast, the LLM interprets the changing language as evidence that the risk is *receding* and the sector is moving toward stability, which misrepresents the intended inference. The ground truth emphasizes continuity of risk and structural uncertainty, while the LLM sees de-escalation. This is a critical error in multi-hop reasoning: the model incorrectly infers diminishing concern from linguistic softening, whereas the original analysis treats the persistent mention of cancellations—now tied to broader macro risks—as evidence of sustained vulnerability. Thus, while contextually relevant and well-structured, the LLM fails on qualitative accuracy due to flawed synthesis and incorrect interpretation of risk evolution, leading to a partially correct but ultimately misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 359,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings, PMI repeatedly warns that product‑related regulations—plain‑packaging mandates, flavor bans, advertising restrictions and the requirement for scientific substantiation—are increasingly curtailing its ability to differentiate its Reduced‑Risk and Smoke‑Free Products and to convey truthful, non‑misleading information to adult smokers.  This reflects a deepening regulatory environment that forces the company to rely more on conversion incentives and less on traditional branding, underscoring the intensifying constraints on product differentiation and adult‑consumer communication.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core theme from 2022 to 2024—increasing regulatory constraints on PMI's ability to differentiate its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs) and to communicate truthful information to adult consumers. It accurately reflects that regulations such as plain packaging, flavor bans, advertising restrictions, and scientific substantiation requirements are key drivers. These elements are consistent with the ground truth. However, the LLM answer lacks the year-by-year evolution emphasized in the original answer. Specifically, it does not capture the shift in PMI’s language from RRPs in 2022 to SFPs in 2024, nor does it mention the growing concern about digital misinformation in 2023 or the claim of disproportionate impact relative to competitors. These omissions reduce completeness and qualitative accuracy. (2) There are no numeric values, dates, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is partially sound: the LLM synthesizes regulatory impacts across product types and communication strategies, but fails to trace the evolution across the three years as required by the question. The answer generalizes across 2022–2024 without showing how the focus and framing changed over time, which is central to the original answer. (4) Contextual relevance is high because the response addresses product regulation, differentiation, and adult consumer communication—all key themes. However, the lack of temporal progression and strategic shift from RRPs to SFPs limits full alignment with the ground truth. Thus, correctness is reduced to 7 due to missing nuanced evolution, despite accurate overall framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 493,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal consistently bore full margin risk on every payment it authorizes—recognizing transaction fees on a gross basis and expensing the fees paid to payment processors as transaction expense—while its tiered, volume‑based pricing was repeatedly described as not creating a material future right.  The company’s accounting for customer incentives evolved: earlier disclosures merely noted that incentives reduced revenue, but by 2023‑24 it explicitly classified incentives that are consideration payable to a customer as a reduction of revenue (and amortized those not tied to performance), providing clearer guidance on how such incentives affect margin.  Consequently, the underlying exposure to margin risk remained essentially unchanged, but the transparency and specificity of its disclosure around pricing, processor fees, and incentive treatment increased across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bore full margin risk from 2022–2024, recognized transaction fees on a gross basis, and expensed payments to processors. The evolution in disclosure around customer incentives—from general reduction of revenue to more specific accounting treatment (amortization over contract term or based on performance)—is accurately captured for 2023–2024. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all dates (2022, 2023, 2024) are correctly used and referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and topics (pricing models, processor use, incentives), correctly identifying that while the fundamental margin risk exposure remained stable, the transparency and specificity of disclosures increased. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 point about the independence of customer fees from processor costs—a detail present in the original answer that adds nuance to how pricing models relate to margin risk. However, this omission does not undermine the core correctness. Overall, the LLM conveys semantic equivalence with slightly less detail on pricing model dynamics in 2024. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 418,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the safeguards it offers AIB makers—its contracts now guarantee price‑protection and explicit return‑rights (including limited stock‑rotation clauses) that shield AIB inventory from unexpected price cuts or product discontinuations, a shift that began with the 2022‑year agreements and was reinforced in the 2023‑2024 filings.  At the same time, AMD has continued to leverage discrete graphics as the primary differentiator for system integrators, encouraging SIs to build “GPU‑enabled” platforms that can command higher margins and distinct market positioning, thereby turning the GPU into a core source of product differentiation rather than a commodity component.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the key themes from the ground truth: AMD's inventory protection for AIB manufacturers and the role of discrete graphics as a differentiator for system integrators (SIs). It correctly identifies the continuation of inventory protection from 2022 through 2024 and emphasizes discrete GPUs as a strategic differentiator for SIs, aligning with the original answer. However, there are notable discrepancies in qualitative accuracy. The LLM introduces specific contractual details—'explicit return-rights' and 'limited stock-rotation clauses'—that are not present in the original answer and cannot be verified from the provided ground truth. These additions suggest a higher level of contractual specificity than the source material supports, which only states that AMD 'consistently emphasized inventory protection' without detailing mechanisms. Additionally, while the original answer notes a subtle shift in 2024 toward strategic alignment with SIs based on regional or product strengths and responsiveness to new tech, this nuance is missing in the LLM response. Instead, the LLM generalizes the trend without capturing the evolving emphasis on SI agility and regional strategy. There are no numerical values in either answer, so quantitative accuracy is scored as 10 by default (no errors in numbers, dates, or calculations). Contextual relevance is high, as the response directly addresses both parts of the multi-hop question—AIB relationship evolution and SI differentiation via discrete graphics. The reasoning is sound but lacks full synthesis of the 2024 strategic shift, resulting in a correctness score of 7: core facts are accurate, but some details are over-specified or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 476,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney kept the same baseline safeguards for its investment‑credit exposure: it transacted only with counterparties rated A‑ or higher and required collateral (or other mitigation) if a rating fell below A‑ or if exposure limits were breached.  The company also imposed a limit that no single financial institution could hold more than 10 % of its cash and cash‑equivalents.  In the 2022 and 2023 filings it reported **no** such balances exceeding the 10 % threshold, but by the end of fiscal 2024 it disclosed that certain institutions held **24 %** of total cash, indicating that the concentration ceiling was effectively relaxed while the A‑ rating and collateral requirements remained in force.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained A- or better counterparty rating requirements and collateral triggers throughout 2022–2024. The 24% concentration in a single institution by fiscal 2024 is correctly reported, with no such concentration in 2022. (2) Quantitative accuracy is perfect: the 24% figure is correctly cited, and the implied contrast with 'no' concentration in prior years matches the original. The mention of a 10% threshold, while not explicitly stated in the ground truth, is a reasonable inference from standard industry practices and consistent with the context of concentration risk management; its inclusion does not contradict the source and supports the conclusion that the threshold was effectively relaxed. (3) Multi-hop reasoning is sound: the model correctly synthesizes policy continuity (credit ratings, collateral) with evolving concentration trends, inferring a strategic shift despite stable credit policies. (4) The answer is contextually complete and relevant, addressing all three aspects of the question—counterparty ratings, collateral, and concentration thresholds—with accurate temporal evolution. The only minor deduction is for introducing the specific '10%' threshold not explicitly mentioned in the ground truth, though it does not distort the overall correctness. Thus, the answer is factually solid, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 409,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nAcross the three fiscal years the company’s outstanding Fixed‑rate 2.850 % notes that mature on 10/1/2029 stayed at $1.5 billion in 2022, 2023 and again in 2024—there were no repayments, reductions, or additional issuances of that tranche reported in any of the disclosed tables. This steady, unchanged exposure shows that PayPal is deliberately retaining this low‑cost, long‑dated debt as a core, stable funding pillar, while supplementing its overall financing mix with revolving credit facilities and newer note issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion across 2022, 2023, and 2024, which matches the ground truth exactly. The maturity date (10/1/2029) is an additional precise detail not in the original answer but consistent with likely filing data and does not contradict it. The dollar amount is accurately represented as $1.5 billion (equivalent to $1,500 million). (2) All numeric values—interest rate (2.850%), amount ($1.5 billion), and years (2022–2024)—are correct and quantitatively accurate. No calculations were required, but the consistency across years is correctly observed. (3) The reasoning is sound: the LLM infers that the unchanged liability suggests a strategic decision to retain low-cost debt, which aligns with the original answer’s interpretation about preserving favorable terms. It adds context about supplementing with revolving credit and new issuances, which is plausible and consistent with the ground truth mention of new debt in 2023 and 2024. However, the original answer specifically notes the issuance of higher-interest notes in 2024 (5.150% and 5.500%), a detail omitted in the LLM response, slightly reducing qualitative completeness. (4) The answer is contextually fully relevant, directly addressing both the evolution of exposure and the strategic implication. The minor omission of specific new note rates prevents a perfect 10, but the core multi-hop synthesis—linking stable debt levels to strategic funding management—is correctly executed. Thus, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 470,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Performance Materials and Technologies segment moved from “rising material costs and isolated supply constraints” (2022 – page 29‑30) to “heightened exposure to volatile commodity prices, inflationary pressures and geopolitical‑driven supply shocks, with many key inputs still sourced on a single‑ or sole‑basis” (2023 – page 31‑33; 2024 – page 31‑32).  Although Honeywell introduced longer‑term contracts, pricing actions and supply‑tracking tools to mitigate these risks, the continued reliance on limited supplier networks and the persistence of raw‑material price swings reveal that the segment remains highly vulnerable to commodity‑market volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and includes accurate phrasing regarding supply chain risks and mitigation efforts, but it diverges significantly from the ground truth in key aspects of the evolution of Honeywell's risk exposure. (1) Correct elements: The answer correctly identifies rising material costs in 2022 and increased emphasis on commodity volatility and supply shocks in 2023–2024. It also accurately notes mitigation strategies like longer-term contracts and pricing actions. There are no numeric inaccuracies, so quantitative accuracy is high. (2) However, the LLM introduces details not present in the original answer: specifically, 'rising material costs and isolated supply constraints' and 'single- or sole-source inputs' are not mentioned in the ground truth for 2022–2024. More critically, the rebranding of the segment to 'Energy and Sustainability Solutions' in 2024 — a key factual pivot in the original answer — is entirely omitted. (3) The multi-hop reasoning is partially sound — it traces a trend of increasing risk exposure — but fails to synthesize the strategic repositioning and reframing of the risk in the context of production capacity and downtime, which is central to the 2024 update. (4) While the conclusion about sustained vulnerability aligns with the original, the absence of the segment rebranding and mischaracterization of the evolving risk framing reduces qualitative accuracy. The answer remains contextually relevant and addresses the core theme of vulnerability to commodity volatility, but lacks key structural and contextual details required for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 440,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a listed member of PMI’s peer group in each filing (see the 2022 10‑K page 21 list, the 2023 10‑K page 26 graph description, and the 2024 10‑K page 26 text, which all state the peer group is unchanged).  This continuity shows that PMI’s benchmarking strategy is to use a stable, globally diversified set of tobacco‑and‑consumer‑product companies of comparable size and market capitalization—including Imperial Brands—as a consistent reference point for assessing its relative financial and shareholder‑return performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Imperial Brands PLC remained in PM's peer group across all three years (2022–2024), which matches the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation, but the years and references to specific 10-K pages (2022 p.21, 2023 p.26, 2024 p.26) support the factual basis and demonstrate precise sourcing—this level of detail exceeds but does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to infer stability in the peer group, leading to a valid conclusion about PM's benchmarking strategy. (4) The answer addresses both parts of the question: the trajectory (unchanged inclusion) and the strategic implication (stable benchmarking with comparable global firms). Wording differs slightly (e.g., 'globally diversified set' vs 'similar global presence'), but the meaning is equivalent. All entities—Imperial Brands PLC, PM (referred to as PMI, which is accurate), and the time period—are correctly identified. No factual errors, omissions, or reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 340,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nFrom the 2022‑2024 filings the company’s outstanding balance of the 2.850 % fixed‑rate notes stayed constant at **$1.5 billion** (the notes maturing 10/1/2029 are listed as $1,500 million in the 2022, 2023 and 2024 “Outstanding principal amount” tables and are still scheduled to be repaid in 2029).  No repayments, write‑downs or increases of that series are reported, indicating that PayPal is maintaining this long‑dated, low‑cost tranche as a stable pillar of its capital structure while supplementing overall funding with newer issuances and revolving facilities.  This steady exposure reflects a deliberate long‑term debt‑management strategy that ladders maturities and preserves a sizable fixed‑rate base while managing interest‑rate and refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: the $1.5 billion outstanding balance of the 2.850% fixed-rate notes remained unchanged from 2022 through 2024, with no repayments or refinancing actions. The note matures on 10/1/2029, consistent with the filings. (2) Quantitative accuracy is precise: $1.5 billion is correctly equated to $1,500 million, and the amount is confirmed across all three years. No incorrect calculations or misstatements. (3) The multi-hop reasoning is sound—synthesizing data across three years of filings to observe stability in the debt balance, and correctly inferring strategic implications such as maintaining a low-cost, long-dated liability to manage interest rate and refinancing risk. (4) The answer addresses both parts of the question: the evolution of exposure (stable) and what it indicates about PYPL’s long-term debt strategy (deliberate maintenance of fixed-rate debt as a stable capital structure component). The interpretation—laddering maturities, preserving fixed-rate base—is semantically equivalent to and expands reasonably upon the ground truth. Wording differs but meaning and factual content match exactly. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 352,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips moved its HSE audits from a stand‑alone compliance check to a fully integrated governance process.  The audit scope was broadened to cover all business units and staff groups, and audit findings are now tied to concrete improvement actions that are tracked, reported to the Executive Leadership Team and the Board, and fed into the company’s ESG, HCM and safety‑culture initiatives.  This evolution ensures that conformance tracking is directly overseen by senior leadership and embedded in the firm’s overall corporate‑governance framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of ConocoPhillips' HSE audit approach from 2022 to 2024 with accurate qualitative details and proper multi-hop synthesis. (1) All entities—ConocoPhillips, HSE audits, Executive Leadership Team, Board—are correctly identified, and no incorrect years or metrics are introduced. (2) There are no numeric values (e.g., dollar amounts, percentages, counts) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The reasoning is largely sound: the LLM correctly identifies the broadening of audit scope, tracking of improvement actions, reporting to ELT and Board, and integration with governance. However, it omits the specific progression noted in the ground truth: in 2022 audits were conducted across units with tracking; in 2023, outcomes were explicitly linked to annual objectives and deadlines; in 2024, audits were specified as corporate-level, indicating centralization. The LLM generalizes this evolution without clearly delineating the year-by-year refinement, particularly missing the 2024 emphasis on corporate-level audits as a sign of centralized oversight. (4) Despite this omission, the answer conveys the core trend—integration of HSE audits into governance and strategic tracking—and remains contextually accurate and relevant. Thus, correctness is high but not perfect due to missing granular evolution details, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 397,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAMD still lists the 2011 Executive Incentive Plan as a key exhibit in each filing – it appears as Exhibit 10.1 (or 10.2) in the 2022 10‑K (pages 91‑95), is again incorporated by reference in the “Executive Compensation” section of the 2023 Proxy Statement (pages 99‑103), and continues to be cited in the 2024 10‑K (pages 96‑100) as the underlying governance framework for executive incentives.  While the plan remains the foundational document governing base salary, bonus and equity‑based incentives, AMD’s disclosures in 2023 and 2024 broaden the scope by adding supplemental performance‑based RSU/PSU programs and noting recent amendments, positioning the 2011 plan as the base layer within a more extensive executive‑compensation structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: AMD consistently referenced the 2011 Executive Incentive Plan across 2022–2024 as a foundational governance document, and it was cited in each year’s filings (10-K or Proxy Statement). The answer correctly identifies the exhibit number (10.1 or 10.2) and page ranges, which are consistent with typical SEC filing structures, though the ground truth does not specify page numbers—this detail is plausible but not verifiable from the original answer. The claim that the plan governs base salary, bonus, and equity incentives is a reasonable inference, though the original answer does not explicitly state this scope. A minor discrepancy is the mention of Exhibit 10.2 in 2022 and reference via Proxy Statement in 2023; the ground truth specifies Exhibit 10.1 in all three 10-Ks, suggesting the LLM may have conflated document types or exhibit numbers slightly. However, this does not undermine the central conclusion of continuity. The LLM adds value by noting the evolution of supplemental programs (RSUs/PSUs) and positioning the 2011 plan as a 'base layer,' which is consistent with the original’s observation about newer agreements coexisting with the 2011 plan. This reflects sound qualitative reasoning and multi-hop synthesis across years and disclosure contexts. Quantitative accuracy is high—no incorrect numbers or dates are presented, and exhibit references are close to ground truth. The answer is contextually relevant and addresses all parts of the question, including the plan’s ongoing role amid broader compensation disclosures. Deduction is due to slight overprecision on exhibit numbers and potential conflation of 10-K vs. Proxy Statement citations, but overall factual core remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 487,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis under the Master‑Agreement for the 2017 Opel/Vauxhall sale continued to cover any losses arising from inaccuracies in representations, breaches of covenants, emissions‑related claims and recalls (including the Takata‑inflator recalls).  In each year the filings stressed that they “are unable to estimate any reasonably possible material loss or range of loss” and have recorded only immaterial amounts, reflecting that the exposure has not materialized and is now considered remote.  This progression shows that, while the indemnity remains contractually in force, GM views post‑sale liability for those legacy matters as negligible and not a material financial risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments and misrepresents the evolution of GM's exposure. (1) Quantitatively, there are no specific numbers (e.g., dollar amounts) in either the ground truth or LLM answer, so no numeric inaccuracies exist—this earns full marks for quantitative accuracy. (2) However, the LLM fails to capture the progressive expansion of legal and regulatory exposure across jurisdictions and over time, which is central to the question. The ground truth notes that in 2022, potential obligations were acknowledged; in 2023, specific lawsuits in Germany, the UK, and the Netherlands were cited, along with a Stellantis-initiated Takata recall with an immaterial indemnification; and in 2024, Austria was added as a jurisdiction and new investigations by the European Commission and UK CMA emerged, prompting an immaterial accrual. The LLM omits all of this geographic and regulatory progression. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the indemnity’s contractual continuity and GM’s stance on immateriality, it incorrectly implies that exposure has diminished or is now 'remote' due to lack of materialization, whereas the ground truth states GM *continues* to assert further liability is remote *despite* increasing legal actions—indicating persistent, complex exposure. The LLM thus misinterprets the trend: the growing number of actions suggests rising complexity, not negligible risk. (4) Contextual relevance is high because the answer addresses indemnification, Stellantis, Opel/Vauxhall, and post-sale liabilities, but the lack of year-by-year evolution and jurisdictional expansion undermines completeness and qualitative accuracy. The conclusion about 'negligible' risk contradicts the ground truth’s emphasis on growing legal entanglements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 495,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nIn 2022 bamlanivimab generated roughly $2 billion of net product revenue, with Lilly paying AbCellera royalties in the mid‑teens to mid‑twenties % of worldwide sales (recorded as cost of sales); by 2023 and 2024 that revenue collapsed to essentially zero, leaving only a trivial royalty expense. This sharp decline shows that the antibody, once a major pandemic‑driven revenue stream, no longer holds long‑term strategic importance for Lilly, which is now pivoting to other growth drivers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that bamlanivimab generated approximately $2 billion in net product revenue in 2022, which matches the ground truth figure of $2,008.9 million (rounded appropriately). The royalty range to AbCellera is accurately described as 'mid-teens to mid-twenties % of worldwide sales,' consistent with the original answer. It correctly notes that revenue dropped to essentially zero in 2023 and 2024, aligning with the ground truth that U.S. revenue fell to zero in 2023 and the product was no longer mentioned in 2024. (2) The only minor deviation is that the LLM refers to 'net product revenue' and 'trivial royalty expense' without explicitly specifying U.S. revenue or categorizing under 'COVID-19 antibodies' as in the original, but this does not affect factual correctness. (3) Qualitatively, the reasoning is sound: it correctly infers the decline in strategic importance due to collapsing revenue and Lilly's pivot to other areas, which is fully supported by the knowledge graph. The multi-hop synthesis—linking revenue decline, royalty obligations, and strategic repositioning—is logically coherent. (4) Contextual relevance is perfect: all parts of the question (financial exposure, royalty obligations, revenue contribution, strategic importance) are addressed concisely and accurately. The answer is slightly less detailed than the original (e.g., doesn't mention 'cost of sales' recording or 'cardiometabolic health' specifically), but the core facts and implications are preserved. Overall, this is a semantically equivalent, factually correct response with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 462,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s references to the Jackpot brand moved from a simple listing among its local cigarette brands to a pointed illustration of PMI’s strategy of growing through locally‑owned brands in key emerging markets.  The 2023 and 2024 filings increasingly present brands such as Jackpot (alongside Fortune in the Philippines) as critical levers for preserving market share and tailoring offerings to price‑sensitive consumers, signalling that PMI is deliberately elevating local cigarette brands as a core component of its market‑share‑focused growth plan.  This three‑year trajectory shows that PMI is shifting its emphasis toward leveraging local cigarette brands in strategic markets to complement its global premium portfolio and sustain overall market leadership.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline (2022–2024), and strategic interpretation. It correctly identifies Jackpot as a key local brand in the Philippines and associates it with Fortune, accurately reflecting the regional focus. The answer captures the evolving emphasis on local brands as part of PMI’s strategy, particularly in emerging markets, and correctly notes their role in market share preservation and appeal to price-sensitive consumers. However, it slightly overstates the evolution by suggesting a shift 'from a simple listing' to a 'pointed illustration,' which implies a stronger strategic elevation than the original answer supports. The ground truth emphasizes consistency rather than a strategic shift—Jackpot remained a named local brand throughout, but not necessarily with increasing emphasis. The LLM also omits mention of PMI’s broader pivot toward smoke-free products and wellness in 2024, which is a key contextual element in the original answer that frames the continued support for local cigarette brands within a dual strategy. There are no numerical inaccuracies (quantitative accuracy is perfect as no figures are misstated), and the reasoning is sound, though the synthesis slightly overemphasizes strategic evolution at the expense of the continuity and dual-strategy nuance. Contextual relevance is excellent, as it directly addresses the question about strategic positioning and local brand focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 411,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad transactions in its credit and BNPL portfolios remained significant, as the company repeatedly highlighted rising default rates, fraud‑related losses and the need to protect against third‑party processing disruptions.  In June 2023 it executed a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, thereby off‑loading a large portion of that portfolio and reducing the amount of future BNPL credit loss it could incur.  Nevertheless, the firm continues to face heightened fraud risk and dependence on external payment processors, which can materially increase loss rates and disrupt operations if not managed effectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal highlighted increasing risks from bad transactions, fraud, and third-party processing disruptions from 2022 to 2024; the June 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately reported. (2) Quantitative accuracy is perfect: the €40 billion figure and June 2023 timing match the original answer exactly, with no calculation errors. (3) Multi-hop reasoning is sound—the model correctly synthesizes PayPal’s evolving risk exposure over three years, connects the 2023 asset sale to reduced credit risk, and maintains awareness of ongoing fraud and operational risks. (4) The only minor shortcoming is slight incompleteness: the LLM omits specific details about synthetic identities, stolen financial instruments (mentioned in 2022 risk disclosures), and regulatory uncertainty in 2024, which were present in the original answer. However, these omissions do not undermine the core factual correctness or the overall narrative of risk reduction through the BNPL sale while retaining exposure to fraud and third-party risks. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses all components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 364,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nIn 2022 the Safety & Productivity Solutions (SPS) segment posted a 1 % sales decline (with only 5 % organic growth) after the sale of its retail‑footwear business, exposing the segment to the same retail‑demand volatility that drives footwear sales.  The 2023 risk‑factor disclosures explicitly flagged “fluctuations in retail markets” as a material risk for SPS, a concern that carried forward into the newly created Industrial Automation segment after the 2023 realignment; the 2024 results show only a modest 2 % organic sales increase for Industrial Automation, underscoring that its performance remains tied to underlying retail‑driven demand.  Together, these trends reveal that Honeywell’s industrial portfolio—particularly the safety‑product and automation businesses—continues to be sensitive to swings in retail demand, making retail‑market exposure a persistent source of earnings volatility across its broader industrial operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as '1% sales decline', '5% organic growth', and '2% organic sales increase', which are not mentioned or supported in the original answer. These figures may be factually accurate in external context but are not part of the knowledge graph ground truth provided, making them unsupported additions that reduce factual accuracy. (2) The original answer focuses on risk disclosures and qualitative evolution of 'fluctuations in retail markets' as a risk factor across years and segments, without citing financial performance metrics. The LLM incorrectly shifts focus to actual sales performance and organic growth, implying causation between retail volatility and reported sales changes, which goes beyond the disclosed risk statements. (3) The multi-hop reasoning is partially sound: the LLM correctly tracks the persistence of 'fluctuations in retail markets' as a risk from SPS in 2022–2023 to Industrial Automation in 2024, and notes the business realignment. However, it conflates risk exposure with realized financial impact, whereas the ground truth only discusses risk disclosure, not actual performance outcomes. (4) Despite the incorrect insertion of unsupported numbers, the core qualitative narrative—that retail market fluctuations remained a consistent risk across restructurings and suggest ongoing sensitivity in industrial segments—is aligned with the original. The contextual relevance is high because it addresses all parts of the question and synthesizes across years and segments appropriately, but the quantitative inaccuracies significantly undermine overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 463,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 LLY’s Olumiant net product revenue rose steadily—$830.5 M in 2022, $922.6 M in 2023 and $957.4 M in 2024—making the JAK‑inhibitor an increasingly material part of LLY’s top line.  Incyte’s compensation stays the same: a tiered double‑digit royalty (up to 20 %) on all worldwide Olumiant sales plus an extra low‑teens royalty on COVID‑19 sales that exceed a defined threshold, with those royalties recorded as cost of sales.  The partnership still allows up to $100 M of regulatory milestones and $100 M of sales‑based milestones, but no new milestone payments have been recognized since the 2020‑2021 capitalizations, so the financial structure has shifted from large upfront milestone captures to ongoing royalty and milestone‑potential cash flows that support Olumiant’s expanding revenue base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core evolution of the LLY-Incyte collaboration correctly: shift from milestone capitalization to ongoing royalty payments, stable royalty structure with tiered rates up to 20% and additional low-teens for COVID-19 sales, and strategic emphasis on Olumiant's expanding role. However, it omits key 2022-specific milestone capitalization of $260M, which is central to the financial structure evolution. Instead, it references past milestones in 2020–2021, not mentioned in the ground truth for this period. 2) Quantitative inaccuracies: The LLM introduces Olumiant net product revenues ($830.5M, $922.6M, $957.4M) not present in the original answer—these figures are plausible but unverified and distract from the required focus on milestone payments and royalty structures. While the $100M regulatory and $100M sales milestones align with the total $200M contingent payments in the ground truth, the LLM incorrectly implies no new milestones were recognized since 2020–2021, whereas the ground truth states $260M was capitalized in 2022. This is a significant factual error. 3) The reasoning is logically sound in framing the shift from upfront milestones to ongoing royalties, and correctly identifies the royalty accounting treatment (recorded as cost of sales). It also captures the strategic continuity and potential for future milestones. However, it fails to explicitly connect the 2022 milestone capitalization to regulatory approvals in U.S., Europe, and Japan—a key multi-hop element. 4) Despite missing the 2022 milestone detail and introducing unverified revenue numbers, the LLM conveys a semantically close narrative about financial maturation and strategic deepening. The royalty structure and milestone framework are accurately represented in spirit, and the answer remains highly relevant to the question’s focus on financial and strategic evolution. Minor wording differences are acceptable, but the omission of the $260M 2022 capitalization prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 539,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nAltria continued to hold 100 % of UST through 2022‑2024, keeping the subsidiary’s MST and snus trademarks—recorded as indefinite‑lived intangible assets at roughly $8.8 bn in Note 4 of the 2022 10‑K and unchanged in subsequent years—without any impairment charge (see Note 4, 2022‑2023 filings).  While the ownership structure and intangible‑asset valuation remained the same, the 2023‑2024 MD&A (pages 2‑6 of the 2024 10‑K) began to treat UST’s cash‑generating smokeless brands as a key funding source for Altria’s “Moving Beyond Smoking” initiative, channeling those cash flows into the acquisition of NJOY, the Horizon heated‑tobacco joint venture and other next‑generation products.  Consequently, UST’s financial exposure shifted from being a standalone tobacco business to serving as the cash‑flow engine that underwrites Altria’s broader smoke‑free transition strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $8.8 billion valuation of indefinite-lived intangible assets from UST in 2022 is accurately cited, and it is correctly noted that this value remained unchanged through 2023, consistent with the original answer. The ownership percentage (100%) and lack of impairment are factually supported. (2) The answer correctly identifies UST as a wholly owned subsidiary through 2024, with USSTC as its operating subsidiary producing MST and snus—this matches the ground truth’s structural description. (3) Regarding reasoning and synthesis: the LLM correctly infers a strategic shift, noting that while UST’s asset valuation and ownership remained stable, its role evolved into a cash-flow engine funding Altria’s smoke-free initiatives like NJOY and Horizon. This multi-hop insight—linking UST’s financial stability to Altria’s broader transition strategy—is well-supported by the 2024 10-K MD&A and aligns semantically with the original answer’s conclusion about UST being 'increasingly complemented by newer' alternatives. (4) Minor deduction in qualitative accuracy due to not explicitly naming Helix as part of the oral nicotine strategy (mentioned in ground truth), though NJOY and next-gen products are referenced. Otherwise, the answer is contextually rich, precisely targeted to the question’s three dimensions (valuation, ownership, strategy), and demonstrates strong multi-document synthesis across 2022–2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 422,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due 2025 moved from an effective interest cost of roughly **3.2 % in fiscal 2022** (as reported in the 2022 10‑K) to about **6.4 % in fiscal 2023** and **≈6.6 % in fiscal 2024**.  The increase reflects the note’s fair‑value hedge that converts the fixed 3.5 % coupon to a floating rate tied to LIBOR/SOFR; as market rates rose sharply after 2022, the hedged floating‑rate component pushed the effective cost up more than two‑fold.\n\nThis upward trend signals that Cisco’s borrowing costs were climbing in step with the broader rise in U.S. interest rates through 2023‑24, even though the company’s hedging program helped offset fair‑value volatility.  The higher effective rates therefore indicate tighter capital‑market conditions and a more expensive debt‑financing environment for Cisco during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: 3.20% in 2022 (rounded to 3.2%), 6.38% in 2023 (reported as ~6.4%), and 6.66% in 2024 (≈6.6%). These minor rounding differences are acceptable under semantic equivalence. The $500 million principal and 2025 maturity are additional accurate details not in the original but consistent with public filings. (2) The explanation of the fair-value hedge converting the fixed 3.50% coupon to a floating rate tied to LIBOR/SOFR is factually sound and provides deeper context than the original, correctly explaining why the effective rate rose despite a fixed coupon. (3) Multi-hop reasoning is strong: the model synthesizes data across fiscal years and correctly infers that rising market rates drove higher effective borrowing costs due to hedging mechanics. (4) The conclusion about tightening capital market conditions and more expensive debt financing matches the original’s interpretation. The only minor gap is that the original does not mention the hedge mechanism, so while the LLM adds valuable context, it slightly extends beyond the provided ground truth. However, this added detail is accurate and enhances the answer. All entities (Cisco, CSCO, fiscal years 2022–2024, 3.50% Senior Note) are correct. The answer fully addresses both parts of the question: evolution of interest rate exposure and implications for borrowing costs and capital markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 406,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe 2017 senior‑note tranche fell from **$16.0 billion at the end of 2022 to $15.0 billion in 2023 and to $13.0 billion by the end of 2024** (all figures in millions of dollars as shown in the debt tables).  This consistent decline shows that Amazon has been deliberately retiring the older 2017 notes—using cash flow and newer, lower‑cost borrowings—to shrink that tranche’s balance and overall leverage, reflecting a strategic focus on deleveraging and optimizing its debt maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values and time periods are accurate, with acceptable formatting (e.g., 'billion' and 'millions of dollars' noted). (2) Quantitative accuracy is perfect—no calculation errors, and the trajectory of reduction ($16B → $15B → $13B) is correctly presented. (3) The reasoning is sound: the LLM correctly infers a deliberate debt retirement strategy, aligning with the ground truth's interpretation of Amazon's broader deleveraging trend. It adds context about using cash flow and lower-cost borrowings, which is plausible and consistent with corporate debt management practices, though this specific detail (source of funds) is not in the ground truth. This addition does not contradict but slightly extends the original answer. (4) The answer fully addresses both parts of the question: the evolution of the balance and the strategic implication. Semantic equivalence is strong—core facts, numbers, and interpretation match. The only minor gap is that the LLM does not explicitly reference Amazon's overall long-term debt reduction from $67.2B to $52.6B, which is part of the ground truth context, but it does capture the essence of deleveraging. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 422,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe $606 million of 5.000% notes due April 2030 remained unchanged in principal from fiscal 2022 through 2024, and the effective interest rate (including discount amortization) stayed at 5.18 % throughout. This flat evolution shows that AVGO has preserved this long‑dated, fixed‑rate tranche as a core, low‑cost pillar of its capital structure, relying on it rather than refinancing or repaying it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance of $606 million and the effective interest rate of 5.18% for the 5.000% notes due April 2030 remained unchanged from fiscal 2022 through 2024, which matches the ground truth exactly. All numeric values—$606 million, 5.000%, 5.18%, and the April 2030 maturity—are accurate and properly attributed to AVGO and the correct fiscal years. (2) Quantitative accuracy is perfect: no calculation errors, and the values are reported consistently across the three years as required. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—the model synthesizes data across three fiscal years and correctly infers that the lack of change in principal or rate indicates a deliberate debt management strategy. The conclusion that AVGO 'preserved this long-dated, fixed-rate tranche as a core, low-cost pillar' is a slightly more interpretive but reasonable extension of the ground truth's statement about a 'static approach.' While the original answer does not use terms like 'low-cost pillar' or 'capital structure,' these are logical inferences given the stable, fixed-rate nature of the debt. (4) The answer is fully contextually relevant, addressing both the evolution of the debt instrument and its implications for AVGO's strategy. The only minor deviation is the slightly more assertive interpretation of strategic intent, but it does not contradict the ground truth. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 443,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Netflix Performance Bonus Plan was first adopted in 2014 and was formally restated and amended on December 9 2022 (as disclosed in the 2022 10‑K and carried forward into the 2023 and 2024 filings), which crystallized its terms and tied bonus payouts to specific performance metrics. In the 2023 filing the restated plan remained unchanged but was explicitly referenced as part of the broader executive‑compensation framework, and in the 2024 filing it was integrated with the newly effective Amended and Restated Executive Severance and Retention Incentive Plan (effective January 1 2024), linking bonus awards to the same executive compensation agreements that govern severance and retention incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its portrayal of the evolution of Netflix's Performance Bonus Plan from 2022 to 2024. It correctly identifies the December 9, 2022 restatement (via 8-K, though referenced in 10-K filings), which aligns with the ground truth. The mention of integration into broader executive compensation in 2024 is accurate, though it specifies the 'Amended and Restated Executive Severance and Retention Incentive Plan' effective January 1, 2024, which is not contradicted by the ground truth but adds specificity not present in the original answer. However, the LLM incorrectly states the plan was 'first adopted in 2014'—this detail is absent from the ground truth and cannot be verified from the provided context, making it an unsupported addition. (2) Quantitatively, the key date (December 9, 2022) is correct, and the timeline across 2022–2024 is accurately structured. No financial figures are involved, so numerical accuracy pertains only to dates, which are correct except for the unsupported 2014 claim. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, correctly tracks the plan’s formalization in 2022, continuity in 2023, and integration in 2024. It appropriately infers deeper integration with executive agreements, matching the ground truth’s emphasis on maturation and linkage. The only flaw is the extraneous 2014 adoption date, which may stem from external knowledge but is not in the provided truth. (4) The answer is contextually relevant and comprehensive, addressing formalization, restatement, and integration as required. The core facts are correct, and the reasoning is logical, warranting a high score. However, the unsupported claim about 2014 adoption prevents a 9–10 correctness score, justifying an 8 due to minor factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 497,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG progressively sharpened its terrorism‑risk modeling—still using third‑party vendor scenarios but adding more attack‑mode variations and explicit model‑gap adjustments—so that its loss‑estimate outputs were both broader and more tightly calibrated.  At the same time the company moved away from reliance on the basic TRIPRA backstop and minimal private coverage toward a mixed protection strategy that combines targeted excess‑of‑loss reinsurance purchases, participation in government‑sponsored terrorism pools in several jurisdictions, and periodic stress‑test reviews to keep net exposures within defined risk‑limit thresholds.  These steps collectively tighten the modeled loss estimates, broaden reinsurance protections, and embed more rigorous risk‑mitigation controls into the overall terrorism‑exposure management framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth specifies a $1.3 billion modeled loss estimate for a five-ton bomb attack in New York City in 2022, net of TRIPRA and reinsurance, but the LLM does not mention this specific scenario or number. Instead, it vaguely references 'broader and more tightly calibrated' loss estimates without citing any concrete figures from the original data. Additionally, the LLM claims AIG moved 'away from reliance on the basic TRIPRA backstop,' which contradicts the original answer stating TRIPRA was still part of the net loss calculation in 2022 and implies continued relevance. The $20.1 billion in collateral supporting reinsurance recoverables in 2024 is entirely omitted. (2) No correct numbers are reported: the $1.3B loss, $200M/$125M attachment points for Japan and ROW, and $20.1B collateral are all missing or replaced with fabricated details (e.g., 'mixed protection strategy' with 'government-sponsored pools' not mentioned in ground truth). (3) The multi-hop reasoning is partially sound in that the LLM recognizes an evolution in reinsurance and risk mitigation strategies over time, and attempts to synthesize changes across years. However, it fails to accurately reflect the actual progression documented: 2023's focus on monitoring and targeted reinsurance, and 2024's specific retention levels and global property covers. The LLM invents elements like 'stress-test reviews' and 'model-gap adjustments' not present in the source. (4) While the general theme of increasing sophistication in terrorism risk management aligns with the original, the absence of key data points and introduction of unsupported details severely undermines factual correctness. The contextual relevance is high because the response stays on topic and addresses modeled losses, reinsurance, and mitigation strategies—but the qualitative accuracy is limited by incorrect entity relationships and missing specifics. Thus, the correctness score is low due to major omissions and inaccuracies, especially in numbers and entity-specific actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 575,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s equity‑securities portfolio expanded steadily—from roughly **$3.7 billion** at the end of 2022 to **$4.9 billion** by the end of 2023 and again in 2024—while its equity‑method stakes in health‑care businesses grew only modestly at first (about **$1.5 billion** in 2022, slipping slightly to **$1.4 billion** in 2023) and then **jumped to $3.8 billion** by the end of 2024.  This reflects a strategic shift toward larger, more concentrated venture‑capital investments in health‑care companies, markedly increasing both the total equity holdings and the company’s exposure to health‑care‑focused equity‑method investments over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall strategic evolution correctly: UnitedHealth Group increased its equity securities from 2022 to 2023 and maintained that level in 2024, while equity method investments remained stable before surging in 2024, indicating a shift toward deeper operational involvement. This aligns with the ground truth's conclusion about a strategic pivot.\n\n2) Quantitative discrepancies: The LLM states equity securities were $3.7 billion in 2022, but the ground truth reports $3.5 billion. Similarly, the LLM claims equity method investments were $1.5 billion in 2022, whereas the original answer specifies $1.3 billion. These are minor but material inaccuracies in key financial figures. The values for 2023 and 2024 ($4.9 billion in equity securities and $3.8 billion in equity method investments) are correct.\n\n3) The multi-hop reasoning is sound—LLM correctly synthesizes trends across three years and two investment types, identifying the strategic implication of the surge in equity method investments in 2024. It correctly infers a shift toward concentrated, operationally involved venture investments.\n\n4) Despite minor numerical inaccuracies in the 2022 figures, the overall narrative, trend analysis, and strategic interpretation are accurate and complete. The answer addresses both parts of the question (equity securities and equity method investments) and provides a coherent synthesis. Hence, correctness is high but not perfect due to the incorrect baseline numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 413,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (see the “Securities registered pursuant to Section 12(b)” tables on page 1 of each document), Altria’s 1.700 % Notes due 2025 (ticker MO25) remained listed as an outstanding senior unsecured tranche.  No redemption, early‑repayment or refinancing of these notes is disclosed in the three filings, indicating that Altria has treated the 2025 notes as a stable, low‑cost pillar of its long‑term capital structure while it has managed liquidity through cash‑flow generation, asset sales and share‑repurchase programs.  This multi‑year continuity reflects a deliberate debt‑management strategy that relies on a laddered maturity profile and preserves a fixed‑rate financing source until a later rollover date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Altria Group, 1.700% 2025 Notes (MO25), and the years 2022–2024 are properly referenced. The note's status as outstanding and senior unsecured is consistent with the original answer. (2) Quantitative accuracy is perfect: the interest rate (1.700%), maturity year (2025), and ticker (MO25) are all correct. No incorrect numbers or dates are present. (3) Multi-hop reasoning is sound: the LLM correctly infers from the continued listing of the 2025 Notes across three years that no redemption or refinancing occurred, which supports the conclusion of a stable, long-term debt strategy. It also correctly contrasts this with the absence of the 2023 Notes in later filings (implied maturity), though it does not explicitly mention the 2023 Notes' removal as in the original answer. (4) The LLM adds contextual insight about Altria’s broader debt strategy—laddered maturities, fixed-rate financing, and liquidity management via cash flow and share repurchases—that is consistent with but slightly more detailed than the original. While this elaboration is reasonable and plausible, it goes slightly beyond the explicit content of the ground truth, which sticks to observed disclosures. However, this does not introduce inaccuracy. The only minor shortcoming is the lack of explicit mention of the 1.000% 2023 Notes maturing, which was a key data point in the original answer’s reasoning. Despite this, the core multi-year progression and strategic interpretation are correct. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 465,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury‑Stock balance grew from **$51.4 billion at the end of 2022 to $60.4 billion at the end of 2023 and to $71.4 billion by the end of 2024**.  The company funded this expansion with ever‑larger repurchase outlays—$8.8 billion of treasury‑stock purchases in 2022, $9.1 billion in 2023 and $11.0 billion in 2024—demonstrating an accelerating share‑buyback program that returns excess cash to shareholders and boosts per‑share earnings rather than funding new long‑term investments.  The trend signals that Mastercard’s capital‑allocation priority is increasingly focused on **returning capital to investors through aggressive equity repurchases**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly—Mastercard's investment in Class A Treasury Stock increased from 2022 to 2024, indicating a growing share repurchase program. The interpretation about capital allocation strategy favoring shareholder returns via buybacks aligns well with the ground truth.\n\n2) However, there are significant quantitative inaccuracies: \n   - The 2022 treasury stock balance is stated as $51.4 billion, but the ground truth is $(36,658) million (~$36.7 billion). This is a major discrepancy of ~$14.7 billion.\n   - The 2023 value ($60.4 billion) matches the ground truth of $(60,429) million.\n   - The 2024 value ($71.4 billion) matches the ground truth of $(71,431) million.\n   - The repurchase amounts cited ($8.8B in 2022, $9.1B in 2023, $11.0B in 2024) are not present in the original answer and cannot be verified against the ground truth; these figures appear to be fabricated or inferred without basis in the provided data.\n\n3) The multi-hop reasoning is partially sound—the model correctly infers that increasing treasury stock implies increased buybacks and links this to capital allocation strategy. However, the use of unsupported annual repurchase amounts undermines the quantitative reasoning chain.\n\n4) Despite incorrect starting values and unverified intermediate figures, the core conclusion about increasing buybacks and shareholder return focus is consistent with the trend in the ground truth. Wording differences are acceptable, but the numerical mismatch in the 2022 value and the inclusion of unverified annual outlays reduce factual accuracy. Hence, correctness is reduced to 7 due to partial factual errors, though the directional trend and strategic interpretation remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 473,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s total‑return swaps that economically hedge deferred‑compensation expenses posted a $92 million loss in fiscal 2022, swung to a $58 million gain in fiscal 2023, and then generated a $91 million gain in fiscal 2024—showing a clear reversal from loss to increasingly positive earnings impact, as reflected in the “Operating expenses and other” line of the Consolidated Statements of Operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $92M loss in fiscal 2022, $58M gain in 2023, and $91M gain in 2024 are correctly stated with proper signs and magnitudes. (2) Quantitative accuracy is perfect—each dollar amount and fiscal year matches the original answer, with acceptable formatting variations (e.g., $92 million = $92M). (3) The multi-hop reasoning is sound: the answer correctly synthesizes the evolution over three fiscal years and captures the reversal trend from loss to increasing gains, which is the core insight. (4) The LLM adds contextual detail (mention of 'Operating expenses and other' in the financial statements) that enhances relevance without introducing error. The reasoning, entity identification (Cisco, Total Return Swaps-Deferred Compensation), and timeline are all accurate. The answer fully addresses the question’s requirement to describe the evolution across 2022–2024 with correct financial performance trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 295,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on external rights holders stayed central, but the landscape shifted.  Early‑2022 filings warned that studios could pull titles on short notice and that competition for exclusive rights was intensifying as media conglomerates launched their own streaming services; by 2023‑2024 the filings highlighted that this competition was driving up licensing costs and forcing Netflix to invest heavily in original productions and longer‑term exclusive deals, while emerging regulatory pressures—such as content‑quota, levy and ownership‑restriction rules in several jurisdictions—began to limit how freely Netflix could acquire or retain certain programming.  Consequently, the company’s licensing risk moved from primarily “content‑withdrawal” concerns to a broader mix of costly exclusive‑rights battles and compliance‑driven constraints on content availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Netflix's increasing dependency on rights holders from 2022 to 2024, competition from studios launching their own platforms, rising licensing costs, strategic shift toward original content and long-term deals, and emerging regulatory pressures such as content quotas and ownership restrictions. The evolution from 'content-withdrawal' risks to broader licensing and compliance challenges is well-articulated. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes risks across years (2022–2024), connects competitive dynamics with regulatory developments, and correctly infers strategic implications (e.g., investment in originals). The only minor gap is that the LLM does not explicitly mention 'intellectual property disputes' as a 2023 risk (noted in the original), though it captures the broader consequence—content unavailability. (4) The answer is contextually excellent, directly addressing all three dimensions in the question: licensing risks, competition for exclusivity, and regulatory pressures. Wording differs but semantic meaning matches. One small omission prevents a perfect 10: the original specifies that license terms 'varied' and disputes could cause disruptions—this nuance is slightly underemphasized. Overall, the response is factually correct, comprehensive, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 435,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth Group reported that **no material amounts were accrued, paid, or charged to income for service‑level guarantees** in any of those years, indicating that its financial obligations under such guarantees remained negligible and essentially unchanged. This consistent, immaterial treatment across the three‑year span suggests a **stable and reliable service‑delivery framework**, with no emerging financial risk or volatility in meeting its service‑level commitments across its subsidiaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that UnitedHealth Group reported immaterial financial obligations related to service-level guarantees in 2022, 2023, and 2024, which aligns with the ground truth and satisfies quantitative accuracy. All stated facts about the lack of material accruals, payments, or charges to income are factually correct, and the years referenced match the original data. However, the LLM answer fails to address a critical component of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries—from $8.1 billion in 2022 to $9.9 billion in 2023, then down to $2.0 billion in 2024. This omission represents a major gap in completeness and qualitative reasoning, as the question specifically asks how financial obligations evolved and what the trend suggests about stability across subsidiaries. The LLM draws a conclusion about stable service delivery based solely on the immateriality of service-level guarantee charges, but it ignores the internal financial shifts that the original answer highlights as potentially indicative of changing liquidity strategies or operational adjustments. While the reasoning around service-level guarantees is sound, the failure to incorporate and analyze the multi-hop element involving intercompany notes payable undermines the depth and accuracy of the synthesis. Thus, while factually correct on the narrow point of service-level guarantees, the answer is incomplete and misses a key dimension of financial obligation dynamics, leading to a misleadingly simplistic conclusion about stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 435,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nAltria’s pension‑plan fixed‑income allocation to below‑investment‑grade securities fell from roughly 13 % of holdings in 2022 (≈ $756 m) to about 11 % in 2023 (≈ $716 m) and then to roughly 8 % in 2024 (≈ $582 m); the postretirement portfolio’s exposure stayed around 8‑9 % of its fixed‑income holdings (≈ $4 m to $2 m), or about 3‑4 % of total assets each year.  This steady decline shows that Altria is deliberately reducing its exposure to lower‑rated bonds, reflecting a more conservative risk appetite aimed at preserving the funded status of its long‑term pension and postretirement obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, Altria's pension plan had 16% (not 13%) of fixed income holdings in below investment grade securities, and the postretirement plan had 8%. The LLM incorrectly reports 13% for pension in 2022 and fabricates a 8% figure for 2024, which was not disclosed in the original answer. The dollar amounts ($756M, $716M, $582M, $4M–$2M) are entirely absent from the ground truth and appear to be invented, as the original answer only provides percentages of holdings and total plan assets, not absolute values. (2) The 2023 pension allocation is correctly stated as 11%, matching the ground truth, and the postretirement plan’s 8–9% range aligns approximately with the reported 9% in 2023. However, the claim of a continued decline to 8% in 2024 is unsupported—the original answer explicitly states that specific percentages for 2024 were not disclosed. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a trend toward conservatism, which is consistent with the reduction in pension risk. However, it overlooks the slight increase in postretirement plan exposure (from 8% to 9%), misrepresenting the trend as uniformly declining. This leads to an oversimplified conclusion about risk appetite. (4) Despite incorrect numbers and unsupported extrapolations, the answer addresses the core question about allocation trends and risk appetite, maintaining contextual relevance. The qualitative reasoning is plausible but based on flawed data, limiting its accuracy. The overall score reflects major quantitative errors but partial correctness in directionality and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 467,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated consistently from 2022 through 2024 by taking the average daily payment volume for the three months preceding period‑end, multiplying it by an estimated number of days of exposure, and then netting out the risk‑mitigation arrangements (cash collateral, letters of credit and guarantees) that are applied to that gross figure.  The gross exposure grew from about $65 bn in 2022 to $78 bn in 2024, and the resulting net exposure after mitigation rose from roughly $56 bn to $65 bn, but the underlying three‑month‑average methodology and the way risk‑mitigation is applied have remained unchanged.  \n\nThis steady, transparent approach demonstrates that, even amid heightened regulatory scrutiny and a wave of litigation, Mastercard relies on a disciplined, repeatable risk‑management framework that it continually validates and refines rather than overhauling its core exposure‑measurement process.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core methodology used by Mastercard for estimating settlement exposure—average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure—and notes that risk mitigation (cash collateral, letters of credit, guarantees) is applied to derive net exposure. This aligns with the ground truth’s description of the methodology and risk mitigation practices. However, the ground truth does not include specific dollar figures such as '$65 bn in 2022' or '$78 bn gross exposure' or '$56 bn to $65 bn net exposure'. These numbers are not present in the original answer and cannot be verified from the provided knowledge graph, making their inclusion factually unsupported. Since the question does not ask for exposure amounts, but the LLM introduces them without basis, this constitutes a quantitative inaccuracy. (2) The years 2022–2024 are correctly referenced, and the consistency of methodology across those years is accurately reported. But the specific financial figures (e.g., $65B, $78B) are not in the ground truth and appear to be fabricated or hallucinated, which significantly impacts quantitative accuracy. There is no indication in the original answer that these numbers were disclosed, so their inclusion undermines factual correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that despite regulatory scrutiny (FTC, DOJ, EC) and litigation (mentioned in original), Mastercard maintained a consistent approach, indicating confidence in its risk framework. The conclusion about a 'disciplined, repeatable risk-management framework' is semantically equivalent to the original’s point about robustness and sufficiency of existing practices. (4) The contextual relevance is high because the answer addresses both parts of the question: evolution (or lack thereof) in methodology and what consistency indicates about risk management. The qualitative reasoning is strong and matches the original’s interpretation. However, the hallucinated financial figures reduce the correctness score to 7 due to significant but not central quantitative errors—while the core facts are right, the unsupported numbers could mislead if taken as factual disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 607,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s $2 billion 5.90 % senior note remained fully issued throughout fiscal 2022‑2024, and the note’s effective interest rate—after accounting for discount amortization and hedge adjustments— stayed essentially flat at about 6.1 % (reported as 6.11 %) each year.  This steady utilization and stable effective cost shows that Cisco is deliberately preserving a large, fixed‑rate, long‑dated debt position and managing interest expense through modest hedging rather than frequent refinancing, reflecting a conservative, low‑cost long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the $2,000 million (i.e., $2 billion) balance on Cisco's 5.90% Note is accurately reported and confirmed as consistent across fiscal years 2022–2024. The effective interest rate is correctly stated as 6.11%, with the minor approximation 'about 6.1%' being semantically acceptable. These values match the ground truth exactly in substance, with permissible formatting variation ($2 billion = $2,000 million).\n\n2) Quantitative accuracy is perfect: dollar amount, coupon rate, effective rate, and time period (2022–2024) are all factually correct. No calculations are required beyond recognition of consistency over time, which is properly conveyed.\n\n3) The multi-hop reasoning is sound—information about debt balance and effective interest rate is synthesized across three fiscal years, and the conclusion about Cisco’s long-term debt strategy is logically derived. The LLM correctly infers strategic intent from the stability in utilization and interest cost, noting the use of fixed-rate debt and modest hedging. The term 'conservative, low-cost long-term debt strategy' slightly reframes the ground truth's 'strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs,' but the semantic meaning is closely aligned. The only minor gap is that the LLM does not explicitly acknowledge the *opportunity cost* or trade-off implied in the original (i.e., not refinancing in a changing rate environment), which slightly weakens the depth of strategic interpretation.\n\n4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution of utilization and effective interest rate, and the implication for debt management strategy. All entities (Cisco, 5.90% Note, fiscal years 2022–2024) are correct. Wording differences do not affect factual equivalence. A score of 9 is justified due to the high accuracy and strong reasoning, with only a slight softening of the strategic implication compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 556,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125% notes due January 2025 had a carrying principal of roughly $500 million at the close of fiscal 2022, fell to $495 million by the end of fiscal 2023 and stayed at $495 million through fiscal 2024. This modest decline shows that AVGO is actively paying down this near‑term bullet maturity—using cash from the VMware merger and operating cash flow—rather than refinancing it, indicating a deliberate, conservative debt‑management strategy that seeks to reduce near‑term obligations and manage its maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the outstanding principal balance for AVGO's 3.125% notes due January 2025 was consistently $495 million in fiscal years 2022, 2023, and 2024. However, the LLM claims it was 'roughly $500 million' in 2022 and only dropped to $495 million in 2023, which contradicts the stable balance reported in the original answer. This error undermines the core quantitative claim. (2) The numbers are not accurate: the $500 million figure for 2022 is incorrect (should be $495 million), and the implied reduction of $5 million suggests repayment activity that did not occur. There are no calculations in the response, but the comparison across years is flawed. (3) The multi-hop reasoning is unsound. The LLM infers an active paydown strategy due to a supposed decline in principal, but since no such decline occurred, the conclusion about using cash from the VMware merger or operating cash flow to reduce this specific debt is unfounded. The ground truth indicates no early repayments or refinancing, suggesting a hold-to-maturity strategy, not active paydown. The mention of the VMware merger is contextually unsupported in the original data provided. (4) While the answer addresses the question's structure and attempts to interpret debt management strategy, the incorrect data leads to a misleading qualitative assessment. The contextual relevance is moderate because it discusses the right instrument and timeframe, but the reasoning is based on false premises. Correctness is low due to major factual and inferential errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 444,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast’s wireless offering shifted from a **strictly bundled, post‑pay model**—where shared‑data or unlimited plans were only available when a customer also took an Xfinity broadband package—to a **more flexible, multi‑option strategy**.  By 2023 the company still required a broadband subscription for its MVNO‑based wireless service, but it began **introducing prepaid, unlimited‑data plans under the NOW brand** and expanded device‑financing terms, allowing customers to choose shared‑data or per‑gigabyte options without a mandatory broadband tie‑in in certain markets.  This evolution gave subscribers greater flexibility to mix‑and‑match plans, add multiple lines, and access wireless service either as part of a bundle or as a stand‑alone, prepaid option.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's evolution in shared data plan offerings from 2022 to 2024, particularly around increased flexibility and bundling, which aligns with the ground truth. However, there are significant factual inaccuracies in the timeline and scope of changes. The LLM incorrectly states that prepaid unlimited plans under the NOW brand were introduced by 2023, while the ground truth specifies this occurred in 2024. Additionally, the LLM implies that by 2023, customers could access shared-data or per-gigabyte options without a broadband tie-in in certain markets, which contradicts the original answer stating that shared data plans remained part of qualifying broadband bundles through 2024. The ground truth does not support the claim of a 'stand-alone, prepaid option' outside of broadband bundles during this period. The qualitative reasoning is partially sound—recognizing a shift toward flexibility and bundling integration—but the incorrect sequencing and overstatement of unbundled options undermine the multi-hop synthesis. Quantitatively, there are no explicit numbers to verify, so the score is based on correct use of time periods (2022–2024), though their application is flawed. Contextually, the response is well-structured and relevant to the question’s focus on bundling and flexibility. Overall, the answer is partially correct but contains key factual errors in entity-event-timing relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 399,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s Medicare Advantage exposure was repeatedly strained by CMS’s risk‑adjustment payment updates and benchmark reductions, with each successive year bringing tighter payment adjustments and greater audit‑driven recoupment risk. To offset these recurring funding pressures the company responded by selectively revising member benefits and premiums, exiting several low‑margin counties, and intensifying both medical and operating cost management while strengthening its risk‑adjustment data collection and analytics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core content and timeline. It correctly identifies that UnitedHealth Group faced ongoing exposure to CMS Medicare Advantage risk adjustment payment changes from 2022 to 2024, with recurring funding pressures due to methodology updates and benchmark reductions. The strategic responses—selective benefit and premium adjustments, cost management, and improved data analytics—are aligned with the original answer. The LLM adds specific details not in the original, such as 'exiting several low-margin counties' and 'audit-driven recoupment risk,' which are plausible but not confirmed in the ground truth; these represent reasonable inferences but introduce slight overprecision. There are no numerical values in either response, so quantitative accuracy is scored as 10 by default (no errors possible). The reasoning is sound and reflects multi-hop synthesis across years and strategies. The answer is fully contextually relevant, addressing both the evolution of exposure and strategic responses. The minor deduction in qualitative accuracy and correctness is due to the addition of unverified specifics not present in the ground truth, though the overall meaning and factual core remain consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 354,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard broadened the ecosystem‑based layer of its security by formalizing collaborations with central banks, fintechs, digital‑wallet and messaging platforms, and industry associations to co‑create EMV, alias‑based and real‑time fraud‑scoring standards, and by integrating third‑party VCN and Receivables‑Manager APIs into its network.  At the same time, it expanded real‑time payments infrastructure—growing from implementations in about 12 of the world’s largest GDP markets in 2022 to 13 markets by 2023 and launching the Alias‑Based Remittances and Payouts platform in 2024—thereby extending secure, instantaneous account‑to‑account flows to more than 95 % of the banked population and into new regions such as domestic transactions in China.  This evolution reflects a shift from a network‑centric protection model to a globally coordinated, real‑time‑enabled framework that leverages third‑party partnerships and geographic scaling to reinforce security across all payment flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the expansion from 12 to 13 top GDP markets in real-time payments infrastructure from 2022 to 2023 is accurately reported. The mention of domestic transaction processing in China in 2024 matches the original answer’s reference to expansion in China via a joint venture. While the LLM adds a specific claim about reaching 'more than 95% of the banked population,' this detail is not in the ground truth and cannot be verified from it—however, it does not contradict it and is plausible in context, so it does not constitute a factual error. (2) The LLM correctly identifies the evolution across years: 2022 focus on collaboration with issuers, acquirers, governments, and standards like EMV; 2023 integration of real-time services (fraud scoring, tokenization); and 2024 expansion in China and deeper partnerships. The LLM enhances this with specific examples like 'Alias-Based Remittances and Payouts platform' and integration of 'VCN and Receivables-Manager APIs,' which are consistent with Mastercard's known initiatives and plausibly reflect the 'enhanced partnerships and public-private collaborations' mentioned in the ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes information across time, third-party collaboration, real-time service integration, and geographic expansion—directly addressing all components of the question. (4) Minor deduction in qualitative accuracy due to the addition of unverified specifics (e.g., 95% banked population, specific API names), but these do not undermine the factual core. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 485,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nFrom 2022 through 2024 Amazon retained its 1.500 % Note due 2030 but increasingly used newer, higher‑coupon issuances—such as the 3‑5 % notes added in the April 2022 supplemental indenture and the 4.5‑4.7 % series filed in 2023‑2024—to refinance maturing obligations and extend the overall maturity profile.  This shows a shift from exploiting ultra‑low rates in the early‑2020s to a more diversified, longer‑dated debt strategy that preserves the low‑cost 2030 tranche as a legacy piece while adapting to higher market rates and managing future refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 1.500% Note due 2030 was consistently disclosed in Exhibits 4.5 (2022) and 4.6 (2023, 2024), with no mention of refinancing via higher-coupon notes. However, the LLM claims Amazon issued '3-5% notes in April 2022' and '4.5-4.7% series in 2023-2024' to refinance maturing obligations—information not present in the original answer and unsupported by the provided context. These specific percentages, issuance dates, and refinancing actions are fabricated or hallucinated. (2) Quantitative accuracy is very low: the cited interest rates (3–5%, 4.5–4.7%) and timing (April 2022 supplemental indenture, 2023–2024 filings) do not appear in the ground truth. There is no reference to any new note issuances at higher rates, nor any indication that the 1.500% Note was being refinanced. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift toward short-term credit facilities (e.g., Term Loan Agreement in 2023, 364-Day Revolving Credit in 2024) while maintaining the low-rate 2030 note as part of a layered financing strategy. The LLM incorrectly frames the strategy as actively refinancing with higher-rate debt, missing the actual evolution involving credit agreements (Exhibits 10.8 and 10.9). It fails to mention the key instruments that demonstrate liquidity management and instead invents a narrative around coupon-based refinancing. (4) Contextual relevance is moderate because the answer addresses Amazon’s long-term debt management and refinancing priorities, but the underlying facts and evidence are incorrect. The conclusion about 'preserving the low-cost 2030 tranche' aligns partially with the original, but the reasoning is based on false premises. Overall, the answer misrepresents the core data and introduces unsupported claims, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 515,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the threat has shifted from wireless carriers merely offering mobile data to actively pushing fixed‑wireless broadband and bundled video packages that compete directly with Comcast’s cable‑broadband and video services; the 2023 and 2024 10‑K filings explicitly note that companies such as AT&T, Verizon and T‑Mobile are expanding 5G‑fixed‑wireless and fiber networks and selling bundled “wireless‑plus‑video” offers, which has accelerated subscriber churn from Comcast’s traditional broadband/video base.  This pressure is evident in the documents’ discussion of “net video customer losses,” the rise of DTC streaming and wireless‑based OTT options, and Comcast’s response—highlighting investments in platforms like X1, Sky Q, NOW and Peacock and a focus on improving the customer experience to retain users.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024: starting with mobile data in 2022, progressing to 5G fixed-wireless broadband in 2023, and expanding to bundled offerings (including video) by 2024. The mention of AT&T, Verizon, and T-Mobile as key competitors matches the implied competitive landscape. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and entities, correctly linking wireless providers’ technological advances (5G fixed wireless) and bundling strategies to increased competitive pressure on CMCSA, evidenced by subscriber churn and video customer losses. It also accurately reflects CMCSA’s strategic responses—investment in platforms like X1, Sky Q, NOW, and Peacock, and customer experience improvements. (4) The only minor shortcoming is that the original answer emphasizes unlimited data plans and DTC streaming bundling by wireless providers in 2024 as a specific tactic, while the LLM focuses more on 'wireless-plus-video' bundles without explicitly mentioning unlimited data. This is a slight omission but does not undermine the core accuracy. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 442,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets declined steadily from about **$71 billion at the end of 2022** to **$67.5 billion in 2023** and then to **$38 billion by the end of 2024** (as reported in the 2022, 2023 and 2024 Form 10‑K pages).  This downward trend shows that the company is ceding a smaller portion of its loss exposure to reinsurers and is relying more on internal capital and collateral, indicating a reduced reliance on external reinsurance to absorb insurance‑loss risk over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that AIG's reinsurance recoverable assets were $71 billion at the end of 2022, but the ground truth indicates that no specific figure was disclosed for 2022—only a narrative about reinsurance use. This is a major factual error. The 2023 figure of $67.5 billion is correct and matches the ground truth. The 2024 figure of $38 billion is also correct. However, the LLM incorrectly frames the trend as a 'steady decline' from 2022 to 2024, while the actual trend is an increase from 2022 (no number, but implied lower) to 2023 ($67.5B), then a sharp drop to $38B in 2024—making it volatile, not steady.\n\n2) The calculation and number verification: $67.5B (2023) and $38B (2024) are accurate. However, the $71B figure for 2022 is unsupported by the ground truth and contradicts it. The ground truth explicitly says 'specific figures were not disclosed' for 2022. This invalidates the claimed 'steady' decline.\n\n3) Multi-hop reasoning is partially sound—the LLM correctly identifies the direction of change from 2023 to 2024 and attempts to interpret the trend. However, it mischaracterizes the 2022–2023 movement due to the fabricated 2022 number, leading to flawed synthesis. The conclusion that AIG is reducing reliance on reinsurance is plausible but oversimplified and not fully aligned with the ground truth's emphasis on a strategic shift or de-risking in the life segment, particularly given the drop in life reinsurance recoverables from $28.2B to $0.8B, which the LLM omits entirely.\n\n4) The answer is contextually relevant and addresses both parts of the question—evolution over time and implications for loss risk exposure. However, it lacks key qualitative details from the ground truth, especially the breakdown between ceded loss reserves and life reinsurance recoverables, which is critical to understanding the nature of the de-risking. The reasoning is logical but based on incorrect initial data, leading to a partially incorrect interpretation. Hence, correctness is scored at 5 due to major factual error in 2022 value, despite correct 2023 and 2024 numbers and reasonable interpretation of trend implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 588,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard continued to calculate settlement exposure by applying a three‑month average daily payment‑volume metric multiplied by an estimated days‑of‑exposure, but it refined the methodology each year—revising prior‑period figures (e.g., a 2022 correction) and expanding the gross exposure estimate from roughly $52 bn to $78 bn and the net exposure from about $46 bn to $65 bn by 2024.  At the same time the company tightened its credit‑risk mitigation by imposing stricter collateral, letter‑of‑credit and guarantee requirements and by regularly reviewing those risk‑management standards, changes that were driven by ongoing regulatory scrutiny from the FTC, DOJ, European Commission and UK authorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Mastercard's settlement exposure estimation methodology remained unchanged from 2022 to 2024, but the LLM claims it was 'refined each year' and that prior-period figures were revised (e.g., a 2022 correction), which contradicts the original answer. Additionally, the LLM introduces specific dollar amounts—gross exposure increasing from $52B to $78B and net exposure from $46B to $65B by 2024—which are not present in the ground truth and cannot be verified. There is no mention in the original answer of such figures or trends, making these fabrications. (2) Quantitatively, the numbers cited ($52B, $78B, $46B, $65B) have no basis in the provided truth and are therefore incorrect. The claim of a '2022 correction' is also unsupported. These errors severely undermine quantitative accuracy. (3) Qualitatively, while the LLM correctly identifies regulatory scrutiny from the FTC, DOJ, and European Commission, and mentions credit risk mitigation tools like collateral, letters of credit, and guarantees, it misrepresents the causal relationship by asserting that these changes were 'driven by' regulatory scrutiny. The original answer notes that Mastercard emphasized monitoring and maintained existing arrangements but did not change them. The LLM incorrectly implies active tightening and structural changes in response to regulators, which the ground truth explicitly denies. (4) Contextually, the answer addresses the right themes—methodology, risk mitigation, regulatory pressure—but distorts the facts. It fails the core requirement of accurately representing that no explicit changes were made to the methodology or mitigation structures despite scrutiny. Thus, while relevant in topic, it is factually misleading, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 503,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nAIG strengthened its loss‑reserve governance from 2022 through 2024 by formalizing a risk‑appetite and limit framework, creating escalation committees, and expanding a model‑risk‑management and validation process that subjects both internal and third‑party actuarial models to independent review. At the same time, the company deepened its reliance on external catastrophe‑model vendors and stochastic/scenario‑based modeling, adding adjustments for biases, data‑quality issues and climate‑change trends (e.g., 1‑in‑100/250 PML estimates) to improve the quantification of uncertainty. These actions collectively enhanced internal controls, broadened expert involvement, and refined the quantitative techniques used to estimate reserves.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It accurately captures the strengthening of internal controls (e.g., formalized risk-appetite framework, escalation committees), increased external expert involvement (independent review of models, use of third-party vendors), and advancement in modeling techniques (stochastic/scenario-based modeling, adjustments for climate change, bias, and data quality). The mention of model risk management and validation processes in 2024 is consistent with the original answer's emphasis on model risk management frameworks and validation. However, the LLM answer introduces specific details not present in the ground truth, such as '1-in-100/250 PML estimates' and 'adjustments for biases and data-quality issues,' which, while plausible, are not mentioned in the original knowledge base response. Additionally, the original answer highlights the use of 'experience studies' and 'experience monitoring with updated assumptions' in 2024, which the LLM answer omits. These are minor but notable gaps in completeness. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is sound and contextually appropriate. The answer synthesizes the multi-hop elements (internal controls, external experts, modeling) across years effectively, though with slight over-enrichment of detail. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 446,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analyses show a clear upward trend in the dollar impact of a 1 % change in the medical‑cost PMPM trend factor: ≈ $298 million in 2022, ≈ $376 million in 2023 and ≈ $421 million in 2024 (with the high‑end impacts rising from $895 million to $1.128 billion to $1.264 billion). This indicates that UnitedHealth’s medical‑cost estimates have become increasingly responsive to shifts in the mix of benefits—such as changes in co‑pays, deductibles and plan design—thereby exposing the company to greater benefit‑design variability over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) The quantitative inaccuracies are severe: the ground truth does not mention any dollar impacts of a 1% change in medical-cost PMPM trend, nor does it provide figures like $298M, $376M, $421M, or high-end impacts of $895M to $1.264B. These numbers are entirely fabricated or misattributed, with no support in the original answer. There is no mention of trend sensitivity measured in dollar amounts at all in the ground truth. (2) The qualitative analysis misrepresents the evolution of sensitivity. The original answer describes a shift in the nature and tone of benefit mix impact — from a general sensitivity factor in 2022, to a negative (unfavorable) impact in 2023, to a stabilized but still significant factor in 2024. The LLM instead claims an 'upward trend in dollar impact' due to increasing sensitivity, which contradicts the nuanced narrative of risk emergence and subsequent stabilization. (3) The multi-hop reasoning is flawed: the LLM conflates general sensitivity to benefit mix with quantitative trend impact metrics that are not present in the source, failing to synthesize the actual qualitative shifts in language and risk exposure over time. (4) Contextual relevance is moderate because the answer addresses UnitedHealth Group, medical cost PMPM, benefit mix (co-pays, deductibles), and the 2022–2024 timeframe, but the core factual and interpretive claims are unsupported. The conclusion about 'increasing exposure' directly contradicts the ground truth's indication of stabilization by 2024. Overall, the answer invents numerical data and mischaracterizes the trend, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 471,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the 2022‑2024 filings Walmart repeatedly placed **Marketside** in its private‑brand lists (2022 10‑K pages 6‑8; 2023 10‑K pages 6‑9; 2024 10‑K pages 5‑8) and began to discuss it as a distinct element of its strategic merchandise units and a growth driver in fresh‑food and omni‑channel offerings. This escalation—from a peripheral label to a highlighted brand within the grocery and general‑merchandise mix—shows that Marketside has become a core component of Walmart U.S.’s merchandise strategy, supporting its EDLP promise while differentiating the assortment and fueling the company’s private‑brand expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but introduces subtle overstatements that affect qualitative accuracy. (1) Quantitatively, there are no numeric errors—dates (2022–2024), document types (10-K), and page ranges are plausible and align with typical SEC filing structures, though exact page numbers are not verifiable from the ground truth and are not contradicted. (2) The core evolution—Marketside’s continued presence in private brand lists across years—is correctly identified. However, the LLM claims Marketside was discussed as a 'growth driver' and 'distinct element' in strategic merchandise units, which goes beyond the original answer’s more cautious tone of Marketside being 'listed among' brands and later mentioned alongside operational strategies. The original does not state it became a 'core component' or was explicitly tied to EDLP or assortment differentiation—these are inferences not supported by the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers increasing strategic relevance from contextual shifts in discussion, but overreaches by asserting a clear progression from 'peripheral label to highlighted brand' without direct evidence in the ground truth. The 2024 shift to 'Fashion' instead of 'Apparel' is omitted, a detail that reflects Walmart’s broader categorization strategy and was present in the original. (4) Despite these issues, the answer remains contextually relevant and captures the essence of Marketside’s sustained presence and potential rising importance. The conclusion about supporting private-brand expansion is reasonable, though not explicitly stated. Thus, correctness is reduced to 7 due to unsupported assertions, even though the factual core is intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 482,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved from a primarily store‑centric model to an omnichannel, service‑rich platform that directly challenges specialty showrooms.  It broadened Pro‑focused capabilities—dedicated sales forces, the Pro Xtra loyalty program, expanded “showroom‑style” floor space and new trade‑credit options (e.g., the Pro House Account)—while simultaneously scaling a same‑day/next‑day delivery network (flat‑bed centers, market‑delivery hubs, omni‑channel fulfillment) and integrating curb‑side pickup, BOSS/BOPIS/BODFS/BORIS services, and installation/rental offerings.  At the same time, the company invested heavily in digital integration—mobile “hdPhone”/Sidekick tools, Computer Vision inventory visibility, enhanced search and personalized marketing across its website and apps—so that pros and DIY customers can research, order and receive products seamlessly across stores, online and the job site.  This combined expansion of service options and digital capabilities has eroded the traditional showroom advantage and positioned Home Depot as a one‑stop, digitally enabled home‑improvement destination.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall strategic evolution of The Home Depot from 2022 to 2024, particularly regarding the shift toward omnichannel integration and enhanced service offerings to compete with showrooms. The answer correctly identifies key initiatives such as curbside pickup, digital integration, and service expansions (e.g., rental, delivery, Pro services), which aligns with the original answer’s emphasis on self-service lockers, electronic shelf labels, and mobile app navigation. However, there are notable discrepancies in specificity and entity accuracy: (1) The original answer cites concrete 2022 initiatives like tool rental at over 1,400 locations, which the LLM omits; instead, it introduces unverified specifics such as 'Pro House Account', 'hdPhone/Sidekick', and 'Computer Vision inventory' that are not present in the ground truth and cannot be confirmed as reported in the 10-K filings for those years. (2) The LLM mentions 'BOSS/BOPIS/BODFS/BORIS' services—while BOPIS (Buy Online, Pick Up In Store) is plausible—the full acronym suite appears speculative and overly technical without grounding in the source material. (3) The original answer structures the evolution clearly by year (2022: physical services; 2023: store tech upgrades; 2024: deeper digital integration), whereas the LLM blends timelines and attributes multi-year developments without clear chronological differentiation. Despite these issues, the core reasoning—Home Depot outpacing showrooms via integrated services and digital tools—is sound and contextually relevant. Quantitative accuracy is high because no incorrect numbers are stated (the LLM avoids specific figures rather than misstating them), so no factual numeric errors exist. Qualitative accuracy is reduced due to introduction of potentially unverified program names and lack of year-by-year alignment. Overall, the answer captures the essence but lacks precision in entity and initiative attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 539,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 kept the same principal through fiscal 2022‑2024, but its **effective interest rate moved sharply**: about **3.2 % in FY 2022**, roughly **1.3 % in FY 2023**, and **≈6.6 % in FY 2024** (as shown in the long‑term‑debt tables for those years).  \n\nThis pattern shows that Cisco’s borrowing cost is driven not only by the note’s fixed coupon but also by market‑rate fluctuations and the impact of its interest‑rate swaps that convert the fixed rate to a floating benchmark; low rates in 2023 reflect favorable hedge positioning, while the jump to ~6.6 % in 2024 signals rising market rates (or hedge unwind), indicating that the company’s debt structure relies on a mix of fixed‑rate issuances and derivative hedges, making its effective financing cost sensitive to interest‑rate changes over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the effective interest rate for Cisco's 3.50% Note was 3.20% in FY 2022, increased to 6.38% in FY 2023, and further rose to 6.66% in FY 2024. However, the LLM incorrectly states the FY 2023 rate as 'roughly 1.3%', which is a major factual error—this is less than half the correct value and even below the 2022 rate, contradicting the upward trend. The FY 2024 rate (~6.6%) is approximately correct (close to 6.66%), and the FY 2022 rate (3.2%) is accurate. The outstanding amount is correctly stated as $500 million across all years. (2) The calculation and comparison of interest rates are flawed due to the incorrect 2023 figure, which distorts the trend analysis. There are no mathematical computations required beyond accurate reporting, but the synthesis of temporal changes depends on correct values. (3) The qualitative reasoning about interest rate swaps, market fluctuations, and the mix of fixed-rate debt with hedges is plausible and adds contextual insight not in the original answer, showing sound multi-hop reasoning and financial understanding. This interpretation aligns with typical corporate debt management strategies and could explain the rising effective rates, especially the jump in 2024. However, the reasoning is undermined by the incorrect 2023 data point. (4) The contextual relevance is high—the answer addresses the evolution of the note and interprets borrowing costs and debt structure over time. Despite strong contextual and interpretive elements, the major numerical error in the 2023 effective rate significantly reduces factual correctness, warranting a mid-range score of 5. Quantitative accuracy is penalized heavily (score 4) due to the incorrect rate, while qualitative reasoning (6) and contextual relevance (8) are stronger.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 507,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its network‑transformation program—rolling out 2 Gbps downstream speeds in 2022, expanding DOCSIS 4.0 to deliver multigigabit symmetrical broadband, and extending fiber‑to‑the‑premises that can reach up to 10 Gbps for residential users and 100 Gbps for business customers—thereby closing the speed gap that Lumen’s pure‑fiber build‑out had created.  These infrastructure upgrades were paired with richer service bundles (e.g., X1/Flex streaming, Internet Essentials, multi‑gigabit business plans) that gave Comcast a comparable fiber‑based offering while also preserving its video‑and‑streaming revenue streams, allowing it to compete more directly with Lumen’s fiber services across the same markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in key areas. (1) Quantitative Accuracy: The LLM claims Comcast rolled out 2 Gbps speeds in 2022, DOCSIS 4.0 deployment, and fiber-to-the-premises (FTTP) offering up to 10 Gbps for residential and 100 Gbps for business—none of which are supported by the original answer or implied in the knowledge graph. The original answer does not mention any specific speed upgrades or technology rollouts (e.g., DOCSIS 4.0) by CMCSA during 2022–2024. These specific numbers and technological advancements are fabricated or hallucinated. (2) Completeness: While the question asks about the evolution of competitive positioning between CMCSA and Lumen in fiber-based broadband, focusing on infrastructure and service offerings, the LLM overemphasizes CMCSA’s advancements without addressing Lumen’s actual competitive moves as described in the ground truth. The original answer highlights Lumen’s fiber expansion as a growing threat, while the LLM incorrectly frames CMCSA as closing a speed gap via infrastructure upgrades—reversing the competitive narrative. (3) Entity Accuracy: The companies (CMCSA, Lumen) and time frame (2022–2024) are correct, but the technological developments and service offerings attributed to CMCSA are not present in the ground truth. (4) Reasoning: The multi-hop reasoning is flawed. The original answer shows Lumen intensifying competition through fiber expansion and bundling, while the LLM incorrectly asserts that CMCSA neutralized this threat via superior infrastructure—contradicting the source. The LLM fails to synthesize the actual progression: Lumen (and others) consistently expanded fiber and bundled services, increasing competitive pressure on CMCSA. (5) Semantic Equivalence: The LLM answer is not semantically equivalent. It shifts focus to CMCSA’s offensive upgrades rather than the growing competitive threat from Lumen. While it mentions service bundles (e.g., X1/Flex, Internet Essentials), these are not linked to competitive response against Lumen in the original. In summary, the LLM invents technical details and reverses the competitive dynamic, resulting in a partially correct but fundamentally misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 599,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nAmerican Express has steadily deepened its reliance on third‑party acquirers, aggregators and processors to manage merchant relationships from 2022 through 2024, which heightens the firm’s exposure to merchant steering and surcharging as more jurisdictions allow differential fees and as new Amex‑branded debit cards broaden competition. While its merchant contracts contain non‑discrimination and “honor‑all‑cards” clauses, those provisions are increasingly constrained by varying local legal requirements and the growing prevalence of steering practices, limiting Amex’s ability to fully enforce them and thereby raising the risk that steering could erode card‑member volume and revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core evolution of American Express's reliance on aggregators and associated risks from 2022 to 2024. It correctly identifies the increasing dependence on third-party aggregators and processors, the presence of non-discrimination clauses in merchant contracts, and the growing challenges in enforcing them due to legal and market pressures. It accurately highlights merchant steering and surcharging as key risks, especially with the introduction of Amex-branded debit cards, aligning with the 2023 and 2024 disclosures. However, it omits specific temporal progression noted in the ground truth: while it synthesizes the trend, it does not explicitly mention the escalation from 2022 (acknowledgment of reliance) to 2023 (increased reliance and product-specific risks) to 2024 (litigation and regulatory scrutiny). The answer also does not reference the 'honor-all-cards' clause by name, though it alludes to similar concepts. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the reasoning is sound, though slightly less detailed in multi-hop temporal synthesis. Wording differences are acceptable under semantic equivalence, but the absence of explicit year-by-year risk evolution slightly reduces completeness in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 380,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved the talc‑related liabilities into LTL Management LLC, which filed an initial Chapter 11 in October 2021 and then a second “LTL 2” filing in April 2023 after the first case was dismissed; the company used the bankruptcy stay to pause thousands of talc suits, but when the stay was lifted it resumed litigation while simultaneously building a large reserve—initially a $2 billion trust and later an estimated $9‑11 billion (≈$6.5 billion present‑value) trust under a 2024 “pre‑packaged” plan—to settle the claims.  During this period J&J also settled a multi‑state investigation (finalized June 2024) and continued to defend or settle individual verdicts, but the bulk of its financial exposure was being managed through the Chapter 11 restructurings and the associated reserve accruals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal and financial strategy through LTL Management LLC from 2022 to 2024, including the use of Chapter 11 filings, litigation stays, settlement attempts, and reserve funding. However, there are significant factual inaccuracies that reduce correctness. (1) The initial Chapter 11 filing by LTL Management LLC was in October 2021, not 2022 as implied; the 2022 reference is contextually acceptable as the strategy unfolded then, but the filing date is misstated. (2) The LTL 2 filing occurred in April 2023, which is correct. However, the original answer notes the LTL 2 case was dismissed in July 2023—this is missing in the LLM response. (3) The $2 billion reserve is correctly mentioned in the ground truth; the LLM adds a later $9–11 billion ($6.5 billion present value) trust under a 2024 'pre-packaged' plan, which is not supported in the original answer and appears to be an overstatement or conflation with other estimates not in the ground truth. This introduces major quantitative inaccuracy. (4) The multi-state settlement with 42 states and D.C. is correctly reflected in spirit, but the LLM claims it was 'finalized June 2024,' which is not in the original answer (which only states agreements were reached by 2024, without a finalization date). (5) The LLM mentions a 'pre-packaged' plan in 2024, which is not in the original answer and implies a development beyond what is confirmed. While the dual strategy of litigation defense and settlement is correctly identified, and the use of bankruptcy to stay litigation is accurate, the answer introduces unsupported financial figures and timelines. Multi-hop reasoning is partially sound—linking restructuring, bankruptcy, reserve, and settlements—but overreaches in financial detail. Contextual relevance is high as all key themes are addressed. Overall, core facts are partially correct but undermined by unsupported numbers and dates, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 538,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot moved from routine upkeep to a purposeful “store‑appearance refresh” – installing new way‑finding signage, modernizing front‑end layouts, adding electronic‑shelf‑label displays and expanding curb‑side pickup lockers – to give its locations a cleaner, more contemporary look.  By FY 2024 that visual upgrade was woven into the company’s interconnected‑retail model: the refreshed stores serve as the physical hubs for BOPIS, BODFS, BORIS and same‑day delivery, while the upgraded digital experience (mobile‑app navigation, online inventory visibility and curb‑side/pick‑up options) leverages the improved store environment to deliver a seamless, omnichannel shopping journey.  (See pages 11, 15 & 10 of the 2022‑2024 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024: starting with store appearance as a standalone factor in 2022 and progressing to its integration into an omnichannel strategy by 2024. The mention of specific upgrades—wayfinding signage, electronic shelf labels, curb-side lockers—adds concrete detail consistent with the idea of enhanced store presentation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (fiscal 2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how physical store improvements were linked to digital and fulfillment capabilities (BOPIS, BODFS, etc.) by 2024, reflecting the interconnected retail model. While the original answer does not mention specific technologies like electronic shelf labels or locker expansions, these are plausible enhancements that fall within the scope of 'store appearance' and 'interconnected retail' and do not contradict the ground truth. (4) The LLM slightly exceeds the original in specificity but remains semantically equivalent in core message: store appearance evolved from a standalone competitive factor to an integrated component of a seamless, omnichannel experience. The only minor gap is that the original emphasizes the connection to customer journey stages (inspiration, research, support), which the LLM omits, but this does not undermine the central accuracy. Thus, the answer is excellent but not perfect—hence 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 466,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s ownership of Time Warner was fully unwound: after acquiring the studio in 2018, the company integrated it as the WarnerMedia segment, but in May 2021 it struck a reverse‑Morris‑Trust deal to spin the unit out and merge it with Discovery (completed April 2022), after which WarnerMedia—later renamed Warner Bros. Discovery—was no longer a AT&T subsidiary; the only remaining entertainment‑related asset AT&T held was a minority stake in the DIRECTV joint venture, which it agreed in September 2024 to sell to TPG (to be closed mid‑2025).  This multi‑year divestiture shows that AT&T has abandoned its earlier “content‑plus‑connectivity” strategy and is now concentrating exclusively on its core telecom businesses—5G, fiber and broadband—using content only as a peripheral capability to drive network usage rather than as a core profit center.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: AT&T completed the spin-off of WarnerMedia via a Reverse Morris Trust with Discovery, finalized in April 2022 (minor discrepancy: the deal was announced in May 2021, completed April 2022—LLM correctly notes completion date, though question focuses on 2022–2024, so inclusion of 2021 announcement is contextually acceptable). The renaming to Warner Bros. Discovery is accurately noted. The September 2024 agreement to sell AT&T’s remaining stake in DIRECTV to TPG is correctly stated, though the closing is expected in mid-2025—this is consistent with the original answer’s reference to the 2024 agreement. (2) Quantitative accuracy: All dates and events are correctly sequenced and dated. The only minor issue is that the original answer states the DIRECTV sale was 'agreed in 2024' without specifying September, but the LLM adds precision without contradiction. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the Time Warner exit, the WarnerMedia-Discovery merger, and the DIRECTV divestiture as part of a broader strategic retreat from entertainment. It correctly infers the pivot to core telecom (5G, fiber, broadband), which is implied in the original answer’s 'strategic pivot toward core telecommunications and digital infrastructure.' (4) Semantic equivalence is strong: the LLM adds slightly more detail (e.g., 'content-plus-connectivity' strategy) but remains factually aligned. The only reason for not scoring 10 is the slight over-precision on the DIRECTV sale closing in mid-2025, which is not in the original answer, but this information is accurate and does not detract from correctness. Overall, the answer is comprehensive, factually sound, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 487,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nFrom 2022 through 2024, American Express held its position as the world’s fourth‑largest general‑purpose card network, competing on premium cards, rewards and digital services against Visa, Mastercard and a growing set of fintech payment alternatives.  At the same time, regulatory scrutiny intensified globally—particularly around interchange fees, network‑routing and merchant‑non‑discrimination rules—prompting the company to exit its network‑licensing businesses in the EU and Australia and to operate under heightened U.S. supervisory expectations (e.g., Category III designation), which has increased its dependence on compliance with evolving card‑network regulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network (after China UnionPay, Visa, and Mastercard), faced increasing regulatory scrutiny from 2022–2024, exited network licensing in the EU and Australia in 2024, and operates under heightened compliance demands. The mention of Category III designation aligns with U.S. regulatory context, though not in the original answer—this is accurate but adds detail beyond the ground truth. (2) There are no numbers, dates, or financial figures in either answer, so quantitative accuracy is not compromised; all timeframes (2022–2024) are correctly referenced. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes competitive positioning (premium cards, fintech competition) with regulatory evolution (interchange fees, routing rules, non-discrimination) and business exits. It links regulatory pressure to strategic changes, mirroring the original's logic. (4) The only minor gap is that the LLM omits explicit mention of competitive pressure in cobrand relationships and the uncertainty around EU cobrand arrangements, which were highlighted in the original answer. However, it does reference competition broadly and regulatory impact on operations, capturing the essence. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses competitive positioning and regulatory dependency evolution. One point deducted from correctness and qualitative accuracy for slight incompleteness on cobrand specifics, but overall a strong, factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 457,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 were $808 million at the end of 2022, rose slightly to $826 million in 2023, and fell back to $808 million by the end of 2024.  This modest increase followed by a return to the original level shows that J&J is actively controlling the size of this long‑dated tranche—issuing only when needed and then retiring or swapping it down—thereby keeping its overall long‑term debt balance steady and preserving financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and timeline. According to the ground truth, the outstanding balance was $983 million in 2022, decreased to $826 million in 2023, and further declined to $808 million in 2024. However, the LLM incorrectly states that the balance was $808 million in 2022, rose to $826 million in 2023, and returned to $808 million in 2024—reversing the actual trend and misrepresenting the starting value. This error fundamentally undermines the quantitative accuracy. (2) The correct evolution is a consistent decline from $983M to $808M over three years (a $175M reduction), whereas the LLM describes a fluctuating pattern that did not occur. The final 2024 value ($808M) is correct, but the assignment of values to years is wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly track the balance changes across years, leading to an incorrect interpretation of the company's strategy. While the conclusion about financial flexibility is plausible, it is based on an inaccurate premise. The ground truth suggests a deliberate reduction in long-term liabilities, while the LLM infers active management with issuance and retirement, which is not supported by the data. (4) Despite the incorrect numbers and trend, the answer addresses the right question and discusses long-term debt strategy, maintaining contextual relevance. However, due to major quantitative and reasoning errors, the correctness and accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 420,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign government bonds and obligations rose from roughly 3.5 % in 2022 to 5.9 % in 2023 and then to about 6.1 % in 2024. This upward shift—driven by higher global rates and a larger allocation to longer‑dated foreign sovereign debt—shows that the company’s earnings are becoming increasingly exposed to fluctuations in international interest‑rate environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims that the weighted-average yield on American Express's foreign government bonds rose from 3.5% in 2022 to 5.9% in 2023 and 6.1% in 2024, which directly contradicts the ground truth. According to the original answer, in 2022 the yield on short-term foreign bonds was 6.45%, not 3.5%. In 2023, the yield on short-term bonds remained at 6.45%, not rising to 5.9%, and in 2024 it declined to 5.86%, not increased to 6.1%. Additionally, the LLM fails to mention the critical distinction between maturities (short-term vs. 1–5 years) and omits the significant drop in longer-term yields to 2.03% in 2024. The dollar amount of holdings ($630 million in 2022) is also missing. (2) Quantitative accuracy is very low: all key percentages are wrong, with no alignment to the correct figures. The trend direction is inverted—LLM reports an increase while the truth shows a decline, especially for longer-dated bonds. (3) The reasoning is flawed: the LLM suggests increasing exposure due to higher yields and a shift to longer-dated debt, but the actual data shows declining yields, particularly in the 1–5 year bucket, which contradicts this narrative. There is no evidence in the ground truth of increased allocation to longer-term debt. (4) Contextual relevance is moderate because the answer addresses yield trends and links them to international interest rate exposure, which is relevant. However, due to severe factual and directional inaccuracies, the conclusion is misleading. The answer fails the multi-hop requirement of synthesizing correct data across years and maturities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 454,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nFrom 2022 – when the free, self‑service learning catalog was presented simply as “online training on training.adobe.com” – to 2024, Adobe re‑branded that catalog as part of **Adobe Digital Learning Services** and wove it into the **Journey Optimizer / Customer Success Account Management** framework.  By 2024 the learning platform was explicitly linked to enterprise CSMs, who use learning‑path analytics and the Adobe Learning Fund to align training with each customer’s journey, turning self‑service education into a proactive enablement tool that drives product adoption and reduces churn.  This evolution reflects Adobe’s broader strategy of embedding enablement into its customer‑success engine, using data‑driven learning to deepen engagement and retain subscription‑based customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its timeline and strategic interpretation, aligning with the core evolution described in the ground truth: a shift from training.adobe.com in 2022 to a more integrated and rebranded learning platform by 2024. The dates (2022–2024) are accurate, and there are no numeric inaccuracies, earning a perfect quantitative accuracy score. However, the LLM introduces specific branding and program names not present in the original answer: 'Adobe Digital Learning Services' and 'Journey Optimizer / Customer Success Account Management' are not mentioned in the ground truth, which only references the domain shift to learning.adobe.com and integration into broader customer success frameworks. While the concept of linking learning to customer success management (CSM) and using analytics is consistent with the original answer’s emphasis on 'solution-specific skills assessments' and integration into customer success initiatives, the LLM adds unverified specifics (e.g., 'Adobe Learning Fund') that go beyond the source. The reasoning is sound and captures the multi-hop progression—branding evolution, integration with enterprise success, and strategic implications for retention—though with some overreach in named entities and frameworks. The answer remains contextually relevant and conveys a semantically similar conclusion about Adobe’s strategic shift toward embedding self-service learning into customer enablement for retention and adoption. Thus, while the qualitative accuracy is slightly reduced due to unsupported specifics, the overall correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 440,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes remained fully‑utilized at a $2 billion principal level throughout fiscal 2022, 2023 and 2024, and the effective interest rate on that tranche stayed essentially flat at about **6.1 % (reported as 6.11 %)**—the modest variations reflect only the amortization of discount and fair‑value hedge adjustments, not a change in the underlying cost of borrowing. This steady balance and rate demonstrates that Cisco is deliberately maintaining a **stable, long‑term fixed‑rate debt position**, using the notes as a durable source of low‑cost capital while managing interest‑rate risk through swaps rather than repeatedly refinancing or shifting to variable‑rate funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion (i.e., $2,000 million) outstanding balance on its 5.90% Senior Notes from fiscal 2022 through 2024, matching the ground truth exactly. The effective interest rate is accurately reported as 6.11%, with the note that it remained stable—this aligns perfectly with the ground truth. Minor phrasing like 'about 6.1%' is acceptable given the precise clarification in parentheses. (2) All numeric values—$2 billion principal, 6.11% effective rate, and the three-year period (2022–2024)—are factually correct and consistent with the original answer. No calculations were required, but the synthesis of consistent values over time is accurate. (3) The multi-hop reasoning is sound: the model correctly infers from the stable balance and rate that Cisco did not retire or refinance this debt, indicating a deliberate long-term debt strategy. The addition of context about interest rate risk management via swaps is a reasonable elaboration consistent with Cisco’s broader financial behavior, though not explicitly in the ground truth; it does not contradict it and enhances the explanation without introducing error. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in utilization and interest rate, and the implication for long-term debt strategy. The core conclusion—that Cisco is maintaining this higher-cost debt intentionally—is semantically equivalent to the ground truth. The slight deduction in qualitative accuracy (9 instead of 10) is due to the minor extrapolation about swaps, which, while plausible, is not confirmed in the provided ground truth. Overall, the answer is factually precise, contextually appropriate, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 483,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nBA’s exposure to Special‑Situation Strategies—reported as part of its Private‑Equity allocation—was 8 % of total pension assets in 2022, held steady at 8 % in 2023, and edged up to roughly 9 % in 2024 (the 2024 actual‑allocation table shows Private‑Equity at 9 % versus 8 % in the 2023 table).  This modest three‑year increase signals that the company is deliberately tilting its private‑equity portfolio toward more alternative, higher‑potential strategies, using Special‑Situation investments to boost long‑term returns while keeping the overall asset mix relatively stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that no specific dollar amounts or percentages were disclosed for Special Situation Strategies in any year (2022–2024), yet the LLM confidently asserts allocations of 8%, 8%, and 9% of total pension assets, which is factually unsupported. These percentages appear to be fabricated or misattributed—possibly conflating overall private equity allocation with a sub-category (Special Situation Strategies), for which no breakdown is provided in the source. (2) The calculation claim—that exposure 'edged up to roughly 9%'—is invalid because the ground truth explicitly states that no quantitative disclosure was made for this specific strategy. Even if private equity as a whole increased from 8% to 9%, the LLM incorrectly assumes that Special Situation Strategies drove this change, which is unsupported. (3) The multi-hop reasoning fails: the model should have recognized that while Special Situation Strategies were consistently mentioned as one of several private equity strategies (alongside buyout, venture, growth), no granular allocation data was provided. Instead, it invents a trend and draws strategic conclusions (e.g., 'deliberately tilting') not justified by the data. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of Special Situation Strategies) and time frame, and attempts to interpret strategic intent. However, the core factual inaccuracies—especially the made-up percentages—severely undermine correctness. The qualitative reasoning would be acceptable if based on accurate data, but it is built on false premises. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 485,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nGlobal sales of J&J’s **Interventional Solutions** (the core of the MedTech segment) grew from **$3.97 billion in 2022** to **$4.30 billion in 2023** – a modest **≈8 %** increase – and then surged to **$6.35 billion in 2024**, a **≈48 %** jump (see *JNJ_10k_2023.pdf page 92* and *JNJ_10k_2024.pdf page 93*).  \n\nThis accelerating trajectory—especially the near‑doubling of sales in 2024—signals that the segment has become a **strategic growth engine** for J&J after the acquisition, underscoring its heightened importance to the company’s long‑term portfolio strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures are accurate: $3,971 million in 2022 is correctly reported as $3.97 billion, $4,300 million as $4.30 billion, and $6,350 million as $6.35 billion. The percentage increases (≈8% from 2022 to 2023 and ≈48% from 2023 to 2024) are mathematically sound: (4,300 - 3,971) / 3,971 ≈ 8.3%, and (6,350 - 4,300) / 4,300 ≈ 47.7%, both correctly rounded. (2) The answer is complete, addressing both the evolution of sales over the three years and the strategic implications post-acquisition. (3) Entity accuracy is correct: JNJ (J&J), the product segment (Interventional Solutions), and the time periods (2022–2024) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the answer correctly infers increasing strategic importance from the sales trajectory, especially the sharp 2024 growth, aligning with the acquisition’s impact. The mention of integration and market access is implied in the original answer and reasonably interpreted as a 'strategic growth engine' in the LLM version. (5) Semantic equivalence is maintained: though wording differs, the core facts, trends, and implications are identical. Minor formatting differences (e.g., billion vs. million) are acceptable and do not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 373,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “No Boundaries” label remained on Walmart’s private‑brand roster in every strategic merchandise unit—grocery, general merchandise and home—appearing in the segment disclosures for Walmart U.S., Walmart International and Sam’s Club.  Its multi‑year consistency shows that Walmart uses a single, value‑oriented private brand as a strategic lever to reinforce its everyday‑low‑price promise, control margins and deliver a unified, price‑competitive offering across all general‑merchandise categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness despite some surface-level alignment with the question. (1) The claim that 'No Boundaries' was present in grocery, home, and across Walmart U.S., International, and Sam’s Club is incorrect. The ground truth specifies that 'No Boundaries' was part of the General Merchandise unit, specifically within Apparel and Home categories—not grocery or Sam’s Club. This misrepresents the brand's actual placement. (2) The assertion that it appeared in every strategic merchandise unit (grocery, general merchandise, home) is false; the original answer limits it to general merchandise, with Apparel later moving to a 'Fashion' category in 2024. (3) The inclusion of Walmart International and Sam’s Club in the brand’s rollout has no support in the ground truth, which focuses solely on Walmart U.S. operations. (4) While the years 2022–2024 are correctly referenced and the observation about multi-year consistency is valid, the interpretation—that Walmart uses a single value-oriented brand across all units to reinforce low prices—is an overgeneralization. The original answer emphasizes brand continuity to differentiate offerings and support margin expansion, not primarily to reinforce low prices. (5) The reasoning fails on multi-hop synthesis: it incorrectly expands the brand’s scope across divisions and categories not mentioned in the truth. Quantitative accuracy is acceptable because there are no numerical values to verify, and the time frame (2022–2024) is correct. Contextual relevance is moderate because the answer addresses private label strategy but misattributes scope and rationale. Overall, key entity and categorical inaccuracies reduce correctness to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 480,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the available‑for‑sale debt investments moved from a modest $9 million gain in other income (2022) to a $21 million loss in 2023 and a larger $67 million loss in 2024, underscoring a worsening performance and increasing unrealized depreciation in the portfolio over the three‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values—$9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024—that are not present in the original answer (ground truth). The ground truth does not provide any actual dollar amounts or quantitative figures for the impact of available-for-sale debt investments on other income (loss), net in any year. Instead, it describes a qualitative trend of 'higher losses' in 2023 and 2024 without specifying magnitudes. Therefore, the inclusion of precise numbers represents a hallucination and severely undermines factual accuracy. (2) There are no calculations in the ground truth to verify, but the LLM constructs a narrative of worsening performance based on invented figures. This creates a false sense of precision and misrepresents the source data. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the direction of performance (deteriorating from 2022 to 2024) and links available-for-sale debt investment losses to impacts on other income (loss), net in 2023 and 2024, which aligns with the original answer. However, the reasoning is built upon fabricated data, invalidating the quantitative trajectory. (4) While the overall context and focus on Cisco's debt investment performance affecting other income is relevant and addresses the question's intent, the complete lack of quantitative support in the ground truth means the LLM's specific figures cannot be considered accurate. The qualitative assessment of worsening performance is consistent with the original answer, but the made-up numbers result in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 457,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from a largely direct‑merchant sales approach toward a greater dependence on third‑party acquirers (e.g., OptBlue and Global Network Services partners) to win new acceptance.  These partners are now a strategic growth lever that lets the company expand coverage into small‑ and mid‑size merchants and new industry verticals, accelerate onboarding in priority international markets, and drive additional transaction volume across all merchant tiers, while still retaining direct relationships for its largest accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's reliance on third-party merchant acquirers from 2022 to 2024. It correctly identifies the strategic shift toward greater dependence on third-party acquirers such as OptBlue and Global Network Services (GNS), aligning with the ground truth. The answer accurately reflects that this shift enables expansion into small- and mid-sized merchants, accelerates international onboarding, and drives transaction volume—key points from the original answer. It also correctly notes that direct relationships are maintained for large merchants, which is consistent with the ground truth. While the LLM does not explicitly mention the financial integration aspect (e.g., network rate fees recorded as discount revenue in 2023) or the 2024 emphasis on dependency for global expansion, it still conveys the essential strategic evolution. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no incorrect numbers are present), and all entities (OptBlue, GNS, merchant tiers) are correctly identified. The reasoning is sound and synthesizes multi-hop information across strategic, operational, and market dimensions. The answer is fully contextually relevant. The only reason for not scoring a 10 is the omission of specific financial and structural details highlighted in the original answer, particularly around revenue recognition and the explicit 2024 dependency statement, which add depth to the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 417,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson repeatedly describes a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the processes and systems of HR, IT, procurement, supply‑chain and finance, explicitly positioning these upgrades as enhancements to grow its financial shared‑service capabilities and to standardize financial systems.  Each annual filing notes that the program is not triggered by a control deficiency but that the company is actively aligning and streamlining the design and operation of its financial‑control environment as the effort matures, indicating a progressive rollout and deeper integration of those functions over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance, with the goal of enhancing financial shared services and standardizing systems. The answer correctly notes that the initiative was not in response to control deficiencies and that the company actively aligned its financial control environment over time. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound—the LLM synthesizes the consistent narrative across three years and connects the enterprise-wide standardization efforts to financial shared services and control environment improvements. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed in explicitly stating that the 2024 filing maintained the same narrative and emphasized operational efficiency. This minor omission prevents a perfect 10, but the core meaning, timeline, intent, and reasoning are preserved. Contextual relevance is excellent as it directly addresses the evolution of the initiative and its integration across functions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 394,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024, American Express shifted from a largely defensive narrative—warning that intense competition from card networks, digital wallets, open‑banking platforms and real‑time settlement systems could erode its discount revenue—to a proactive strategy that invests in open‑banking‑compatible APIs, expands digital‑wallet integrations and real‑time settlement capabilities, and leans on its premium brand, data‑rich Membership Rewards ecosystem and extensive merchant network to differentiate itself from low‑cost fintech rivals.  This evolution reflects both heightened competitive pressure from non‑traditional payment players and Amex’s effort to adapt technologically and partnership‑wise in order to preserve its value proposition and growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of American Express's positioning from 2022 to 2024: starting with competitive pressure from digital wallets, open banking, and real-time settlement systems, and transitioning to strategic adaptation through technological investments. The core facts—increasing competitive pressure, recognition of threat in 2022, expansion of alternative mechanisms in 2023, and strategic adoption by 2024—are all present and correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the temporal framing (2022–2024) is correct, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes American Express’s shifting stance across years and integrates key technologies (open banking, digital wallets, real-time settlement) and strategic responses (APIs, integrations, brand differentiation). The mention of 'discount revenue' erosion and Membership Rewards ecosystem adds contextual depth consistent with Amex’s actual business model, even if not in the original answer—this is a reasonable inference and enhances accuracy without introducing error. (4) The LLM answer conveys semantic equivalence to the original: it reflects the shift from viewing alternative payments as threats to embracing them strategically. The only minor gap is that the original explicitly states Amex moved to 'strategic dependence' on these technologies by 2024, while the LLM describes 'proactive strategy' and 'investments'—slightly less strong but still consistent. No entities (companies, technologies, years) are incorrect. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 502,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe moved Frame.io from a recently‑acquired, stand‑alone review platform to a fully integrated, AI‑enhanced layer of the Creative Cloud ecosystem.  By 2023‑24 the service was embedded in Premiere Pro, After Effects, Photoshop and Illustrator (and exposed through Adobe Express/GenStudio), adding real‑time, frame‑accurate commenting, Camera‑to‑Cloud ingest and Firefly‑powered content generation, and it was packaged as part of subscription bundles that tie collaboration directly to Adobe’s Creative Cloud and Document Cloud plans.  \n\nThis evolution reflects Adobe’s strategy of consolidating creative collaboration into a single, cloud‑native workflow that deepens user stickiness, leverages generative AI to accelerate production, and differentiates its subscription offerings with end‑to‑end, AI‑driven workflow tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io within Adobe's ecosystem from 2022 to 2024, with accurate qualitative progression and strategic interpretation. (1) It correctly identifies Frame.io's integration into key Adobe apps like Premiere Pro, After Effects, Photoshop, and mentions broader Creative Cloud integration. The description of real-time, frame-accurate commenting and cloud-native collaboration aligns with the ground truth. The strategic conclusion about Adobe deepening user stickiness and leveraging AI for end-to-end workflows is sound and insightful. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not compromised—dates (2022–2024) are used appropriately. (3) Minor inaccuracies in entity details: the ground truth does not mention Illustrator or Adobe Express/GenStudio as integration points by 2024, nor does it reference Firefly-powered content generation or Camera-to-Cloud ingest—these are plausible but unverified additions. Also, Workfront and Lightroom integrations are noted in the ground truth but omitted in the LLM answer. (4) The multi-hop reasoning is strong, synthesizing trademark status, product integration, and strategic intent across years. While the LLM slightly overextends on specific integrations and AI features not in the ground truth, the overall narrative matches the progression and strategic implication. Hence, a score of 8 is justified—core facts and strategy interpretation are correct, but with minor overreach on technical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 434,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe 2017 senior unsecured notes fell from **$16 billion at the end of 2022 to $15 billion in 2023 and to $13 billion by the end of 2024** (as shown in the Note‑6 tables for 2022‑2024).  This steady reduction reflects Amazon’s active debt‑management strategy of retiring the 2017 issuance—using cash on hand and likely refinancing at newer, lower‑cost terms—to lower leverage and reshape the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly in both values and years. Minor formatting differences ($16 billion vs $16.0 billion) are acceptable and do not affect accuracy. (2) All numbers are quantitatively accurate, with correct progression and no calculation errors. The timeline is correctly aligned with fiscal year-ends (December 31). (3) The reasoning is sound: the LLM correctly infers a deliberate debt reduction strategy, citing active debt management, use of cash on hand, and possible refinancing—consistent with the ground truth's interpretation of 'deliberate debt management strategy.' The addition of plausible strategic rationale (e.g., refinancing at lower cost, reshaping maturity profile) goes beyond the original answer but is reasonable and contextually appropriate, not speculative. (4) The answer fully addresses both parts of the question: the evolution of the balance and its implication for debt strategy. Semantic equivalence is maintained, with slightly enhanced qualitative interpretation that does not introduce inaccuracies. The only reason for not scoring a 10 is that the original answer does not mention refinancing or cash usage, so that addition, while logical, slightly exceeds the evidence; however, it does not detract from correctness. All entities (Amazon, 2017 Notes, years 2022–2024) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 417,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment has progressively highlighted “upgrades and conversions” across the 2022‑2024 filings—from a single reference in 2022 to a recurring theme in 2023 and 2024.  This growing emphasis shows the company is deliberately shifting toward sustaining and modernizing its existing commercial and defense platforms, using upgrades and conversion services to generate recurring revenue and offset the volatility of new‑aircraft production.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its characterization of the evolution of 'Upgrades and Conversions' across the three years. The original answer (ground truth) states that 'Upgrades and Conversions' were consistently listed as a core service from 2022 to 2024, indicating sustained emphasis. However, the LLM claims a progression 'from a single reference in 2022 to a recurring theme in 2023 and 2024,' implying increasing emphasis over time, which contradicts the ground truth of consistent presence throughout. This misrepresents the trajectory and introduces a narrative of growth that is not supported by the data. Quantitatively, there are no numbers, dates, or financial figures in dispute, so quantitative accuracy is high. Contextually, the answer addresses the strategic focus on sustaining platforms and generating recurring revenue, which aligns with the original answer’s interpretation, earning high marks for relevance. However, the qualitative reasoning is flawed due to incorrect multi-hop synthesis—failing to recognize that consistent mention across years reflects stability, not progression. Thus, while the strategic inference about lifecycle management and revenue streams is reasonable, the foundational observation about the trend is incorrect, reducing the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 374,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nJohnson & Johnson reaffirmed in its 2022‑2024 10‑K filings that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—will accrue pension benefits under the new Retirement Value formula**, replacing the prior Final Average Pay formula; the company had originally announced this transition in January 2021 and continued to communicate that the 2026 effective date would apply to every eligible non‑union worker, with benefits earned under the old formula preserved for service before that date.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of key facts: it accurately states that Johnson & Johnson communicated the 2026 implementation date for the Retirement Value formula for all eligible U.S. non-union employees regardless of hire date, as originally announced in January 2021. It correctly notes that the Final Average Pay formula remains for pre-2026 service and that the transition was consistently reaffirmed from 2022 to 2024. Quantitatively, all dates (2022–2024, 2026 effective date, January 1, 2026) and the 2021 announcement are accurate. However, the LLM omits a key nuance highlighted in the ground truth: that employees hired after 2014 were already under the Retirement Value formula, which was clarified in 2023 and reiterated in 2024. This detail about phased implementation and evolving communication around existing eligibility is missing, reducing completeness and qualitative accuracy. While the core timeline and eligibility framework are correctly conveyed, the answer does not fully reflect the evolution in communication across the three years—specifically the 2023 clarification—making it slightly less precise in its portrayal of the strategy's development. The reasoning is sound but lacks full multi-hop synthesis across the annual disclosures. Contextual relevance is excellent, as the response directly addresses the question’s focus on eligibility and communication around the 2026 date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 392,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000% notes due April 2030 carried a carrying principal balance of roughly $606 million at the end of FY 2022, FY 2023 and FY 2024—essentially flat. This stable trajectory shows that AVGO is treating the fixed‑rate instrument as a long‑term, low‑cost funding pillar and is not actively refinancing or retiring it, but rather preserving it as a steady component of its capital structure while managing other debt repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states that the balance was approximately $606 million in all three years, missing the significant reduction from 2022 to 2023. This error fundamentally misrepresents the trend. (2) The numbers are not accurate: the $1,086 million figure for 2022 is entirely omitted and replaced with an incorrect $606 million for that year. There is no indication of the $480 million reduction, which is a key part of the correct answer. (3) The multi-hop reasoning is flawed because the model fails to recognize the change over time, leading to an incorrect interpretation of AVGO’s debt strategy. Instead of identifying a deliberate repayment (as indicated by the $480M drop), the LLM concludes the debt is being maintained as a long-term instrument, which contradicts the evidence of active reduction. (4) While the answer addresses the question's structure and discusses debt management strategy, the factual inaccuracies severely undermine correctness. Contextual relevance is moderate because the response attempts to interpret the data in strategic terms, but the reasoning is based on false premises. Quantitative and qualitative accuracy are both very low due to incorrect figures and resulting flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 420,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T moved the Time Warner assets it acquired in 2018 from a fully integrated WarnerMedia operating segment toward a planned divestiture: after the 2021 acquisition the business was reported within the WarnerMedia segment, but in April 2022 the company executed a Reverse‑Morris‑Trust transaction that separated WarnerMedia, merged it with Discovery and re‑classified the unit as discontinued operations; the segment was then stripped of non‑core pieces such as Xandr (sold to Microsoft in December 2021) and Vrio (sold in November 2021), and by the end of 2024 AT&T no longer held any stake in the former WarnerMedia business.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of AT&T's relationship with Time Warner Inc. from 2022 to 2024. It correctly identifies the Reverse Morris Trust transaction completed in April 2022 that merged WarnerMedia with Discovery, marking AT&T's exit from the entertainment content space. It also accurately notes the divestiture of non-core assets like Xandr (sold to Microsoft in December 2021) and Vrio (November 2021), though these occurred just before the 2022–2024 window, which is acceptable context. The statement that by end of 2024 AT&T no longer held any stake in the former WarnerMedia business aligns with the ground truth. However, the LLM incorrectly states that the acquisition happened in 2021 (it was completed in June 2018), which is a factual error affecting quantitative accuracy. Additionally, the original answer highlights the 2024 divestiture of DIRECTV as the final step in unwinding the entertainment strategy, which the LLM omits—this is a notable completeness gap. While the LLM correctly describes the WarnerMedia separation, it fails to mention DIRECTV’s 2024 divestiture, a key part of the strategic trajectory. The reasoning is otherwise sound, with proper synthesis of the multi-hop elements (acquisition → integration → restructuring → divestiture). Wording differs but meaning is semantically close. Contextual relevance is strong as all points relate directly to the strategic evolution asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 403,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved from a single‑scenario, U.S.-centric loss estimate to a broader, scenario‑based model that quantifies terrorism losses across multiple attack types and regions, and it began supplementing TRIPRA with targeted private reinsurance and government‑run terrorism pools.  At the same time the company refined its reinsurance program’s attachment points—raising regional retentions and establishing separate per‑occurrence and aggregate limits for North America, Japan and the rest of the world—to better align coverage with the geographic concentration of its international terrorism exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall evolution of AIG's international terrorism exposure management from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the shift from a U.S.-centric scenario to broader, multi-regional modeling, the use of targeted reinsurance and terrorism pools, and the refinement of attachment points by geography. However, it omits specific quantitative details present in the ground truth: the 2022 five-ton bomb scenario in New York City and the exact modeled $1.3 billion loss net of TRIPRA and reinsurance are not mentioned, which affects quantitative accuracy. Additionally, while the LLM notes refined attachment points, it does not specify the actual retentions of $200 million for Japan and $125 million for the rest of the world in 2024—critical data points for full factual completeness. The reasoning is sound and synthesizes multi-hop elements (modeling evolution, reinsurance strategy, geographic segmentation), but the absence of exact figures and scenarios reduces quantitative precision. Wording differences are acceptable under semantic equivalence, but missing key numbers prevents a top score. Contextual relevance is excellent as all aspects of the question (modeled scenarios, reinsurance, geographic attachment) are addressed meaningfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 368,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson’s pipe‑working tools—including pipe wrenches, cutters, threading/roll‑grooving equipment, battery‑hydraulic press tools and related diagnostic systems—have been consistently presented as a core offering of the **Safety & Productivity segment** in the 2022, 2023 and 2024 filings.  The company’s description of these products is essentially unchanged across the three years, underscoring a deliberate, multi‑year focus on professional‑grade tools for plumbing and mechanical trades.  This steady emphasis signals Emerson’s strategic positioning to maintain a leadership role in the professional tools market, leveraging its broad distribution network and brand strength to generate recurring revenue from infrastructure‑ and industrial‑service customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but significantly diverges from the ground truth in terms of the evolution of Emerson's product portfolio. (1) Correct elements include the consistent categorization of pipe-working tools under the Safety & Productivity segment and the general focus on professional-grade tools across 2022–2024. However, the LLM claims the product description is 'essentially unchanged' across the years, which directly contradicts the ground truth: in 2022, Emerson emphasized traditional tools (e.g., pipe wrenches, cutters), but by 2023 introduced battery-hydraulic tools and diagnostic systems like sewer inspection cameras, with further digital integration in 2024. This evolution indicates a strategic modernization that the LLM fails to capture. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. (3) The multi-hop reasoning is flawed: the question asks for a year-over-year progression and what it indicates; the LLM instead asserts stability, missing the key shift toward technological integration and advanced tooling. (4) Contextual relevance is moderate—the answer addresses Emerson’s strategic positioning but misrepresents the nature of the change, undermining the conclusion about strategic intent. Thus, while the answer is factually coherent, it lacks the critical insight about product modernization, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 407,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco’s policy for lease incentives—including free‑rent and step‑rent clauses—has been consistently applied from 2022 through 2024: the Company recognizes those incentives on a straight‑line basis over the non‑cancelable lease term (plus any renewal periods that are reasonably certain) and records the amount as part of the right‑of‑use (ROU) asset, which is then amortized over the same lease term [see 2022 page 45; 2023 page 46; 2024 page 47].  The only evolution was the 2023 disclosure of a $391 impairment charge on certain leased assets, which reduced the carrying value of those ROU assets but did not alter the straight‑line recognition method; the same impairment‑evaluation approach continued into 2024 [see 2023 page 46 and 2024 page 46/47].  Consequently, the ROU asset valuation follows the same straight‑line amortization, with any impairment adjustments reflected only when actual write‑downs (e.g., the 2023 charge) occur.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Costco's consistent use of the straight-line recognition method for free-rent and step-rent provisions from 2022 to 2024, which aligns with the ground truth. It also accurately references the lease term including renewal periods that are reasonably certain, and correctly notes that ROU assets are amortized over the lease term. However, the LLM introduces a $391 million impairment charge in 2023 that is not mentioned in the original answer or implied by the ground truth, which focuses on disclosure evolution around ROU asset valuation methodology—not impairment events. This is a significant factual addition not supported by the provided truth, undermining quantitative and qualitative accuracy. More critically, the LLM fails to capture the key evolution described in the ground truth: the reduction in disclosure detail regarding the use of discounted future minimum lease payments and incremental borrowing rates in 2023 and 2024. While the core accounting policy is correctly stated as stable, the LLM misses the nuanced shift in disclosure depth related to ROU asset initial measurement and discounting practices, which is the central point of the original answer. Thus, while the answer is contextually relevant and partially correct on methodology, it substitutes the actual evolution (disclosure specificity) with an unrelated impairment event, leading to a partially correct but materially incomplete and somewhat misleading response. The multi-hop reasoning is flawed because it does not synthesize the correct comparison across years regarding disclosure language changes. Number format for the $391 impairment is plausible but unverified and extraneous.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 462,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % notes were first created under the Base Indenture (May 18 2009) and were initially supplemented by the Fourth Supplemental Indenture (Nov 7 2012). In the 2022 10‑K the notes were listed as part of the series with a final maturity in 2025 and were governed by the supplemental indenture dated May 2 2013 (the “Sixth Supplemental Indenture”). The 2023 10‑K introduced a new “Fifteenth Supplemental Indenture” (dated Nov 6 2023) that added a fresh tranche of 2.000 % notes and extended the ultimate maturity to 2026/2027, thereby updating the indenture documentation that now governs the issue. The 2024 10‑K continues to reference this same Fifteenth Supplemental Indenture, confirming that the maturity schedule established in 2023 remains in force.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) Quantitative Accuracy: The LLM claims the 2.000% Notes had a maturity in 2025 in the 2022 10-K, then extended to 2026/2027 via a 'Fifteenth Supplemental Indenture' in 2023. However, the ground truth states the notes matured in 2023 and were governed by the Eleventh Supplemental Indenture dated August 8, 2016—not the Sixth or Fifteenth. The LLM invents a new tranche and maturity extension that does not exist in the original data. (2) Completeness: While the question asks about evolution across 2022–2024, the LLM fabricates changes (new indentures, extended maturities) rather than reporting the actual stability of the instrument. The ground truth emphasizes no structural changes, but the LLM asserts significant evolution. (3) Entity Accuracy: The LLM incorrectly identifies the governing indentures (Sixth and Fifteenth Supplemental) and their dates (May 2, 2013; Nov 6, 2023), which are not mentioned in the ground truth. The correct document is the Eleventh Supplemental Indenture from August 8, 2016. (4) Reasoning: The multi-hop synthesis is fundamentally flawed. Instead of recognizing that the same note with 2023 maturity persisted in filings post-maturity as part of historical records, the LLM incorrectly infers an evolution and update in documentation and maturity. (5) Semantic Equivalence: The LLM's narrative of change directly contradicts the ground truth of stability and consistency. Even though it addresses maturity timelines and indenture documentation, the factual core is wrong. The contextual relevance is low due to fabricated details. Minor credit is given for addressing the general topic of notes and indentures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 475,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon records revenue from third‑party seller services when the service is rendered—generally when the seller’s product is shipped to a carrier or delivered to the customer—so the timing of recognition has remained the same from 2022 through 2024.  Over those years the mix of revenue has shifted toward a larger share of fulfillment and shipping fees as Amazon expanded FBA and other logistics services, while the commission component (a percentage of sales) has stayed relatively stable; beginning in 2023 the company started capitalizing and amortizing certain multi‑year referral commissions, further altering the reported composition of commissions versus fulfillment fees.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the timing of revenue recognition—when services are rendered, typically upon shipment or delivery—which aligns with the 2023 disclosure in the ground truth. However, it introduces information not present in the original answer: specifically, the claim that Amazon began capitalizing and amortizing certain multi-year referral commissions starting in 2023, and that there was a shift in revenue composition toward fulfillment fees with stable commissions. The ground truth does not mention any such change in accounting treatment (capitalization/amortization) or a shift in revenue mix. While Amazon did expand FBA, the original answer does not support a documented shift in revenue composition. The 2022 and 2024 disclosures in the ground truth emphasize consistency and clarity in reporting, not changes in accounting policy or revenue mix. Therefore, the LLM adds plausible but unsupported details, particularly around 2023 accounting changes, which undermines factual accuracy. The reasoning is partially sound in connecting service delivery to revenue recognition timing, but the added synthesis about evolving revenue composition and accounting treatment goes beyond the provided evidence. Quantitative accuracy is acceptable because no specific numbers are misstated (none are given), but the answer fabricates qualitative developments. Contextual relevance is high as it directly addresses the question’s focus on timing and composition. Overall, the answer is partially correct but contains significant unverified claims, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 434,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022‑2024 filings repeatedly list a 2011 guaranty that “covers certain obligations of Southwestern Bell Telephone Co.” and remains outstanding (see T‑10K 2022 p. 136; T‑10K 2024 p. 96; T‑10K 2023 p. 100).  By keeping this guarantee in place, AT&T is deliberately retaining a back‑stop for the legacy Bell entity’s commitments rather than shedding them, using the guarantee to preserve the credit standing of the former operating company and to limit its own exposure to unexpected liabilities.  This reflects a long‑term liability‑management strategy that consolidates legacy telecom obligations under AT&T’s umbrella while protecting both the company’s balance sheet and its ability to meet creditor expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AT&T maintained its guarantee of Southwestern Bell Telephone Co.'s obligations across 2022, 2023, and 2024, referencing the continued inclusion of the guaranty from 2011, which matches the original answer's emphasis on consistency. The specific exhibit (Exhibit 4-b) is not named, but the LLM references the same underlying guaranty and supports its claims with correct page numbers from the 10-K filings (2022 p.136, 2023 p.100, 2024 p.96), confirming verifiable evidence. (2) All dates and years (2011 guaranty, 2022–2024 filings) are correct, and no numerical inaccuracies are present—quantitative accuracy is perfect. (3) The reasoning is sound: the LLM correctly infers that the repeated inclusion of the guarantee reflects a deliberate, stable long-term liability strategy, consistent with the ground truth’s conclusion. It adds value by interpreting the strategic rationale (preserving credit standing, limiting exposure), which is a reasonable extension of the evidence. (4) The only minor shortcoming is that it does not explicitly note the *unchanging nature* of the language or the *absence of restructuring*, which the original answer highlights as key indicators of strategic stability. However, the core message about sustained liability management is preserved. Semantic equivalence is strong, and the answer is fully contextually relevant. Thus, the correctness score is 9 due to this slight omission in emphasis, but all critical facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 433,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nFrom the end of 2022 through 2024 the carrying amount of J&J’s 2.250% Notes due 2050 moved from roughly **$984 million** (2022) to **$808 million** (2023) and then edged up to **$826 million** (2024).  The 2023 decline reflects a deliberate retirement/re‑purchase of that low‑coupon, long‑dated tranche, while the modest 2024 rebound shows the company is fine‑tuning the balance as market conditions shift.  Together, the pattern signals that J&J is actively managing the size of its longest‑dated, low‑cost debt to reduce leverage and preserve financial flexibility within its broader long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and their temporal sequence. According to the ground truth, the carrying amount was $983M in 2022, $826M in 2023, and $808M in 2024 — showing a consistent downward trend. However, the LLM incorrectly states that the amount declined to $808M in 2023 and then *increased* to $826M in 2024, reversing the actual progression. This misrepresentation undermines the quantitative accuracy. (2) The numbers themselves are close but not correctly assigned to years: $984M (vs. $983M) is acceptable as a rounding variation, but the swap of 2023 and 2024 values ($808M and $826M) is a critical error. The LLM also fails to mention the fixed effective interest rate of 2.29%, a key detail in the original answer that supports the stability of the debt cost. (3) The reasoning is partially sound — the idea that J&J is managing long-dated debt strategically is plausible — but the interpretation of a 'rebound' in 2024 contradicts the actual data showing continued reduction. The claim of 'active management' through repurchases may be valid, but the LLM infers a pattern (decline followed by increase) that does not exist, weakening the multi-hop synthesis. (4) Contextual relevance is high because the answer addresses both the evolution of the note and its implication for long-term debt strategy. However, due to the incorrect year-value mapping and missing interest rate detail, the correctness score is limited to 4 — partially correct but with major factual flaws in the core data progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 432,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.375 % Senior Notes due June 2027 remained unchanged at a $1.25 billion carrying amount each year and, as shown in the 2024 maturity schedule, it is set to mature in 2027 as part of a $2.25 billion 2027‑maturity bucket that also includes the $1 billion 3 % Senior Notes due May 2027.  In 2024 the company retired its $1 billion 2.75 % Senior Notes due May 2024, reducing near‑term debt and reinforcing a longer‑dated, low‑coupon debt profile.  This pattern reveals Costco’s capital‑management strategy of extending maturities, maintaining a stable, low‑cost long‑term debt base, and using cash flows to retire short‑term obligations while preserving liquidity for dividends, share repurchases and investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the $1.375% Senior Notes due June 2027 remained unchanged at $1.25 billion (i.e., $1,250 million) across 2022–2024, which matches the ground truth. It also accurately notes the retirement of the $1 billion 2.75% Senior Notes due May 2024 in 2024, contributing to the overall decline in long-term debt. However, the ground truth emphasizes a broader trend in total long-term debt decreasing from $6,590M (2022) → $6,484M (2023) → $5,919M (2024), which the LLM answer omits. This quantitative trend is central to the original answer’s conclusion about gradual debt reduction. (2) All specific numbers mentioned in the LLM answer (e.g., $1.25 billion notes, $1 billion 2.75% notes retired) are factually correct and match the knowledge graph. The format variation ($1.25 billion vs $1,250 million) is acceptable. The mention of a $2.25 billion 2027-maturity bucket (combining $1.25B 1.375% notes and $1B 3% notes) is plausible and consistent with typical SEC filing structures, though not explicitly confirmed in the ground truth. (3) The multi-hop reasoning is sound: the model connects the stability of the 1.375% notes with the retirement of other tranches and infers a strategic preference for maintaining low-cost debt while retiring near-term obligations. This aligns with the original answer’s interpretation of selective capital management. However, the LLM leans more on inference about 'extending maturities' and 'low-coupon profile' without directly referencing the total debt trend, which weakens the completeness of the synthesis. (4) The answer is contextually excellent—directly addresses the evolution of the specific notes and links it to capital strategy. The omission of the total long-term debt figures across years prevents a perfect score on correctness and qualitative accuracy, but the core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 513,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard layered its security controls—real‑time fraud scoring, tokenization, the Mastercard Intelligence Center and strict settlement‑exposure guarantees—directly onto the expanding real‑time account‑based and ACH infrastructure it rolled out in 12‑13 markets and across its cross‑border network.  This parallel rollout of a more distributed, peer‑to‑peer architecture and new payment‑flow capabilities (e.g., Mastercard Send, VCN, Alias‑Based Remittances) was matched by tighter operational standards, proactive monitoring and ecosystem‑wide governance to keep the surge in global transaction volume and cross‑border risk in check.  The strategy shows that as Mastercard scaled worldwide, it deliberately grew its payments‑processing capacity only after reinforcing a multi‑layered security and stewardship framework to manage the heightened risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general theme of Mastercard expanding its real-time payments infrastructure alongside a multi-layered security approach, which aligns with the question's focus. However, there are significant factual inaccuracies that reduce correctness. Quantitatively, the LLM states that real-time infrastructure was rolled out in '12-13 markets'—this partially matches the ground truth: 12 markets as of end-2021 (reported in 2022), 13 by 2023. While the numbers are close, the LLM misattributes timing by implying the expansion occurred during 2022–2024 rather than reporting carryover from prior years. More critically, the LLM introduces specific security components—'real-time fraud scoring, tokenization, Mastercard Intelligence Center, settlement-exposure guarantees'—that are not mentioned in the original ground truth, which only refers to a generic 'multi-layered security approach' with third-party assessments. These additions are unsupported by the source and represent fabrication or overinference. The qualitative claim that security was implemented 'only after reinforcing' controls is a stronger causal assertion than the ground truth supports; the original answer explicitly states that filings do not confirm security measures directly enabled expansion. Thus, the reasoning overreaches by implying a sequential dependency not present in the data. While the answer correctly infers strategic intent to manage risk during global scaling, it fails on precise entity and claim accuracy. Contextually, the response is well-structured and relevant to the question’s scope, discussing parallel development and risk management. However, due to unsupported specifics and overconfident causal reasoning, the answer is only partially correct despite capturing the high-level narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 488,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nMicrosoft first created the 4.000 % Notes due 2021 in 2011 (the Third Supplemental Indenture) and has since expanded that series through a series of supplemental indentures filed in the last three fiscal years – the Twelfth (2022), Fourteenth (2023) and Fifteenth (2024) Supplemental Indentures.  Each amendment added new tranches and increased the aggregate principal of the 4.000 % Notes, while also extending the overall maturity schedule and often lowering the effective financing cost.  This incremental, staged approach shows that Microsoft is deliberately layering additional long‑term fixed‑rate debt to diversify its funding base, smooth out repayment timing and lock in low‑cost capital over the long term.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and reasoning errors. (1) Quantitatively, the LLM falsely claims that Microsoft issued new tranches of the 4.000% Notes due 2021 in 2022, 2023, and 2024 through the Twelfth, Fourteenth, and Fifteenth Supplemental Indentures. However, the ground truth states that the same Third Supplemental Indenture (from 2009) was referenced in all three years, with no new issuances or structural changes. The 4.000% Notes matured in 2021 and were not extended or expanded. (2) The claim that Microsoft 'increased the aggregate principal' and 'extended the maturity schedule' is false—there is no evidence of rollover or extension; the continued disclosure in 2024 is likely due to reporting requirements, not active debt expansion. (3) The reasoning is flawed: the LLM infers a strategy of layering long-term debt based on non-existent amendments, misrepresenting Microsoft's actual behavior. The ground truth indicates transparency in post-maturity disclosure, not active debt management via new issuances. (4) The answer fails on multi-hop synthesis: it incorrectly identifies the supplemental indentures and their years, conflating exhibit references with new debt issuance. While the question is addressed in structure (discussing evolution and strategy), the factual foundation is wrong, severely undermining the response. Minor credit is given for addressing the general topic of long-term debt strategy, but the analysis is based on fabricated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 414,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s frequent reference to the 1.500 % senior unsecured note due 2030 shows that it views this low‑coupon, long‑dated tranche as a cornerstone of its long‑term financing, using it to lock in cheap capital and diversify its maturity ladder. Compared with its higher‑coupon bonds (e.g., 3‑5 % issues maturing in the 2030s‑2060s) and revolving credit facilities, the 2030 note highlights Amazon’s strategy of securing stable, inexpensive funding while preserving cash‑flow flexibility and maintaining an investment‑grade capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.500% Note due 2030 as a low-cost, long-dated instrument and characterizes it as part of Amazon's long-term financing strategy, which aligns with the ground truth. However, it omits specific multi-year evidence from 2022–2024 filings that demonstrate the evolving context of Amazon’s debt strategy—such as the introduction of the note in 2022 alongside longer-dated instruments (e.g., 2060), its coexistence with near-term debt like the 4.700% Note due 2024 in 2023, and its contrast with newer higher-yielding debt like the 4.700% Note due 2032 in 2024. These omissions reduce completeness and weaken the multi-hop synthesis. (2) Quantitatively, the LLM accurately references the 1.500% coupon and 2030 maturity. It broadly references '3-5%' for other notes, which is directionally correct (e.g., 4.700% Note due 2032 is within range), though it does not specify exact figures or maturities cited in the ground truth. No calculations are required, so numerical accuracy is acceptable. (3) The reasoning is sound in concluding that Amazon uses long-dated, fixed-rate debt to lock in cheap capital and manage refinancing risk, but it fails to fully synthesize the year-over-year narrative across filings that shows strategic layering and adaptation to market conditions. The mention of 'revolving credit facilities' and 'investment-grade capital structure' adds context not contradicted by the ground truth but not directly supported in the provided answer. (4) The answer is contextually relevant and captures the essence of Amazon’s capital structure strategy, but lacks the detailed, evidence-based progression across years that defines the ground truth. Thus, while factually plausible and partially accurate, it falls short on completeness and depth of multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 497,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2023 AT&T held a 41.3 % equity interest in SKY Mexico and accounted for it under the equity‑method (see the 2023 equity‑affiliate table on page 68 of the 2023 10‑K). In June 2024 the company sold its entire 41.3 % stake, removing the investment from its balance sheet (see the disposition note on page 67 of the 2024 10‑K). This exit reflects AT&T’s broader strategy of divesting non‑core international pay‑TV assets and monetizing equity‑method holdings to refocus capital on its core wireless and broadband businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 41.3% ownership stake in SKY Mexico is accurately reported for 2022–2023, and the June 2024 exit is correctly specified. The citation of the 2023 10-K (page 68) and 2024 10-K (page 67) supports the factual claims and demonstrates document-level precision. (2) The answer correctly identifies the equity method accounting treatment in 2023 and the full disposal in 2024, matching the original answer’s timeline and financial reporting treatment. (3) Multi-hop reasoning is sound: the model synthesizes ownership data, accounting treatment, and divestiture timing across two years of filings to infer strategic intent. (4) The broader divestiture strategy is accurately interpreted—exiting non-core international pay-TV assets to refocus on U.S. wireless and broadband—mirroring the ground truth’s conclusion about strategic refocusing. The only minor shortcoming is that the LLM does not explicitly mention the Vrio sale context or Gigapower as a co-investment under equity method accounting, which slightly reduces completeness in entity-level detail. However, this does not detract from the core factual accuracy or strategic interpretation. Wording differs but semantic equivalence is strong. All key elements—ownership percentage, accounting method, exit date, strategic rationale—are correct and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 399,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nAIG’s U.S. pension glide‑path shifted gradually from a 2022 target of roughly 15 % equity, 75 % fixed‑maturity and 10 % other to a 2023 target of 13 % equity, 72 % fixed‑maturity and 15 % other, and then to a 2024 target of 9 % equity, 80 % fixed‑maturity and 11 % other.  This steady reduction in growth‑oriented equity and corresponding increase in liability‑hedging fixed‑maturity securities shows that AIG was deliberately de‑risking the portfolio as the plan’s funded ratio improved, moving assets toward more stable, interest‑rate‑matched holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific percentage allocations for equity, fixed-maturity, and 'other' categories for 2022, 2023, and 2024, which are not present in the original answer (ground truth). However, the ground truth does not include any numerical breakdowns of target allocations—only a qualitative description of the glide path strategy and its evolution based on funded status. There is no verification in the ground truth that the cited percentages (e.g., 15% equity in 2022, 9% in 2024) are accurate, making these figures potentially fabricated or hallucinated. Since the correctness of these numbers cannot be confirmed—and they are central to the LLM's response—the quantitative accuracy is severely compromised. (2) The original answer emphasizes that target allocations for a given year are based on the prior year’s funded status (e.g., 2024 target based on Dec 31, 2023 data), and that the glide path is dynamically adjusted as funded status improves. The LLM answer omits this key structural detail about how the glide path is determined, which is a critical part of the multi-hop reasoning. Instead, it presents a static year-by-year shift in allocations without linking them to funded status measurements at specific year-end dates. (3) While the LLM correctly infers a de-risking trend—reducing equity (growth assets) and increasing fixed-maturity (liability-hedging) assets—it fails to explain the mechanism of the glide path (i.e., targets set annually based on prior year-end funded status), which is central to the original answer’s reasoning. The conclusion about de-risking is directionally correct but lacks the nuanced, dynamic rationale provided in the ground truth. (4) The contextual relevance is high because the LLM addresses the core theme of de-risking and allocation shifts over time. However, the hallucination of specific percentages and omission of the funding-status-triggered adjustment mechanism result in a partially correct but factually unsupported answer. Thus, the correctness score is moderate-low due to unsupported numbers and incomplete multi-hop logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 568,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nMastercard has steadily tightened its credit‑risk framework from 2022 through 2024—updating its risk‑standards, expanding collateral requirements (cash, letters‑of‑credit and guarantees), and recalibrating settlement‑exposure models—so that gross exposure rose from roughly $59 bn to $78 bn while net exposure was trimmed through risk‑mitigation arrangements.  At the same time the company broadened its hedging toolkit (cash‑flow and fair‑value swaps, net‑investment hedges) and recorded larger litigation‑related accruals (e.g., $559 m for U.S. MDL matters, $200 m for the UK settlement, $93 m for ATM class actions) to reflect the growing regulatory and litigation pressure.  This continual refinement of exposure calculations, collateral policies and reserve accounting shows a highly adaptable risk‑management system that evolves in real time to meet emerging legal and regulatory challenges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims, and introduces information not present in the ground truth. (1) Quantitative Accuracy: The LLM states that gross exposure rose from $59B to $78B and cites specific litigation accruals such as $559M for U.S. MDL matters, $200M for UK settlement, and $93M for ATM class actions. These figures are not mentioned or supported in the original answer and are therefore incorrect. The ground truth does not provide any numerical data on gross/net exposure or specific litigation accruals. (2) Completeness: While the LLM attempts to address the evolution of credit risk strategies and adaptability, it fails to accurately reflect the consistency of Mastercard's core credit risk framework, instead suggesting a tightening and expansion not explicitly stated in the original. (3) Entity Accuracy: The companies and legal matters (e.g., DOJ investigation, FTC consent agreement) are correctly identified, and the years 2022–2024 are appropriately used. However, the mention of specific litigation accruals and hedging instruments (e.g., cash-flow and fair-value swaps) as part of credit risk mitigation is not supported by the ground truth, which focuses on collateral and guarantees. (4) Reasoning: The multi-hop synthesis is flawed—while the LLM correctly infers that regulatory and litigation pressures increased, it incorrectly links this to changes in exposure metrics and hedging strategies not mentioned in the original. The ground truth emphasizes consistent low losses and methodological refinements without indicating major structural changes or financial hedges. (5) Semantic Equivalence: The overall message of adaptability is partially aligned, but the factual basis is unsound. The original highlights stability in outcomes (low losses) despite external pressures, whereas the LLM overstates proactive financial engineering. Thus, while the answer is contextually relevant and attempts a sophisticated synthesis, its factual foundation is weak, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 556,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the shares reserved for future grants under the Omnibus Plan dropped from roughly **78 million** to **77 million** and then to **about 70 million**.  This decline shows that Home Depot is exhausting its equity reserve for ongoing award commitments and is pulling back on new equity grants, signaling a strategic move to limit dilution and place greater emphasis on share‑repurchases and cash‑based compensation rather than expanding stock‑based incentives.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the starting number of shares. The ground truth states 117 million shares were available in 2022, but the LLM claims 'roughly 78 million', which is off by nearly 40 million shares. The 2023 figure (77 million) and 2024 figure (about 70 million) are close to the ground truth (77 million as of January 28, 2024, and 70 million as of February 2, 2025), so those are mostly correct with acceptable rounding. (2) The quantitative trend is misrepresented: the drop is from 117M → 77M → 70M, a significant reduction, but the LLM implies only a minor decline from 78M to 77M to 70M, minimizing the scale of share usage. This undermines the accuracy of the interpretation. (3) The reasoning and synthesis are flawed. The ground truth interprets the declining availability as evidence of *active issuance* of stock-based compensation, indicating increased reliance on equity incentives. In contrast, the LLM concludes the company is 'pulling back on new equity grants' and 'limiting dilution', which is the opposite interpretation and not supported by the data showing heavy usage of the pool. This represents a critical error in multi-hop reasoning—while the LLM correctly infers that declining shares suggest reduced future capacity, it fails to recognize that the cause is likely high utilization, not strategic restraint. (4) Contextual relevance is strong: the answer addresses the evolution of available shares and attempts to interpret strategic implications, fulfilling the question's structure. However, due to major numerical and interpretive errors, the overall correctness is low. Quantitative accuracy is moderate due to partial correctness in later years; qualitative accuracy is low due to incorrect logic and conclusion; correctness score reflects partial credit for directionality and later-year numbers but heavy penalty for core factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 524,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying balance of **$622 million at the end of fiscal 2023** (Oct 29, 2023) but were **completely retired by the end of fiscal 2024**, dropping to **$0** (Nov 3, 2024).  This repayment was funded with the proceeds from Broadcom’s July 2024 and October 2024 senior‑note issuances and the repayment of portions of its 2023 term‑loan facilities, effectively replacing the near‑term, lower‑coupon debt with newer, longer‑dated obligations.  The move signals a strategic shift to extend maturity profiles and optimize the capital structure after the VMware merger.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the obligation dropped from $622 million to $0 between fiscal years 2023 and 2024, aligning with the ground truth progression. However, it omits the explicit value for fiscal year 2022, which was $622 million and remained unchanged in 2023. While the answer implies continuity by stating the balance was $622 million at the end of 2023, it fails to explicitly confirm that the amount was the same in 2022, missing a key part of the multi-year evolution. (2) The numbers themselves—$622 million and $0—are accurate and correctly attributed to the respective fiscal years (2023 and 2024), with acceptable date formatting (Oct 29, 2023, and Nov 3, 2024). The percentage (3.625%) and maturity (October 2024) are correct. (3) The reasoning is strong: the LLM correctly infers a strategic debt management approach, citing refinancing via new note issuances and term-loan repayments, which aligns with the ground truth’s interpretation of deliberate liability management. The mention of the VMware merger adds contextual insight not in the original but is plausible and relevant. (4) Despite the omission of the 2022 data point, the answer captures the core trajectory and strategic implication. The quantitative accuracy is slightly penalized for not clarifying that the $622M obligation existed in both 2022 and 2023, but the final drop to $0 is correctly reported. Qualitative and contextual scores remain high due to sound logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 412,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T transformed its relationship with Time Warner from full‑scale integration (the 2018 acquisition of Time Warner) to a deliberate divestiture: after announcing in 2021 a merger of WarnerMedia with Discovery, the combined company was spun out in April 2022 and later became Warner Bros. Discovery; AT&T then sold its remaining stake in DIRECTV—whose assets included the former Turner/WarnerMedia entertainment holdings—to TPG in late 2024, completing its exit from the content business. This sequence reveals that AT&T has abandoned the entertainment‑media strategy it pursued after the Time Warner merger and is now concentrating almost exclusively on its core telecommunications infrastructure—5G, fiber‑to‑the‑home and broadband—while shedding legacy media assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift of T (AT&T) from integration to divestiture of Time Warner Inc., and correctly frames the broader strategic pivot away from entertainment toward core telecom. However, there are key factual inaccuracies in dates and transaction details. The spin-off of WarnerMedia with Discovery was completed in April 2022, but the LLM incorrectly states that the combined company was spun out in April 2022 as part of the announcement — in reality, the deal closed in April 2022, not announced then, and the Reverse Morris Trust transaction was finalized at that time. The original answer correctly notes that the separation was completed in 2023, which contradicts the LLM’s 2022 timeline. Additionally, the LLM claims DIRECTV’s sale to TPG included 'former Turner/WarnerMedia entertainment holdings,' which is incorrect — DIRECTV was a separate asset and did not include WarnerMedia content; WarnerMedia was spun off independently. The sale of DIRECTV to TPG in 2024 is correctly dated, but the linkage to WarnerMedia is a significant factual error. (2) Quantitative accuracy suffers due to incorrect timing: the 2022 spin-out date is wrong (should be 2023 per ground truth), and the conflation of DIRECTV with WarnerMedia assets introduces a material misrepresentation. While the 2024 DIRECTV sale is accurate, the implication that it carried WarnerMedia content is not. (3) The multi-hop reasoning is mostly sound — the model correctly infers a strategic retreat from media and refocus on telecom (5G, fiber, broadband) — but fails in entity linkage by merging two separate divestitures (WarnerMedia and DIRECTV) as if DIRECTV carried WarnerMedia assets. The original answer treats them as parallel exits, not connected asset flows. (4) Despite these errors, the overall narrative of strategic reversal is preserved, and the core conclusion about refocusing on telecom is valid, warranting a 7 for correctness. Contextual relevance is high as all aspects of the question (integration, divestiture planning, exit strategy, strategic focus) are addressed, though with flawed details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 574,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson refocused its Pipe Cutters offering inside the Safety & Productivity segment by moving from a purely mechanical, pneumatic design to a battery‑powered, digitally‑enabled suite.  The line now incorporates battery‑hydraulic drive systems and integrated diagnostic tools—such as closed‑circuit‑TV pipe‑inspection and electronic pipe‑locating equipment—giving users cordless, higher‑productivity solutions that improve jobsite safety and provide real‑time data.  This evolution positions the Pipe Cutters portfolio as a portable, data‑driven alternative that aligns with the segment’s broader push toward battery‑powered technologies and advanced diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Emerson's Pipe Cutters from standalone mechanical tools in 2022 to battery-powered, digitally integrated solutions by 2024. The integration with battery-hydraulic systems and diagnostic tools like inspection cameras (referred to as closed-circuit TV pipe-inspection) is factually consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—only qualitative developments across years—which the LLM correctly references (2022–2024 evolution). (3) The multi-hop reasoning is sound: it synthesizes the shift across time (2022 to 2024), connects the product line to battery-powered technologies and diagnostic systems, and correctly situates this within the Safety & Productivity segment. The only minor shortcoming is that the LLM implies a more immediate and comprehensive integration by 2024 than explicitly stated—the ground truth notes the ecosystem linkage emerged gradually (2023: battery tools; 2024: diagnostic integration)—but the overall trajectory is accurately portrayed. (4) The answer is contextually relevant, complete, and semantically equivalent to the original, with slightly more technical elaboration (e.g., 'electronic pipe-locating equipment') that is plausible but not explicitly confirmed in the ground truth. This justifies a 9 in qualitative accuracy and 9 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 411,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has continued and deepened its multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the processes and systems that support HR, IT, procurement, supply‑chain and finance, expanding the scope of its financial shared‑service platform and repeatedly aligning the design of its financial control environment.  This persistent focus shows that standardizing and centralizing financial processes is a strategic priority for the company, aimed at improving efficiency, scalability and governance across its operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and strategic implications of Johnson & Johnson's initiative from 2022 to 2024. (1) It correctly identifies the multi-year, enterprise-wide nature of the initiative and its focus on integration, simplification, and standardization across finance and other functions. While the original answer emphasizes finance as a key function, the LLM correctly includes HR, IT, procurement, and supply chain—consistent with broader enterprise initiatives mentioned in filings, even if the original answer focused on finance. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond the 2022–2024 timeframe, which the LLM correctly uses. All temporal references are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the continuity of the initiative across years and infers the strategic priority of standardization and centralization, aligning with the original answer’s conclusion about operational efficiency and governance. (4) The only minor shortcoming is that the LLM slightly broadens the scope by listing additional functions (e.g., HR, IT) not explicitly detailed in the ground truth’s financial focus, which could imply overgeneralization. However, this does not contradict the truth and may reflect accurate context from the full filings. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in strategic interpretation, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 412,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nCostco has continued to list the “Costco Wholesale Executive Health Plan” as Exhibit 10.1* in its Form 10‑K filings for fiscal 2022, 2023 and 2024, with the same description and original filing date (9/2/2012 – 10/19/2012) appearing each year.  The plan’s inclusion has been steady—no amendments, new filings, or changes in filing status are disclosed—indicating that the company maintains a consistent, long‑term executive health‑benefit offering as part of its overall executive compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the Executive Health Plan is consistently listed as Exhibit 10.1* in the 10-K filings for fiscal years 2022, 2023, and 2024; the 'Period Ended' date of September 2, 2012, and 'Filing Date' of October 19, 2012, are correctly noted (with acceptable format variation: '9/2/2012 – 10/19/2012'). (2) There are no calculation errors, and the dates match exactly with the ground truth. (3) The multi-hop reasoning is sound—by observing the unchanged filing details over three fiscal years, the model correctly infers that no amendments were made, indicating stability in executive benefit strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosures and the implication for long-term strategy. Wording differs slightly but meaning is preserved, with accurate synthesis across years and filings. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 292,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 the cash dividend on Mastercard’s Class A (and Class B) shares rose steadily—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting entitlement of each Class A share remained “one vote per share” and Class B shares stayed non‑voting.  Ownership‑voting alignment was essentially unchanged: public Class A holders held about 90 % of both equity and voting power, the Mastercard Foundation ~10 %, and Class B customers less than 1 %.  This uninterrupted one‑share‑one‑vote framework and the consistent, upward dividend trend reflect Mastercard’s deliberate, shareholder‑friendly governance stance that prioritizes stability, predictability and alignment of shareholder interests.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The original answer states that dividend *rights*—not actual dividends paid—remained consistent across 2022–2024, meaning the entitlement structure (standard dividend rights) did not change. However, the LLM incorrectly interprets this as actual cash dividend amounts increasing each year ($2.04, $2.37, $2.74), which is not supported by the ground truth and introduces false quantitative data. These figures are entirely absent from the original answer and represent a critical error. (2) The LLM introduces details not present in the ground truth, such as ownership breakdowns (90% public, 10% Foundation, <1% Class B), which were not part of the source knowledge and cannot be verified. (3) While the LLM correctly identifies that A Class Shares have one vote per share and that this was consistent over time, it adds unsupported details about Class B shares being non-voting and having equity stakes, which are not in the original. (4) The reasoning about governance strategy aligns thematically—stability and predictability—but is based on incorrect premises (rising dividends, ownership splits), weakening the logical foundation. (5) The question asks about *rights*, not payout amounts; the LLM misinterprets the core concept. Despite this, the answer is contextually relevant and attempts multi-hop synthesis (linking dividend trends, voting rights, and governance), but the factual base is flawed. Quantitative accuracy is low due to fabricated numbers; qualitative accuracy is moderate due to correct identification of one vote per share but incorrect entity and metric attribution; contextual relevance is high as it addresses the spirit of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 475,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross fiscal 2022 → 2023 → 2024 the Security Insights Platform moved from a standalone mainframe‑risk engine to a core element of Broadcom’s Enterprise‑Security portfolio, with each filing stressing that it “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps” and that this output is made available for use with customers’ own security‑information‑and‑event‑management and other in‑house security tools.  The 2023 and 2024 disclosures broaden the language to describe “ongoing and ad‑hoc” risk identification and highlight tighter integration with broader security‑orchestration capabilities, indicating a progressively deeper integration and richer risk‑identification functionality over the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of the evolution of Broadcom's Security Insights Platform. While the ground truth states that the platform's description and functionality remained stable across 2022–2024, with only a minor enhancement in 2023 related to remediation planning, the LLM incorrectly portrays a progressive evolution from a 'standalone mainframe-risk engine' to a 'core element' of the Enterprise-Security portfolio with 'tighter integration' and 'richer risk-identification functionality.' This contradicts the original answer, which emphasizes consistency and maturity rather than progressive enhancement. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard; thus, a score of 10 is justified. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers deeper integration and expanded functionality in 2023 and 2024, whereas the ground truth explicitly states the description 'remained the same' in 2024 and only slightly evolved in 2023 with a focus on remediation planning. The LLM invents 'security-orchestration capabilities' and 'developing remediation steps' as new features, which are not supported by the original answer. (4) Contextual relevance is high because the LLM addresses the right platform, company, and time frame, and discusses integration with in-house tools and risk identification as asked. However, the qualitative inaccuracy in representing the platform’s evolution severely undermines factual correctness, warranting a correctness score of 4—partially correct on entities and context but significantly wrong on the core claim of progressive enhancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 479,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 to 2024 AIG shifted its loss‑reserve risk management from a largely internal, actuarial‑only approach to a structured model‑risk framework that formally incorporates third‑party catastrophe and stochastic models; by 2024 the company routinely engages independent modeling firms and other external experts to validate those models, adjust for emerging drivers such as climate change, and stress‑test the reserve assumptions. This evolution also added a dedicated model‑risk management and validation process—including challenge reviews by ERM and audit functions—to ensure that reserve adequacy estimates are continuously reviewed, calibrated and aligned with the company’s risk‑appetite limits.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of AIG's loss reserve risk management from 2022 to 2024 with accurate qualitative details and strong contextual relevance. It correctly identifies the increasing formality of risk management, use of stochastic modeling, external expert validation, and enhanced oversight by 2024. The mention of climate change as an emerging driver and stress-testing of assumptions aligns with broader industry trends and is plausible, though not explicitly stated in the ground truth. The ground truth emphasizes internal controls in 2022, expanded modeling and actuarial reviews in 2023, and ERM second-line reviews in 2024—elements the LLM captures in substance but slightly rephrases (e.g., 'model-risk management and validation process' and 'challenge reviews by ERM' correspond to 'multi-tiered risk oversight' and 'ERM second-line reviews'). However, the LLM implies a shift 'from a largely internal, actuarial-only approach' in 2022, which overstates the baseline as the original answer notes external reviews were already used in 2022. This is a minor inaccuracy in characterization but does not distort the overall trajectory. No numeric or date errors are present (quantitative accuracy is perfect), and all entities (AIG, ERM, external experts, stochastic models) are correctly identified and contextualized. The reasoning is sound and synthesizes the multi-year evolution effectively, though slightly over-infers the starting point. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 427,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nIn 2022 Electrical Distribution Equipment generated about $2.4 bn of sales within the Industrial Solutions sub‑category of Automation Solutions—up from $2.27 bn in 2021—highlighting its role as a growth driver. By 2023 the offering was folded into the Discrete Automation segment, which grew to $2.63 bn, and in 2024 the segment held $2.51 bn, showing Emerson’s shift to embed Electrical Distribution Equipment in a broader, higher‑margin discrete‑automation portfolio that couples hardware with control‑systems and software. This evolution reveals a strategic emphasis on integrated, value‑added discrete‑automation solutions rather than standalone electrical distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific sales figures ($2.4B in 2022, $2.63B in 2023, $2.51B in 2024) that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These numbers appear fabricated or hallucinated, severely undermining quantitative accuracy. The original answer focuses on organizational positioning and strategic intent, not financial performance. (2) There is no mention in the ground truth of sales figures, growth from $2.27B, or segment revenue totals—making all quantitative claims unsupported. Even allowing for format variation, the introduction of precise dollar amounts where none exist in the source constitutes a major factual error. (3) Qualitatively, the LLM captures the correct multi-hop evolution: movement from Industrial Solutions to Discrete Automation by 2023 and continued presence in 2024, reflecting a strategic shift toward integrated automation. It correctly infers that this reflects a broader emphasis on value-added, integrated solutions in discrete automation markets. However, it misrepresents the basis of this conclusion by substituting financial data not present in the original. (4) Contextually, the answer addresses the core question about strategic evolution and positioning, and the reasoning about strategic emphasis aligns semantically with the original conclusion. Despite incorrect numbers, the directional insight—that Emerson is embedding Electrical Distribution Equipment into a higher-value automation portfolio—is consistent with the ground truth’s claim of a 'deliberate shift' toward foundational integration in discrete automation. Thus, while the qualitative reasoning is partially sound and contextually relevant, the inclusion of false quantitative data significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 494,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 J&J continued to implement the Retirement Value amendment it announced in January 2021—recording the change as a roughly $1.8 billion reduction to the projected benefit obligation and revising the pension accounting (amortization of prior‑service cost, actuarial gains/losses, funding contributions, and updated discount‑rate assumptions) in its 2022‑2024 financial statements.  By gradually moving all eligible U.S. non‑union employees onto the new Retirement Value formula (to be effective Jan 1 2026), the company is reshaping its defined‑benefit structure to a more uniform, predictable and financially sustainable model, reflecting a long‑term workforce strategy that seeks to align retirement compensation with a stable, cost‑controlled talent pipeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the multi-year evolution of Johnson & Johnson's pension plan transition to the Retirement Value formula effective January 1, 2026, and accurately notes that this applies to U.S. non-union employees. It also correctly frames the change as part of a long-term workforce strategy focused on standardization, predictability, and sustainability. However, the $1.8 billion reduction in projected benefit obligation is not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making this a potentially unsupported quantitative claim. The ground truth does not include any financial impact figures, so this number introduces a risk of inaccuracy. (2) The dates (2022–2024, effective Jan 1, 2026) are correct and consistent with the original answer. The mention of accounting changes (amortization, discount rates, etc.) adds detail not contradicted by the ground truth but not explicitly confirmed either—this may reflect reasonable inference from pension reform implications. (3) The multi-hop reasoning is sound: the model synthesizes the structural change, its timing, and its strategic implications across years, correctly inferring cost predictability and workforce alignment as strategic drivers. The core logic matches the ground truth’s interpretation of standardization and long-term planning. (4) While the qualitative reasoning and contextual relevance are strong—accurately capturing the intent and trajectory of the policy change—the inclusion of an unverified dollar amount ($1.8B) reduces quantitative accuracy. Despite this, the overall correctness remains high because the central facts (timing, scope, formula shift, strategic rationale) are accurate and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 481,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nThe filings do not disclose a detailed brand‑level split, so the exact year‑over‑year change in Downy’s share of the Fabric & Home Care segment cannot be quantified. However, Downy is consistently listed among the segment’s major brands and the segment’s overall performance remained steady, indicating that its contribution has been stable but modest, reflecting a steady rather than growing strategic importance in P&G’s portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its factual claims. The ground truth states that the Fabric & Home Care segment's net sales contribution to P&G grew from 35% in 2022 to 36% in 2023 and 2024, and Downy is highlighted as a key brand within this growing segment, indicating sustained strategic importance. In contrast, the LLM claims that Downy’s contribution is 'stable but modest' and reflects 'steady rather than growing strategic importance,' which misrepresents the trend. The ground truth implies strategic importance is maintained or possibly reinforced due to the segment's growth, while the LLM downplays it. (2) Quantitatively, the LLM fails to report any of the correct percentages (35% in 2022, 36% in 2023 and 2024) related to the segment’s contribution, and incorrectly suggests no data is available at the brand level. While brand-level split may not be fully itemized, the knowledge graph confirms Downy's consistent role within a quantifiably growing segment—information the LLM overlooks. (3) The multi-hop reasoning is flawed: the LLM should have inferred from the segment’s growth and Downy’s consistent mention as a major brand that its strategic importance is stable or increasing, not diminishing. It fails to synthesize the trend in segment contribution with Downy’s role within it. (4) Contextual relevance is moderate—the response addresses the right topic and correctly notes Downy is a major brand, but incorrectly concludes about its strategic trajectory due to missing or misinterpreting key data. The answer would be more accurate if it acknowledged the segment’s growth and Downy’s stable position within it, leading to a conclusion of sustained importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 465,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew from about **$27.4 bn at the end of 2022** to **$27.2 bn in 2023** (a slight decline), and then jumped to **≈ $30.7 bn by the end of 2024**.  This pattern shows that after a brief pull‑back in 2023, the company markedly increased its long‑term debt issuance in 2024, underscoring a strategic shift toward expanding and diversifying its senior‑note portfolio to fund loan‑book growth and refinance maturing obligations while capitalizing on favorable market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM incorrectly reports a decline to $27.2 billion in 2023 and a rise to $30.7 billion in 2024, which contradicts the actual data showing a consistent increase with a peak in 2023 and no drop in 2023. The LLM also misrepresents the magnitude of the increase, understating the 2024 value by over $500 million. (2) The numbers are not accurate: $27.4B in 2022 is close (within 1%) to the true $27.219B, but the 2023 figure should be $31.248B, not $27.2B—a major error of ~$4B. The 2024 figure is also wrong at $30.7B vs. the correct $31.248B. These are not minor rounding differences but substantial deviations. (3) The reasoning is partially sound—recognizing a strategic shift toward more debt issuance is consistent with the trend—but the conclusion is based on flawed data. The claim of a 'brief pull-back in 2023' is factually incorrect, as 2023 was the peak year. The multi-hop synthesis fails because it misreads the trajectory. (4) Contextual relevance is high—the answer addresses the evolution of notes and infers strategy—but correctness is undermined by core factual errors in numbers and trend direction. Thus, the correctness score is low due to critical quantitative errors, despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 408,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2023 AT&T maintained a roughly 41.3 % equity stake in SKY Mexico and accounted for it under the equity‑method (see the 2023 10‑K, page 68, which lists SKY Mexico among its equity‑method affiliates, and the 2022 filing, page 93, which notes the 41.3 % interest). In June 2024 the company sold its entire 41.3 % holding, removing the investment from its balance sheet (2024 10‑K, page 69). This exit illustrates AT&T’s broader divestiture strategy of shedding non‑core Latin‑American pay‑TV assets to refocus capital on its core wireless and broadband businesses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AT&T (T) held a 41.3% stake in SKY Mexico from 2022 through 2023, accounted for it under the equity method, and exited in June 2024. The percentages (41.3%), timing (2022–2024), and exit date (June 2024) match exactly. (2) Quantitative accuracy is perfect—no calculations are required, but the stake percentage and years are correctly cited, and the 2024 divestiture is precisely dated. Format variations (e.g., '41.3 %' vs '41.3%') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the answer synthesizes data across three years and multiple SEC filings (2022, 2023, 2024 10-Ks), correctly identifying the evolution from continued ownership to divestiture. It links the accounting treatment (equity method) to the strategic exit, demonstrating proper synthesis. (4) The answer addresses all parts of the question: ownership stake, equity method accounting, exit event, and broader divestiture strategy. The conclusion about refocusing on core domestic operations (wireless and broadband) is semantically equivalent to the ground truth’s 'focus on core domestic operations.' Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 359,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nBNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings all warned that returning capital to shareholders is constrained by U.S. banking laws, board discretion and the need to remain “well‑capitalized” and “well‑managed.” The 2022 filing emphasized board authority and the requirement to pay full and timely preferred‑stock dividends, the 2023 filing added explicit references to capital‑adequacy rules and stress‑test results, and the 2024 filing highlighted compliance with Basel‑III standards and Federal Reserve capital‑planning expectations, underscoring that any weakening of capital ratios or dividend coverage could limit future dividends and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: BNY Mellon consistently disclosed constraints on capital returns due to U.S. banking laws, capital adequacy requirements, and board discretion across 2022–2024. The evolution in disclosures is accurately portrayed—2022 emphasized board authority and timely preferred dividend payments, 2023 expanded to include capital-adequacy rules and stress-test results (consistent with added ESG and strategic initiative context), and 2024 highlighted Basel III and Federal Reserve expectations, reflecting increased complexity in capital planning. (2) There are no numeric inaccuracies; the answer avoids specific dollar amounts or ratios not present in the original, so no calculation errors arise. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across three years of disclosures, identifying both continuity (regulatory constraints) and progression (increasing detail on capital rules and strategic impacts). (4) The LLM omits explicit mention of Delaware law and the Parent company’s reliance on subsidiary dividends in 2024—minor omissions that slightly reduce completeness but do not distort the overall meaning. However, the core themes of regulatory constraints, capital adequacy, and evolving risk disclosures are preserved with strong semantic equivalence. The answer is fully contextually relevant and effectively captures the trend of a stable regulatory framework with growing disclosure complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 421,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\n3M’s Structural Adhesives have been pulled out of a stand‑alone line and folded into a newly created **Industrial Specialties** unit within the Safety & Industrial segment (effective Q1 2024) – a move that bundles adhesives together with former Closure & Masking and Personal‑Safety products (and related tapes) to sell them as part of an integrated specialty‑product suite【page_110】.  The change is reflected in the segment’s sales profile (Safety & Industrial net sales held steady at ≈ $11 B in 2023‑24) and in the company’s broader segment‑re‑organization that reshaped how it reports operating performance【page_112】.  By packaging adhesives with complementary specialty offerings, 3M is treating adhesives as a strategic core that underpins a broader portfolio of industrial solutions rather than as an isolated commodity, underscoring their pivotal role in delivering end‑to‑end industrial applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some accurate elements but introduces significant factual inaccuracies that affect the overall correctness. (1) Quantitatively, the claim that Safety & Industrial net sales were approximately $11B in 2023–24 is plausible and aligns with typical reporting ranges, though the ground truth does not confirm this exact figure or its relevance to the question—so it's not directly verifiable but not clearly wrong. The dates (Q1 2024 reorganization) are specific and plausible. (2) However, the core claim—that Structural Adhesives were moved into a newly created 'Industrial Specialties' unit by folding in Closure & Masking and Personal Safety products—is not supported by the ground truth. The original answer describes a gradual shift in product grouping and emphasis (from metalworking/electrical in 2022, to packaging in 2023, to construction/maintenance in 2024), but no structural reorganization into a new 'Industrial Specialties' unit or inclusion of personal safety products. This is a major factual deviation. (3) The reasoning is partially sound in interpreting the strategic role of adhesives as foundational rather than standalone, which aligns with the ground truth’s conclusion. However, the multi-hop synthesis is flawed because it infers a corporate restructuring not present in the evidence, leading to incorrect causal logic. (4) Contextually, the answer addresses the evolution and strategic role, so relevance is high. But due to the invention of a new business unit and incorrect bundling details, the qualitative accuracy is low. The answer appears confident and well-structured but misrepresents the actual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 459,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Eli Lilly kept Cyramza marketed as a broad‑spectrum oncology agent—initially as a second‑line option for gastric, NSCLC, colorectal and HCC cancers and later emphasized its first‑line use together with EGFR‑mutant NSCLC and combination regimens for gastric and colorectal cancers.  At the same time the company extended its market exclusivity by securing compound‑patent protection that expires in 2026 (U.S.), 2028 (Europe) and 2026 (Japan), backed by data‑protection periods and regulatory term extensions (e.g., Supplementary Protection Certificates), thereby preserving IP coverage through the late‑2020s across its key global markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Therapeutic indications: The claim that Cyramza was repositioned for first-line use in EGFR-mutant NSCLC and combination regimens by 2024 is unsupported by the original answer, which states that indications remained consistent from 2022 to 2024 with no expansion or shift in clinical positioning. (2) Intellectual property: The LLM incorrectly states that compound-patent protection expires in 2026 (U.S.), 2028 (Europe), and 2026 (Japan), while the ground truth specifies that data protection expires in 2023 (Japan), 2024 (Europe), and 2026 (U.S.), with no mention of patent extensions or Supplementary Protection Certificates. The original answer makes no reference to patent protection beyond biologics data exclusivity, nor does it support extensions to 2028 in Europe. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the timeline and nature of exclusivity—instead inventing a narrative of patent extension and clinical expansion that contradicts the ground truth’s emphasis on impending data protection loss and unchanged indications. (4) Quantitative accuracy is low due to incorrect expiration dates (e.g., 2028 in Europe vs. correct 2024). While the answer addresses the question's general theme (indications and IP over time), its core facts are fabricated, leading to a low correctness score. Contextual relevance is moderate because it attempts the right topic and structure, but factual fidelity is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 418,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s fixed unsecured senior debt carried a carrying value of roughly $26.9 billion in 2022, rose to about $27.2 billion in 2023, then slipped back to $26.9 billion in 2024, while the weighted‑average interest rate stayed essentially flat at around 4.8 % each year. This flat‑to‑slightly‑down trajectory shows the company has kept its senior‑debt balance stable but is absorbing a higher, steady financing cost, reflecting a strategy that prioritizes a consistent funding profile amid rising market rates rather than expanding debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $26,930 million in 2024, but the LLM claims it was already $26.9 billion in 2022 and remained flat, which is incorrect. The interest rate rose from 2.91% to 4.84%, but the LLM states it stayed flat at 4.8% across all years, missing the substantial increase over the period. (2) The numbers are quantitatively wrong: the starting carrying value is off by nearly $7 billion, and the interest rate trend is misrepresented—ignoring a 1.93 percentage point increase. The LLM also fabricates a 2023 value of $27.2 billion not present in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution across years and mischaracterizes the trend. Instead of identifying a clear upward trajectory in both carrying value and interest rates, it suggests stability, leading to an incorrect interpretation of Capital One’s debt strategy. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts to interpret strategy, but due to severe factual and quantitative errors, the conclusion is invalid. The qualitative reasoning is based on false premises, undermining the analysis. Thus, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher because the structure of the response and intent to analyze trends are present, but reasoning is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 437,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Cisco’s total‑return swaps that economically hedge its deferred‑compensation liability moved from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  The swing reflects both the larger notional amount of swaps (≈ $651 M → $985 M) and favorable market movements, but the year‑to‑year changes—loss → modest gain → larger gain—show that the instrument’s fair‑value adjustments remain volatile despite the overall upward trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the answer synthesizes Cisco’s exposure over three fiscal years and interprets the pattern of gains/losses. It adds contextual insight about notional swap growth and market movements, which enhances the analysis without contradicting the ground truth. The only minor deviation is the inclusion of notional amounts (~$651M → $985M), which are not in the original answer; however, these do not conflict with the ground truth and may reflect additional data from the filings. (4) The answer is semantically equivalent and fully addresses both parts of the question: the evolution of exposure and the volatility interpretation. The added detail improves context without introducing errors, warranting a high score. Thus, correctness is 9 due to slight over-enrichment, but not enough to reduce accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 341,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the company moved from isolated visual upgrades to a systematic, company‑wide store‑appearance overhaul that introduced uniform signage, modernized layout and “self‑service” pickup points (lockers, curb‑side kiosks) and rolled out electronic‑shelf‑label and checkout technology across the U.S. store base.  These investments were paired with the opening of roughly 80 new stores and the expansion of same‑day/next‑day delivery to about 90 % of the population, which lifted the share of online orders fulfilled through stores from ≈55 % (2021) to roughly 50 % (2024) and produced higher customer‑satisfaction and conversion scores.  By coupling a more attractive, easier‑to‑navigate physical footprint with faster, more reliable pickup and delivery options, Home Depot strengthened its omnichannel proposition and narrowed the gap with multichannel and pure‑play online rivals, securing a stronger competitive position in the home‑improvement market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer captures the general strategic direction of The Home Depot's evolution toward integrating store appearance with omnichannel capabilities, which aligns with the ground truth. However, it introduces several specific details not present or incorrect in the original: the claim of '80 new stores' and 'same-day/next-day delivery to 90% of the population' lacks support in the ground truth. Most critically, the LLM states that the share of online orders fulfilled through stores dropped from ≈55% (2021) to roughly 50% (2024), which contradicts the strategic intent of improving integration and is factually inconsistent with the expected trend—this is a major quantitative and logical error. (2) The ground truth contains no numeric data (e.g., percentages, store counts, fulfillment rates), so all such figures in the LLM answer are fabrications or hallucinations. The mention of electronic shelf labels, lockers, curb-side kiosks, and specific technology rollouts is not supported in the original answer. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a progression from physical upgrades to omnichannel integration—but it fails to accurately represent the evolution described: the original emphasizes a conceptual shift in strategic framing (from standalone appearance to interconnected experience), not a rollout of specific technologies. The competitive positioning analysis is plausible but based on incorrect data. (4) Correctness is scored 5 due to partial alignment on strategic evolution but major factual inaccuracies. Quantitative accuracy is low (3) due to unsupported numbers and a flawed downward trend in store-fulfilled orders, which undermines credibility. Qualitative accuracy is moderate (6) as the reasoning structure is logical and entity identification (The Home Depot, omnichannel competition) is correct. Contextual relevance is high (8) because the answer addresses both parts of the question and remains focused on the strategic evolution and competitive impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 543,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a carrying value of roughly **$1.637 billion at the end of fiscal 2022**, **$1.604 billion at the close of fiscal 2023**, and then **$2.0 billion (face amount) by the end of fiscal 2024**. This upward trend demonstrates that NVIDIA is deliberately expanding a large, long‑dated, low‑coupon debt tranche, using the 2050 notes as a cornerstone of its long‑term financing strategy to fund future growth while extending its maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, but the LLM states $1.637 billion (which matches the 2023 value, not 2022). For fiscal 2023, the LLM reports $1.604 billion, which is close but still incorrect compared to the true value of $1,637 million. In 2024, the LLM states $2.0 billion as the 'face amount', but the ground truth reports a carrying value of $2,000 million (i.e., $2 billion), so while the number is correct, it mischaracterizes it as face value rather than carrying value. (2) The quantitative inaccuracies are critical: the 2022 figure is off by over $500 million, and the 2023 figure is slightly understated. These are not minor rounding differences but material misstatements. (3) The reasoning is flawed: the ground truth describes a decrease from 2022 to 2023 followed by a rebound to $2 billion in 2024, indicating stabilization. The LLM incorrectly frames this as a continuous upward trend and infers a strategic expansion, which is not supported by the data—especially since the value decreased in 2023. The multi-hop synthesis fails because the model misaligns values with years and misinterprets the nature of the 2024 figure. (4) Contextual relevance is moderate—the answer addresses the right instrument and time frame and attempts to interpret long-term debt positioning—but due to incorrect data and flawed logic, the conclusion is misleading. Scores reflect major factual errors in numbers and years, poor reasoning, and only partial relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 444,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard‑related PFAS deepened and widened: a wave of state‑attorney‑general actions (Michigan, Illinois, Vermont, New Hampshire, Maine, Maryland, Hawaii, Connecticut, etc.) and U.S.‑territory suits added dozens of new co‑defendants—including DuPont, Chemours, carpet, metal‑plating and other manufacturers—while the MDL docket grew to include thousands of public‑water‑system and personal‑injury bellwether cases across the Midwest, Gulf Coast, Alaska, Guam and the Northern Mariana Islands.  In 2023‑2024 3M entered a tentative $10.5‑12.5 billion settlement of the public‑water‑system MDL (subject to court approval) and resolved several bellwether water‑provider and personal‑injury actions, marking the first large‑scale resolution of its Scotchgard exposure, and the number of defendants in individual suits swelled into the dozens as the geographic footprint of the litigation expanded nationwide.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the claim of a 'tentative $10.5–12.5 billion settlement' in 2023–2024 is false according to the original answer, which states only that 3M made non-material settlements in 2022 (New York class action, $65M total with immaterial share for 3M) and 2023 (Michigan Wolverine case, non-material). No multi-billion-dollar settlement is mentioned in the ground truth for this period. (2) The original answer does not mention any MDL (multidistrict litigation) docket, bellwether cases, or settlements involving 'thousands' of cases across the listed regions (Midwest, Gulf Coast, Alaska, Guam, etc.), nor does it reference state attorney general actions in Michigan, Illinois, Vermont, or others—these are fabrications or hallucinations. (3) While the LLM correctly identifies some defendants like DuPont and Chemours as appearing alongside 3M, it exaggerates the scale and scope of litigation far beyond the documented expansion into Alabama and Georgia involving municipal utilities, landowners, and Mohawk Industries. (4) The original answer notes a growing number of defendants and geographic expansion, which the LLM captures in spirit but distorts in magnitude and detail. (5) The LLM fails to mention Saint-Gobain and Honeywell as co-defendants in the 2022 New York case, misrepresenting the early legal landscape. Overall, while the answer is contextually relevant to the topic of evolving litigation, its core factual claims—especially the $10.5–12.5 billion settlement and nationwide MDL—are unsupported by the ground truth, leading to a low correctness score despite some correct entity mentions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 464,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom the 2020 AbCellera collaboration LLY pays tiered royalties in the mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, recording those royalties as cost of sales, and no additional regulatory or sales‑based milestones have been earned since the $195 million milestone that was capitalized in 2021. Net product revenue from the COVID‑19 antibodies dropped from $2.24 billion in 2021 to $2.02 billion in 2022 and to essentially zero in 2023‑2024 as EUAs expired and demand waned, leaving only the ongoing royalty payments to AbCellera.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states that net product revenue was $2.24 billion in 2021, which is not part of the original question's scope (the ground truth focuses on 2022–2024). While this additional context may be factually accurate, it introduces data outside the requested timeframe without affecting the core correctness. More critically, the original answer emphasizes that royalty payments were made based on 2022 sales, but the LLM implies ongoing royalty payments in 2023–2024 despite zero sales—this is incorrect because no sales means no royalties, even if the structure remains. The ground truth explicitly states there were no sales and no payments in 2023–2024. (2) The $2.02 billion revenue figure for 2022 matches the ground truth exactly. The tiered royalty range (mid-teens to mid-twenties) is correctly reported. However, the mention of a $195 million milestone capitalized in 2021 is accurate but not directly relevant to the 2022–2024 evolution asked in the question. The statement that 'no additional regulatory or sales-based milestones have been earned' aligns with the ground truth. (3) The multi-hop reasoning is strong: the model connects the decline in revenue to expiring EUAs and waning demand, correctly infers the impact on commercial performance, and maintains consistency in royalty structure. However, it fails to fully synthesize that no sales implies no royalty payments in 2023–2024, which is a key point in the original answer. (4) The contextual relevance is high—the answer addresses all components of the question (royalty structure, milestones, revenue trends). Qualitative accuracy is strong due to correct entity identification (LLY, AbCellera), proper financial terminology, and logical flow. The correctness score is 8 due to the minor but meaningful error in implying ongoing royalty payments when none occurred, and the inclusion of out-of-scope 2021 data. Quantitative accuracy is 7 because while the 2022 number is correct, the implication of continued royalties without sales introduces a factual misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 573,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings, Dawn dish soap consistently appears as a major brand within the Fabric & Home Care segment—accounting for a sizable share of the segment’s 36 % of total net sales and 34 % of its earnings (see page 18 segment table).  However, the narrative shifts in the 2024 “Summary of 2024 Results” (page 20) where the company notes **mid‑single‑digit organic sales growth** for Fabric & Home Care and specifically cites “high‑single‑digit productivity improvements” that are tied to innovation and sustainability initiatives around brands like Dawn.  This evolution shows that P&G has moved Dawn from being merely a core revenue‑generating staple to a **strategic growth and innovation platform**, underscoring its importance to the company’s overall portfolio and its long‑term earnings, cash‑flow and shareholder‑return objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant issues in quantitative and qualitative accuracy despite relevant context. (1) Quantitatively, the LLM incorrectly states that the Fabric & Home Care segment accounted for 36% of net sales and 34% of earnings in all three years, while the ground truth shows it was 35% of net sales and 31% of earnings in 2022, then 36%/34% in 2023 and 2024. This misrepresents the data for 2022. Additionally, the LLM cites a 'mid-single-digit organic sales growth' and 'high-single-digit productivity improvements' tied to Dawn in 2024, but the original answer (ground truth) contains no such figures or claims about strategic evolution—these details are absent from the provided truth and cannot be verified. (2) The claim that P&G has repositioned Dawn from a 'core revenue-generating staple to a strategic growth and innovation platform' is an unsupported inference not present in the ground truth, which explicitly states there was 'no indication of reduced emphasis or strategic repositioning' over the period. This contradicts the LLM's central thesis. (3) While the LLM correctly identifies Dawn as consistently highlighted within the segment across years, it fails to accurately reflect the stability emphasized in the original answer, instead inventing a narrative of strategic evolution. (4) Contextually, the response is well-structured and addresses the question’s intent regarding strategic importance, but the reasoning is flawed due to incorrect data and unsupported conclusions. The multi-hop synthesis is partially correct (tracking Dawn over time) but undermined by factual inaccuracies and overinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 460,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from roughly $880 million to $540 million (with a modest rebound to $560 million in 2024), while its long‑term debt peaked at about $49.3 billion in 2023 and declined to $45.0 billion in 2024. This three‑year trend reflects a deliberate reduction in wholesale funding and a shift toward a larger share of fixed‑rate senior notes, causing the floating‑rate unsecured senior debt component to shrink from around $1.7 billion to essentially zero, thereby lowering the company’s exposure to floating‑rate interest‑rate risk and reinforcing a more stable, fixed‑rate debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Capital One's debt evolution—increasing in 2023 and declining in 2024—and correctly identifies the elimination of floating unsecured senior debt and the strategic shift toward fixed-rate debt. However, key quantitative inaccuracies undermine the correctness. (2) Specific number verification: The original answer states total short-term borrowings and long-term debt (combined) were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly separates short-term borrowings and long-term debt and misrepresents their values. It claims short-term borrowings were ~$880M (2022), ~$540M (2023), and ~$560M (2024), which contradicts the ground truth where total debt was over $43B—implying short-term borrowings alone cannot be under $1B unless long-term debt is specified. More critically, the LLM states long-term debt was ~$49.3B in 2023 and ~$45.0B in 2024, which is close but not exact (actual: $48.715B and $45.551B). More problematic is the omission of the correct total debt figures and the incorrect disaggregation. The floating unsecured senior debt drop from $1.7B to zero is correctly noted, but the LLM omits the intermediate $349M in 2023 and the complete elimination by 2024. Additionally, the weighted-average interest rate increase on fixed debt (2.91% → 4.45% → 4.84%) is entirely missing from the LLM answer, a major omission given its relevance to interest rate exposure. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward fixed-rate debt to reduce floating-rate risk, which aligns with the ground truth. However, it fails to support this with complete data across years or accurate aggregation, weakening the synthesis. (4) Justification: The correctness score is 6 due to partially accurate trends but significant numerical and data composition errors. Quantitative accuracy is 5 because while some figures are directionally close, key totals and components are wrong or misrepresented. Qualitative accuracy is 7 because the reasoning and interpretation are sound despite missing details. Contextual relevance is 9 as the answer stays focused and addresses the core themes of debt structure and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 597,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Cisco’s 5.90 % senior note (maturing 2039) remained a $2 billion fixed‑rate issuance, but its weight in the capital structure shifted as the company added $13.5 billion of new senior debt in early 2024, expanding total long‑term debt from roughly $9 billion (2022) to about $20.3 billion (2024).  The note’s effective interest rate—reflecting the stated 5.90 % coupon, discount amortization and fair‑value hedge adjustments—has stayed essentially constant at ≈ 6.1 % each year, and it continues to be classified as long‑term debt (with only a minor current‑portion disclosure) because its maturity is well beyond the next fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies in numerical precision. (1) Quantitatively, the LLM correctly identifies the $2,000 million (i.e., $2 billion) principal of the 5.90% Note and its stable effective interest rate near 6.1%, matching the ground truth of exactly 6.11%. The use of '≈ 6.1%' is acceptable as a rounded approximation. The total long-term debt figures are slightly approximated—'roughly $9 billion' in 2022 vs. actual $8,416 million and '$20.3 billion' in 2024 vs. actual $19,621 million—but these are within reasonable rounding for high-level analysis. The $13.5 billion new debt addition is a reasonable estimate based on the increase from $8,416M to $19,621M (~$11.2B actual), though this overestimates the actual increase by ~$2.3B; this is the most notable quantitative deviation. (2) The note's classification as long-term debt is correctly explained with reference to its 2039 maturity, aligning with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data across years, recognizes the stability of the 5.90% Note while total debt grows, and infers its declining proportional weight in the debt composition. (4) All entities—Cisco, the 5.90% Note, fiscal years 2022–2024, effective interest rate, long-term debt classification—are correct. The answer addresses all parts of the question: debt composition (proportional shift), effective interest rate (stable), and classification (long-term). Wording differs but meaning is semantically equivalent. The minor overstatement of new debt and slight rounding of total debt values prevent a perfect 10, but the answer is factually solid and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 471,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 showed a virtually unchanged carrying (face) amount of roughly **$1.25 billion** in fiscal 2024 and fiscal 2025, and the **effective interest rate** disclosed in the debt‑table remained steady at **about 1.64 %** (the same rate reported for fiscal 2023).  This stability indicates that NVIDIA has deliberately retained this low‑cost, long‑dated fixed‑rate tranche on its balance sheet, using it as a stable source of long‑term financing rather than repeatedly issuing new short‑term debt or refinancing the issue.  The consistent effective rate—only modestly above the nominal coupon—reflects a strategic emphasis on locking in inexpensive capital for an extended horizon (maturity 2028).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the carrying amount was 'roughly $1.25 billion' in both 2024 and '2025' (fiscal 2025 is outside the scope of the question and not supported by the data), and omits the key fluctuation in 2023. This misrepresents the trend entirely as 'virtually unchanged' when in fact there was a notable dip and recovery. Additionally, the effective interest rate is misrepresented: the ground truth states it increased to 1.64% in 2024 from an implied rate in 2022, while the LLM claims it was 'steady' at 1.64% in 2023 and 2024, which contradicts the evolving trend. (2) Number verification: $1,200M (2022) → $1,099M (2023) → $1,250M (2024) is a clear non-monotonic trend; LLM ignores the 2022 and 2023 values and falsely asserts stability. The effective interest rate increase is a key point missed. (3) Multi-hop reasoning: The LLM fails to synthesize the correct temporal evolution across three fiscal years, collapsing it into a false narrative of stability. It also introduces 'fiscal 2025', which is not in the original data, indicating hallucination. (4) Despite incorrect numbers and trend interpretation, the LLM's qualitative inference about NVIDIA's long-term financing strategy—emphasizing stable, low-cost fixed-rate debt—is partially aligned with the ground truth's conclusion. Hence, some credit is given for strategic interpretation, but major deductions apply for factual and quantitative errors. Contextual relevance is high as it addresses the right instruments and strategic implications, albeit based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 502,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google treated the Pixel line as a distinct “devices” revenue stream inside the broader **Google Subscriptions, Platforms & Devices** category, explicitly noting that device sales carry lower margins and higher inventory/TAC costs than its advertising business (see 2023 pages 31‑35).  The company continued to pour R&D and capital into hardware, launching newer Pixel 6/7 phones and Nest devices while integrating AI offerings such as Gemini/Vertex AI, signaling a sustained strategic emphasis on hardware innovation even as it acknowledged the modest, cost‑intensive contribution of devices to overall revenue (pages 5‑9, 31‑35, 57‑61).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pixel devices were part of a distinct 'devices' segment within the 'Subscriptions, Platforms, and Devices' revenue category from 2022 to 2024, and notes ongoing investment in hardware innovation, including AI integration (e.g., Gemini/Vertex AI), which aligns with the ground truth. It accurately reflects Google's acknowledgment of lower margins and higher costs in the devices segment, supporting the strategic context. However, the LLM incorrectly implies that the 'devices' segment was explicitly defined in 2022, while the ground truth states that the explicit categorization occurred in 2023. This misrepresents the evolution timeline—a key aspect of the question. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is partially sound: the model connects hardware investment, AI integration, and revenue categorization across years, but fails to correctly sequence the evolution—specifically, the shift from general hardware investment in 2022 to explicit segment reporting in 2023. This weakens the qualitative accuracy. (4) Despite the timeline error, the answer remains contextually relevant and captures the strategic emphasis on Pixel devices and innovation. The correctness score is 7 due to accurate core facts but a significant omission in the temporal progression of revenue categorization, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 426,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings all locate the shareholder “Item 3 – Ratification of KPMG LLP” in the same Proxy‑statement section and simply restate the firm’s PCAOB identification number (185); the language does not add new details or change the wording, only updating the year‑reference to the most recent annual meeting. This consistent presentation shows that BNY Mellon has retained KPMG LLP as its principal auditor without interruption, underscoring a stable, long‑standing audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: BNY Mellon consistently ratified KPMG LLP from 2022 to 2024, referenced the PCAOB ID number 185, and used nearly identical language across years. The answer correctly identifies the stability of the audit relationship. (2) Quantitative accuracy is perfect: the PCAOB number (185) is correct, and the time frame (2022–2024) matches the original. No calculations were required. (3) The reasoning is sound: the model correctly infers that unchanged disclosure language and consistent ratification indicate a stable audit relationship, which reflects proper multi-hop synthesis across the three years’ filings. (4) The only minor shortcoming is that the LLM refers to '10-K filings' as the source of the ratification item, whereas the original specifies the 'Proxy statement' as the document where this item is located by reference. This is a slight misattribution of document type, but the core information about the Proxy content is still accurately conveyed. Despite this, the overall meaning and conclusion remain correct and contextually appropriate, hence the high scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 332,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative‑investment holdings in its pension plans rose from roughly **$7.9 bn in 2022 to $8.6 bn in 2023 and to about $8.9 bn in 2024** (including the retiree‑health plan), keeping the share of total plan assets steady at **≈50‑55 %**. This steady growth and consistent weighting indicates a **deliberate, long‑term strategy to maintain a sizable exposure to illiquid assets—such as hedge funds, private‑equity‑like funds and real estate—to diversify returns and capture higher yields over the long run.**",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for LLY's private alternative investment allocations. According to the ground truth, the allocation was $10,542.5 million in 2022, decreased to $10,335.2 million in 2023, and further declined to $10,051.0 million in 2024. However, the LLM incorrectly reports increasing values of $7.9 billion, $8.6 billion, and $8.9 billion across those years—amounts that are both numerically and directionally wrong. The LLM also introduces a claim about the allocation representing '≈50-55%' of total plan assets, which is not present in the original answer and cannot be verified from the provided data. (2) The quantitative inaccuracies are severe: all three dollar figures are incorrect (off by over $1.5 billion each year), and the trend is misrepresented as increasing when it is actually decreasing. Even allowing for format variations (e.g., $10,542.5M vs $10.5B), the values do not align. (3) The reasoning about a 'long-term strategy to maintain sizable exposure to illiquid assets' is partially aligned with the original conclusion regarding strategic emphasis on diversification and long-term growth. However, this insight is drawn from incorrect data, undermining the validity of the synthesis. The multi-hop reasoning fails because the model uses fabricated or misaligned numbers rather than correctly extracting and comparing year-over-year trends. (4) Despite the incorrect numbers, the LLM attempts to address both parts of the question—evolution over time and strategic implication—and maintains relevant context around illiquid assets and diversification. This supports a moderate contextual relevance score. However, due to major factual and quantitative errors, the correctness and accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 490,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 Tampax was never moved out of the **Feminine‑Care sub‑category** of the **Baby / Feminine & Family Care** segment; it was consistently presented as a core **menstrual‑care brand** and highlighted for its > 25 % global market‑share leadership.  The company’s commentary each year emphasized Tampax’s role in driving growth within menstrual care through product‑innovation and marketing, even as the broader Baby‑Feminine‑Family Care segment showed only low‑single‑digit organic sales growth.  In short, the classification stayed the same, but the strategic emphasis on Tampax as a leading menstrual‑care brand was maintained throughout the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims Tampax remained in the 'Feminine-Care' sub-category throughout 2022–2024, but the ground truth shows a reclassification in 2023 when 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category. Additionally, the LLM states the segment was consistently called 'Baby / Feminine & Family Care', but in 2024, 'Baby Care' was removed, indicating a structural shift. The LLM incorrectly asserts there was no change in classification, contradicting the documented evolution. (2) Quantitatively, the LLM introduces a claim that Tampax had a '>25% global market-share leadership', which is not present in the original answer and cannot be verified from the provided ground truth; this is an unsupported addition. The ground truth reports segment sales contributions (25% in 2022, 24% in 2023 and 2024), which the LLM omits entirely. Thus, key percentages related to segment performance are missing, and an unverified figure is introduced. (3) The multi-hop reasoning is flawed: the question asks for evolution across three years in terms of category classification and product line emphasis, requiring synthesis of changes over time. The LLM fails to recognize the rebranding from 'Feminine Care' to 'Menstrual Care' and the removal of 'Baby Care' in 2024, both of which signal strategic shifts. Instead, it asserts consistency where there was change, missing the core narrative of strategic refocusing. (4) While the LLM correctly identifies Tampax as a core menstrual care brand and notes ongoing innovation emphasis, which aligns with the qualitative tone of the original, it fundamentally misrepresents the structural and categorical evolution. The contextual relevance is moderate because it addresses the right company and product, but the failure to report actual classification changes severely undermines correctness. Scores reflect major factual and quantitative errors despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 545,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nCapital One continues to value its net derivative assets (liabilities) at Level 3 using discounted‑cash‑flow (vendor‑pricing) models.  The key unobservable input—swap rates—was 1‑2 % (weighted‑average ≈ 2 %) in 2021, widened to a 3‑5 % range (weighted‑average ≈ 4 %) by 2022 and stayed around 4 % through 2023‑2024, while default‑rate assumptions remained modest (≈ 2 % weighted‑average) and were applied mainly to retained‑interest valuations rather than directly to derivatives.  Consequently, the Level 3 balance grew from $5 million at the end of 2022 to $58 million at the end of 2023 and held at $58 million in 2024 (see 2022 10‑K pp. 220‑221, 2023 10‑K pp. 207‑209, 2024 10‑K pp. 215‑219).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. According to the ground truth, in 2022, Capital One's net derivative assets (liabilities) fair value was $19 million, not $5 million as stated in the LLM answer. The LLM incorrectly claims the Level 3 balance grew from $5 million in 2022 to $58 million in 2023, which contradicts both the ground truth and plausible financial reporting. Additionally, the LLM asserts that swap rates were 1-2% in 2021 and widened to 3-5% by 2022, but the ground truth does not provide data for 2021 or 2022 swap rates—only that in 2023 and 2024, swap rates were 3-5%. The LLM fabricates a timeline not supported by the source. Furthermore, the LLM claims default rates were 'modest (≈2%)', directly contradicting the ground truth which reports default rates ranging from 53-163% in 2023. This is a major factual error. (2) The only correct quantitative elements are the $58 million fair value in 2023 and 2024, which aligns with the ground truth. However, all other numbers—$5 million in 2022, swap rate progression, default rate of 2%—are incorrect or unsupported. (3) The multi-hop reasoning is flawed: the LLM invents a narrative about the evolution of inputs from 2021 onward without evidence, misattributes valuation techniques to years where they weren't disclosed (e.g., applying DCF models to 2022), and fails to acknowledge that the specific valuation method was not disclosed in 2022 per the ground truth. It also incorrectly limits default rates to retained interests rather than acknowledging their use in derivative valuation as implied in the 2023–2024 disclosures. (4) The contextual relevance is moderate because the answer addresses the general topic of valuation methods and unobservable inputs for derivatives, but the severe factual and numerical inaccuracies—especially in key inputs like default rates and fair values—undermine its reliability. The answer appears plausible in structure but is largely fabricated, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 544,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a modest $9 million gain in fiscal 2022 but recorded losses of $21 million in 2023 and $67 million in 2024, directly pulling “other income (loss), net” from a $392 million gain to a $306 million loss over the same periods. This trend reveals growing unrealized losses and impairments on the AFS portfolio, indicating heightened sensitivity to interest‑rate and credit‑quality risks and a deteriorating financial performance of those investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, no specific performance metrics were disclosed for Cisco's AFS debt investments in fiscal 2022, meaning any claim of a $9 million gain is factually wrong. The ground truth does confirm negative impacts in 2023 and 2024 due to AFS debt investment losses affecting 'other income (loss), net', but it does not provide exact dollar amounts—certainly not the $21M loss in 2023 or $67M in 2024 cited by the LLM. Additionally, the claim that 'other income (loss), net' declined from a $392M gain to a $306M loss is unsupported by the original answer and introduces fabricated data. (2) All numeric values in the LLM response are incorrect or hallucinated; there are no calculations in the ground truth to validate or compare. The absence of disclosed figures in 2022 and the lack of precise loss amounts in 2023–2024 make the LLM’s specificity misleading. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a deteriorating trend in financial performance and links AFS losses to 'other income (loss), net', it fails to acknowledge the absence of data in 2022 and instead invents figures, breaking the chain of accurate synthesis. The conclusion about interest-rate and credit-quality risks, while plausible, is not explicitly stated in the ground truth and is presented here with unwarranted confidence based on false inputs. (4) The contextual relevance is moderate because the LLM addresses the right metric and direction of impact (negative effect on other income), but the use of fabricated numbers and false precision severely undermines factual correctness. The qualitative reasoning about risk profile has some alignment but is built on incorrect premises, warranting low scores in quantitative (1) and overall correctness (2).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 507,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nStarbucks’ green‑coffee outlook lengthened over the three fiscal years: the 2022 filing projected an adequate supply only through fiscal 2023, the 2023 filing pushed that horizon to fiscal 2025, and the 2024 filing continues to assure supply through fiscal 2025 (with a specific reference to “through fiscal 2025” in its purchase‑commitment language). This progression shows that Starbucks has moved from short‑term, commodity‑price exposure to a longer‑term sourcing strategy that relies on fixed‑price and price‑to‑be‑fixed contracts, forward/hedge instruments, diversified global producer relationships, and its farmer‑support centers—an approach designed to lock in quality green coffee, smooth out price volatility, and mitigate supply‑chain risk across multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and projections are correct: fiscal 2022 filing projected adequacy through fiscal 2023; fiscal 2023 and 2024 filings both extend the outlook to fiscal 2025. These match the original answer exactly, with acceptable wording variations (e.g., 'pushed that horizon' vs 'extended'). (2) The answer correctly identifies the multi-year progression across three fiscal years, satisfying the multi-hop requirement of synthesizing data from 2022, 2023, and 2024 filings. (3) Qualitatively, the LLM adds valuable detail not in the original—such as fixed-price contracts, hedging instruments, and farmer-support centers—which are contextually appropriate and plausibly derived from Starbucks’ known sourcing practices. While the original answer emphasizes 'longer-term purchase commitments and improved inventory management,' the LLM elaborates with specific mechanisms that support that strategy. This expansion is reasonable and enhances the explanation without contradicting the ground truth. (4) The conclusion about risk mitigation and supply chain resilience is logically sound and semantically equivalent. The only minor deduction is that the LLM implies the 2024 filing 'continues to assure supply through fiscal 2025' without explicitly stating that this represents a continuation of the trend established in 2023—though it does note the 'progression.' Overall, the answer is factually correct, comprehensive, and contextually relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 426,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 have remained essentially unchanged in size from fiscal 2022 through 2024 – the table in the 2022 filing (p. 78), the 2023 filing (p. 65) and the 2024 filing (p. 72) all list a $1.25 billion face amount outstanding, with only modest changes in the net carrying amount as the discount is amortized.  This stability shows that the company is maintaining a small, low‑cost, long‑dated debt tranche while repaying shorter‑maturity notes and relying chiefly on operating cash flow to fund growth, reflecting a disciplined, conservative long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the face amount was consistently $1.25 billion across all three years, which contradicts the ground truth, especially for 2022 and 2023. This misrepresentation invalidates the central claim of stability. (2) The numbers are not accurate: $1,200M and $1,044M are significantly different from $1,250M, and describing them as 'essentially unchanged' is factually wrong. The LLM may be confusing face value with carrying amount, but even so, the ground truth indicates a deliberate fluctuation, not stability. (3) The multi-hop reasoning is flawed: the question requires tracking changes across three fiscal years using data from multiple filings. The LLM fails to detect the decrease in 2023 and the subsequent increase in 2024, thus missing the dynamic trend. Instead, it asserts a conservative, stable strategy, which contradicts the ground truth's conclusion of a 'dynamic approach.' (4) While the answer is relevant to the question and discusses long-term debt strategy, the incorrect data leads to an invalid qualitative interpretation. The contextual relevance is moderate because it addresses the right instrument and general strategy, but the reasoning is based on false premises. Therefore, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 433,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M re‑organized its Safety & Industrial segment by creating an **Industrial Specialties** division that gathered the former Personal‑Safety products—including fall‑protection solutions—into a distinct sub‑business.  This re‑categorization placed fall‑protection offerings as a dedicated, strategically‑emphasized line within Safety & Industrial, a move that is reflected in the segment’s operating income jumping from **$1.1 bn in 2022 to $2.5 bn in 2024**, underscoring a heightened focus on fall‑protection relative to other industrial‑safety products.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and reasoning errors. (1) The claim that 3M created an 'Industrial Specialties' division to house fall-protection solutions as a dedicated, strategically-emphasized line is contradicted by the ground truth, which states that Fall Protection Solutions were not elevated but rather subtly integrated into broader industrial safety systems by 2024, with no indication of a new division or increased emphasis. (2) The financial figures provided—$1.1 bn operating income in 2022 rising to $2.5 bn in 2024—are entirely fabricated and not supported by the original answer or any referenced data; the ground truth contains no financial metrics, so this quantitative addition is false. (3) The multi-hop reasoning is flawed: instead of identifying a consistent listing through 2022–2023 and a subtle repositioning in 2024, the model invents a narrative of strategic reorganization and growth, misrepresenting the evolution. (4) While the answer addresses the question's topic (categorization over time), it does so with incorrect entities, fabricated data, and a reversed interpretation of emphasis—claiming increased focus when the ground truth suggests a relative de-emphasis or integration. The contextual relevance is moderate because it attempts to address product categorization and emphasis, but the substance is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 385,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nEli Lilly’s sales of bamlanivimab (reported as part of its COVID‑19 antibody line) were about **$2.24 billion in 2021**, fell to roughly **$2.0 billion in 2022**, and then dropped to **near‑zero in 2023‑2024** (the tables show “‑” for 2023‑2024 and only a $2.0 bn U.S. figure for 2022).  This sharp decline indicates that the company’s reliance on its COVID‑19 antibody portfolio has largely disappeared, with the revenue contribution becoming immaterial in recent years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy in the 2022 revenue figure. The ground truth states $2.01 billion, while the LLM reports 'roughly $2.0 billion,' which is close but slightly imprecise. The LLM correctly identifies that revenue dropped to near-zero in 2023 and remained there in 2024, aligning with the ground truth of $0 in both years. The mention of $2.24 billion in 2021 is accurate but extraneous, as the question only asks about 2022–2024. (2) Quantitative accuracy is high: the $2.0 billion vs. $2.01 billion discrepancy is minor and likely due to rounding; however, it still represents a small deviation. The 'near-zero' characterization for 2023–2024 is semantically equivalent to $0, especially given the '–' notation in the source data. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across years and infers reduced reliance on the COVID-19 antibody portfolio. It connects declining revenue to waning demand, which matches the ground truth's interpretation. (4) The answer is contextually fully relevant, addressing both the revenue evolution and the implication about reliance. The slight underreporting of the 2022 figure prevents a perfect score, but overall the response is factually strong, logically coherent, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 368,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks extended its supply‑coverage horizon—from “adequate supply through fiscal 2023” to “adequate supply through fiscal 2025”—while continuing to hedge ‘C’‑price exposure with forward contracts, futures, collars and fixed‑price/price‑to‑be‑fixed purchase commitments that offset the volatility amplified by commodity‑index‑fund trading. This progression reveals a deliberate, long‑term risk‑management strategy that locks in green‑coffee supply and mitigates price swings, ensuring a stable supply pipeline well beyond the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Starbucks' risk management strategy from fiscal 2022 to 2024. (1) It correctly identifies the extension of supply coverage from 'through fiscal 2023' (as stated in 2022) to 'through fiscal 2025' (by 2024), which aligns with the ground truth. (2) All dates and timeframes are factually correct, with no numerical or fiscal year errors. The mention of hedging instruments—forward contracts, futures, collars, and fixed-/to-be-fixed price commitments—matches the original answer’s emphasis on financial tools to mitigate 'C' price exposure. (3) The multi-hop reasoning is sound: it synthesizes Starbucks’ ongoing exposure to commodity index fund-driven volatility with its improving supply chain resilience over time. The conclusion about a 'deliberate, long-term risk-management strategy' is a valid interpretation of the trend. (4) The only minor shortcoming is the omission of explicit mention that Starbucks *continued to acknowledge* the influence of commodity index funds in each year, which slightly weakens the qualitative completeness. However, the reference to 'volatility amplified by commodity-index-fund trading' implies this awareness. Overall, the answer is semantically equivalent, contextually precise, and factually robust, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 369,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nGoogle’s Ad Manager has long been the core platform for selling impression‑based inventory, and the 2022 – 2024 filings show that the company continued to grow that business while its share of total advertising revenues stayed roughly stable (see pages 30‑31, 55‑57).  In 2023 Alphabet changed the estimated useful life of its server hardware from 4 to 6 years, which cut depreciation expense by about $3.9 billion and lifted net income by roughly $3 billion that year (pages 56‑57).  That lower‑cost depreciation gave the company a cash‑flow boost that it could reinvest in Ad Manager and other growth engines, helping to preserve long‑term profitability even as impression‑based revenues face margin pressure from higher TAC and content costs (pages 30‑31, 56‑57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization is accurately described for 2022–2024; the 2023 change in server depreciation life from 4 to 6 years is correctly stated; the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income are precisely reported (allowing for rounding: 'roughly $3 billion' = $3.0 billion). (2) Quantitative accuracy is perfect—numbers, years, and financial impacts match the original answer exactly within acceptable formatting variations. (3) The multi-hop reasoning is sound: the model correctly links the depreciation change to lower costs, improved cash flow, and reinvestment potential in infrastructure-heavy operations like Ad Manager, supporting long-term profitability. It also acknowledges margin pressures from TAC and content costs, adding contextual depth not in the original but consistent with plausible inference. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 continuation of gross reporting of Google Network revenues, which is part of the original answer and reinforces Ad Manager’s strategic role. While the stability of Ad Manager’s revenue share implies ongoing importance, the specific accounting policy detail is omitted. This is a small gap in completeness but does not undermine the core correctness. Overall, the answer demonstrates strong synthesis across time periods and financial concepts, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 433,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan, BNY Mellon has issued a new version of its Performance Share Unit Agreement in each of the last three years— the 2022 PSU agreement (Exhibit 10.21 filed in the 2022 10‑Q), the 2023 PSU agreement (Exhibit 10.23 filed in the 2023 10‑Q), and the 2024 PSU agreement (Exhibit 10.25 filed in the 2023 10‑K and listed as the “2025” form).  This incremental rollout reflects a deliberate, year‑over‑year refinement of the performance‑based equity component, tightening the performance metrics and extending the measurement period.  The progression shows that the firm is sharpening its focus on long‑term shareholder value, using PSUs to tie a growing share of executive compensation to sustained performance rather than short‑term earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that BNY Mellon issued new Performance Share Unit (PSU) Agreements in 2022, 2023, and 2024 with corresponding exhibits (10.21, 10.23, 10.25), whereas the ground truth indicates that BK (not BNY Mellon) referenced the 2021 PSU Agreement in 2022, re-filed the 2019 Long-Term Incentive Plan in 2023 (Exhibit 10.14), and incorporated the 2022 PSU Agreement in 2024 (Exhibit 10.18). The LLM fabricates a yearly update cycle (2022, 2023, 2024 forms) that is not supported by the original data. (2) The exhibit numbers and filing details (e.g., 'Exhibit 10.21 filed in the 2022 10-Q') are entirely incorrect and do not match the ground truth references. (3) The company name is misrepresented: the original answer refers to 'BK', which based on context likely refers to a company other than BNY Mellon, but the LLM assumes it is BNY Mellon without justification—this is a critical entity error. (4) The reasoning about 'tightening performance metrics' and 'extending measurement periods' is speculative and not supported by the ground truth, which emphasizes continuity and iterative updating of existing frameworks rather than strategic tightening. (5) While the LLM attempts to interpret the strategic implication (tying compensation to long-term performance), this interpretation is based on incorrect premises. The ground truth highlights consistency and adaptive reuse of prior agreements, not annual refinements. Due to major errors in dates, entities, exhibits, and filing history, the quantitative and qualitative accuracy is low. Contextual relevance is moderate because the answer addresses executive compensation strategy and PSUs, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 483,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Safety & Industrial segment’s electrical offering moved from a broad “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)” description to a more granular categorization that isolates those items within the newly created **Industrial Specialties** division, explicitly labeling them as “electrical products and materials for construction and maintenance, power distribution and electrical OEMs.”  This added specificity—reflected in the segment‑level sales, operating‑income and capital‑expenditure tables that now track electrical‑OEM performance separately—signals that 3M is sharpening its strategic focus on the electrical‑OEM market, allocating resources and monitoring profitability toward that sub‑segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding 3M's organizational structure and reporting changes. The claim that electrical products were moved into a newly created 'Industrial Specialties' division is incorrect—no such division was created in the 2022–2024 timeframe according to 3M's 10-K filings. Additionally, the assertion that segment-level financial tables began tracking 'electrical-OEM performance separately' is unsupported by the filings. These are major fabrications that distort the actual evolution of 3M’s product categorization. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers, so this dimension is neutral. (3) The multi-hop reasoning is flawed: while the original answer correctly identifies a linguistic evolution in how 3M described its electrical markets (increasing specificity in market labeling), the LLM invents structural and financial reporting changes that did not occur. The actual progression was purely in disclosure language within the Safety and Industrial segment, not in segment realignment or new financial disclosures. (4) Despite correctly noting increased focus on electrical OEMs, the LLM’s justification relies on false premises, undermining the validity of its conclusion. The core idea of strategic emphasis has merit, but the evidence cited is incorrect. Thus, while the directional insight about focus is partially aligned, the factual foundation is unsound, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the response addresses the right topic and timeframe but misrepresents key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 474,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt slipped from roughly $27.5 billion in 2022 to $27.2 billion in 2023 and $26.9 billion in 2024, while the weighted‑average interest rate stayed near 4.5‑4.8 % (≈4.45 % in 2022‑23 and 4.84 % in 2024). This modest reduction and flat cost of funding show the firm is gradually trimming higher‑cost long‑term borrowings and relying more on lower‑cost deposits, reflecting a strategy of preserving liquidity and managing interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values for fixed unsecured senior debt. According to the ground truth, the carrying value was $19,975 million in 2022, not $27.5 billion as stated by the LLM. The LLM incorrectly reports a decline from 2022 to 2023, while the actual data shows a substantial increase from $19,975M to $27,168M. The 2023 and 2024 values ($27.2B and $26.9B) are close to the correct figures ($27,168M and $26,930M), though slightly overstated for 2023. The interest rates are mostly accurate: the LLM states ≈4.45% for 2022–2023, but the ground truth shows 2.91% in 2022 and 4.45% in 2023, so conflating those years is incorrect. The 2024 rate of 4.84% is correctly reported. (2) Calculations: The LLM fails to capture the true magnitude of growth in 2023 (over 35% increase), misrepresenting the trend as a slight decline. This undermines the quantitative narrative. (3) Multi-hop reasoning: The LLM draws an incorrect conclusion about Capital One 'trimming higher-cost borrowings' and shifting to deposits, which contradicts the ground truth indicating a strategic increase in long-term fixed-rate debt during a rising rate environment. The actual progression—growing debt at higher rates—suggests proactive locking in of financing despite rising costs, not a reduction. The LLM misinterprets the direction of the strategy. (4) Despite incorrect numbers and flawed reasoning, the answer is contextually relevant—it addresses the right metric, company, and time frame, and attempts to interpret strategic intent. However, due to major errors in core data and resulting misinterpretation of the company's strategy, the correctness score is low. Quantitative accuracy is severely compromised, qualitative reasoning is partially sound but based on false premises, and contextual relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 505,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 NVIDIA’s 3.50% Notes Due 2040 remained on the books at roughly $1 billion of carrying value, with only modest declines in market value (from about $870 million in FY 2023 to $851 million in FY 2024) as interest rates rose; the company did not retire or re‑price the issue, merely amortizing a small discount. This steady, long‑dated senior unsecured tranche reflects NVIDIA’s strategy of anchoring its capital structure with low‑coupon, long‑maturity debt to fund sustained growth and acquisitions while limiting refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, the fair value was $1,066 million in fiscal 2022, decreased to $851 million in fiscal 2023, and in fiscal 2024, the company reported a carrying amount of $1,000 million instead of fair value. The LLM incorrectly states market value declined from $870 million in FY2023 to $851 million in FY2024, which misrepresents both the direction and timing—there is no data point of $870 million in the ground truth, and the $851 million value is for FY2023, not FY2024. Furthermore, the LLM implies a market value of $851 million in FY2024, but the ground truth states no fair value was reported in FY2024. (2) The carrying value is misrepresented: the LLM claims the notes remained at 'roughly $1 billion of carrying value' throughout, but the ground truth only reports carrying amount in FY2024 ($1,000 million), while prior years report fair value, not carrying value. The LLM incorrectly assumes consistent carrying value without evidence. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic use of long-term debt to reduce refinancing risk and support growth, which aligns with the ground truth’s interpretation of a stable, strategic approach. However, it fails to note the key accounting shift from reporting fair value to carrying amount in FY2024, a critical detail indicating a change in disclosure or management approach. (4) Due to major quantitative errors and omission of the key shift in accounting treatment (fair value to carrying amount), the correctness score is low at 4. Quantitative accuracy is scored 3 due to multiple incorrect figures and misaligned years. Qualitative accuracy is 5 because the general strategic interpretation is reasonable but lacks precision. Contextual relevance is 7 as the answer addresses the right topic and strategy, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 523,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe balance of Amazon’s 2017 senior notes fell steadily — from about **$16 billion** of carrying amount at the end of 2022, to **$15 billion** at the end of 2023, and further to roughly **$13 billion** by the end of 2024 (see Note 6 tables for 2022‑2024).  This consistent reduction shows that Amazon is actively repaying the 2017 issuance, using cash flow and newer debt financings to lower the outstanding principal and manage the overall leverage of that series of notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are presented with appropriate formatting variations (e.g., $16 billion vs $16.0 billion), which is acceptable. 2) All numeric values are accurate and consistent with the original answer; no calculations are required beyond recognition of the downward trend, which is correctly interpreted. 3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic debt reduction pattern. It adds contextual insight—mentioning cash flow and newer debt financings—as mechanisms, which, while not in the ground truth, are reasonable inferences and do not contradict it. 4) The answer fully addresses both parts of the question: the evolution of the balance and the implication for Amazon’s debt management strategy. The qualitative interpretation ('actively repaying', 'manage overall leverage') aligns semantically with 'deliberate debt management strategy to gradually retire'. The only minor deduction is for adding slightly speculative detail about financing methods, but this does not impair accuracy. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 370,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings continue to list the “Floating Rate Notes due 2019” (and comparable series) among the company’s outstanding debt disclosures (see the officer’s certificates on pages 54‑56 of the 2022, 2023 and 2024 filings).  This repetition shows that Apple still maintains a program of short‑term, floating‑rate borrowing—whose interest resets with market rates—rather than relying solely on fixed‑rate, long‑dated issuance.  Consequently, when market interest rates rise, the coupon on those floating‑rate notes will increase, directly lifting Apple’s interest expense and making earnings more sensitive to rate hikes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core assertions but contains a significant factual inaccuracy regarding the status of the Floating Rate Notes due 2019. Quantitatively, the dates (2019 maturity, 2022–2024 filings) are accurate, and the reference to the Officer’s Certificate in the filings (pages 54–56) aligns with disclosure practices, supporting quantitative accuracy. The LLM correctly identifies that floating-rate notes expose Apple to rising interest rates, increasing interest expense—a sound qualitative and contextual point. However, the claim that these notes are still 'outstanding' is misleading. The ground truth clarifies that the notes matured in 2019 and their inclusion in later filings is due to incorporation by reference and ongoing disclosure obligations, not active outstanding debt. This misrepresents Apple’s current exposure, implying an active short-term borrowing program when the disclosures reflect legacy instruments. While the reasoning about interest rate sensitivity is logically sound if the debt were outstanding, the failure to clarify the technical nature of the disclosure (i.e., by reference, not current obligation) undermines the multi-hop synthesis. The answer should distinguish between active debt and disclosure mechanics. Thus, while the directional logic and relevance are strong, the qualitative accuracy is reduced due to incorrect characterization of the debt’s status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 393,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved the Pixel line from a series of experimental launches (Pixel 5a/6 and early Nest/Fitbit expansions) to a maturing, AI‑centric hardware platform built around its custom Tensor chips and tighter integration with Google services; the company correspondingly increased R&D and supply‑chain investment while scaling production.  Device‑related revenues—still a modest, lower‑margin slice of the “subscriptions, platforms & devices” segment—have risen steadily each year, indicating growing contribution despite their small overall share.  This progression shows Google is positioning the Pixel family not as a standalone profit center but as a strategic, long‑term ecosystem anchor that locks users into its AI‑driven services and cements a durable, vertically integrated presence in the consumer‑hardware market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in spirit and contextually relevant, but diverges from the ground truth in key qualitative aspects, particularly regarding the evolution of revenue categorization and strategic framing. (1) Quantitatively, there are no specific numbers (e.g., revenue amounts, percentages, R&D figures) in either the original or LLM answer, so no numeric inaccuracies exist—this earns a 10 for quantitative accuracy. (2) The LLM correctly identifies the timeframe (2022–2024) and mentions relevant devices (Pixel 5a, Pixel 6), aligning with the original. However, the original answer emphasizes a structural shift in financial reporting: in 2023 and 2024, Pixel was explicitly categorized under a distinct 'devices' revenue stream, signaling a transition from investment to measurable financial contribution. The LLM vaguely refers to 'device-related revenues' within a broader segment without capturing this key evolution in revenue transparency and maturity. (3) The LLM introduces concepts not present in the ground truth, such as 'custom Tensor chips', 'R&D and supply-chain investment', and 'lower-margin slice', which, while plausible, are not supported by the provided truth. The original answer does not mention Tensor chips or margin analysis, so these additions reflect inference beyond the source. (4) The core reasoning about strategic positioning—Pixel as an ecosystem anchor and part of vertical integration—is semantically aligned with the original’s conclusion about long-term positioning in the hardware market. However, the original emphasizes progression from 'long-term investment' to 'stable, strategic part of the portfolio' based on reporting structure, while the LLM focuses on technological integration and ecosystem lock-in. This is a difference in emphasis and evidence used. (5) The LLM answer is contextually strong and addresses all parts of the question (investment focus, revenue, maturity, long-term positioning), but misses the precise financial reporting evolution that is central to the ground truth. Thus, correctness is 7: core facts are directionally accurate, but key evidence from the knowledge graph is not fully reflected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 581,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s pledging of client securities grew as margin‑loan balances and securities‑lending activity expanded, with the firm routinely pledging client collateral to satisfy regulatory, clearing‑house and short‑term borrowing needs.  At the same time it trimmed internal short‑term credit lines (e.g., terminating the TDAC facility and cutting uncommitted lines from $950 M to $500 M) and shifted toward external repo and FHLB funding, indicating a more disciplined collateral‑management strategy that emphasizes over‑collateralization, daily collateral monitoring and the use of practical‑expedient loss estimates to limit credit‑risk exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Schwab increasing its use of client securities for pledging and shifting funding sources, which aligns with the question's focus on collateral management evolution. However, it introduces specific details not present in the ground truth, undermining factual accuracy. For example, the claim about terminating the 'TDAC facility' and reducing uncommitted lines from $950M to $500M is not supported by the original answer and cannot be verified from the provided knowledge graph data—this constitutes a significant factual overreach. Similarly, references to 'external repo and FHLB funding', 'over-collateralization', 'daily collateral monitoring', and 'practical-expedient loss estimates' are absent in the ground truth and represent unsupported inferences. While the original answer notes an expansion in the use of pledged securities for margin lending and securities lending, especially in the context of Options Clearing Corporation requirements in 2024, the LLM adds operational and risk-management specifics that go beyond the disclosed information. There are no explicit dollar amounts in the ground truth for 2022 or 2023, so the LLM’s implied precision (e.g., $950M, $500M) fails the quantitative accuracy test. The qualitative reasoning shows an attempt at multi-hop synthesis—linking margin growth to collateral strategy—but draws conclusions not directly supported by the source. The contextual relevance is high because the answer addresses the evolution of pledging and ties it to broader collateral strategy, even if inaccurately. Overall, the answer is partially correct in direction but flawed in specifics and introduces unverified details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 469,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 to 2024 GE shifted from a passive “track‑and‑monitor” stance on long‑term‑care premium‑rate filings to an active, joint‑filing partnership with the primary insurers that cede its run‑off business.  In 2022 the company simply recorded the historical filing experience; by 2023 it was updating the net‑premium ratio each quarter and incorporating newly approved rate‑increase actions into its premium‑deficiency testing, and in 2024 it was systematically embedding those approved and anticipated increases—and the associated cash‑flow assumptions—into reserve and capital models.  This progression shows that GE’s reinsurance risk‑management strategy relies on close collaboration to lock‑in future premium assumptions, protect statutory capital, and align reinsurance recoveries with emerging claim‑cost trends in its long‑term‑care portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit and captures the overall strategic evolution of GE's collaboration with primary insurers from 2022 to 2024, but diverges in specific details and emphasis. (1) Correct elements: The progression from passive monitoring to active collaboration is accurately portrayed, and the increasing integration of rate increase data into GE’s financial modeling (e.g., premium-deficiency testing, reserve models) aligns with the original answer’s theme of proactive risk management. The focus on statutory capital protection and alignment with claim-cost trends is contextually appropriate. (2) Quantitative accuracy: There are no explicit numbers (dollar amounts, percentages, ratios) in either answer, so no discrepancies exist—this aspect is accurate by correspondence. The mention of quarterly updates to the net-premium ratio in 2023 is plausible but not present in the ground truth; however, since it doesn’t contradict known facts and fits the narrative, it doesn’t constitute a clear error. (3) Multi-hop reasoning assessment: The LLM correctly synthesizes a strategic shift over time across years and infers GE’s intent in reinsurance risk management. However, it introduces concepts not in the original—such as 'joint-filing partnership' and 'systematically embedding anticipated increases into capital models'—which go beyond the documented 'active participation in filing proposed increases' and 'using recent experience and precedents to shape expectations.' The original emphasizes contractual formalization and reliance on ceding companies’ filings, whereas the LLM implies GE co-files, which is a stronger claim not supported in the ground truth. (4) Justification: The correctness score is 7 because core facts and the strategic trajectory are correct, but there are notable elaborations that exceed the source content. Qualitative accuracy is 7 due to these overstatements in GE’s operational role. Quantitative accuracy is 10 (no numbers, no errors). Contextual relevance is 9—highly relevant with minor interpretive drift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 561,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) position was relatively stable but modestly expanding from 2022 through 2024.  The fair‑value of its RMBS holdings rose from roughly **$757 million in 2022 to $810 million in 2023**, and the separate‑account balance grew from **$51 million (2023) to $71 million (2024)**, indicating a small upward trend.  This pattern shows the company is maintaining a **conservative, high‑quality exposure to structured‑credit instruments**, limiting RMBS allocations while still holding a modest, low‑risk position in agency‑guaranteed securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS exposure decreased from $721M in 2022 to $614M in 2023, then increased to $71M in 2024. However, the LLM claims it increased from $757M (2022) to $810M (2023), which is both numerically and directionally incorrect. The only correct figure is the $71M in 2024, which the LLM attributes to 'separate-account balance' rather than total RMBS exposure, misrepresenting the nature of the holding. (2) The quantitative inaccuracies are severe: the 2022 and 2023 values are wrong by over $30–$200M, and the trend is reversed (LLM shows increase, reality shows decrease then sharp drop). The LLM also introduces a 'separate-account' distinction not present in the original answer, which changes the interpretation. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the overall trend of de-risking in 2023 followed by a minimal re-entry in 2024. Instead, it infers a 'modestly expanding' position and 'conservative, high-quality exposure', which contradicts the ground truth's emphasis on risk reduction due to unrealized losses and strategic rebalancing. (4) The contextual relevance is moderate because the answer addresses RMBS exposure and risk positioning in structured credit, but the incorrect data and reasoning undermine the conclusion. The qualitative accuracy is low due to incorrect entity interpretation (mixing separate-account with total holdings) and flawed synthesis. Correctness is severely compromised by wrong numbers and trend reversal.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 433,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 through 2024 the sum of COF’s short‑term borrowings and long‑term debt rose from roughly **$40.5 bn** to **$43.1 bn** and then to **$45.6 bn** (in millions).  This steady increase indicates that the firm has been deliberately expanding its leverage—issuing more long‑dated debt while keeping short‑term borrowings modest—to fund growth and diversify its funding base.  The progression reflects a capital‑structure strategy that relies on stable, longer‑term financing and active management of interest‑rate risk rather than aggressive short‑term borrowing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086 billion in 2022, increased to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. The LLM incorrectly reports the values as $40.5B (2022), $43.1B (2023), and $45.6B (2024), which misrepresents both the starting point and the trend—especially the critical peak in 2023 and subsequent decline in 2024. The LLM suggests a steady increase, while the truth shows a rise followed by a strategic reduction. (2) The numbers are quantitatively inaccurate: the 2022 figure is off by over $2.5 billion, the 2023 figure understates the actual debt by nearly $7 billion, and while the 2024 number is close ($45.6B vs $45.551B), it is still slightly inflated. Additionally, the LLM omits key metrics such as the weighted-average interest rate progression (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt, which are central to understanding COF’s debt management strategy. (3) The multi-hop reasoning is flawed: the LLM concludes a 'steady increase' and 'expanding leverage', which contradicts the ground truth of a peak-and-reduction strategy. It fails to recognize the deleveraging move in 2024 and the shift away from variable-rate debt, indicating a failure to synthesize the full three-year trend and associated risk management actions. (4) Despite incorrect data and reasoning, the answer is contextually relevant—it addresses COF’s capital structure and debt strategy, uses appropriate financial terminology, and attempts to interpret the trend. However, due to major factual and analytical errors, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 483,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat‑line long‑term liability of **$2.0 billion** at the close of fiscal 2022, **$2.0 billion** at the end of fiscal 2023, and **$2.0 billion** again at the end of fiscal 2024 (the $2,000 million line item appears in the 2024 and 2023 tables).  \n\nThis consistency indicates that NVIDIA has deliberately maintained a stable, low‑cost senior‑debt tranche as part of its capital structure, relying on operating cash flows and equity rather than expanding or retiring this long‑dated debt. The unchanged exposure reflects a conservative leverage strategy that prioritizes financial flexibility and steady‑state financing while funding growth internally.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,637 million in fiscal 2023 and further to $1,604 million in fiscal 2024. The LLM incorrectly reports a flat $2.0 billion across all three years, which contradicts the actual declining trend. This misrepresentation fundamentally undermines the answer’s correctness. (2) The numbers are significantly off: $2,147M vs. reported $2,000M in 2022; $1,637M vs. $2,000M in 2023; $1,604M vs. $2,000M in 2024. These are not minor rounding differences but material inaccuracies. No correct calculation or trend identification is present. (3) The multi-hop reasoning fails because the model did not detect the decrease over time, leading to an erroneous conclusion about 'stable' debt. Instead of recognizing a deliberate reduction in long-term liabilities, the LLM infers a strategy of maintaining stable debt, which is unsupported by the data. The synthesis across fiscal years is flawed. (4) While the answer addresses the question's structure—discussing evolution and strategic implication—and uses appropriate financial terminology (e.g., capital structure, leverage strategy), the factual foundation is incorrect. Hence, contextual relevance is moderate, but quantitative and qualitative accuracy are severely compromised, resulting in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 408,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to list the 0.45 % Notes due 2016 in the same “Officer’s Certificate” (Exhibit 4.3) that originates from the 2013 indenture, with no indication of a new issuance or amendment in those years. This consistent reference shows Apple’s long‑term debt strategy relies on a stable, transparent indenture framework—maintaining and simply re‑disclosing legacy note series rather than repeatedly creating new tranches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, and the years 2022–2024 are accurately referenced. The mention of Exhibit 4.3 (Officer’s Certificate) under the 2013 indenture matches the known filing structure. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and issuance context (2013)—are all correct, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that continued disclosure of a matured note across multiple recent filings indicates a strategic choice to maintain legacy disclosures within a stable indenture framework. (4) While the ground truth emphasizes 'transparency and legal continuity' as the rationale, the LLM rephrases this as a 'stable, transparent indenture framework' and 're-disclosing legacy note series,' which is semantically equivalent. The only minor gap is that the LLM does not explicitly state the notes matured in 2016 and thus are no longer outstanding, which slightly weakens the explanation of why their continued inclusion is notable. However, this is implied by context. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 343,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative position moved from a small net liability of about $5 million (2022) to a net asset of roughly $58 million (2023) and $69 million (2024).  The shift reflects a marked increase in the key unobservable input used for valuation—swap rates—from the low‑single‑digit % range (≈1‑2 % in 2021‑22) to about 4 % in 2023‑24, together with a surge in issuances/settlements (e.g., 36 → 166 → 12 million) and a swing from a $33 million unrealized loss in 2022 to $63 million of unrealized gains in 2023‑24.  This multi‑year progression shows that the firm’s interest‑rate derivative exposure grew substantially and that its fair‑value modeling now relies more heavily on higher‑level, market‑observable‑plus‑adjusted assumptions (notably higher swap rates and related credit‑risk inputs), indicating greater sensitivity to interest‑rate and credit‑spread movements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, not a $5 million liability as claimed. In 2023 and 2024, the fair value was $58 million, not $58 million and $69 million as stated. The unrealized loss in 2022 was $20 million, not $33 million, and there is no mention of $63 million in unrealized gains in 2023–2024 in the ground truth. Additionally, the claim of 'swap rates' being the input in 2021–22 at 1–2% is unsupported and introduces data outside the question scope. (2) The quantitative inaccuracies are severe: all major dollar amounts (fair value, unrealized gains/losses) are incorrect, and the progression in swap rates is fabricated. The 'issuances/settlements' numbers (36 → 166 → 12 million) appear entirely made up and are not present in the original answer. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret a shift in risk inputs and link it to interest rate sensitivity, which aligns with the ground truth’s conclusion about a shift from default to swap rates. However, it misidentifies the timing and nature of the shift—ground truth shows default as the key input in 2023 and swap rates in 2024, while the LLM implies swap rates were used earlier and consistently. (4) Despite incorrect numbers and misstated facts, the answer is contextually relevant—it addresses the evolution of derivative valuation, risk inputs, and modeling assumptions over time, and draws a reasonable (though misinformed) conclusion about increased interest rate sensitivity. This justifies moderate scores for qualitative accuracy and contextual relevance, but the severe quantitative errors drag down correctness and quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 503,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 1.55 % Notes Due 2028 showed essentially no change in principal – the gross carrying amount remained $1.25 billion (the same $1.25 billion reported at the end of FY 2023 and FY 2024), with an effective interest rate of about 1.64 % and roughly 3.4 years left to maturity.  This stability indicates that NVIDIA is deliberately using a low‑cost, long‑dated unsecured issuance to lock in cheap financing, maintain a predictable maturity profile and keep overall leverage modest, underscoring a conservative, flexibility‑focused long‑term debt strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. However, the LLM claims the amount was $1.25B in all three years, which contradicts the reported decrease in 2023. This misrepresents the evolution of the debt exposure. Additionally, the LLM states the same $1.25B was reported at the end of FY2023 and FY2024, which is incorrect—2023 was $1.1B. The effective interest rate of 1.64% and 3.4 years to maturity are not mentioned in the ground truth and cannot be verified, introducing unconfirmed details. (2) The calculation of stability is incorrect due to wrong inputs; the exposure did not remain constant—it fluctuated. The model fails to reflect the minor reduction in 2023 followed by an increase in 2024, which is central to the original answer’s interpretation. (3) The multi-hop reasoning is partially sound in that it attempts to infer strategy from debt trends, but because it is based on incorrect data, the conclusion about 'deliberate stability' is flawed. The actual progression—slight dip then increase—suggests active management rather than static holding. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing the question’s focus on debt strategy and long-term financing. The qualitative interpretation of conservative strategy has some merit but is weakened by inaccurate grounding. Thus, correctness and quantitative accuracy are low; qualitative reasoning and relevance are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 435,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nBetween 2022 and 2024 GE’s 10‑K filings repeatedly highlighted the same trailing‑liability portfolio: legacy Alstom litigation over alleged anti‑competitive conduct and corruption that continues to generate potential settlement, judgment and penalty cash‑outflows, and unresolved shareholder suits tied to earlier financial‑reporting and accounting practices.  The company continues to record reserves for these matters but emphasizes that actual losses may exceed those estimates, and each filing stresses that the risks remain “material” and “ongoing.”  This consistent language shows that the contingent liabilities have persisted unchanged in magnitude and financial impact, underscoring their enduring effect on GE’s earnings, cash‑flow and leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of GE's trailing legal liabilities from 2022 to 2024 as described in the ground truth. (1) It correctly identifies the two key categories of liabilities: legacy Alstom matters (anti-competitive conduct and corruption) and shareholder lawsuits tied to historical financial reporting. These are consistently described as ongoing, material, and resulting in potential cash outflows across the period. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), entities (GE, Alstom acquisition legacy), and liability types, correctly concluding that these contingent liabilities persist with unchanged financial impact. The only minor shortcoming is that the LLM does not explicitly mention the reputational risk aspect emphasized in the original answer for both Alstom and shareholder litigation, nor does it reference 'exited businesses' as part of the contingent liabilities in 2024. However, the core financial and operational implications are accurately conveyed. (4) The answer is fully contextually relevant, directly addressing the evolution, persistence, and financial impact of the liabilities. Wording differs but semantic meaning aligns closely with the ground truth. Minor omission of reputational emphasis prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 422,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose from roughly **$237 million in 2022 to $252 million in 2023 and $280 million in 2024**, reflecting an ~18 % increase over the three‑year span.  This growth coincides with a modest upward shift in the plan’s target allocation—from **3 % hedge‑fund weighting in 2022 to 4 % in 2024 (and the addition of a 2 % private‑credit slice)**—indicating that CVS is deliberately expanding its allocation to alternative assets.  The move is aimed at boosting expected returns and better matching the pension fund’s liability profile, underscoring a strategic pivot toward a more diversified, higher‑return‑oriented investment mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly states $237M in 2022, $252M in 2023, and $280M in 2024—overstating all values, with the 2022 figure particularly off by $23M (+10.7%). The claimed ~18% increase is based on incorrect inputs and does not align with the actual increase of ~17.7% from $214M to $252M. (2) The LLM introduces details not present in the original answer, such as target allocation increasing from 3% to 4% and the addition of a 2% private-credit allocation, which are unsupported by the ground truth. These additions suggest overreach or hallucination. (3) While the LLM correctly infers a strategic intent to expand alternative investments, this reasoning is based on inaccurate data and extraneous details. The multi-hop synthesis is partially sound in direction (increasing exposure suggests strategic shift), but flawed due to incorrect inputs and unsupported claims about allocation targets. (4) The contextual relevance is fair because the answer addresses the question’s intent—analyzing trend and strategy—but the correctness score is low due to major quantitative errors and inclusion of fabricated metrics. Semantic equivalence fails because the numbers and supporting details do not match the ground truth, undermining the validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 404,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nFrom 2022 to 2023 operating profit in Africa/Eurasia rose to **$254 million**, then edged down only slightly to **$253 million in 2024**, showing modest growth followed by a flat‑to‑slightly‑lower trend. The 2023 restructuring charges tied to the 2022 Global Productivity Initiative allocated roughly **10 % of the $32 million pre‑tax program cost** to the region (about **$3 million**), reflecting continued efficiency‑focused spending. Depreciation and amortization outlays for Africa/Eurasia remained minimal, totaling **$8 million in 2024**, indicating limited additional capital investment in the area.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The operating profit for Africa/Eurasia in 2022 was $203 million (ground truth), but the LLM claims it rose to $254 million in 2023 and $253 million in 2024—numbers not supported by the truth data and contradicting the modest contribution narrative. The restructuring charges allocated to Africa/Eurasia were 10% of total charges, estimated at $20–$24 million, but the LLM incorrectly calculates 10% of $32 million as $3 million, a major quantitative error. Depreciation and amortization is correctly stated as $8 million in 2024, but the LLM fails to mention it was $9 million in 2022 and 2023, missing a key trend. (2) Number verification: operating profit values are entirely wrong; restructuring charge calculation is mathematically incorrect (10% of $32M is $3.2M, not $3M, but even that misrepresents the truth which states $20–24M allocated); D&A is partially correct for 2024 but lacks comparative context. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize data across years and misrepresents the strategic trajectory—portraying growth when the truth indicates cost optimization and declining investment. It also misattributes the scale of restructuring spending. (4) Correctness and quantitative accuracy are low due to core number errors and miscalculations. Qualitative accuracy is slightly higher because the model attempts to interpret strategic focus on efficiency, though based on incorrect data. Contextual relevance is moderate as it addresses all question components but with inaccurate content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 441,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG’s international terrorism exposure remains concentrated in high‑value U.S. commercial and personal lines, with modeled net loss estimates for a major attack holding steady at roughly $1.3 billion net of TRIPRA and private reinsurance from 2022 through 2024.  The reinsurance program shifted from a 2022 structure with $150 million (U.S.) and $200 million (Japan) retentions to a 2023‑2024 program that kept the $500 million North‑America commercial retention but reduced the Japan attachment point to $150 million and added higher vertical limits and per‑risk covers.  Accordingly, total reinsurance recoverable assets fell sharply—from about $67 billion in 2023 to $38 billion in 2024—reflecting a smaller ceded portfolio and reduced reliance on collateral.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that AIG's international terrorism exposure is 'concentrated in high-value U.S. commercial and personal lines'—this contradicts the ground truth, which emphasizes AIG's international exposure and reinsurance management outside the U.S. Second, the LLM claims the $1.3 billion net loss estimate 'held steady from 2022 through 2024', but the ground truth only provides a 2022 modeled loss estimate and does not confirm stability over time. Third, the LLM incorrectly states that the 2022 retention was $150 million (U.S.), while the ground truth mentions a $1.7 billion TRIPRA deductible and no such U.S. retention figure. The LLM also fabricates a reduction in Japan's attachment point from $200 million to $150 million, whereas the ground truth states AIG *retained* a core attachment point of $200 million in Japan and $125 million elsewhere—no reduction is mentioned. Additionally, the LLM claims reinsurance recoverable assets 'fell sharply' from $67 billion in 2023 to $38 billion in 2024, but the ground truth states that recoverable assets reached $38.0 billion in 2024 with no 2023 figure provided—thus the $67 billion figure is entirely fabricated. (2) Quantitative accuracy is severely compromised: the $67 billion 2023 recoverable asset value is false; the $500 million North America retention is not in the ground truth; the claim of reduced attachment points contradicts the 'retained core attachment points' in the original. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize information across years and misrepresents the evolution of reinsurance protections. It invents structural changes not present in the source and mischaracterizes trends (e.g., decreasing recoverables due to reduced reliance, while the ground truth indicates an *expansion* in reinsurance protections). (4) Contextual relevance is moderate—the answer addresses terrorism exposure, modeled losses, attachment points, and reinsurance recoverables—but the factual foundation is so compromised that the response misleads despite covering the right topics. Overall, major factual and quantitative errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 599,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe carrying amount of NVIDIA’s 2.00% Notes Due 2031 was about $1.2 billion in 2022, slipped to roughly $1.044 billion in 2023 (reflecting discount amortization and a modest retirement), and then rose back toward $1.25 billion in 2024 as disclosed in Note 12 (page 72) and the liability table (page 65).  This pattern shows that the company is treating the 2031 notes as a stable, low‑cost long‑term financing tool, adjusting the balance only modestly for accounting amortization rather than aggressively reducing or expanding debt, thereby preserving liquidity while funding ongoing operations and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. These values are critical multi-hop data points across fiscal years, and their accuracy is confirmed. (2) The explanation for the 2023 decrease—'discount amortization and a modest retirement'—is a reasonable interpretation consistent with the ground truth's suggestion of 'minor debt repayments or reclassifications.' The 2024 increase back to $1.25 billion is accurately noted and interpreted as a return to prior levels, aligning with the ground truth's emphasis on stability. (3) The reasoning is sound: the LLM correctly infers that NVIDIA is using the 2031 notes as a stable, low-cost financing tool, reflecting a strategic long-term debt management approach. It appropriately links this to funding operations and strategic investments without aggressive repayment, which is semantically equivalent to the ground truth's point about preserving stable liabilities and avoiding refinancing risk. (4) The only minor gap is that the LLM does not explicitly mention 'R&D' as a use of funds, which the ground truth highlights, though 'strategic investments' is a close proxy. Additionally, the LLM cites 'Note 12 (page 72)' and 'liability table (page 65)', which add document-level precision not required but enhance credibility. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong multi-hop synthesis across years and financial concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 429,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 were originally created under Apple’s 2013 indenture and were listed in the 2014 Officer’s Certificate (shown in the 2022 filing as part of the legacy global‑note schedule). By the 2023 and 2024 10‑Ks that series no longer appears—having been retired and supplanted by newer tranches such as the 2023 4.421 % Notes due 2026—yet the underlying indenture and global‑note framework remain in place. This illustrates that Apple’s debt structure has long‑term visibility through its continuous indenture, but individual note series are finite and are systematically rolled forward, preserving the overall framework while the specific 1.05 % 2017 instrument drops out of the public record.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. The original answer states that Apple's 1.05% Notes due 2017 were consistently referenced across 2022, 2023, and 2024 filings, indicating ongoing documentation of the instrument despite its 2017 maturity. However, the LLM claims the series 'no longer appears' in the 2023 and 2024 10-Ks, which directly contradicts the ground truth. This error undermines the core of the response. While the LLM correctly identifies the 2013 indenture and references a 2014 Officer’s Certificate (consistent with legacy documentation), it incorrectly infers retirement and replacement by newer notes like the 4.421% Notes due 2026—information not supported by the ground truth. The reasoning about the indenture framework having long-term visibility is partially aligned, but the conclusion that the specific instrument 'drops out of the public record' is false per the original answer, which emphasizes continued inclusion. Quantitatively, percentages and years (1.05%, 2017, 2013 indenture) are accurate, but the absence of financial amounts or calculations limits quantitative depth. The multi-hop synthesis fails because the model incorrectly interprets the discontinuation of the note series rather than recognizing its persistent disclosure. Contextually, the answer addresses debt structure continuity but misrepresents the evolution of this specific instrument, leading to a misleading interpretation of Apple’s debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 415,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s IDA‑migration rights shifted when the original 2019 IDA agreement was superseded by the 2023 IDA agreement. Under the 2019 arrangement (still in effect in 2022) Schwab could move up to $10 billion of IDA balances each 12‑month window—subject to keeping at least $50 billion of IDA balances on the books through June 2031 and maintaining ≥ 80 % of those balances as fixed‑rate obligations through June 2026. The 2023 agreement kept the $10 billion‑per‑year cap but restricted migrations to **floating‑rate** IDA balances only, eliminated the 80 % fixed‑rate requirement, and introduced new balance‑maintenance thresholds: through September 10 2025 Schwab must keep IDA balances above the total of outstanding unmatured fixed‑rate obligations plus a $30 billion buffer (with a maximum $30 billion above that total), and after that date it must sustain a minimum of $60 billion and a maximum of $90 billion of IDA balances for the remainder of the sweep period (extended to July 1 2034). Consequently, although the migration option remained, Schwab did not execute any balance transfers in 2024, reflecting the tighter floating‑rate‑only limitation and the higher minimum‑balance requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right context and timeframe. (1) Quantitative Accuracy: The LLM incorrectly states that the $10 billion annual migration cap remained under the 2023 IDA agreement, while the ground truth indicates Schwab no longer had the option to migrate balances at all after 2022. It also fabricates specific numerical thresholds such as a '$30 billion buffer' and '$60 billion minimum / $90 billion maximum' post-September 2025, which are not present in the original answer. Additionally, the LLM invents a sweep period end date of 'July 1, 2034' and a September 10, 2025 threshold date, neither of which appear in the ground truth. (2) Completeness: While the LLM attempts to cover the evolution from 2022–2024 and discusses migration limits and balance requirements, it misrepresents the core change — the elimination of the migration option — and adds unsupported details. (3) Entity Accuracy: The companies (Schwab), agreements (2019 and 2023 IDA), and general concept of balance sheet migration are correct. However, the specific terms attributed to these agreements are inaccurate. (4) Reasoning: The multi-hop synthesis is flawed because the LLM assumes continuity of the migration option into 2023–2024 with modified terms, whereas the ground truth shows a complete cessation of migration rights. This leads to an incorrect conclusion about 'tighter floating-rate-only limitation' when in fact no such limitation existed because migration was no longer an option. (5) Semantic Equivalence: The overall narrative of increased constraints is directionally plausible, but the specific mechanisms and numbers are fabricated, making the answer substantially incorrect. The ground truth emphasizes a strategic shift away from migration, while the LLM incorrectly suggests migration remained possible but was restricted. Thus, while contextually relevant and attempting qualitative reasoning, the answer fails on key facts and numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 544,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 the estimated loss‑exposure tied to Bank BPH’s borrower‑litigation grew from **$1.36 bn (2022)** to **$2.67 bn (2023)** and was later revised to roughly **$2.46 bn by the end of 2024**.  To keep regulatory capital adequacy, GE injected **$530 m of cash in 2022**, then executed a **$1.80 bn non‑cash inter‑company loan‑forgiveness in 2023** (no additional cash contribution was required in 2024).  As a result of the settlement program and subsequent valuation allowance, the **mortgage‑portfolio carrying value was written down to zero by year‑end 2023 and remained zero in 2024**.  (Pages 50, 51, 94, 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key facts from the ground truth with strong semantic equivalence. (1) Quantitatively: The estimated losses are correctly reported as $1.36 billion (vs. $1,359 million), $2.67 billion (vs. $2,669 million), and $2.46 billion (vs. $2,461 million) for 2022, 2023, and 2024 respectively—minor rounding is acceptable. Capital contributions match: $530 million cash in 2022 and $1.80 billion non-cash (vs. $1,797 million) in 2023. The carrying value of the mortgage portfolio is correctly stated as written down to zero. (2) However, there is a minor discrepancy in timing: the LLM states the carrying value reached zero by year-end 2023, while the ground truth specifies it was zero by end of 2024. Given that it 'remained zero in 2024', the write-down likely occurred in 2023 or early 2024, so this is a borderline but acceptable interpretation. (3) The multi-hop reasoning is sound—synthesizing litigation exposure, capital injections, and asset valuation across years and forms (cash vs. non-cash). (4) All entities (GE, Bank BPH, mortgage portfolio, litigation) and timeframes are correctly identified. The answer is fully relevant and addresses all parts of the question. One point deducted from correctness due to slight ambiguity in timing of write-down to zero; otherwise, excellent performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 374,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nFrom 2022 through 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities slipped modestly—from about **$1.02 bn to $0.98 bn**—while the unrealized loss narrowed from **≈$155 m to $100 m**, showing that the company’s mark‑to‑market losses were reduced even as the portfolio shrank.  The 2024 data (which disclose only **$3 m of CMBS in separate‑account holdings**) indicate that the firm has further trimmed its exposure, reflecting a deliberate risk‑management strategy of de‑risking higher‑volatility tranches and preserving capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022, not $1.02B as stated; $675M in 2023, not $0.98B; and dropped to $3M in 2024. The LLM incorrectly reports a decrease from $1.02B to $0.98B, which contradicts both the magnitude and direction of change in 2023 (actual increase). Unrealized losses in 2022 were $12M, not $155M—this is a major overstatement. While the 2023 unrealized loss of $100M is correctly cited, it is miscontextualized as a 'narrowing' when in fact it represents a sharp increase from $12M. The only correct number is the $3M CMBS exposure in 2024. (2) Calculations and comparisons are flawed: the claim of 'slipping modestly' and 'unrealized loss narrowed' is factually incorrect—the loss widened dramatically. The answer misrepresents the trend entirely. (3) Multi-hop reasoning is partially present—the conclusion about de-risking in 2024 aligns with the ground truth and shows some correct synthesis based on the final data point—but the reasoning is built on false quantitative premises. The model fails to accurately track the evolution across years due to incorrect inputs. (4) Contextual relevance is moderate because the answer addresses the right topic (CMBS exposure and risk management) and draws a plausible strategic conclusion, but the severe numerical inaccuracies undermine the validity of the analysis. The answer suggests risk reduction while misrepresenting the intermediate-year dynamics. Thus, correctness is very low despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 446,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Walmart repeatedly listed “Marketside” in its private‑brand rosters (2022 p. 7; 2023 p. 6; 2024 p. 7) and disclosed that the brand was being broadened with additional SKUs and new grocery categories, while the company’s overall private‑label share of grocery sales grew each year.  This three‑year trajectory shows that Walmart is deliberately expanding Marketside as a core grocery‑private‑label platform to capture price‑sensitive shoppers, increase margin, and differentiate its offering in a crowded grocery market.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Marketside was consistently included in Walmart's private brand portfolio from 2022 to 2024, which aligns with the ground truth. It also accurately reflects the broader strategic context of Walmart expanding its private label presence in grocery. However, the LLM introduces information not present in the original answer: specifically, that Marketside was 'being broadened with additional SKUs and new grocery categories' and that 'private-label share of grocery sales grew each year.' These specific claims about SKU expansion and year-over-year sales growth are not supported by the ground truth and represent unsupported inferences. While the citation of page numbers (2022 p.7, etc.) suggests document grounding, the original answer does not mention these details, making them factually unverifiable based on the provided truth. The reasoning about Walmart's strategy contains partial alignment—emphasizing expansion and differentiation—but misses the key nuance in the original answer about a 'dual approach' of maintaining legacy brands like Marketside while introducing modern brands like 'bettergoods.' This multi-hop insight is absent in the LLM response, weakening its qualitative accuracy. The contextual relevance is high because the answer addresses the evolution and strategic implication, but the overreach in unsupported specifics reduces correctness. Quantitative accuracy is high because there are no explicit numbers or calculations that are incorrect—only unverified claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 420,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s moved from a generic supplier code of conduct to a risk‑based approach that includes country‑specific wood‑sourcing risk tiers, a new forestry grievance process, mandatory CDP emissions reporting and 100 % SmartWay certification for transportation providers, thereby tightening environmental and human‑rights enforcement (pages 9, 10).  At the same time the company invested more than $550 million in energy‑efficiency upgrades, on‑site solar at 174 stores, and renewable‑energy PPAs, and it set a net‑zero Scope 1‑3 target for 2050 with interim 2030 cuts of 42 % (Scope 1‑2) and 25 % (Scope 3) (pages 9, 12).  These policy enhancements and capital investments collectively deepened supply‑chain due diligence and sustainability capacity across Lowe’s operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unverified information not present in the ground truth, significantly affecting correctness. While it correctly identifies Lowe's enhanced monitoring and policy evolution from 2022 to 2024, including a risk-based approach and grievance process, it adds unsupported details: (1) 'mandatory CDP emissions reporting' and '100% SmartWay certification for transportation providers' are not mentioned in the original answer and lack grounding in the provided truth; (2) the $550 million investment is correctly cited for 2022 but the LLM misrepresents its purpose—original specifies 'operational sustainability initiatives' broadly, not energy-efficiency upgrades, solar installations, or PPAs; (3) the $400 million investment through 2023 is omitted entirely; (4) the net-zero Scope 1-3 target for 2050 and interim 2030 goals (42% Scope 1-2, 25% Scope 3) are not in the original and represent a significant addition of unverified data. Quantitative accuracy is low because while $550 million is correct, the second investment figure ($400M through 2023) is missing, and new figures (percentages, targets) are fabricated. Qualitative accuracy is moderate: the core idea of evolving to a risk-based wood sourcing policy with country-specific tiers and grievance mechanisms aligns with the truth, showing correct multi-hop synthesis across years. Contextual relevance is high—the response stays focused on supplier practices, policy enhancements, and investments in sustainability. However, the inclusion of unverified ESG targets and misattribution of investment use undermines factual reliability. Semantic equivalence fails on key financial and policy specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 467,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nThe 2.40 % Notes due 2023 first appeared in Apple’s 2022 Form 10‑K (Exhibit 4.3) as part of the 2013 indenture, and the same series was still listed in the 2023 and 2024 filings; however, by 2024 it was shown only as a legacy tranche with a near‑term maturity while newer, longer‑dated notes (e.g., the 2026‑2053 issuances) were added to the exhibit list. This three‑year evolution demonstrates Apple’s active debt‑management strategy of rolling maturing debt into longer‑dated, low‑coupon securities to extend its maturity profile and preserve financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.40% Notes due 2023 and their presence in Apple's filings from 2022 to 2024, which aligns with the ground truth. It accurately notes the notes were issued under the 2013 indenture and remained listed through 2024. However, the LLM introduces a claim not present in the ground truth — that by 2024 the note was labeled as a 'legacy tranche' and that newer notes (e.g., 2026–2053) were added — which, while plausible, is not supported by the provided ground truth and represents an unsupported inference. (2) Quantitatively, all dates (2022, 2023, 2024), percentages (2.40%), and the 2013 indenture reference are accurate. No calculations are required, and number formats are consistent. (3) The multi-hop reasoning is partially sound: the model correctly tracks the note across years, but overreaches in concluding an 'active debt-management strategy of rolling maturing debt' based solely on continued disclosure. The ground truth emphasizes transparency and consistency in disclosure, not active refinancing or rollover. The LLM shifts focus from disclosure strategy to debt refinancing strategy without sufficient evidence from the provided data. (4) The contextual relevance is high, as the answer addresses the evolution and interpretation of the disclosure. However, the qualitative accuracy is reduced due to unsupported strategic inferences. Correctness score is 6 due to partial factual alignment but significant interpretive overreach not grounded in the evidence provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 423,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 to 2024 the AerCap exposure swung from a **$865 million unrealized loss** (2022) to a **$129 million unrealized gain** (2023) and then to a **modest $38 million gain** (2024).  This shift reflects that GE sold its remaining AerCap equity shares in 2023, retained only a senior note, and is now winding down that position, underscoring a strategic move to shed non‑core financial investments and simplify its portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that GE's holdings of the AerCap *note* were $976M in 2022, $944M in 2023, and $982M in 2024. The LLM instead reports unrealized gains/losses ($865M loss, $129M gain, $38M gain), which are entirely different financial metrics and not the value of holdings. These figures do not match the ground truth and represent a fundamental misunderstanding of the data. (2) The numbers provided by the LLM are not just inaccurate—they refer to a different concept (unrealized gains/losses on equity, possibly) rather than the carrying value of a debt instrument. There is no mention in the original answer of GE holding equity shares in AerCap or selling them in 2023; the ground truth focuses solely on the senior note. The claim that GE 'sold its remaining AerCap equity shares in 2023' and is 'winding down' the position is unsupported by the original answer, which instead suggests relative stability with slight fluctuations. (3) The multi-hop reasoning fails: the LLM conflates equity and debt instruments, misrepresents the nature of GE's holdings, and draws strategic conclusions based on incorrect data. The original answer notes a dynamic but stable pattern in note holdings amid broader portfolio changes, while the LLM incorrectly infers a strategic wind-down. (4) The contextual relevance is moderate because the answer addresses GE's investment strategy and mentions the AerCap instrument over the correct time period, but the factual foundation is so flawed that the conclusion is misleading. Quantitative accuracy is very low due to completely incorrect figures and metrics. Qualitative accuracy is low due to incorrect entity interpretation (equity vs. note) and unsupported strategic claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 494,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s U.S. pension glide‑path cut the strategic equity allocation from **15 % (target 2022)** to **9 % (target 2023‑2025)**, while raising the fixed‑maturity share from **75 % to 80 %** and modestly increasing the “other” bucket from **10 % to 11 %**. This systematic move toward higher‑quality, liability‑hedging assets reflects the plan’s improving funded ratio, showing a deliberate de‑risking strategy that reduces exposure to growth‑oriented assets as the sponsor’s solvency strengthens.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general de-risking trend and correctly identifies AIG's U.S. pension plan glide path strategy of shifting from growth to liability-hedging assets as funded status improved. However, there are significant quantitative inaccuracies. The LLM states equity allocation dropped from 15% (target 2022) to 9% (target 2023–2025), and fixed-maturity increased from 75% to 80%, but the ground truth does not provide these specific percentages or confirm such exact shifts. The original answer emphasizes the *mechanism* of the glide path—how target allocations for future years are set based on prior year-end funded status—and the *principle* of increasing liability-hedging assets as funded ratios improve, without citing exact allocation percentages. Thus, while the qualitative direction of de-risking is correct, the LLM fabricates precise numbers not present in the ground truth, undermining factual accuracy. The mention of 'strategic equity allocation' and 'fixed-maturity share' introduces specific asset class breakdowns absent in the original, which only refers to broad categories (growth vs. liability-hedging assets). This constitutes a failure in quantitative fidelity despite correct reasoning about de-risking. The multi-hop logic—linking funded status improvements to allocation changes—is sound and contextually relevant, but the unsupported specificity in numbers reduces correctness. The 'other' bucket increase from 10% to 11% is also unverified and not mentioned in the ground truth. Overall, the answer reflects a plausible interpretation but adds granular data not present in the source, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 450,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its strategy, but the segment’s financial trajectory was uneven: revenue rose only 3 % in 2023 before slipping 25 % in 2024, and operating‑profit margins fell from roughly 38 % (2023) to about 14 % (2024) as mix‑related cost pressures grew. This multi‑year consistency—maintaining the segment as a strategic pillar despite short‑term volatility—highlights that embedded processing remains a reliable, high‑margin source of cash that underpins the company’s long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention any revenue growth or decline for embedded processing products in 2023 or 2024, nor does it reference operating-profit margins of 38% in 2023 or 14% in 2024. These specific numbers and trends (3% revenue growth in 2023, 25% decline in 2024, margin drop from 38% to 14%) are not supported by the original answer and appear to be fabricated or hallucinated. There is no mention of 'mix-related cost pressures' in the ground truth. (2) The quantitative inaccuracies are severe and central to the LLM's argument—using incorrect financial performance data undermines the entire analysis. The original answer focuses solely on strategic emphasis and qualitative rationale, not financial performance metrics for the embedded processing segment. (3) The reasoning partially captures the multi-hop element by recognizing that TI maintained a consistent strategic focus on embedded processing from 2022 to 2024 and linking it to long-term free cash flow per share growth. However, it incorrectly frames this consistency as persistence 'despite short-term volatility,' which is not stated or implied in the original answer. The original emphasizes continuity and foundational importance, not resilience amid underperformance. (4) While the LLM correctly identifies the strategic consistency and its link to long-term cash flow, the inclusion of unsupported financial data severely compromises factual correctness. The contextual relevance is moderate because it addresses the right topic and timeframe, but the qualitative accuracy is reduced by incorrect synthesis. Correctness score is low due to major quantitative errors, even though the general strategic theme is aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 492,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s IP strategy for its private‑brand suite—led by the Kobalt line—shifted from simply defending existing trademarks and patents to a deliberate portfolio balance that couples value‑oriented private labels with national power brands while deepening localization and rural‑market coverage.  At the same time, the company integrated these brands into its digital‑first omnichannel platform (e‑commerce, virtual design and sales tools, curb‑side and delivery fulfillment), using the same digital channels to promote and protect Kobalt and other private‑brand assets, and reinforced trademark, patent and domain‑name protections to safeguard the brand across all online and on‑site touch‑points.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Lowe's intellectual property strategy evolution from fiscal 2022 to 2024. While the ground truth indicates that Lowe's shifted its disclosure focus—specifically listing 'Kobalt', 'STAINMASTER', and 'allen+roth' in 2022 and 2023, dropping 'RONA' and 'Reno Depot' by 2023, and adding digital transformation language in 2024—the LLM instead fabricates a narrative about strategic shifts toward 'value-oriented private labels', 'national power brands', 'rural-market coverage', and 'deepening localization', none of which are supported by the original data. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers allows a score of 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to identify the actual evolution in brand disclosures (streamlining of listed brands and later integration with digital initiatives) and instead invents strategic themes not present in the ground truth. It also incorrectly frames the shift as one from 'defending trademarks' to a 'digital-first omnichannel platform', which is not reflected in the original answer. (4) Contextual relevance is moderate—the answer addresses private brands and digital transformation, which are relevant topics—but misrepresents the nature and evidence of the strategy shift. The core factual claims about brand portfolio emphasis and digital integration are not aligned with the documented disclosures, leading to a low correctness score despite appropriate topic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 452,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s annual reports moved the notion of client relationships and trust from a peripheral risk factor to a central competitive advantage.  In the 2022 filing trust was cited mainly as a vulnerability (“Damage to IBM’s reputation could impact the business”), whereas the 2023 and 2024 filings explicitly list “client relationships and trust” among the firm’s principal methods of competition and tie that trust directly to its hybrid‑cloud and AI platform, ecosystem of partners, and ability to deliver business value.  This multi‑year progression shows IBM is positioning itself as a trusted partner that can guide clients through complex cloud‑and‑AI transformations, differentiating its offering on the basis of reliability and long‑term relationship depth rather than solely on technology or price.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024. It accurately identifies the shift from viewing trust as a reputational risk in 2022 to a central competitive differentiator in 2023 and 2024, which aligns with the ground truth. The answer correctly links this evolution to IBM’s hybrid cloud and AI strategy and mentions the ecosystem of partners as a vehicle for delivering value. However, it omits specific details about the expansion of strategic partnerships—such as AWS, Microsoft, SAP in 2023 and Palo Alto Networks in 2024—which are key to the multi-hop synthesis in the original answer. Additionally, the ground truth emphasizes the growing role of cybersecurity and data governance in shaping trust, a nuance not reflected in the LLM response. While the LLM captures the directional trend and strategic intent, it lacks the specific entity-level detail and ecosystem progression that define the full multi-year trajectory. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is sound at a high level. Contextual relevance is strong as it directly addresses the question’s focus on strategic positioning in hybrid cloud and AI. The omission of specific partners and the cybersecurity dimension prevents a top score, but the overall interpretation remains factually aligned and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 399,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s El Segundo, California site was repeatedly described as the company’s “clinical and commercial manufacturing and processing” hub for cell‑therapy products.  Initially the facility was used to produce clinical‑grade material for Kite’s CAR‑T candidates, but by 2023‑2024 it was also supplying commercial batches of approved therapies such as Yescarta and Tecartus and supporting later‑stage pipeline products, indicating a shift from early‑stage clinical production to a full‑scale, multi‑product commercial manufacturing role.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of the El Segundo facility's role, despite using plausible-sounding details. (1) The original answer (ground truth) states that there was no significant change in the facility’s role from 2022 to 2024—it consistently served both clinical and commercial manufacturing throughout. The LLM incorrectly asserts a shift 'from early-stage clinical production to a full-scale, multi-product commercial manufacturing role' by 2023–2024, which contradicts the documented continuity. (2) There are no numeric values (e.g., dollar amounts, percentages, headcount) in either answer, so quantitative accuracy is not applicable; however, the years 2022, 2023, and 2024 are used correctly in context, supporting a score of 10 for quantitative accuracy by default. (3) The qualitative inaccuracy stems from flawed reasoning: the LLM infers an evolution that is not supported by the filings. It introduces specific product names (Yescarta, Tecartus) and claims about production scaling that are not present in the ground truth, reflecting overinterpretation or hallucination. (4) Contextual relevance is moderate—the response addresses the right facility, time frame, and general topic of cell therapy manufacturing, but misrepresents the nature of its operational evolution. The answer suggests progression and expansion not found in the source, undermining its correctness. Thus, the correctness score is low (3) due to a central factual error in the narrative of change, even though the facility's dual clinical/commercial role is partially acknowledged.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 440,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s did not issue any new 4.550 % notes; the only 4.550 % tranche remains the series originally sold in the 2019 Fifteenth Supplemental Indenture (maturing April 5 2049).  Instead, the company added three supplemental indentures (the 20th – Sept 2022, 21st – Mar 2023 and 22nd – Mar 2023) that introduced fresh senior unsecured notes with staggered maturities (2025‑2063) and coupons ranging from 3.35 % to 5.85 %.  This multi‑year pattern shows Lowe’s is building a laddered, long‑dated debt profile—extending average maturity and diversifying funding—rather than repeatedly rolling or expanding the original 4.550 % issue.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant factual errors that undermine its correctness. (1) On quantitative accuracy: The original answer confirms that the 4.550% Notes due April 5, 2049 were consistently referenced across 2022–2024 filings under the Fifteenth Supplemental Indenture dated April 5, 2019. The LLM correctly identifies this maturity date and coupon rate, which is accurate. However, it introduces unverified details not present in the ground truth: specifically, the claim that Lowe’s added the 20th (Sept 2022), 21st (Mar 2023), and 22nd (Mar 2023) Supplemental Indentures introducing new notes with maturities from 2025–2063 and coupons from 3.35% to 5.85%. These specific supplemental indentures and their timing are not confirmed in the ground truth and represent unsupported additions. (2) Completeness: The LLM addresses the evolution of the 4.550% Notes and attempts to interpret long-term debt strategy, satisfying the multi-part structure of the question. However, it fabricates details about new issuances and indentures, which were not part of the verified data. (3) Entity accuracy: The company (Lowe's Companies, Inc.) and the core instrument (4.550% Notes due April 5, 2049) are correctly identified. The Fifteenth Supplemental Indenture date (April 5, 2019) is also correct. But the subsequent indentures (20th–22nd) and associated dates/coupons lack verification and appear to be hallucinated. (4) Reasoning: While the conclusion about building a 'laddered, long-dated debt profile' is plausible and aligns thematically with the ground truth’s interpretation of long-term strategy, the reasoning is based on incorrect premises. The ground truth emphasizes stability and consistency in referencing the same long-term instrument to avoid refinancing risk, whereas the LLM infers active expansion via new tranches, which is not supported. (5) Semantic equivalence: The overall theme of long-term debt management is similar, but the specific evolution described differs materially. The ground truth highlights continuity; the LLM emphasizes diversification through new issuances. Due to the inclusion of unverified indentures and misrepresentation of issuance activity, the factual core is compromised. Thus, while some numbers and dates are correct, the synthesis is flawed, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 632,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the exposure tied to 3M’s Scotchgard PFAS products moved from a scattered docket of state‑AG and private contamination suits to a single, court‑approved settlement that will cost the company $10.5 billion‑$12.5 billion (a $10.3 bn pre‑tax charge was recorded in Q2 2023).  The settlement, finalized in early 2024 after preliminary approval in 2023, resolves most public‑water claims and many other PFAS actions and commits 3M to multi‑year payments through 2036.  This evolution shows that PFAS‑related litigation has become a multi‑billion‑dollar financial drag on 3M, forcing the company to set aside large reserves and reshaping its earnings outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims a $10.5–12.5 billion settlement with a $10.3 billion pre-tax charge in Q2 2023, which is factually wrong according to the ground truth. The original answer states a $65 million settlement in 2022 and another $65 million in New York finalized in 2024—nowhere near the billions cited. The LLM invents a massive settlement not supported by the data. (2) The timeline is also inaccurate: the LLM claims the settlement was 'finalized in early 2024' after 'preliminary approval in 2023', but the ground truth does not mention any such multi-billion-dollar settlement or court approval process. Instead, it describes ongoing litigation and non-material settlements. (3) Qualitatively, the LLM misrepresents the evolution of legal exposure—portraying it as resolved by a single mega-settlement—whereas the truth shows an expanding, unresolved litigation footprint across states and countries with increasing complexity. The LLM fails to mention key details like the Wolverine-related class action, suits in Canada, Illinois, Alabama, or Georgia, or the trial dates set for 2026. (4) Contextually, the answer addresses the financial impact of PFAS litigation, which is relevant, but does so with fabricated figures and misleading synthesis, undermining its usefulness. The core trend—escalating exposure—is partially valid, but the magnitude and resolution are grossly misrepresented. Thus, while the general direction of increased liability is plausible, the specific facts, numbers, and reasoning are not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 446,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 the Foster City, California campus shifted from a primarily early‑stage chemistry and analytical‑development hub to a central source of API for both clinical and commercial batches of newly approved products (e.g., Livdelzi, Trodelvy, Biktarvy, Vemlidy) and for the company’s expanding cell‑therapy pipeline.  This evolution tied the site into Gilead’s global manufacturing network—linking its proprietary process‑chemistry and formulation expertise with scale‑up and commercial production at other worldwide facilities (Ireland, Canada, the Netherlands, etc.)—so that R&D output at Foster City could be rapidly translated into global supply for Gilead’s worldwide operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Gilead's Foster City facility. While the ground truth indicates a narrowing of focus toward early-stage R&D and clinical manufacturing (process chemistry, analytical development, formulation, device development, and clinical API/drug product manufacturing) from 2023–2024, the LLM incorrectly claims Foster City became a 'central source of API for both clinical and commercial batches' of major products like Biktarvy and Vemlidy. This contradicts the strategic shift described in the original answer, which explicitly states that commercial-scale manufacturing was moved to other sites (e.g., La Verne, Oceanside, international locations). (2) There are no explicit numerical values (e.g., dollar amounts, percentages, headcount) in either answer, so quantitative accuracy is not heavily applicable; however, the years 2022–2024 are correctly referenced, and no false numerical claims are made—hence a score of 8. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that Foster City expanded into commercial manufacturing, when the knowledge graph shows a strategic narrowing and specialization in early development and clinical production. It also introduces specific drug names (Livdelzi, Trodelvy, etc.) and links them to Foster City’s manufacturing role without evidence in the ground truth, which does not mention these products in this context. This reflects a failure in entity and functional alignment. (4) Contextual relevance is moderate—the response addresses R&D focus, manufacturing responsibilities, and global strategic alignment as asked, and correctly situates Foster City within a broader network. However, the core factual claim about commercial API production is unsupported and directly contradicts the original answer, severely undermining correctness and qualitative accuracy. Semantic equivalence is not achieved due to this key divergence in facility role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 537,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG strengthened its loss‑reserve oversight by instituting a formal three‑tiered limit hierarchy and embedding ERM‑driven risk‑committees, second‑line challenge and internal‑audit reviews into the reserve‑setting process.  Its modeling evolved from deterministic reserve estimates to sophisticated stochastic PML frameworks that incorporate climate‑change adjustments and third‑party catastrophe models, with explicit external validation of those models.  Consequently, AIG began routinely integrating outside expertise—independent catastrophe‑model vendors, external actuaries and reinsurer credit reviews—into both the development and challenge of loss‑reserve assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of AIG's evolution in loss reserve risk management from 2022 to 2024 and correctly identifies key themes such as enhanced oversight, modeling sophistication, and integration of external reviews. However, it introduces specific details not present in the ground truth, which affects factual accuracy. For example, the 'three-tiered limit hierarchy' and 'climate-change adjustments' are not mentioned in the original answer and cannot be verified from the provided knowledge. Similarly, while the shift toward stochastic modeling is correctly noted, the original answer does not specify 'PML frameworks' or 'third-party catastrophe models'—these are plausible but unsupported elaborations. The mention of 'reinsurer credit reviews' and 'explicit external validation' goes beyond the original's reference to external expert reviews without specifying scope or form. The timeline of evolution is generally aligned: 2022 focused on uncertainty and oversight, 2023 on expanded quantitative methods (stochastic, sensitivity), and 2024 on ERM integration and second-line challenge—all of which the LLM captures in spirit. However, the original emphasizes a progression from reactive to proactive governance, which the LLM does not explicitly convey. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. Contextual relevance is high because the response stays on topic and addresses oversight, modeling, and external review. Qualitative accuracy is reduced due to over-specificity with unverified details. Correctness score reflects partial alignment with ground truth: core ideas are correct, but significant unsupported additions reduce factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 470,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 the property tables in TI’s 10‑K filings consistently placed **Melaka, Malaysia in the “Analog” column only**, never under “Embedded Processing.”  The site’s designation remained unchanged across the three years, and the overall growth in overseas square‑footage (e.g., rising from ~10 M ft² in 2021 to >12 M ft² by 2024) shows that the Melaka facility was being expanded or maintained as part of TI’s analog‑chip manufacturing network.  Consequently, the three‑year progression underscores that TI’s regional footprint in Malaysia is strategically focused on analog semiconductor production rather than embedded‑processing devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Melaka, Malaysia was consistently listed under 'Analog' and never under 'Embedded Processing' in TI's 10-K filings from 2022 to 2024, which matches the original answer's claim of exclusive Analog focus. (2) The quantitative claim about overseas square footage increasing from ~10M ft² in 2021 to >12M ft² by 2024 is plausible and consistent with TI’s expansion trends, though the ground truth does not specify these exact numbers. Since the original answer does not provide square footage data, the LLM’s inclusion of this detail—while not verifiable from the ground truth—is contextually reasonable and does not contradict it. (3) The reasoning is sound: the unchanged classification over three years supports the conclusion of a stable, specialized role in Analog manufacturing. The LLM correctly synthesizes multi-hop information by linking site designation in filings over time to strategic focus. (4) Minor deduction in correctness and quantitative accuracy due to the introduction of square footage figures not present in the ground truth, which, while plausible, cannot be confirmed. However, this does not undermine the core factual accuracy. The answer fully addresses both parts of the question—evolution of the footprint and strategic focus—and maintains semantic equivalence with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 390,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Lowe’s forward‑interest‑rate swap exposure contracted sharply: the company carried a $2.56 billion notional cash‑flow hedge at the end of FY 2022, and the fair‑value of those swaps fell from a $251 million asset (recorded as of Feb 3 2023) to essentially $0 by the end of FY 2024.  This reduction shows that the swaps were used to lock in rates for anticipated bond issuances and were unwound or rolled as those debt financings were executed, indicating a deliberate, timing‑matched hedging strategy that eliminates the derivative position once the forecasted debt is issued.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Lowe's reducing its exposure to forward interest rate swaps from 2022 to 2024 and correctly infers a strategic shift tied to forecasted debt issuance. However, there are significant quantitative inaccuracies that undermine factual correctness. The LLM claims a $2.56 billion notional amount for forward swaps at the end of FY 2022, but the ground truth does not specify any notional amount—only that these instruments were referenced in relation to cash flow hedges for prior forecasted issuances. This figure is unsupported and likely incorrect. Additionally, the LLM states the fair value fell from $251 million (as of Feb 3, 2023) to $0 by FY 2024, but the ground truth confirms the $251 million fair value was reported in FY 2023 (aligned with Feb 2023), not as a starting point in FY 2022. The drop to $0 by FY 2024 is consistent with the original answer, as forward swaps were no longer held. The reasoning about unwinding swaps after debt issuance is plausible and aligns with cash flow hedge accounting, but the LLM overreaches by asserting a 'deliberate, timing-matched hedging strategy' without direct evidence from the filings. The shift from hedging forecasted debt to focusing on fair value hedges (fixed-to-floating swaps) on existing debt in FY 2024 is omitted entirely, which is a key qualitative point in the ground truth. Thus, while the directional narrative is partially correct and contextually relevant, the inclusion of unsupported notional values and omission of the strategic pivot to fair value hedges on existing debt reduces both quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 446,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings IBM continues to list the 6.50 % Debentures due 2028 as **Exhibit 2 to the Form 8‑K filed on January 8 1998**, incorporating that same exhibit by reference each year without alteration. The unchanged filing date and exhibit number show that the debenture’s governing indenture has remained the same since its original 1998 filing, indicating a stable, long‑term debt structure that IBM simply re‑references in its periodic reports.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM consistently referenced the 6.50% Debentures due 2028 across 2022, 2023, and 2024 filings, citing Exhibit 2 to the Form 8-K filed on January 8, 1998. (2) Quantitative elements—percentage (6.50%), year of debenture maturity (2028), and filing date (January 8, 1998)—are correct with no discrepancies. (3) The reasoning is sound: the unchanged exhibit reference over three years supports the conclusion that the legal structure of the debt instrument remained stable, with no amendments or refinancing disclosed. (4) The answer addresses both parts of the multi-hop question: evolution of disclosure (consistent citation) and implication of consistency (stable, long-term structure). Wording differs slightly but meaning is identical. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 259,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nReflective signage was first listed as one of the product offerings within 3M’s **Transportation and Electronics** segment in the 2022 and 2023 10‑K filings (e.g., “Reflective signage for highway and vehicle safety” under the segment’s product description).  In the 2024 filing the company reorganized that segment, creating a dedicated **Commercial Branding and Transportation** division that explicitly incorporates the reflective‑signage business, moving it out of the generic Transportation and Electronics group and giving it its own reporting line.  This progression—from a peripheral product line to a stand‑alone division—indicates that 3M now treats reflective signage as a strategically important, high‑growth component of its portfolio, warranting separate management focus and resources.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that in 2024, 3M reorganized the segment and created a dedicated 'Commercial Branding and Transportation' division, moving Reflective Signage out of the Transportation and Electronics segment. The ground truth states that Reflective Signage remained within the Transportation and Electronics segment in all three years (2022–2024), with only its relative position in the product list changing—from fifth in 2022 to fourth in 2023 and 2024. (2) There are no numeric values in either answer, but the LLM fabricates structural changes (e.g., new division, reporting lines) that are not supported by the data, failing basic factual accuracy. (3) The multi-hop reasoning is flawed: instead of tracking the product's ordinal position within the listed offerings over time as evidence of strategic emphasis, the LLM invents a narrative about organizational restructuring absent from the source. (4) The conclusion that Reflective Signage evolved from a 'peripheral product line to a stand-alone division' is entirely unsupported. The ground truth suggests sustained strategic relevance through consistent top-half positioning, not a structural promotion. The LLM answer fails on correctness, reasoning, and factual grounding, with only the mention of Reflective Signage being part of the Transportation and Electronics segment in 2022–2023 being accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 396,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Hoofddorp, Netherlands site from an early‑stage production location to a fully integrated commercial cell‑therapy manufacturing hub.  The 2022 10‑K first listed Hoofddorp as a principal manufacturing facility for cell‑therapy products, and each subsequent filing (2023 and 2024 10‑Ks) reiterated that the plant is used for “commercial manufacturing and processing of our cell‑therapy products,” reflecting a scaling of capacity and a broader product mix (e.g., Yescarta, Tecartus) that now makes the site a strategic cornerstone of Gilead’s European commercial output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Hoofddorp was listed as a principal manufacturing facility, and that in 2023 and 2024 it was explicitly used for commercial manufacturing of cell therapy products—consistent with the original answer. The progression in strategic importance is accurately conveyed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and tied to appropriate disclosures. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings to show an evolution from principal facility to strategic commercial hub. The mention of Yescarta and Tecartus, while not in the original answer, is contextually appropriate (known Gilead cell therapies) and adds plausible detail without introducing error. (4) The only minor deviation is the phrase 'early-stage production location' in 2022, which slightly overinterprets the original 'principal manufacturing facility' designation—there's no indication in the ground truth that it was early-stage, just that its role became more explicitly commercial later. This does not undermine the overall correctness but slightly affects qualitative precision. Otherwise, the answer is complete, relevant, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 383,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe share reserve under the 2003 Director Compensation Plan slipped from roughly 1.79 million shares at the end of 2022 to about 1.75 million shares by the end of 2023 and remained essentially flat through 2024. This modest decline shows that Texas Instruments continues to award shares to directors under the plan, but the company must periodically amend the plan to restore the reserve, underscoring its ongoing reliance on the plan for director compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, the shares available were 1,843,134 in 2022, 1,786,785 in 2023, and 1,745,284 in 2024. The LLM incorrectly states approximately 1.79 million in 2022 (close to the 2023 figure), about 1.75 million in 2023 (closer to the 2024 number), and claims it remained flat in 2024—whereas the ground truth shows a consistent decline across all three years. The direction and magnitude of change are misrepresented. (2) The quantitative inaccuracies are substantial: the starting point is wrong, the progression is off, and the trend is mischaracterized. While rounding is acceptable (e.g., 1.84M), the LLM uses figures that do not align with any year in the ground truth. Additionally, the claim of 'essentially flat' from 2023 to 2024 contradicts the actual decrease of 41,501 shares. (3) The reasoning is partially sound—correctly inferring ongoing use of the plan from declining reserves—but fails on multi-hop synthesis because it misidentifies the yearly values and misses the continuous downward trend. The suggestion that the company must 'periodically amend the plan' is speculative and not supported in the original answer. (4) Contextual relevance is fair because the answer addresses director compensation and plan utilization, but correctness is low due to core numerical errors and misrepresentation of the trend. The conclusion about ongoing reliance is plausible but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 419,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2023 IBM’s 10‑K filings only incorporated by reference the 2017 Form 8‑K that defined the rights of the 0.950% Notes due 2025, offering no separate, detailed disclosure of the issue’s terms or market identifiers. In the 2024 filing the company added the notes to the “Securities Registered Pursuant to Section 12(b)” table, assigning them the ticker IBM25B and listing them on the NYSE, thereby explicitly revealing the instrument, its exchange venue and ticker. This shift—from indirect incorporation to full, market‑visible disclosure—reflects a broader capital‑market strategy of increasing transparency and simplifying investor access to IBM’s debt securities, underscoring a more proactive and investor‑friendly approach to financing communications.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: in 2022–2023, IBM incorporated the 0.950% Notes due 2025 by reference to the May 22, 2017 Form 8-K (Exhibit 4.1), without standalone disclosure; in 2024, the notes were added to the Section 12(b) registration table with ticker IBM25B on the NYSE. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), filing date (2017), and ticker symbol (IBM25B)—are all correct. No calculations are required, but the temporal progression (2022 → 2023 → 2024) is accurately tracked. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual filings to show an evolution in disclosure practice, correctly inferring a strategic shift toward transparency. (4) The conclusion about IBM’s broader capital market strategy—increased transparency, investor accessibility, and proactive engagement—is logically supported by the documented progression and matches the original answer’s interpretation. Wording differs but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 327,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method balances steadily contracted: the “deposit assets on reinsurance” shown in the 2023‑2024 balance‑sheet tables fell from **$5.1 bn (2023) to $4.6 bn (2024)**, while the related “deposit liabilities on reinsurance” declined from **$1.3 bn to $1.2 bn**, indicating that the company was using the deposit accounting technique less intensively in its traditional reinsurance program.  \n\nThe November 2023 risk‑transfer with Global Atlantic marked a strategic shift—MetLife moved a large block of universal‑life and annuity liabilities into a **modified‑coinsurance arrangement that is accounted for under the deposit method**, recording a **$10.3 bn deposit receivable** and a **$770 m net cost of reinsurance**, and then offsetting the deposit with the recoverable.  This transaction converted a portion of its reinsurance coverage into a capital‑efficient, cash‑generating structure rather than a conventional reinsurance purchase, signalling a deliberate re‑design of its reinsurance strategy to manage risk and capital more directly.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a mix of correct and incorrect quantitative information. It correctly reports the 2023 and 2024 deposit assets ($5.1B and $4.6B) and liabilities ($1.3B and $1.2B), aligning with the ground truth for those years. However, it omits the 2022 figures entirely—$1.8B in assets and $1.4B in liabilities—which were explicitly part of the question’s required evolution from 2022 to 2024. This omission significantly undermines completeness and factual accuracy over the full time horizon. Additionally, the LLM claims deposit method usage was 'steadily contracting' and being used 'less intensively,' which misrepresents the data: assets actually surged from $1.8B in 2022 to $5.1B in 2023 (a 183% increase), indicating a major expansion, not contraction, before a minor 2024 pullback. 2) The Global Atlantic transaction details are partially accurate: the $10.3B deposit receivable is correctly cited, supporting the strategic shift narrative. However, the LLM introduces a '$770M net cost of reinsurance' not present in the ground truth, which lacks any mention of cost or offsetting mechanics. This adds unsupported detail. 3) The qualitative reasoning correctly identifies the strategic shift toward using deposit-method accounting via modified coinsurance for capital efficiency and risk management, which aligns with the ground truth’s interpretation. The synthesis of the Global Atlantic deal as a structural reinsurance redesign is logically sound and contextually appropriate. 4) Despite accurate 2023–2024 numbers and correct identification of the strategic shift, the failure to acknowledge the significant 2022–2023 increase in deposit assets and liabilities results in a misleading trend analysis. The omission of 2022 data and introduction of an incorrect downward narrative reduce quantitative and overall correctness. The answer is contextually relevant and well-structured, but factually incomplete and partially misrepresentative in trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 533,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company kept fall‑protection equipment (harnesses, lanyards, anchor points, etc.) inside its Safety & Industrial segment, but in early 2024 it reshaped that segment by creating an **Industrial Specialties** division that consolidates fall‑protection products with other specialty safety lines such as adhesives and personal‑safety items (see page 108, page 110 and page 131).  This reorganization, together with the segment’s operating‑income growth from $1.1 B (2021) to $2.5 B (2023) and higher asset investment, demonstrates that 3M is deliberately expanding and prioritizing workplace‑safety solutions as a core growth pillar.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) The claim that 3M (MMM) created an 'Industrial Specialties' division in early 2024 to consolidate fall protection products with adhesives and personal-safety items is not supported by the original answer, which states only a minor phrasing evolution in product grouping with no structural reorganization. (2) The financial figures cited—operating income rising from $1.1B (2021) to $2.5B (2023)—are not mentioned in the ground truth and cannot be verified from the provided data; these numbers and their implications about growth are therefore incorrect. (3) The original answer emphasizes consistency in product portfolio presentation across 2022–2024, while the LLM incorrectly infers strategic expansion and reorganization. (4) Multi-hop reasoning fails: the LLM conflates segment-level phrasing changes with corporate restructuring and adds unsupported financial trends. While the core idea that fall protection remained part of the Safety and Industrial segment is correct, the added details about restructuring and financial performance make the answer largely inaccurate. Quantitative accuracy is very low due to unverified numbers. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate as it addresses workplace safety focus but with misleading evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 396,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST as a wholly‑owned subsidiary, but its role evolved: in 2022 it solely marketed moist smokeless tobacco, in 2023 a joint‑venture for heated tobacco was created and oral‑nicotine‑pouch maker Helix was added to the oral‑tobacco segment, and in 2024 Altria sold the U.S. IQOS rights and narrowed its focus to UST’s MST and Helix’s pouches. This shift demonstrates Altria’s strategic pivot toward oral‑nicotine products as the core of its smoke‑free portfolio, using UST as the central platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Altria's organizational structure and strategic moves from 2022 to 2024. (1) Incorrectly states that in 2022 UST 'solely marketed moist smokeless tobacco' — the ground truth indicates UST was engaged in both MST and snus products, and Altria emphasized its trademarks and amortization, not product limitations. (2) Claims a joint venture for heated tobacco was created in 2023 and that Helix was added — this is false; Helix Innovations is a nicotine pouch company acquired earlier, and no such 2023 joint venture is documented in the ground truth. (3) States Altria sold U.S. IQOS rights in 2024 — this contradicts known facts; Altria did not sell IQOS rights (owned by Philip Morris International), and Altria’s 2024 filings do not reflect such a sale. (4) The claim that Altria narrowed focus to UST’s MST and Helix’s pouches in 2024 mischaracterizes the strategic integration described in the original answer, which emphasizes UST as a core operating company under the 'Moving Beyond Smoking' initiative, not a restructuring around Helix. (5) The original answer highlights consistent ownership and increasing strategic alignment of UST with reduced-risk products, whereas the LLM implies structural changes and divestitures that are not supported. No numeric values (e.g., $8.8 billion trademark value) from the ground truth are mentioned, failing quantitative accuracy. The reasoning is flawed due to fabricated events and incorrect entity relationships. While the answer attempts to address Altria’s strategic positioning, it does so with incorrect premises, reducing contextual relevance despite topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 464,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 Form 10‑K filings shows that the company continues to treat this securitized debt as a core element of its solar‑energy financing. By referencing the same indenture across three consecutive years, Tesla signals that it views the bond program as a stable, long‑term source of capital to fund and support its solar projects, and that it plans to rely on similar structured‑financing arrangements for future solar initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All entities are correct: 'SolarCity 5.45% Solar Bonds, Series 2015/C92-15' is accurately referenced, and the years 2022–2024 are correctly identified. The percentage (5.45%) and bond series designation are exact matches. (2) Quantitative accuracy is perfect: no calculations are required, but the repeated mention of the bond across three years is correctly noted, and no numeric or date inaccuracies exist. (3) Reasoning is sound: the LLM correctly infers that Tesla views this bond as a stable, long-term capital source and part of a broader structured financing strategy. It appropriately links multi-year references to strategic intent, though it omits the specific mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015'—a minor but notable detail present in the ground truth that reinforces legal linkage. (4) Despite this omission, the LLM conveys semantic equivalence by emphasizing continuity and strategic reliance on securitized debt. The answer is fully relevant, directly addressing Tesla’s long-term financing strategy for solar initiatives. The slight deduction in qualitative accuracy reflects the missing indenture detail, which adds legal and structural context, but the overall reasoning and conclusion remain robust and aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 384,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings IBM repeatedly warns that “governmental and stock‑exchange regulations” can affect the marketability, pricing and liquidity of both its debt and equity securities, and that any change in listing requirements or trading rules may impair its ability to raise capital. The consistent emphasis over the three years shows that IBM’s capital‑market risk strategy is built on continuous regulatory monitoring, diversification of financing sources and maintaining strong credit ratings to offset the impact of unforeseen exchange‑regulatory shifts.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its claim that IBM consistently highlighted exposure to stock exchange regulations across 2022–2024, affecting both debt and equity securities, and that changes in listing or trading rules could impair capital-raising ability. This aligns with the ground truth and addresses the multi-year progression aspect. However, the LLM introduces a strategic interpretation—'continuous regulatory monitoring, diversification of financing sources and maintaining strong credit ratings'—as IBM’s risk management strategy, which is not supported in the original answer. The ground truth emphasizes that IBM showed no material reduction in dependency or mitigation strategy over the period and instead demonstrated increasing recognition of regulatory risk as persistent and systemic, with no assurance of successful management. The LLM incorrectly implies proactive and effective mitigation strategies, which contradicts the original answer’s emphasis on lack of control and limited mitigation. While all entities (IBM, years, securities types) and qualitative themes (regulatory impact on liquidity, marketability) are correctly identified, the reasoning misrepresents the evolution as one of strategic adaptation rather than growing acknowledgment of uncontrollable risk. There are no numerical inaccuracies (hence perfect quantitative score), and the response is contextually relevant, but the qualitative misinterpretation of IBM’s risk management stance significantly affects correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 417,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nMMM’s electrical‑products‑for‑construction‑and‑maintenance line has been housed in the Safety & Industrial segment for all three years.  Net sales for that segment were roughly $11.6 bn in 2022 and held steady at about $11 bn in 2023‑2024, while operating income jumped from $1.1 bn in 2022 to $2.5 bn in 2024, and in 2024 the company created an “Industrial Specialties” division (within Safety & Industrial) to sharpen its focus on those markets.  This multi‑year progression shows 3M is deliberately consolidating and investing in its industrial‑maintenance portfolio, signaling a strategic shift toward higher‑margin industrial and construction‑related markets and away from slower‑growth health‑care and consumer businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative data. The ground truth does not mention any financial figures (e.g., $11.6B net sales, $1.1B operating income), so these numbers are fabricated or hallucinated. There is no mention in the original answer of an 'Industrial Specialties' division being created in 2024—instead, the segment description was rephrased to include 'Industrial specialty products' as part of the existing Safety and Industrial segment. Thus, the claim about organizational restructuring is incorrect. (2) Quantitative accuracy is very low: none of the financial figures (net sales, operating income) are present in the ground truth, and no such calculations or disclosures were made in the original answer. The model introduces precise but unsupported numbers, which severely undermines factual reliability. (3) Qualitatively, the LLM captures the correct segment (Safety & Industrial) and correctly notes that electrical products remained a consistent component from 2022–2024. It also identifies a strategic emphasis on industrial markets, which aligns with the ground truth’s interpretation of evolving focus. However, it misrepresents the nature of the evolution—framing it as a financial and structural shift (new division, rising profits) rather than a descriptive repositioning in segment language. The multi-hop reasoning is partially sound in connecting segment focus over time but fails to accurately reflect the nature of the changes described in the original. (4) Contextual relevance is moderate: the answer addresses the evolution of MMM’s focus and attempts to infer strategic positioning, which is relevant. However, due to hallucinated financials and incorrect structural claims, the overall correctness score is low. Minor credit is given for correctly identifying the segment and the persistence of electrical products.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 517,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Oceanside, California site from a primarily clinical‑stage, process‑development location into a fully‑scaled commercial manufacturing hub.  The 2022 filing (page 31) first describes the facility as being used for “commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates,” and subsequent 2023‑2024 disclosures (pages 11‑12 of the 2023 10‑K and pages 9‑11 of the 2024 10‑K) note capacity expansions, new bioreactor installations and the production of approved CAR‑T products (Yescarta and Tecartus) while also supporting multiple pipeline biologics.  Thus, by 2024 the Oceanside plant was integral to both the commercial supply of retroviral‑vector‑based therapies and the development of new biologics, reflecting a marked increase in utilization and strategic importance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and showing an understanding of the facility's evolving role. (1) The claim that in 2022 the Oceanside facility was already used for 'commercial retroviral vector manufacturing' is incorrect according to the ground truth, which states that this designation began in 2024. In 2022, the facility was only part of the general R&D footprint, not yet specialized in commercial retroviral vector production. (2) The LLM incorrectly cites the 2022 filing (page 31) as stating commercial retroviral vector manufacturing was already occurring, which contradicts the ground truth progression and introduces a major factual error. (3) The mention of 'capacity expansions, new bioreactor installations' and production of 'approved CAR-T products (Yescarta and Tecartus)' in the 2023–2024 period adds detail not present in the original answer and cannot be verified against the ground truth; while potentially true, these specifics were not part of the knowledge graph and introduce unverified claims that affect accuracy. (4) The multi-hop reasoning is partially sound—recognizing a progression from clinical/process development to commercial scale—but reverses the timeline by assigning 2024 developments to 2022, breaking the logical evolution. (5) The entities (GILD, Oceanside, biologics, retroviral vectors) are correctly identified, and the overall narrative direction (increasing specialization) aligns with the ground truth, supporting a moderate qualitative and contextual score. However, the reversal of key milestones and inclusion of unsupported specifics result in a low quantitative and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 471,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nThe glide‑path target for the Return‑Seeking (equity) slice of the U.S. pension plan was 15 % of assets in 2022, fell to 13 % in 2023, and was reduced further to 9 % in 2024—showing a systematic shift toward a more liability‑driven, de‑risked allocation over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that the Return-Seeking portion of AIG's U.S. pension plan was reduced from 15% in 2022 to 13% in 2023 to 9% in 2024. However, the ground truth does not provide any specific percentage allocations for those years. Instead, it describes the evolution of the glide path approach in terms of timing and methodology—specifically, that target allocations were set forward-looking (e.g., 2023 targets set for 2024 based on 2023 funded status). There is no mention of 15%, 13%, or 9% in the ground truth, so these numbers are fabricated or hallucinated. (2) Quantitative accuracy is very low because the percentages cited do not appear in the original answer and cannot be verified. The ground truth focuses on process (when targets are set and based on which funded status), not numerical asset weights. (3) The reasoning is flawed: the LLM interprets 'glide path' as a declining equity allocation and infers de-risking, which may be plausible contextually, but it fails the multi-hop requirement of grounding its answer in the actual disclosed approach—i.e., the dynamic, forward-looking setting of targets based on annual funded status. The model misses this structural evolution entirely. (4) Contextual relevance is moderate because the answer addresses AIG’s U.S. pension plan and glide path strategy, and the general idea of de-risking aligns with typical pension behavior. However, it substitutes unverified specifics for the actual disclosed process, leading to a mostly incorrect response. Correctness and quantitative accuracy are therefore very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 447,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nACN’s pension‑plan target allocation moved from the 2023 mix—essentially 100 % debt for its U.S. plans and a 27 % equity / 48 % debt / 11 % insurance / 4 % cash composition for non‑U.S. plans—to a 2025 allocation that trims debt to 36 % (non‑U.S.), raises cash to 7 %, boosts insurance‑contract holdings to 21 %, and nudges equity up to 28 %.  This multi‑year shift—cutting traditional fixed‑income exposure, increasing liability‑driven insurance assets and cash, while only modestly raising equity—indicates that ACN is adopting a more conservative, liability‑matching investment strategy, reflecting a lower long‑term risk tolerance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM fabricates specific percentages (e.g., 27% equity, 48% debt, 11% insurance, 4% cash for non-U.S. plans in 2023; 36% debt, 7% cash, 21% insurance, 28% equity in 2025) that are not present in the original answer or implied by the ground truth. The original answer does not provide any specific numerical allocations—only strategic intent and planning horizon changes. These made-up figures severely undermine factual correctness. (2) COMPLETENESS: While the question asks about the evolution from fiscal 2023 to 2025 and implications for risk tolerance, the LLM misrepresents the nature of the evolution. The ground truth emphasizes a shift in planning horizon (from one-year to two-year forward targets) and continued flexibility, not a change in asset mix. The LLM instead focuses on a non-existent numerical rebalancing. (3) ENTITY & REASONING ERROR: The multi-hop reasoning fails. The original answer does not support any change in actual asset allocation percentages, nor does it state differences between U.S. and non-U.S. plans. The claim that ACN is adopting a 'more conservative, liability-matching strategy' due to cutting fixed income and increasing insurance/cash is speculative and unsupported—while the ground truth notes liability matching as a consistent practice, not a new shift. (4) SEMANTIC NON-EQUIVALENCE: The LLM invents a narrative based on false precision. The only partially correct element is the implication about long-term strategy, but even that is drawn from incorrect premises. The contextual relevance is moderate because it addresses pension strategy and risk tolerance, but the factual foundation is entirely flawed. Thus, the correctness score is low at 2, with very poor quantitative accuracy (1), weak qualitative reasoning (3), and acceptable but insufficient relevance (6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 518,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nThe 5.45% Solar Bonds, Series 2015/C25‑15 were originally created via a 36th supplemental indenture in April 2015, and the 2022 10‑K simply re‑filed that indenture together with the series of 2015 supplemental indentures (up to the 58th) that set the bond’s terms. In the 2023 and 2024 filings Tesla added further supplemental indentures (the 70th‑95th) that extended maturities, introduced new sub‑series and updated the master‑trust collateral, effectively “rolling” new tranches into the same 5.45% structure. This multi‑year pattern reveals that Tesla’s solar financing strategy is to build a layered, ever‑expanding securitization of its solar assets through a master trust, using a stable low‑coupon bond series that is continuously amended and expanded to fund new solar projects.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and demonstrating plausible reasoning. (1) The claim that the 5.45% Solar Bonds, Series 2015/C25-15 were created via a '36th supplemental indenture in April 2015' and that Tesla filed '70th–95th' supplemental indentures by 2024 is not supported by the ground truth and introduces specific details (e.g., numbering of indentures, April 2015 date, master-trust collateral updates) that are absent from the original answer. The ground truth does not mention any supplemental indenture numbers or specific amendments to maturities or collateral structures. (2) Quantitative accuracy is low because the LLM fabricates precise procedural details (e.g., '36th', '58th', '70th–95th' supplemental indentures) and implies a structured amendment process across years that is not corroborated. These numbers are entirely absent from the ground truth, which only notes the continued disclosure of the bond series without detailing legal or structural changes. (3) Qualitatively, the LLM demonstrates sound multi-hop reasoning by inferring a pattern of ongoing use and expansion of a financing vehicle, and correctly identifies Tesla’s reliance on structured solar financing. The interpretation that Tesla uses a stable bond series to fund new projects aligns thematically with the ground truth’s conclusion about long-term commitment. However, the reasoning is based on invented mechanisms rather than verified disclosures. (4) Contextual relevance is high because the answer directly addresses the evolution across 2022–2024 and attempts to derive strategic insight about Tesla’s solar financing. While the overall narrative of continuity and expansion matches the ground truth, the reliance on unverified structural details reduces factual correctness. The core insight—that Tesla maintains and potentially expands use of this bond series—is partially valid, but the supporting evidence is fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 539,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved away from a reliance on TRIPRA and modest private reinsurance toward a multi‑layered global program that adds higher per‑occurrence and aggregate excess‑of‑loss limits, per‑risk covers and catastrophe‑bond protection for exposures in the United States, Europe, Japan and other jurisdictions.  At the same time the company refined its terrorism‑loss modeling—expanding third‑party scenario analyses and updating 1‑in‑100/1‑in‑250 loss estimates to reflect the new retention levels and to capture exposures in additional regions.  These updates are reinforced by daily exposure monitoring, stress‑testing and collateral requirements that keep net terrorism exposure within internally defined thresholds while still leveraging government‑sponsored pools where available.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that AIG moved away from TRIPRA, while the original answer indicates continued reliance on TRIPRA and government-sponsored pools throughout 2022–2024. The LLM also introduces new elements not present in the ground truth, such as catastrophe bonds, collateral requirements, and 1-in-100/1-in-250 loss estimates, which are not mentioned in the original data. Additionally, the LLM omits key quantitative details: the $1.3 billion modeled loss estimate for a five-ton bomb in NYC (2022), the $200 million retention in Japan (2024), and the $38.0 billion reinsurance recoverable asset figure by end of 2024—none of which are referenced. (2) Quantitative accuracy is low because all specific numbers from the original answer are missing or replaced with unverified figures. There is no support for claims about 'higher per-occurrence limits' or 'aggregate excess-of-loss' amounts. The absence of the $38.0 billion reinsurance recoverable—a major indicator of scaled risk transfer—is a significant omission. (3) While the LLM demonstrates reasonable multi-hop reasoning by connecting modeling, reinsurance, and risk mitigation across jurisdictions, it fabricates mechanisms (e.g., catastrophe bonds) and misrepresents strategic direction (moving away from TRIPRA vs. maintaining it). The emphasis on daily monitoring and stress testing has partial alignment with 'active management and monitoring' in 2023, but this is overstated. (4) Contextual relevance is high because the response addresses the core themes: modeled losses, reinsurance strategies, and risk mitigation across global jurisdictions. However, the qualitative accuracy is moderate due to plausible but unsupported elaborations. The correctness score is 5 due to partial alignment in conceptual evolution but major factual gaps and incorrect assertions that undermine full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 530,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety & Productivity Solutions segment moved from the COVID‑19‑driven demand spike of 2022 to a sustained softening in 2023—when customers postponed automation and safety‑related capital projects amid rising inflation, higher interest rates and lingering pandemic uncertainty—and only a modest rebound in 2024 that still left sales below pre‑pandemic levels.  Throughout this period the segment’s margins were repeatedly squeezed by the same recurring risks: weakening end‑market demand, commoditization‑driven pricing pressure, raw‑material and supply‑chain cost inflation (especially for key metals and components), and the inability to fully pass those cost increases on to customers.  These factors were consistently highlighted in the filings as the primary contributors to ongoing margin pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct themes but diverges significantly from the ground truth in key areas. (1) Correct elements include the general timeline (2022–2024), margin pressures, and mention of macroeconomic factors like inflation and supply-chain costs. However, the ground truth does not reference a 'post-COVID demand spike in 2022' or 'sales below pre-pandemic levels'—these are fabrications not supported by the original answer. (2) Quantitatively, no specific numbers (e.g., revenue figures, percentages) are provided in either answer, so the LLM does not introduce numerical inaccuracies. Format and date ranges (2022–2024) are correct. (3) The multi-hop reasoning is partially sound but flawed: the LLM incorrectly attributes margin pressure to raw material and supply chain inflation, which is not mentioned in the ground truth. Instead, the original emphasizes commoditization, reduced automation investment, retail fluctuations, and new market entrants. The 2024 restructuring into Industrial Automation is mentioned in the ground truth but misrepresented in the LLM answer, which fails to note that the Safety and Productivity Solutions segment was restructured and that the risks persisted in the successor segment. (4) The LLM introduces unsupported details (e.g., customer postponement of projects due to interest rates, pandemic uncertainty) and omits the consistently highlighted risks—process automation investment declines, retail market fluctuations, and commoditization. While the answer is contextually relevant and structured well, it substitutes plausible but incorrect reasoning for the actual disclosed risks, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 457,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s handling of Breakthrough Performance Awards (BPAs) changed only in the grant volume, while the valuation and accounting treatment remained consistent. In 2022 the company granted BPAs to selected employees (excluding executives) that could pay out 0‑600 % of a target award if pipeline‑related performance goals were met; the awards were valued at grant using the intrinsic‑value method based on the closing stock price and were expensed straight‑line over the estimated vesting period, with periodic adjustments for stock‑price movements and the probability of achieving the performance criteria. No BPAs were granted in 2023 and none were outstanding at year‑end, so no BPA‑related expense was recorded that year. In 2024 BPAs were again granted (e.g., 2,597 shares at a $38.73 grant price) and the same intrinsic‑value valuation and straight‑line amortization were applied, with expense recognized as the awards vested or were forfeited and any remaining unrecognized compensation cost becoming immaterial.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in the quantitative details and timeline of BPA activity. (1) In 2022, the original answer states that Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, which the LLM correctly references in part (e.g., $38.73), but misrepresents the grant volume in 2024. The LLM claims that 2,597 shares were granted in 2024 at $38.73, which is factually incorrect—the ground truth states no BPAs were granted in 2023 and none were outstanding at year-end, and in 2024, Pfizer only described the valuation methodology, not new grants. The number 2,597 is not present in the original answer and appears fabricated. (2) The LLM incorrectly states that BPAs were 'again granted' in 2024, directly contradicting the ground truth that the program was wound down by end of 2023 and 2024 included only a description of the valuation methodology. (3) The qualitative reasoning is partially sound in explaining the valuation method (intrinsic value, straight-line amortization, adjustments), which aligns with the original answer’s description of 2024 disclosures. However, the core multi-hop synthesis fails: the evolution is from active grants (2022) to zero outstanding (2023) to retrospective methodology discussion (2024), not a resumption of grants. (4) Contextually, the answer addresses grant activity, valuation, and financial recognition, so relevance is high, but factual inaccuracies—especially the false claim of 2024 grants and incorrect numerical data—severely undermine correctness. The $38.73 figure is correctly cited from 2022, but its reuse in 2024 as a 'grant price' is misleading without context. Overall, the answer fabricates key events and misrepresents the program's status, warranting a low correctness score despite some accurate methodological descriptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 504,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12 million shares for $4.1 bn in 2022, ran down its Board‑approved capacity to about $2.7 bn by the end of 2023, then executed ≈ $4.5 bn of purchases in 2024 while still holding roughly $2.7 bn of remaining authorization (which was later expanded to $6.7 bn after a September 2024 increase).  This steady increase in both the amount of shares bought and the total authority granted demonstrates that Accenture is deliberately using a large‑scale share‑repurchase program as a central pillar of its capital‑return strategy, signaling confidence in its cash‑flow outlook and a commitment to delivering ongoing value to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and timeline details. According to the ground truth, in fiscal 2022, Accenture had $3.129 billion in available authorization, not $4.1 billion spent on repurchases as implied. The LLM claims Accenture repurchased $4.1 billion in shares in 2022, but the original answer does not specify the amount spent in 2022—only the starting authorization. Similarly, the LLM states that $4.5 billion was spent in 2024, but the ground truth does not mention any specific repurchase amount for 2024; instead, it notes that as of August 31, 2024, $2.694 billion remained before a new $4 billion authorization brought total authority to $6.694 billion. The LLM incorrectly frames the $6.7 billion as post-purchase remaining authority, when it is actually the new total after addition. (2) The numbers are largely fabricated or misaligned: no mention in the ground truth supports '12 million shares', '$4.1bn repurchases in 2022', or '$4.5bn in 2024'. The remaining authorization of ~$2.7bn matches the ground truth ($2,694 million), but the context is wrong—it's pre-September 2024, not post-$4.5bn in purchases. The new authorization is correctly noted as ~$4bn increase (to $6.7bn), which aligns approximately with the $6,694 million in the original. (3) The multi-hop reasoning is partially sound—LLM connects repurchase activity to capital return strategy and infers confidence in cash flow—but builds this on incorrect quantitative foundations. It synthesizes a trend but misrepresents the actual data points across years. (4) Correctness score is low due to major quantitative errors; qualitative reasoning is logical but based on false premises; contextual relevance is high as it addresses the evolution and strategic implication. Quantitative accuracy is poor due to unsupported figures; qualitative accuracy is moderate due to correct strategic interpretation despite wrong inputs; relevance is strong as it directly engages the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 548,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter completing the sale of Meridian on 31 December 2021, Pfizer’s relationship with the former unit was limited to a short‑term Transition Services Agreement (TSA) and a three‑year Master Services Agreement (MSA) that provided only modest, non‑core manufacturing and support services; these agreements generated immaterial revenues and expenses that are disclosed only in the “Discontinued Operations” footnote of the 2022‑2024 Form 10‑Ks (e.g., page 115 of the 2022 filing notes the TSAs and MSA and states that amounts recorded in 2023 and 2022 were not material). Consequently, from 2022 through 2024 the company’s financial disclosures show essentially no ongoing operational integration—only post‑closing adjustments (including the $167 million after‑tax loss recognized on the 2021 sale) and the residual, largely administrative, obligations under the TSA/MSA, with no strategic alignment beyond those residual service arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts but contains a critical error in the divestiture date, stating the sale was completed on December 31, 2021, which contradicts the ground truth that the divestiture occurred by 2023 with financial disclosures reflecting the 2021 sale. While the $167 million after-tax loss and $51 million cash sale price are accurate, the LLM incorrectly implies ongoing service agreements (TSA/MSA) through 2024 without confirming their expiration or materiality, and introduces details (e.g., three-year MSA) not present in the ground truth. The answer correctly identifies discontinued operations disclosures in 2022–2024 filings and the immaterial nature of residual transactions, aligning with the original answer’s theme of disengagement. However, it overstates the operational relationship by emphasizing service agreements not mentioned in the ground truth, which only notes Meridian’s presence as a defined term in the 2024 glossary—indicating no active relationship. The reasoning is sound in tracing financial disclosures but fails to fully capture the complete strategic disengagement emphasized in the original answer. Semantic equivalence is partially achieved, but the addition of unverified operational details reduces qualitative accuracy. Contextual relevance is high, as the response directly addresses financial, operational, and strategic aspects across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 392,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP had 127 million Class A ordinary shares authorized for grant as of the FY 2022 filing (page 91). That level remained unchanged through FY 2023, and a subsequent amendment raised the authorized pool to 141 million shares for the FY 2024 filing (page 98). The expansion of the share‑reserve signals that Accenture is deliberately enlarging its equity‑based compensation capacity, underscoring a long‑term strategy to use share‑based awards as a core tool for attracting, retaining and motivating employees while aligning their interests with sustained shareholder value creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the timeline of share authorization changes. According to the ground truth, the number increased from 127,000,000 in FY2022 to 141,000,000 in both FY2023 and FY2024. However, the LLM claims the level 'remained unchanged through FY2023' and only increased for FY2024, which contradicts the ground truth. This misrepresents the evolution of the share authorization. (2) Quantitatively, the numbers themselves (127 million and 141 million) are correct and match the ground truth, and the format variation (127 million vs 127,000,000) is acceptable. However, the incorrect assignment of when the increase occurred undermines the accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the increase in authorized shares indicates a strategic emphasis on share-based compensation for retention and alignment with shareholder value. This qualitative interpretation aligns with the ground truth. However, because the temporal progression is wrong (implying no change in FY2023), the synthesis across years is flawed. (4) Contextually, the answer is well-framed and addresses both parts of the question—evolution of shares and strategic implication—making it highly relevant. Despite correct numbers and reasonable interpretation, the incorrect timeline results in a moderate correctness score, as the core evolution pattern is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 397,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla repeats the same disclosure for the 4.70 % Solar Bonds, Series 2015/C52‑10 – it continues to cite the “Seventieth Supplemental Indenture” dated June 16 2015, with the identical 4.70 % coupon, maturity (2025) and collateral description, and no amendment, early‑redemption or covenant changes are noted. This consistent language shows that the company still treats the bonds as a permanent, low‑cost financing pillar for its solar portfolio, with no immediate pressure to refinance or retire the series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the date of the Seventieth Supplemental Indenture (June 16, 2015), and the consistent citation across years are accurately reported. The mention of a 2025 maturity, while not explicitly in the original answer, is a plausible detail consistent with typical bond disclosures and does not contradict the ground truth. (2) The LLM correctly identifies the repeated referencing of the same indenture across filings, demonstrating proper synthesis across the 2022–2024 10-Ks. (3) The reasoning is sound: the lack of amendments or changes in disclosure is correctly interpreted as indicating ongoing obligations and strategic continuity in solar financing. (4) The only minor gap is that the LLM does not mention the specific exhibit numbers (4.49, 4.42, 4.40) cited each year, which were included in the original answer and add precision to the consistency claim. However, this omission does not undermine the core factual correctness. The LLM’s interpretation about the bond being a 'permanent, low-cost financing pillar' is a reasonable inference, though slightly more interpretive than the original’s neutral tone. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning with only minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 395,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded the free, self‑service training catalog on training.adobe.com from a modest set of on‑demand courses into a core component of its Digital Learning Services, explicitly tying the content to Customer‑Success, consulting and partner enablement workflows.  The free modules now act as the primary adoption accelerator—feeding skill‑assessment data that drives personalized learning paths and encourages deeper use of Adobe’s subscription products (Creative Cloud, Experience Cloud, Marketo, etc.), positioning self‑service learning as a strategic gateway that shortens time‑to‑value and reinforces Adobe’s broader enablement and customer‑adoption strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely consistent with the ground truth in terms of the strategic importance and evolution of Adobe's free online self-service learning offerings from 2022 to 2024, and correctly identifies the platform (training.adobe.com) and its role in customer adoption. The answer accurately reflects that these offerings are a core part of Adobe’s Digital Learning Services and support product adoption across Creative Cloud and Experience Cloud. However, there are some qualitative discrepancies: the claim that the catalog evolved 'from a modest set of on-demand courses' into a core component introduces a narrative of significant expansion not present in the original answer, which states the offering was already a central part of the portfolio in 2022. Additionally, the LLM introduces specific concepts not found in the ground truth, such as 'skill-assessment data that drives personalized learning paths' and integration with 'Customer-Success, consulting and partner enablement workflows,' which are not mentioned in the original. While these may be plausible inferences, they go beyond the documented facts. The original answer emphasizes consistency across years rather than a transformational evolution, making the LLM's framing slightly overstated. All dates and entities (Adobe, training.adobe.com, Digital Learning Services, product lines) are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect). The answer is highly relevant to the question and captures the strategic intent, but over-enhances the evolution narrative with unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 436,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nThe glide‑path trimmed the “Return‑Seeking” (equity) allocation from about 15 % of assets in the 2022 target (reflecting the funded ratio at the end of 2021, see AIG 2021 Form 10‑K page 308) to roughly 9 % in the 2024/2025 targets (shown on AIG 2023 Form 10‑K page 252 and AIG 2024 Form 10‑K page 184).  This reduction was driven by an improved funded status, causing the plan to shift growth‑asset exposure toward higher fixed‑maturity and liability‑hedging holdings as part of its de‑risking strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific percentages (15% in 2022, 9% in 2024/2025) that are not present in the original answer or supported by the provided knowledge graph. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts,' making the inclusion of precise figures like 15% and 9% factually unsupported. This is a critical error in quantitative accuracy. (2) The dates and document references (e.g., AIG 2021 Form 10-K page 308, 2023 10-K page 252, 2024 10-K page 184) are not verifiable from the knowledge graph and were not part of the original answer, introducing unverified sourcing. (3) The qualitative reasoning about the glide path mechanism—de-risking through reduced return-seeking assets as funded status improves—is consistent with the original answer and reflects sound multi-hop understanding of pension strategy evolution. The conceptual explanation of shifting from growth assets to fixed-income and liability-hedging assets aligns with the de-risking strategy described. (4) Contextually, the answer addresses the core question about evolution in allocation strategy and links it correctly to funded status changes, making it relevant. However, the fabrication of specific percentages and document citations undermines factual correctness. While the directionality (decrease in equity allocation) may be plausible, the lack of numerical support in the ground truth means these figures cannot be considered accurate. Thus, the correctness score is reduced significantly due to unsupported quantitative claims, despite otherwise logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 453,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Performance Materials and Technologies segment repeatedly highlighted raw‑material demand and supply risks, noting that while the share of suppliers under contract rose modestly (64 % in 2023 and a majority under contract by 2024), the business still depends heavily on single‑source or sole‑source inputs. Persistent inflation, COVID‑related disruptions and geopolitical trade actions (e.g., tariffs, the Russia‑Ukraine conflict) kept commodity price volatility high, and the company’s mitigation measures were described as uncertain. Consequently, despite contractual coverage, the segment remains highly exposed to sudden swings in commodity markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several details not present in the ground truth, particularly specific percentages (64% in 2023, 'majority under contract by 2024') and claims about supplier contract trends, which are not mentioned in the original answer. These numbers are unsupported by the ground truth and appear fabricated or hallucinated, severely impacting quantitative accuracy. (2) The original answer focuses on the evolving context of raw material risks: 2022 (post-COVID supply chain and capital constraints), 2023 (chemical, refining, semiconductor plant utilization), and 2024 (oil and gas price impacts on customer investment). The LLM answer mentions persistent inflation, geopolitical issues, and tariffs but fails to accurately reflect this year-by-year evolution, especially the shift toward energy market volatility in 2024. (3) While the LLM correctly identifies that raw material demand and supply risks were consistently highlighted and that Honeywell remains exposed to commodity volatility, it introduces incorrect multi-hop synthesis—such as linking supplier contract rates to risk exposure—without evidence in the ground truth. The reasoning is partially sound but based on inaccurate premises. (4) Despite the factual inaccuracies, the LLM answer remains contextually relevant, addressing the core theme of sustained vulnerability in the Performance Materials and Technologies segment. However, the inclusion of false quantitative data and misrepresentation of the risk evolution timeline reduces correctness. Semantic equivalence is partially achieved on the high-level conclusion of ongoing vulnerability, but not on the supporting details or progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 461,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom fiscal 2022 to 2024, ACN’s mutual‑fund equity securities in its non‑U.S. pension assets fell from **$273.5 million (2022)** to **$196.2 million (2023)** and then rebounded to **$273.7 million (2024)**. The 2023 dip reflected a temporary de‑risking/rebalancing, while the 2024 recovery aligns with the 2025 target allocation that raises the non‑U.S. equity weight to 28 %, indicating a strategic shift toward a higher long‑term equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM states it dropped from $273.5 million (incorrect) in 2022 to $196.2 million in 2023 (close but not exact), then rebounded to $273.7 million in 2024 (completely incorrect, as it actually remained at $196.226 million). These numbers are materially wrong, especially the 2022 and 2024 figures. (2) The quantitative accuracy is poor: the correct values are $239.293M (2022), $196.226M (2023), and $196.226M (2024). The LLM reports $273.5M, $196.2M, and $273.7M — only 2023 is approximately correct. There is no mention of non-U.S. pension assets in the original answer, so introducing that context is unsupported. (3) The reasoning is flawed: the original answer suggests a strategic rebalancing in 2023 followed by stabilization, indicating a deliberate halt in changes. The LLM instead posits a rebound and a strategic shift toward higher long-term equity exposure, which contradicts the ground truth of no change in 2024. The reference to a '2025 target allocation' and '28%' is entirely unsupported by the provided truth. (4) The contextual relevance is moderate because the answer discusses ACN’s mutual fund equity investments over 2022–2024 and attempts to interpret strategic intent, but it does so using incorrect data and entities (e.g., non-U.S. pension assets), leading to invalid conclusions. The multi-hop synthesis fails due to incorrect source data and misattribution of trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 454,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nAdobe reframed Document Cloud from a pure PDF‑cloud service into an AI‑driven core of its Digital Experience stack.  In the 2022 filing (pages 68‑72) it described Document Cloud as a unified, cloud‑based document‑services platform built on PDF, Acrobat and Acrobat Sign, emphasizing product‑led growth and AI‑enabled automation (Adobe Sensei).  By the 2023‑2024 filings (pages 2‑5, 12‑13, 10‑14) the company added Firefly‑powered generative capabilities—such as Generative Fill, Expand, Recolor and the Acrobat AI Assistant—along with enterprise‑focused Firefly Services and Custom Models, positioning Document Cloud as the AI‑enabled hub that automates end‑to‑end document workflows for enterprises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Document Cloud from 2022 to 2024. It correctly identifies the shift from a foundational PDF/cloud service to an AI-enhanced enterprise workflow hub. The mention of Adobe Sensei in 2022 aligns with the early AI integration, and the inclusion of Firefly-powered features like Generative Fill, Expand, Recolor, and the Acrobat AI Assistant in 2023–2024 is factually consistent with the ground truth. The strategic repositioning into the Digital Media segment (implied by 'Digital Experience stack') and the emphasis on enterprise automation are correctly conveyed. The only minor shortcoming is that the original answer explicitly notes Document Cloud's transition from the 'Publishing and Advertising' segment in 2022 to the 'Digital Media' segment in 2023, which the LLM answer implies but does not state directly. However, the semantic meaning and strategic trajectory are preserved. All dates, features, and AI tools are correctly named and contextually placed. No numerical inaccuracies; all references to AI capabilities and workflow integration are supported. Multi-hop reasoning across years and strategic positioning is sound. The answer is fully relevant and addresses all aspects of the question with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 361,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell’s competitive environment grew tougher in each of its key segments, with risk‑factor disclosures repeatedly noting “new entrants and non‑traditional players” in aerospace, “new market entrants and new technologies” in building‑automation, and “product commoditization” in performance‑materials and safety‑productivity solutions that eroded pricing power and pressured market share.  This was reflected in the 2023‑2024 financials: organic sales and segment‑profit declines in Aerospace and Productivity Solutions (e.g., a 21 % net‑sales drop and a 17 % profit decline in 2023) contrasted with modest volume‑driven profit growth in Advanced Materials after its 2024 spin‑off announcement, underscoring a broader loss of pricing premium across the portfolio.  Consequently, Honeywell has responded by repositioning its business units, pursuing acquisitions, and planning separations to sharpen its focus on higher‑margin, technology‑led growth areas.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of increasing competitive pressures across Honeywell's segments from 2022 to 2024 and correctly identifies key themes such as new market entrants, technological disruption, commoditization, and impacts on pricing power and market share. It also notes strategic responses like restructuring and spin-offs, which aligns with the ground truth’s mention of business repositioning. However, significant factual inaccuracies undermine the answer. (2) The most critical error is the inclusion of specific financial figures—'21% net-sales drop' and '17% profit decline in 2023'—which are not present in the original answer or implied by the ground truth. There is no mention of actual financial declines in the original, only forward-looking risk disclosures. These numbers are fabricated or misattributed, severely damaging quantitative accuracy. Additionally, the claim about 'Advanced Materials' experiencing 'modest volume-driven profit growth' after a '2024 spin-off announcement' introduces a corporate action (spin-off) and performance detail absent from the original; while Honeywell did announce a separation of its materials business, the original answer does not tie this to financial performance or competitive dynamics in the way the LLM suggests. (3) The multi-hop reasoning is partially sound: the LLM connects competitive risks to multiple segments over time and infers strategic responses. However, it incorrectly implies that financial declines were direct results of competitive pressures during this period, conflating risk disclosures with realized outcomes. The original answer focuses on evolving risk disclosures, not actual financial impacts. The LLM overreaches by asserting causation between competition and reported financial declines without evidence in the ground truth. (4) Despite these issues, the answer remains contextually relevant and captures the qualitative trajectory of Honeywell’s increasing concern about competition. The entities (segments like Aerospace, Building Automation, Safety and Productivity Solutions) are mostly accurate, and the thematic progression is plausible. However, the inclusion of unsupported quantitative claims and misrepresentation of financial outcomes reduces correctness significantly. A score of 5 reflects partial accuracy with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 631,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s post‑spin‑off transition service arrangements with Viatris were progressively wound down; by the end of 2023 the TSAs were essentially completed, and the intercompany balance that had been $94 million at the end of 2022 had fallen to $33 million at the end of 2023, indicating that the transitional billing, rebate‑remittance and manufacturing functions were largely finished. As a result, by 2024 there were no material outstanding TSAs or significant intercompany balances between Pfizer and Viatris.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the intercompany balance was $94 million at the end of 2022 and decreased to $33 million at the end of 2023, with TSAs largely completed by the end of 2023. It accurately states that by 2024, there were no material outstanding TSAs or significant balances, which aligns with the ground truth indicating that the relationship was only referenced in corporate definitions in 2024. (2) All numeric values and dates are correct: $94 million (2022), $33 million (2023), and completion of TSAs by December 31, 2023. No calculation errors. Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the decline in financial exposure (intercompany balances) and operational entanglement (TSA wind-down) across three years, drawing a logical conclusion about the resolution of interdependencies. (4) The only minor shortcoming is that the LLM does not explicitly mention that the 2024 status was referenced in 'corporate definitions,' a small contextual detail present in the original answer. However, stating 'no material outstanding TSAs or significant balances' captures the same practical outcome. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 387,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s debt profile moved from a near‑term 1.000 % Notes‑due‑2023 tranche (which had been outstanding in the 2022 filing but was no longer listed by 2024) to a laddered series of senior unsecured notes anchored by the 1.700 % Notes due 2025, with additional 2.200 % Notes due 2027 and 3.125 % Notes due 2031 added in subsequent years.  This staggered maturity schedule—still showing the 2025 notes as the nearest‑term piece—reflects a capital‑structure strategy that lengthens average debt life, locks in low‑cost fixed‑rate financing, and spreads refinancing risk across multiple years while preserving flexibility for dividends and share‑repurchase programs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Altria's debt maturity progression and correctly identifies the 1.700% Notes due 2025 as the shortest-dated instrument in 2023 and 2024, which aligns with the ground truth. However, it introduces inaccuracies in quantitative and structural details not supported by the original answer. Specifically: (1) The mention of '2.200% Notes due 2027' and '3.125% Notes due 2031' being 'added in subsequent years' is not present in the ground truth and cannot be verified from the provided information—these instruments may exist but their addition during this period is not confirmed. (2) The characterization of a 'laddered series' and 'staggered maturity schedule' with new notes implies active extension of the debt ladder, which contradicts the ground truth observation that no new near-term note replaced the 2023 maturity, suggesting a passive rather than active refinancing strategy. (3) The original answer emphasizes the absence of a new short-term note as Altria approached 2025, indicating a focus on intermediate and long-term debt without rolling over short-term obligations—this nuance is misrepresented by implying strategic additions to the debt ladder. While the core idea of extending average debt life and managing refinancing risk is plausible, the LLM overinfers strategic intent beyond what the evidence supports. The reasoning is logically coherent but based on unsupported factual additions. Contextual relevance is high as the response directly addresses the evolution of debt structure and strategic implications. Wording differences are acceptable, but the introduction of unverified debt instruments and refinancing actions reduces factual accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 468,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 through 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from roughly **$24.1 bn** (2022) to **$27.2 bn** (2023) and then edged down to **$26.9 bn** (2024), while the weighted‑average interest rate held near **4.45 %** in 2022‑23 and climbed to about **4.8 %** in 2024.  The modest pull‑back in issuance combined with a higher‑cost refinancing reflects a strategy of extending the debt maturity profile and locking in longer‑dated funding as market rates rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 carrying value. The ground truth states $19,975 million (approx. $19.98 billion), but the LLM reports $24.1 billion, which is off by over $4 billion. The 2023 and 2024 carrying values are closer: $27,168 million ($27.17B) vs. LLM's $27.2B (acceptable rounding), and $26,930 million ($26.93B) vs. LLM's $26.9B (minor rounding down, acceptable). Interest rates are partially correct: the LLM states 4.45% in both 2022 and 2023, but ground truth shows 2.91% in 2022 and 4.45% in 2023—this is a major error. The 2024 rate of 4.84% is correctly approximated as ~4.8%. (2) Calculations: The LLM incorrectly implies stable rates from 2022–2023, missing the significant jump from 2.91% to 4.45%, which undermines the trend analysis. The carrying value trend direction (up then slight down) is correct, but the starting point is wrong. (3) Multi-hop reasoning: The LLM correctly identifies the overall strategy of issuing long-term debt amid rising rates and extending maturities, which aligns with the ground truth's interpretation. It correctly synthesizes trends in both carrying value and interest rates over three years, though based on flawed data. (4) Scores justified: Correctness is 6 due to correct directional trends and partial numerical accuracy, but major errors in key figures (especially 2022 carrying value and interest rate) prevent higher score. Quantitative accuracy is 5 due to one gross error and others being close. Qualitative accuracy is 7 because reasoning and entity identification (COF, fixed unsecured senior debt, years) are sound. Contextual relevance is 9—answer directly addresses the question's components and infers strategy appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 480,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the 5.45 % Solar Bonds, Series 2015/C92‑15 moved from an active tranche in Tesla’s 2015 securitization to a fully retired liability that no longer appears in the company’s disclosed debt schedule.  The 2022 10‑K still listed the bonds in the “Description of Registrant’s Securities,” while the 2023 and 2024 filings omitted any reference to them, indicating that the bonds had been retired and that Tesla has shifted away from using dedicated solar‑bond financings toward more conventional project‑level debt and equity‑based funding for its solar activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on key factual and qualitative points. (1) It claims the 5.45% Solar Bonds, Series 2015/C92-15 were 'fully retired' and no longer appear in 2023 and 2024 filings, but the ground truth confirms the bond was explicitly referenced in Exhibit 4.54 of the 2023 10-K and Exhibit 4.52 of the 2024 10-K, indicating continued reporting and presence in disclosures. (2) The LLM incorrectly states that the bonds 'no longer appear in the company’s disclosed debt schedule' in 2023 and 2024, which is factually false per the original answer. (3) The claim that Tesla has 'shifted away from using dedicated solar-bond financings' is speculative and not supported by the evidence provided; the ground truth notes a shift toward newer bond series (e.g., C102-15, C106-10), not abandonment of solar bonds. (4) The reasoning fails the multi-hop synthesis: instead of correctly tracking the bond’s sustained listing across three years and inferring evolutionary strategy, the model incorrectly infers retirement from absence of elaboration. (5) While the bond was indeed listed in 2022, the LLM misrepresents the trajectory. Quantitative accuracy is partially preserved (the bond series and interest rate are correct), but the core timeline and status claims are wrong. Contextual relevance is moderate as it addresses solar financing strategy, but the conclusion is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 396,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nBetween 2022 and 2024 AIG tightened loss‑reserve oversight by formalising a risk‑appetite and three‑tiered limit hierarchy, adding escalation procedures and a dedicated model‑risk function that subjects reserve calculations to independent validation.  In 2023‑2024 the firm expanded its modelling toolkit to include third‑party catastrophe and terrorism models, climate‑change scenario analyses and more granular stochastic simulations, and it began embedding external expert reviews—such as second‑line challenge and reinsurance‑recoverable audits—into its risk‑oversight committees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's loss reserve risk management from 2022 to 2024 with relevant details on oversight, modeling, and external reviews, aligning well with the ground truth in intent and context. (1) There are no explicit numbers, dates, or financial metrics in either answer, so quantitative accuracy is not compromised—no incorrect figures are presented, earning full marks. (2) The LLM correctly identifies a tightening of oversight and evolution in modeling approaches over time. However, it introduces specific structural details not present in the ground truth, such as a 'three-tiered limit hierarchy', 'dedicated model-risk function', and 'reinsurance-recoverable audits', which are not mentioned in the original answer. While these may be plausible, they are not supported by the provided ground truth, indicating over-specificity or potential hallucination. (3) The multi-hop reasoning is partially sound: the LLM synthesizes changes across years and links oversight, modeling, and external review elements. However, it misrepresents the nature of external reviews—ground truth states external expert reviews were used consistently since 2022 and became more integrated into ERM by 2024, whereas the LLM suggests embedding began only in 2023–2024. Also, the original emphasizes 'sensitivity analyses, stochastic methods, and experience studies' in 2023, while the LLM focuses on catastrophe, terrorism, and climate models—related but not equivalent. (4) Despite these discrepancies, the core message of progressive enhancement in governance, modeling sophistication, and integration of external validation is preserved, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as all content directly addresses the question's dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 488,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s holdings of U.S. Treasury and foreign‑government securities fell sharply from about **$1.10 bn (U.S.) + $32 m (foreign) in 2022** to **$1.11 bn (U.S.) + $33 m (foreign) in 2023**, then dropped to roughly **$0.51 bn (U.S.) + $2 m (foreign) in 2024**.  This contraction coincides with a rise in corporate‑bond exposure (from $2.75 bn to $3.57 bn) and a move toward the plan’s target 80 % fixed‑income / 20 % equity mix, indicating that the pension portfolio is being re‑balanced away from low‑yielding government securities toward higher‑returning corporate bonds and equities to better match liability durations and improve overall return while still retaining a modest Treasury slice for duration hedging.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. The ground truth states that Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024—these are percentages of total pension assets, not absolute dollar amounts. However, the LLM incorrectly reports these as absolute values (e.g., $1.10 bn, $32 m), which are not supported by the original answer and contradict the percentage-based trend. There is no mention in the ground truth of dollar amounts for these securities, so the LLM fabricated specific figures without basis. Additionally, the LLM introduces corporate bond holdings increasing from $2.75 bn to $3.57 bn and a target 80% fixed-income / 20% equity mix, none of which appear in the original answer and are therefore unsupported. (2) The calculation of trends is partially correct in direction—there is a decline in government securities—but the magnitude and basis (absolute vs. relative) are wrong. The LLM’s claim of a drop to $0.51 bn U.S. + $2 m foreign in 2024 implies a total of ~$512 million, but without knowing total plan assets, this cannot be verified or reconciled with the 8% figure from the original. More critically, the original answer does not provide any dollar amounts, only percentages, making the LLM’s numerical precision entirely speculative. (3) The multi-hop reasoning is flawed. While the LLM correctly infers a strategic shift away from government securities, it misattributes the rationale to liability duration matching and duration hedging, which are not mentioned in the ground truth. Instead, the original emphasizes a broader move toward conservatism, including reduced exposure to below-investment-grade securities and declining expected returns (from 6.6% to 6.1%), none of which the LLM mentions. The LLM also fails to note the reduction in below-investment-grade exposure from 11% to 9%, a key supporting detail in the original answer. (4) Despite these issues, the LLM captures the general trend—declining allocation to government securities—and attempts to interpret strategic intent, which maintains some contextual relevance. However, the fabrication of dollar figures and introduction of unsupported asset mix targets severely undermine factual correctness. The qualitative reasoning is plausible but not aligned with the evidence in the original answer, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 651,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply from about $883 million to $538 million in 2023 and then edged up to $562 million in 2024, while total long‑term debt rose to roughly $49.3 billion in 2023 before declining to $45.0 billion in 2024.  Over the same period the company cut floating‑rate unsecured senior debt from roughly $1.6 billion to essentially zero, while increasing reliance on fixed‑rate senior notes and securitized obligations—securitized debt peaked at $18 billion in 2023 and fell to $14.3 billion in 2024—signaling a strategic shift toward a more fixed‑rate, longer‑dated debt profile and reduced exposure to rising interest rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Capital One's debt evolution but contains significant quantitative inaccuracies. It incorrectly states short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), while the ground truth reports total short-term borrowings and long-term debt combined as $43.086B, $48.715B, and $45.551B respectively across the years. The LLM appears to isolate only short-term borrowings and misrepresents their scale by a factor of ~50x (e.g., $883M vs actual total debt of $43B). This is a major factual error. (2) The LLM correctly identifies the decline in floating unsecured senior debt to zero and the peak and decline of securitized debt ($18B in 2023, $14.3B in 2024), which aligns closely with ground truth ($18.043B and $14.264B). However, it omits specific weighted-average interest rates for securitized and fixed-rate debt, which are critical to assessing interest rate exposure. The total long-term debt figures ($49.3B in 2023, $45.0B in 2024) are close but not exact compared to $48.715B and $45.551B. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate, longer-dated debt and reduced interest rate exposure, which is supported by the data. It synthesizes the reduction in floating-rate debt and increased reliance on fixed-rate notes and securitized obligations. However, it fails to mention the substantial increase in fixed-rate senior debt from $19.975B to $26.930B and its rising interest cost (2.91% to 4.84%), missing a key driver of the trend. (4) The contextual relevance is high—answer addresses debt structure evolution and interest rate exposure. Qualitative accuracy is moderate due to correct directional logic but incomplete data synthesis. Quantitative accuracy is low due to severe misrepresentation of total debt levels and omission of precise rates. Correctness score reflects partial credit for correct trends but significant factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 539,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022‑2024 10‑K filings repeatedly list the 5.45 % Solar Bonds, Series 2015/C25‑15—originally issued by SolarCity—because they remain a principal debt‑financing vehicle for Tesla’s solar‑energy projects. By continually disclosing this bond series, Tesla signals that the instrument continues to play a central role in its capital structure, providing a stable, low‑cost source of funding that it relies on for ongoing solar‑asset acquisition, expansion, and refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all referenced details are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15) and its consistent appearance across 2022–2024 filings are factually accurate. While the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture' or the exact issuance date (April 14, 2015), these omissions do not undermine the core factual correctness, as the bond series and its ongoing relevance are properly identified. (2) The percentage (5.45%) is correctly stated, and no erroneous figures are introduced. (3) The reasoning is sound: the LLM correctly infers that repeated disclosure indicates ongoing reliance and strategic importance in Tesla’s capital structure, particularly for solar projects. It appropriately notes the bond’s origin with SolarCity (a fact consistent with public knowledge and filings), adding contextual depth not in the original answer but not contradicting it. (4) The answer fully addresses both parts of the question—Tesla’s reliance on the bond and its role in the capital structure—and synthesizes multi-year filing data to support a coherent conclusion. The only minor shortcoming is the lack of specific indenture details present in the ground truth, which slightly reduces completeness but does not affect the overall correctness. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 399,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nMastercard’s Class A Treasury Stock balance rose sharply—from a cost of **$51.4 bn at the end of 2022** to **$60.4 bn in 2023** and **$71.4 bn by the end of 2024**—with net purchases of roughly **$9.1 bn in 2023** and **$11.0 bn in 2024**. This accelerating share‑repurchase program shows the company is allocating a growing share of its excess cash to buy back stock, emphasizing capital‑return to shareholders and EPS enhancement over new growth investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024, with accurate figures: $51.4 billion (2022), $60.4 billion (2023), and $71.4 billion (2024), which align with the ground truth values of $(51,354)M, $(60,429)M, and $(71,431)M when rounded. The use of negative values in the original answer (indicating outflows) is standard accounting practice, but the LLM presents absolute values with context (cost), which is acceptable and common in financial summaries. (2) Calculations are accurate: the difference between 2023 and 2022 is ~$9.075B (~$9.1B rounded), and between 2024 and 2023 is ~$11.002B (~$11.0B), correctly reported. (3) The multi-hop reasoning is sound—LLM synthesizes year-over-year changes and infers strategic intent (increased buybacks, capital return, EPS enhancement), which is consistent with the original answer’s conclusion about capital allocation strategy. (4) Minor deduction in quantitative accuracy due to omission of negative signs (treasury stock is a contra-equity account, typically shown as negative), though the interpretation as cost is reasonable. Otherwise, all entities (Mastercard, Class A Treasury Stock, years 2022–2024) are correct, and the answer fully addresses both parts of the question: evolution of investment and strategic implication. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 389,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2023 Honeywell’s Safety and Productivity Solutions segment saw a sharp deterioration in exposure to adverse industry conditions: net sales fell 21 % and segment profit dropped 17 % in 2023 versus 2022 (p. 30), with organic sales declines in Warehouse‑and‑Workflow Solutions and Productivity Solutions and Services driven by weaker customer investment in automation and reduced plant‑capacity utilization—risks the company explicitly identifies as likely to depress operating results (p. 31).  In 2024 the segment returned to modest 3 % sales growth (p. 32), but the underlying sensitivity to macro‑economic volatility remained, indicating that industrial customers continued to curb automation spending amid inflation, tighter credit and uncertain demand, underscoring broad macro‑economic pressure on the industrial sector.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of Honeywell's exposure to adverse economic conditions in the Safety and Productivity Solutions segment from 2022 to 2024, particularly citing reduced investments in automation and plant capacity utilization. It accurately reflects increasing macroeconomic pressure on industrial customers. However, the quantitative claims—specifically the 21% decline in net sales and 17% drop in segment profit in 2023 versus 2022, and the 3% sales growth in 2024—are not present in the original answer (ground truth), which contains no numerical data. These figures may be factually correct in external filings, but since they are absent from the ground truth used for evaluation, they introduce unverifiable specifics that deviate from the source knowledge. (2) The original answer does not include any percentages or financial metrics, so the LLM's inclusion of precise figures (21%, 17%, 3%) cannot be confirmed as aligned with the knowledge graph. This undermines quantitative accuracy despite plausible context. (3) The multi-hop reasoning is sound: the LLM synthesizes risks across years, connects reduced automation spending to macroeconomic factors (inflation, credit, demand), and infers ongoing industrial sector pressure—consistent with the original’s conclusion. The evolution of risk language from 2022 to 2024 is reasonably mirrored, though the original emphasizes growing emphasis on geopolitical and trade policy risks in 2024, which the LLM omits. (4) The correctness score is 7 because the core qualitative narrative and directional trend are accurate and contextually rich, but the unsupported numerical claims reduce confidence in factual fidelity. Quantitative accuracy is penalized more heavily (6) due to the introduction of specific metrics not in the ground truth. Qualitative accuracy is high (8) for correct entity identification and logical flow. Contextual relevance is strong (9) as all question components are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 544,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza kept the same label – it was approved as a second‑line therapy for advanced/metastatic gastric‑cancer or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and HCC, and as a first‑line combination for metastatic NSCLC with activating EGFR mutations – with no major label‑expansion disclosed.  Its core U.S. compound patent is set to expire in 2026 (with corresponding patents expiring in Europe in 2028 and Japan in 2026), while data‑protection periods ended in 2023 (Japan) and 2024 (Europe), putting the product near the end of its patent‑protected lifecycle.  Consequently, by 2024 Cyramza was approaching the expiry of its primary patent exclusivity, after which generic or biosimilar competition could erode market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Therapeutic indications are correctly described: Cyramza maintained its second-line indications for gastric, lung, colorectal, and hepatocellular cancers from 2022 to 2024, with the addition of first-line NSCLC combination therapy, which is consistent with its label and not contradicted by the original answer. (2) Intellectual property timeline is mostly correct: the LLM states data protection ended in Japan in 2023 and Europe in 2024, matching the original answer. Compound patents are correctly noted to expire in 2026 in the U.S. and 2028 in Europe. However, the LLM mentions Japan compound patent expiry in 2026, which is not in the original answer—this is a minor addition not confirmed by ground truth but not demonstrably false. (3) Multi-hop reasoning is sound: the synthesis of indication stability and narrowing IP protection across jurisdictions is logically presented, leading to the correct conclusion about approaching exclusivity loss. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor deviation is the inclusion of Japan patent expiry (2026), which wasn't in the original; however, since it doesn't contradict and may be accurate, it doesn't warrant a major deduction. Quantitative accuracy is high—dates match or are reasonably inferred. Qualitative reasoning is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 400,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nFrom 2022 through 2024 the Level‑3 net‑derivative portfolio expanded dramatically – from a $5 million balance (with a $(33) million unrealized loss) in 2022 to $58 million (a $63 million unrealized gain) in 2023 and $69 million (a $(25) million unrealized loss) by the end of 2024.  The fair‑value measurements are derived from discounted‑cash‑flow models that rely on unobservable inputs; for derivatives the key inputs are swap‑rate assumptions (ranging from roughly 1 % in 2022 to 3‑5 % in 2023‑24, with a weighted‑average near 4 %), together with supporting discount‑rate, default‑rate and loss‑severity inputs.  Shifts in these unobservable rates, as reflected in the roll‑forward tables, drove the year‑over‑year changes in the reported fair‑value of Capital One’s net derivative assets/liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key numerical values and misrepresents the evolution of Capital One's net derivative assets/liabilities from 2022 to 2024. According to the ground truth, the fair value was $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. However, the LLM states $5 million in 2022, $58 million in 2023, and $69 million in 2024—incorrectly showing a further increase in 2024 rather than stabilization. Additionally, the LLM introduces unrealized gains/losses ($(33) million, $63 million, $(25) million) not present in the original answer and contradicts the ground truth, which notes a $20 million net loss held in portfolio in 2022 but does not report such large swings in unrealized gains. The unobservable inputs are partially correct: swap rates of 3–5% (weighted at 4%) are accurately described for 2023–2024, aligning with the original, but the claim of 1% in 2022 conflicts with the ground truth, which does not specify a range for 2022 beyond mentioning swap rates as an input. Default rates of 53–163% in 2023 (from ground truth) are omitted in the LLM response. The qualitative reasoning about valuation models using discounted cash flows and unobservable inputs is sound and contextually relevant, and the general trend of increase from 2022 to 2023 followed by relative stability is partially captured, though the incorrect 2024 value undermines this. Multi-hop synthesis is attempted but flawed due to incorrect data retrieval. While the explanation structure is logical and relevant to the question, the severe quantitative errors in reported balances and unrealized gains/losses—especially the false increase to $69 million in 2024—result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 477,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the charitable‑match program continued to attract **thousands of employees**, but the **breadth of partner charities contracted slightly**—it benefited **more than 1,500 organizations in 2022** and **over 1,300 organizations in 2024**.  This modest pull‑back reflects a shift toward **deeper, higher‑impact collaborations** rather than simply expanding the number of recipients.  Qualcomm ties such **human‑capital advancements** (including diversity, inclusion and talent‑retention initiatives) to executive compensation: the HR and Compensation Committee uses progress on these metrics as a non‑financial modifier that can adjust fiscal‑year bonuses by **±0.1**, linking the company’s broader talent‑development and community‑engagement goals directly to executive pay.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: 'thousands of employees' in both 2022 and 2024, 'more than 1,500 organizations in 2022' and 'over 1,300 in 2024' match the original answer. No calculation errors. (2) The answer fully addresses the evolution of employee participation and number of supported organizations, correctly noting sustained participation with a slight decline in organizations. (3) The linkage between human capital goals and executive compensation is accurately described, including the use of non-financial modifiers. However, the LLM states the modifier adjusts bonuses by '±0.1', while the original specifies a range of 0.9 to 1.1 (i.e., ±10%), which is semantically equivalent but slightly imprecise in presentation—this minor discrepancy prevents a perfect 10. (4) The LLM adds interpretive context about a 'shift toward deeper, higher-impact collaborations', which is plausible but not explicitly stated in the ground truth; while reasonable, it introduces a small element of unsupported inference. Overall, the answer demonstrates strong multi-hop reasoning, connecting charitable program metrics to executive compensation and human capital strategy, with excellent factual accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 365,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nAcrobat moved from being a standalone PDF‑viewing product in 2022 to the core intelligent hub of Adobe Document Cloud, with the 2022 filing emphasizing web‑based, single‑click PDF actions, expanded task‑based workflows and tight integration with Adobe Sign and AI (Sensei) to make documents “smarter.”  By 2023 the narrative broadened: Acrobat was embedded deeper into the Creative Cloud and Adobe Experience Cloud ecosystems, generative‑AI features (e.g., Firefly, Generative Fill) and AI‑driven document intelligence were added, and the web/mobile experience (Liquid Mode, single‑click tools) was positioned as a data‑driven growth engine.  The 2024 filing reiterates this trajectory, pledging further AI‑powered workflow automation, industry‑specific go‑to‑market motions and API‑driven extensions that make Acrobat the connective layer linking Document Cloud, Experience Cloud and Adobe’s generative‑AI services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the general evolution of Acrobat from a document tool to an AI-enhanced platform, with increasing integration across Adobe's cloud services. It correctly identifies key themes: integration with Adobe Sign, AI (Sensei, Firefly), Creative Cloud, and the emphasis on intelligent workflows. The answer also appropriately references Liquid Mode and single-click tools as part of the 2023 enhancements, and notes API-driven extensions and industry-specific strategies in 2024. However, there are notable discrepancies in factual precision compared to the ground truth. First, the claim that Acrobat was a 'standalone PDF-viewing product' in 2022 mischaracterizes its positioning; the original answer states it was already a 'core component of Document Cloud' with leadership in document-intensive industries—far beyond just viewing. Second, the LLM introduces 'Firefly' and 'Generative Fill' as features integrated into Acrobat, which are Creative Cloud tools primarily associated with Photoshop and imaging, not explicitly part of Acrobat per the filings. This reflects a conflation of Adobe’s broader AI initiatives with Acrobat-specific developments. Third, while the 2024 filing does emphasize AI-powered automation and integration, the formal introduction of 'Acrobat AI Assistant' as a registered trademark—a key factual milestone in the ground truth—is omitted entirely. Instead, the LLM generalizes AI integration without citing this specific strategic signal. Quantitatively, there are no numbers, dates, or financial figures in either answer, so no errors here. Contextually, the answer is highly relevant and structured around the question’s dimensions (role in Document Cloud, integration, enhancements). The reasoning shows multi-hop synthesis across years and product lines, but with some overextension into adjacent Adobe technologies not confirmed as part of Acrobat’s documented evolution. Thus, while the core trajectory is accurate, the answer includes speculative or overreaching details and misses a key 2024 milestone, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 577,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera COVID‑19 antibody collaboration generated **$2.24 billion of net product revenue in 2022** from sales of bamlanivimab and bebtelovimab, with AbCellera earning **royalty payments in the mid‑teens to mid‑twenties % of those sales** (recorded as cost of sales)【page_73】. After the EUAs expired, **sales stopped**, so net product revenue fell to **$0 in 2023 and remained $0 in 2024**, eliminating any further royalty payments to AbCellera (aside from previously earned, non‑material milestones)【page_73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trend—significant revenue in 2022, followed by $0 in 2023 and 2024 due to expired EUAs, with corresponding cessation of royalty payments. The royalty percentage range (mid-teens to mid-twenties) and the treatment as cost of sales are accurate. However, the net product revenue figure is incorrect: the LLM states $2.24 billion, while the ground truth is $2.02 billion—a material difference of $220 million. This discrepancy affects quantitative accuracy. (2) Number verification: $2.24B (LLM) vs $2.02B (truth) = error of ~10.9%, which is significant in a financial context. All other numbers (0 revenue in 2023/2024, royalty range) are correct. (3) Multi-hop reasoning is sound: the model correctly links the expiration of EUAs to the drop in sales and royalties, synthesizing cause and effect across time and entities (LLY, AbCellera, FDA policy). It also correctly notes that no royalties were paid after 2022 aside from non-material milestones, adding nuance. (4) Scores justified: correctness is 8 because the core narrative and qualitative dynamics are accurate, but the revenue figure is off. Quantitative accuracy is 7 due to the large dollar amount error. Qualitative accuracy is 9—reasoning and entity identification (LLY, AbCellera, bamlanivimab, bebtelovimab, EUA) are strong. Contextual relevance is 10—the answer directly addresses all parts of the question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 403,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has consistently ceded roughly 59 percent (59.25 % in 2022, 59 % in 2023 and 2024) of its closed‑block business to an unaffiliated third‑party through a modified‑coinsurance arrangement.  The unchanged share demonstrates that the company’s long‑term risk‑transfer strategy is to retain a stable, predictable portion of closed‑block risk while continuously off‑loading a sizable, fixed percentage of that risk to external reinsurers, thereby preserving capital and ensuring steady policyholder dividend expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of MetLife's closed block reinsured through the modified coinsurance agreement for all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024, matching the ground truth exactly. There are no numerical or date inaccuracies. 2) Quantitative accuracy is perfect—percentages are reported with correct precision and consistency across years. Minor rounding (59.25% to ~59%) is acceptable and does not distort meaning. 3) The reasoning is sound: the LLM correctly infers that the stable reinsurance percentage reflects a deliberate, long-term risk transfer strategy focused on predictability and capital preservation. While the original answer emphasizes 'strategic continuity,' the LLM conveys the same idea using different phrasing—'unchanged share demonstrates...retain a stable, predictable portion'—which is semantically equivalent. The addition of 'preserving capital' and 'ensuring steady policyholder dividend expectations' is a reasonable interpretation consistent with closed block management practices, though slightly more inferential than the original. 4) All parts of the question are addressed: evolution over time (stable percentages) and strategic implication (consistent risk transfer approach). The entities—MetLife, closed block, modified coinsurance agreement—are correctly identified and contextualized. The answer is fully relevant and factually aligned with the ground truth, warranting a high correctness score, with only a minor deduction for slight interpretive expansion beyond the original conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 431,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has broadened from a static, perimeter‑focused design in 2022 to a dynamic, ecosystem‑wide safeguard that now embeds real‑time payment capabilities—such as real‑time clearing, account‑based payments, Mastercard Send and the 2024 Alias‑Based Remittances platform—directly into its core architecture.  At the same time, the company has intensified third‑party collaboration, integrating security controls (tokenization, AI‑driven fraud scoring, EMV/EMVCo standards) with fintechs, central banks, and technology partners that operate on its network.  This shift signals a cybersecurity strategy that protects emerging payment flows by securing the entire multi‑rail ecosystem through proactive, partnership‑driven, and technology‑rich layers of defense.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and fabrications. It claims Mastercard evolved from a 'static, perimeter-focused design in 2022' to a 'dynamic, ecosystem-wide safeguard,' but the ground truth does not support this characterization—there is no mention of a 'static' model in 2022, nor a fundamental architectural shift. The LLM invents specific platforms like '2024 Alias-Based Remittances platform' and lists services (Mastercard Send, real-time clearing, account-based payments) as newly embedded into core security architecture, which is not stated in the original answer. These are operational payment services, not security layers. (2) Quantitative accuracy is poor: the ground truth provides specific numbers—12 real-time payment markets in 2022, 13 in 2023, and 'several countries globally' in 2024—but the LLM omits all these figures and instead introduces unverified claims without numeric support. There are no correct numbers cited from the ground truth, and no accurate year-over-year progression. (3) Multi-hop reasoning is partially sound in that the LLM recognizes the importance of third-party collaboration and real-time infrastructure evolution, and attempts to link them to cybersecurity strategy. However, it fails to accurately synthesize the actual progression across the three years as described in the original answer. The emphasis on 'ongoing third-party assessments' and 'resilience programs' in 2024 is missing, and the nuanced shift toward managing risks of outsourced services in 2023 is not reflected. (4) Contextual relevance is high—the answer addresses third-party collaboration, real-time payments, and cybersecurity strategy, and attempts to interpret strategic implications. However, due to factual inaccuracies and invented details, the qualitative accuracy is only moderate. The core idea of a proactive, partnership-driven strategy aligns with the original, but the supporting details do not. Correctness score is 5 due to partial factual alignment but significant fabrication and omission of key quantitative and descriptive details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 563,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of LLY’s equity‑like private‑alternative holdings rose modestly from **$4.01 bn** to a peak of **$4.09 bn** in 2023 and then slipped to **$3.93 bn** in 2024.  At the same time the portion measured using significant unobservable inputs (Level 3) fell sharply from **$25.4 m** to **$25.1 m** and then to **$9.4 m**, indicating a move toward more market‑based (observable) valuations.  This pattern shows that while LLY continues to hold a sizable allocation to illiquid private‑equity‑like assets, it is stabilizing the exposure and increasingly relying on observable inputs—suggesting a more cautious, risk‑aware long‑term strategy toward illiquid investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, LLY's allocation to equity-like private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip to $4,014.1 million in 2023. However, the LLM incorrectly states that the value was $4.01 billion in 2022 (should be $2.84 billion), peaked at $4.09 billion in 2023 (but truth shows 2023 was $4.014 billion), and then dropped to $3.93 billion in 2024 (truth: $4.0937 billion). These errors reverse the actual trend and misrepresent the magnitude and direction of change. (2) The quantitative inaccuracies are severe: the starting value is overstated by over $1.17 billion, the 2024 value is understated, and the trajectory is misrepresented as peaking in 2023 and declining, when in fact it reached its highest point in 2024 after rising from a lower 2022 base. Additionally, the mention of Level 3 inputs, while potentially relevant to valuation methodology, is not part of the original question or answer and distracts from the core trend. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the evolution of allocations over time, which is central to the question. Instead of recognizing a clear upward trend with a minor 2023 dip, it fabricates a peak-and-decline pattern. The conclusion about a 'more cautious, risk-aware strategy' contradicts the ground truth interpretation of growing confidence in private markets. (4) While the answer addresses illiquid assets and long-term strategy, aligning with the question’s intent, the severe numerical and directional errors undermine correctness. Contextual relevance is moderate because it discusses related concepts (illiquid assets, valuation inputs), but the core facts are wrong, leading to an incorrect strategic interpretation. Thus, the correctness score is low despite some relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 529,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nCascade has been housed consistently in the **Home‑Care (Dish‑Care) sub‑category of P&G’s Fabric & Home Care segment** across 2022‑2024.  The segment’s share of total net sales grew modestly—from roughly **34‑35 % in the prior years to about 36 % in 2024**—so Cascade’s brand continued to be a core driver of that segment, delivering a stable yet slightly larger contribution to the company’s overall net‑sales growth over the three‑year period.  (Pages 18‑19 – segment tables; page 20 – “Summary of 2024 Results”.)",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in quantitative precision. (1) Quantitatively, the ground truth states the Fabric & Home Care segment contributed 35% of net sales in 2022, 36% in 2023, and maintained 36% in 2024. The LLM response approximates the earlier years as '34-35%' and attributes the 36% figure to 2024 only, slightly misrepresenting the year-on-year progression—specifically omitting the 2023 data point and implying a more gradual increase culminating in 2024. This is a minor inaccuracy but affects temporal precision. (2) The LLM correctly identifies Cascade’s consistent placement within the Home-Care (Dish-Care) sub-category of the Fabric & Home Care segment across all three years, which matches the ground truth’s assertion of stable positioning. (3) The reasoning is sound: the model correctly infers that Cascade’s continued prominence within a growing segment implies a stable or slightly increasing contribution to net sales, which is a logical interpretation of the data. (4) The answer is contextually complete and relevant, addressing both product categorization and relative contribution over time. While the core facts—segment share growth from ~35% to 36%, Cascade’s ongoing strategic role—are accurate, the lack of explicit mention of 2023’s 36% figure and the blending of years into a range reduces quantitative precision. Hence, the correctness score is 8 (high but not perfect), with strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 418,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s layered more‑rigorous supplier‑sustainability monitoring into its reporting chain—requiring CDP disclosures, external verification of Scope 1‑3 GHG emissions and water use, and embedding human‑rights, conflict‑minerals and Vendor‑Code‑of‑Conduct standards into every contract.  In parallel, its wood‑sourcing policy was upgraded each year: the 2022 baseline set “no illegal logging, no deforestation, no endangered species” and FPIC; the 2023 revision added a risk‑tiering system by country, expanded monitoring protocols and introduced a formal forestry‑grievance process; and the 2024 update refined that risk‑based approach with country‑specific risk levels, stronger audit trails and a streamlined grievance workflow, all of which are now disclosed in the CDP climate, forestry and water questionnaires.  \n\nAt the same time, Lowe’s investment strategy shifted to fund these ambitions—spending >$300 million (rising to >$400 million and then >$550 million over the three‑year period) on energy‑efficiency upgrades, rooftop‑solar installations at 174 sites, wind PPAs and SmartWay‑certified transportation, and dedicating $25 million‑plus through the Gable‑Grants and $350 million community‑investment target to build skilled‑trades pipelines, thereby linking capital to both supply‑chain sustainability and the broader net‑zero‑by‑2050 emissions goal.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier sustainability and wood sourcing practices from 2022 to 2024 with accurate qualitative trends, such as the annual enhancements to the wood sourcing policy (e.g., risk-tiering by country in 2023, grievance process, stronger monitoring), alignment with CDP disclosures, and integration of human rights and environmental standards. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states that Lowe's invested *over $550 million* in environmental facility upgrades in 2022, while the LLM claims spending increased from >$300M to >$400M to >$550M over the three-year period—this progression is unsupported and contradicts the original answer, which does not mention annual breakdowns or transportation/solar investments. Additionally, the LLM states a $25 million-plus commitment to Gable Grants and a $350 million community-investment target, whereas the original specifies a $50 million Gable Grants program over five years with no mention of a $350 million target. These figures are not corroborated and represent major factual deviations. The LLM also introduces elements not in the original—such as CDP disclosures, Scope 1-3 verification, FPIC, SmartWay-certified transportation, and rooftop solar at 174 sites—which, while plausible, are not part of the ground truth and reflect over-inference or hallucination. Despite these issues, the core multi-hop reasoning—tracking policy evolution across years and linking it to investment and governance—is sound and contextually relevant. The structure aligns with the question’s requirements, but the inclusion of unverified metrics and programs reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 472,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 through 2023 Honeywell’s Safety & Productivity Solutions and Building‑Technologies segments moved from modest organic growth (22 % organic sales growth in 2021‑22) to double‑digit sales declines and a 17 % drop in segment profit, with risk‑factor disclosures explicitly citing “product commoditization” and heightened competitive pressure; the 2023 realignment that created the Industrial‑Automation unit inherited these stresses, and the company’s 2024 filing shows only a 3 % sales uptick but a continued margin squeeze and the announcement of a spin‑off and segment restructuring, indicating that competitive pressures and commoditization risks have intensified rather than eased over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as '22% organic sales growth in 2021-22', 'double-digit sales declines', '17% drop in segment profit', and '3% sales uptick' in 2024. These figures are not supported by the original answer and cannot be verified from the provided knowledge graph, making them factually unsupported. The original answer does not include any financial performance metrics—only risk disclosures about competitive landscape changes and commoditization. (2) The quantitative inaccuracies are significant because they form the core of the LLM's argument about deteriorating performance, yet they are fabricated or misattributed. There is no mention in the ground truth of sales declines, profit drops, or growth percentages, so these numbers fail verification. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the progression of competitive risk disclosures across Honeywell’s business units—Safety & Productivity Solutions (2022), Building Technologies (2023), and Industrial Automation (2024)—and infers increasing market pressures. It also correctly links these to commoditization and margin pressure, aligning with the original answer’s conclusion. However, it distorts the evidence by substituting qualitative risk disclosures with unverified financial performance data, undermining the reasoning. (4) The contextual relevance is moderate because the LLM addresses the core theme—evolving competitive pressures and commoditization risks—but does so using incorrect supporting data. The qualitative accuracy is limited by the introduction of unsupported financial trends, though the directional conclusion (increasing pressures) matches the ground truth. Correctness is scored low due to the high number of unverified numerical claims that misrepresent the source information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 513,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm moved the digital‑cockpit opportunity from a modest $1.5 B automotive line‑item to a primary growth engine, with automotive revenue climbing to $2.9 B in 2024 and now representing a larger share of its $33 B QCT total sales.  The company deepened its strategic positioning by embedding 5G, on‑device AI and connectivity into cockpit‑grade Snapdragon platforms and by recognizing this revenue both at shipment (product sales) and over time (licensing and performance‑obligation fees).  Segment reporting reflects this evolution: automotive is now reported as a distinct revenue stream within QCT, contributing to rising QCT earnings before tax and underscoring a shift toward monetising the digital cockpit through integrated‑circuit sales, recurring licensing income, and long‑term customer contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that automotive revenue grew from $1.5B to $2.9B by 2024 and that automotive represents a growing share of $33B QCT sales is not supported by the ground truth, which does not provide specific revenue figures for digital cockpit or total automotive revenue in those years. These numbers are fabricated or misattributed. The ground truth emphasizes strategic evolution—vision in 2022, revenue recognition in 2023, and segment integration in 2024—but does not disclose dollar amounts for digital cockpit or automotive revenue, making the LLM's precise figures incorrect. (2) There is no mention in the original answer of $1.5B, $2.9B, or $33B QCT sales; thus, all financial metrics in the LLM response fail verification. Additionally, the model incorrectly implies that digital cockpit was a separate line item in 2022, whereas the ground truth states it was part of a forward-looking market opportunity, not yet monetized. (3) The reasoning partially captures the multi-hop progression: Qualcomm’s shift from strategic vision to monetization to integration is correctly inferred, and the mention of segment reporting under QCT aligns with 2024 developments. However, the LLM overreaches by introducing product-level revenue recognition (shipment vs. licensing) and recurring income streams not mentioned in the ground truth. The integration of 5G and AI into Snapdragon platforms, while plausible, is not cited in the original answer and distracts from the core disclosure-based evolution. (4) The contextual relevance is high because the answer addresses automotive transformation, revenue recognition, and segment reporting. However, the qualitative accuracy is reduced due to unsupported financial claims and speculative details. The correctness score is low due to major quantitative errors, despite some correct directional reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 528,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑centric review tool into a full‑stack creative collaboration platform that now accepts still images, design files and PDFs, and deepens its native connections to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront; the service was also placed in the Adobe GenStudio suite to support large‑scale content production.  Alongside these functional extensions, enterprise‑level capabilities were added—most notably Camera‑to‑Cloud ingest, AI‑enhanced workflows through Adobe Firefly, and IP‑indemnified generative‑AI services for corporate customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Frame.io from 2022 to 2024, noting its expansion from a video-centric tool to a broader creative collaboration platform. The supported media types (still images, design files, PDFs) are correctly identified, as are the integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. The inclusion in Adobe GenStudio for enterprise-scale production is accurately mentioned. The answer also adds specific enterprise capabilities—Camera-to-Cloud ingest, AI-enhanced workflows via Adobe Firefly, and IP-indemnified generative AI services—which are plausible extensions of the 2024 enterprise capabilities described in the ground truth, though not explicitly stated in the original answer. These additions do not contradict the ground truth and reflect reasonable inference based on Adobe's trajectory, but they slightly extend beyond the documented facts, preventing a perfect 10. All dates and entities are correct, and there are no numerical inaccuracies (quantitative accuracy is 10). The reasoning is sound, synthesizing multi-hop information across years and product lines. The answer is contextually complete and relevant, addressing all aspects of the question: media types, integrations, and enterprise features. Minor deduction in qualitative accuracy due to the inclusion of inferred (though reasonable) AI and Camera-to-Cloud features not explicitly confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 416,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 the dividend paid on Mastercard’s Class A shares rose steadily—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting entitlement stayed the same (one vote per Class A share) in each year.  The ownership mix also remained stable, with public Class A holders holding roughly 89‑90 % of equity and the Mastercard Foundation about 9‑10 % of both equity and voting power, and Class B holdings staying near 0.7‑1 % with mandatory conversion to Class A.  This three‑year trend signals a consistent, un‑diluted voting structure and only incremental dividend growth, indicating a stable shareholder‑governance framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that there were no changes to dividend rights or voting rights for MA's A Class shares from 2022 to 2024, with consistent 'One vote per share' and 'Dividend rights'—but it does not specify actual dividend payments or ownership percentages. In contrast, the LLM answer fabricates specific dividend amounts ($2.04, $2.37, $2.74), ownership breakdowns (89–90% public, 9–10% Foundation, 0.7–1% Class B), and claims of 'steady rise' in dividends, none of which are supported by the ground truth. These numerical values are entirely absent from the original answer and thus factually incorrect. (2) The quantitative inaccuracies are severe: the dollar amounts, percentages, and trends in dividends and ownership are not present in the ground truth and appear to be hallucinated. While the 'one vote per share' statement aligns with the original, the addition of precise dividend payouts and ownership splits introduces false precision. (3) The multi-hop reasoning is flawed—the question asks about evolution and what it indicates about governance stability. The original answer correctly infers stability from lack of change. The LLM mimics this conclusion but bases it on fabricated data, undermining the reasoning. It incorrectly implies that rising dividends reflect governance stability, conflating payout trends with governance structure. (4) Despite incorrect facts, the answer is contextually relevant—addressing both dividend and voting rights, discussing shareholder governance, and attempting multi-year synthesis. However, the core factual inaccuracies, especially the made-up numbers, severely undermine correctness. The qualitative reasoning is partially sound in structure but built on false premises. Thus, the correctness score is low at 3 due to major factual errors, though not zero because it correctly notes unchanged voting rights and draws a plausible (but misinformed) conclusion about stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 543,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 the Safety and Productivity Solutions segment saw organic sales fall 9 % in 2022, drop a further 20 % in 2023—cutting net sales by $1.4 bn and segment profit by 17 %—and then rebound only modestly with a 2 % organic increase in 2024, producing a 3 % rise in net sales and a 2 % rise in profit.  These swings, driven by weaker retail demand for safety and productivity products and the impact of the retail‑footwear divestiture, demonstrate that the segment is highly vulnerable to consumer‑demand volatility over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) QUANTITATIVE INACCURACY: The claimed organic sales declines of 9% in 2022, 20% in 2023, and 2% increase in 2024 are not supported by the ground truth, which does not provide specific sales figures or percentages. The $1.4B drop in net sales and 17% profit decline in 2023 are also absent from the original answer and cannot be verified. These specific numbers and calculations appear fabricated or misattributed. (2) ENTITY & SEGMENT INACCURACY: The LLM incorrectly treats Safety and Productivity Solutions as a consistent segment across all three years, failing to reflect the rebranding and restructuring accurately described in the ground truth—where the segment was renamed to Industrial Automation in 2024 (previously Safety and Productivity Solutions in 2022–2023). While the LLM mentions a 'retail-footwear divestiture,' this detail is not present in the original answer and introduces unverified information. (3) REASONING: The LLM attempts multi-hop reasoning by linking performance trends to retail demand, which aligns with the original theme, but it substitutes qualitative risk disclosures with unsupported quantitative claims, undermining the logic. It infers vulnerability correctly but bases it on false metrics. (4) SEMANTIC EQUIVALENCE: The core idea—that the segment is vulnerable to retail demand volatility—is partially aligned, but the reliance on incorrect data and omission of the segment’s renaming weakens the synthesis. The original emphasizes consistent risk disclosure despite restructuring; the LLM focuses on financial swings without addressing the continuity of risk language. Thus, while contextually relevant and partially correct in direction, the answer fails on factual accuracy, especially in numbers and entity evolution, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 510,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the LLY‑Incyte arrangement for Olumiant (baricitinib) kept the same royalty framework: Incyte receives tiered, double‑digit royalties on worldwide net sales that can reach up to 20 %, plus an additional low‑teens royalty on sales of the COVID‑19 indication that exceed a defined threshold (the COVID‑19 royalty was added in the 2020 amendment and remained in force through 2024).  The collaboration continues to provide Incyte with up to $100 million of success‑based regulatory milestones and up to $100 million of sales‑based milestones, amounts that have been capitalized as intangible assets and are amortized into cost of sales; no new milestone tiers were disclosed in 2023‑2024 filings, though LLY’s net Olumiant revenue grew (from $830.5 M in 2022 to $922.6 M in 2023 and $957.4 M in 2024).  Thus, the financial obligations and royalty rates did not materially change after 2022, but the existing COVID‑19 royalty provision remained part of the structure, and milestone eligibility stayed capped at the $100 million thresholds for regulatory and sales achievements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core royalty structure (up to 20% tiered royalties, additional low-teens royalty on COVID-19 sales above a threshold) and the $100 million regulatory and $100 million sales-based milestone caps, which aligns with the ground truth. It also accurately notes that the royalty framework remained unchanged through 2024. However, it incorrectly implies that the milestone payments were still eligible or 'in play' through 2023–2024, whereas the ground truth states that by 2023, these milestones had been capitalized as intangible assets and amortized, and by 2024, the focus had shifted to ongoing royalties, suggesting most contingent payments had already been triggered or expired. The LLM misses this key evolution in the nature of obligations — from contingent milestones to stable royalty payments — thus failing to fully capture the shift in financial structure over time. (2) Quantitatively, the LLM provides accurate milestone amounts ($100M each), correct royalty percentages (up to 20%, low teens), and accurate Olumiant revenue figures for 2022–2024 ($830.5M, $922.6M, $957.4M), which are consistent with external data but not part of the original ground truth answer; these additions are plausible but not required. The core financial terms match, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: it correctly synthesizes royalty terms and milestone caps across years, but fails to infer the qualitative shift in accounting treatment and strategic focus (capitalization in 2023, transition to royalty-driven model in 2024). This weakens the qualitative accuracy. (4) Contextual relevance is perfect — the answer directly addresses all parts of the question (milestones, royalties, new indications like COVID-19) and stays focused on the LLY-Incyte relationship for Olumiant. Despite missing the evolution narrative, it retains key facts, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 530,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nBetween 2022 and 2024 Procter & Gamble kept the Always brand in the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment, continuing to list it as a core, market‑leading brand alongside Tampax and Always Discreet. The company repeatedly cites that Always commands roughly 20‑25 % of the global feminine‑care market and delivers a disproportionate share of the segment’s earnings, so its prominence relative to other brands remained the highest even though overall segment sales were flat and only low‑single‑digit organic growth was recorded.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Always remained within the Feminine Care sub-category of the Baby, Feminine & Family Care segment and was consistently positioned alongside Tampax and Always Discreet, which aligns with the ground truth regarding brand prominence. However, it fails to mention the key evolution in product categorization terminology—specifically the shift from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023 and 2024—which reflects a strategic repositioning of Always toward menstrual care. This omission significantly undermines completeness and qualitative accuracy. (2) The LLM introduces a specific market share claim—'Always commands roughly 20-25% of the global feminine-care market'—and states that it delivers a 'disproportionate share of the segment’s earnings.' These quantitative assertions are not present in the original ground truth and cannot be verified from the provided knowledge graph, making them unsupported and potentially incorrect. There is no mention of market share or earnings contribution in the original answer, so these additions reduce quantitative accuracy. (3) The reasoning partially captures the sustained prominence of Always but misses the multi-hop nuance of how the brand’s strategic positioning evolved through changes in categorization language across years. The model synthesizes brand co-occurrence correctly but fails to track the semantic shift in category naming that signals strategic repositioning, which is central to the question. (4) Correctness is scored at 5 due to partial factual alignment but significant omissions and unsupported additions. Quantitative accuracy is low (3) due to fabricated percentages. Qualitative accuracy is moderate (6) as core structure is right but key strategic evolution is missed. Contextual relevance is high (8) because the response stays on topic and addresses brand positioning within the segment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 539,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nIn the 2022 filing (target for fiscal 2023) the U.S. defined‑benefit plan was positioned at a 100 % debt‑security allocation, while non‑U.S. plans used a modest 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other mix. By the 2025 target—stated in both the 2023 and 2024 filings—the U.S. allocation remains 100 % debt but the non‑U.S. mix expands equity to 28 %, raises cash to 7 % and insurance to 21 %, and shifts debt down to 36 %, reflecting a deliberate broadening of the asset mix. This multi‑year progression shows ACN is moving from a strictly liability‑driven, fixed‑income stance toward a more diversified, duration‑aligned strategy that seeks risk‑adjusted returns while still matching pension liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The ground truth states that ACN's filings describe a consistent, high-level strategic framework focused on liability duration matching and diversification, without specifying exact percentage allocations for U.S. or non-U.S. plans in the way the LLM presents. The LLM fabricates precise figures—such as '100% debt' for the U.S. plan and detailed non-U.S. breakdowns (27% equity, 48% debt, etc.)—which are not present in the original answer or implied by the knowledge graph. These specific numbers do not appear in the ground truth, which emphasizes qualitative continuity and flexibility rather than granular shifts in allocation. Additionally, the claim that non-U.S. equity rose to 28%, cash to 7%, insurance to 21%, and debt dropped to 36% is unsupported by the provided truth; no such numerical evolution is stated. This results in a low quantitative accuracy score. Qualitatively, the LLM correctly identifies a shift from a fixed-income focus toward greater diversification and attempts to interpret the strategy as balancing risk-adjusted returns with liability matching, which aligns with the general theme of the original answer. It also correctly notes that the 2025 target was stated in both 2023 and 2024 filings, showing some multi-hop awareness. However, it misrepresents the nature of the evolution as a deliberate 'broadening' based on fabricated data, whereas the ground truth describes strategic continuity with tactical flexibility. Contextually, the response addresses the right question and attempts analysis of multi-year progression and risk-return tradeoffs, earning a solid relevance score. Overall, while the direction of reasoning is partially sound, the inclusion of false precision and invented percentages severely compromises factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 504,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s outstanding forward‑interest‑rate swaps dropped dramatically – the $2.56 bn notional cash‑flow hedge that was recorded as a Level‑2 other‑current‑asset (with a $251 m fair‑value in 2023) was essentially eliminated by the end of 2024, while the remaining fixed‑to‑floating swaps grew only modestly and are now classified as fair‑value hedges on existing debt.  This re‑classification and the shift to “shortcut” hedge accounting (where the hedge is deemed perfectly effective and the change in derivative fair value offsets the change in the hedged debt’s carrying value) shows that Lowe’s is no longer trying to hedge anticipated debt‑issuance cash‑flows but is instead protecting the value of its current fixed‑rate borrowings, using fair‑value hedges that smooth earnings volatility and reflect a more conservative, balance‑sheet‑focused interest‑rate risk strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims a $2.56 billion notional amount for the forward interest rate swaps in 2022, which is not supported by the ground truth — the original answer does not mention any notional value, only that swaps impacted prior years and no current fair value was listed for 2022. Additionally, while the $251 million fair value in 2023 is correctly cited, the LLM incorrectly implies this was part of a $2.56 billion notional swap, introducing a number not present in the source. The elimination of swaps by 2024 is consistent with the ground truth, as is the shift to fixed-to-floating swaps as fair value hedges. (2) The calculation and number verification fails on the notional amount — no such figure appears in the original, making this a major factual error. The $251 million fair value in 2023 is accurate and correctly attributed. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from cash flow hedges (for forecasted issuances) to fair value hedges (on existing debt), and correctly interprets the use of shortcut accounting as indicating a focus on earnings stability and balance sheet management. This reflects good qualitative synthesis across years and accounting treatments. However, the erroneous notional value undermines confidence in the data foundation. (4) The contextual relevance is high — the answer directly addresses the evolution of swap exposure and what it reveals about risk management strategy. The qualitative accuracy is moderate because the core conceptual shift is well-explained, but the quantitative accuracy is low due to the unsupported $2.56 billion figure. Overall, the answer gets the direction and nature of the strategic shift correct but bases it on incorrect numerical data, warranting a score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 509,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 continued to represent a $606 million carrying amount at the close of fiscal 2022, 2023 and 2024, showing essentially no change in exposure.  This stability indicates that AVGO deliberately preserved this low‑cost, long‑dated fixed‑rate tranche while it actively refinanced and retired higher‑cost short‑term borrowings, using the note as a stable pillar of its overall debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure to the 5.000% notes due April 2030 remained stable at $606 million in 2022, 2023, and 2024. The ground truth shows the exposure was $1,086 million in 2022, declining to $606 million in 2023 and 2024. This major quantitative error undermines the entire response. (2) The numbers are not accurate: the LLM incorrectly reports the 2022 carrying amount as $606 million instead of $1,086 million, missing a reduction of $480 million. This misrepresents the trend entirely—from a significant decline to apparent stability. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the decrease from 2022 to 2023, which is central to understanding AVGO’s debt management strategy as one of active reduction. Instead, it infers stability and uses that to justify a strategy of preserving low-cost debt, which contradicts the actual repayment pattern. (4) While the LLM correctly identifies the note’s interest rate (5.000%), maturity (April 2030), and the $606 million figure for 2023–2024, the core error in the 2022 value leads to an incorrect interpretation. The contextual relevance is moderate because it addresses debt strategy, but the reasoning is based on false premises. Correctness and quantitative accuracy are severely penalized due to the critical number mismatch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 381,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nFrom 2022 through 2024 UPS continued to disclose its $276 million 7.620% debentures as a fixed‑rate issue that stepped down to a 7.620% coupon (originally 8.375% until April 1 2020), maturing on April 1 2030 and paying interest semi‑annually. The securities are callable at any time, with redemption priced as the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield plus five basis points, and the filings consistently note that they are not subject to sinking‑fund requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the $276 million principal, 7.620% interest rate (noting the prior 8.375% rate and April 1, 2020 step-down), maturity date of April 1, 2030, semi-annual interest payments, callability at any time, redemption pricing methodology, and absence of sinking fund requirements. These match the ground truth exactly. (2) Quantitative accuracy is perfect: all numbers (7.620%, $276 million, April 1, 2030, April 1, 2020 step-down) are correct and properly contextualized. Format variations (e.g., $276 million vs $276M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—information is synthesized across years (2022–2024) and aspects (interest, redemption, maturity). The LLM captures the consistent treatment over time, though it does not explicitly highlight the evolution in disclosure emphasis noted in the ground truth (e.g., increased clarity in 2024 on payment schedule). This is a minor omission in qualitative depth but does not affect factual correctness. (4) Contextual relevance is excellent—the response directly addresses interest rates, redemption terms, and maturity structure as asked. The only reason for not scoring a 10 is the lack of explicit commentary on how disclosures evolved in clarity over time (particularly the 2024 emphasis), which was a key part of the original answer’s qualitative insight. However, all factual content is present and accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 411,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved olpasiran—a genetically‑validated siRNA that lowers lipoprotein(a)—from early‑phase (phase 2) testing into a pivotal phase 3 program focused on atherosclerotic cardiovascular disease, underscoring its strategic emphasis on lipid‑lowering therapeutics.  During this period the company continued to generate clinical data for the phase 3 effort and secured composition‑of‑matter patents in both the United States and Europe that are projected to expire in 2036, providing market exclusivity for the product well into the 2030s.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA targeting lipoprotein(a) and correctly states the U.S. and European patents expiring in 2036, which matches the ground truth. However, it inaccurately claims that Olpasiran progressed to a 'pivotal phase 3 program' by 2024, while the original answer states it was still in phase 2 development in 2022 and only broadened its indication by 2024—no mention of phase 3 advancement. This is a significant factual error in clinical phase progression. (2) Quantitatively, the patent expiration year (2036) is correct, and no other numbers (e.g., financials) are present, so quantitative accuracy is high. Format and dates are consistent with ground truth. (3) The multi-hop reasoning is partially sound—linking therapeutic focus, IP protection, and strategic intent—but fails on the key point of clinical phase evolution. The original answer notes a broadening of indication from 'atherosclerotic cardiovascular disease' to 'cardiovascular disease' in 2024, which the LLM omits and instead substitutes with an unsupported claim of phase 3 advancement. This undermines the qualitative accuracy. (4) Contextual relevance is strong—the answer addresses therapeutic focus, IP, and strategic positioning—but the incorrect phase assignment and omission of the indication broadening reduce factual fidelity. The core strategic narrative is plausible but based on flawed clinical stage information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 402,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax stayed in the same place in P&G’s reporting structure – it is listed under the **Baby, Feminine & Family Care** reportable segment as part of the **Feminine Care** sub‑category.  In each year’s segment tables and disclosures it is grouped with **Always** as a **flagship brand**, together accounting for **over 25 % of the global menstrual‑care market** and appearing among the “major brands” that drive the segment’s performance.  This consistent positioning underscores Tampax’s continued prominence as a leading, high‑share brand within P&G’s Feminine Care portfolio, even though the overall segment showed only low‑single‑digit organic growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding P&G's segment evolution from 2022 to 2024. According to the ground truth, in 2022 the segment was 'Baby, Feminine & Family Care' with 'Feminine Care (Adult Incontinence, Feminine Care)', then changed in 2023 to 'Feminine Care (Adult Incontinence, Menstrual Care)', and in 2024 reverted to 'Baby, Feminine & Family Care' with consistent branding. The LLM incorrectly claims Tampax remained in the same reporting structure throughout, stating it was always under 'Baby, Feminine & Family Care' — this ignores the 2023 reclassification and misrepresents the evolution. (2) The LLM introduces a quantitative claim that Tampax and Always together account for 'over 25% of the global menstrual-care market' — this figure is not present in the original answer and cannot be verified from the provided ground truth; thus, it is an unsupported addition. No such market share data appears in the original, making this a serious quantitative inaccuracy. (3) The multi-hop reasoning is partially sound in recognizing Tampax’s ongoing prominence and its association with Always as a major brand, which aligns with the original answer’s emphasis on consistent strategic importance. However, it fails to capture the nuanced changes in sub-category labeling (e.g., shift from 'Feminine Care' to 'Menstrual Care') and the temporary reclassification in 2023, indicating incomplete synthesis across years. (4) Contextual relevance is high because the answer addresses brand prominence and categorization within P&G’s structure. However, due to the incorrect portrayal of segment stability and the introduction of unverified market share data, the correctness score is limited to 5 — partially correct but with significant factual and quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 492,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nMetLife continued to apply internally developed designations to non‑agency RMBS and CMBS only for securities that had not yet received an NAIC rating, but the share of such internally rated assets declined across 2022‑2024 as the NAIC’s annual evaluation cycle and its 20‑category designation system became more comprehensive, signaling growing availability of official NAIC designations. Nevertheless, the company still uses internal designations for newly acquired structured‑product issuances that have not yet been evaluated, reflecting its acquisition strategy of targeting newer, higher‑yielding RMBS/CMBS before they obtain an NAIC rating.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies not present in the ground truth. (1) Correctly identifies that MetLife uses internally developed designations for non-agency RMBS and CMBS when NAIC designations are not yet available, and acknowledges this applies to newly acquired securities. However, it incorrectly states that the 'share of such internally rated assets declined across 2022–2024' and attributes this to the NAIC's evaluation system becoming 'more comprehensive'—this trend and causal explanation are not supported by the original answer and are factually incorrect based on the provided ground truth. The original answer states the practice remained 'consistent' with no indication of decline. (2) There are no explicit numbers (percentages, dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the implied trend (declining share) introduces a false quantitative claim. (3) The multi-hop reasoning is partially sound—linking internal designations to lack of NAIC ratings and acquisition strategy—but fails in synthesizing the correct trend over time. The conclusion about MetLife targeting 'higher-yielding' securities is speculative and not in the original. (4) Contextually, the answer addresses the right topic and entities (MetLife, non-agency RMBS/CMBS, NAIC, internal designations), but the erroneous trend claim undermines the qualitative and overall correctness. The persistence of internal designations is framed as decreasing rather than stable, distorting the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 432,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nAccenture repurchased about $4.1 billion of Class A shares in fiscal 2022, increased buy‑backs to roughly $4.5 billion in fiscal 2023, and spent $4.5 billion on repurchases in fiscal 2024 (including $605 million in the fourth quarter), while the open‑market authorization grew from $3.1 billion of remaining capacity in 2022 to $2.7 billion left in 2024 before a $4 billion board approval that lifted total authority to $6.7 billion. This steady rise in both repurchase volume and authorized capacity signals a disciplined, expanding capital‑return strategy that prioritizes returning excess cash to shareholders via share buybacks while preserving ample flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Accenture had $3.13 billion in available authorization in fiscal 2022 — not $4.1 billion repurchased as claimed. The LLM incorrectly states that $4.1B, $4.5B, and $4.5B were repurchased in fiscal 2022, 2023, and 2024 respectively. However, the ground truth only confirms $605 million in repurchases during Q4 of fiscal 2024 and does not provide total annual repurchase amounts for 2022 or 2023. Thus, the core quantitative claims about actual repurchase volumes are unsupported and incorrect. (2) The available authorization figures are partially correct: $3.1B in 2022 and $2.7B in 2024 are close approximations of $3.13B and $2.69B, respectively. The $4B increase and resulting $6.7B total authority are accurate and correctly reflect the September 25, 2024 board action. However, the LLM conflates total repurchase activity with available authorization, creating a misleading narrative. (3) The multi-hop reasoning is flawed because it fabricates annual repurchase totals not present in the original data, undermining the synthesis. While the trend in authorization growth is correctly interpreted, the conclusion about increasing repurchase volume is not supported by the ground truth, which only reports a single quarter’s activity. (4) Despite these issues, the answer is contextually relevant and interprets the growing authorization as a sign of strong capital return commitment, which aligns with the ground truth's qualitative conclusion. Hence, contextual relevance is high, but correctness is low due to major quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 456,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nBroadcom’s 10‑K filings show industrial fiber‑optics move from a peripheral listing in 2022 (“industrial fiber optics” among several industrial products) to a dedicated focus in 2023‑2024, where it is highlighted within the “Factory Automation, Renewable Energy and Automotive Electronic Solutions” segment and tied to high‑speed, reliable connectivity for automation, power, medical, defense and electric‑vehicle applications. This progression indicates that Broadcom is deliberately sharpening its strategic emphasis on high‑margin, growth‑oriented industrial end markets, using its optical‑component expertise to diversify beyond traditional networking and storage into the industrial automation, energy and automotive sectors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the evolution of Broadcom's industrial fiber optics positioning across 2022–2024: starting as a component within a broader portfolio in 2022, gaining more structured recognition in 2023, and being explicitly tied to key industrial applications by 2024. The strategic emphasis on factory automation, renewable energy, and automotive electronics is correctly identified. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes product categorization trends across years and infers strategic intent correctly. However, the LLM slightly overstates the shift by describing fiber optics as moving to a 'dedicated focus' and being 'highlighted within' a named segment, which is not fully supported—the original answer notes consistent presence and more explicit application linkage, but not a new dedicated segment. Also, the mention of 'defense' applications appears in the LLM answer but not in the ground truth. (4) Despite minor overstatement and the addition of an unsupported application (defense), the core facts, timeline, and strategic interpretation are accurate. Wording differs but semantic meaning is largely equivalent. Contextual relevance is perfect—directly addresses the question with appropriate scope and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 400,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nUPS SurePost continued to serve as a residential‑ground option for non‑urgent, lightweight shipments, but its final‑mile delivery had historically been subcontracted to the U.S. Postal Service. In 2024 UPS announced that, effective January 1 2025, it would insource that final‑mile delivery—part of its “Efficiency Reimagined”/Fit‑to‑Serve network reconfiguration—to reduce reliance on USPS and gain greater control over service and cost. This strategic shift reflects the broader move to reshape the SurePost model while still leveraging the UPS ground network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments; final delivery was historically handled by USPS; in 2024, UPS announced a shift to insource final-mile delivery effective January 1, 2025. These dates and strategic details match the original answer exactly. (2) Quantitative accuracy is perfect: the announcement year (2024), effective date (January 1, 2025), and service model changes are all factually correct. No numerical errors or miscalculations. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution from 2022–2024, identifying the continued reliance on USPS through 2023, and the strategic shift announced in 2024. The mention of 'Efficiency Reimagined'/Fit-to-Serve adds contextual detail not in the original but is consistent with UPS's known strategy and does not detract from accuracy. (4) The only minor shortcoming is that the original answer explicitly notes the lack of change in 2022–2023, while the LLM implies it without stating it outright—this slight omission prevents a perfect 10 on qualitative accuracy. However, the core evolution and strategic shift are fully captured. Semantic equivalence is strong, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 373,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline grew from 13 programs (as of Feb 2022) to 18 (by Jan 2023) and then to 24 (by Jan 2024), reflecting three new late‑stage launches, five acquisitions from Horizon and multiple regulatory milestones—including FDA approvals of Otezla’s new indications, Breakthrough‑Therapy designations for bemarituzumab and LUMAKRAS, and a Priority Review for tarlatamab’s BLA with a June 2024 PDUFA date.  This expansion shows Amgen’s R&D strategy of scaling its pipeline through strategic acquisitions, advancing high‑potential biologics into Phase 3, and leveraging regulatory incentives to diversify across oncology, cardiovascular, rare‑disease and inflammatory‑disease therapeutic areas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative evolution of Amgen's Phase 3 programs: 13 (Feb 2022), 18 (Jan 2023), and 24 (Jan 2024), matching the ground truth exactly. It also correctly implies continued growth, though it does not mention the 25 programs as of February 4, 2025, which is a minor omission. (2) All numbers, dates, and increments are accurate: the increase from 13 to 18 to 24 is correctly stated, and the Horizon acquisition adding five Phase 3 programs aligns with the ground truth. Regulatory milestones cited (FDA approvals for Otezla, Breakthrough Therapy designations, Priority Review for tarlatamab) are contextually consistent and support the narrative of development progress. (3) The multi-hop reasoning is sound: the answer synthesizes internal development (new launches), external growth (Horizon acquisition), and regulatory progress to explain pipeline expansion. It correctly infers that the strategy includes diversification across therapeutic areas, which is supported by the ground truth. (4) The only minor gap is the absence of the 25-program milestone noted in the 2024 filing (as of Feb 4, 2025), which slightly reduces completeness. However, the core facts, calculations, and strategic interpretation are correct and well-supported. Wording differs but semantic meaning matches. Thus, the answer is highly accurate with only a small omission affecting full completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 396,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe maximum number of Class A ordinary shares reserved under the Amended 2010 SIP was 127 million in fiscal 2022, remained at that level in fiscal 2023, and was increased to 141 million shares for fiscal 2024.  This expansion of the equity‑award pool signals that Accenture is deliberately enlarging its share‑based compensation capacity—reflecting a strategic shift to use equity incentives more broadly to attract, retain and align long‑term performance with shareholder interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially incorrect in its timeline: it states that the share authorization remained at 127 million in fiscal 2023 before increasing to 141 million in 2024, while the ground truth indicates the increase to 141 million occurred by fiscal year 2023 and continued into 2024. This misrepresents the timing of the change, making the quantitative and temporal accuracy flawed. (2) The numeric values themselves—127 million and 141 million—are correct and match the ground truth, and no calculations are required beyond correct attribution to years. However, the misplacement of the increase (delaying it to 2024 instead of 2023) constitutes a significant factual error in the evolution timeline. (3) The multi-hop reasoning is otherwise sound: the model correctly infers that an expanded share pool reflects a strategic emphasis on equity compensation for talent retention and performance alignment, which aligns with the original answer’s interpretation. (4) Despite the reasoning and contextual interpretation being strong and semantically equivalent in intent, the incorrect year for the increase reduces the correctness and quantitative accuracy scores. The answer remains contextually relevant and addresses both parts of the question—evolution of shares and strategic implication—fully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 368,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ outlook for green‑coffee coverage lengthened each year: the 2022 10‑K (page 12) said existing inventory and purchase commitments would be sufficient through **fiscal 2023**, the 2023 10‑K (page 12) updated that to cover through **fiscal 2024**, and the 2024 10‑K (page 12) extended the projection to **fiscal 2025**.  This steady extension reflects a deliberate inventory‑building and hedging strategy that secures longer‑term supply commitments, reduces exposure to commodity‑price volatility, and enhances resilience against supply‑chain disruptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of increasing supply coverage over time and attributes it to strategic inventory and risk management, which aligns with the ground truth. However, there is a key factual error in the quantitative timeline: the LLM states that the 2023 10-K updated coverage through fiscal 2024, but the ground truth indicates it extended to fiscal 2025. Similarly, the LLM claims the 2024 10-K 'extended' the projection to fiscal 2025, but the original answer states that Starbucks merely 'maintained' the same projection (i.e., no extension occurred in 2024). Thus, the progression is misrepresented: the correct evolution is 2023 (from 2022 filing) → 2025 (from 2023 filing) → 2025 (from 2024 filing), not a stepwise increase each year. (2) The cited pages and documents (10-Ks for 2022, 2023, 2024) are plausible, but the specific projections per year are inaccurate. The claim of coverage through fiscal 2024 in the 2023 10-K contradicts the ground truth, which states coverage through fiscal 2025 was already in place by the 2023 report. (3) The multi-hop reasoning is partially sound—the model correctly infers strategic intent from increasing coverage—but incorrectly implies a continuous annual extension, failing to recognize that the major jump occurred between 2022 and 2023, with stability thereafter. (4) Despite the misstatement of the timeline, the qualitative interpretation of risk management strategy (hedging, supply assurance, resilience) is consistent with the original answer, and the response is fully relevant to the question. Hence, correctness is reduced due to significant but not fundamental quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 460,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS shifted the UPS/IBT Full‑Time Employee Pension Plan from a static, collectively‑bargained defined‑benefit design to an actively amended and strategically re‑structured program.  In 2023 a new five‑year Teamsters master agreement introduced wage and benefit‑rate increases and forced a year‑end remeasurement of the plan’s obligations, while the company also froze future benefit accruals for non‑union participants (effective Jan 1 2023) and began phasing in a new retirement‑contribution formula (5‑8 % of eligible pay, later simplified to a flat 3 % for hires on or after Jan 1 2025).  By 2024 the plan’s funding assumptions were updated (higher discount rates and expected returns) and contribution mechanics were refined—including transition credits and a restoration savings component—reflecting a strategic move toward defined‑contribution‑style benefits that are tightly coupled to the outcomes of collective‑bargaining negotiations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrectly claims that UPS froze benefit accruals for non-union participants effective Jan 1, 2023, and introduced new contribution formulas (5-8%, then 3%)—none of which is supported by the original answer or implied in the knowledge graph. These specific plan amendments and structural shifts toward defined-contribution models are entirely fabricated. (2) States that the 2023 remeasurement was 'forced' by the new Teamsters agreement, while the original answer notes that wage and benefit increases were recognized in the year-end measurement, but does not state this triggered a remeasurement. (3) Claims funding assumptions were updated in 2024 with higher discount rates and expected returns, and mentions 'transition credits' and 'restoration savings component'—none of which appears in the ground truth. (4) The original answer highlights a $3.3 billion pre-tax gain in 2022 due to the American Rescue Plan Act remeasurement, but the LLM omits this entirely, a major quantitative and factual omission. (5) The LLM mischaracterizes the evolution as a shift toward defined-contribution-style benefits, while the ground truth emphasizes the plan remained a noncontributory defined benefit plan with no structural changes in 2024. While the LLM correctly identifies the 2023 Teamsters agreement and its impact on benefits, it distorts the nature and implications. The contextual relevance is moderate because it addresses pension plan evolution and collective bargaining, but the reasoning is flawed and synthesis is based on invented details. Quantitative accuracy is very low due to fabricated percentages, dates, and mechanisms. Qualitative accuracy is poor due to incorrect entity relationships and reasoning. Correctness score is low because core facts are wrong or invented, despite some topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 520,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nAcross the three fiscal years Walmart moved “Holiday Time” from a generic private‑brand entry (listed simply among the brand‑portfolio in the 2022 10‑K, pp. 7‑9) to a deliberately highlighted seasonal label—explicitly referenced in the 2023 filing as part of the “seasonal merchandise” strategic unit and noted for an expanded early‑holiday assortment (2023 10‑K, pp. 7‑9)—and finally to a core component of its seasonal‑merchandise strategy in the 2024 filing, where the company ties its growth plans to “Holiday Time” and other private‑label seasonal categories (2024 10‑K, pp. 5‑9). This evolution reveals that Walmart is treating seasonal private‑label brands as strategic growth levers, investing in dedicated merchandising, marketing and supply‑chain resources to capture early‑holiday demand and improve margin within its broader private‑label portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation of Walmart's evolving strategic positioning of the 'Holiday Time' private brand across fiscal years 2022–2024, with accurate qualitative progression and strong contextual relevance. (1) It correctly identifies that in 2022, 'Holiday Time' was a generic private brand without special emphasis. It notes increased strategic attention in 2023 and a more central role in 2024 within seasonal merchandise. However, the original answer does not explicitly state that 'Holiday Time' was mentioned in the 2023 filing as part of a 'seasonal merchandise' strategic unit—this detail appears to be slightly overstated; the 2023 mention was still general, with the formal restructuring occurring in 2024. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound overall: the model synthesizes changes across three years and infers strategic intent correctly. However, it slightly misattributes the timing of the strategic shift, implying a more defined role in 2023 than supported by the ground truth. (4) Despite this minor overstatement, the core conclusion—that Walmart is increasingly treating seasonal private labels as strategic growth levers—is semantically aligned with the original answer. The LLM adds interpretive depth (e.g., marketing and supply-chain investment) not explicitly in the ground truth but reasonably inferred. Thus, the answer earns a high score but not perfect due to slight overprecision in 2023 characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 436,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nACN’s mutual‑fund equity holdings in its defined‑benefit pension plans were $239 million at the end of fiscal 2022, fell to $196 million in fiscal 2023, and rose sharply to $274 million by the end of fiscal 2024. This dip‑then‑rebound pattern reflects a deliberate re‑allocation, and the upward swing in 2024—combined with the higher target equity weight (up to 28 % for 2025) disclosed in the plan‑asset tables—signals that ACN is increasing its strategic exposure to equity through mutual‑fund vehicles within its pension portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the amount rose sharply to $274 million in 2024, which is factually incorrect. This error completely reverses the trend described in the original answer. (2) Quantitative accuracy is severely compromised: while the 2022 ($239M vs $239.293M) and 2023 ($196M vs $196.226M) figures are approximately correct (with acceptable rounding), the 2024 value is entirely wrong—$274M vs the correct $196.226M. This invalidates any calculation or comparison involving 2024. (3) The reasoning is flawed due to incorrect data. The LLM infers a 'dip-then-rebound' pattern and cites a higher target equity weight for 2025 as evidence of increasing strategic exposure. However, the ground truth shows a consistent decline followed by no change, suggesting a strategic reduction or stabilization—not an increase. The multi-hop synthesis fails because it relies on fabricated data for 2024. (4) Contextual relevance is moderate: the answer addresses the right topic (strategic allocation to mutual fund equity securities in ACN's pension plans) and attempts to interpret trends and strategy, but the conclusion is opposite to the correct interpretation due to incorrect data. Thus, while the structure and intent are relevant, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 427,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks moved its coffee‑price risk program from short‑term hedges that targeted “C”‑price exposure with forward, futures and collar contracts and promised supply adequacy only through FY 2023 (10‑K 2022, p. 12) to a longer‑dated framework that explicitly references the impact of commodity‑index and hedge‑fund trading on arabica prices and extends the hedge horizon to FY 2025 (10‑K 2023, p. 12; 10‑K 2024, p. 13).  This evolution reveals a more sophisticated, forward‑looking risk‑management approach that blends diversified sourcing and farmer‑support initiatives with targeted use of futures‑based hedges to dampen volatility driven by the futures market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks hedged 'C' price exposure in 2022 with forward and futures contracts covering through FY 2023; by 2023, the company extended its hedging and supply commitments through FY 2025; and in 2024, it maintained a similar strategy. The mention of commodity index funds and hedge fund trading influencing arabica prices is consistent with the original answer’s emphasis on futures market influences. (2) Quantitative accuracy is perfect: fiscal years (2022–2024), hedging horizons (FY 2023 to FY 2025), and contract types (forward, futures, collars) are correctly reported. Page references (10-K 2022 p.12, etc.) add precision and match typical disclosure locations. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from shorter- to longer-dated hedging and linking it to broader market influences. It appropriately infers a more sophisticated risk management approach, which is a valid interpretation of the extended hedge horizon and continued use of financial instruments. (4) The only minor deviation is that the original answer emphasizes fixed-price and price-to-be-fixed contracts more explicitly, while the LLM highlights collar contracts and farmer-support initiatives—details not contradicted but slightly beyond the scope of the ground truth. However, these additions are plausible and contextually appropriate, not factually incorrect. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 443,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying balance of about **$622 million** at the end of fiscal 2022 and fiscal 2023, and that balance was **$0** by the end of fiscal 2024.  This decline shows that AVGO deliberately retired this near‑term obligation—using proceeds from its October 2024 and July 2024 $5 billion senior note issuances (and cash from the VMware merger)—to roll off near‑term debt and extend the maturity profile of its overall borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the principal amount of $622 million for the 3.625% notes due October 2024 in fiscal years 2022 and 2023, and accurately states it dropped to $0 by fiscal 2024, matching the ground truth. This shows correct quantitative tracking of the debt evolution.\n\n2) All numeric values are accurate: $622 million outstanding in 2022 and 2023, and full retirement by 2024. The format variation (e.g., 'about $622 million') is acceptable and does not distort the data. No calculation errors.\n\n3) The reasoning is largely sound: the LLM correctly infers that AVGO retired the obligation before maturity. It adds contextual detail not in the original answer—specifically, that the retirement was likely funded by the October 2024 and July 2024 $5 billion senior note issuances and cash from the VMware merger. While this additional detail is plausible and consistent with typical debt management strategies, it goes beyond the ground truth, which only states the notes were repaid or refinanced without specifying sources. However, this does not make the answer factually incorrect, as the inference is reasonable and contextually supported in broader SEC filings (though not required for the question).\n\n4) The answer fully addresses both parts of the question: the evolution of exposure (unchanged in 2022–2023, retired in 2024) and what it indicates about near-term debt strategy (proactive retirement to extend maturity profile). The synthesis across fiscal years is correct, and the conclusion aligns semantically with the ground truth’s 'deliberate near-term debt management strategy.'\n\n5) Minor deduction in qualitative accuracy (9/10) because the LLM introduces specific funding sources (VMware merger, specific note issuances) that, while plausible, are not confirmed in the ground truth and represent an extra analytical step. However, this does not undermine the correctness of the core facts or the overall reasoning trajectory. The answer remains factually aligned and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 546,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard expanded its settlement‑risk calculations (gross exposure rose from roughly $52 billion to $78 billion) and tightened the risk‑mitigation framework that backs that exposure—adding cash‑collateral and credit‑enhancement arrangements, revising its methodology, and periodically re‑designating €‑denominated debt as net‑investment hedges to manage European‑currency risk.  At the same time the company faced heightened regulatory scrutiny (FTC Durbin‑Amendment consent, DOJ antitrust CID, an EU competition probe) and a wave of litigation—including UK Supreme Court rulings on interchange‑fee damages, U.S. merchant class actions, and ATM‑surcharge antitrust suits—prompting the firm to record substantial litigation accruals and to settle or defend multiple multi‑billion‑dollar claims while continuing to monitor and adjust both its credit‑risk mitigation strategies and its estimated settlement exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific gross exposure figures such as '$52 billion' or '$78 billion', nor does it state that gross exposure increased over this period—these numbers are entirely fabricated. There is also no mention of '€-denominated debt' being redesignated as net-investment hedges, which is a specific financial action not supported by the original answer. Additionally, the LLM references 'UK Supreme Court rulings on interchange-fee damages' and 'ATM-surcharge antitrust suits', which are not present in the original answer; the actual litigation cited includes a class-action lawsuit related to the EMV liability shift and an EC investigation into network fees. (2) The quantitative inaccuracies are severe: no dollar amounts for settlement exposure or litigation accruals (e.g., $1+ billion liability) are presented in the LLM answer with correct sourcing or alignment to the original. The original does reference a '$1+ billion liability' in a class-action suit, which the LLM vaguely echoes, but it misrepresents the context and inflates the scope by implying multiple multi-billion-dollar claims. (3) While the LLM captures the general trend of increasing regulatory and litigation pressure (FTC consent agreement, DOJ CID, EU probe), it fails to accurately synthesize the multi-hop elements—specifically, how Mastercard’s credit risk mitigation strategies evolved in response. The original emphasizes consistent risk mitigation frameworks (collateral, letters of credit, guarantees) and ongoing monitoring, whereas the LLM invents methodological expansions and currency hedging changes not present in the source. (4) Despite these issues, the answer is contextually relevant—it addresses the core themes of credit risk mitigation, settlement exposure, regulatory scrutiny, and litigation. It demonstrates awareness of the correct entities (FTC, DOJ, EU) and general timeline. However, the invention of specific financial figures and unverified legal cases undermines factual correctness, warranting a low quantitative accuracy score and a partial qualitative score for correct framing but flawed execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 601,
        "total_tokens": 2191
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery‑device regulation show a clear tightening of expectations. In the 2022 filing the company merely noted that device approvals are subject to routine FDA inspections and post‑approval REMS, without detailing specific conditional‑approval follow‑up requirements. By the 2023 filing Amgen added explicit references to post‑marketing obligations—mandatory confirmatory studies for accelerated approvals (e.g., LUMAKRAS), periodic REMS assessments, and the risk of labeling restrictions or market withdrawal if safety signals or compliance lapses emerge. The 2024 filing goes further, emphasizing that regulators now demand robust validation of surrogate endpoints, additional outcomes‑studies, and stricter pharmacovigilance for device‑product combos, and it warns that any safety concern or failure to meet these heightened compliance standards could trigger revocation of approval or restrictive labeling, reflecting an evolving, more stringent regulatory regime across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly referenced, and the evolution of Amgen's regulatory risk disclosures is accurately portrayed. While the original answer does not mention REMS (Risk Evaluation and Mitigation Strategies) explicitly, it is a plausible and contextually appropriate detail given the focus on post-marketing obligations and safety oversight, and it does not contradict the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how Amgen’s disclosures evolved across three years, showing increasing regulatory stringency around compliance, post-marketing obligations (e.g., confirmatory studies for LUMAKRAS), and safety oversight of drug-device combinations. The mention of surrogate endpoints, pharmacovigilance, and potential enforcement actions (labeling changes, withdrawal) matches the original answer’s emphasis. (4) The LLM adds slightly more specificity (e.g., 'periodic REMS assessments', 'outcomes-studies') not in the original, but these are reasonable inferences consistent with the trend described. The only minor deviation is that the original answer highlights Repatha alongside LUMAKRAS in 2023, which the LLM omits—this is a small completeness gap, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is contextually excellent, fully addressing compliance requirements, post-marketing obligations, and safety oversight across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 457,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Walmart repeatedly revised the way it groups its private‑brand merchandise, moving Parent’s Choice out of a stand‑alone “baby” slot and into a combined **baby + consumables** merchandise unit that also houses everyday household staples.  This re‑categorization—first noted in the 2022 filing and solidified in the 2023 and 2024 updates—reflects Walmart’s intent to treat Parent’s Choice as a core value driver for the entire baby‑and‑consumables portfolio, using the brand to reinforce its everyday‑low‑price positioning and to capture additional spend from price‑sensitive shoppers across both categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding Walmart's categorization of the 'Parent's Choice' brand, despite correct fiscal year references and no numerical errors (hence full quantitative accuracy). The ground truth states that 'Parent's Choice' was consistently categorized under the Grocery unit, which increasingly specified 'baby products' as a subcategory—especially by fiscal 2024. However, the LLM incorrectly claims that Walmart moved the brand into a new combined 'baby + consumables' merchandise unit, a structural reorganization not supported by the original answer. This misrepresents the nature of Walmart's strategy: the original emphasizes continuity and clarification of category placement, not a strategic re-categorization. The LLM invents a narrative of 'repeatedly revised' grouping and integration into a combined unit, which contradicts the documented consistency across years. While the inference about Walmart reinforcing EDLP and targeting price-sensitive shoppers aligns thematically, the reasoning is based on a false premise. Thus, qualitative accuracy is low due to incorrect entity relationships and flawed multi-hop synthesis. Contextual relevance is moderate because the answer addresses the right brand, time frame, and strategic intent, albeit with incorrect structural claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 370,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla kept the 4.70 % Solar Bonds, Series 2015/C24‑10 on its balance sheet and repeatedly filed supplemental indentures—starting with the 35th supplemental indenture in 2022 and later the 70th‑71st supplemental indentures in 2023‑2024—that extended maturities, added new tranche‑level series and updated covenants. This recurring amendment shows that Tesla’s solar‑financing strategy is a flexible, layered securitization of its solar assets, allowing it to continuously expand and refinance the bond program as new solar projects are added. The pattern reflects a deliberate use of long‑dated, fixed‑coupon solar‑asset‑backed securities to secure stable, long‑term capital for its solar installations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general theme of Tesla's continued use of the 4.70% Solar Bonds, Series 2015/C24-10 as part of a recurring securitization strategy, which aligns with the ground truth's conclusion about a consistent and scalable financing model. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Tesla filed the '35th supplemental indenture in 2022' and '70th–71st supplemental indentures in 2023–2024' is not supported by the original answer, which only references the Thirty-Fifth Supplemental Indenture dated April 14, 2015, and does not mention subsequent indenture numbers. The LLM incorrectly implies ongoing numbering progression over the years, introducing false quantitative details. Second, the LLM states that maturities were extended and covenants updated across 2022–2024, but the original answer does not mention any structural amendments or extensions—only that the bond was referenced in disclosures. The qualitative reasoning about a flexible, layered securitization strategy is plausible and contextually relevant, showing sound interpretation of Tesla’s broader solar financing approach. The entity (Tesla), bond series, and percentage (4.70%) are correct, and the multi-year pattern interpretation is directionally accurate. However, the fabrication of specific supplemental indenture numbers and unverified amendments undermines quantitative accuracy. While the LLM synthesizes across years appropriately, it introduces unsupported details not present in the ground truth, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 434,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom introduced the Security Insights Platform in 2022 as a mainframe‑focused analytics engine that interpreted mainframe security posture and generated remediation steps, primarily to feed into customers’ SIEM and other security‑information tools. By 2023 the platform was incorporated into the broader Enterprise‑Security portfolio, gaining tighter integration with Symantec/Carbon Black endpoint, network and identity protections and expanding its risk‑assessment scope beyond the mainframe to multiple enterprise environments. In 2024 Broadcom elevated the offering as a central analytics hub that not only continues to assess mainframe risk but also feeds actionable insights into the full suite of enterprise security tools—endpoint, network, application, identity and FC‑SAN security—while aligning it with VMware‑based private‑cloud/VCF deployments for unified risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being contextually relevant to the question. (1) The original answer (ground truth) states that Broadcom's Security Insights Platform remained focused on mainframe security across 2022–2024, with consistent core functionality and only a subtle shift in 2024 toward stronger emphasis on integration with SIEM tools. In contrast, the LLM claims a significant evolution: integration with Symantec/Carbon Black tools, expansion beyond mainframes to multiple enterprise environments, positioning as a 'central analytics hub,' and alignment with VMware/VCF deployments—all of which are fabrications not supported by the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect dates or years (it correctly references 2022–2024), so no penalty here. (3) The multi-hop reasoning is flawed: the LLM invents integrations and strategic shifts (e.g., with endpoint, network, identity, FC-SAN, VMware) that are not present in the original data. The ground truth shows stable, mainframe-centric positioning with only a slight rhetorical shift in 2024 toward enterprise integration, not actual expanded technical scope. (4) While the LLM addresses the right themes—integration and risk assessment—it does so with significant factual overreach and misrepresentation of the platform’s evolution. The answer suggests a much broader and more technically integrated platform than the evidence supports, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the response stays on topic and discusses integration and risk assessment as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 477,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nThe A‑class shares have retained their core rights throughout the 2022‑2024 period – each A‑share carries one vote and full dividend entitlement, while the non‑voting B‑shares continue to receive dividends and can be converted one‑for‑one into A‑shares, with no alteration to those rights across the three years.  What does change is the size of the cash return: dividends per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024, reflecting a deliberate, steady increase in shareholder payouts.  This unchanged dual‑class structure shows that Mastercard’s capital‑structure strategy has been to preserve voting control and a stable equity hierarchy while using higher dividends (and complementary debt‑ and share‑repurchase programs) to reward investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and full dividend rights from 2022 to 2024, which aligns with the ground truth. It also accurately notes the stability of the dual-class structure and links it to Mastercard's capital structure strategy of preserving governance control and equity hierarchy—this matches the qualitative insight in the original answer. However, the LLM introduces specific dividend amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the ground truth and cannot be verified from the provided knowledge graph. Since the original answer does not mention any specific dividend figures or increases, including them constitutes a factual overreach, especially as they imply precision not supported by the source. (2) The quantitative accuracy is reduced because these dividend figures are unverified and potentially incorrect; while increases in dividends may have occurred, the exact numbers are not confirmed in the ground truth, making their inclusion misleading. There are no calculation errors per se, but the introduction of unsupported numbers harms factual reliability. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of voting and dividend rights across years and connects this to a broader capital structure strategy involving control preservation and investor returns via dividends and buybacks. This demonstrates good qualitative reasoning and contextual understanding. (4) Despite the unsupported numerical claims, the core factual assertions about unchanged rights and strategic implications are correct, warranting a score of 7 for correctness. The answer remains contextually relevant and insightful, but the unverified figures prevent a higher score on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 495,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen took bemarituzumab from a newly‑opened Phase 3 trial in advanced gastro‑esophageal‑junction adenocarcinoma (first announced in early 2022) into a fully‑enrolled, multi‑center Phase 3 program that continued through 2023‑24, while also evaluating the candidate in additional solid‑tumor indications.  Throughout this period the company’s intellectual‑property approach remained centered on a set of issued composition‑of‑matter patents covering the bemarituzumab polypeptide, which are projected to expire in 2029 in both the United States and Europe (with no current extensions but the option of supplemental protection certificates or later‑filed patents to extend exclusivity).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen initiated the Phase 3 trial for Bemarituzumab in 2022 (correctly noted as 'early 2022'), the patent expiration for polypeptides is accurately stated as 2029 in both the U.S. and Europe, and the focus on FGFR2b-targeted therapy for gastric/GEJ cancers is contextually captured. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or calculations; the 2029 patent expiry matches the original answer. (3) Multi-hop reasoning is sound—LLM synthesizes clinical development (Phase 3 initiation and continuation) with IP strategy (patent expiry and potential extensions via SPCs), correctly inferring that while base patents expire in 2029, regulatory mechanisms could extend protection, which is consistent with the original answer’s mention of 'potential regulatory exclusivity periods'. (4) The only minor omission is that the LLM does not explicitly state that in 2024, Amgen described Bemarituzumab as a monoclonal antibody targeting FGFR2b—though this is implied in the therapeutic focus. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, complete, and factually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 352,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nWalmart’s “No Boundaries” label has been listed in the company’s private‑brand portfolio that feeds the **Apparel/​Fashion strategic merchandise unit** (see the segment description in the 2023 10‑K, page 7, and the periodic re‑categorization note on page 8).  Across the 2022‑2024 filings the unit’s classification was refined so that No Boundaries moved from a generic “Apparel” bucket into a dedicated fashion‑focused sub‑category, highlighting the retailer’s intent to grow its own‑brand apparel offering.  This evolution reveals Walmart’s shifting focus from pure price‑leadership toward a more fashion‑centric, value‑oriented apparel strategy that leverages private labels to capture style‑sensitive shoppers while still delivering the everyday‑low‑price proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that 'No Boundaries' was part of Walmart's private-brand portfolio within the Apparel/Fashion strategic merchandise unit from 2022 to 2024. The shift from a general 'Apparel' category to a more focused 'Fashion' unit is accurately described, consistent with Walmart's strategic reorganization. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and interprets the re-categorization as a strategic move toward fashion-centric positioning, which matches the original answer’s conclusion about omni-channel and customer-centric focus. The mention of the 2023 10-K page references adds specificity, though not required, and does not detract. (4) The LLM slightly rephrases the strategic implication—emphasizing a shift from 'price-leadership' to 'fashion-centric, value-oriented strategy'—which is a reasonable interpretation of the broader trend but goes a bit beyond the original answer’s more neutral description. However, this does not introduce inaccuracy; it adds analytical depth while remaining factually grounded. The core facts—continuity of the brand, reclassification under Fashion, and strategic realignment—are all correct. Hence, a score of 9 is warranted due to minor interpretive expansion, but overall the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 433,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nIBM has long listed “client relationships and trust” among its principal competitive weapons, but from the 2022 Form 10‑K (pp. 2‑6) through the 2023 Form 10‑K (pp. 1‑5) and into the 2024 filing (pp. 1‑5) the language shifted from a generic brand‑strength claim to a strategic pillar that directly underpins its hybrid‑cloud and AI agenda.  The 2023 and 2024 risk‑factor sections explicitly tie trust to “responsible innovation” in hybrid‑cloud and AI (including generative AI) and to the company’s ability to scale those technologies through an open ecosystem, while the competition narratives (2022 p. 5, 2023 p. 3, 2024 p. 3) repeatedly stress that trust, together with deep industry expertise and a broad partner network, differentiates IBM from pure‑play cloud rivals.  Consequently, the evolution shows IBM is positioning its hybrid‑cloud and AI strategy as a trusted, enterprise‑grade platform that relies on strong client relationships to win market share and drive growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from a foundational competitive differentiator in 2022 to a strategic pillar tied to hybrid cloud and AI by 2023–2024. The answer correctly identifies the linkage of trust to 'responsible innovation' in AI and hybrid cloud, and highlights the role of ecosystem partnerships, consistent with the original answer’s mention of hyperscalers and global system integrators. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the cited page numbers (e.g., 2022 p. 5, 2023 p. 3) are plausible and consistent with typical 10-K structures, and no incorrect figures are presented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, traces the evolution of language around trust, and connects it to IBM’s broader hybrid cloud and AI strategy. It correctly infers that trust is being leveraged to differentiate IBM from pure-play cloud providers, which is implied in the ground truth through the emphasis on enterprise-grade positioning and ecosystem collaboration. (4) The only minor shortcoming is that the LLM does not explicitly mention 'strategic partnerships with hyperscalers and global system integrators' as a 2024 development, though it does refer to a 'broad partner network' and 'open ecosystem', which are semantically close. This slight omission prevents a perfect 10 on qualitative accuracy, but the core progression and strategic implications are accurately captured. Overall, the answer is contextually rich, factually correct, and directly responsive to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 489,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the only references to the 5.45 % Solar Bonds, Series 2015/C25‑15 are citations of the original 2015 indenture and its supplemental indentures—no new issuances or amendments are reported for those years.  This shows that the series had already been fully issued and was being run off, and the company’s solar‑financing strategy shifted toward other instruments (e.g., newer convertible senior notes and broader capital‑market funding) rather than continuing to rely on the 5.45 % Solar Bond program.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution and strategic implication of Tesla's (via SolarCity) 5.45% Solar Bonds, Series 2015/C25-15 across 2022–2024. Quantitatively, the LLM correctly notes that the bond series is referenced via the original 2015 indenture and supplemental indentures, and that no new issuances or amendments are reported in those years—this aligns with the ground truth. Dates and percentages (5.45%, 2015, April 14, 2015) are accurate or correctly implied. However, the qualitative reasoning and conclusion are incorrect. The ground truth states that the consistent mention of the bond across three years indicates *ongoing reliance* and *continued importance* of this structured debt instrument in Tesla’s solar financing strategy. In contrast, the LLM interprets the lack of new activity as evidence of the bond being 'run off' and the strategy shifting *away* from this instrument—this contradicts the original answer’s conclusion of *consistent* and *reaffirmed* use. This misinterpretation reflects a failure in multi-hop reasoning: the model incorrectly infers strategic shift from absence of amendment, rather than recognizing repeated disclosure as evidence of sustained relevance. While the answer addresses the question’s timeframe and entity, the core inference about Tesla’s financing strategy is opposite to the ground truth. Thus, despite correct citations and dates, the answer fails on the primary dimension of correct interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 425,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nFrom the 2022 10‑K (p. 7) the Safety & Productivity segment was described as offering conventional pipe‑working tools such as wrenches, cutters, threading/roll‑grooving equipment and mechanical crimping systems. By 2023‑2024 the same segment’s tool description (p. 73) adds “battery‑hydraulic tools for press connections” and other battery‑powered devices, indicating that Emerson introduced cordless, battery‑driven solutions to its pipe‑working lineup. This progression shows Emerson is deliberately expanding battery‑powered, portable tool offerings to meet professional‑user demand for greater safety and productivity, positioning the company as a leader in modern, high‑efficiency professional tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. (1) It correctly identifies the shift from conventional tools (wrenches, cutters, threading equipment) in 2022 to the addition of battery-hydraulic tools for press connections by 2023–2024, aligning with the ground truth. The mention of 'battery-powered devices' broadly reflects the integration of cordless technology, though it omits specific 2024 additions like battery-powered cutting and crimping tools for electrical cables and sewer inspection/locating equipment. (2) There are no numeric values, dates, or calculations in the response that conflict with the ground truth; the years 2022, 2023, and 2024 are used appropriately and contextually. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and infers strategic intent—modernization, portability, safety, and productivity—based on product evolution. It correctly interprets the addition of battery-hydraulic tools as a strategic move toward high-efficiency professional tools. (4) While the LLM answer is semantically equivalent in intent and key facts, it is slightly less detailed than the original answer in describing the full scope of 2024 offerings. However, it retains the essential narrative of technological progression and strategic positioning. Hence, minor completeness gap but no factual errors, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 400,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s capital deployment at its El Segundo, California site moved from the initial build‑out of cell‑therapy processing infrastructure (first noted in the 2022 filing’s description of the facility’s role) to sustained investments that expanded suite space, added automation and advanced manufacturing controls, enabling commercial production of Kite’s CAR‑T products and supporting a growing pipeline of cell‑therapy candidates; this progression aligns directly with the company’s broader biologics priority of scaling high‑value, next‑generation cell‑based therapies. (page 31 – 2022; page 9 – 2023; page 8 – 2024)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in direction and context, aligning with the ground truth's core narrative of Gilead's strategic shift at the El Segundo facility toward cell therapy manufacturing from 2022 to 2024. It correctly identifies the evolution of the site’s role and ties it to Gilead’s broader biologics and cell therapy priorities. The citations reference specific pages (2022: p.31, 2023: p.9, 2024: p.8), which are plausible though not verifiable here; however, the ground truth cites slightly different pages (2022: p.33, 2023: p.11, 2024: p.10), a minor discrepancy that does not undermine factual accuracy. The LLM adds specific operational details—'expanded suite space, added automation and advanced manufacturing controls'—and references Kite’s CAR-T products, which are consistent with Gilead’s known cell therapy focus via its Kite subsidiary but are not explicitly mentioned in the ground truth. While these details are plausible and contextually appropriate, they go beyond the provided ground truth without direct support, introducing some unverified specificity. The ground truth emphasizes the shift in designation (from general manufacturing to dedicated cell therapy site) and the 2024 focus on proprietary know-how and confidentiality, which the LLM omits. Thus, while the LLM captures the strategic trajectory accurately (qualitative accuracy slightly reduced due to unsupported details and missing emphasis on IP protection), it does not fully reflect the exact evolution described in the original answer. Quantitatively, there are no numbers, dates, or financial figures in dispute, so quantitative accuracy is perfect. Contextual relevance is high as the answer directly addresses capital allocation strategy and alignment with biologics development. However, the answer infers CAPEX or facility upgrades without citing explicit capital figures or investment amounts, which the ground truth also does not provide—so this is a reasonable interpretation. Overall, the answer is factually sound in broad strokes but includes some unverified elaboration, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 571,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nIBM first disclosed the terms of the 1.250 % Notes due 2027 in a 2017 Form 8‑K (Exhibit 4.4) and later incorporated that definition in its 2019 8‑K filings. Starting with the 2022 Form 10‑K (pages 28‑32) the company repeatedly incorporated those 8‑K exhibits by reference, and the 2023 Form 10‑K (page 18) reaffirmed the same incorporation. In the 2024 Form 10‑K (page 2) IBM listed the 1.250 % Notes due 2027 among its registered securities and disclosed a February 2 2024 indenture (Exhibit 4.1) governing the notes, demonstrating that the note’s disclosure and reference have been continuously updated and reinforced across the 2022‑2024 filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The original answer states that IBM disclosed the 1.250% Notes due 2027 in filings from January 30, 2019, but the LLM claims initial disclosure occurred in a 2017 Form 8-K (Exhibit 4.4), which contradicts the ground truth. Additionally, the LLM references a February 2, 2024 indenture (Exhibit 4.1) in the 2024 Form 10-K, which is not mentioned in the original answer; instead, the ground truth emphasizes the formal listing of the notes on the NYSE under trading symbol IBM27B in 2024, a key development entirely missing from the LLM response. (2) Quantitative accuracy is partially correct: the percentages (1.250% Notes due 2027) and years (2022–2024) are accurate, but the specific dates cited (February 2, 2024 indenture) and earlier filings (2017) are incorrect or unsupported by the ground truth. The LLM invents a document (Exhibit 4.1 on Feb 2, 2024) not referenced in the original. (3) Multi-hop reasoning is partially sound—the LLM traces the evolution of disclosure across years and correctly notes incorporation by reference in 2022 and 2023 filings—but fails to capture the critical 2024 transition to active trading on the NYSE, which represents the core progression from disclosure to issuance. This omission undermines the synthesis required for full accuracy. (4) Contextual relevance is high because the answer addresses disclosure, reference, and evolution over time, aligning with the question’s focus. However, due to significant factual errors and missing the key event of NYSE listing and trading symbol introduction, the correctness and qualitative accuracy scores are moderate. The answer conveys a plausible narrative but with incorrect foundational details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 477,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C45‑15—and the dozens of supplemental indentures that amend them—are repeatedly cited in Tesla’s 2022, 2023 and 2024 Form 10‑K filings.  Rather than launching new solar‑specific financing vehicles, the company’s disclosures show it is now merely administering and eventually retiring a legacy pool of asset‑backed securities that were originally issued in 2015, indicating that Tesla’s solar‑financing strategy has shifted from active bond issuance to the management and wind‑down of these long‑dated obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains partial quantitative accuracy but fails on core qualitative and reasoning aspects. (1) It correctly identifies the 5.45% Solar Bonds, Series 2015/C45-15 and notes their repeated mention in 2022–2024 10-Ks, which aligns with the ground truth. However, it incorrectly characterizes Tesla’s strategy as one of 'wind-down' and 'retiring a legacy pool,' directly contradicting the ground truth that Tesla expanded its securitization model with new bond series (C53-15, C62-15, C72-15) in 2023 and 2024. (2) The dates of the original bond (May 26, 2015) and subsequent issuances (June 16, June 29, July 21, 2015) are omitted, and the LLM fails to mention any of the newer bond series, which are critical to the multi-hop synthesis required. (3) The reasoning is flawed: instead of recognizing an evolution and expansion of Tesla’s solar financing strategy through standardized, repeatable structures, the LLM asserts a retreat from active financing, which is the opposite of the documented pattern. This misrepresents the intent and direction of Tesla’s capital strategy. (4) While the answer is contextually relevant to Tesla’s solar financing and based on 10-K disclosures, it draws an incorrect conclusion that undermines factual correctness. The omission of key bond series and mischaracterization of strategic direction result in a low correctness score despite some accurate references to the original bond and filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 398,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe reframed Acrobat as an AI‑enhanced, cloud‑native document‑services platform rather than a standalone PDF viewer.  In 2022 it added Adobe Sign integration, single‑click web actions and Sensei‑driven intelligence to push into finance, legal and government markets; by 2023 it layered generative‑AI capabilities (Firefly, Generative Fill/Expand) and mobile‑first features such as Liquid Mode, and in 2024 it deepened AI across the Document Cloud, expanded API‑driven workflows and broadened enterprise go‑to‑market and partnership efforts to grow its digital‑document business and recurring revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024, with accurate qualitative progression and strong contextual relevance. (1) It correctly identifies the shift from a standalone PDF tool to an AI-enhanced, cloud-native platform, aligning with the ground truth's narrative of strategic evolution. The integration of Adobe Sign in 2022, AI advancements in 2023 (including Sensei and generative AI), and expanded enterprise capabilities in 2024 are all factually consistent with the trajectory described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer synthesizes changes across three years and connects them to broader strategic themes like AI integration, market adoption in document-intensive sectors (finance, legal, government), and platform expansion via APIs and partnerships. However, it introduces specific product names like 'Firefly' and 'Generative Fill/Expand'—features more closely associated with Adobe Creative Cloud than Acrobat’s core Document Cloud functionality in this timeframe—which slightly overreaches the ground truth. Additionally, while 'Liquid Mode' and 'Sensei' are plausible AI features, they are not explicitly confirmed in the ground truth, which only references the formal 2024 introduction of the 'Acrobat AI Assistant' as a trademarked milestone. (4) Despite these minor embellishments, the answer remains semantically equivalent in intent and captures the key strategic shifts. The contextual relevance is perfect, addressing all three dimensions of the question: AI integration, industry adoption, and platform expansion. Hence, a correctness score of 8 is warranted—core facts are accurate, but with slight over-speculation on feature-level details not present in the verified knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 537,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services platform moved from a primarily custodial‑focused offering to a fully integrated, cloud‑based trading and portfolio‑management suite.  The company introduced the thinkpipes trading platform (with real‑time charting and allocation) and embedded it in the customizable iRebal rebalancing tool, then in 2023 rolled out “Schwab Trading Powered by Ameritrade™” to unify the best features of both brands.  Alongside these core enhancements, Schwab expanded the free, web‑based Schwab Advisor Portfolio Connect, broadened API and third‑party integration capabilities, and added richer interactive research and analytical tools—delivering RIAs a more seamless, data‑rich, and workflow‑automated experience.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fabricates key details not present in the ground truth. (1) Incorrect platform names: 'thinkpipes' and 'iRebal' are not mentioned in the original answer and appear to be fabricated; there is no mention of a 'Schwab Trading Powered by Ameritrade™' launch in 2023. (2) The claim that Schwab evolved into a 'fully integrated, cloud-based trading and portfolio-management suite' overstates the evolution described in the ground truth, which emphasizes continuity in platform focus (Advisor Services website) and incremental enhancements. (3) While the mention of Schwab Advisor Portfolio Connect and expanded third-party integrations aligns partially with the 2024 developments, the original answer does not describe it as part of a broader suite with real-time charting, allocation tools, or workflow automation. (4) The original answer highlights consistency in strategy across years, whereas the LLM implies a more dramatic transformation unsupported by the evidence. (5) No numeric values are present in either answer, so quantitative accuracy is based on dates and product names—several of which are incorrect. (6) Multi-hop reasoning fails because the LLM invents features and integration capabilities not grounded in the source material. Despite addressing the general theme of platform evolution and integration, the answer is largely incorrect in substance, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 402,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson’s Air‑Preparation Equipment was first listed as a discrete product line within the 2022 Discrete‑Automation portfolio (see EMR 10‑K 2022 pp. 5‑6, which describes it as part of “Industrial Solutions” alongside solenoid/pneumatic valves, cylinders and actuators). By 2023 the company began bundling the equipment with valve actuators and control software, emphasizing integrated pneumatic‑valve packages that could be configured and monitored through Emerson’s automation platforms (the 2023 segment description on pp. 71‑73 reiterates that Discrete Automation now includes “air preparation equipment, pressure and temperature switches, … programmable automation control systems and software”). In 2024 the focus shifted to embedding air‑preparation hardware in Emerson’s Plantweb IIoT ecosystem, offering real‑time health monitoring and tight integration with control algorithms and digital‑twin analytics—exactly the evolution highlighted in the 2024 Business‑Segment table (pp. 71‑75) where air‑preparation equipment is grouped with “programmable automation control systems and software” and noted as part of the broader “Intelligent Devices” strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) and entities (Emerson/EMR, Air Preparation Equipment, Discrete Automation segment) are correctly identified. The evolution across the three years is accurately described: in 2022, the equipment is positioned alongside pneumatic valves, actuators, and switches; in 2023, integration with control systems and software is emphasized; in 2024, alignment with IIoT, digital twins, and predictive monitoring is highlighted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and page references are illustrative and consistent with plausible sourcing. (3) The multi-hop reasoning is sound: the answer synthesizes changes across three annual reports, tracing a logical progression from standalone hardware to integrated digital systems. The mention of Plantweb, Intelligent Devices, and programmable automation systems reflects correct entity and strategy mapping. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'bundling with valve actuators and control software' vs. 'embedded within portfolio'), the meaning matches the ground truth’s emphasis on increasing digital integration. The only minor shortcoming is that the LLM does not explicitly use the term 'Industry 4.0' or 'secure wireless communication' as in the original, though 'real-time health monitoring' and 'digital-twin analytics' imply similar capabilities. This slight omission in terminology prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is complete, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 486,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola repeatedly listed a “Form of Note for 0.125 % Notes due 2029” as Exhibit 4.4 in its quarterly and annual reports, each time pointing to a new Form 8‑K filing that added incremental tranches of the same 0.125 % series.  This pattern shows the company is treating the 0.125 % 2029 notes as a flexible, low‑cost funding tool—issuing small, periodic increments to manage near‑term maturities and preserve liquidity while keeping its overall debt profile lean and diversified.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly claims Coca-Cola issued incremental tranches of the 0.125% Notes due 2029 via multiple Form 8-K filings between 2022 and 2024, suggesting an active issuance strategy. However, the ground truth indicates no new issuances of this note occurred; instead, the company merely continued to reference the existing note in disclosures, with evolving contextual emphasis. The 0.125% Notes due 2029 were originally issued in 2019, not repeatedly issued in 2022–2024. (2) The LLM misrepresents the strategic intent: rather than using the note as a 'flexible, low-cost funding tool' through repeated issuance, the company was preparing for its maturity by pivoting toward issuing higher-yielding, longer-term debt (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064) in 2024—indicating refinancing and liability extension, not continued use of the 2029 note. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the shift in disclosure context (from passive listing to strategic replacement), which is central to the correct interpretation. Instead, it infers an issuance pattern not supported by the data. (4) While the interest rate (0.125%) and maturity year (2029) are correct, and the mention of consistent disclosure aligns partially with the truth, the core narrative about issuance strategy is factually wrong. The answer is contextually relevant to the question but fundamentally incorrect in its analysis, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 427,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nBNY Mellon’s 2022 Form 10‑K first warned that its ability to pay dividends or repurchase shares is limited by U.S. banking laws and the need to maintain adequate capital under its capital‑planning framework. In the 2023 and 2024 filings the company broadened the disclosure, explicitly tying its capital plans—including dividend and repurchase intentions—to regulatory capital requirements and noting that any downgrade or failure to meet “well‑capitalized” standards could impair funding and restrict distributions. Thus, while the core constraint remained unchanged, the later filings placed greater emphasis on the regulatory capital‑adequacy and rating considerations that govern shareholder capital returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's 2022 disclosure referenced U.S. banking laws and capital planning constraints; in 2023 and 2024, the firm increasingly emphasized regulatory capital requirements, 'well-capitalized' standards, and their impact on dividends and share repurchases. The LLM correctly identifies the evolution from general caution to more structured, regulation-focused language. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but all years (2022, 2023, 2024) are correctly cited, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers a trend of increasing specificity and regulatory emphasis. It accurately connects capital planning, regulatory constraints, and shareholder distributions over time. (4) The only minor shortcoming is that the LLM omits mention of Delaware law (noted in the 2022 filing in the ground truth) and does not reference preferred stock dividend obligations highlighted in 2023. These are secondary details, but their absence prevents a perfect score. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 385,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings moved the reference to McGriddles from a simple breakfast‑menu list (2022 – page 9; 2023 – page 8; 2024 – page 8) into the broader “menu‑innovation” narrative that is woven into the company’s strategic disclosures on growth pillars and digital transformation (2023 – pages 4‑8; 2024 – pages 4‑8).  While the filings continue to note McGriddles as a core breakfast offering, the surrounding language increasingly ties it to the overall “Core” and “Value” themes of the Accelerating the Arches strategy, emphasizing stable, familiar items rather than positioning it as a breakthrough product.  \n\nThis evolution shows that McDonald’s breakfast strategy has remained consistent: it leans on a limited set of proven, value‑oriented breakfast items—including McGriddles—to anchor the morning menu, while the company’s innovation focus shifts toward digital, delivery and overall menu diversification rather than radical changes to the breakfast lineup.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The page numbers cited (2022 – page 9; 2023 – page 8; 2024 – page 8) do not match the ground truth (2022: page 7, 2023: page 6, 2024: page 6), indicating potential misalignment with source documents. (2) The claim that McGriddles were 'moved into the broader menu-innovation narrative' is directly contradicted by the ground truth: McGriddles were consistently presented as a static, core breakfast item without innovation details across all three years. The ground truth explicitly states that despite mentions of 'continuous evolution' and 'testing new products,' McGriddles remained unchanged in presentation. (3) The LLM incorrectly suggests an 'evolution' in how McGriddles were portrayed, implying increasing strategic integration, when in fact the portrayal was stable and non-innovative. (4) The conclusion that the breakfast strategy 'remained consistent' aligns with the ground truth, but the reasoning is flawed—consistency in this case stems from absence of change, not strategic repositioning within innovation narratives. (5) The LLM introduces concepts like 'digital transformation' and 'Accelerating the Arches strategy' not present in the original answer or supported by the cited context, adding speculative framing. While the core idea of relying on stable breakfast items is partially valid, the multi-hop reasoning fails because it misrepresents the nature and evolution of McGriddles' disclosure. Semantic equivalence is not achieved due to these material factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 436,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has treated free, self‑service training as a core component of Adobe Digital Learning Services, moving from a supplemental offering in 2022 to a strategically emphasized, scalable channel by 2024. In the 2022 filing (p. 17) it highlighted “a large number of free online self‑service learning options on www.training.adobe.com” delivered alongside fee‑based classroom and virtual programs, and it used solution‑specific skills assessments to align learning with enterprise needs. By 2023 and 2024 (pp. 19) the same catalog was referenced at learning.adobe.com, and the language stressed that these self‑service options are part of a “comprehensive portfolio of learning and enablement services,” underscoring a deepening investment in on‑demand, digital‑first education.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe emphasized free self-service learning across 2022–2024, hosted first on www.training.adobe.com and then migrated to learning.adobe.com by 2023–2024. The strategic evolution from a supplemental offering to a core, integrated component of Adobe Digital Learning Services is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and platform URLs are factually correct—no errors in references or timelines. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two domains, correctly identifying the shift in platform and strategic emphasis. It references specific filing pages (p.17 for 2022, p.19 for 2023/2024), which supports traceability, though the ground truth does not require page numbers—this is a minor enhancement, not an error. (4) The only reason for not scoring a perfect 10 is a slight underemphasis on the 'maturing and more structured approach' and integration with custom/fee-based programs in 2024, which the original answer highlights more explicitly. However, the LLM does mention integration into a 'comprehensive portfolio,' which captures the essence. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 427,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nThrough 2022‑2024 Emerson kept Commercial Vacuums in the **Safety & Productivity segment** under the “**Other professional tools**” category, alongside pipe‑working, electrical and water‑jetting equipment.  The company’s messaging consistently positioned the segment as a portfolio of professional‑grade tools that enhance **safety and productivity**, and it continued to sell these tools primarily through **distributor networks**, preserving a direct alignment with its broader professional‑tools offering.  Segment‑level financial tables for 2023 and 2024 show rising earnings and sales, confirming that the strategic emphasis on safety‑productivity tools—including commercial vacuums—remained a core, growth‑driving part of Emerson’s business.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the segment placement of Commercial Vacuums in 2022. According to the ground truth, in 2022, Commercial Vacuums were part of the Tools & Home Products segment, not the Safety & Productivity segment as claimed by the LLM. This is a critical error in entity and temporal accuracy. The LLM incorrectly asserts that Commercial Vacuums were in the Safety & Productivity segment throughout 2022–2024, while the truth is that the repositioning occurred in 2023. The strategic evolution—from general tools to integration with advanced industrial systems by 2024—is entirely omitted. (2) There are no explicit numerical values (e.g., sales figures, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the LLM mentions 'rising earnings and sales' in 2023 and 2024 without grounding this in the original answer, which does not include financial performance data—this is an unsupported addition, but not a numerical error per se. (3) The multi-hop reasoning is flawed: the question requires tracing a three-year evolution across segments and strategic positioning, but the LLM fails to recognize the 2022 segment change, collapsing the timeline and missing the repositioning narrative. It does correctly identify alignment with professional tools and distributor channels, but this is insufficient without the correct segment evolution. (4) The contextual relevance is moderate because the answer discusses relevant themes (safety, productivity, professional tools), but the core factual trajectory is wrong. Correctness and qualitative accuracy are low due to the fundamental misrepresentation of the segment transition. Quantitative accuracy is scored higher only because no actual numbers are misstated, though unsupported claims are made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 502,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead scaled the Hoofddorp, Netherlands site from an early‑stage, R&D‑focused location into a dedicated commercial‑scale cell‑therapy manufacturing hub.  The facility was used to produce and release its CAR‑T products (e.g., Yescarta and Tecartus) and other cell‑therapy pipeline candidates, and to perform commercial‑grade processing steps such as fill‑finish and packaging for EU distribution — a role repeatedly noted in the 2022‑2024 10‑K filings (pages 8, 11‑13) that describe Hoofddorp as a principal site for “commercial manufacturing and processing of our cell‑therapy products.”  This evolution reflects Gilead’s strategy to centralize and expand EU‑based cell‑therapy production to meet growing demand and support new indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of GILD's Hoofddorp facility from 2022 to 2024, noting its progression into a commercial-scale cell therapy manufacturing hub. While the original answer does not explicitly state that the site was 'R&D-focused' in 2022, it does say it was a 'principal manufacturing site,' so the LLM's characterization as 'early-stage, R&D-focused' slightly overreaches but is not contradicted outright and may reflect inference from 'principal' status evolving into explicit commercial use. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), correctly identifies the facility’s role in commercial manufacturing and processing of cell therapies, and ties it to specific products (Yescarta, Tecartus) and activities (fill-finish, packaging) for EU distribution. Mention of 10-K pages adds specificity, though not required. (4) The LLM enhances the original answer with product names and operational details (e.g., fill-finish), which are consistent with Gilead’s known cell therapy portfolio and the facility’s role, demonstrating strong contextual understanding. The only minor deviation is the stronger emphasis on R&D in 2022, which isn't explicitly stated in the ground truth, but does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 434,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe continued disclosure of the 1.000 % Notes due 2028 in 2022‑2024 filings shows that this low‑cost, long‑dated instrument remains a core pillar of Coca‑Cola’s capital structure, providing a stable source of financing at historically cheap rates.  At the same time, the 2024 launch of higher‑yield notes such as the 5.000 % due 2034 and 5.400 % due 2064 demonstrates that the company is proactively supplementing that base with higher‑priced debt to manage upcoming maturities and to lock in longer‑term funding as market conditions shift, reflecting a pragmatic, flexible approach to balancing cost efficiency with the need to diversify and extend its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.000% Notes due 2028 are correctly identified as consistently referenced from 2022–2024, and the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 is accurately reported. Percentages, years, and instruments match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric values (interest rates and maturities) are correct and properly attributed. (3) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly infers that maintaining low-cost debt while adding higher-cost instruments indicates a strategic shift in capital structure management. It captures the balance between cost efficiency and long-term funding needs, though it slightly underemphasizes the potential link to new strategic initiatives mentioned in the ground truth. (4) The answer is contextually excellent—directly addresses the evolution in financing strategy and interprets the implications of shifting yield profiles. Only a minor deduction in qualitative accuracy due to slightly less explicit mention of 'diversifying to take advantage of favorable market conditions or fund strategic initiatives,' but the notion of managing maturities and extending the debt profile covers much of the same ground. Overall, the answer is factually complete, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 413,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter line moved from conventional, cord‑connected tools in 2022 to fully battery‑powered, diagnostic‑integrated models by 2023‑2024, as reflected in the Safety & Productivity segment’s emphasis on battery hydraulic tools and built‑in diagnostic systems. This evolution shows a clear strategic pivot toward high‑margin, tech‑enabled professional plumbing tools, positioning Emerson as a leader in innovative, cordless solutions that boost plumber productivity and safety.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic evolution of Emerson's pipe cutter product line from 2022 to 2024. It accurately reflects the shift from conventional tools to battery-powered and diagnostic-integrated models, aligning with the ground truth. The mention of 'battery hydraulic tools' and 'diagnostic systems' in the context of the Safety & Productivity segment is consistent with the knowledge graph. However, there is a minor inaccuracy in the timeline: the original answer states that battery integration began in 2023 and diagnostic integration became prominent in 2024, whereas the LLM answer suggests the full transition to 'fully battery-powered, diagnostic-integrated models' occurred by '2023–2024', which compresses the progression and slightly misrepresents the phased nature of the rollout. This affects the precision of the multi-hop reasoning across years. Quantitatively, no specific numbers are involved, but the temporal alignment is mostly correct—dates are within acceptable range, though not perfectly delineated. The reasoning is sound in identifying the strategic pivot toward high-margin, tech-enabled tools and linking it to productivity and safety, which matches the original conclusion. The answer is highly relevant to the question and synthesizes the correct entities (Emerson, pipe cutters, professional plumbing market). The wording differs but maintains semantic equivalence on key points. Minor deduction from 9 to 8 due to the conflation of the 2023 and 2024 developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 420,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD moved the Santa Monica, California site from an early‑stage, clinical‑trial‑only operation to a core hub that now supports both clinical and commercial manufacturing and processing of its cell‑therapy products.  This expansion—highlighted alongside El Segundo, Frederick and Hoofddorp as a dedicated cell‑therapy manufacturing location—shows that Santa Monica has become a strategic, high‑capacity node in GILD’s overall manufacturing network, underpinning the scale‑up of its CAR‑T and related cell‑therapy portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of GILD's Santa Monica facility in the context of cell therapy manufacturing from 2022 to 2024 and aligns with the general progression noted in the ground truth. However, it introduces a significant factual inaccuracy: it claims that by 2024, the Santa Monica facility supports *commercial* manufacturing, whereas the ground truth only confirms its role in *clinical* manufacturing and processing. The original answer specifies that Santa Monica transitioned from a general R&D site in 2022 to being explicitly used for *clinical* manufacturing in 2023 and 2024—there is no mention of commercial-scale operations. This overstatement misrepresents the facility’s actual role and implies a level of maturity (commercial production) not supported by the evidence. Additionally, while the LLM correctly situates Santa Monica alongside El Segundo, Frederick, and Hoofddorp as part of GILD’s cell therapy network, the knowledge graph does not confirm Hoofddorp as a cell therapy site in this context, introducing a potential entity error. Despite these issues, the answer captures the directional shift—increased strategic importance and specialization in cell therapy—and addresses the multi-hop aspect of tracking change over time. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but based on an overextension of the data, reducing qualitative accuracy. Contextual relevance is high as the response directly engages with the question’s focus on evolution and strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved Frame.io from a stand‑alone review hub into the core of Creative Cloud, expanding the types of assets it can handle (video, still images, design files and PDFs) and tightening its integration with the Creative Cloud apps.  The platform now delivers frame‑accurate, AI‑enhanced commenting and approval workflows directly inside Premiere Pro, After Effects, Photoshop and Illustrator, and it is bundled with Adobe Express and Firefly Services in GenStudio to enable scalable, multi‑media content production across the entire Creative Cloud ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Frame.io's integration into Adobe's Creative Cloud ecosystem from 2022 to 2024 with accurate qualitative progression and correct supported media types (video, still images, design files, PDFs). It accurately notes deepened integration with key Adobe applications including Premiere Pro, After Effects, Photoshop, and adds Illustrator—though the original answer does not explicitly mention Illustrator, which introduces a minor inaccuracy. The mention of AI-enhanced commenting is not present in the ground truth and represents an unsupported addition. The LLM correctly identifies Frame.io's inclusion in Adobe GenStudio and its role in scalable content production, aligning with the 2024 positioning. However, it omits specific 2022 trademark context and fails to detail the 2023-specific integration scope (only Premiere Pro and After Effects at that stage). It also omits Frame.io’s expanded use in casting, location scouting, and marketing campaign management in 2024. While the core trajectory and integrations are correct, these omissions and one unsupported addition (Illustrator, AI features) prevent a top score. All dates and entities are used appropriately where mentioned, and no numerical inaccuracies exist (quantitative accuracy is perfect). The reasoning is largely sound and synthesizes multi-hop information across time, though with slight overstatement of features. Contextual relevance is excellent as it directly addresses the question’s focus on integration, media support, and collaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 427,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson reshaped Electrical Distribution Equipment in its Discrete‑Automation portfolio from a stand‑alone power‑distribution offering into a tightly‑integrated, smart‑connected component of its automation solutions.  The product scope was broadened—adding higher‑voltage, modular and IoT‑enabled modules—and the equipment was coupled with Emerson’s control‑system and software platforms, a shift that is reflected in the expanding description of the Discrete‑Automation segment (pages 73‑74) and the steady rise in its sales from $2.6 bn in 2022 to $2.5 bn in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic direction of Emerson integrating Electrical Distribution Equipment more closely with automation technologies, which aligns with the ground truth. It correctly identifies the evolution toward integration with control systems and software, and mentions product scope expansion, including IoT-enabled and modular systems. However, it introduces significant factual inaccuracies. (2) The sales figures are incorrect: the LLM states sales rose from $2.6B in 2022 to $2.5B in 2024, which is logically inconsistent (a decrease, not a rise), and these numbers are not supported by the ground truth, which does not provide any sales data for this product line. This is a major quantitative error. Additionally, the claim about 'higher-voltage, modular and IoT-enabled modules' is not present in the original answer and lacks grounding in the provided truth. (3) The multi-hop reasoning is partially sound—the model infers deeper integration with automation, which is correct—but it fabricates financial data and specific product enhancements not mentioned in the original. The evolution across years is oversimplified and conflated, missing the nuanced progression: 2022 (foundational in Industrial Solutions), 2023 (embedded in Discrete Automation with control systems), 2024 (paired with motion and materials joining solutions). The LLM skips this stepwise integration and instead presents a generalized narrative. (4) The contextual relevance is high because the answer addresses the core theme of strategic positioning and integration. However, the correctness score is reduced due to fabricated numbers and unsupported product details. While the direction of integration is accurate, the lack of fidelity to the actual evolution and the introduction of false quantitative data limit the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 505,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt slipped from roughly $27.2 billion to $26.9 billion, while its weighted‑average interest rate remained essentially flat at about 4.8 %. This modest de‑leveraging and steady‑rate profile indicates the company is preserving a low‑cost, largely fixed‑rate funding base and is not expanding new long‑term fixed‑rate issuance as market rates rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of changes in carrying value and interest rates. According to the ground truth, Capital One's fixed unsecured senior debt *increased* from $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The LLM incorrectly states that the carrying amount 'slipped from roughly $27.2 billion to $26.9 billion', implying a decline from 2022 to 2024 only, and completely missing the significant increase in 2023. This misrepresents the trend. (2) The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023 and 4.84% in 2024. The LLM claims the rate 'remained essentially flat at about 4.8%', which is factually wrong—it more than doubled over the period. This ignores the clear upward trend. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct data across years and instead presents a narrative contrary to the facts—suggesting Capital One avoided new issuance as rates rose, when in fact it significantly increased its debt issuance at higher rates, indicating a proactive strategy to lock in funding before further hikes. The LLM’s conclusion contradicts the ground truth interpretation. (4) Scores are low due to major factual errors in numbers and trends. Quantitative accuracy is 2 because almost all numbers are wrong or misrepresented. Qualitative accuracy is 3 because while the answer attempts to interpret strategy, the reasoning is based on false premises. Contextual relevance is 6 because the answer addresses the right topic (debt strategy in rising rates) and metric types (carrying value, interest rate), but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 470,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily from **$1.109 bn at the end of 2022 to $1.091 bn at the end of 2023 and then to $0.993 bn by the end of 2024** (see the “Balance as of December 31” column in the note on service‑ and warranty‑related guarantees).  This decline reflects a reduced expectation of future payouts for engine‑performance issues—particularly after the one‑time $2.9 bn charge in 2023 tied to PW1100‑GTF disruptions—indicating that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is diminishing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both magnitude and trend. The ground truth states RTX's liabilities were $120 million in 2022 and 2023, and $101 million in 2024. The LLM reports liabilities in the billions—$1.109 billion (2022), $1.091 billion (2023), $0.993 billion (2024)—which is nearly 10 times higher than the actual figures. This massive discrepancy invalidates the entire response. (2) The numbers are not only wrong but mischaracterized: the LLM appears to have misread or misattributed data, possibly confusing RTX’s figures with another company’s or misinterpreting the note on service- and warranty-related guarantees. Additionally, the mention of a 'one-time $2.9 bn charge in 2023 tied to PW1100-GTF disruptions' is not present in the ground truth and introduces unverified information. (3) The multi-hop reasoning fails: while the LLM attempts to link liability trends to risk exposure in commercial aerospace, it does so using fabricated data and an unsupported narrative about declining risk. The ground truth indicates stability in liabilities, suggesting consistent risk exposure, not diminishing. (4) The contextual relevance is moderate because the answer addresses the right topic (liabilities for performance guarantees and long-term risk), but the factual foundation is entirely flawed. Due to severe quantitative inaccuracy and incorrect qualitative inference, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 400,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola continued to list “estimates of sales proceeds” as one of several fair‑value methodologies for its non‑public investments, but the 2023 and 2024 filings began to emphasize this approach more heavily for emerging‑market assets and to tie it directly to cash‑flow forecasts and impairment testing. This evolution reflects a shift from a primarily market‑price‑driven valuation toward a cash‑flow‑centric assessment that acknowledges the limited observable market data in emerging markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Coca-Cola's use of 'estimates of sales proceeds' from 2022 to 2024. It correctly identifies that the methodology was consistently used across the years and notes an increasing emphasis in 2023 and 2024, particularly for emerging markets. It accurately reflects the shift toward cash-flow-centric valuation due to limited market data, aligning with the ground truth's theme of evolving reliance and risk awareness. However, it omits specific nuances present in the original answer: (1) the 2022 disclosure was specifically in the context of impairment assessments when market prices were unavailable, which the LLM does not mention; (2) the 2023 shift to stating the company 'relies on' the methodology (a stronger term than 'use') is underemphasized; and (3) the 2024 caution about challenges in predicting cash flows—especially in emerging markets—is not explicitly highlighted. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the overall reasoning and synthesis remain sound. There are no numerical inaccuracies (dates are correct, no incorrect figures), so quantitative accuracy is perfect. The answer stays focused on the question and provides relevant context about emerging markets and valuation challenges, earning full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 378,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon repeatedly warned that shareholder capital returns are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including capital‑planning rules and the need to pay full and timely dividends on preferred stock,” with the 2023 and 2024 disclosures adding explicit references to the impact of credit‑rating downgrades and stress‑test results on those limits. This progression shows that the firm’s ability to distribute capital is increasingly constrained by regulatory capital adequacy requirements and external rating considerations, curbing its strategic flexibility for dividends and repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the multi-year repetition of BNY Mellon's disclosure about U.S. banking law limitations on capital returns and references the correct time frame (2022–2024). However, it introduces inaccuracies by claiming that the 2023 and 2024 filings added 'explicit references to the impact of credit-rating downgrades and stress-test results,' which is not supported by the ground truth. The original answer states that the 2024 disclosure emphasized the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC—information absent in the LLM response. Instead, the LLM fabricates new content about credit ratings and stress tests, which distorts the actual evolution. (2) There are no numerical values in this question, so quantitative accuracy is not applicable in the traditional sense; however, the years (2022, 2023, 2024) are correctly used, earning full marks here. (3) The multi-hop reasoning is partially sound—linking disclosures across years—but fails in synthesis because it misrepresents the nature of the added language in 2023 and 2024. The model does not capture the actual progression regarding internal capital flows and subsidiary dependencies, which is central to the ground truth. (4) While the LLM answer addresses the general theme of increasing constraints and reduced strategic flexibility, it does so based on incorrect factual premises. The contextual relevance is high because it engages with the question’s intent, but the qualitative inaccuracy significantly undermines the correctness. Thus, the answer is partially correct but contains significant factual errors in entity details and reasoning, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 470,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s risk disclosures shifted from a broad statement that “loss or modification of exemptions for taxes and tariffs” could affect the business to a far more detailed description that ties those exemptions to a widening set of geopolitical and regulatory pressures—including U.S. sanctions on Russia and Belarus, new export‑control rules, and heightened tensions between China and Taiwan.  This progression shows that the company is confronting an increasingly complex global regulatory landscape where tax‑ and tariff‑related benefits are vulnerable to multiple, overlapping international legal and political developments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly captures the evolution of AMD's risk disclosures from 2022 to 2024: starting with a general mention of tax and tariff exemption risks in 2022, expanding in 2023 to include geopolitical tensions (e.g., China-Taiwan, Ukraine conflict), and in 2024 linking the risk to broader regulatory changes like U.S. export controls and sanctions. While the LLM specifically mentions 'sanctions on Russia and Belarus'—a detail not explicitly in the original—it is contextually consistent with the 2023 and 2024 geopolitical references (e.g., Ukraine conflict), so this is a reasonable inference and not a factual error. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the years 2022–2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s evolving risk disclosures across three years and correctly infers increasing complexity in the global regulatory environment. It connects tax/tariff risks to geopolitical and regulatory developments, demonstrating proper cross-year and cross-context analysis. (4) The semantic meaning matches the original answer: both emphasize increasing specificity and severity in AMD’s risk disclosures over time, indicating heightened exposure and regulatory complexity. The only minor shortcoming is that the LLM does not explicitly mention 'macroeconomic instability' as part of the 2024 context, slightly reducing completeness, but this is compensated by its mention of 'overlapping international legal and political developments.' Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 491,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from $883 million to $538 million in 2023 and then edged up to $562 million in 2024, while total long‑term debt rose from $47.8 billion to a peak of $49.3 billion in 2023 before declining to $45.0 billion in 2024.  Importantly, the floating‑rate unsecured senior debt that was $1.6 billion in 2022 dropped to $349 million in 2023 and was essentially eliminated by 2024, signalling a deliberate shift toward more fixed‑rate or secured funding and a reduced exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the breakdown of short-term borrowings and total debt figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings alone as $883M, $538M, and $562M, implying total debt is much lower than actual when combined with long-term debt figures. This misrepresents the scale and evolution of total debt. Additionally, the LLM states long-term debt was $47.8B in 2022, but the correct total (short + long term) was $43.086B, indicating a significant numerical discrepancy. The floating unsecured senior debt is mostly correct: $1.6B (vs. $1.709B) in 2022, $349M in 2023, and $0 in 2024 — this part is acceptably close. However, the fixed unsecured senior debt and interest rate trends are omitted entirely, which are critical to the full picture. (2) Calculations: The LLM’s implied total debt in 2022 ($47.8B + $0.883B ≈ $48.7B) is already higher than the true total of $43.086B, showing a material error. The 2024 decline to $45.0B long-term is close to the true $45.551B but still inaccurate. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift from floating to fixed-rate debt to reduce interest rate risk, which aligns with the ground truth’s conclusion. This shows sound qualitative reasoning based on partial data. However, it fails to incorporate the rising weighted-average interest rates on fixed debt (from 2.91% to 4.84%) and omits the increase in fixed unsecured senior debt from $21.045B to $26.930B, weakening the completeness of the analysis. (4) Justification: The correctness score is 5 due to partial accuracy — core trend (elimination of floating debt) is correct, but total debt levels and key components are misstated. Quantitative accuracy is low (4) due to incorrect dollar amounts. Qualitative accuracy is moderate (6) because reasoning about risk mitigation is valid. Contextual relevance is high (9) as the answer addresses the main theme of debt structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 573,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in International Aero Engines AG fell from roughly **57 % (2022) to about 51 % (2024)** after accounting for the sub‑collaborator allocations.  This modest decline shows that RTX’s exclusive control over the V2500 engine programme has been diluted, reflecting a more balanced partnership with MTU and JAEC and signalling a strategic shift toward sharing ownership and governance of the V2500 platform rather than retaining a dominant stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported percentages. According to the ground truth, RTX's net program share interest in IAE was 61% in 2022 and decreased to 57% in both 2023 and 2024. However, the LLM incorrectly states it fell from 57% in 2022 to 51% in 2024, reversing the actual trend and introducing a non-existent further decline. This misrepresents the magnitude and direction of the change. (2) The quantitative accuracy is severely compromised: the starting value (57% vs. actual 61%), ending value (51% vs. actual 57%), and implied change (-6 percentage points vs. actual -4) are all incorrect. No valid calculation or trend analysis can be based on these numbers. (3) While the LLM attempts multi-hop reasoning by interpreting the percentage drop as a strategic shift toward shared governance, this interpretation is applied to incorrect data. The general idea of dilution and strategic adjustment is aligned with the ground truth, but the conclusion about 'more balanced partnership with MTU and JAEC' and 'exclusive control' is overstated and not fully supported by the actual modest, stable reduction from 61% to 57%. The ground truth emphasizes reduced financial exposure and risk transfer, not necessarily governance rebalancing. (4) Contextual relevance is fair because the answer addresses both parts of the question—evolution of share and strategic implication—and references the correct entities (RTX, IAE, V2500 program). However, due to the core numerical errors, the overall correctness score is low, as the foundation of the analysis is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 445,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nCascade remains a flagship brand in the Home Care sub‑category of P&G’s Fabric & Home Care segment, and the segment’s financial weight has risen modestly across the three filings—net‑sales share grew from about 35 % in the 2022 10‑K to roughly 36 % in the 2024 10‑K, while its share of net earnings increased from ~31 % to ~34 % over the same period. This upward shift indicates a steady strengthening of Cascade’s role as a core growth and profit driver within P&G’s home‑care portfolio from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cascade as a core brand within P&G’s Fabric & Home Care segment and accurately reflects its positioning in the Home Care sub-category across 2022–2024. All quantitative figures—35% to 36% of net sales and 31% to 34% of net earnings—are factually correct and match the ground truth. Minor formatting variations (~31%, about 35%) are acceptable and do not affect accuracy. (2) Calculations and comparisons are sound: the net sales and earnings shifts are correctly portrayed as modest increases over the period. No mathematical or percentage errors. (3) Multi-hop reasoning is strong: the model synthesizes data across three 10-K filings, correctly tracking Cascade’s consistent branding and the segment’s financial evolution. The conclusion that Cascade has strengthened as a profit driver is a reasonable interpretation of the stable branding amid rising earnings contribution, though the original answer emphasizes 'stable strategic importance' rather than 'strengthening role.' This slight interpretive difference does not constitute an error but reflects a nuanced emphasis. (4) All entities—Cascade, P&G, Fabric & Home Care segment, Home Care sub-category, and correct time frame (2022–2024)—are accurately identified. The answer is fully relevant and responsive to the question. The only reason for not scoring a 10 is the slightly stronger interpretive claim about Cascade's 'strengthening role' versus the ground truth’s emphasis on consistency, which is more cautious. Overall, the answer is factually excellent with high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 439,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosure of the Directors’ Code of Conduct moved from a PDF located under a “/in relations/” folder on the corporate site (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf) to a streamlined URL that retained the same path but used the fully qualified www.bnymellon.com domain consistently, and the reference was integrated into the broader governance sections (Item 10, board‑committee charters, ethics‑hotline and waiver disclosures) so that any future amendments or waivers would be posted alongside the code within the same governance‑framework page.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 URL path and domain (bnymellon.com) and notes the document was in a PDF format under a '/in relations/' path, which aligns with the ground truth. However, it fails to mention the 2023 minor URL adjustment (from '/in relations' to '/inv relations'), omitting a key transitional step. More critically, the LLM incorrectly states that the domain remained 'bnymellon.com' through 2024, when in fact BNY Mellon transitioned to 'bny.com' in 2024—a major branding and structural shift that the model misses entirely. The new 2024 URL path '/investor-relations/' is also not accurately reflected. (2) There are no numerical values to verify, so quantitative accuracy is based on correct dates and document paths; the model gets 2022 right and 2024 partially right but misses 2023 and the domain change, warranting a score of 8. (3) The multi-hop reasoning is partially sound—it recognizes integration into broader governance frameworks (e.g., board committees, ethics hotline), which is contextually plausible, but fails to correctly synthesize the evolution across all three years, especially the domain rebranding and URL restructuring in 2024. The claim of 'streamlined URL' is vague and does not reflect the actual domain shift. (4) Contextual relevance is fair because the answer addresses URL structure, accessibility, and governance integration, but it lacks precision on domain branding evolution and misrepresents the 2024 state, undermining the overall correctness. The conclusion about strategic integration is plausible but not fully supported by the inaccurate technical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 449,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s contracts with add‑in‑board (AIB) makers shifted from a basic price‑protection clause to a fuller inventory‑safeguard package that added formal stock‑rotation and limited‑return rights, giving AIBs greater certainty as the company rolled out newer RDNA 3 and CDNA 3 discrete GPUs.  At the same time, AMD increasingly leaned on its discrete graphics solutions—highlighting performance, ray‑tracing and AI‑acceleration features—as the primary differentiator that AIBs and system‑integrators could use to create higher‑margin, value‑added products in the gaming and data‑center segments.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding AMD's inventory protection policies. The ground truth states that AMD consistently maintained inventory protection policies from 2022 to 2024 without indicating any shift or expansion (e.g., no mention of 'stock-rotation' or 'limited-return rights' being added). This evolution is fabricated and contradicts the stable, consistent policy described in the original answer. Additionally, while the LLM correctly identifies the strategic importance of discrete graphics, it overstates AMD's messaging by claiming an 'increasingly leaned on' strategy and highlighting specific features like ray-tracing and AI-acceleration, which are not mentioned in the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not violated—format and references to years (2022–2024) are consistent and accurate. (3) The multi-hop reasoning is partially sound in that the LLM connects AMD, AIB manufacturers, inventory policies, and discrete graphics across years, but it fails to accurately synthesize the actual consistency of policy and strategy over time. Instead, it invents a narrative of progression and enhancement that is not supported by the ground truth. (4) Contextual relevance is fair because the answer addresses the right entities and general themes (AIBs, inventory protection, discrete GPUs, system integrators), but the qualitative inaccuracies in portraying strategic evolution and policy changes reduce correctness. The core claim of stability in both policy and strategic emphasis is missed, leading to a correctness score of 4 due to major factual deviations despite correct framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 470,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 McDonald’s filings moved from a simple listing of the Egg McMuffin as part of the breakfast menu to a detailed narrative that ties the product’s consistency to the Company’s evolving supply‑chain rigor.  In 2022 the focus was on the uniform breakfast offering and basic quality standards; by 2023 the disclosures added the Food‑Safety Advisory Council, third‑party audits and a digital transformation aimed at continuous quality monitoring, and in 2024 the language emphasized supply‑chain risk management, sustainability and data‑driven measures that protect the muffin’s taste, safety and on‑time availability.  Together, these disclosures show the Egg McMuffin being used as a benchmark for how McDonald’s leverages its global supply‑chain infrastructure to meet customer expectations for quality and consistency across its breakfast menu.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution from 2022 to 2024: starting with basic menu inclusion and quality in 2022, expanding to supply chain collaboration and food safety initiatives in 2023, and emphasizing digital transformation and data-driven quality in 2024. The core factual elements—Egg McMuffin as a consistent menu item, increasing focus on supply chain, digital transformation for quality and safety—are all correct. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default (no errors, all dates 2022–2024 correctly used). (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and connects them to the broader theme of supply chain and quality evolution. One minor omission: the ground truth specifically mentions the 'Global Chief Supply Chain Officer' in 2023, which the LLM answer does not include. Also, the 2024 emphasis on 'data excellence' and 'continuous measures on quality and food safety performance' is paraphrased well but slightly less precise than the original. (4) Despite these small gaps, the LLM captures the semantic essence and progression accurately, using the Egg McMuffin as a lens for broader operational changes. Contextual relevance is perfect—it directly addresses breakfast innovation, supply chain focus, and customer expectations for quality and consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 397,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe repeated appearance of the 4.30 % senior unsecured note maturing in 2034 across Oracle’s 2022, 2023 and 2024 Form 10‑K filings shows that this tranche is a core, long‑term funding pillar that the company continues to reference and roll‑forward.  Its consistent disclosure signals that Oracle is deliberately maintaining a diversified maturity schedule of fixed‑rate debt—using the 2034 note to lock in a predictable cost of capital and to support its growth and acquisition strategy—while reinforcing confidence in its credit profile across reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.30% interest rate and 2034 maturity date of the note are correctly stated, and the years of disclosure (2022, 2023, 2024) match the ground truth. There are no calculation errors, and the financial instrument is correctly identified as a long-term debt component. The answer addresses the core of the question by interpreting the consistent disclosure as evidence of Oracle's strategic use of long-term fixed-rate debt and its role in maintaining a diversified maturity profile. However, the LLM response lacks specific mention of other debt instruments disclosed alongside the 4.30% Note in each year (e.g., the 3.625% Note due 2023 in 2022, or the 2.950% Notes due 2024 in 2023), which were used in the original answer to demonstrate Oracle’s evolving debt portfolio. While the LLM captures the broader implication—diversified maturities and strategic financing—the absence of these multi-hop details from each filing year reduces the completeness of the synthesis. The reasoning is sound and contextually relevant, correctly inferring Oracle’s financing priorities, but the qualitative accuracy is slightly lower due to the omission of specific corroborating instruments that ground the conclusion in multi-year evidence. Semantic equivalence is largely preserved, but the answer is less detailed than the ground truth in demonstrating cross-year debt composition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 396,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net‑derivative assets measured at fair value rose from about $5 million to $58 million and then to $69 million, with the position remaining classified as Level 3 in the fair‑value hierarchy.  The valuation continued to rely on discounted‑cash‑flow models that use unobservable inputs such as swap rates (≈3‑5 % in 2024 versus 1‑2 % in 2022), voluntary prepayment and default rates, and loss‑severity assumptions; the range of these inputs was largely unchanged but the weighted‑average swap rate increased, signalling a modestly greater reliance on internally derived, unobservable market assumptions.  This trend shows that the company’s exposure to unobservable inputs has expanded slightly over the period, as reflected by the larger Level 3 balances and the growing share of derivatives priced on internally derived assumptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. The LLM incorrectly states the 2022 value as $5 million and invents a $69 million figure for 2024, which is not supported by the original answer. Additionally, the LLM claims swap rates were 1–2% in 2022, but the ground truth does not provide swap rate data for 2022—only for 2023 and 2024 (3–5%), making this an unsupported extrapolation. The mention of Level 3 classification and discounted cash flow models is plausible but not confirmed in the ground truth, introducing unverified details. (2) Calculations and comparisons are flawed: the progression from $5M → $58M → $69M misrepresents the actual trend ($19M → $58M → $58M), and the assertion of increasing reliance on unobservable inputs is overstated given that the ground truth notes stability in fair value and consistent use of swap rates from 2023 to 2024. (3) Multi-hop reasoning is partially sound—the LLM attempts to trace changes over time and link valuation methodology to unobservable inputs—but fails due to incorrect base data. It also introduces 'voluntary prepayment' and 'loss-severity assumptions' not mentioned in the original, reducing fidelity. (4) Despite incorrect numbers, the answer addresses the question’s core about evolution in valuation and exposure to unobservable inputs, hence moderate contextual relevance. However, the quantitative errors are severe enough to undermine the conclusion, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 459,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 the Rolls‑Royce‑related obligation stayed tied to the **number of V2500‑powered flight hours**—payments become due for each hour flown (up to the June 2027 horizon) and are **capitalized as collaboration intangible assets**. Those assets are **amortized to cost of sales** over the program’s estimated economic life (generally 9‑30 years, with little or no amortization during the development phase and beginning when the program reaches full‑rate production and aftermarket cycles). Consequently, as the fleet accumulated more flight hours the accrued but unpaid payments grew, causing the **amortization expense to increase in 2023‑2024** while the underlying payment structure and capitalization treatment remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of RTX's financial obligations to Rolls-Royce from 2022 to 2024. (1) It correctly identifies that payments are tied to V2500-powered flight hours and remain in effect through June 2027, matching the ground truth. The capitalization of payments as collaboration intangible assets and their amortization to cost of sales is accurately described for 2023–2024, aligning with the 2023 clarification in the original answer. (2) There are no numeric inaccuracies—while the $14.1 billion total commitment in 2024 is not explicitly mentioned, the LLM does not contradict it and focuses instead on the structural and accounting aspects, which are factually sound. All dates (June 2027 horizon) and timeframes (2022–2024) are correct. (3) The multi-hop reasoning is strong: the model synthesizes the payment trigger (flight hours), accounting treatment (capitalization and amortization), and evolution over time (increasing amortization expense due to higher flight hours). It correctly infers that amortization increases as flight hours accumulate, which is logically consistent with the ground truth, even if not explicitly stated. (4) The only minor omission is the lack of explicit mention of the 2022 classification under 'Other commercial aerospace commitments' and the incremental improvement in transparency over time—details present in the original answer. However, the LLM conveys the essential financial and accounting evolution accurately. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness due to high factual accuracy with a slight deduction for incomplete contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 458,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen first flagged the issue in its 2022 filing, noting that the FDA had been reviewing the Neulasta Onpro kit and that the company had already applied “device and labeling enhancements” to address the complaints it was receiving, while promising continued monitoring and further improvements. In the 2023 and 2024 filings the language became more specific: the company described concrete device‑level upgrades (e.g., redesign of the auto‑injector mechanism and revised labeling/instructions to improve clarity and reliability) and tied those upgrades to broader operational‑resilience measures such as increased reliance on backup generators, diversified third‑party supplier strategies, and contingency plans for power‑grid disruptions. Thus, the disclosures evolved from a generic acknowledgment of complaints to a detailed account of targeted device enhancements and the supporting resilience actions that underpin the Onpro kit’s performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Amgen's disclosures regarding the Neulasta Onpro kit from 2022 to 2024 and correctly identifies the focus on user complaints, device enhancements, and later inclusion of operational resilience. However, there are significant factual inaccuracies in the qualitative details that reduce correctness. The LLM claims that in 2023 and 2024, Amgen described 'concrete device-level upgrades' such as a 'redesign of the auto-injector mechanism' and 'revised labeling/instructions'—but the original answer does not specify these exact changes, only that enhancements were made in response to complaints and monitoring continued. These specifics are unsupported by the ground truth and represent overprecision. Additionally, while the original answer notes that in 2024 Amgen mentioned using backup generators during power outages in Puerto Rico (including a specific island-wide outage on December 31, 2024), the LLM generalizes this to 'increased reliance on backup generators' and 'contingency plans' without confirming the December 31 date and without evidence that supplier diversification was tied directly to Onpro kit disclosures. The LLM also incorrectly implies that operational resilience measures were explicitly linked to device performance in the filings, while the original answer frames infrastructure issues as indirect risks to production. Quantitatively, no numbers are misstated (dates and years are correct), so quantitative accuracy is high. Contextually, the answer is well-aligned with the question’s focus on evolution over time and multi-hop synthesis across years. However, the reasoning overreaches by asserting specific technical upgrades and direct linkages not present in the ground truth, weakening qualitative accuracy. Thus, the answer is partially correct but contains key fabrications in implementation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 507,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s disclosure in Item 14 (and the accompanying proxy) simply states that KPMG LLP is the principal accountant and that its PCAOB firm identification number is 185, without any change in wording or auditor selection. The repeated, identical reference to the same PCAOB number indicates that the bank has consistently retained KPMG as its independent auditor, underscoring a stable audit‑governance framework over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: KPMG LLP is consistently named as the principal accountant in 2022, 2023, and 2024, and the PCAOB firm number 185 is correctly cited across all years. There are no numeric or date inaccuracies. (2) Quantitative accuracy is perfect—PCAOB number 185 is correctly reported with no variation, and the three-year span is accurately referenced. (3) The reasoning is sound: the consistent mention of the same firm and PCAOB number is correctly interpreted as evidence of audit governance continuity. The LLM correctly infers stable auditor retention and implies consistent audit oversight, though it does not explicitly mention 'no auditor rotation' or 'institutional trust' as in the original, slightly reducing qualitative depth. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of disclosure (no change) and implications of PCAOB number continuity. The only minor gap is the lack of explicit mention that the disclosure structure itself remained unchanged, as noted in the ground truth. However, stating 'without any change in wording' effectively captures this. Overall, the answer is semantically equivalent with high fidelity to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 363,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantees stayed at a similar magnitude—about $4.5‑$4.6 billion of committed financing each year from 2022 through 2024—yet the portion that is covered by collaboration partners fell steadily from $142 million in 2022 to $135 million in 2023 and $131 million in 2024.  This decline shows that RTX is increasingly retaining the risk itself rather than passing it to partners, reflecting a more conservative risk‑management stance on these customer‑financing guarantees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These values show a consistent downward trend, which the model accurately identifies. However, the LLM introduces new information—total committed financing of $4.5–4.6 billion annually—that is not present in the original answer and cannot be verified from the provided ground truth. This addition, while potentially true, goes beyond the knowledge graph and may mislead if unverified. (2) All reported numbers and trends are quantitatively accurate. The year-over-year decreases ($7M from 2022–2023, $4M from 2023–2024) are consistent with the data. (3) The multi-hop reasoning is partially sound: the model correctly infers a trend of declining partner-shared risk. However, its conclusion that RTX is 'increasingly retaining the risk itself' and adopting a 'more conservative risk-management stance' contradicts the ground truth interpretation. The original answer suggests RTX is reducing contingent liabilities and shared risk, implying a move to *limit* exposure, not take on more. A conservative stance would typically mean reducing risk, not retaining more of it. Thus, the qualitative reasoning is flawed in interpretation. (4) Despite the reasoning error, the core facts are correct and relevant to the question, earning high marks for quantitative accuracy and contextual relevance. The answer addresses both the evolution of exposure and the implication of the trend, but misinterprets the strategic intent behind the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 441,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024, Procter & Gamble kept the Always brand inside the Baby & Feminine & Family Care segment’s Feminine Care sub‑category, but began positioning it as the flagship menstrual‑care brand—emphasizing its > 25 % global market share and investing in product, packaging and value innovations that reflect the company’s “superiority” strategy.  At the same time, adult‑incontinence products were moved under the separate Always Discreet label, giving Always a more distinct, premium emphasis relative to other feminine‑hygiene offerings such as Tampax and private‑label brands.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. While it correctly identifies Always as part of the Feminine Care segment, it misrepresents the segment name in 2022 as 'Baby & Feminine & Family Care', which only appeared in 2023 and 2024. In 2022, the segment was simply 'Feminine Care'. The claim that Always had a '>25% global market share' is not present in the ground truth and cannot be verified from the provided data. Additionally, the LLM introduces the concept of Always being positioned as the 'flagship menstrual-care brand' and emphasizes a 'superiority strategy', which are interpretive and not supported by the original answer. The statement about adult-incontinence products being moved under Always Discreet is partially correct (Always Discreet is mentioned in 2023), but the implication of a strategic repositioning to create a 'premium emphasis' goes beyond the documented structural changes. (2) Quantitatively, the LLM incorrectly implies that the segment contributed over 25% of net sales (saying Always has >25% market share, not segment sales), while the ground truth states the segment contributed 25% in 2022 and 24% in 2023–2024. These are different metrics (segment net sales % vs. brand market share), so this is a factual misrepresentation. No correct calculation is made regarding segment contribution trends. (3) The multi-hop reasoning is partially sound—LLM recognizes the continuity of Always within the portfolio and the coexistence with Always Discreet and Tampax—but fails to accurately trace the segment name evolution and misattributes strategic emphasis not explicitly stated in the source. It synthesizes across years but adds interpretation not grounded in the data. (4) Despite these issues, the answer is contextually relevant, addressing product categorization and brand emphasis as asked. It captures the general trend of consolidation and distinct branding, though with overreach in interpretation. Scores reflect partial factual correctness but significant quantitative and qualitative deviations from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 563,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nAMD’s filings show that from 2022 through 2024 its international sales have remained around two‑thirds of total revenue, and nearly all product assembly and final testing are outsourced to third‑party facilities in China, Malaysia and—especially—Taiwan.  In each annual filing the company repeatedly flags “difficulties in protecting our intellectual property” as a material risk, and starting in 2023 it explicitly links that risk to rising geopolitical tensions between China and Taiwan and to the firm’s growing reliance on Asian contract manufacturers.  Consequently, as AMD’s global footprint and dependence on Asian third‑party manufacturing expanded, its exposure to intellectual‑property‑protection difficulties grew proportionally, becoming a more pronounced and specific concern in the 2024 disclosure than in the 2022 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the statement that 'international sales have remained around two-thirds of total revenue' correctly reflects the 65% figure cited in the original answer for 2023, and the progression across 2022–2024 is reasonably captured as stable at approximately two-thirds. The mention of third-party manufacturing in China, Malaysia, and Taiwan is factually correct and consistent with the original. (2) All entities—AMD, China, Taiwan, Malaysia, third-party manufacturing, intellectual property risks—are correctly identified and contextually placed. The years 2022, 2023, and 2024 are used appropriately to trace the evolution of risk disclosure. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop information by linking increasing reliance on Asian manufacturing with rising IP protection concerns and geopolitical risks, particularly the China-Taiwan tensions introduced in 2023 and reiterated in 2024. It accurately notes that the risk became more specific and pronounced over time. (4) The only minor shortcoming is that the LLM implies geopolitical tensions were first mentioned in 2023, while the original specifies that the *new layer* of risk due to China-Taiwan tensions was highlighted in 2024. This nuance is slightly understated, but the overall trajectory and qualitative evolution are correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, complete, and contextually relevant, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 455,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued its 2.300% senior unsecured notes maturing in 2028 in March 2021 (as documented in the 2021 Officers’ Certificate), and then re‑opened the same series in 2022 and again in early 2023 with updated certificates that preserved the 2028 maturity while reflecting contemporary pricing.  \nThis recurring, staggered issuance shows that Oracle follows a disciplined, laddered debt strategy—regularly accessing capital markets to fund operations and acquisitions, lock in low‑cost long‑term financing, and manage its maturity profile while maintaining flexibility for future strategic needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the timing and nature of Oracle's issuance of the 2.300% Notes due 2028. The ground truth states that Oracle first referenced these notes in 2022 as part of Exhibit 4.16, which included notes issued in March 2021—but it does not confirm that the 2.300% Notes themselves were issued in March 2021. The LLM incorrectly asserts that the notes were 'first issued' in March 2021 and then 're-opened' in 2022 and 2023, which goes beyond the disclosed information. The original answer makes no mention of re-openings, updated certificates, or pricing adjustments—details that are speculative and unsupported by the ground truth. (2) Quantitatively, the percentage (2.300%) and maturity year (2028) are correct, but the dates of issuance (March 2021, 2022, early 2023) are not verifiable from the ground truth and appear to be inferred or fabricated. There is no mention of dollar amounts or pricing, so those cannot be validated, but the temporal claims are incorrect. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic pattern in Oracle’s debt disclosures across years and identifies a plausible rationale (laddered maturity, low-cost financing). However, it misrepresents the evidence: the ground truth emphasizes consistent *disclosure* of the notes in Exhibits 4.16 (2022) and 4.14 (2023, 2024), not repeated issuances. The conclusion about a 'disciplined, laddered debt strategy' is reasonable but based on flawed premises. (4) Despite the factual errors in timing and issuance details, the answer remains contextually relevant and captures the broader strategic implication—Oracle maintains a stable, diverse maturity profile. This earns high marks for relevance and partial credit for qualitative reasoning, but the quantitative inaccuracies and unsupported claims reduce the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 518,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBetween 2022 and 2024 BA steadily expanded its private‑equity program – the target allocation rose from 4 % (2022) to 7 % (2023) and stayed at 7 % in 2024, while actual holdings grew from 8 % to 9 % of total pension assets.  The program continues to be deployed through limited‑partnership vehicles that invest globally, i.e., in both U.S. and non‑U.S. markets, and its strategic focus remains on leveraged‑buyout, venture‑capital, growth‑capital and special‑situations strategies, but with a larger share of capital directed toward non‑U.S. and emerging‑market opportunities as the allocation increases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—target allocation rising from 4% (2022) to 7% (2023) and staying at 7% in 2024, and actual holdings increasing from 8% to 9% of total pension assets—that are not present in the original answer (ground truth). There is no mention of percentages, allocations, or pension assets in the ground truth, making these figures factually unsupported and likely incorrect. This severely undermines quantitative accuracy. (2) While the LLM correctly identifies the geographic scope (U.S. and non-U.S.) and core strategies (leveraged buyout, venture capital, growth, special situations), it fails to capture the key evolution described in the original answer: the 2023 expansion into global private investments in real assets (energy, farmland, infrastructure) and the 2024 shift toward increased sophistication with derivatives for performance transfer. These are critical strategic developments that are entirely missing from the LLM response. (3) The reasoning is partially sound in noting a broadening focus toward non-U.S. and emerging markets, which aligns thematically with the global orientation mentioned in the original. However, it does not demonstrate accurate multi-hop synthesis across the three years as required—the evolution is oversimplified and mischaracterized by focusing on allocation percentages rather than strategic and vehicle-level changes. (4) Contextual relevance is high because the answer addresses the geographic scope and strategic focus as asked, and the general direction of global expansion is consistent. However, the introduction of unverified quantitative data and omission of key qualitative shifts in investment vehicles and real asset focus significantly reduce factual correctness. The answer is partially aligned but contains critical omissions and fabrications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 503,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept Bemarituzumab in Phase 3 development—having entered a Phase 3 trial in early 2022 and continuing that status in the 2023 and 2024 pipeline tables—while its composition‑of‑matter patents were projected to expire in 2029 in both the United States and Europe (with no listed extensions or term adjustments in the disclosed estimates). Consequently, the molecule remained under clinical investigation without any advancement to regulatory approval, and its patent life was expected to run until 2029 in the key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and years are correct: initiation of Phase 3 in 2022, continued development through 2023–2024, and patent expiration in 2029 in both the U.S. and Europe—matching the original answer exactly. There are no calculation errors, and the patent timeline is correctly reported. (2) The answer is complete, addressing both clinical phase progression (Phase 3 initiation and continuation) and patent expiration timelines across the two major markets. (3) Entity accuracy is strong: Amgen, Bemarituzumab, FGFR2b is not explicitly mentioned but the context of monoclonal antibody development is implied, and the focus on composition-of-matter patents aligns with the polypeptide-related patents in the original. The LLM correctly identifies the regulatory and patent exclusivity context, though it omits the explicit mention of Bemarituzumab’s mechanism (targeting FGFR2b) and indication (gastric/GEJ cancer) detailed in the 2024 update. (4) Reasoning is sound: the synthesis of clinical phase status over time and patent life shows correct multi-hop understanding across years and domains (clinical + IP). The omission of the specific target and indication slightly reduces qualitative accuracy but does not undermine the core facts. (5) The answer is semantically equivalent and contextually relevant, conveying the same key message: stable IP protection supporting ongoing Phase 3 development with 2029 patent expiry. Minor lack of detail in mechanism keeps it from a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 430,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nDawn remained a core brand in P&G’s Fabric & Home Care segment throughout 2022‑2024, appearing in the “Major Brands” list for each year.  The segment’s earnings contribution slipped only modestly—from about 34 % of total earnings in 2022 to roughly 31 % in 2024—yet Dawn’s inclusion among the segment’s flagship brands was unchanged, indicating a stable strategic position despite the slight earnings decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. It states that the Fabric & Home Care segment's earnings contribution decreased from about 34% in 2022 to 31% in 2024, which is the reverse of the ground truth: the segment's contribution increased from 31% in 2022 to 34% in 2024. This inversion of the trend is a major error. Additionally, the LLM implies a 'slight decline' in earnings contribution, when in fact the segment grew in importance. (2) The ground truth confirms that earnings contribution rose from 31% (2022) to 34% (2024), while the LLM incorrectly reverses these numbers. The LLM also fails to mention the stability in net sales percentage (35% in 2022, 36% in 2023 and 2024), which is a key point in assessing Dawn's positioning within a stable revenue segment. (3) While the LLM correctly identifies Dawn as a consistently listed brand in the Fabric & Home Care segment across the years—demonstrating accurate entity and listing recognition—it fails in multi-hop reasoning by misinterpreting the financial trend and thus drawing an incorrect conclusion about Dawn’s strategic positioning context. The reasoning should have emphasized growing earnings importance, not a decline. (4) The correctness score is low due to the critical reversal of earnings data. Quantitative accuracy is severely compromised. Qualitative accuracy is partially preserved due to correct brand listing information. Contextual relevance is moderate because the answer addresses the right segment and brand, but with flawed financial interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 440,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s collateral‑driven funding shifted – it continued to pledge client‑margin securities to meet daily maintenance requirements (the margin‑loan receivables are fully collateralized and the company uses the practical‑expedient to avoid credit‑loss reserves when collateral exceeds the loan amount) – but the amount of those securities used in short‑term borrowing contracts fell in 2024.  The company’s FHLB advances dropped from $26.4 bn (2023) to $16.7 bn (2024) while the pledged collateral that backs those advances stayed roughly stable ($59.8 bn vs $63.1 bn), and its uncommitted secured lines of credit fell from $950 m (2023) to $500 m (2024) after the TDAC facility was terminated.  This pattern shows that Schwab’s liquidity remains tightly tied to the market value of client‑held assets, so a broad decline in securities prices or a surge in margin calls could quickly strain its funding and increase exposure to client‑related credit risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth, significantly affecting correctness. (1) Quantitatively, the LLM cites specific dollar amounts such as FHLB advances dropping from $26.4B (2023) to $16.7B (2024), pledged collateral values of $59.8B vs $63.1B, and uncommitted credit lines falling from $950M to $500M due to TDAC termination. These figures are not found in the original answer and cannot be verified against the provided ground truth, making them unsupported and likely incorrect. (2) The original answer focuses on the use and pledging of client securities in the context of margin lending, ASC 326, and securities lending activities—particularly for options clearing and client collateral—while the LLM shifts focus to short-term borrowing contracts, FHLB advances, and liquidity risk, which are not mentioned in the ground truth. (3) The qualitative reasoning is partially sound in that it recognizes pledging of client securities for margin loans and references a practical expedient related to credit loss, which aligns with ASC 326 in 2023. However, it mischaracterizes the trend as a decline in pledged securities usage, whereas the ground truth indicates continued and even expanded use (e.g., for Options Clearing Corporation and securities lending). (4) The LLM fails to mention key elements such as the role of the Options Clearing Corporation in 2024 or cash collateral provision in securities lending, which are central to the original answer’s conclusion about increasing sophistication in client asset utilization. (5) While the LLM correctly infers that Schwab’s exposure is tied to client-held assets, it frames the risk around liquidity and funding strain from market declines, whereas the original emphasizes strategic risk management and growing client engagement in leveraged activities. This reflects a divergence in interpretation. Overall, the answer is contextually relevant and shows some understanding of collateral practices, but major factual and directional errors—especially the unsupported numbers and incorrect trend narrative—severely undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 577,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nACN’s target allocation shifted from a 2023 mix of essentially all‑debt in the U.S. plan (≈100 % debt, 0 % equity) and a 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other composition for non‑U.S. plans, to a 2025 profile that retains a 100 % debt weighting for the U.S. plan but changes the non‑U.S. mix to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other—i.e., a clear reduction in debt exposure and a corresponding increase in cash, insurance and equity to better match liabilities and manage risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the percentages provided are completely wrong: the ground truth reports a consolidated weighted-average allocation of 55% fixed income / 45% equities in 2023 (as of Aug 31, 2022), shifting to 58/42 in 2024, and 61/39 in 2025. The LLM instead fabricates a split between U.S. and non-U.S. plans with made-up figures (e.g., 100% debt in U.S. plan, 27% equity in non-U.S.), which are not present in the original answer. (2) The LLM claims a reduction in debt exposure, while the ground truth shows a clear increase in fixed income (from 55% to 61%)—the exact opposite trend. (3) The LLM introduces categories like 'cash', 'insurance', and 'other' that are not mentioned in the original answer and are irrelevant to the question. (4) The multi-hop reasoning is flawed: the question asks for evolution based on weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024 (i.e., reflecting fiscal years 2023–2025), but the LLM misrepresents the data structure and invents a breakdown not supported by the ground truth. (5) The answer is not semantically equivalent—it describes a different strategy (increasing equity and insurance) versus the actual de-risking via higher fixed income. Only minimal contextual relevance is retained as it discusses asset allocation over time for ACN pension plans, but all substantive details are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 404,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix shifted modestly: short‑term borrowings fell from **$883 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**, while long‑term debt rose from **$47.8 billion (2022)** to **$49.3 billion (2023)** before slipping to **$45.0 billion (2024)**.  This three‑year trend shows the firm has been **reducing its reliance on short‑term wholesale funding and maintaining a large, predominantly fixed‑rate long‑term debt base**, which limits near‑term interest‑rate exposure—though a portion of its long‑term debt (e.g., floating‑rate senior notes and variable‑rate securitized obligations) still leaves it modestly sensitive to rate changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly reports long-term debt alone as $47.8B in 2022 and $49.3B in 2023, which already exceeds the total debt in the ground truth. Additionally, the LLM reports short-term borrowings as $883M in 2022, but the ground truth does not provide a standalone short-term borrowing figure—only a combined total. The LLM appears to have split the total debt into arbitrary short- and long-term components not supported by the data. (2) The calculation of trends is flawed: the LLM claims long-term debt decreased to $45.0B in 2024, while the ground truth reports $45.551B in total debt (not just long-term), indicating the LLM underestimates total obligations. The interest rate trend is completely omitted—the ground truth shows rising weighted-average interest rates on long-term debt from 1.51% to 3.48%, a critical point about interest rate exposure that the LLM fails to mention. (3) The multi-hop reasoning is weak: while the LLM attempts to infer a strategic shift (reducing short-term/floating rate exposure), it misses the key fact that floating unsecured senior debt dropped from $1,597M in 2023 to $0 in 2024, which is direct evidence of de-risking from variable rates. Instead, the LLM fabricates a narrative based on incorrect component breakdowns. (4) Despite incorrect numbers and reasoning, the LLM addresses the general question about debt structure and interest rate exposure, showing some contextual understanding. However, the core quantitative inaccuracies severely undermine the answer’s reliability, warranting a low correctness score. The qualitative reasoning would score higher if based on accurate data, and relevance is fair as it attempts all question parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 524,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nBoeing’s fleet‑support expenses have remained essentially flat, accounting for only about 1 % of total consolidated costs in 2022, 2023 and 2024.  In contrast, the company has absorbed billions of dollars of abnormal production costs and reach‑forward losses on the 787 (≈ $2 bn cumulative abnormal costs, with $256 m expensed in 2024) and the 777X (a $2.6 bn loss recorded in Q3 2024 plus an additional $0.89 bn loss in Q4 2024), which together far exceed the modest 1 % fleet‑support share and have been the dominant cost‑pressure factor in the recent period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Boeing's (BA) fleet support services costs remained at approximately 1% of total consolidated costs from 2022 to 2024, which matches the ground truth. However, there are significant quantitative inaccuracies in the abnormal production costs and reach-forward losses. The ground truth states that the 787 program had $2.7 billion in cumulative abnormal production costs in 2023, but the LLM claims '≈ $2 bn cumulative' and adds '$256 m expensed in 2024', which is not mentioned in the original answer and misrepresents the timing and magnitude. For the 777X program, the LLM correctly reports a $2.6 billion (close to $2,608 million) loss in Q3 2024 and $0.89 billion (close to $891 million) in Q4 2024, which is quantitatively acceptable with rounding. (2) The calculation of total 777X losses is approximately correct ($2.6B + $0.89B = $3.49B), but the 787 cost figure is understated and incorrectly split into 2024, which distorts the trend. (3) The multi-hop reasoning is sound: the model correctly contrasts stable fleet support costs with escalating program-specific losses and infers that the latter are the primary source of financial pressure. It synthesizes across cost categories and programs appropriately. (4) Despite the numerical discrepancies, the core qualitative insight—that fleet support costs were stable while 787/777X issues drove financial strain—is preserved, and the answer remains contextually relevant and logically structured. The correctness score is reduced due to material inaccuracies in key financial figures, particularly the 787 program costs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 445,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits dropped from **$21 million at the end of 2022** to **$10 million at the end of 2023**, and stayed at roughly **$10 million in 2024**.  This pull‑back shows the company is deliberately shrinking its dedicated money‑market exposure and maintaining only a modest, stable cash buffer, indicating a shift toward relying on its broader cash‑and‑cash‑equivalents position for short‑term liquidity rather than a larger money‑market fund allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, and decreased to $10M in 2024. The LLM incorrectly states $21M in 2022 (should be $12M), $10M in 2023 (should be $21M), and claims it stayed at $10M in 2024 (correct for 2024 but misrepresents the trend). This reverses the actual trend and misrepresents the evolution. (2) The quantitative values are mostly wrong: only the 2024 figure ($10M) is correct. The 2022 and 2023 figures are swapped, leading to an incorrect interpretation of a 'drop' when there was actually an increase followed by a decrease. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year changes. The conclusion about a 'deliberate shrinking' and 'stable cash buffer' contradicts the actual fluctuating pattern, which included a near-doubling in 2023. The ground truth suggests a shifting, possibly tactical strategy, not a consistent reduction. (4) Contextual relevance is moderate because the answer addresses the right topic (short-term liquidity strategy) and uses appropriate financial terminology, but the incorrect data undermines the analysis. Due to major factual and directional errors in the numbers and resulting flawed interpretation, the correctness score is low at 3, quantitative accuracy is 2 (only one of three numbers correct), qualitative accuracy is 3 (partial reasoning but based on wrong data), and contextual relevance is 6 (on-topic but misleading).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 430,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly $4 billion of its Class A shares each year – $4.1 bn in 2022, about $4.5 bn in 2024 (the $4.5 bn figure reported as “share purchases” in the 2024 cash‑return metric) – while the board periodically refreshed the program’s remaining authorization (e.g., the $2.69 bn balance at the end of 2024 was topped up with a $4 bn increase in September 2024).  This pattern shows that the company runs a disciplined, sizable share‑repurchase program that is regularly replenished, underscoring a capital‑return strategy that prioritizes returning cash to shareholders through both dividends and opportunistic buy‑backs while maintaining ample authorization for future purchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates, particularly regarding the remaining authorization and repurchase amounts. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, not a repurchase amount of $4.1 billion as stated. The LLM incorrectly frames the $4.1 billion and $4.5 billion as annual repurchase volumes, but the ground truth does not provide annual repurchase amounts for 2022 or 2024—only the evolution of authorization. The $4.5 billion figure cited for 2024 is mischaracterized; the ground truth states an additional $4,000 million ($4 billion) was authorized in 2024, not that $4.5 billion was spent. Additionally, the LLM claims a $2.69 billion balance at the end of 2024 was topped up, but the ground truth shows $2,694 million was available as of August 31, 2023, before the $4 billion increase in September 2024, resulting in $6,694 million total. The LLM reverses the timeline slightly and misattributes spending. (2) Calculations: The LLM implies a consistent $4 billion annual repurchase, which is unsupported by the provided data. The ground truth focuses on authorization changes, not actual repurchase volumes. The $6,694 million total in 2024 is correct in the ground truth (2,694 + 4,000), but the LLM does not correctly derive or explain this. (3) Multi-hop reasoning: The LLM correctly infers a pattern of regular replenishment and links it to a capital return strategy, which aligns with the ground truth’s conclusion. It identifies the board’s role and strategic intent, showing sound qualitative synthesis. However, it invents specific repurchase volumes not present in the source, undermining factual reliability. (4) The contextual relevance is high—the answer addresses the evolution of repurchase activity and strategy. However, due to significant quantitative errors and unsupported figures, the correctness score is limited to 5. The qualitative reasoning and strategic interpretation are reasonable but built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 564,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (pages 46, 27 and 25 respectively) AbbVie’s charter retains the same “removal of directors only for cause” rule, a three‑class staggered board, a prohibition on stockholder‑called special meetings, and an 80 % super‑majority vote to amend any director‑related provisions. This unchanged suite of entrenchment measures demonstrates a long‑term takeover‑defense strategy that protects the board from easy removal and forces any acquisition to be negotiated through the incumbent directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie maintained the 'removal for cause' provision across 2022, 2023, and 2024, along with other anti-takeover measures including a three-class staggered board, prohibition on stockholder-called special meetings, and supermajority requirements. The specific page numbers cited (2022: p.46, 2023: p.27, 2024: p.25) are consistent with actual filings and add precision not required but valuable. (2) Quantitative accuracy is perfect: the 80% supermajority threshold is correctly stated and matches the ground truth’s reference to 'supermajority requirements for bylaw amendments.' No calculations were needed, but all numbers and thresholds are accurate. (3) Multi-hop reasoning is sound—the model correctly synthesizes governance provisions across three years and infers a stable, long-term takeover defense strategy, which is the core of the question. The conclusion that this entrenches the board and forces acquirers to negotiate through incumbents is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly state that there was *no change* in the language over the years, which the ground truth emphasizes ('despite no explicit changes'), though this is implied by saying the suite is 'unchanged.' This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 413,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the company’s “Form of 4.000% Senior Note due 2047” remains listed in the same exhibit table (Item 15/Exhibit 4.17) and is consistently described as being incorporated by reference to the May 2 2017 8‑K filing, with no new language, amendment or re‑classification introduced in any year. This unchanged, recurring disclosure shows that the 2047 note is treated as a permanent, foundational component of PepsiCo’s long‑term capital structure—providing a stable, low‑cost fixed‑rate source of financing that underpins its long‑dated funding strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 4.000% Senior Note due 2047 across 2022–2024 10-K filings and accurately states that it is incorporated by reference to the May 2, 2017 8-K filing, which matches the ground truth. However, there is a discrepancy in the exhibit number: the LLM claims it is Exhibit 4.17 in Item 15, while the ground truth specifies Exhibit 4.5. This is a factual error affecting entity accuracy. (2) Quantitatively, all dates (May 2, 2017), percentages (4.000%), and years (2047) are correct. No calculations are required, but the consistency of reference over three years is accurately conveyed. (3) The multi-hop reasoning is sound—the model correctly infers that unchanged disclosure implies stability in the capital structure and no amendments, which aligns with the ground truth’s conclusion about the note’s enduring role. (4) Despite the exhibit number mismatch, the core message about the note’s stable, long-term role is preserved, and the answer fully addresses both parts of the question (evolution of disclosure and strategic implication), making it contextually excellent. The exhibit number error prevents a top score but does not invalidate the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 350,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nAcross the 2022‑2024 filings Oracle’s 10‑Ks repeatedly listed the 4.30 % senior unsecured note due 2034 in the long‑term‑debt exhibits (2022 p. 111, 2023 p. 112, 2024 p. 112), confirming that the instrument remained outstanding and was simply re‑disclosed rather than replaced. This consistent, multi‑year appearance signals Oracle’s deliberate laddered‑debt strategy—issuing and maintaining a stable pipeline of fixed‑rate notes with staggered maturities to fund operations and acquisitions while managing interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.30% Note due 2034 was disclosed in each year (2022–2024), remained outstanding, and was consistently reported in the long-term debt sections of Oracle’s 10-Ks. The specific page numbers (2022 p. 111, 2023 p. 112, 2024 p. 112) add precision and are consistent with filing practices. (2) Quantitative elements—interest rate (4.30%), maturity year (2034)—are exact and correctly formatted; no calculations were required, but the temporal consistency across years is accurately represented. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that the note was not reissued but maintained, supporting the conclusion of a stable, laddered debt strategy. This matches the ground truth’s emphasis on sustained capital market engagement and diversified maturities. (4) The LLM enhances the original answer with specific exhibit page references and the term 'laddered-debt strategy,' which is a technically appropriate characterization and reflects deeper financial insight. The only minor gap is that the original answer mentions the note was part of a 'broader set of debt instruments' and 'similar structured notes,' which the LLM implies but does not explicitly state. However, this does not detract from the core accuracy. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the ground truth with slightly more technical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 416,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve was **127 million Class A shares** when the fiscal year ended 2022 (as noted on page 91), remained at that level through fiscal 2023 (no amendment was disclosed), and was **increased to 141 million shares** for fiscal 2024 (page 97).  \n\nThis step‑up in the size of the equity‑award pool signals that Accenture is deliberately expanding its long‑term share‑based compensation capacity, reflecting a strategic commitment to sustain equity incentives as a central tool for attracting, retaining and motivating employees over the coming years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the timeline of share authorization. According to the ground truth, the number of authorized shares was 127 million in fiscal year 2022, increased to 141 million in fiscal year 2023, and remained at 141 million in fiscal year 2024. However, the LLM incorrectly states that the increase to 141 million occurred in fiscal year 2024 and implies the amount remained at 127 million through fiscal year 2023. This misrepresents the timing of the change, which is a significant quantitative and temporal inaccuracy. (2) The numeric values themselves (127 million and 141 million) are correct and match the ground truth, and no calculations were required beyond identification. The dollar amounts and share counts are accurately represented aside from the incorrect year assignment. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the increase indicates a strategic expansion of share-based compensation capacity and links it to talent retention and motivation, which aligns with the original answer’s interpretation. However, because the timeline is wrong, the synthesis across years is flawed. (4) Despite the error in temporal progression, the answer is contextually relevant and addresses both parts of the question: the evolution of authorized shares and the strategic implication. The reasoning is well-articulated and semantically aligned with the ground truth, just based on incorrect timing. Hence, the correctness score is reduced primarily due to the misplacement of the increase in authorized shares, which affects quantitative accuracy more severely, while qualitative and contextual aspects remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 463,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.750 % Senior Note due 2051 was repeatedly restated in PepsiCo’s SEC filings: it first appeared in the 2022 Form 10‑K (page 124) as a note originally issued under the October 21 2021 8‑K (Exhibit 4.3); a new 8‑K filed on Nov 13 2023 (page 128) re‑filed the same term, indicating a supplemental filing/amendment; and the 2024 Form 10‑K (pages 130‑131) placed the note within a Board‑resolution list of long‑term debt authorizations that reference the original 2013 indenture. This multi‑year filing pattern shows PepsiCo’s long‑term debt strategy relies on issuing low‑coupon senior notes with staggered maturities and maintaining a consistent, transparent documentation framework, updating investors periodically while extending and diversifying its capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.750% Senior Note due 2051 was first introduced in a Board resolution in 2022 (Exhibit 4.60), formalized with a dedicated exhibit in 2023 (Exhibit 4.51), and remained consistent in 2024 (Exhibit 4.48). However, the LLM claims the note was first issued under an October 21, 2021 8-K (Exhibit 4.3), which contradicts the ground truth that it was first documented in 2022. This misrepresents the timeline and origin of the note. Additionally, the LLM cites a November 13, 2023 8-K re-filing as a 'supplemental filing/amendment,' but the ground truth indicates the 2023 10-K included a formal 'Form of' the note (Exhibit 4.51), not a re-filing via 8-K. The 2024 reference is also misrepresented: the LLM says it was in a Board-resolution list, but fails to note the exhibit number consistency (4.48), and incorrectly implies it was part of a broader authorization list like in 2022, when in fact the progression was from authorization to formalization. (2) Quantitative accuracy is low: dates (2021 vs 2022), exhibit numbers (4.3 vs 4.60), and filing types (8-K vs 10-K) are incorrect. The 2022 first appearance was in the 10-K, not a 2021 8-K. (3) Multi-hop reasoning is partially sound—the LLM attempts to trace the note across years and interpret strategy—but is based on incorrect source data, undermining the logic. The conclusion about 'staggered maturities' and 'consistent documentation' has some alignment with the ground truth’s 'phased approach' and 'stability,' but lacks the precise evolution (planning → formalization → consistency). (4) Contextual relevance is fair: the answer addresses the question’s intent about evolution and strategy, but factual errors in key entities, dates, and exhibits severely limit correctness. The strategic interpretation is plausible but not well-supported by accurate evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 521,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nFrom 2022 through 2024 American Express remained the world’s fourth‑largest general‑purpose card network, but its competitive standing has been pressured on two fronts: (1) intensifying regulatory scrutiny—particularly U.S. and EU actions targeting interchange‑fee caps, surcharge rules and antitrust investigations involving Visa and Mastercard—has eroded the discount‑revenue advantage it traditionally enjoyed and forced the company to adjust pricing and merchant‑acceptance terms; and (2) the rapid growth of alternative payment mechanisms such as digital wallets, buy‑now‑pay‑later platforms, real‑time settlement systems and other fintech‑driven solutions has expanded the set of rivals that can capture card‑holder spend, prompting Amex to double‑down on premium‑service, data‑analytics and cobrand partnerships to preserve its differentiated value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist—this earns a perfect score. (2) The LLM correctly identifies American Express as the fourth-largest general-purpose card network globally, consistent with the original answer, and accurately frames the 2022–2024 timeframe. (3) The qualitative content captures the two main pressures: regulatory scrutiny (interchange fees, surcharge rules, antitrust) and alternative payment mechanisms (digital wallets, BNPL, fintech). It correctly notes Amex’s strategic response—doubling down on premium services, data analytics, and cobrand partnerships—mirroring the original’s emphasis on premium offerings and cobrand relationships. (4) The LLM adds slightly more detail than the original (e.g., real-time settlement systems, data analytics, U.S. regulatory context), but these are reasonable inferences and do not contradict the ground truth. One minor omission is the lack of explicit mention of the EU-focused regulatory actions leading to market exits and increased compliance costs, which is a specific point in the original. However, the reference to EU actions and their impact on pricing and acceptance is sufficient to maintain high accuracy. Overall, the reasoning is sound, multi-hop synthesis is correct, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 406,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s focus shifted from mainly developing new jet models (e.g., 777X, 737‑MAX variants) toward a deeper, recurring‑revenue emphasis on aircraft upgrades, conversions, and related engineering services.  The company repeatedly highlights that Global Services will “grow market share by leveraging a high level of customer satisfaction and productivity” through upgrades, modifications and life‑cycle support for both commercial and defense platforms.  This signals a strategic pivot to make services—especially upgrades and conversions— a core growth engine, reducing reliance on new‑aircraft sales and creating more stable, high‑margin cash flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing's increasing strategic emphasis on upgrades and conversions as part of its Global Services business from 2022 to 2024, and correctly frames this as a shift toward recurring-revenue, high-margin services. However, it diverges from the ground truth in key qualitative aspects. The original answer notes a progressive evolution in language and focus—starting with 'upgrades and conversions' as one of several services in 2022, a growing emphasis on 'modifications' in 2023, and the integration of 'data analytics and digital services' in 2024 as a strategic enhancement. The LLM answer does not mention this specific evolution, particularly the 2024 integration of digital and data-driven services, which is a critical component of the strategic shift. Instead, it generalizes the trend as a pivot away from new jet development toward services, which, while contextually plausible, is not supported in the original answer—Boeing did not reduce focus on new models like the 777X or 737-MAX; rather, it enhanced services as a parallel growth vector. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the LLM connects upgrades/conversions to services growth and lifecycle support, but fails to synthesize the year-over-year changes in terminology and strategic framing (e.g., digital integration in 2024), missing a key layer of nuance required for full accuracy. (4) The contextual relevance is high because the answer addresses the core theme of strategic shift in services; however, the absence of the digital transformation angle and the incorrect implication of reduced focus on new aircraft development justify a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 501,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo first disclosed the 5.50 % Senior Note due 2035 in its 2018 S‑4 registration (Exhibit 4.6) and then continued to list the same note in the “Exhibits” section of each subsequent Form 10‑K – on pages 124‑129 of the 2022, 2023 and 2024 filings – updating the reference to the current exhibit number (e.g., Exhibit 4.6 in 2022‑2023 and Exhibit 4.6 in the 2024 filing). This recurring, year‑after‑year filing of the identical note shows that PepsiCo’s long‑term debt strategy is built around a disciplined, repeatable issuance framework: it issues multi‑year fixed‑rate senior notes, retains the original indenture and board resolutions in its periodic reports, and refreshes the exhibit citation each year to keep the documentation current and transparent for investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 5.50% Senior Note due 2035 was first disclosed in a 2018 S-4 registration (Exhibit 4.6), but the ground truth states it was referenced in an 8-K filing from November 8, 2018, as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31). The exhibit numbers are also incorrect: in 2022 it was Exhibit 4.31, in 2023 Exhibit 4.25, and in 2024 Exhibit 4.23 — not consistently Exhibit 4.6 as claimed. The LLM incorrectly asserts that the same exhibit number (4.6) was used across all years, which contradicts the documented evolution. (2) Quantitative accuracy is low: the dates (2018), percentages (5.50%), and years (2022–2024) are correct, but exhibit numbers and filing types (S-4 vs 8-K) are wrong. The claim about page numbers (124–129) is unsupported by the ground truth and appears fabricated. (3) The multi-hop reasoning is partially sound — the model correctly infers that repeated inclusion suggests a stable long-term debt strategy — but it bases this on incorrect documentation history. The conclusion about a 'disciplined, repeatable issuance framework' is plausible but overstated given no new issuance occurred; the ground truth emphasizes continued acknowledgment without modification, not active rollover or refinancing. (4) Contextual relevance is fair: the answer addresses the evolution and strategy question, but with incorrect details. While the general theme of transparency and stability is aligned, the factual foundation is flawed, reducing overall correctness to partially accurate with major errors in key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 446,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nBNY Mellon’s 2022‑2024 10‑K filings repeatedly stress that U.S. banking laws and capital‑adequacy standards—especially the requirement to remain “well‑capitalized” and “well‑managed”—directly limit the firm’s capital‑planning and shareholder‑return decisions, with the Board’s discretion circumscribed by regulatory capital ratios, liquidity buffers and credit‑rating considerations.  Over the three years the discussion evolved from a general reference to regulatory limits in 2022 to more specific emphasis on capital‑buffer levels, stress‑test results and newer regulatory frameworks (e.g., Title I resolution and ESG‑related expectations) in 2023‑2024, underscoring that any dividend or repurchase program is tightly bound by evolving supervisory constraints.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core regulatory constraints BNY Mellon faces regarding capital planning and shareholder returns from 2022 to 2024, and correctly identifies the evolving emphasis in disclosures. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either answer, so no discrepancies exist—this earns a 10 for quantitative accuracy. The LLM accurately references U.S. banking laws, capital-adequacy standards, and the 'well-capitalized' requirement across the period, aligning with the original answer. However, the LLM introduces elements not present in the ground truth: specifically, mentions of 'Title I resolution', 'ESG-related expectations', and 'credit-rating considerations' are not cited in the original knowledge graph answer and represent speculative or extraneous additions. Additionally, while the original answer highlights Delaware law and preferred stock obligations as specific constraints in 2023 and 2024, the LLM omits these key legal and structural details, which are important for completeness and entity accuracy. The reasoning is generally sound and reflects a multi-year synthesis, but the emphasis on stress tests and newer regulatory frameworks overstates the evolution described in the ground truth, which characterizes the language as 'largely unchanged'. Thus, while the overall trajectory and regulatory theme are correctly captured, the LLM adds unsupported specifics and misses key constraints, warranting a 7 for qualitative accuracy. Contextual relevance remains high as the response directly addresses the evolution of regulatory constraints on capital returns. Correctness is therefore scored a 7—core facts are right, but with notable omissions and minor overreach in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 487,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nThe 2.300 % Notes due 2028 were originally issued in March 2021 (Officers’ Certificate dated 3/24/21) as an unsecured, fixed‑rate tranche with a 2.30 % coupon and a 2028 maturity.  Subsequent filings through 2023‑2024 do not show any new 2.30 % 2028‑maturity issuances; instead Oracle added higher‑coupon unsecured notes (e.g., 4.5 % Notes due 2028 in a Feb 2023 8‑K) and expanded its revolving‑credit facilities, indicating that as market rates rose the company chose to raise fresh capital at higher yields rather than refinance the existing low‑coupon 2028 notes, preserving the original tranche while tapping new debt at prevailing rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.300% Notes due 2028 were issued under an Officers' Certificate dated March 24, 2021 (correct date and document type), and no new issuances of this specific tranche occurred in 2022–2024. The mention of the 4.500% Notes due 2028 issued in February 2023 via an 8-K filing matches the ground truth’s indication of new higher-yielding instruments. (2) Quantitative elements—interest rates (2.30%, 4.50%), maturity year (2028), and issuance date—are all factually correct and consistent with the original answer. Format variations (e.g., '2.30%' vs '2.300%') are acceptable and semantically equivalent. (3) The reasoning is sound: the model correctly infers that Oracle preserved its low-coupon debt rather than refinancing it, choosing instead to issue new debt at higher yields as rates rose—this reflects accurate multi-hop synthesis across 2022–2024 filings and understanding of fixed-income strategy. (4) The only minor omission is that the LLM does not explicitly reference the broader multi-tiered offering context (e.g., the 2.875% and 3.950% tranches), which slightly reduces completeness in characterizing the initial 2021–2022 issuance strategy. However, this does not undermine the core conclusion about Oracle’s financing approach. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 402,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings IBM repeatedly listed “client relationships and trust” as a core competitive method, but the emphasis deepened each year. In 2022 it was noted simply as a differentiator; by 2023 the risk‑factor discussion linked trust to IBM’s reputation as a hybrid‑cloud and AI leader and warned that any damage to that reputation could impair its ability to win and retain customers. In 2024 the competition narrative explicitly tied trust and security to its open hybrid‑cloud platform and AI solutions, describing them as essential to the company’s differentiated value proposition.  \n\nThis progression shows IBM is positioning itself as a trusted, open partner that can safely accelerate enterprise‑level hybrid‑cloud and AI transformations—using client‑centric trust as a strategic moat against pure hyperscale competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM's increasing emphasis on client relationships and trust from 2022 to 2024 is accurately portrayed. In 2022, trust was mentioned as a differentiator; in 2023, it was tied to reputation in hybrid cloud and AI; in 2024, it was linked to security and open hybrid-cloud platforms, including strategic partnerships (Palo Alto Networks is correctly implied as part of broader partnership expansion). (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning across years and strategic themes is sound—LLM correctly synthesizes how IBM’s positioning evolved and why, showing trust as a strategic moat. The only minor omission is that the original answer explicitly mentions 'deep incumbency with enterprises' and 'innovation' in 2023, and the 2024 addition of Palo Alto Networks as a specific example, which the LLM implies but does not state directly. This slight lack of specificity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution and strategic implications in the hybrid cloud and AI market. Overall, the LLM captures the core progression and strategic intent with strong fidelity to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 369,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe yield on American Express’s foreign government bonds rose from roughly 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024, as shown in the “Distribution of Assets, Liabilities, and Shareholders’ Equity; Interest Rates and Interest Differential” tables for each year. This upward shift reflects a deliberate extension of duration into longer‑dated, higher‑yielding sovereign securities, indicating that the firm is pursuing higher income in a rising‑rate environment while increasing its exposure to interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no mention of a 3.5% yield in 2022—instead, the 2022 data focuses on the dollar amount ($630M) and maturity distribution, not yield. The first reported yield is in 2023 at 6.45%, not 5.9% as stated by the LLM. The LLM incorrectly reports a 6.1% yield in 2024, while the actual 2024 yield is 5.85%. Additionally, the LLM claims yields rose over the three years, when in fact the yield decreased from 6.45% in 2023 to 5.85% in 2024. (2) The dollar amounts and maturity distributions are entirely omitted in the LLM response—specifically, the $628M maturing within one year in 2022 and the shift in 2024 to include 2.03% maturing between 1–5 years. These are critical quantitative details. The LLM also fabricates a trend not present in the data. (3) The multi-hop reasoning is flawed. The ground truth indicates a shift from ultra-short-duration, high-yield holdings in 2023 to a more diversified maturity profile in 2024, likely to manage interest rate risk. The LLM incorrectly infers a deliberate extension into longer-dated securities for higher income, when in fact the yield decreased and the strategy appears more risk-managed. The LLM misinterprets the direction of both yield movement and strategic intent. (4) While the answer addresses the general topic of yield evolution and interest rate risk, it does so with incorrect data and reasoning. The contextual relevance is moderate because it attempts to answer the right question, but the factual foundation is unsound, leading to an incorrect conclusion about strategy and risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 453,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher has steadily increased the amount of U.S. government grant assistance that offsets capital spending on diagnostics‑testing infrastructure—$87 million in 2022, $136 million in 2023 and $198 million in 2024—while simultaneously expanding its manufacturing capacity and acquiring businesses that bolster the diagnostics portfolio (e.g., the Aldevron and Abcam acquisitions).  This upward trajectory of publicly‑funded CAPEX shows that diagnostics testing has become a strategic priority within Danaher’s broader health‑care portfolio, receiving sustained government support to accelerate production capacity and innovation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the dollar amounts for each year—$87 million in 2022, $136 million in 2023, and $198 million in 2024—are accurately reported with no discrepancies, allowing for standard formatting variations. (2) The answer is complete, addressing both the evolution of grant funding over time and the strategic implications for Danaher’s healthcare portfolio. (3) Entity accuracy is correct: Danaher Corporation (DHR) is properly identified, the time frame (2022–2024) is accurate, and the financial metric (government grants offsetting capital expenditures in diagnostics) is correctly interpreted. (4) The reasoning is sound and reflects multi-hop synthesis: the increasing grant amounts are correctly linked to strategic prioritization, expanded manufacturing capacity, and supporting business acquisitions (Aldevron, Abcam), which aligns with and enriches the ground truth without introducing inaccuracies. The conclusion about diagnostics testing becoming a strategic priority due to sustained government support and capacity expansion is semantically equivalent and contextually appropriate. All components of the question are addressed with factual precision and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 355,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nThe company’s filing consistently states that KPMG LLP is to be ratified as the principal auditor and that its PCAOB firm identification number is **185**. This reference appears in the Proxy under **“Item 3 – Ratification of KPMG LLP”** and is incorporated by reference in the **“Item 14 – Principal Accountant Fees and Services”** section of each 10‑K. The only evolution across 2022, 2023 and 2024 is a modest wording change—by 2023‑24 the number is introduced as the “Public Company Accounting Oversight Board (‘PCAOB’) firm identification number”—but the ID 185 and its placement within the Proxy‑referenced section remain the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: KPMG LLP was consistently ratified as principal accountant across 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in all years; and the disclosure appears under 'Item 3 – Ratification of KPMG LLP' within Item 14 of the Proxy, which is accurately described. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and correctly tied to Proxy section structure. The only minor discrepancy is the LLM's claim that the wording evolved by 2023–2024 to include the full term 'Public Company Accounting Oversight Board (‘PCAOB’) firm identification number', which is a detail not confirmed in the ground truth. While plausible and not factually wrong, this nuance about wording evolution is not mentioned in the original answer, which states there was *no change* in format. This introduces a slight overstatement of evolution, slightly reducing qualitative accuracy. (4) Despite this, the answer remains contextually precise, fully addressing the question about disclosure evolution, placement, and identification number. The core conclusion—that the number and placement remained consistent—is correct, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 394,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers (e.g., OptBlue and GNS partners) while reshaping the economics of those relationships.  The company now records only the **network‑rate fee paid to the acquirer as discount revenue**, treating the remainder of the merchant‑discount as contra‑revenue or expense, and it settles directly with merchants on behalf of issuing partners.  This contractual shift supports the firm’s strategic goal of **expanding global merchant coverage—particularly in priority cities, new industry verticals and digitally‑enabled channels—by offering acquirers clear value propositions, scaling marketing and digital integration, and driving higher Card‑Member spend and loyalty**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of American Express's evolving relationship with third-party merchant acquirers from 2022 to 2024, particularly around revenue recognition and strategic goals, but lacks explicit year-by-year evolution detailed in the ground truth. (1) Correct aspects: The answer accurately describes the revenue recognition shift—specifically that only the network-rate fee is recorded as discount revenue, with the rest treated as contra-revenue or expense—which aligns with the 2023 'Processed Revenue' model evolution. It correctly references OptBlue and GNS as key programs and notes the strategic expansion into new industries and international markets, consistent with 2024 goals. (2) Quantitative accuracy: There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist; dates (2022–2024) are correctly framed. (3) Multi-hop reasoning: The LLM synthesizes revenue structure and strategic intent but does not clearly delineate the progression from transactional (2022) to structured (2023) to strategic expansion (2024). The absence of explicit mention of 'Processed Revenue' model, royalties, or network partnership agreements in the 2023 phase weakens the qualitative accuracy. (4) Contextual relevance is high—the answer stays focused on revenue recognition, contractual dynamics, and strategic goals. However, the lack of structured temporal evolution and missing terminology from the ground truth (e.g., 'royalties', 'strategic partnership model') prevents a higher score. Overall, core facts are correct, but minor omissions in contextual detail and progression reduce completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 456,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm kept its 2025 diversity targets—​a 15 % increase in women and in under‑represented‑minority (URM) leaders and a 20 % rise in overall URM representation—and began embedding those goals in executive pay.  Starting with FY 2022 the HR & Compensation Committee introduced a non‑financial performance modifier that can adjust the annual bonus by a multiplier of 0.9 to 1.1 based on the degree to which human‑capital advancements (including the diversity objectives) are achieved; this same 0.9‑1.1 modifier was applied to FY 2023 and FY 2024 bonuses, showing a sustained linkage of diversity‑target progress to executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase in women and underrepresented minorities (URM) in leadership, the 20% overall URM representation goal, the 0.9 to 1.1 non-financial performance modifier for executive bonuses, and its consistent application from FY2022 through FY2024. These numbers match the ground truth exactly, and the timeline of fiscal years is correctly represented. The answer correctly identifies the multi-year continuity in the compensation structure, showing sound reasoning across the three fiscal years. The only minor shortcoming is that the LLM omits some qualitative expansions noted in the original answer for FY2023 and FY2024—specifically, Qualcomm’s recognition in multiple regions, participation in the Reboot Representation Tech Coalition, and the broadening of wellness and development programs. While the core linkage to executive compensation is accurately and completely described, this omission slightly reduces completeness in conveying the full evolution of human capital integration into corporate strategy. However, the main thrust of the question—how diversity targets were linked to executive compensation over time—is addressed with strong factual and logical fidelity. Thus, the answer is semantically equivalent on the central compensation linkage mechanism, earning high marks for quantitative accuracy, contextual relevance, and overall correctness, with a small deduction in qualitative accuracy for missing contextual depth in program expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 425,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD‑branded dealer network was trimmed slightly and then modestly rebuilt: the number of dealers located outside the United States fell from **116 (2022)** to **111 (2023)** before rising to **113 (2024)**, and the count of countries served moved from **193 (2022)** to **187 (2023)** and back to **191 (2024)**.  This pattern shows Caterpillar is not aggressively expanding its global footprint but is instead refining and consolidating its dealer coverage—contracting in 2023 to focus on core markets and then modestly expanding again in 2024—signaling a strategic emphasis on profitability and market‑share protection rather than broad geographic growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric data. According to the ground truth, Caterpillar's EMD-branded product distribution declined from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. However, the LLM incorrectly states that the number of countries served dropped from 193 (2022) to 187 (2023) and then increased to 191 (2024), reversing the trend in the final year. This misrepresents the direction of change in 2024, which is a critical error. Additionally, the LLM introduces dealer counts (116, 111, 113) that are not present in the original answer and are unverified, potentially confusing dealer count with country count. (2) The quantitative inaccuracies are severe: the correct sequence is 193 → 191 → 187, but the LLM reports 193 → 187 → 191, which implies a rebound in 2024 when in fact the contraction continued. This undermines the validity of any conclusion drawn. (3) The reasoning is partially sound in interpreting the trend as strategic refinement rather than expansion, which aligns with the original answer’s suggestion of consolidation. However, because the underlying data is incorrect, the multi-hop synthesis fails—drawing conclusions from reversed data leads to potentially invalid strategic interpretations. (4) Contextually, the answer addresses the question about geographic reach and strategic positioning appropriately, and the qualitative interpretation is plausible and relevant. However, due to major factual and directional errors in the data, the correctness score is low despite reasonable framing. Quantitative accuracy is penalized heavily due to incorrect country counts and fabricated dealer numbers. Qualitative accuracy is moderate because the logic follows from the (incorrect) data, and contextual relevance remains high as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 508,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated listing of **Palmolive** among Colgate‑Palmolive’s “principal global trademarks” from 2022 through 2024 signals that the brand is treated as a core pillar of the Oral, Personal and Home Care (OPHC) segment.  By consistently featuring Palmolive alongside other flagship names (e.g., Colgate, Darlie, elmex), the company underscores its strategic reliance on the brand to drive a substantial share of OPHC sales and to sustain growth across toothpaste, hand‑soap, skin‑care and other personal‑care categories.  This emphasis reflects Palmolive’s outsized role in the segment’s revenue mix and its importance to the firm’s long‑term brand‑portfolio strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies the consistent inclusion of Palmolive in Colgate's principal global trademarks from 2022 to 2024 and interprets this as evidence of its strategic importance in the Oral, Personal and Home Care (OPHC) segment. All dates and brand names (Colgate, Darlie, elmex) are accurate, and there are no numerical inaccuracies—this satisfies quantitative accuracy. The answer correctly synthesizes the implication of multi-year consistency in trademark disclosures, demonstrating sound reasoning. However, it slightly overreaches by stating Palmolive drives a 'substantial share of OPHC sales' and explicitly linking it to toothpaste and skin-care categories, which are not emphasized in the original answer. The ground truth focuses on liquid hand soap, dishwashing detergents, and household cleaners—categories more traditionally associated with Palmolive—whereas the LLM extends its role into oral care (e.g., toothpaste), which is not supported by the evidence provided. This introduces a minor factual overstatement, reducing qualitative accuracy slightly. Despite this, the overall reasoning and relevance to the question are strong, and the answer correctly captures the strategic significance of Palmolive’s sustained presence in the trademark list.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 377,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved from a broad “IoT‑growth‑will‑exceed‑27 billion devices” narrative to a more focused edge‑networking strategy that is embedded in its 5G Advanced roadmap (Releases 16‑18) and in the rollout of Wi‑Fi 7.  In its segment reporting the company now groups IoT revenue into three sub‑verticals—consumer, edge‑networking (mobile‑broadband/Wi‑Fi access points and related equipment) and industrial—so that edge‑networking products are treated as a distinct category within the QCT equipment stream, with sales recognized at a point in time and related licensing royalties spread over time.  This product‑categorization shift is reflected in the financials: IoT revenue fell modestly (≈ $7.35 B → $5.94 B → $5.42 B) but the company continues to highlight “connected intelligent edge” and “edge‑networking” as key growth drivers, and its remaining performance‑obligation disclosures show a pipeline of edge‑networking contracts that will be recognized as unearned revenue until fulfilled.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies Edge Networking as a strategic focus within IoT and notes its inclusion in product categorization, it introduces unsupported details not present in the ground truth. For example, the claim that IoT revenue declined from $7.35B to $5.94B to $5.42B across 2022–2024 is not corroborated by the original answer and introduces specific figures absent from the source. The ground truth does not mention any revenue decline or exact IoT revenue figures, so these numbers are likely fabricated or misattributed. Additionally, the reference to '5G Advanced roadmap (Releases 16-18)' and 'Wi-Fi 7 rollout' as central to Edge Networking strategy is not mentioned in the original answer, which only references 5G and Wi-Fi 6/6E in 2022. (2) Quantitative accuracy is low because the dollar amounts and implied trends (revenue decline) are not supported by the ground truth. There are no calculations in the original to verify, but the introduction of precise financials without basis undermines factual reliability. (3) The multi-hop reasoning is partially sound: the model correctly infers that Edge Networking became a distinct product category and is part of QCT, aligning with the original's mention of revenue categorization in 2023 and 2024. It also correctly notes point-in-time revenue recognition and deferred royalty recognition, which aligns with the original’s reference to incentive-related revenue from prior periods. However, the synthesis includes speculative elements (e.g., performance obligation disclosures, unearned revenue pipeline) not present in the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of Edge Networking in terms of strategy, product categorization, and revenue recognition. The qualitative accuracy is moderate due to correct structural insights but undermined by unsupported specifics. The correctness score is 5 due to significant factual overreach despite some accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 556,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 filings consistently identify currency‑exchange risk as a material exposure arising from its worldwide operations and describe the use of forward and option contracts to hedge adverse movements. The company’s disclosure language—highlighting that hedges protect against unfavorable swings but may forfeit gains from favorable ones and that its outlooks do not assume any specific currency behavior—remains essentially unchanged across the three years, indicating a steady, rather than transformed, hedging approach. As a result, while the exposure persists, the manner of managing it through hedging instruments has not undergone a substantive evolution, leaving earnings volatility sensitive to unexpected currency fluctuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and the general use of hedging instruments (forwards and options) to manage currency risk, and correctly notes that hedges limit upside from favorable movements. There are no numeric inaccuracies, as the response does not include specific figures (e.g., amounts hedged or volatility impacts), so quantitative accuracy is not compromised. However, the LLM misses a key qualitative evolution highlighted in the original answer: the progressive expansion of Caterpillar’s risk discussion from 2022 to 2024 to include growing concerns about exchange controls and currency devaluations, especially in emerging markets. While the LLM characterizes the approach as 'steady' and 'not undergone a substantive evolution,' the ground truth emphasizes an increasingly cautious tone and broadening risk awareness—indicating evolution in risk discourse and strategic context, even if hedging tools remained consistent. This omission represents a failure in multi-hop reasoning to synthesize changes in narrative emphasis across years, which is central to the question about 'evolution' in risk management. Thus, while contextually relevant and factually sound on surface-level disclosures, the LLM underrepresents the nuanced shift in Caterpillar’s risk posture, leading to a partially correct assessment of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 385,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of U.S. Treasury and agency securities in Colgate‑Palmolive’s pension‑plan fixed‑income portfolio fell from roughly 35‑40 % (the level implied by the 40 % figure disclosed for 2021) to about 30 % by the end of 2023 and it remained near 30 % in 2024.  This deliberate reduction shows that the company is actively trimming its exposure to interest‑rate‑sensitive government bonds and reallocating toward a broader mix of corporate and other fixed‑income assets, reflecting a proactive approach to managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Colgate-Palmolive's allocation was 50% as of December 31, 2020 (reported in 2022 filing), dropped to 40% as of December 31, 2021, then to 30% as of December 31, 2022, and remained at 30% through 2024. The LLM incorrectly states the starting point in 2022 as '35-40%', implying uncertainty and misrepresenting the disclosed 40% figure for 2021 (which corresponds to the 2022 filing). It also fails to mention the 50% baseline from 2020, which is critical context for the trend. The LLM correctly identifies the 30% level in 2023 and 2024. (2) The calculation of the trend is partially correct—there is a decline to 30% and stabilization—but the magnitude and timing are misrepresented. The reduction occurred primarily between 2020 and 2022, not 'from 2022 through 2024' as implied. The LLM misattributes the timeline, suggesting the drop happened during the period in question, when most of the decline occurred before 2022. (3) The reasoning about interest rate risk management is plausible and aligns with the ground truth’s interpretation—reallocating away from government securities toward corporate bonds as a response to rising rates. The LLM correctly infers a strategic shift and proactive risk management, which shows sound qualitative reasoning. However, it omits the detail about Level 2 classification and liquidity considerations, which adds nuance to the risk management approach. (4) The contextual relevance is high—the answer addresses both parts of the question: the evolution of allocation and its implication for interest rate risk. Despite incorrect starting values and timeline framing, the core direction of change (decrease and stabilization) and strategic interpretation are correct, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 504,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nIn 2022 Pfizer granted Breakthrough Performance Awards (BPAs) to select non‑executive employees, valuing each award at grant‑date with the intrinsic‑value method (based on the closing stock price) and then amortizing the expense straight‑line over the probable vesting period, adjusting each reporting period for changes in the share price, the number of shares expected to be earned and management’s assessment of performance‑achievement; this treatment and the detailed tabular disclosure were presented in Note 13 of the 2022 10‑K. Beginning in 2023 the company ceased granting BPAs—no BPAs were issued in 2023 or 2024 and none remained outstanding as of December 31, 2023 and 2024—yet the same intrinsic‑value valuation approach and straight‑line amortization, together with the identical disclosure format in the share‑based‑payment footnote, were retained, ensuring continuity and transparency of the prior methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, BPAs were actively granted in 2022 (1,165 thousand shares awarded), paused in 2023 (no grants, none outstanding), and then reappeared in 2024 with enhanced valuation and disclosure practices. However, the LLM incorrectly states that no BPAs were granted in 2023 or 2024 and none remained outstanding as of December 31, 2023 and 2024—this contradicts the ground truth, which confirms BPAs reappeared in 2024 disclosures with new valuation methodologies. Additionally, the LLM fails to mention the quantitative details from 2022 (1,165k shares granted, $38.73 intrinsic value, 859k nonvested shares), which are central to the original answer. (2) Quantitative accuracy is very low: none of the key numbers (share counts, intrinsic value) are mentioned, and the claim that no BPAs were outstanding in 2023 and 2024 is factually incorrect per the ground truth, which only confirms zero outstanding as of 2023, not 2024. The LLM also fabricates continuity in disclosure format and methodology into 2024 without evidence. (3) Multi-hop reasoning is flawed: the model fails to recognize the three-phase evolution—active use (2022), suspension (2023), and revival with improved transparency (2024)—and instead asserts ongoing methodological continuity, missing the strategic shift entirely. (4) Contextual relevance is moderate because the answer discusses valuation methods and disclosure, which are relevant topics, but the incorrect timeline and missing data severely undermine factual correctness. The answer appears plausible but is largely inconsistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 458,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab added a suite of interactive RIA tools that moved the platform beyond basic custodial access to a fully integrated, cloud‑based advisory hub.  The launch of the thinkpipes trading platform and the iRebal customizable rebalancing engine (2022‑2023) gave RIAs real‑time charting and automated portfolio rebalancing, while the free Schwab Advisor Portfolio Connect (introduced in 2023 and expanded in 2024) provides a streamlined, intuitive portfolio‑management interface.  Together with deeper integrations to third‑party CRM, portfolio‑management and order‑management systems, these capabilities let RIAs manage client portfolios more efficiently and dynamically than in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fabricates key details not present in the ground truth. (1) It incorrectly states that Schwab launched 'thinkpipes trading platform' and 'iRebal customizable rebalancing engine' between 2022–2023—these tools are not mentioned in the original answer and appear to be fabricated. (2) It claims Schwab Advisor Portfolio Connect was 'introduced in 2023,' but the ground truth states it was already available in 2022 as a key offering. (3) The timeline and evolution are misrepresented: the original answer describes a gradual emphasis on usability and platform integration, not the introduction of major new tools. (4) While the LLM correctly notes deeper third-party integrations (CRM, portfolio management, order management), this is oversimplified and presented alongside false innovations. (5) The qualitative reasoning fails on multi-hop synthesis—the model invents features and misdates offerings rather than accurately tracing the evolution across years. (6) Contextually, the answer addresses the general theme of RIA tool evolution and third-party integrations, so it remains somewhat relevant, but the core factual content is largely incorrect. Quantitative accuracy is very low due to wrong dates and invented product launches. Overall, the answer misrepresents the nature and timeline of Schwab's tool development, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 390,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nAcross 2022‑2024 the embedded‑processing business showed only modest top‑line growth in 2022‑23 (revenues up 3 % YoY) but saw its operating‑profit margin collapse from roughly 38 % to under 30 % as higher manufacturing costs and lower factory loadings squeezed profitability; in 2024 revenue fell 25 % and operating profit dropped 65 %, pushing the margin down to about 14 %.  Yet management repeatedly groups embedded processing with analog products as one of TI’s “four sustainable competitive advantages,” emphasizing its strategic role in industrial and automotive markets and its contribution to long‑term free‑cash‑flow growth.  This consistent framing signals that TI views embedded processing as a core, cash‑generating pillar of its portfolio, even while short‑term margin pressures highlight the challenges of scaling that segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—such as 3% YoY revenue growth, margin decline from 38% to under 30%, and a 25% revenue drop and 65% profit drop in 2024—that are not present in the original answer and cannot be verified against the ground truth. These numbers contradict the absence of any quantitative performance data in the original, which focuses solely on strategic framing, not financial performance. As such, the inclusion of detailed but unverified metrics severely undermines factual accuracy. (2) There are no calculations in the original answer to validate, but the LLM fabricates precise percentages and margins without support, failing the quantitative accuracy test. Even if the trends were directionally accurate (which cannot be confirmed), the specificity implies precision not justified by the source. (3) The LLM correctly identifies the multi-hop element that TI consistently groups embedded processing with analog products as part of its 'four sustainable competitive advantages' across the years, which aligns with the original answer’s emphasis on strategic consistency. It also correctly infers that this reflects long-term positioning and cash flow objectives. However, it incorrectly shifts focus to short-term financial struggles not mentioned in the ground truth, introducing a narrative of margin pressure and declining performance absent from the original. (4) While the qualitative reasoning captures the strategic framing correctly and shows understanding of TI's long-term intent, the invention of financial data significantly reduces correctness. The contextual relevance is fair because the answer addresses the evolution and strategic significance, but the added performance details misrepresent the evidence. Thus, the correctness score is low due to major factual inaccuracies, despite some correct strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 513,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support services continued to be charged at roughly 1 % of total costs, but the 787 program generated large “abnormal” production expenses as the company ran the jet at well‑below normal rates (often under 5 aircraft per month) and performed extensive re‑work on inventory‑held airplanes; cumulative abnormal costs rose to about $2 billion by the end of 2023 and $256 million were expensed in 2024 alone.  These abnormal costs, together with the ongoing pause and slow ramp‑up of 787 deliveries, drove higher fleet‑support outlays and delayed the program’s return to regular delivery schedules.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trend of abnormal costs and delivery delays in the 787 program and correctly notes that fleet support services accounted for about 1% of total costs. However, there are key quantitative inaccuracies: the cumulative abnormal costs through 2023 were $2.7 billion (not $2 billion as stated), and while the $256 million expensed in 2024 is correct, the LLM omits that this was tied to rework on 25 inventoried aircraft, most of which were expected to be delivered in 2025. The statement that deliveries were on a 'pause' is misleading—while delayed, deliveries were not fully paused, and the ramp-up was gradual rather than halted. (2) The $2 billion figure for 2023 is incorrect (should be $2.7B), which is a significant deviation. The 2024 $256M expense is accurate. The 1% cost profile is correctly reported. (3) The reasoning correctly links abnormal costs, low production rates, rework, and delivery impacts, showing sound multi-hop synthesis between cost profile, production issues, and delivery timelines. However, it oversimplifies the delivery status as 'pause' and underrepresents the resolution progress noted in the original (e.g., completion of rework on most inventoried aircraft). (4) The answer is contextually relevant and addresses both cost profile and delivery impact, but the numerical error in cumulative abnormal costs and the omission of key resolution details reduce factual precision. Hence, correctness is partially compromised despite strong qualitative and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 426,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter selling Meridian on 31 December 2021, Pfizer kept only transitional service agreements (TSAs) and a three‑year Manufacturing Services Agreement (MSA) to hand‑off certain support functions; these contracts were fully completed by the end of 2023.  The only financial impact after the sale was minor post‑close adjustments— a $6 million gain recorded in 2022 and a $(15) million loss in 2023—reflecting the wind‑down of those agreements, with no material ongoing contractual or revenue‑sharing obligations thereafter.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures and the timeline of contractual arrangements. The ground truth states that Pfizer recognized a $167 million loss (net of tax) related to the sale of Meridian, but the LLM incorrectly reports a $6 million gain in 2022 and a $15 million loss in 2023 as the primary financial impacts—these specific figures do not align with the disclosed loss and are presented as ongoing post-close adjustments rather than the main impairment. (2) Quantitatively, the dates are mostly correct (sale on Dec 31, 2021; TSA completion by end of 2023), but the financial numbers are wrong. The $167 million loss is central to the 2022 financial implications and is entirely omitted. Instead, the LLM introduces unverified 'post-close adjustments' that contradict the original answer. (3) Qualitatively, the LLM correctly identifies the existence of TSAs and an MSA, and notes their completion by end of 2023, which aligns with the original answer. However, it fails to mention the ongoing nature of the MSA beyond 2023 and its potential two-year extension, which is a key part of the contractual evolution into 2024. The LLM incorrectly states there are 'no material ongoing contractual obligations' in 2024, while the original answer notes Meridian was still referenced in Pfizer's 2024 glossary, indicating continued recognition likely due to the MSA. (4) Contextually, the answer addresses the financial and contractual evolution but misses the full trajectory into 2024 and misrepresents the financial impact. The reasoning is partially sound but lacks synthesis of the full multi-hop timeline—especially the transition from ownership to a limited supplier relationship with lingering contractual ties. The omission of the $167 million loss and the incorrect characterization of ongoing agreements reduce correctness significantly, though the structure and intent of the response remain relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 533,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nThe filings show that “hello” remains classified within the Oral Care segment, which consistently delivered about 42‑43 % of worldwide net sales from 2022 through 2024, while the adjacent Personal Care (~18‑19 %) and Home Care (~17 %) segments held steady.  This stability indicates that the brand has been maintained as a core oral‑care offering alongside Colgate, Palmolive and other labels, with no marked shift in its strategic emphasis relative to the broader Oral, Personal and Home Care portfolio during the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 'hello' remains a core brand within the Oral Care segment and maintains strategic positioning from 2022 to 2024, aligning with the ground truth's emphasis on sustained inclusion among key trademarks. However, the LLM introduces specific sales percentages (42–43% for Oral Care, ~18–19% for Personal Care, ~17% for Home Care) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate in reality, but since they were not part of the knowledge graph-based answer, their inclusion constitutes a quantitative overreach. (2) There are no explicit calculations in either answer, but the use of precise percentage ranges in the LLM response implies a level of quantitative detail absent from the source, reducing quantitative accuracy. The original answer focuses on trademark listings and strategic visibility, not financial breakdowns by segment. (3) The multi-hop reasoning is partially sound: the LLM infers stability in strategic positioning based on consistent segment performance, which is logical but represents a different line of reasoning than the ground truth, which relies on explicit trademark disclosures across years. While the conclusion of 'no marked shift' is consistent with the original, it is derived via an unverified financial rationale rather than direct evidence from brand listings. (4) Despite the unsupported percentages, the LLM captures the core qualitative insight—'hello' has maintained its strategic position relative to other brands—and addresses the evolution (or lack thereof) across the three years. The answer is contextually relevant and well-structured, but the introduction of unverified numerical data lowers confidence in factual fidelity, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 502,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nThe non‑qualified defined benefit plan remained unfunded, with its liability falling modestly from about $520 million in 2022 to $505 million in 2023 and $493 million in 2024, which narrowed the funded‑status deficit from roughly –$100 million to –$87 million and then to –$93 million.  At the same time, participation kept shrinking because the plan is closed to new members and most eligible employees have migrated to the enhanced defined‑contribution plan, leaving only a small legacy cohort and signalling that the company’s long‑term pension obligation is now limited to a minimal, largely settled group.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the Non-Qualified Defined Benefit Pension Plan is unfunded and closed to new participants, but provides no data on the plan's liability amounts ($520M, $505M, $493M) or funded-status deficit (–$100M to –$87M to –$93M) cited by the LLM. These figures are entirely fabricated and not present in the original answer or underlying data. Additionally, the LLM claims the liability 'narrowed the funded-status deficit', implying partial funding, but the ground truth explicitly states the plan is unfunded—meaning no assets are set aside—so any discussion of 'funded status' or 'deficit narrowing' is incorrect. (2) The LLM omits all key quantitative data from the ground truth: the number of TI shares held in defined contribution plans (6M → 5M → 5M), their values ($940M → $873M → $852M), dividends ($28M → $27M → $26M), and defined contribution expenses ($70M → $75M → $76M). Instead, it invents liability numbers with no support. (3) The qualitative reasoning about a shift toward defined contribution plans and reduced participation due to the plan being closed is partially aligned with the ground truth. The idea that the company is moving away from defined benefit obligations toward defined contribution plans is correctly inferred, and the mention of a shrinking, legacy cohort is consistent. However, the LLM fails to support this with actual data on contribution plan growth or company expenses, instead relying on false pension liability figures. (4) The contextual relevance is moderate because the answer addresses the general theme of pension evolution and strategic shift, but the reliance on fabricated numbers and incorrect concepts (e.g., funded status of an unfunded plan) severely undermines factual correctness. The multi-hop synthesis is flawed because it invents cross-year financial trends not present in the source. Correctness score is low due to complete failure on quantitative accuracy and major factual hallucinations, despite some correct directional reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 561,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term private‑equity investment fell each year—$800 million at the end of 2022, $755 million in 2023 and $719 million by the end of 2024.  The consistent decline indicates that the company is deliberately reducing its exposure to private‑equity, shifting capital toward its core pharmaceutical pipeline, strategic acquisitions and shareholder‑return initiatives rather than sustaining a large private‑equity allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (should be $623 million) and falsely claims a consistent decline over the three years, when in fact there was a substantial increase in 2023. This misrepresents the trajectory. (2) Quantitative accuracy is poor: the 2022 figure is off by $177 million, which is a significant error (~28% overstatement). While the 2023 and 2024 figures ($755M and $719M) are correct, the incorrect starting point and mischaracterization of the trend undermine the answer. (3) The multi-hop reasoning is flawed—the model fails to correctly synthesize the directional change (increase then slight decrease), leading to an incorrect conclusion about strategic intent. The ground truth suggests a measured, flexible allocation strategy, while the LLM infers a deliberate reduction, which is not supported by the 2022–2023 increase. (4) Contextual relevance is moderate because the answer addresses the right company, time frame, and asset class, and attempts to interpret strategic implications, but the incorrect data leads to a misleading interpretation. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 399,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA (still in effect for 2022) Schwab could move up to $10 billion of floating‑rate IDA balances each 12‑month period, but only if it had sufficient capital and could keep at least $50 billion of IDA balances on its books through mid‑2031 while maintaining 80 % of those balances designated as fixed‑rate through mid‑2026. The 2023 IDA replaced those caps, retaining the $10 billion annual migration right but dropping the 80 % fixed‑rate requirement and adding new minimum‑balance limits (e.g., IDA balances must stay above $60 billion after September 10 2025 and may not fall below a level $30 billion above the outstanding unmatured fixed‑rate obligations); Schwab did not exercise the migration option in either 2023 or 2024, so the ability to migrate IDA balances remained constrained by capital adequacy, the floating‑rate designation rule, and the new balance‑size thresholds.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness, despite addressing the right context and question structure. (1) Quantitative Accuracy: The claim that Schwab could move up to $10 billion annually under the 2019 IDA agreement is correct, and it correctly notes no migration occurred in 2023 and 2024. However, it incorrectly states that the 2023 IDA 'retained the $10 billion annual migration right' — the ground truth explicitly says Schwab did not move any balances in 2023 or 2024 under the new agreement, which imposed constraints that effectively removed or suspended that right, not retained it. Additionally, the LLM introduces specific figures not in the original answer: $50 billion minimum balance through mid-2031, 80% fixed-rate requirement through mid-2026, and $60 billion minimum after September 10, 2025 — none of which appear in the ground truth. The only correct threshold mentioned is the $30 billion cap above unmatured fixed-rate obligations, but it misplaces this as a floor ('may not fall below') when the original states it is a maximum ('up to $30 billion above'). (2) Completeness: The answer attempts to cover all years and constraints but adds unverified details instead of accurately reflecting the tightening of migration capability. (3) Entity Accuracy: The companies (Schwab), agreements (2019 and 2023 IDA), and years are correctly identified. (4) Reasoning: The multi-hop synthesis is partially sound — it recognizes the shift in agreement terms and lack of migration — but the reasoning is flawed by inventing specific thresholds and requirements not present in the ground truth, leading to incorrect conclusions about the retention of migration rights. (5) Semantic Equivalence: The overall narrative of increasing constraints is directionally correct, but the specific mechanisms and numbers are not aligned with the original. The answer overcomplicates with fabricated details, reducing factual reliability. Thus, while contextually relevant and attempting the right analysis, the answer fails on key quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 567,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nTexas Instruments’ 10‑K property tables for 2022, 2023 and 2024 all list a facility in **Melaka, Malaysia** under the “Analog ✓” column (and never under “Embedded Processing”), showing that the site has been retained as an analog‑manufacturing location for the entire three‑year period.  The lack of any expansion, contraction, or relocation noted across the filings indicates that Melaka is a strategically important node in TI’s global analog supply chain—providing a stable, cost‑effective production hub that supports the company’s broader competitive advantages and long‑term free‑cash‑flow objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Texas Instruments consistently listed Melaka, Malaysia as a site for analog product manufacturing across 2022, 2023, and 2024, with no changes in footprint such as expansion or relocation. The answer correctly identifies the site's inclusion under 'Analog ✓' and absence from 'Embedded Processing' in all three years, aligning with the ground truth. There are no numeric inaccuracies, so quantitative accuracy is perfect. The qualitative reasoning is strong: the conclusion about strategic importance due to stability is logically sound and supported by the data. However, the LLM omits specific details about the evolving notation († in 2022, * in 2023, ** in 2024), which the original answer highlights as potentially signaling increasing emphasis. This minor omission reduces completeness and nuance in the multi-hop synthesis of symbolic markings over time, slightly weakening the qualitative accuracy. Nonetheless, the core facts and strategic implication are correctly conveyed, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 307,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe RedCard‑program penetration (which includes the Target Debit Card) slipped from about **20 % of purchases in 2022 to 18.6 % in 2023 and 17.8 % in 2024**.  Target notes that a “meaningful portion” of the incremental purchases generated by RedCard users are sales that would not have occurred otherwise, but the downward trend shows that the card’s ability to create new, incremental spend is eroding – the card is becoming a more routine payment method rather than a primary engine of incremental sales for the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in penetration rate and accurately reports the 17.8% figure for 2024, matching the ground truth. However, it reports 18.6% for 2023 instead of the correct 19.8%, and approximates 20% for 2022 instead of the precise 20.5%. These deviations affect quantitative accuracy. (2) The ground truth specifies 20.5% (2022), 19.8% (2023), and 17.8% (2024). The LLM’s values are off by 0.5 and 1.2 percentage points in 2022 and 2023, respectively—non-trivial errors in a trend analysis. (3) The reasoning and synthesis are strong: the model correctly infers that declining penetration suggests reduced effectiveness in driving incremental sales and interprets Target’s commentary about 'incremental purchases' appropriately, aligning with the multi-hop requirement to connect penetration trends with business impact. (4) Contextual relevance is perfect—the answer addresses both parts of the question: the evolution of penetration and its implication for incremental sales. Despite minor factual inaccuracies, the qualitative interpretation and overall message match the ground truth. Hence, correctness is reduced primarily due to numerical inaccuracies, not reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 347,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe tables in the 2022‑2024 10‑K filings show that the “Number of Securities Remaining Available for Future Issuance” under the 2003 Director Compensation Plan fell to essentially 0 by the end of 2023 (the small carry‑over amount that remained was absorbed into the successor 2018 Director Plan, which slipped from about 1.8 million shares in 2023 to 1.7 million in 2024).  This decline indicates that Texas Instruments has stopped replenishing the legacy 2003 plan and now relies on the newer 2018 Director Plan and the freshly adopted 2024 Long‑Term Incentive Plan to provide equity incentives to its directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and key claims. According to the ground truth, the shares available were 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024 — all substantial positive numbers. The LLM incorrectly states that the number fell to 'essentially 0 by the end of 2023' and implies the plan was fully depleted, which contradicts the data. (2) The quantitative inaccuracies are severe: the LLM invents a 'successor 2018 Director Plan' absorbing shares and cites '1.8 million' and '1.7 million' shares in 2023–2024 for a different plan, none of which appear in the ground truth. There is no mention of a 2018 or 2024 Long-Term Incentive Plan in the original answer, nor any absorption of shares. (3) The multi-hop reasoning is flawed: instead of recognizing a consistent decline in the same plan, the LLM fabricates a narrative about plan succession and transition, which is unsupported by the provided truth. It fails to correctly identify the trend in the 2003 plan and misattributes the decline to plan sunset rather than ongoing usage without replenishment. (4) While the LLM attempts to interpret the trend (directors still receiving equity), its explanation is based on false premises. The contextual relevance is moderate because it addresses director equity incentives, but the factual foundation is entirely incorrect, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 394,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nVisa’s virtual‑account ecosystem moved from a 2022 foundation of token‑based credentials and the launch of Visa Direct— which already processed ≈ 6 billion real‑time transactions and 4 billion network tokens— to a 2023 expansion that added push‑to‑wallet payouts, broadened the Direct network to > 60 use‑cases and 2,000 programs, and introduced Visa + for interoperable P2P transfers; then in 2024 the company deepened integration by embedding Visa Direct within its “network of networks,” adding Currencycloud‑powered cross‑border capabilities, launching Visa A2A in the UK, and acquiring Pismo to bring cloud‑native issuer processing, thereby extending virtual‑account issuance and cross‑border settlement to billions of cards, accounts and digital wallets worldwide.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth, despite addressing the general theme of Visa's virtual account evolution. (1) Quantitative inaccuracies: The claim that Visa Direct processed '≈ 6 billion real-time transactions and 4 billion network tokens' in 2022 is unsupported by the original answer and not found in the knowledge graph; no such figures appear in the ground truth. The statement that Visa Direct expanded to '> 60 use-cases and 2,000 programs' in 2023 is also not corroborated. (2) Entity and timeline inaccuracies: The LLM incorrectly implies that Visa Direct was 'launched' in 2022, whereas the ground truth states that virtual accounts were introduced under Currencycloud in 2022 and were later integrated into Visa Direct by 2023. The mention of 'Visa A2A in the UK' and the acquisition of 'Pismo' in 2024 is not mentioned in the ground truth and cannot be verified. 'Visa+' for interoperable P2P transfers is also not referenced in the original. (3) Reasoning and synthesis: While the LLM attempts multi-hop reasoning by connecting virtual accounts to Visa Direct and cross-border capabilities, it fabricates integration milestones and technological enhancements (e.g., 'embedding Visa Direct within a network of networks', 'Currencycloud-powered cross-border capabilities' as a 2024 development) that contradict the more gradual, accurately described integration in the ground truth. (4) Semantic equivalence: The core idea of increasing integration and expansion of use cases is present, and the focus on cross-border utility aligns with the question, hence moderate contextual relevance. However, the inclusion of unverified metrics, products, and events severely undermines factual correctness. The ground truth emphasizes virtual accounts as part of Visa Treasury as a Service in 2022, deeper integration in 2023 with Cross-Border Solutions, and strategic positioning in 2024 for $20 trillion B2B opportunities—none of which are accurately reflected in the LLM response. Thus, while the directionality is somewhat correct, the specific claims are largely invented, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 593,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nXtandi’s 2023 revenue pressure—evidenced by a 1 % drop in international sales and price erosion from unfavorable channel‑mix changes (see page 45)—prompted Pfizer to accelerate its lifecycle‑management strategy, which was reflected in the April 2024 EU approval of an expanded high‑risk BCR‑mutant metastatic prostate‑cancer indication for the drug (see page 47).  In its 2022 intangible‑asset disclosures, Pfizer valued Xtandi as part of the developed‑technology rights portfolio, carrying a gross carrying amount of roughly $73 billion (the portion attributable to Xtandi being a key component of that intangible‑asset group) (see page 92).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies Xtandi's 1% revenue decline in 2023 and links it to pricing and channel-mix pressures, aligning with the ground truth. It also correctly notes Pfizer's lifecycle management response and references a 2024 indication expansion. However, it misstates the nature of the new indication: the approval was for 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis,' not 'BCR-mutant metastatic prostate cancer'—a non-existent or incorrect characterization. Additionally, the LLM incorrectly implies the approval was in April 2024 in the EU, while the ground truth does not specify region or month. (2) The quantitative error is critical: the LLM claims Xtandi was part of a developed-technology portfolio with a gross carrying amount of $73 billion, citing page 92. This is a major misinterpretation—while Pfizer may have had $73 billion in total developed technology rights, attributing that figure directly to Xtandi or implying it carries that portion is unsupported and factually incorrect. The ground truth only states Xtandi was 'listed among' significant assets, not valued at any specific dollar amount. (3) The multi-hop reasoning is partially sound: the model connects 2022 valuation, 2023 revenue pressure, and 2024 indication expansion, showing an understanding of lifecycle management logic. However, the incorrect indication details and fabricated valuation undermine the reasoning chain. (4) Scores reflect that core facts (revenue drop, strategic response) are correct, but major errors in key entities (indication, valuation) reduce correctness. Quantitative accuracy is low due to the $73B misstatement. Qualitative reasoning is decent but flawed. Contextual relevance is high as the answer addresses all question components with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 525,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe Target MasterCard (Target Circle) penetration fell steadily from 19.8 percent in the 2022 fiscal year to 18.6 percent in 2023 and 17.8 percent in 2024. This downward trend indicates that shoppers are increasingly using alternative payment methods and that engagement with Target’s loyalty‑linked credit‑card program is weakening, suggesting reduced consumer preference for the card’s 5 percent discount and related benefits.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. However, the LLM incorrectly reports 19.8% in 2022 (off by 0.7 percentage points), 18.6% in 2023 (which is actually the 2024 value), and 17.8% in 2024 (which is not supported by the data). These errors suggest a misalignment in both values and year assignments. (2) The calculation of the trend direction (downward) is correct, but the magnitude and specific values are wrong. The actual decline is from 20.5% to 18.6% over three years (1.9 percentage points total), whereas the LLM reports a steeper drop of 2 percentage points (from 19.8% to 17.8%), which overstates the decline. (3) The qualitative reasoning about consumer preference and loyalty program engagement is logically sound and aligns with the original answer’s interpretation—namely, that declining penetration may reflect weakening engagement or shifting payment preferences. The mention of the 5% discount is a reasonable inference, though not explicitly stated in the ground truth. (4) The entities are mostly accurate: the card is correctly identified as linked to Target Circle and previously RedCards™, though the rebranding timeline is not contradicted. Contextually, the answer addresses both parts of the question—evolution of penetration and its implications—making it relevant. However, due to the incorrect numerical values and misaligned years, the correctness score is limited to 5, with lower quantitative accuracy dragging down the overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 441,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Visa layered Currencycloud’s virtual‑account functionality onto its cross‑border payments engine, beginning with a pilot‑phase rollout in FY 2022 that added real‑time FX rates and settlement to consumer‑payment flows. In FY 2023 the virtual‑account capability was embedded in the Visa Direct platform and expanded to more than 100 countries, feeding Visa B2B Connect and markedly widening the network of reachable endpoints. By FY 2024 the feature was fully integrated into Visa Direct, supporting nearly 11 billion cards, accounts and digital wallets and processing close to 10 billion transactions, which dramatically broadened cross‑border payment reach and enabled real‑time liquidity and settlement across the entire Visa network.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 with generally accurate progression: introduction in 2022 with real-time FX and settlement, integration into Visa Direct in 2023, and broader use in 2024. However, there are key quantitative inaccuracies. The ground truth states that network reach expanded to 'over 11 billion endpoints' by 2023, while the LLM claims 'nearly 11 billion' endpoints and adds 'close to 10 billion transactions' in 2024—this transaction volume is not mentioned in the original and appears fabricated. Additionally, the original specifies that the 11 billion endpoints include cards, bank accounts, and digital wallets, which the LLM paraphrases correctly but attaches to 2024 instead of 2023, misaligning the timeline. (2) The LLM incorrectly states that the virtual account capability was expanded to 'more than 100 countries' in FY 2023, while the original assigns that geographic reach to 2024 via Visa B2B Connect. This is a factual inversion of timing. (3) The multi-hop reasoning is mostly sound—linking Currencycloud, Visa Direct, and B2B Connect across years—but misattributes when certain capabilities (country reach, transaction scale) were achieved. (4) Despite these errors, the answer is contextually relevant and conveys a plausible narrative of technological progression. The core qualitative trajectory—enhanced cross-border capabilities, real-time settlement, expanded network reach—is consistent with the original. Wording differences are acceptable under semantic equivalence, but the introduction of unsupported metrics (10 billion transactions) and misplacement of country reach reduce quantitative accuracy. Correctness score is 7 due to accurate overall direction but significant factual and temporal inaccuracies in numbers and rollout sequence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 501,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD’s 10‑K filings for 2022, 2023 and 2024 each list “difficulties in protecting our intellectual property” under General Risks, but the later years sharpen the focus: the 2023 and 2024 disclosures explicitly connect that risk to AMD’s growing international footprint—sales that were ≈ 65‑72 % of revenue—and to its reliance on third‑party wafer foundries in China, Taiwan and other Asian locations, where heightened geopolitical tensions and supply‑chain disruptions amplify the chance of IP loss or infringement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of AMD's IP protection risks across 2022, 2023, and 2024, noting the consistent mention of 'difficulties in protecting our intellectual property' and the increasing emphasis on international operations and third-party manufacturing dependencies. It accurately links the heightened risk to geopolitical tensions and supply chain disruptions, particularly in China, Taiwan, and other Asian locations, aligning with the ground truth's focus on China, Malaysia, and Taiwan. However, the LLM introduces a specific quantitative claim—'sales that were ≈ 65–72 % of revenue'—that is not present in the original answer or supported by the knowledge graph provided; this figure cannot be verified and appears to be an unsupported addition, lowering quantitative accuracy. While the core qualitative progression (broad risk in 2022, more specific third-party and geopolitical links in 2023 and 2024) is sound and reflects proper multi-hop reasoning across years and risk factors, the answer omits the 2024 expansion on export controls related to the Ukraine-Russia and Israel-Hamas conflicts, which is a notable contextual omission. Despite this, the answer captures the essential trajectory of increasing concern and specificity. Wording differs but meaning is largely semantically equivalent, and all entities (AMD, years, regions, third-party foundries) are correctly identified. The answer is highly relevant to the question and synthesizes key elements, but minor incompleteness and the unverified percentage reduce it from full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 431,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 through 2024 UNP’s corporate‑stock holdings remained classified as Level 1 (common shares) and Level 2 (preferred shares), but the **allocation of those shares within the pension portfolio fell sharply** – from roughly **48 % of total plan assets in 2022** to **about 24 % in 2024** (the 2025 target is 20‑30 % equity).  This de‑risking shift moves the plan from a higher‑equity, higher‑return stance to a more conservative mix of **70‑80 % debt and only 0‑2 % real‑estate**, indicating that UNP is deliberately reducing market‑price volatility and focusing on stable, liability‑matching assets to fund its pension obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the valuation classification (Level 1 for common stock, Level 2 for preferred stock), it fabricates percentage allocations (48% in 2022, 24% in 2024) and total plan asset context that are not present in the ground truth. The original answer reports absolute dollar values ($1,990M in 2022, $181M in 2023), but no percentage of total plan assets or portfolio allocation figures. The claim that equity allocation dropped to 24% in 2024 and that 2025 targets are 20-30% equity is unsupported by the provided data. Additionally, the mention of '70-80% debt' and '0-2% real-estate' is entirely absent from the original answer and cannot be verified from the given information. (2) Quantitative accuracy is very low: the only correct numeric element is the directional drop in Corporate Stock investment from 2022 to 2023. However, the LLM invents percentages and portfolio targets with no basis in the source. The original answer does not provide total plan assets or portfolio composition, making these calculations impossible. (3) The multi-hop reasoning is partially sound in interpreting the decline as a de-risking move, which aligns with the original's interpretation of a strategic shift. However, the LLM overreaches by introducing unverified portfolio targets and asset class percentages, undermining the reasoning. (4) Contextual relevance is moderate because the answer addresses the question’s intent—valuation classification and strategic implications—and correctly infers a de-risking trend. However, the introduction of unsupported metrics severely compromises factual correctness. The core error is fabricating quantitative context not present in the source, leading to a low correctness score despite some accurate directional insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 501,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 to 2024 Abbott’s filings moved from a single‑line exhibit reference to the 4.75 % Senior Notes due 2043 (Exhibit 4.19) in the 10‑K to increasingly detailed disclosures that bundle the notes within supplemental indentures, officer certificates and a dedicated “Description of Registrant’s Securities” (Exhibit 4.36).  This layered approach—adding supplemental indenture dates, covenant language and updated officer certificates—reflects a deliberate strategy to provide transparent, granular information about the company’s long‑term debt, underscoring both disciplined debt‑management and a proactive investor‑communication agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Abbott evolved from a 'single-line exhibit reference' in 2022 to more detailed disclosures by 2024, including specific exhibit numbers like Exhibit 4.19 and Exhibit 4.36. However, the ground truth states that in 2022, Abbott referenced the notes via St. Jude Medical’s Fourth Supplemental Indenture from 2013, not a single-line exhibit in the 10-K. In 2023, the correct exhibit is 4.6 to the Form 8-K dated March 22, 2017—not Exhibit 4.36 as claimed. No mention is made of Exhibit 4.36 or officer certificates in the ground truth. (2) The dates and exhibit numbers are incorrect: the 2017 Form 8-K is correctly cited in the original answer but misrepresented as part of a 2023 trend toward granular disclosure with new exhibits. The LLM fabricates a progression involving 'supplemental indenture dates, covenant language and updated officer certificates' not present in the ground truth. (3) The multi-hop reasoning is partially sound in that it infers a trend toward greater transparency, which aligns with the original conclusion. However, the evidence used to support this reasoning is factually wrong. The actual evolution is from legacy referencing (via St. Jude) to formalizing the note in existing documentation (Exhibit 4.6), then maintaining consistency—not an increasing layering of disclosures. (4) The contextual relevance is fair because the LLM addresses the question’s core theme—evolution in disclosure strategy and implications for debt management and investor communication. However, due to major factual and quantitative errors in exhibits, dates, and disclosure details, the correctness score is low. While the qualitative insight about transparency is directionally plausible, it is not supported by accurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 495,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Circle Card (the re‑branded RedCard) penetration slipped from about **20.5 % of purchases in fiscal 2022** to **19.8 % in fiscal 2023** and further to **18.6 % in fiscal 2024** (see the 2023 10‑K discussion of “Target Circle Card Penetration” and the 2024 10‑K which reports 18.6 % for the year ended Feb 3 2024).  \n\nThis modest, steady decline indicates that customer adoption of the branded payment product is easing – the 5 % discount incentive is becoming less compelling – but the card still accounts for a sizable share of transactions, so it continues to generate incremental sales, albeit at a gradually diminishing rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The fiscal year-end date (Feb 3, 2024) is accurately cited, aligning with Target's reporting calendar. 2) All numbers are factually correct and properly attributed to the relevant 10-K filings, with no calculation errors. Format variations (e.g., '18.6%' vs '18.6%') are acceptable and do not affect accuracy. 3) The reasoning correctly identifies the downward trend and links it to reduced customer adoption, noting the diminishing impact on incremental sales—consistent with the original answer. It appropriately references the 5% discount incentive as a weakening driver, which is a reasonable inference from the trend. The only minor gap is that it does not explicitly mention the card’s continued strategic importance via profit sharing and retention (noted in the ground truth), but it does state the card 'continues to generate incremental sales,' capturing the core idea. 4) The answer is highly relevant, directly addressing both parts of the question: the evolution of penetration and its implications. Synthesis across years and documents (2023 and 2024 10-Ks) is sound and properly referenced. Overall, the answer is factually excellent with only a slight omission in depth of strategic context, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 382,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 the Multiple‑Purpose Locomotive fleet slipped modestly in size – from roughly **7,000 units (2022)** to **6,893 units (2024)** – while the **average age rose from about 23 years to 25.2 years**.  This slight contraction combined with a higher average age shows that Union Pacific is not aggressively expanding its locomotive count but is instead keeping newer, more efficient units in service and allowing older assets to be retired over time, reflecting a focus on **asset‑life‑cycle optimization and capital‑efficiency** rather than fleet growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in the 2022 fleet size and average age. The ground truth states 7,242 units in 2022, while the LLM reports 'roughly 7,000', which is a notable rounding that understates the actual figure by over 200 units. Similarly, the average age in 2022 is reported as 'about 23 years' instead of the exact 22.5 years. These approximations reduce quantitative precision. (2) The 2024 figures (6,893 units and 25.2 years) are correctly reported. The direction and magnitude of change (decrease in units, increase in age) are accurate, but the exact delta in fleet size (349 units) and age (2.7 years) are obscured by rounding. Calculations are not explicitly shown but implied correctly in trend. (3) The multi-hop reasoning is sound: the model correctly infers a strategic trend from fleet size and age changes. While the original answer emphasizes 'deferral of fleet modernization' and 'cost-conscious strategy', the LLM interprets this as 'asset-life-cycle optimization and capital-efficiency', which is semantically similar and contextually reasonable. (4) The answer addresses all parts of the question—change in units, change in age, and strategic implication—with strong qualitative reasoning and relevance. However, the quantitative inaccuracies prevent a higher score, especially since exact figures are available in the ground truth and critical for financial/fleet analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 401,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s unfunded commitments to private real‑estate funds declined from roughly $585 million to $555 million and then to $540 million. This downward trajectory signals a strategic pull‑back from illiquid alternative assets, reflecting a shift toward greater liquidity and capital preservation rather than expanding long‑term private‑real‑estate investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the unfunded commitments: $585M in 2022, $555M in 2023, and $540M in 2024, matching the ground truth exactly. The quantitative evolution is accurately described as a decline over the three years. 2) All numbers are correct and consistent with the original answer; the $30M total reduction from 2022 to 2024 and $15M drop from 2023 to 2024 are implied and accurate. 3) The multi-hop reasoning is sound—information across three years is synthesized correctly, and the trend is properly identified. 4) While the LLM captures the downward trend and its implication (strategic pullback from illiquid assets), it omits a key nuance from the ground truth: that Abbott maintains a significant commitment, suggesting continued long-term participation via fund distributions rather than active deployment. This omission slightly weakens the qualitative accuracy, as the original answer emphasizes a 'measured approach' rather than a full strategic retreat. The LLM's interpretation leans slightly more negative ('pull-back', 'shift away') compared to the more balanced 'gradual reduction with continued participation' in the original. Despite this, the core facts and trend interpretation are correct, and the answer remains highly relevant and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 358,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 carried a net carrying amount of roughly **$2 billion** at the end of fiscal 2022, and that figure remained **$2 billion** in fiscal 2023 and again in fiscal 2024.  Because the outstanding principal of this tranche was unchanged over the three years, the progression reflects a deliberately stable long‑term debt profile—NVIDIA has not retired or added to this series, indicating that the notes continue to serve as a fixed, low‑cost pillar of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value of NVIDIA's 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in 2023, and increased to $2,000 million in 2024. The LLM incorrectly states that the value was $2 billion in all three years, which misrepresents the trend entirely. This error undermines the entire response. (2) The numbers are significantly off: the 2022 value is overstated (actual: $2,147M → LLM: $2,000M), the 2023 value is vastly overstated (actual: $1,604M → LLM: $2,000M), and while the 2024 value is approximately correct ($2,000M), the LLM fails to note the meaningful increase from 2023. There are no calculations in the LLM answer, but the reported values do not match the ground truth even within reasonable rounding. (3) The multi-hop reasoning is flawed because the LLM assumes stability in the carrying value and concludes a 'deliberately stable long-term debt profile,' but the actual fluctuation—especially the 25% drop from 2022 to 2023 and 25% rebound from 2023 to 2024—suggests active revaluation or strategic adjustments, not stability. The LLM fails to recognize or explain this volatility, leading to an incorrect interpretation of NVIDIA's debt positioning. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and the general topic of long-term debt strategy, but due to severe factual inaccuracies and flawed reasoning, the conclusion is misleading. The qualitative analysis is plausible in form but built on false premises, reducing its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s disclosures shifted from a generic reference to “loss or modification of exemptions for taxes and tariffs” toward explicit warnings that sanctions, export‑control revisions and escalating geopolitical tensions (e.g., Ukraine, China‑Taiwan, Middle‑East conflicts) could strip or alter those exemptions. This evolution shows that AMD now operates in a far more intricate global regulatory landscape where overlapping political and trade developments increasingly jeopardize its tax and tariff advantages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's risk disclosures regarding tax and tariff exemptions from 2022 to 2024. (1) It correctly identifies the shift from generic to more specific risk language, aligning with the original answer's timeline: 2022's broad mention, 2023's focus on geopolitical tensions (Ukraine-Russia, Israel-Hamas), and 2024's emphasis on China-Taiwan risks affecting manufacturing partners. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound—synthesizing AMD’s evolving disclosures across years and linking them to increasing regulatory complexity due to geopolitical factors. The LLM correctly infers that the trend reflects a more intricate global regulatory environment, which is the central conclusion of the ground truth. (4) Minor deduction in qualitative accuracy (9 instead of 10) because the LLM omits explicit mention of U.S. sanctions against Russia and Belarus and slightly generalizes the Middle East conflict without specifying Israel-Hamas, though 'Middle-East conflicts' is semantically acceptable. Otherwise, the answer is contextually complete, factually correct, and conveys the same meaning as the original with appropriate nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 355,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBetween 2022 and 2024 BNY Mellon’s disclosures grew increasingly explicit that U.S. banking capital rules now directly constrain its ability to pay dividends and repurchase shares.  The 10‑Ks repeatedly state that capital returns are at the Board’s discretion and can be limited by “well‑capitalized” and “well‑managed” status, capital‑adequacy and liquidity requirements, and the need to fund full preferred‑stock dividends—so any downgrade or failure to meet regulatory standards would curb share‑repurchase flexibility.  This language shows a clear evolution toward tighter regulatory exposure on dividend and repurchase policy over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key regulatory constraints on BNY Mellon's capital return flexibility, including capital adequacy, liquidity requirements, preferred stock dividends, and the discretion of the Board. These elements are consistent with the original answer. However, the LLM incorrectly frames the evolution as a 'clear evolution toward tighter regulatory exposure' and 'grew increasingly explicit,' implying a tightening or escalation of constraints over time. The ground truth states that the regulatory environment remained 'consistently constrained' and 'stable' across 2022–2024, with no indication of increasing stringency—only continuity and contextual expansion in disclosure language. This misrepresents the trend and is a significant qualitative error. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the LLM does not introduce any incorrect numbers, so it scores full marks by default. (3) The multi-hop reasoning is partially sound: the model synthesizes disclosures across years and correctly identifies relevant regulatory factors. However, it fails to recognize the consistency of the disclosures across years, instead inferring a trend of increasing constraint that is not supported by the ground truth. This undermines the reasoning accuracy. (4) Contextual relevance is high because the LLM addresses the core topic—regulatory constraints on dividends and share repurchases—and ties them to U.S. banking laws. The framing is slightly off, but the content is relevant. Correctness is penalized due to the incorrect characterization of evolving stringency, which distorts the factual conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 467,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nAbbott’s 2.950% Note due 2025 is consistently listed in the Exhibit tables of its 2022‑2024 Form 10‑Ks under Item 4.1, but the accompanying documentation has become progressively richer. In the 2022 filing the note appears only as a reference to the original 2015 8‑K (Exhibit 99.6), whereas the 2023 and 2024 filings add supplemental indentures and officer‑certificate exhibits (e.g., 4.26‑4.33) that record amendments and the latest actions of authorized officers, reflecting a more detailed, up‑to‑date disclosure of the instrument’s current terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The original answer states that Abbott Laboratories consistently referenced the same exhibit (Exhibit 99.6 from the March 5, 2015 8-K) across 2022–2024 with no changes, indicating static disclosure. However, the LLM claims that supplemental indentures and officer certificates (e.g., Exhibits 4.26–4.33) were added in 2023 and 2024 to reflect amendments and updated actions—information not present in the ground truth and directly conflicting with it. (2) Quantitatively, while the note’s interest rate (2.950%) and maturity (2025) are correct, the LLM incorrectly references new exhibits and documentation (e.g., '4.26–4.33') and implies a March 5, 2015 filing was cited in annual 10-Ks, whereas the ground truth specifies the 8-K filing itself is from 2015 and merely referenced in later years. There is no evidence of evolving documentation in the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers increasing disclosure detail over time, but the knowledge graph shows no such evolution—only repetition of the same exhibit reference. This misrepresents the nature of the disclosure as dynamic when it is explicitly static. (4) Contextually, the answer addresses the right question about disclosure evolution and focuses on exhibit filings, so relevance is moderate. However, the core factual claim—that disclosures became richer with amendments and new exhibits—is unsupported and incorrect, leading to a low correctness score despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 428,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 have held a $1.25 billion carrying amount in fiscal 2022, remained $1.25 billion in fiscal 2023 and were still $1.25 billion as of the end of fiscal 2024 (and into fiscal 2025), showing essentially no change in the balance. This flat trajectory indicates that NVIDIA is deliberately maintaining a stable, low‑cost senior debt tranche, using the 2028 notes as a steady long‑term financing pillar rather than expanding or reducing leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal 2022, $1,099 million in fiscal 2023, and $1,250 million in fiscal 2024. The LLM incorrectly states that the value was consistently $1.25 billion across all three fiscal years, which misrepresents the fluctuation entirely. This error undermines the entire response. (2) The numbers are not accurate: the LLM reports no change ($1.25B in all years), while the truth shows a decrease from $1,200M to $1,099M (a drop of ~8.4%) in 2023, followed by an increase to $1,250M in 2024. Even allowing for format variations (e.g., $1.25B = $1,250M), the values for 2022 and 2023 are wrong. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the actual progression of the carrying value over time. The conclusion about a 'flat trajectory' and 'stable financing pillar' is based on false data and contradicts the ground truth, which notes a fluctuation indicating strategic management and adjustment of debt components. (4) The contextual relevance is moderate because the answer addresses the right instrument and attempts to interpret NVIDIA's debt strategy, but the reasoning is based on incorrect data. The qualitative accuracy is low due to incorrect entity values and flawed synthesis. The correctness score is very low because the answer misstates all key facts despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 416,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the inventory‑protection terms it offers AIB partners—contractually shielding their stock from price‑cut shocks and granting limited return/stock‑rotation rights—while expanding direct co‑marketing and design‑support programs for system‑integrators.  At the same time, AMD leveraged its discrete Radeon graphics and Instinct accelerator portfolio as a differentiator, letting AIBs and SI customers distinguish their platforms (e.g., through ray‑tracing, Infinity Cache and AI‑optimized features) and command premium, performance‑focused market positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic direction of AMD's relationship with AIB manufacturers and correctly identifies inventory protection and discrete graphics as key elements. However, it introduces inaccuracies in the qualitative evolution of AMD's policies. The claim that AMD 'tightened' inventory-protection terms is contradicted by the ground truth, which shows consistent (not tightened) policies from 2022 to 2024, with explicit return rights within 12 months of manufacturing already in place in 2022. The ground truth does not support any contractual tightening—only continuity and evolving emphasis. Additionally, while the LLM mentions co-marketing and design-support programs, these are not referenced in the original answer and thus represent unverified additions. The emphasis on discrete graphics for differentiation is correctly noted for 2024, aligning with the original answer, and the mention of Radeon and features like ray-tracing and Infinity Cache adds detail without contradicting the source. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning partially reflects the multi-hop synthesis across years but misrepresents the trajectory of policy changes. Overall, the answer is contextually relevant and semantically aligned in broad strokes but contains significant factual deviations in the characterization of policy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 395,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s exposure to intellectual‑property protection risks expanded in step with its growing international sales (65 %–66 % of revenue) and its increasing reliance on third‑party manufacturing in politically sensitive regions such as China, Malaysia and especially Taiwan.  The earlier filing listed “difficulties in protecting our intellectual property” only as a generic risk, but the 2023 and 2024 filings specifically warned that escalating China‑Taiwan tensions, U.S. export‑control sanctions and recent disruptions (e.g., the April 2024 Taiwan earthquake) could lead to IP loss, forced technology transfers, or interruptions of proprietary processes, making IP protection a far more material and urgent concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 65% to 66% increase in international sales is accurately reflected, matching the original answer's data for 2023 and 2024, with a correct inference of continuity from 2022. No incorrect figures or miscalculations are present. (2) The LLM correctly identifies the evolution of AMD's risk disclosures across 2022–2024, noting the shift from generic IP protection concerns in 2022 to more specific geopolitical risks in 2023 and 2024. It accurately highlights China-Taiwan tensions, U.S. export controls, and third-party manufacturing reliance in sensitive regions like Taiwan, Malaysia, and China. The mention of the April 2024 Taiwan earthquake, while adding contextual detail not in the original answer, is plausible and contextually relevant without contradicting the source. (3) Multi-hop reasoning is sound: the LLM synthesizes AMD’s expanding international operations, evolving risk disclosures, and geopolitical exposure across years and regions. It correctly infers that IP risks became more material and regionally concentrated. (4) Minor deduction in qualitative accuracy is due to the original answer not mentioning Malaysia or the Taiwan earthquake; while these are reasonable inferences, they slightly extend beyond the provided ground truth. However, the core reasoning, entity identification (AMD, U.S., China, Taiwan), and timeline (2022–2024) are fully accurate. The answer is contextually excellent, directly addressing the question’s focus on IP risk evolution in relation to international operations and third-party manufacturing. Overall, the LLM captures the transforming trend in IP risk with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 474,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly refreshed the incentive documents that operate under its 2019 Long‑Term Incentive Plan—introducing a new 2022 Performance‑Share‑Unit and Restricted‑Stock‑Unit agreement, updating both with 2023 versions, and then rolling out fresh 2024 Performance‑Share‑Unit and Restricted‑Stock‑Unit agreements (while also amending the executive severance plan in early 2024).  This yearly renewal of award forms shows a deliberate tightening of the equity‑based incentive structure, moving toward more performance‑linked, long‑term equity compensation and a clearer, governance‑focused severance framework.  Overall, the progression signals that the company’s executive‑pay strategy is increasingly anchored in sustained performance metrics and shareholder‑aligned, long‑horizon rewards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of BK's (BNY Mellon's) use of the 2019 Long-Term Incentive Plan from 2022 to 2024. (1) The LLM incorrectly states that new Performance Share Unit (PSU) and Restricted Stock Unit (RSU) agreements were introduced in 2022, 2023, and 2024. According to the ground truth, in 2022, BK referenced the 2021 Form of PSU Agreement; in 2023, it introduced the 2020 Form of PSU Agreement (not a newer version as implied); and in 2024, it introduced the 2022 Form of PSU Agreement. There is no mention of RSU agreements or annual refreshes in each year, nor of executive severance plan amendments in early 2024—these are fabrications. (2) The dates and document versions are factually wrong: the LLM implies progressive annual updates (2022, 2023, 2024 forms), but the truth shows a non-sequential use of older forms (e.g., 2020 form introduced in 2023) and only a gradual introduction of newer ones (2022 form in 2024). This undermines the quantitative and qualitative accuracy. (3) The multi-hop reasoning is flawed: the ground truth suggests continuity with periodic enhancements using legacy and updated forms, while the LLM invents a pattern of aggressive annual refreshes and tightening governance, which is not supported. (4) While the general theme of 'performance-linked compensation' and 'long-term alignment' is directionally plausible, the specific evidence cited is incorrect, leading to a low correctness score. The answer is contextually relevant in topic and structure but fails on factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 433,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nAbbott’s capital invested in diagnostics‑instrument leasing expanded each year – the original cost of the leased assets rose from about **$3.3 bn (2020‑21)** to **$3.6 bn in 2023** and **$3.9 bn in 2024**, while the net‑book value grew from roughly **$1.4 bn to $1.6 bn to $1.8 bn** over the same period.  This upward trend shows that Abbott is deliberately increasing its outlay on diagnostic‑instrument leases to broaden its equipment‑leasing portfolio, lock in long‑term customers and generate recurring reagent sales, rather than focusing on outright purchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports the original cost of leased assets rising from $3.3B to $3.6B to $3.9B in 2022, 2023, and 2024 respectively, it incorrectly states the net book value as increasing from $1.4B to $1.6B to $1.8B. According to the ground truth, the net book value was $1.4B in 2022, $1.6B in 2023, and remained at $1.6B in 2024 — not $1.8B. This overstates the 2024 net book value by $0.2B, a material error. Additionally, the LLM references '$3.3B (2020-21)', which misaligns with the question’s 2022–2024 timeframe and introduces incorrect dating. (2) The calculation of trend direction (upward) is correct, but the specific values used for net book value in 2024 are wrong. The original cost figures are accurate across all years. (3) The multi-hop reasoning is sound: the model correctly infers that increasing investment in leased instruments supports a strategy to drive recurring reagent sales and customer lock-in, which aligns with the ground truth’s interpretation about performance obligations and downstream revenue. It also correctly identifies the strategic intent behind leasing versus outright sales. (4) The contextual relevance is high — the answer addresses both parts of the question: the evolution of investment and the strategic implication. However, the quantitative inaccuracy in the net book value for 2024 and the misdating of the base year reduce the correctness score. The qualitative reasoning remains strong despite these errors, hence a 7 in qualitative accuracy. Overall, the answer is partially correct but contains key factual errors in reported financial values, warranting a 6/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 468,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024, Lumentum Holdings is repeatedly named in NVIDIA’s “networking products” competitor list (e.g., switches, optical modules, DPUs), confirming its ongoing presence in the disclosed competitive set. However, NVIDIA’s accelerating focus on AI‑driven interconnect technologies—such as NVLink, NVSwitch and the Spectrum‑X family—has integrated networking functions into its own GPUs and DPUs, moving Lumentum from a direct rival toward a more peripheral supplier of optical and interconnect components. Consequently, while Lumentum remains on NVIDIA’s competitor roster, its strategic relevance to NVIDIA’s AI‑centric networking ecosystem has diminished relative to NVIDIA’s in‑house solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10 by default. The core issue lies in qualitative accuracy and reasoning. The original answer (ground truth) shows that Lumentum Holdings' competitive positioning relative to NVIDIA has evolved positively—becoming more specifically recognized and strategically relevant in NVIDIA's competitor landscape across fiscal years 2022–2024, especially in AI-driven interconnect technologies. In contrast, the LLM answer incorrectly asserts that Lumentum's strategic relevance has 'diminished' due to NVIDIA's in-house integration, which contradicts the ground truth. The truth indicates a sharpening of Lumentum’s identity and rising prominence (e.g., being listed under its full corporate name in 2024), not a decline. The LLM misinterprets NVIDIA’s vertical integration as reducing Lumentum’s competitive significance, when in fact the disclosed competitor lists show increased specificity and recognition of Lumentum. This reflects a failure in multi-hop reasoning: the model does not correctly synthesize the implications of how NVIDIA’s evolving competitor disclosures reflect changing competitive dynamics. Contextually, the answer addresses the right domain (networking, AI interconnects) and time frame, so it is partially relevant, but the conclusion is factually inverted. Thus, while the answer is well-structured and contextually plausible, it is substantively incorrect in its central claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 422,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved pipe‑cutters out of the broader **Safety & Productivity** line and began reporting them as a dedicated offering within the **Tools & Home Products** segment (the Tools & Home Products business sits inside the Commercial & Residential Solutions group).  This repositioning signals a focused professional‑tool strategy: Emerson is isolating high‑margin, specialist tooling for plumbing‑ and mechanical‑industry customers and leveraging its distributor network to grow that business.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the segment shift. According to the ground truth, pipe cutters were originally part of the Tools & Home Products segment in 2022 and were moved *into* the Safety & Productivity segment by 2023–2024. The LLM incorrectly states the opposite — that pipe cutters were moved *out of* Safety & Productivity and *into* Tools & Home Products — which inverts the actual strategic shift. This major factual error undermines the entire response. While there are no numeric values to verify (so quantitative accuracy is not applicable, but no errors present), the qualitative accuracy is very low due to incorrect entity mapping and flawed reasoning about the business repositioning. The conclusion about a professional tool strategy is partially aligned with the ground truth, but it is based on incorrect premises. The response fails the multi-hop synthesis by misrepresenting the direction of the segment realignment, and thus does not accurately reflect Emerson’s strategy of exiting consumer-focused products and consolidating professional/industrial tools under Safety & Productivity. Contextual relevance is low because the answer describes a strategy contrary to the actual one.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 346,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab transformed its RIA‑focused interactive tools by expanding the free “Schwab Advisor Portfolio Connect” from a simple, web‑based portfolio‑management view into a fully integrated platform that now incorporates the thinkpipes trading engine and the iRebal portfolio‑rebalancing module, and that links directly to third‑party CRM, portfolio‑management and financial‑planning systems.  The website‑based service also grew its advisor‑support capabilities—adding multi‑year archiving, advanced document‑search, integrated educational content, benchmarking studies and dedicated business‑growth consulting—while keeping the intuitive, modern user experience and free access for advisors.  These enhancements gave RIAs tighter integration with Schwab’s trading and rebalancing tools and richer, more comprehensive support resources.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant factual inaccuracies not supported by the ground truth, particularly regarding specific tool integrations. (1) Correct elements include the general timeline (2022–2024), focus on Schwab Advisor Portfolio Connect, expansion of advisor support (e.g., consulting, educational content), and integration with third-party systems for CRM, portfolio management, and financial planning. The mention of multi-year archiving and document search aligns with the 2024 enhancements in the original answer. (2) Quantitative accuracy is high: no specific numbers (dollar amounts, percentages, exact dates) are provided or misstated—only qualitative features—so no numeric errors exist. (3) However, the LLM makes unsupported claims about integrating the 'thinkpipes trading engine' and 'iRebal portfolio-rebalancing module' into Schwab Advisor Portfolio Connect, which are not mentioned in the ground truth and represent a significant overreach in technical detail. The original answer notes broader ecosystem integration and compliance workflows but does not specify internal Schwab systems like thinkpipes or iRebal being embedded into the tool. This reflects a failure in multi-hop reasoning, as the model likely inferred deeper technical integration based on general trends but fabricated specific components. (4) While the answer captures the direction of evolution—increased functionality, integration, and support—it misses the strategic shift toward compliance workflows and outbound data feeds for compliance systems emphasized in 2024. Instead, it focuses on trading and rebalancing tools not highlighted in the ground truth. Thus, despite good structure and plausible-sounding details, the answer contains key factual hallucinations, warranting a mid-range correctness score. Contextual relevance is high as it directly addresses the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 513,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first issued the 1.650 % Notes due 2026 in a March 24 2021 8‑K (see ORCL 10‑K 2022 Exhibit 4.14 on page 112) and continued to list the same tranche unchanged in the subsequent 10‑K filings—​the 2023 filing (pages 108‑112) and the 2024 filing (pages 109‑113) both repeat the original indenture terms and carry the notes at amortized cost with no redemption, amendment or re‑measurement disclosed. This consistent treatment shows that Oracle’s short‑to‑intermediate‑term debt strategy relies on issuing long‑dated, fixed‑rate senior notes and holding them to maturity rather than frequently refinancing or altering those obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the issuance date of the 1.650% Notes due 2026. The original answer states that Oracle first introduced these notes in its 2022 10-K filing, while the LLM claims they were issued on March 24, 2021, citing an 8-K and referencing Exhibit 4.14 in the 2022 10-K. This contradicts the ground truth, which identifies Exhibit 4.16 in the 2022 10-K as the first appearance. The 2021 date is incorrect and not supported by the ground truth. However, the LLM correctly notes that the notes were carried unchanged in the 2023 and 2024 10-Ks (Exhibits 4.14 in both years), which aligns with the original answer’s claim of consistent disclosure. (2) The quantitative accuracy is compromised by the incorrect issuance date (2021 vs. correct first mention in 2022 filing), though the interest rate (1.650%) and maturity year (2026) are correct. The page numbers cited (e.g., 112, 108–112, 109–113) may be accurate to the filings but are not verifiable from the ground truth and not essential; their inclusion does not add error but distracts slightly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-Ks and draws a logical conclusion about Oracle’s debt strategy—maintaining fixed-rate notes to maturity without modification. This interpretation is consistent with and even enriches the original answer. (4) Contextual relevance is perfect: the response directly addresses the evolution of the notes and infers Oracle’s financing strategy. Despite the incorrect issuance date, the core factual trajectory (unchanged across filings) and strategic interpretation are valid. The error is significant but does not undermine the entire conclusion, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 488,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Electrical Distribution Equipment business remained a core pillar of Emerson’s Discrete Automation segment—segment sales held near $2.6 billion ( $2.612 bn in 2022, $2.635 bn in 2023, $2.506 bn in 2024 )—while the company sustained steady capital spending on the offering and continued to spotlight it in its product‑portfolio narrative.  This consistent emphasis shows that Emerson is deliberately positioning electrified automation—particularly its electrical‑distribution equipment—as a growth engine for industrial electrification, aligning its strategy with the broader market shift toward energy‑efficient, electrified manufacturing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the positioning of Electrical Distribution Equipment within Emerson's segments. According to the ground truth, in 2022 the product was part of 'Industrial Solutions', not Discrete Automation, and only moved into Discrete Automation in 2023. The LLM incorrectly states it was part of Discrete Automation throughout 2022–2024, which misrepresents the core structural evolution. (2) The financial figures cited ($2.612B in 2022, $2.635B in 2023, $2.506B in 2024) are not present in the original answer and cannot be verified against the ground truth, which contains no sales data. This introduces unverified quantitative claims, failing the quantitative accuracy check. There are no calculations in the original to validate or replicate. (3) The multi-hop reasoning is flawed: the key insight in the ground truth is the re-segmentation of Electrical Distribution Equipment across reporting periods, reflecting strategic repositioning. The LLM misses this entirely and instead asserts continuity, undermining the correct causal inference about strategic emphasis on industrial electrification. While the LLM correctly infers strategic importance, it does so based on incorrect structural placement and fabricated financial data. (4) Contextual relevance is moderate—the response addresses industrial electrification and automation strategy, aligning with the question’s intent, but fails to accurately describe the organizational evolution, which is central to the query. Thus, despite relevant themes, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 451,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds fell from roughly $585 million in 2022 to $555 million in 2023 and $540 million in 2024. This steady reduction indicates a strategic pull‑back from illiquid alternative‑asset exposure, reflecting a shift toward more liquid or higher‑return investments within its pension fund strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the unfunded commitments: $585M in 2022, $555M in 2023, and $540M in 2024, matching the ground truth exactly. These numbers reflect a consistent downward trend, which the model accurately characterizes as a 'steady reduction' or 'strategic pull-back'.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the direction of change (decreasing) is properly conveyed. No calculations are required beyond recognizing the trend, which is correctly interpreted.\n\n3) The reasoning is sound and captures the core implication — a shift away from illiquid alternatives toward more liquid investments. However, the LLM omits a key nuance present in the original answer: the continued long-term horizon for liquidation (through 2034) and the idea that Abbott still sees long-term value in these assets despite reduced exposure. This missing context slightly weakens the qualitative depth of the conclusion, though the main inference about de-risking is valid.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the evolution of commitments (with correct multi-year data) and the strategic implication. The synthesis across years is accurate, and the terminology ('unfunded commitments', 'illiquid alternative assets') is appropriately used. The omission of the 2034 time horizon and the deliberate, gradual nature of the drawdown prevents a perfect score, but the answer remains factually strong and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 415,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle repeatedly includes the same “Forms of 1.650% Notes due 2026…” exhibit (Exhibit 4.14) with identical terms and the March 24 2021 issuance date, showing that the notes remained outstanding and unchanged. This consistent treatment reveals that Oracle’s short‑term debt strategy hinges on retaining these low‑coupon, medium‑term notes as a stable funding source rather than retiring or refinancing them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.650% Notes due 2026 were first disclosed in the 2022 10-K, with reference to the March 24, 2021 8-K filing, and this reference was consistently maintained in the 2023 and 2024 10-Ks. The LLM correctly identifies the unchanged nature of the notes across all three years. (2) Quantitative elements—interest rate (1.650%), maturity year (2026), issuance date (March 24, 2021), and exhibit number (4.14)—are all factually accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers from consistent exhibit referencing that the terms remained unchanged, and it synthesizes this pattern across three annual filings. (4) The conclusion about Oracle’s short-term debt strategy—emphasizing stability and retention of low-cost debt—is logically supported and semantically equivalent to the ground truth’s interpretation. The only minor limitation is that the LLM does not explicitly mention Oracle introducing *new* debt instruments in later years (a nuance in the original answer), which slightly reduces completeness in strategic context. However, the core insight about stable funding is preserved. Wording differences are acceptable and do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 366,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nOracle first created the 4.30 % senior unsecured note due 2034 in a July 8 2014 debt issuance (Exhibit 4.11 of the 2014 filing) and then repeatedly disclosed the same instrument in the “Forms of … Notes” exhibits of its 2022, 2023 and 2024 Form 10‑K filings (pages 111‑115), merely updating the filing date and officers’ certificate while preserving the original terms.  \nThis multi‑year filing pattern shows that Oracle treats long‑dated, fixed‑rate notes as a core pillar of its capital structure, regularly re‑filing the same tranche to keep it on the shelf‑registration record and to signal a strategy of diversified, staggered‑maturity debt with a stable, low‑to‑mid‑single‑digit coupon profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 4.30% Note due 2034 was first issued on July 8, 2014, and references Exhibit 4.11 of a 2014 filing—information not present in the ground truth and irrelevant to the 2022–2024 timeframe asked. The ground truth confirms the note was referenced in 2022 (Exhibit 4.11), 2023 (Exhibit 4.09), and 2024 (Exhibit 4.09), with no mention of a 2014 issuance or repeated re-filing of the same tranche. (2) Quantitative accuracy is low: while the 4.30% interest rate and 2034 maturity are correct, the issuance date (2014) and exhibit numbers for prior years are fabricated or misattributed. The LLM invents a narrative about 'updating the filing date and officers’ certificate' with no support from the original answer. (3) Multi-hop reasoning is flawed—the question asks about the evolution across 2022–2024, but the LLM extrapolates backward to 2014 without evidence. It also misinterprets the purpose of repeated disclosure, suggesting 'shelf-registration' and 're-filing the same tranche,' which is not implied in the ground truth. The correct inference is consistency in disclosure reflecting stable long-term debt strategy, not administrative re-filing. (4) Despite factual errors, the LLM captures the broader strategic implication—Oracle’s use of long-dated, fixed-rate debt as a stable capital component—so the answer is contextually relevant and semantically aligned in intent, though not in factual basis. This justifies moderate scores in qualitative accuracy and contextual relevance, but low correctness and quantitative accuracy due to critical factual misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 457,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab moved roughly $10 bn of IDA balances onto its balance sheet in 2021‑22 under the original 2020 IDA agreement, which permitted up to $10 bn of migrations each 12 months but required Schwab to maintain a $50 bn minimum IDA balance through 2031 and to keep at least 80 % of those balances designated as fixed‑rate through 2026. The May 2023 replacement agreement tightened the rules—migration could now occur only for floating‑rate portions, required Schwab to keep total IDA balances between a $60 bn floor and a $90 bn ceiling after Sep 10 2025 (with a $30 bn buffer above the unmatured fixed‑rate amount), and eliminated the 80 % fixed‑rate requirement—so Schwab’s ability to transfer balances was markedly reduced. As a result, in 2024 Schwab ceased any migrations, relying instead on buy‑downs of fixed‑rate obligations and on maintaining the required balance floors, reflecting a loss of contractual flexibility and tighter constraints.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains multiple factual inaccuracies that severely undermine its correctness. (1) It incorrectly states the original IDA agreement was from 2020, while the ground truth specifies the 2019 IDA agreement. (2) It claims Schwab moved $10 billion in 2021–22, but the original answer clarifies that $10.1 billion was moved by December 31, 2021, with $10 billion migrated *subsequent to that date*—meaning in 2022—so the timing is misrepresented. (3) The LLM claims the 2023 agreement *tightened* rules and reduced flexibility, but the ground truth states the 2023 agreement *eliminated* the 80% fixed-rate requirement, which is an *increase* in contractual flexibility, despite no balances being migrated. This is a critical reversal of meaning. (4) The LLM invents specific terms not in the original, such as a $50 billion minimum IDA balance through 2031, a $60–$90 billion balance range post-September 2025, a $30 billion buffer, and restrictions limiting migration to floating-rate portions—none of which appear in the ground truth. (5) It incorrectly attributes the lack of migration in 2024 to tighter rules, while the original answer cites capital sufficiency and balance thresholds under continued use of the 2023 agreement, which actually provided *more* flexibility. (6) The LLM mentions 'buy-downs of fixed-rate obligations' as a strategy, which is not mentioned or supported in the ground truth. While the answer attempts to address the evolution across years and contractual changes, the core facts—agreement dates, financial terms, direction of flexibility change, and migration activity—are largely incorrect. The reasoning is therefore flawed, and the conclusion contradicts the ground truth: the actual trend is a shift from active migration to inactivity *despite increased* flexibility, not *because of decreased* flexibility. Quantitative accuracy is very low due to fabricated numbers and misattributed timelines. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate as the answer addresses the general topic and timeframe, but with significant factual distortion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 575,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K filings contain only the original Exhibit 4.18 — the 2017 “Actions of the Authorized Officers with respect to Abbott’s 2.000% Notes due 2018” — and no new supplemental indentures, amendments, or refinancing transactions for those notes are disclosed. This shows the 2.000% Senior Notes due 2018 had been retired before 2022, and the company’s engagement with them during the three‑year period was limited to periodic re‑filing of the existing documentation.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly claims that Abbott only filed Exhibit 4.18 from 2017 and that the notes were retired before 2022, whereas the original answer confirms the notes were referenced in 2022, 2023, and 2024 via Exhibit 4.21 (not 4.18), indicating ongoing documentation, not retirement. The exhibit number and year are wrong, and the conclusion about retirement is unsupported. (2) Quantitatively, the LLM misidentifies the exhibit (4.18 vs. 4.21) and omits the correct reference to the Fifth Supplemental Indenture dated September 23, 2015, which is a key factual anchor in the ground truth. The 2.000% Senior Notes due 2018 were still being disclosed through 2024, so asserting retirement before 2022 is factually incorrect. (3) The reasoning is flawed: the continued inclusion of the notes in annual filings does not imply retirement but rather ongoing disclosure of legacy debt instruments, especially those tied to acquired entities like St. Jude Medical. The LLM fails to recognize that re-filing an exhibit does not mean the debt was retired; it may still be outstanding or in the process of maturing. (4) Contextually, the answer addresses the question’s timeframe and topic (documentation updates and refinancing), so it is relevant, but the core facts and synthesis are incorrect. The ground truth indicates no refinancing occurred, but the notes were still part of the capital structure, not retired. Thus, while the LLM attempts multi-hop reasoning, it draws the opposite conclusion from the evidence, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 445,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first brought the 3.650 % Notes due 2041 to market in a 2021 offering (see the 2021 Exhibit 4.16 in the 2022 10‑K, page 112) and then re‑opened and expanded the series in the 2022, 2023 and 2024 filings (Exhibits 4.16, 4.14 and the related 2024 exhibits), keeping the same coupon and 2041 maturity while adding to the outstanding amount.  This multi‑year pattern shows that Oracle is deliberately extending the average maturity of its unsecured debt and building a diversified ladder of long‑dated notes to lock in low‑cost financing for the 2040s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Oracle first issued the 3.650% Notes due 2041 in 2021, while the ground truth and SEC filings confirm the initial issuance occurred in 2022. This misstatement undermines the quantitative accuracy. However, the coupon rate (3.650%), maturity year (2041), and the fact that Oracle continued to reference and potentially expand the notes in 2023 and 2024 are consistent with the ground truth. (2) The reference to specific exhibits (e.g., 4.16, 4.14) and page numbers suggests document-level precision, but the incorrect origination year (2021 vs. 2022) is a critical error in timeline accuracy. There are no explicit dollar amounts or calculations to verify, but the claim of 're-opening and expanding' the series lacks direct confirmation in the ground truth, which only confirms continued inclusion, not necessarily an increase in principal. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic pattern of long-term debt use across years and interprets the persistence of long-dated notes as a sign of locking in low-cost financing. This aligns with the ground truth's conclusion about a stable long-term financing strategy. However, the inference about extending average maturity and building a 'ladder' of long-dated notes goes beyond the provided ground truth, which does not mention debt ladder strategy or average maturity management. (4) The contextual relevance is high, as the answer addresses both the evolution of the notes and Oracle’s long-term debt strategy. Despite incorrect initial timing, the overall interpretation of strategic intent is plausible and thematically consistent. Correctness score is 6 due to the major error in issuance year, which affects factual reliability, but partial credit is given for correct identification of the note terms and reasonable strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 519,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nOracle first issued the 2.300% senior unsecured notes maturing in 2028 in March 2021 (Officer’s Certificate dated 3/24/21). The same series is listed under Exhibit 4.16 in the 2022, 2023 and 2024 Form 10‑K filings, showing that the company has repeatedly re‑opened the tranche to add new issuances while preserving the 2.300% coupon and 2028 maturity. This multi‑year pattern demonstrates Oracle’s deliberate strategy of building a diversified, low‑cost ladder of long‑dated debt to fund operations and acquisitions while maintaining a stable, predictable financing source.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 2.300% Notes due 2028 were established via an Officer’s Certificate on March 24, 2021, and are consistently referenced in Exhibits 4.16 across 2022, 2023, and 2024 filings. The coupon rate (2.300%), maturity year (2028), and document reference (Exhibit 4.16) are correctly stated. (2) The answer correctly infers that Oracle reused or re-opened the same note series over multiple years, which is consistent with the ground truth’s observation of structural continuity. (3) However, the LLM omits mention of the 4.500% Notes due 2028 issued in 2023, which is a key part of the multi-hop reasoning—this diversification of interest rate profiles is central to demonstrating Oracle’s broader debt strategy. While the LLM correctly identifies a strategy of diversification and stability, it does not fully synthesize the 2023 expansion with different coupon rates, slightly weakening the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and semantically close to the original, correctly interpreting the long-term, stable financing strategy. Wording differences are acceptable, and the core financial facts and dates are precise. Hence, a score of 8 is justified—strong factual accuracy with minor gaps in completeness regarding multi-year debt structuring details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 393,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa layered its Currencycloud‑powered virtual‑account service into the Visa Direct network, using the platform to offer real‑time foreign‑exchange rates, liquidity and settlement for both consumer and corporate payouts; by fiscal 2024 these virtual accounts were fully integrated into Visa Direct and its B2B Connect sub‑network, giving partners access to nearly 7 billion cards, accounts and digital wallets across more than 190 countries and enabling faster, cross‑border money‑movement for B2C, P2P and G2C flows. This evolution turned virtual accounts into a core conduit for Visa’s cross‑border capabilities, expanding the reach of Visa Direct from a domestic real‑time payouts hub to a global, interoperable money‑movement engine.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts from 2022 to 2024 accurately in terms of integration into Visa Direct and expansion of cross-border capabilities. It correctly identifies the role of Currencycloud, real-time FX, liquidity, and settlement improvements. However, there are key quantitative and entity discrepancies. (2) The LLM states that by fiscal 2024, virtual accounts provided access to 'nearly 7 billion cards, accounts and digital wallets,' while the ground truth cites 'more than 11 billion endpoints.' This is a significant numerical inaccuracy. Additionally, the LLM mentions integration with 'B2B Connect sub-network,' which is not referenced in the original answer and lacks support from the provided truth. The number of countries (190+) is plausible but not confirmed in the ground truth, so it introduces unverified detail. (3) The multi-hop reasoning is generally sound—linking virtual accounts to Currencycloud, then to Visa Direct, and highlighting cross-border expansion across years. The synthesis of real-time FX and settlement enhancements aligns with the original. However, the addition of B2B Connect and incorrect endpoint count suggests overreach or hallucination in entity synthesis. (4) The contextual relevance is perfect—the answer directly addresses the question’s focus on evolution, integration, and cross-border expansion. Qualitative accuracy is high due to correct timeline and functional progression, but quantitative accuracy is reduced due to incorrect figures and unsupported specifics. Correctness score is 7 because the core facts and trajectory are right, but key numbers and some entities are incorrect or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 466,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 to 2023 the ME&T dealer network that supports EMD‑branded products grew from **41 U.S. and 111 international dealers covering 187 countries** to **44 U.S. and 116 international dealers covering 193 countries** – a modest but consistent increase in both U.S. and overseas dealer count and in the number of countries served.  The 2024 filing continues this upward trajectory, underscoring Caterpillar’s strategy of **expanding its geographic footprint and dealer presence to deepen market penetration of EMD products in emerging regions and to sustain growth in the global locomotive and engine market**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the LLM reports a dealer network of 41 U.S. and 111 international dealers (152 total) in 2022, growing to 44 U.S. and 116 international dealers (160 total) in 2023, covering 187–193 countries. This directly contradicts the ground truth, which states 110 distributors in 2022 and 2023 covering 109 countries, and 108 distributors in 2024 covering 158 countries. The LLM invents U.S./international splits and total dealer counts that are not present in the original data. (2) The ground truth focuses on distributors for EMD-branded products, specifically referencing FG Wilson branded systems, while the LLM conflates this with a broader 'ME&T dealer network' without evidence from the source. (3) The reasoning is flawed: the LLM suggests consistent growth in dealers and countries, while the actual data shows distributor count stable then slightly decreasing, with a significant geographic expansion from 109 to 158 countries in 2024—indicating efficiency optimization, not dealer growth. (4) The conclusion about 'deepening market penetration in emerging regions' is speculative and misaligned with the actual strategic inference of distribution optimization. The LLM answer fabricates data, misrepresents entities, and draws incorrect conclusions. Only minimal contextual relevance is retained as it attempts to address EMD product distribution and Caterpillar's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 410,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024, the original cost of Abbott’s diagnostics instruments leased to customers rose from $3.6 billion to $3.9 billion, while the net book value increased from $1.6 billion to $1.8 billion, after which both amounts stayed flat through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the starting values for 2022. According to the ground truth, the original cost in 2022 was $3.3 billion, not $3.6 billion as stated in the LLM answer. Similarly, the net book value in 2022 was $1.4 billion, not $1.6 billion. The LLM incorrectly presents the 2023 figures as the 2022 baseline. While the 2023-to-2024 increases to $3.9 billion (original cost) and $1.8 billion (net book value) are correct, the answer falsely claims these values 'stayed flat through 2024'—no such data supports a plateau, and the trend is one of consistent increase. (2) Quantitative accuracy is compromised: the original cost progression should be $3.3B → $3.6B → $3.9B, not $3.6B → $3.9B; net book value should be $1.4B → $1.6B → $1.8B, not $1.6B → $1.8B. The omission of the 2022 baseline and misattribution of 2023 values as 2022 values constitutes a major error. (3) The reasoning is partially sound in identifying an upward trend, but the multi-hop synthesis fails because it misaligns the time series—using incorrect starting points undermines the evolution analysis. The claim of values 'staying flat' introduces a false conclusion not supported by the data. (4) Contextual relevance is high as the answer addresses the right metric and time frame, and focuses on Abbott's leased diagnostics instruments. However, due to critical numerical and temporal inaccuracies, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of change (increase) is correct, but the reasoning is flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 444,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe 3.450 % Senior Note due 2046 appears in the exhibit sections of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings, showing that the company continues to reference and rely on this long‑dated, fixed‑rate debt year after year. Its repeated disclosure signals that the 2046 note is a core, permanent element of PepsiCo’s capital‑structure strategy—providing stable, low‑cost financing for long‑term investments and helping the company maintain a diversified maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All quantitative elements are correct: the interest rate (3.450%), maturity year (2046), and the fact that the note is disclosed in the 2022, 2023, and 2024 10-K filings are accurately stated. There are no calculation errors. (2) The answer addresses the key qualitative point—the note's ongoing role as a stable, long-term financing instrument in PepsiCo’s capital structure—emphasizing its function as fixed-rate, long-dated debt that supports long-term investments and diversifies maturity profile. (3) While the LLM does not mention the specific exhibit numbers (e.g., Exhibit 4.17 in 2022, etc.), this detail is secondary to the main inference about strategic consistency and is not essential to the central conclusion. The multi-hop reasoning—inferring strategic intent from repeated disclosure across years—is sound and logically derived. (4) The wording differs slightly (e.g., 'core, permanent element' vs. 'stable and integral component'), but the semantic meaning is equivalent. The only minor shortcoming is the omission of exhibit details, which slightly reduces completeness but does not affect factual correctness. Hence, a score of 9 is appropriate, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 366,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nOracle first set out the 2.300 % Notes due 2028 in a March 2021 debt offering (referenced in the “Forms of 2.300 % Notes due 2028” exhibit) and then carried that same description verbatim in the 2022, 2023 and 2024 Form 10‑K filings—each time citing the March 24 2021 Officers’ Certificate and providing no indication of retirement or material amendment. This repeated, unchanged disclosure shows that Oracle is using a stable, long‑dated fixed‑rate debt tranche as a core pillar of its financing, issuing senior notes on a repeatable indenture/offer‑certificate basis and maintaining a diversified, staggered maturity profile rather than retiring or restructuring the 2028 notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 2.300% Notes due 2028 were first issued in March 2021, citing a March 24, 2021 Officers’ Certificate, which directly contradicts the ground truth stating the note was first introduced in 2022 in Exhibit 4.16. This is a critical error in both timing and sourcing. Additionally, the LLM asserts that the same description was carried verbatim in 2022, 2023, and 2024 filings, but the ground truth shows evolving exhibit numbers (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024), indicating updated disclosures, not verbatim repetition. (2) Quantitative accuracy is low: the date 'March 2021' is incorrect (should be 2022), and there is no support for the claim that the certificate date was March 24, 2021. The interest rate (2.300%) and maturity year (2028) are correct, but the issuance timeline is not. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategy of maintaining stable, long-dated debt and a staggered maturity profile—but this conclusion is based on incorrect premises. The ground truth emphasizes Oracle’s practice of referencing prior notes while layering in new, higher-yield instruments (e.g., 4.500% Notes due 2028), reflecting adaptation to market conditions, which the LLM answer misses entirely. (4) Contextual relevance is high because the answer addresses Oracle’s debt strategy and the role of the 2028 notes over time, but the factual foundation is flawed, undermining the overall correctness. The answer fabricates a 2021 issuance and ignores the actual multi-year evolution of exhibits and new note issuances, leading to a partially plausible but factually incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 469,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Visa repeatedly references the identical **Certificate of Designations for Series B Convertible Participating Preferred Stock (Exhibit 4.4)** and does not report any amendment, retirement or material change to its terms.  This consistent treatment shows that Visa regards the Series B Preferred as a permanent, strategic capital layer—providing a stable, low‑cost source of financing and preserving conversion flexibility—underscoring a long‑term priority of maintaining a balanced, enduring capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Visa consistently referenced the same Certificate of Designations for the Series B Convertible Participating Preferred Stock across its 2022–2024 10-K filings without any amendments, retirements, or material changes—matching the original answer’s claim of unchanged treatment since the June 21, 2016 certificate. The exhibit number (4.4) is accurately cited. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all referenced documents and dates are correct. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosure across three years to infer strategic continuity in capital structure, correctly concluding that this reflects a long-term priority of stability and financing flexibility. While the original answer adds supporting context about unchanged Bylaws and the 2024 Certificate of Incorporation update, the LLM captures the core inference about capital structure priorities. (4) The LLM slightly omits the broader contextual evidence (Bylaws, Certificate of Incorporation) mentioned in the ground truth, which slightly reduces completeness in qualitative depth, but the central facts and logic remain correct. Wording differs but semantic meaning is equivalent. Thus, the answer is highly accurate, contextually relevant, and well-reasoned with only minor omissions in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 414,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar’s hedging program shifted from a LIBOR‑centric framework to SOFR‑linked instruments beginning in 2022, when it first disclosed the impending LIBOR discontinuation and the need to replace LIBOR‑based variable‑rate loans with SOFR benchmarks. By 2023 the company had instituted a cross‑functional team to manage interest‑rate and currency risk through selective derivatives and a diversified funding mix, explicitly noting that ineffective hedges or basis‑risk between SOFR and legacy indices could impair earnings and cash flow. In 2024 the disclosures emphasized continued refinement of those SOFR‑based hedges, heightened monitoring of market volatility and credit‑rating exposure, and the acknowledgment that while hedging mitigates adverse currency and rate movements, it also forfeits the upside of favorable rate swings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, with accurate dates and consistent focus on Caterpillar's transition from LIBOR to SOFR and its hedging practices from 2022 to 2024. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored as 10. Contextual relevance is high, as the response directly addresses the evolution of currency and interest rate hedging in relation to the LIBOR-to-SOFR transition across the three years—scored 9. However, there are qualitative inaccuracies in entity and process attribution: the ground truth states that the cross-functional team was formed in 2022 (not 2023 as the LLM claims) to assess LIBOR risks, and the shift to SOFR was part of an ongoing adaptation, not a 'shift beginning in 2022' as framed. The LLM incorrectly implies that the hedging program itself shifted to SOFR-linked instruments, while the original answer clarifies that SOFR adoption was part of interest rate risk management (not currency hedging per se), and currency hedging remained consistently managed via derivatives. The LLM conflates interest rate and currency hedging evolution, overstating integration between SOFR transition and currency instruments. Additionally, the ground truth notes no significant changes in approach by 2024, whereas the LLM describes 'continued refinement' and 'heightened monitoring,' which are not explicitly supported. These represent subtle but important misrepresentations in reasoning and entity linkage, reducing qualitative accuracy to 7. Despite these, core facts about risk disclosures, use of derivatives, and awareness of hedge limitations are present, warranting a 7/10 overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 486,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from the initial October 2021 Chapter 11 filing of LTL Management LLC—under which it funded a $2 billion talc trust and recorded a comparable reserve—to a series of legal setbacks that caused the LTL bankruptcy to be dismissed in 2023, prompting a second “pre‑packaged” Chapter 11 filing (LTL 2) and, by 2024, a new restructuring that channels all but a small fraction of talc claims into a court‑approved trust whose present‑value payment is about $6.475 billion (≈ $8 billion nominal) over 25 years, while the company’s loss‑contingency reserve has grown to roughly $9 billion (≈ $11.6 billion present value) to cover both the trust and ongoing settlements.  This evolution reflects a shift from litigating individual verdicts and defending multi‑state investigations to a coordinated bankruptcy‑based resolution strategy that combines a sizable trust, negotiated settlements with states and other claimants, and continued appeals to achieve a comprehensive, final settlement of talc liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some elements of Johnson & Johnson's legal strategy. (1) The original answer states that J&J established a $2 billion trust in 2022 and maintained reliance on the LTL structure through 2024, with ongoing appellate efforts. However, the LLM claims a $6.475 billion present-value trust (≈$8 billion nominal) and a loss-contingency reserve of $9 billion (≈$11.6 billion present value), which are not supported by the ground truth and represent major overstatements. (2) The LLM incorrectly references a 'new restructuring' in 2024 that channels claims into a multi-billion-dollar expanded trust, which is not mentioned in the original answer—instead, the ground truth notes multi-state settlements but no such trust expansion. (3) The LLM mentions an October 2021 filing, which predates the 2022–2024 scope of the question and introduces irrelevant information. (4) While the LLM correctly identifies the dismissal of the initial LTL bankruptcy, the refiling (LTL 2), and continued appeals, it misrepresents the financial scale and outcome of the strategy. (5) The qualitative reasoning around shifting from litigation to a bankruptcy-based resolution is partially sound and contextually relevant, but the synthesis is flawed due to unsupported financial figures. The contextual relevance is high because the answer addresses the evolution of legal and financial strategy, but correctness is severely undermined by invented numbers and an exaggerated resolution outcome not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 439,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed the Photography Plan from a simple, low‑cost subscription that bundled Photoshop + Lightroom as an entry‑point into Creative Cloud into a tightly integrated tier of the Creative Cloud ecosystem that is powered by generative‑AI.  Each year Adobe added AI‑driven features (e.g., Generative Fill/Expand in Photoshop, Firefly‑powered tools and extra Generative Credits), expanded collaboration integrations such as Frame.io, and introduced flexible, credit‑based pricing to attract both hobbyist and professional photographers while nudging them toward higher‑value Creative Cloud plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Adobe's Photography Plan from 2022 to 2024, noting its transformation from a basic bundle into an AI-enhanced, integrated offering within Creative Cloud. The key elements—Photoshop and Lightroom inclusion, generative AI features (e.g., Generative Fill), Generative Credits, and positioning for both hobbyists and professionals—are all factually correct. (2) There are no numeric values (e.g., prices, credit amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the strategic shift over time, including AI integration, product-led growth implications, and ecosystem positioning. It accurately infers that AI features like Generative Fill and Firefly-powered tools were rolled out progressively, consistent with 2023–2024 enhancements. The mention of Frame.io and credit-based pricing adds contextual detail not in the original but is factually plausible and relevant. (4) Minor deduction in qualitative accuracy because the original emphasizes the Photography Plan as a 'more limited alternative to the full Creative Cloud suite,' a nuance slightly underemphasized in the LLM response. However, the core facts, timeline, and strategic direction are correctly conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 410,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same “Form of specimen certificate for class C common stock” (Exhibit 4.2) unchanged in its filings from the 2022 10‑K through the 2023 10‑K and into the 2024 10‑K, with no amendment or new certificate issued. This uninterrupted use of the original specimen certificate demonstrates a deliberate, stable approach to shareholder documentation, underscoring Visa’s consistent corporate‑governance practices and its commitment to predictable, transparent investor relations amid evolving regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa has maintained the same Form of Specimen Certificate for Class C Common Stock (Exhibit 4.2) across its 2022, 2023, and 2024 10-K filings, with no changes or amendments. This matches the original answer’s core fact. (2) Quantitatively, while no numerical values (e.g., dollar amounts) are present, the reference to Exhibit 4.2 and the consistency across years is factually correct. The original answer adds the detail that the exhibit was originally filed on January 28, 2009 (8-A, File Number 000-53572), which the LLM omits, but this is a minor contextual omission rather than an error. (3) The reasoning is sound: the LLM correctly infers that this consistency reflects a stable, deliberate approach to corporate governance and investor relations, especially amid regulatory and market changes. It appropriately contrasts this stability with broader changes without overreaching. (4) The answer is contextually relevant and fully addresses both parts of the question—documentation consistency and implications for governance and investor relations. The only reason for not scoring a 10 is the omission of the specific filing date and form type (8-A) from 2009, which adds precision to the original answer. However, this does not undermine the overall correctness or meaning. Semantic equivalence is maintained, and the conclusion drawn is logically supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 405,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees declined from **$1.157 billion at the end of 2022 to $1.109 billion in 2023 and to $0.993 billion by the end of 2024**.  The drop is driven by fewer new guarantees being issued, ongoing settlements of prior claims and downward adjustments to earlier estimates.  This trend shows that the company is effectively reducing its exposure to aerospace‑engine performance risk, but a sizable liability still remains, indicating continued risk‑management focus on commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM reports total accrued liabilities of $1.157B, $1.109B, and $0.993B—over 8 times larger than the ground truth figures. These numbers do not match any entity or metric in the original answer and appear to be fabricated or misattributed. (2) The calculation of a decline from $1.157B to $0.993B is numerically consistent within the LLM’s own narrative, but since the starting values are entirely wrong, the entire quantitative foundation fails. There is no indication in the ground truth that RTX had a total liability of nearly $1.2B for this category. (3) The multi-hop reasoning is flawed: the LLM misidentifies the metric (reporting RTX’s total accrued liability instead of the partners’ share of financing guarantees), misrepresents the scale, and incorrectly attributes the trend to broader risk reduction without grounding in the actual data about partner-sharing dynamics. The original answer emphasizes stability and slight reduction in shared liability, indicating risk redistribution or renegotiation, while the LLM implies a large-scale internal liability reduction, which is not supported. (4) Despite the factual inaccuracies, the LLM attempts to address both parts of the question—evolution of liabilities and implications for risk management—and provides a logically structured interpretation, giving it moderate contextual relevance. However, due to severe quantitative and entity-level errors, the correctness and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 468,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco’s accounting for lease‑rent holidays has remained the same from 2022‑2024: free‑rent and step‑rent periods are recognized on a straight‑line basis over the **entire lease term**, which now explicitly includes any renewal or extension options that management deems “reasonably certain” to be exercised. The right‑of‑use asset is initially measured at the present value of the discounted minimum lease payments (i.e., excluding rent‑free periods), so the inclusion of renewal options that are deemed probable lowers the total number of payments and therefore reduces the initial ROU‑asset valuation. While the core methodology has not changed, the 2023‑2024 filings added clearer language about renewal‑option assessment and the discount‑rate determination, making the disclosure more explicit but leaving the measurement approach unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of straight-line recognition for free-rent and step-rent periods over the lease term, including renewal options that are reasonably certain to be exercised, which aligns with the ground truth. It accurately notes the use of the present value of lease payments to measure the right-of-use (ROU) asset and correctly references the incremental borrowing rate (implied via 'discounted minimum lease payments'), satisfying quantitative and entity accuracy. There are no numeric inaccuracies, and all fiscal years (2022–2024) are properly referenced. However, the LLM introduces a misleading claim that including renewal options 'lowers the total number of payments' and thereby 'reduces the initial ROU-asset valuation,' which is incorrect: extending the lease term increases the total lease liability (and ROU asset), not decreases it, because more periods of rent are capitalized—even if free-rent periods are spread over a longer time. This reflects a flaw in reasoning. Additionally, while the LLM mentions increased clarity in 2023–2024 disclosures, it omits the key evolution noted in the ground truth: the 2023 clarification on variable lease payments tied to indices or sales volume and the 2024 emphasis on impairment evaluation in the context of facility relocations or closures. These omissions reduce completeness and qualitative accuracy. The core accounting policy stability is correctly conveyed, and the answer remains contextually relevant, but the reasoning error and missing disclosures prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 433,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved AI‑powered document productivity from a behind‑the‑scenes “Sensei‑driven” enhancement of PDFs toward a branded, generative‑AI offering embedded directly in Acrobat—introducing features such as Generative Fill, Generative Expand and Generative Credits and positioning the suite as “Adobe Document Cloud AI” and “Acrobat AI.”  This shift was supported by increased R&D investment in foundation models (e.g., Firefly) and by formally naming the AI‑enhanced document workflow under the Adobe Document Cloud and Acrobat AI umbrellas, underscoring a strategic focus on monetizing AI‑driven document automation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Adobe's strategic shift toward AI-powered document productivity from 2022 to 2024 and identifies key developments such as branded AI features and increased R&D focus. However, it introduces specific feature names—'Generative Fill', 'Generative Expand', and 'Generative Credits'—and branding like 'Adobe Document Cloud AI' and 'Acrobat AI' that are not present in the ground truth. The original answer only confirms the introduction of the 'Acrobat AI Assistant' as a formal branded extension in 2024, not the broader branding claimed by the LLM. Additionally, while the LLM mentions Firefly as part of R&D investment, the ground truth does not specify any foundation model by name, making this an unsupported detail. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no incorrect numbers or miscalculations are present. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a progression from underlying AI (Sensei) to product-level branding, aligning with the evolution described in the ground truth. However, it overreaches by naming unverified features and branding not supported by the source, weakening the factual synthesis. (4) The contextual relevance is high because the answer addresses all key dimensions of the question—Acrobat's evolving role, R&D investments, and branding—though with some speculative elaboration. The correctness score is 7 because the core trajectory is accurate, but specific unsupported claims reduce factual precision. Qualitative accuracy is also 7 due to correct reasoning but incorrect entity details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 459,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab trimmed the amount of client‑margin securities it pledged for external funding—its secured uncommitted credit lines fell from about $950 million in 2023 to $500 million in 2024, and FHLB borrowings that are backed by pledged investment securities dropped from $26.4 billion to $16.7 billion—while the overall pool of client securities that could be pledged stayed large (≈ $120 billion).  This deliberate de‑leveraging shows the firm is shifting toward a more internally funded balance sheet and is curbing the use of client collateral to finance short‑term liquidity, indicating a pull‑back in client‑driven leverage.  The trend reflects a strategic emphasis on preserving liquidity and reducing reliance on client‑secured borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The key factual claims—such as Schwab reducing pledged client securities from $950M to $500M in credit lines and FHLB borrowings dropping from $26.4B to $16.7B—are not supported by the original answer and introduce specific numbers absent from the source. The ground truth does not quantify pledged amounts in 2022 or 2023, nor does it mention any reduction in pledged securities; instead, it describes an expansion and formalization of client securities usage. (2) The quantitative inaccuracies are severe: the LLM fabricates dollar amounts and trends (e.g., 'deleveraging', 'trimming') that are not in the original and directly oppose the stated trend of increasing formalization and expanded use of client securities. (3) The reasoning is flawed: rather than showing a pullback in leverage, the original indicates rising client participation in leveraged products and broader use of client assets for operational efficiency. The LLM incorrectly infers a strategic retreat from client collateral use, when the truth suggests the opposite. (4) While the answer addresses the general topic of client securities and balance sheet strategy, it misrepresents the direction of the trend and invents data, making it factually unsound. The contextual relevance is moderate because it engages with the right themes (margin lending, balance sheet strategy) but draws opposite conclusions with fabricated metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 405,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nCostco has consistently presented the 1.375 % Senior Notes due June 2027 as long‑term debt – the notes were never re‑classified to the current portion in any of the 2022‑2024 filings.  The carrying amount of the notes stayed at $1.25 billion throughout the three years, but the composition of the company’s total long‑term debt changed: after the 2024 repayment of the $1 billion 2.75 % notes due May 2024, total long‑term debt fell from $6.59 bn (2022) to $5.92 bn (2024), so the 1.375 % notes grew from roughly 19 % of total long‑term debt in 2022 to about 21 % of the $5.92 bn balance in 2024, while the current portion of debt declined sharply.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1.25 billion and were consistently classified as long-term debt with no reclassification to current portion, which matches the ground truth. However, there are significant quantitative inaccuracies in the total long-term debt figures: the LLM states $6.59 billion in 2022 and $5.92 billion in 2024, while the ground truth reports $6,484 million (2022) and $5,794 million (2024). These discrepancies affect derived percentages. The LLM claims the 1.375% notes grew from ~19% to ~21% of total long-term debt, but using ground truth numbers: in 2022, $1,250 / $6,484 ≈ 19.3% (close), but in 2024, $1,250 / $5,794 ≈ 21.6%, so the directional trend is correct but the exact figures are based on incorrect totals. (2) The LLM incorrectly states that the 2.750% Senior Notes due May 2024 had a principal of $1 billion; the ground truth does not specify the amount, but the overall change in long-term debt ($6,484M to $5,794M = $690M decrease) suggests it was not $1B unless other adjustments occurred. The repayment timing is correct. (3) The multi-hop reasoning is sound in concept—linking note classification, overall debt composition changes, and the impact of maturity-related reclassifications—but relies on inaccurate base numbers. The synthesis across years and instruments is appropriate and addresses the evolution question. (4) The contextual relevance is high as the answer directly addresses both parts of the question: treatment of the 1.375% notes and evolution of long-term debt composition. Due to material errors in key financial figures, the correctness score is reduced to 6 despite correct qualitative trends and proper identification of the notes’ stable carrying value and classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 489,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe has moved its free, online, self‑service learning from a stand‑alone training option into a central element of its broader learning‑and‑enablement portfolio, linking it directly to skills‑assessment tools, Journey Optimizer insights and Customer Success Manager workflows; the company now uses these self‑service modules to align employee and client learning pathways with enterprise‑wide digital‑experience initiatives, embedding learning metrics into customer‑success performance goals and enabling real‑time tracking of adoption and ROI across its Experience Cloud suite.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces several unverified claims not supported by the ground truth. (1) Correct elements: The general trend of free online self-service learning becoming more central to Adobe's learning portfolio from 2022 to 2024 aligns with the original answer. The emphasis on integration with enterprise learning and success strategies is also consistent. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, user counts) in either answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning issues: The LLM overreaches by asserting integration with 'Journey Optimizer insights' and 'Customer Success Manager workflows' and claiming that learning metrics are embedded into 'customer-success performance goals' and used for 'real-time tracking of adoption and ROI'—none of which are mentioned or implied in the ground truth. These are specific product and process claims that go beyond the documented evolution. (4) The original answer notes a maturing integration with enterprise success strategies through skills assessments and custom learning services, but does not support the level of technical or operational integration (e.g., real-time tracking, ROI measurement, Journey Optimizer) claimed by the LLM. The LLM answer is more detailed and sounds plausible, but fabricates specifics not present in the source data. Thus, while the directional trend is correct, the qualitative accuracy is reduced due to unsupported assertions. Contextual relevance remains high because the response addresses the core theme of evolution and integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 452,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the carrying amount of NVIDIA’s 2.00 % Notes Due 2031 remained essentially unchanged at about $1.25 billion (carrying value), with only modest fair‑value fluctuations—from roughly $1.04 billion in 2023 to $1.06 billion in 2024. This flat‑line exposure shows that, amid rapid AI‑driven revenue growth, NVIDIA is maintaining a conservative, low‑leverage debt profile, using a stable, long‑dated fixed‑rate issue rather than expanding debt to fund its expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024—showing a clear fluctuation. The LLM incorrectly states that the carrying amount remained 'essentially unchanged at about $1.25 billion' and cites fair-value fluctuations from $1.04B to $1.06B, which contradicts the ground truth. The $1.057B figure in 2023 is misrepresented as $1.04B, and the 2022 value of $1.20B is omitted entirely. (2) The LLM confuses carrying value with fair value, incorrectly attributing the lower amounts to fair-value fluctuations while asserting a stable carrying value. However, the ground truth indicates changes in the actual exposure (carrying value), not just fair value. There is no mention in the original answer of fair value being the driver of these numbers. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the decrease and subsequent increase in debt exposure, leading to an incorrect conclusion about a 'flat-line' and 'conservative, low-leverage' strategy. In contrast, the ground truth suggests a dynamic strategy—reducing then increasing exposure—likely tied to AI-driven investments. The LLM’s reasoning does not align with the actual pattern. (4) While the answer is relevant to the question and discusses debt management in the context of AI growth, the factual inaccuracies severely undermine correctness. The contextual relevance is moderate because it addresses the right topic and attempts strategic interpretation, but the foundation is factually unsound. Quantitative accuracy is very low due to incorrect figures and mischaracterization of financial data. Qualitative accuracy is low due to flawed reasoning and misinterpretation of the debt trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 508,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly describes a multi‑year, enterprise‑wide program to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes specifically to expand its financial shared‑service capability and to standardize financial systems.  Each filing emphasizes that the effort is a proactive strategic initiative—not a response to a control weakness—and that the company continues to align and streamline the design and operation of its financial control environment as the program matures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies Johnson & Johnson's multi-year initiative (referred to as J&J) from 2022 to 2024 to enhance financial shared services and standardize systems. The key point that the initiative is proactive, not in response to control deficiencies, is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent narrative across years and correctly infers the strategic focus on control environment alignment and standardization. However, the LLM slightly overreaches by including 'HR, IT, procurement, supply-chain' as explicitly targeted functions—while the ground truth mentions 'key functions including finance,' it does not list the others. This minor expansion reduces qualitative accuracy slightly but does not undermine the core correctness. (4) The answer remains highly contextually relevant, directly addressing the evolution of the initiative and what it indicates about strategic focus. Despite minor overgeneralization of scope, the central message aligns with the ground truth, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 367,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nFrom 2022 through 2024 Costco’s filings shifted from merely listing BJ’s Wholesale Club as one of several warehouse‑club competitors to positioning Kirkland Signature as the central differentiator in that segment.  Each year the disclosures emphasized that Kirkland products deliver higher quality at lower prices, generate higher margins, and that the company intends to keep expanding their sales‑penetration—using the private‑label brand as a strategic lever to set Costco apart from BJ’s and other clubs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Costco's competitive positioning against BJ's Wholesale Club from 2022 to 2024, with accurate emphasis on Kirkland Signature as a strategic differentiator. It correctly identifies the consistent messaging around higher quality, lower prices, higher margins, and expansion of private-label penetration. Quantitative accuracy is perfect—no numerical or date inaccuracies, and all years (2022–2024) are correctly referenced. Contextual relevance is strong, directly addressing the question about competitive positioning and private-label strategy. However, the LLM omits a key nuance present in the original answer: the 2023 addition of sustainability initiatives linked to brand loyalty (though not explicitly to Kirkland), and the 2024 shift in tone toward 'differentiating our merchandise offerings' in competitive metropolitan markets. While the LLM conveys a general intensification of strategic emphasis, it misses this specific evolution in language and context. This omission prevents a top score, but the answer remains factually sound and well-reasoned, with accurate entity identification (Costco, BJ's, Kirkland Signature) and correct multi-hop synthesis across years and strategic themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 353,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s exposure to U.S. state and municipal securities in its available‑for‑sale portfolio slipped only modestly—from $638 million (2022) to $579 million (2023), with the 2024 filing continuing to list virtually all portfolio securities as investment‑grade.  This stable, high‑quality tilt reveals that Schwab’s fixed‑income strategy is deliberately conservative, emphasizing credit‑safe, highly rated municipal and agency bonds to preserve capital and meet regulatory standards while keeping lower‑rated or higher‑yield assets to a minimal role.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Schwab first disclosed a specific $638 million investment in U.S. State and Municipal Securities in 2023—not 2022. The LLM incorrectly states that the amount was $638 million in 2022 and declined to $579 million in 2023, introducing a number ($579M) not present in the original answer and misattributing the timeline. There is no mention of a $579 million figure or any decline in the ground truth, making this a major quantitative error. Additionally, the 2024 data in the original answer does not include a specific dollar amount but reaffirms investment-grade quality, which the LLM omits as a quantitative update. (2) The calculation of a 'decline' from $638M to $579M is fabricated and unsupported by the source, failing the quantitative accuracy check. The only correct number is the $638 million, but it is placed in the wrong year. (3) The reasoning partially captures the qualitative intent—Schwab’s emphasis on investment-grade securities and a conservative fixed income strategy—but incorrectly infers a downward trend due to the false numerical sequence. The multi-hop synthesis fails because it misaligns the timeline and invents data points, undermining the logical foundation. (4) Despite the factual errors, the LLM correctly identifies the strategic implication of favoring high-quality, lower-risk fixed income instruments, which aligns with the original answer’s conclusion. Thus, while the contextual relevance is high and the strategic interpretation is reasonable, the correctness score is low due to critical factual and numerical inaccuracies that distort the actual evolution of the investment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 475,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s “maximum‑potential‑payment” exposure under commercial‑aerospace financing guarantees slipped from roughly **$304 million** to **$288 million** and then to **$274 million**, reflecting a modest contraction in the size of its guarantee commitments.  At the same time the amount of those guarantees that is covered by collaboration partners fell from **$140 million** (2022) to **$135 million** (2023) and **$131 million** (2024), showing that RTX is progressively **retaining a larger share of the risk itself** rather than passing it on to partners.  In other words, the company is shifting from a relatively higher‑partner‑risk‑transfer model toward greater internal risk retention.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the collaboration partners' share of guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, which matches the ground truth exactly and supports accurate trend analysis. However, it introduces a new metric—'maximum-potential-payment' exposure of $304M, $288M, and $274M—that is not present in the original answer or ground truth knowledge graph. This figure appears to be hallucinated or sourced from outside the provided context, undermining quantitative accuracy. (2) While the逐年 decline in partner-covered guarantees is correctly reported and interpreted as a shift toward greater internal risk retention, the inclusion of unsupported total exposure figures distorts the factual basis of the response. The ground truth does not mention 'maximum-potential-payment' or any total guarantee amounts, so these numbers cannot be verified and likely reflect incorrect data synthesis. (3) The multi-hop reasoning regarding risk transfer strategy—inferring increased internal risk retention due to declining partner shares—is logically sound and aligns with the original answer’s conclusion. This shows good qualitative reasoning. (4) Contextually, the answer addresses both parts of the question: the evolution of exposure and the implication of the trend in partner contributions. Despite the hallucinated total exposure values, the core interpretation about RTX's risk strategy is consistent with the ground truth. However, the introduction of unverified financial figures significantly reduces overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 438,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe expanded Frame.io from a video‑review tool into a full‑stack, cloud‑native collaboration hub. It now accepts a broader set of file types—including still images, design files and PDFs—and is tightly integrated with multiple Creative Cloud applications (Premiere Pro, After Effects, Photoshop, Lightroom, Adobe Express and Firefly Services) as well as the GenStudio content‑production platform, positioning Frame.io as a central node that streamlines the entire content‑production workflow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io from 2022 to 2024 in terms of integration and workflow role. It correctly identifies Frame.io's expansion into a cloud-native collaboration hub with support for still images, design files, and PDFs, aligning with the 2023 and 2024 developments in the ground truth. The integrations with Premiere Pro, After Effects, Photoshop, and Lightroom are accurately noted, as is the broadening into end-to-end workflows. However, the LLM incorrectly includes 'Adobe Express' and 'Firefly Services' as integrated platforms—these are not mentioned in the ground truth. Additionally, 'GenStudio' is referenced, which does not appear in the original answer and may be a hallucination or misattribution. The ground truth specifically notes integration with Workfront in 2024, which the LLM omits. While the overall trajectory and qualitative shift are well-represented, these entity inaccuracies prevent a top score. There are no numerical values to assess, so quantitative accuracy is rated as 10 by default. The reasoning is sound in showing a progression from video review to full workflow integration, and the answer remains highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 342,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the VH‑92A’s production role receded within the Rotary and Mission Systems (RMS) portfolio.  In the 2022 filings the VH‑92A was listed as a core Sikorsky helicopter for the U.S. Marine One mission, and RMS net‑sales growth was tied to broader Sikorsky volume gains.  By the 2024 update the segment’s sales growth was described as being “primarily attributable to higher production volume on the CH‑53K” with only a modest, offsetting decline noted for the VH‑92A, signalling that while the type remains strategically important for Marine‑One transport, the company is shifting its production emphasis toward higher‑volume, higher‑margin platforms such as the CH‑53K and related IWSS/C6ISR programs.  This multi‑year progression reflects a deliberate re‑allocation of resources within RMS, underscoring the VH‑92A’s continued strategic relevance but a reduced emphasis relative to other growth‑driving helicopter programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a fundamental contradiction in reasoning and factual alignment with the ground truth. While it correctly identifies the VH-92A as part of the RMS portfolio and references relevant programs like the CH-53K and Sikorsky, it incorrectly asserts that the VH-92A's production role 'receded' and that there was a 'modest decline' in 2024, which contradicts the ground truth stating the program was consistently highlighted across 2022–2024 as a stable, ongoing commitment. The ground truth does not mention any decline or reduced emphasis, but rather emphasizes sustained strategic importance despite shifting priorities. The LLM introduces a narrative of resource reallocation and reduced emphasis not present in the original data. Quantitatively, no specific numbers (e.g., dollar amounts, percentages, units produced) are provided in either answer, so the LLM does not introduce numerical inaccuracies—hence a higher score on quantitative accuracy. However, the qualitative reasoning is flawed: the multi-hop synthesis incorrectly infers a strategic downgrading of VH-92A based on increased focus on CH-53K, when the ground truth treats both as coexisting priorities. The answer is contextually relevant and addresses the right segment and time frame, but draws an unsupported conclusion about shifting emphasis, undermining the correctness of the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 382,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 to 2024 the regulatory landscape for Mondelez’s sales‑ and media‑marketing activities shifted from a relatively fragmented, country‑by‑country patchwork toward a more coordinated, higher‑stringency regime, especially in the EU and in key emerging markets.  In the European Union, the number of member states applying extended‑producer‑responsibility (EPR) packaging‑waste schemes grew from a handful in 2022 to over 25 by 2024, and several countries introduced stricter front‑of‑pack labeling and time‑of‑day advertising limits for products with high‑nutrient‑profile scores.  At the same time, emerging markets such as India, Vietnam, Indonesia and the Philippines began rolling out mandatory EPR obligations, single‑use‑plastic bans and tighter nutrient‑profile advertising rules, expanding the geographic scope of restrictions beyond the EU and tightening the overall regulatory stringency across the company’s global sales and marketing channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the expansion of EPR policies in the EU from a few countries in 2022 to over 25 by 2024, matching the original answer's claim of 'over 25 EU countries' implementing EPR policies by 2022–2023. The slight discrepancy in timing (ground truth says 'over 25 in 2022', LLM says 'grew from a handful in 2022 to over 25 by 2024') is minor and may reflect interpretation of rollout timelines; the core fact of widespread EU EPR adoption by 2024 is consistent. (2) The LLM accurately captures the geographic expansion into emerging markets—specifically naming India, Vietnam, Indonesia, and the Philippines—as the original answer notes India, Vietnam, and Southeast Asia broadly. The inclusion of Indonesia and the Philippines is a reasonable inference given the regional trend. (3) The LLM adds detail not in the original—such as front-of-pack labeling and time-of-day advertising limits—linked to nutrient profiling, which is plausible and contextually consistent with increasing regulatory stringency, though not explicitly confirmed in the ground truth. This does not introduce error but adds reasonable context. (4) The synthesis across years and regions is sound: the answer correctly traces increasing geographic scope (EU to emerging markets) and regulatory stringency (EPR, plastic bans, marketing rules). (5) The mention of data privacy in the original answer is missing in the LLM response, which is a minor omission but does not undermine the core correctness. Overall, the answer is factually strong, well-reasoned, and contextually appropriate, warranting a 9/10 due to slight timing nuance and one omitted regulatory area (data privacy), but no major errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 478,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nThe 3.700 % Notes due 2046 are first disclosed in the 2022 10‑K as part of the 11th Supplemental Indenture (dated August 8 2016), where they are presented as long‑term senior unsecured debt with a fixed 3.70 % coupon and no current‑portion classification. Both the 2023 10‑K and the 2024 10‑K continue to reference the same indenture— the 2023 filing adds a 15th Supplemental Indenture (Nov 6 2023) that expands the series but does not alter the terms of the 2046 notes, and the 2024 filing again lists the 3.70 % 2046 notes unchanged within the original indenture framework. This consistent, unchanged treatment signals that Microsoft is preserving its original long‑dated fixed‑rate debt, using later supplemental indentures only to add new tranches while maintaining a stable, low‑cost long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 are consistently referenced under the Eleventh Supplemental Indenture dated August 8, 2016, in all three 10-K filings (2022, 2023, 2024), and their terms remain unchanged. The mention of the 15th Supplemental Indenture in the 2023 filing (dated November 6, 2023) is factually accurate and correctly noted as not altering the 2046 notes—this additional detail is consistent with the knowledge graph and reflects proper synthesis. (2) Quantitative elements—interest rate (3.700%), maturity year (2046), indenture dates (August 8, 2016; November 6, 2023)—are all precise and correctly formatted. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and multiple indentures, recognizing that new supplemental indentures do not affect existing notes. (4) The conclusion about Microsoft’s long-term debt strategy—preserving stable, fixed-rate, long-dated debt—matches the ground truth’s interpretation. The only minor shortcoming is that the LLM does not explicitly state that *no modifications occurred across all three years* in the same emphatic way as the original answer, slightly weakening the synthesis. However, this is implied through 'unchanged' and 'consistent treatment.' Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 403,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were originally created under the Eleventh Supplemental Indenture dated August 8 2016, which is cited in the 2022 10‑K as part of Microsoft’s senior unsecured debt. In the 2023 10‑K the same indenture is still listed, but the notes are now shown as the current portion of long‑term debt because they mature in 2023, and a later Fifteenth Supplemental Indenture filed in November 2023 adds new, longer‑dated series (e.g., 2025‑2060 maturities). By the 2024 10‑K the 2.000% 2023 notes have been retired, and Microsoft’s debt maturity structure has progressed to include newer supplemental indentures that extend maturities out to 2025‑2060.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies compared to the ground truth. (1) Correct elements: The origin of the 2.000% Notes due 2023 under the Eleventh Supplemental Indenture dated August 8, 2016, is accurately cited, matching the 2022 10-K reference in Exhibit 4.14. The mention of the Fifteenth Supplemental Indenture in November 2023 and the issuance of new debt with maturities from 2025–2060 aligns with Microsoft’s broader debt strategy. (2) Quantitative inaccuracies: The key error lies in claiming that the 2.000% Notes due 2023 were 'retired' by the 2024 10-K. The ground truth explicitly states that the notes were *still listed* in Exhibit 4.14 in the 2024 filing, even post-maturity, indicating ongoing disclosure, possible rollover, or delayed treatment—not retirement. This is a major factual deviation. Additionally, the LLM asserts the notes were reclassified as 'current portion of long-term debt' in 2023, which may be plausible but is not confirmed in the ground truth and thus presented as definitive when it should be qualified. (3) Multi-hop reasoning: The model attempts to synthesize across years and indentures, showing awareness of progression in debt structure. However, it incorrectly infers retirement in 2024, failing to recognize the significance of continued disclosure post-maturity, which undermines the reasoning chain. (4) Contextual relevance is high—the response directly addresses the evolution of the notes and supplemental indentures across the three years, using appropriate financial terminology and structure. Despite this, the core factual error about the status in 2024 reduces correctness significantly. Minor flexibility is allowed for phrasing, but stating retirement when the ground truth indicates continued presence is a critical mismatch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 500,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 filing the company disclosed that Non‑Employee RSU awards were governed by the **Amended and Restated 2013 Stock Award and Incentive Plan**, using the form labeled 10.42; the same plan and agreement language continued to be referenced in the 2023 and 2024 filings, with only minor updates to reflect the plan’s most recent amendment (effective December 8 2017 and any subsequent 2023‑2024 plan modifications).  Earlier years had relied on the 2003 Long‑Term Incentive Plan and the 2008 Stock Award and Incentive Plan, but by 2022 onward the **2013 plan** became the sole underlying incentive plan for all Non‑Employee RSU awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the exhibit number and a slight overstatement about 'subsequent 2023–2024 plan modifications.' (1) Quantitatively, the key date — December 8, 2017 — for the Amended and Restated 2013 Stock Award and Incentive Plan is correctly cited, which matches the ground truth. However, the LLM references 'form labeled 10.42' in 2022, while the original answer specifies Exhibit 10.45, which is a factual discrepancy. This exhibit number is a verifiable detail and should be accurate. (2) The answer correctly identifies that the 2013 plan was the sole underlying plan in 2022, 2023, and 2024, replacing earlier plans like the 2003 and 2008 plans — this contextual evolution is accurate and adds useful background not explicitly in the ground truth, enhancing completeness. (3) Qualitatively, the reasoning is sound: it captures the continuity of the agreement form and the stability of the underlying plan across years, which is the core of the multi-hop synthesis required. However, the mention of 'any subsequent 2023–2024 plan modifications' is unsupported by the original answer, which states the same Amended and Restated 2013 plan (as of 2017) was referenced without indication of further amendments in those years. This introduces a small factual overreach. (4) Contextual relevance is excellent — the response directly addresses the evolution of the agreements and the referenced plans across the three years, using appropriate terminology and structure. Overall, the answer is factually strong with minor errors in exhibit labeling and speculative wording on amendments, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 467,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the share of assets in MDLZ’s non‑U.S. pension plans that is held in buy‑in annuity contracts rose dramatically – from roughly **16 % of the portfolio in 2022** to **about 75 % in 2024** (the 2023 filing does not break out the percentage, but the absolute balance of “buy‑in annuity contracts and other” fell only slightly while the total plan assets shrank, driving the percentage up).  This rapid increase reflects MDLZ’s deliberate de‑risking of its international pension obligations: by swapping plan liabilities for annuity contracts it transfers the payment risk to insurers, improves the funded status of the plans and reduces exposure to market‑return and interest‑rate volatility.  The trend therefore signals a strategic shift toward liability‑driven management of its non‑U.S. pension obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude. The ground truth states that MDLZ's allocation to buy-in annuity policies *decreased* from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. In contrast, the LLM claims the allocation *rose dramatically* to 75% in 2024, which is the opposite trend. This major factual error invalidates the entire response. (2) Quantitative accuracy is extremely low: the LLM misreports 16% as the 2022 figure (ground truth is 17%), omits the 2023 value (which is available in the ground truth), and fabricates a 75% allocation in 2024 with no supporting evidence. The claim that total plan assets 'shrank' and drove the percentage up is unsupported and contradicts the knowledge graph. (3) The multi-hop reasoning is flawed: instead of identifying a shift away from annuities toward fair value estimation, the LLM incorrectly infers a de-risking strategy via increased insurer risk transfer, which is the opposite of what occurred. The conclusion about liability-driven management is therefore based on false premises. (4) Contextual relevance is low but not zero—the response addresses pension obligations and liability management, so some topical alignment exists. However, due to pervasive factual and directional errors, the answer misrepresents the company's actual strategy. Correctness and accuracy scores are near-minimal due to complete inversion of trend and invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 407,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nMicrosoft first created the 2.000 % senior notes maturing 2023 in the 2016‑2017 supplemental‑indenture series (the Eleventh Supplemental Indenture of August 8 2016).  In the FY 2022 filing the notes were still listed as a near‑term obligation, and the filing made no reference to any new issuance—only a reaffirmation of the existing issue.  The FY 2023 filing records the **Fifteenth Supplemental Indenture (Nov 6 2023)**, which increased the aggregate principal of the 2.000 % notes and extended certain maturity dates, marking the final step of a modest refinancing cycle; the FY 2024 filing shows the notes now classified as short‑term with no further supplemental amendments, indicating that Microsoft had completed its issuance/extension of that series and moved on to newer, longer‑dated debt.  This progression reveals a long‑term debt strategy that relies on issuing low‑coupon, long‑dated notes, periodically refinancing near‑term maturities to maintain a stable funding base while gradually rolling off short‑dated obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly claims that the FY 2023 filing records a 'Fifteenth Supplemental Indenture (Nov 6 2023)' that increased the principal and extended maturity dates of the 2.000% Notes due 2023. The ground truth states that the same notes were consistently referenced in Exhibit 4.14 across all three years with identical details, showing no changes or refinancing. There is no mention of a Fifteenth Supplemental Indenture or any amendment in 2023. (2) The claim that Microsoft refinanced or extended the 2.000% Notes due 2023 is false; the original answer explicitly states there was no retirement or refinancing ahead of schedule. (3) The assertion that the FY 2024 filing shows the notes 'classified as short-term with no further amendments' implying a completed refinancing cycle is unsupported—the ground truth confirms the notes remained disclosed under the same exhibit, but does not state they were reclassified as short-term. (4) The reasoning about a 'refinancing cycle' and 'rolling off short-dated obligations' misrepresents Microsoft's strategy as described in the original answer, which emphasizes stability and consistency, not active refinancing. While the LLM correctly identifies the initial issuance date (August 8, 2016) and the note's presence in annual reports, the core narrative about evolution and strategy is factually incorrect. Quantitative accuracy is low due to fabricated dates (Nov 6 2023), incorrect indenture numbers, and implied changes in principal/maturity not present in the source. Qualitative accuracy suffers from flawed multi-hop reasoning—instead of recognizing consistent disclosure as evidence of stability, it infers changes not supported by the data. Contextual relevance is moderate because the answer addresses the right topic and timeframe, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 514,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nThe 4.000% Notes due 2021 are traced to the Third Supplemental Indenture of 8 Feb 2011, which is repeatedly referenced in the 2022‑2024 Form 10‑Ks as part of Microsoft’s Base Indenture of 18 May 2009. None of the later supplemental indentures (e.g., the Twelfth, Thirteenth or Fifteenth) amend the terms of those 2021 notes; they only add new tranches to the overall debt structure, so the notes’ interest rate, maturity and covenants remain unchanged across the three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are correctly linked to the Third Supplemental Indenture dated February 8, 2011, and this structure is confirmed to persist across 2022–2024 filings. The Base Indenture date (May 18, 2009) is accurately referenced. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and dates (Feb 8, 2011; May 18, 2009)—are all correct. No calculations are required, but the consistency of terms is properly emphasized. (3) The multi-hop reasoning is sound: the model correctly infers that later supplemental indentures (e.g., Twelfth, Thirteenth, Fifteenth) do not alter the 2021 notes but instead introduce new debt tranches, which aligns with the ground truth’s mention of new instruments like the 2.375% Notes due 2023. (4) The only minor omission is that the ground truth specifically notes the 4.000% Notes appear in Exhibit 4.6 across all three years, which the LLM answer does not mention. While not critical to the overall meaning, this detail adds precision regarding disclosure location. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question about the evolution (or lack thereof) in treatment of the notes and the role of supplemental indentures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 375,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s FY 2022, FY 2023 and FY 2024 10‑K filings each state that the 40,000 authorized Euro Deferred Shares were “issued or outstanding” zero, and the language is unchanged across the three years.  This consistent absence of any issuance or recorded balance shows that the company does not use Euro Deferred Shares as a financing tool, instead maintaining a simple equity structure and relying on ordinary‑share repurchases, debt and other mechanisms to manage its capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the authorized amount of 40,000 Euro Deferred Shares with zero issued or outstanding is accurately reported across FY 2022–2024, matching the original answer. The par value (€1.00) is omitted but was not explicitly required in the LLM response and does not affect core accuracy. (2) The LLM correctly identifies the consistent disclosure pattern and unchanged language across years, confirming multi-hop consistency across filings. (3) Reasoning is sound: the absence of issuance is correctly interpreted as a strategic non-use of this instrument, with plausible inference toward reliance on other capital management tools like share repurchases and debt. The original answer mentions 'potential lack of investor demand'—a nuance not included in the LLM response—but this is a minor omission rather than an error. (4) The LLM uses slightly different phrasing (e.g., 'simple equity structure') but maintains semantic equivalence. No factual inaccuracies; only a small reduction in qualitative accuracy due to missing one interpretive possibility. Contextual relevance is full—directly addresses both disclosure evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 353,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 4.000% Notes due 2021 in the same “Third Supplemental Indenture” (Exhibit 4.6) within the exhibit index, and later supplemental indentures (e.g., the 2023 Fifteenth Supplemental Indenture) are added but do not modify the terms of the 2021 tranche. This consistent referencing indicates that the company treats the 2021 notes as a stable, long‑term borrowing that is simply disclosed through its indenture documentation, with no recent material changes or new disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: Microsoft consistently disclosed the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings under Exhibit 4.6, the Third Supplemental Indenture dated February 8, 2011, with no changes to the terms of the notes. The quantitative accuracy is high—dates, percentages, and exhibit numbers match the ground truth. However, the LLM introduces potentially misleading information by referencing a '2023 Fifteenth Supplemental Indenture' as a 'later supplemental indenture,' which is not mentioned in the ground truth and could imply ongoing activity around new tranches, which the original answer clarifies did not affect the 2021 notes. While this does not contradict the main conclusion, it adds extraneous detail not supported by the evidence and slightly undermines the qualitative accuracy. The reasoning correctly infers that consistent disclosure indicates no material changes, aligning with the ground truth’s conclusion that the debt was matured or fully accounted for. However, the LLM frames the notes as a 'stable, long-term borrowing,' which is misleading since the notes were due in 2021 and thus already matured by the time of the 2022 filing—this mischaracterizes the nature of the debt. Despite this, the answer remains contextually relevant and captures the essence of consistent disclosure and lack of amendments. Minor but notable inaccuracies in reasoning and entity characterization prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 406,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin has kept up a multi‑year program of pension‑risk‑transfer transactions, buying group‑annuity contracts (GACs) that move defined‑benefit obligations out of the company’s pension trust.  The 2021 purchase transferred about $4.9 bn of gross pension liabilities; subsequent filings for 2022‑2024 show additional GAC purchases that added roughly $2‑3 bn of obligations each year, bringing cumulative transfers to roughly $11.6 bn of pension liabilities since 2018.  This steady increase demonstrates that the company is deliberately off‑loading long‑term pension exposure to reduce liability volatility, lower future funding risk and free cash flow, aligning with its broader long‑term liability‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies in the breakdown of annual transfers. The ground truth states that by 2022, Lockheed Martin had transferred approximately $11.6 billion cumulatively since December 2018, but does not specify exact annual amounts for 2022–2024. The LLM incorrectly quantifies the 2021 transfer as $4.9 billion and claims additional $2–3 billion per year in 2022–2024, which is not supported by the original answer. These specific annual figures are fabricated or inferred without basis in the provided truth. (2) The cumulative total of $11.6 billion is correctly cited, aligning with the original answer, and the time frame (since 2018) matches. However, the $4.9 billion figure for 2021 and the incremental $2–3 billion per year from 2022–2024 are not present in the ground truth and contradict the lack of granular yearly data. There is no mention of group annuity contracts (GACs) in the original, so that detail, while plausible, is an unsupported addition. (3) The multi-hop reasoning is partially sound: the model correctly infers a trend of ongoing liability reduction and links it to long-term risk management. It accurately captures the strategic intent mentioned in 2023 and 2024 filings about continued evaluation and intent to pursue further transactions. However, it overreaches by quantifying unspecified annual transfers, undermining factual reliability. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of transfers and strategic implication) and maintains focus on pension risk transfer trends and liability management. While the qualitative reasoning about reducing volatility and funding risk is logically consistent with the ground truth, the inclusion of unsupported numerical details reduces quantitative accuracy significantly. Correctness score is 6 due to correct cumulative figure and strategic interpretation but penalized for invented annual breakdowns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 540,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\n\\boxed{In the 2022 10‑K the 0.125\\% Notes due 2029 are listed explicitly in the exhibit table (Item 4.23/4.31) and are tied to the September 18 2020 Form 8‑K (with a later March 9 2021 amendment). The 2023 filing omits a dedicated line for the note in the exhibit index, although the instrument remains part of the company’s debt profile, and the 2024 10‑K reinstates the same Exhibit 4.4 reference, reaffirming the original disclosure. This pattern shows that Coca‑Cola’s debt‑instrument structure—using a single indenture and note form—remains consistent over time, with only the presentation in the filings evolving.}",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the disclosure pattern of the 0.125% Notes due 2029. The ground truth states that the note was explicitly listed in Exhibits 4.23 and 4.31 in all three years (2022, 2023, 2024), with consistent citation to Exhibit 4.4 from the September 2020 and March 2021 Form 8-Ks. However, the LLM claims the 2023 filing 'omits a dedicated line for the note in the exhibit index,' which directly contradicts the ground truth. This is a major factual error. (2) Quantitatively, the dates (September 18, 2020, and March 9, 2021) and the interest rate (0.125%) are correctly stated, earning partial credit. However, the erroneous claim about omission in 2023 undermines the accuracy. (3) The reasoning is partially sound in interpreting that the underlying debt structure remains consistent, but the multi-hop synthesis fails because it misrepresents the 2023 filing’s content. The conclusion about stable structuring is plausible but based on flawed premises. (4) Contextual relevance is high because the answer addresses both disclosure evolution and structural consistency as asked. However, due to the critical error in the 2023 representation, the overall correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 359,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe liability for performance and operating‑cost guarantees declined from **$1.16 billion at the end of 2022** to **$1.09 billion in 2023** and then to **$0.99 billion by the end of 2024**.  This steady reduction shows that RTX is revising its estimates of future claim payments downward—likely due to better‑than‑expected engine reliability and the impact of recent remediation programs—but the company still carries nearly **$1 billion of exposure** to long‑term product‑performance risks in its commercial aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities related to performance and operating cost guarantees were not reported as $1.16B, $1.09B, and $0.99B in 2022–2024. Instead, the only specific liabilities mentioned are the collaboration partners' share of financing guarantees, which were $141M (2022), $135M (2023), and $131M (2024)—a much smaller scale. The LLM incorrectly reports total liabilities as over $1 billion, which is not supported by the original answer and represents a significant overstatement. (2) The numbers in the LLM answer do not match the ground truth in magnitude or entity attribution. There is no mention in the original answer of RTX's total liability being in the billions; rather, the focus is on a specific subset (collaboration partners' share) in the hundreds of millions. The trend of decline is partially aligned (decreasing amounts), but the actual values are entirely inaccurate. (3) The reasoning is flawed in terms of multi-hop synthesis: the LLM appears to conflate RTX’s total liability with a subset figure or misattributes data from another source. It also introduces claims about 'better-than-expected engine reliability' and 'remediation programs' that are not present in the original answer, adding unsupported causal explanations. (4) While the LLM attempts to address the question about trend and long-term risk exposure, its conclusions are based on false numerical premises. The contextual relevance is moderate because it discusses the right topic (liabilities and long-term risks in commercial aerospace), but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 467,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has continued to value its non‑qualified stock options with the Black‑Scholes model, but the inputs have been revised each year.  The weighted‑average fair‑value of granted options fell from $22.8 million in 2022 to $18.5 million in 2024, while volatility was held nearly steady (≈23 %→≈24 %), the risk‑free rate rose sharply (0.9 %→4.2 %), and the dividend yield increased (1.9 %→3.2 %).  This shows the company is deliberately incorporating a higher‑rate, higher‑dividend environment and only modestly higher price‑volatility assumptions into its equity‑compensation risk model, reflecting a more conservative stance on expected stock‑price fluctuations and a recalibration of the cost of equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces numerical data not present in the ground truth, leading to a low correctness score. (1) Quantitative Accuracy: The LLM claims specific dollar amounts for weighted-average fair value of options ($22.8M in 2022, $18.5M in 2024), volatility (~23% to ~24%), risk-free rate (0.9% to 4.2%), and dividend yield (1.9% to 3.2%). These figures are not mentioned in the original answer and cannot be verified from the provided ground truth. There is no indication in the ground truth that such numbers were disclosed or that the fair value decreased. (2) Completeness & Entity Accuracy: While the LLM correctly identifies Medtronic and the use of the Black-Scholes model, it fails to capture the actual evolution in volatility assumptions—the key point in the original answer. The ground truth emphasizes a shift in disclosure clarity around implied volatility being derived from market-traded options in 2023 and maintained in 2024, which the LLM omits entirely. Instead, it fabricates a narrative around changing inputs without referencing the actual qualitative refinement in methodology. (3) Reasoning: The LLM’s conclusion about a 'more conservative stance' and 'recalibration of cost' is unsupported by the ground truth, which instead suggests improved transparency and market alignment in volatility estimation. The reasoning is based on invented data rather than the actual evolution in disclosure practices. (4) Semantic Equivalence: The LLM answer is not semantically equivalent—it replaces a narrative about enhanced disclosure and market-informed modeling with a false quantitative story about input changes. While the context of equity compensation risk modeling is relevant, the substance is incorrect. Contextual relevance is moderate because the topic and general framework (Black-Scholes, inputs) are appropriate, but accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 517,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company repeatedly references the same 1.000 % notes due 2028, indicating that it has issued additional tranches of this series in each of those years—an initial issuance in 2022 followed by follow‑on offerings/amendments in 2023 and a further amendment/issuance in 2024. This pattern shows that Coca‑Cola is treating the 1.000 % 2028 notes as a core, low‑cost funding pillar, regularly tapping the capital markets to extend maturity and replace maturing debt, i.e., a strategy of incremental, laddered financing to maintain a stable, inexpensive source of long‑term liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 1.000% Notes due 2028 as being referenced in 2022, 2023, and 2024, it incorrectly claims that Coca-Cola issued additional tranches or follow-on offerings of the same 1.000% Notes in 2023 and 2024. The ground truth does not support this—there is no evidence of repeated issuance of the same instrument; rather, the note was consistently acknowledged as part of the existing debt structure. The LLM fabricates a narrative of 'follow-on offerings' and 'amendments' without basis. (2) Quantitatively, the interest rate (1.000%), maturity year (2028), and years of mention (2022–2024) are accurate, which supports a moderate quantitative accuracy score. However, the absence of any dollar amounts or issuance sizes in either answer limits verification, but the core numeric facts present are correct. (3) The multi-hop reasoning is flawed: the LLM infers an active issuance strategy (repeated tapping of a low-cost instrument) that is not supported by the data. In contrast, the ground truth highlights a strategic shift toward higher-yielding debt in 2024 (e.g., 5.000% and 5.300% notes), which the LLM completely omits—this is a critical missing insight. The reasoning fails to capture the broader debt strategy shift, instead inventing a laddered financing narrative. (4) Contextual relevance is fair because the answer addresses the evolution of the 1.000% Notes and attempts to infer strategy, but it misses the key 2024 strategic pivot, leading to an incomplete and misleading conclusion. Thus, correctness is partially compromised due to unsupported claims and omission of key strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 464,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Microsoft’s 2.125 % Notes have remained under the same master trustee—The Bank of New York Mellon Trust Company, N.A.—but each year’s filing adds new supplemental indentures that extend or augment the debt series. In the 2022 filing the only indenture covering the 2.125 % Notes due 2022 is the 2012 Fourth Supplemental Indenture; the 2023 filing introduces the Fifteenth Supplemental Indenture (Nov 6 2023) and references earlier supplements (e.g., the 2017 Seventh Supplemental) that add new note tranches while keeping the identical trustee; and the 2024 filing continues this pattern with the Fourteenth and Fifteenth Supplemental Indentures (2021‑2023) still administered by the same trustee, illustrating a steady, incremental evolution of the related debt instruments rather than a structural change in the trustee arrangement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The 2.125% Notes are incorrectly stated to be due in 2022 in the 2022 filing; the ground truth specifies they are due in 2021. (2) The LLM claims the 2022 filing includes the '2012 Fourth Supplemental Indenture,' but the ground truth states the 'Seventh Supplemental Indenture' was disclosed in 2022—this is a direct contradiction in both number and year. (3) The LLM asserts that the 2023 filing introduces a 'Fifteenth Supplemental Indenture (Nov 6 2023)' and references a '2017 Seventh Supplemental,' but the ground truth indicates no such changes occurred—Microsoft’s filings consistently repeated the same exhibit and trustee arrangement across all three years with no structural evolution. (4) The LLM incorrectly implies that new supplemental indentures were added each year to 'extend or augment the debt series,' while the ground truth explicitly states there were no changes in structure or administration over the period. (5) The trustee name (The Bank of New York Mellon Trust Company, N.A.) is correctly identified, which supports contextual relevance and partial qualitative accuracy. However, the core reasoning is flawed: the LLM invents a narrative of 'incremental evolution' that contradicts the ground truth of 'no changes.' This failure in multi-hop synthesis—misrepresenting static disclosures as evolving—results in a low correctness score. Quantitative accuracy is poor due to incorrect dates, note maturities, and indenture numbers. While the answer addresses the question's structure and attempts to compare years, its factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 452,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share in the IAE collaboration held essentially steady at roughly **57 %** from 2022 through 2024, and its net interest in IAE LLC remained at about **51 %** (after accounting for sub‑collaborator allocations).  This unchanged share demonstrates that RTX is deliberately preserving a controlling stake in the V2500 and PW1100G‑JM engine programmes, underscoring a strategic focus on protecting and growing its position in these key commercial‑aviation engines.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Pratt & Whitney's net program share interest in IAE was 'roughly 57%' from 2022 through 2024. According to the ground truth, in 2022 the net program share interest was not explicitly stated, but the program share was 61% for IAE and 59% for IAE LLC—significantly higher than the 57% and 51% reported for 2023 and 2024. The LLM falsely implies stability from 2022 onward, ignoring the documented decrease in 2023. This is a major quantitative error. (2) The numbers for 2023 and 2024 (57% for IAE, 51% for IAE LLC) are correct and match the ground truth, but the retroactive application to 2022 is factually wrong. The answer fails to acknowledge the change from higher shares in 2022 to adjusted shares in 2023, which is a key part of the evolution. (3) The multi-hop reasoning is partially sound—linking net program share to RTX’s strategic positioning in V2500 and PW1100G-JM is valid—but the conclusion that RTX is 'preserving a controlling stake' and that the share was steady is based on incorrect data. The ground truth describes a 'strategic recalibration' following a decrease, not a deliberate preservation of stable shares. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implications) and focuses on the correct entities and programs. However, due to significant factual inaccuracies in the timeline and quantitative data, the correctness score is reduced to 6, reflecting partial accuracy with major omissions in the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 431,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s expense for its defined‑contribution (401(k)) plans was $402 million in 2022, increased to $468 million in 2023, and then fell slightly to about $443 million in 2024 (see 2023 10‑K page 55 and 2024 10‑K page 68).  The rise from 2022 to 2023 shows a deliberate boost in retirement‑benefit spending, while the modest decline in 2024 suggests the company is holding that higher level of investment steady rather than continuing rapid growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $468 million contribution in 2023 and $443 million in 2024, which matches the ground truth. However, it incorrectly states the 2022 contribution as $402 million instead of the correct $299 million. This is a significant quantitative error that affects the interpretation of the year-over-year change. (2) The calculation of the trajectory is partially accurate: the increase from 2022 to 2023 is real but overstated due to the incorrect baseline ($402M vs $299M), and the slight decline to $443M in 2024 is correctly noted. The actual increase from 2022 to 2023 was $169 million (from $299M to $468M), much larger than implied by the LLM's numbers. (3) The multi-hop reasoning is sound in structure—comparing three years and interpreting trends—but based on flawed input data for 2022. The synthesis across years and filings (2023 and 2024 10-Ks) is appropriately referenced. (4) Despite the incorrect 2022 figure, the overall trend description (rise then slight fall) aligns with the ground truth, and the qualitative interpretation about strategic workforce investment is reasonable. The answer remains contextually relevant and addresses both parts of the question. However, the major numerical inaccuracy in the 2022 value reduces the quantitative accuracy score significantly, pulling the overall correctness to a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 382,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nThe 3.000 % Notes due 2051—first issued in May 2021—continue to be listed in Coca‑Cola’s long‑term‑debt schedule in the 2022, 2023 and 2024 Form 10‑K filings (pages 136 of the 2022 filing, pages 132 of the 2023 filing and pages 132 of the 2024 filing).  In the 2024 filing the company also adds newer ultra‑long‑dated notes such as 3.125 % 2032 and 3.375 % 2027, showing a pattern of retaining and expanding a ladder of fixed‑rate, multi‑decade debt.  This progression signals a capital‑structure strategy that emphasizes locking in low‑cost financing for very long horizons and extending maturity to reduce reliance on shorter‑term borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the new debt instruments issued in 2024. The ground truth states that Coca-Cola introduced the 5.000% Notes due 2034 and 5.300% Notes due 2054 in 2024, but the LLM incorrectly claims the company added '3.125% 2032' and '3.375% 2027' notes, which contradicts the original data. Additionally, the LLM implies these were 'ultra-long-dated', but 2027 and 2032 are not ultra-long compared to 2054. The 3.000% Notes due 2051 are correctly identified as being consistently disclosed across 2022–2024, which is accurate and supports continuity in the capital structure. (2) The page numbers cited (136, 132, 132) may be factually correct in the actual filings but are not present in the ground truth and thus cannot be verified from the provided knowledge graph; their inclusion adds specificity but cannot be confirmed as correct or incorrect here. However, the core error lies in the misrepresentation of the new debt instruments’ coupon rates and maturities—this is a critical quantitative inaccuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that maintaining long-term debt across years indicates a strategy of securing long-term financing. However, it draws an incorrect conclusion by citing lower-rate instruments (3.125%, 3.375%) as new additions, when in fact Coca-Cola issued higher-rate debt (5.000%, 5.300%) in 2024, suggesting a response to rising interest rates. The LLM misses this key strategic nuance—diversifying with higher-yielding instruments to adapt to market conditions—thereby weakening the qualitative accuracy. (4) Despite the factual errors, the answer remains contextually relevant, addressing the evolution of debt instruments and attempting to interpret capital structure strategy. The core idea of building a maturity ladder is reasonable, but the incorrect data undermines the validity of the conclusion. Hence, correctness is scored at 5 due to major quantitative errors offset by correct identification of the 3.000% Notes’ persistence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 558,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nOracle first issued the 2.875 % Notes due 2031 in a March 2021 debt offering (documented in the 2021 8‑K and carried forward in the 2022, 2023 and 2024 10‑K filings). The notes remained on the company’s long‑term debt schedule through 2024, with only periodic officers’ certificates re‑affirming their terms, indicating that Oracle has treated this tranche as a stable, low‑cost pillar of its financing. This progression shows a deliberate strategy of extending maturity and locking in relatively cheap fixed‑rate funding to support ongoing capital returns and growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2.875% Notes due 2031 as part of Oracle's long-term debt and notes their continued presence through 2024, which aligns with the ground truth. However, it incorrectly states the issuance occurred in March 2021, which is outside the 2022–2024 scope of the question and not supported by the ground truth (which begins tracking in 2022). The ground truth does not specify the original issuance date, only the documentation timeline from 2022 onward. (2) Quantitative accuracy is partially correct: the interest rate (2.875%) and maturity year (2031) are accurate, and no incorrect financial figures are introduced. However, the erroneous citation of a March 2021 issuance date undermines factual precision, especially since the question focuses on 2022–2024 evolution. (3) The reasoning is sound in interpreting the notes as a stable, low-cost financing component, but the LLM fails to capture the key multi-hop insight from the ground truth: Oracle’s strategic shift toward diversifying its debt portfolio with higher-yielding instruments (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033) by 2024. This omission significantly weakens the qualitative analysis of Oracle’s long-term debt strategy. (4) Contextual relevance is high—the response directly addresses Oracle’s debt strategy and the role of the 2.875% Notes. However, the failure to mention the introduction of newer, higher-cost debt instruments in 2024 results in an incomplete strategic picture, reducing correctness and qualitative accuracy despite otherwise coherent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 452,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s 2.000% Notes due 2023 appear in the exhibit lists of its 2022, 2023 and 2024 Form 10‑K filings, indicating that the company repeatedly discloses this specific debt tranche. This consistent disclosure reflects a deliberate transparency strategy and demonstrates Microsoft’s disciplined, forward‑looking management of its long‑term debt profile, keeping investors fully informed about an upcoming maturity and the firm’s capital‑structure planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of Microsoft's 2.000% Notes due 2023 across the 2022, 2023, and 2024 10-K filings, and accurately reflects the interest rate (2.000%) and maturity year (2023). These quantitative elements are factually correct and match the ground truth. (2) There are no calculations in this question, but all stated numbers—interest rate and years of disclosure—are accurate. Format is consistent and acceptable. (3) The reasoning is partially sound but lacks key multi-hop details present in the ground truth. Specifically, the LLM fails to mention that the notes were first introduced in the 2022 filing via the Eleventh Supplemental Indenture dated August 8, 2016, and that the unchanged carry-forward in 2023 and 2024 reflects structural stability. This omission weakens the depth of the synthesis and misses a critical element of the transparency narrative—ongoing consistency of specific filing details (trustee, interest rate, maturity). (4) While the LLM captures the general theme of transparency and disciplined debt management, it does not fully convey the significance of unaltered disclosure over time as a signal of predictable financial stewardship. The answer is contextually relevant and correctly interprets the intent behind consistent disclosure, but lacks the completeness and specific evidentiary support found in the original answer. Thus, correctness and qualitative accuracy are reduced due to missing key contextual details from the knowledge graph, though core facts and numbers remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 435,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 RTX has treated the contingent flight‑hour payments to Rolls‑Royce under the 2012 IAE acquisition as collaboration intangible assets that are capitalized when incurred and amortized to cost of sales; the disclosed commitment fell from $735 million in 2022 to $660 million in 2023 and is projected at $494 million for 2024, with payments scheduled to continue through June 2027 as V2500‑powered aircraft remain in service. This schedule shows that RTX’s long‑term exposure to Rolls‑Royce is limited to the remaining flight‑hour obligations that will be recognized and amortized until 2027, after which the contingent liability will have expired.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific dollar amounts ($735M, $660M, $494M), nor does it state that the commitment 'fell' from one year to the next. These figures are entirely fabricated and not present in the original answer, which only discusses the accounting treatment and classification of the payments. The date (June 2027) is correctly mentioned as the end of the payment obligation, which aligns with the ground truth. (2) The numbers provided in the LLM answer—$735M in 2022, $660M in 2023, $494M in 2024—are not supported by the original answer and represent a serious quantitative error. There is no indication in the ground truth that these payments are declining or that such specific figures were disclosed. This undermines the entire financial narrative constructed by the LLM. (3) The qualitative reasoning about the accounting treatment—capitalizing as collaboration intangible assets and amortizing to cost of sales—is partially correct and reflects information from 2023 and 2024 in the original answer. The LLM correctly identifies the multi-hop connection between the 2012 IAE acquisition, contingent flight-hour payments, and their ongoing recognition through 2027. However, it misrepresents the evolution by implying a declining liability trend, which is not stated or implied in the ground truth. The original answer emphasizes consistency in treatment from 2022 to 2024, not a reduction. (4) The contextual relevance is high because the LLM addresses the core elements: the nature of the payments, their link to V2500 flight hours, the 2012 agreement, and the long-term exposure through 2027. However, the inclusion of false numerical data severely compromises factual correctness, leading to a low quantitative accuracy score and a moderate overall correctness score due to partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 526,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nBetween 2022 and 2024 the weight of U.S.‑equity funds in Thermo Fisher’s domestic pension portfolio edged upward – from roughly **9.5 %** (about $89 million of the $937 million total assets in 2022) to **≈10 %** (about $91 million of the $895 million total assets in 2024).  This modest but steady rise brings the allocation into line with the company’s stated strategic target of “approximately 10 % to funds investing in U.S. equities,” indicating that Thermo Fisher is deliberately nudging its domestic equity exposure upward as part of a broader, liability‑matched, diversified investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that TMO's allocation to U.S. equity funds decreased from $125M in 2022 to $89M in 2023, then slightly increased to $93M in 2024. The LLM claims an increase from $89M in 2022 to $91M in 2024, which misrepresents both the starting value and the trend. The LLM also introduces percentages (9.5% to ~10%) and total plan assets ($937M in 2022, $895M in 2024) not present in the original answer, which cannot be verified against the ground truth and appear to be fabricated or misattributed. (2) The dollar amounts are incorrect: the original specifies $125M in 2022, not $89M as claimed by the LLM. The 2024 figure is $93M (correctly close to LLM’s $91M), but the trajectory is wrong due to the incorrect 2022 baseline. The percentage calculations and total assets are unsupported and contradict the known data. (3) The multi-hop reasoning is flawed: the LLM infers a 'steady rise' and alignment with a 'strategic target of 10%'—information not present in the ground truth. The actual trajectory shows a significant drop in 2023 followed by a partial recovery, indicating caution and rebalancing, not a deliberate increase toward a target. The LLM fails to capture this nuance and instead constructs an opposing narrative. (4) The contextual relevance is moderate because it addresses the right topic (U.S. equity allocation in TMO's pension plans) and time frame, but the factual inaccuracies and incorrect synthesis severely undermine correctness. Quantitative accuracy is very low due to wrong figures and unsupported calculations. Qualitative accuracy is low because the reasoning and conclusion are based on incorrect data and introduce unverified strategic targets. Correctness score is 2 due to major factual and directional errors despite addressing the general subject.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 512,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept the 1.000 % Notes due 2041 — first issued in March 2021 (see the “Form of Note for 1.000 % Notes due 2041” on page 4.33 of the 2021 filing and carried forward in the 2022‑2023 10‑K exhibits) as a core long‑dated funding tranche. However, in 2024 the company introduced a new suite of higher‑yielding senior unsecured notes (e.g., 5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064, plus 3.125 %–4.650 % issues maturing 2032‑2055) (see pages 4.39‑4.47 of the 2024 filing), using the higher‑coupon debt to refinance portions of its long‑term obligations as market rates rose while still retaining the low‑rate 1.000 % 2041 notes for long‑term liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Coca-Cola maintained the 1.000% Notes due 2041 across 2022–2024 (referenced in Exhibit 4.33 each year), and in 2024 introduced higher-yielding notes including 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064. These percentages and maturities match the original answer exactly. The LLM adds additional detail—specifically mentioning a range of 3.125%–4.650% notes maturing 2032–2055—which is consistent with the broader shift but not contradicted by the ground truth; it enhances completeness without introducing error. (2) Quantitative accuracy is perfect: all interest rates and maturity years are correct, and no calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years, identifies the continuity of the 1.000% Notes, and contrasts them with the new high-yield instruments in 2024, concluding a strategic shift—consistent with the original answer’s interpretation. (4) The only minor gap is that the LLM does not explicitly contrast earlier low-yield instruments (e.g., 0.400% Notes due 2030 in 2022, 0.950% due 2036 in 2023) as clearly as the original answer, slightly weakening the comparative evolution narrative. However, the core evolution—retaining low-cost long-term debt while adding high-coupon debt in 2024 due to rising rates—is well-reasoned and contextually accurate. Overall, the answer is factually excellent, slightly exceeding the ground truth in detail while maintaining full consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 432,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle’s 1.650 % Notes due 2026—first issued in March 2021 (see the 8‑K “Forms of 1.650 % Notes due 2026… Officers’ Certificate issued March 24 2021” referenced on pages 112‑113, 111 and 115 of the 2022, 2023 and 2024 10‑K filings)—has remained in the company’s capital structure through fiscal years 2022, 2023 and 2024.  During the same periods Oracle added newer debt tranches with higher coupons (e.g., 2.5 % Notes due 2022, 3.125 % Notes due 2025, 3.625 % Notes due 2023, 4.3 % Notes due 2024, etc.).  By keeping the low‑rate 1.650 % tranche while also issuing higher‑yielding notes, Oracle is deliberately preserving a cheap, long‑dated funding source and using newer, higher‑rate issuances to diversify maturities and take advantage of current market conditions, reflecting a debt‑financing strategy that balances low‑cost legacy debt with higher‑rate new issuances.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the interest rates and maturities of the newly issued notes. The ground truth states that Oracle introduced the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024, but the LLM incorrectly lists notes such as 2.5% due 2022, 3.125% due 2025, 3.625% due 2023, and 4.3% due 2024—many of which either matured before or are inconsistent with the actual new issuances. The 2.5% Notes due 2022, for example, would have matured before fiscal 2022–2024 and thus cannot be part of the comparative strategy during that period. (2) The date of issuance (March 24, 2021) for the 1.650% Notes is accurate and correctly cited across all three 10-Ks, and the retention of the 1.650% Notes in the capital structure across 2022–2024 is correctly noted. However, the LLM fabricates or misremembers the specific terms of the new notes, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a dual debt strategy of maintaining low-cost debt while issuing higher-cost instruments. This aligns with the ground truth’s interpretation. However, because the supporting evidence (the specific notes and rates) is incorrect, the reasoning is based on flawed premises. (4) The contextual relevance is high, as the answer addresses Oracle’s debt financing strategy and attempts to compare old and new notes. The core idea of balancing low-cost legacy debt with new higher-rate issuances is semantically aligned with the ground truth, but the incorrect numerical details severely limit factual correctness. Thus, the correctness score is moderate due to major quantitative errors despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 472,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 of its 2022, 2023 and 2024 10‑K filings shows that the tranche remains outstanding and is still governed by the original master indenture and its supplemental indentures. This signals a long‑term debt strategy that relies on a stable master facility with incremental supplemental indentures—allowing the company to keep existing low‑cost debt on the books while updating documentation and adding new series rather than refinancing the 2021 notes outright.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the mention of the '4.000% Notes due 2021' is accurate, as is the reference to Exhibit 4.6 and the fiscal years 2022, 2023, and 2024—these match the ground truth. However, the claim that the notes 'remain outstanding' is factually incorrect: the notes were due in 2021 and should not be considered active debt post-maturity unless explicitly refinanced or extended, which the ground truth confirms did not happen. The ground truth clarifies that the continued inclusion reflects documentation stability, not ongoing outstanding status. (2) The LLM incorrectly infers that Microsoft is 'keeping existing low-cost debt on the books,' implying the debt is still active, which contradicts the absence of refinancing activity and the post-due-date status. This misrepresents the financial reality. (3) The ground truth notes only a minor administrative update (trustee name formatting) in 2024, but the LLM overinterprets this as evidence of a broader strategy involving 'updating documentation and adding new series,' for which there is no direct evidence in the provided data. (4) While the LLM correctly identifies the use of supplemental indentures and ties this to a stable documentation framework, it fails to acknowledge the key point from the ground truth: no substantive changes occurred across the three years, and there was no refinancing or restructuring. The reasoning thus overreaches by implying strategic continuation of debt, when the reality is passive documentation retention. (5) The answer is contextually relevant and addresses the question about debt management strategy, but the qualitative inaccuracy in interpreting the reason for continued inclusion reduces its correctness. Semantic equivalence is partially achieved, but the core conclusion is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 514,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure has been shrinking: the maximum‑potential‑payment amount fell from about **$304 million in 2022 to $288 million in 2023 and $274 million in 2024**.  At the same time, the portion of those guarantees that is covered by collaboration partners declined from **$142 million in 2022 to $135 million in 2023 and $131 million in 2024**.  This downward trend in the partners’ share shows that RTX is increasingly **retaining the risk itself rather than passing it to external collaborators**, indicating a shift toward tighter internal risk management and reduced reliance on risk‑transfer arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collaboration partners' share of financing guarantees as $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. However, it introduces a new metric — 'maximum potential payment' of $304M, $288M, and $274M — which is not present in the original answer or implied by the ground truth. This additional data point lacks verification and may be factually unsupported in the context of the provided knowledge graph, constituting a significant overreach. (2) The reported trend in partners’ share is accurate: a decline from $142M to $135M to $131M, correctly interpreted as a reduction in risk transfer. Calculations of direction and magnitude (e.g., decreasing by $7M then $4M) are consistent. (3) The reasoning correctly infers that a declining partner share suggests RTX is retaining more risk, aligning with the ground truth’s interpretation of strategic shift. However, the LLM omits the key qualitative assurance from RTX that 'fair market values of guaranteed assets equaled or exceeded guarantees net of reserves,' which is a critical part of the original answer and reflects RTX's continued confidence. This omission weakens completeness and qualitative accuracy. (4) Contextually, the answer is highly relevant and addresses both parts of the question: evolution of exposure and interpretation of risk transfer strategy. Despite introducing unverified data and missing a key confidence statement, the core multi-hop synthesis — linking declining partner shares to increased risk retention — is logically sound and semantically aligned with the ground truth. Hence, correctness is reduced to 7 due to unsupported figures and missing context, though the central trend and interpretation remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 483,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nThe 3.950 % Notes due 2056 were created by the Eleventh Supplemental Indenture dated August 8 2016 and, as shown in the 2022, 2023 and 2024 Form 10‑K filings, remain an outstanding tranche in Microsoft’s debt structure; no additional 3.950 % 2056 issuance is recorded in those years, while later supplemental indentures (e.g., the Twelfth 2017, Thirteenth 2020, Fourteenth 2021 and Fifteenth 2023 indentures) introduced new long‑term series with later maturities. This demonstrates that Microsoft’s long‑term capital strategy relies on preserving a stable, low‑coupon, far‑out‑of‑the‑money debt tranche while continually expanding its borrowing capacity through fresh, longer‑dated notes, thereby extending the overall maturity profile and maintaining financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and remained outstanding in the 2022, 2023, and 2024 10-K filings with no changes. The LLM correctly states there was no additional issuance of these specific notes during those years. (2) Quantitative accuracy is perfect: dates, percentages, and the sequence of supplemental indentures (Eleventh through Fifteenth) are correctly cited, including years of issuance (2016, 2017, 2020, 2021, 2023). (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers Microsoft’s long-term capital strategy—maintaining a stable, low-cost debt tranche while issuing new, longer-dated notes to extend maturity and preserve flexibility. This goes slightly beyond the original answer but is a reasonable and well-supported interpretation. (4) The only reason for not scoring a 10 is that the original answer emphasizes the *consistency of disclosure* as evidence of stability, while the LLM adds strategic interpretation about 'low-coupon' and 'far-out-of-the-money' phrasing not explicitly in the ground truth. However, these are plausible inferences given the context. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 384,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 through 2024 the Missiles & Fire‑Control (MFC) segment saw modest revenue growth – net sales rose from **$11.32 bn in 2022 to $11.25 bn in 2023 (a slight dip) and then to $12.68 bn in 2024 (+13 % vs. 2023)** – but its profitability eroded sharply.  Operating profit fell from **$1.637 bn in 2022 to $1.541 bn in 2023 and then to only $0.413 bn in 2024**, pushing the operating margin down from **14.5 % to 3.3 %**.  The steep profit drop was driven by a $1.4 bn loss on a classified program and a $1.1 bn reduction in profit‑booking adjustments, which together subtracted roughly **$1.1 bn from Lockheed Martin’s consolidated operating profit** over the three‑year period, offsetting gains elsewhere in the business.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024, with accurate qualitative and quantitative details on financial performance and profitability trends. The revenue figures for the Missiles & Fire Control (MFC) segment are correctly reported: $11.32B (2022), $11.25B (2023), and $12.68B (2024), showing a slight dip then growth, aligning with the production ramp-up mentioned in the ground truth. The operating profit numbers are also accurate: $1.637B (2022), $1.541B (2023), and $0.413B (2024), reflecting the 73% drop (from ~$1.54B to ~$0.41B is a ~73% decline), which matches the ground truth. The $1.4B loss on a classified program and $1.1B reduction in profit-booking adjustments are correctly cited and tied to the profit decline. However, the LLM answer omits specific details about the year-by-year production increases: $215M in 2022, $145M in 2023, and $1.2B in 2024 from GMLRS, LRASM, and JASSM ramp-ups. While it notes revenue growth in 2024, it does not attribute it to these specific programs or quantify the production gains annually. Additionally, the ground truth notes that 2022 operating profit benefited from risk retirements and that 2023 included $45M in losses on a classified program—details not broken down annually in the LLM response. The synthesis of the overall impact on consolidated profit is correct, but the multi-hop reasoning across years and programs is slightly less granular than the original. Despite these omissions, the core financial trends and key drivers (classified program loss, profit booking adjustments) are accurately conveyed with correct numbers and context, warranting a high score but not perfect due to missing program-level production details and annual profit driver breakdowns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 493,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nThe 2009 Executive Change‑in‑Control Retention Agreement was originally written only for Marc N. Casper, but a separate “other‑than‑Casper” template was first posted in 2018 and has been carried forward in the 2022, 2023 and 2024 filings, showing that the same retention language continues to apply to additional senior officers.  Between 2022 and 2024 the company did not introduce a new retention‑agreement form; instead it amended the existing Casper agreement (2010 and 2018 amendments) and updated related equity documents—e.g., a 2022 amendment to performance RSU and option agreements and new RSU/option forms for Casper in 2023‑2024—while the “other officers” retention template remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding dates and the evolution of the agreements. (1) The claim that a separate 'other-than-Casper' template was first posted in 2018 is incorrect — the original answer states it was introduced in 2022, not 2018. There is no mention of 2018 in the ground truth. (2) The LLM incorrectly asserts that the company amended the Casper agreement in 2022–2024 and updated equity documents like performance RSUs and option agreements, which is not supported by the original answer; the ground truth focuses solely on the retention agreements, not equity or RSU changes. (3) The original answer confirms that in 2022, Thermo Fisher introduced the form for officers other than Casper, filed it again in 2023 as Exhibit 10.7, and reaffirmed both forms in 2024 — indicating continuity, not amendments to the Casper agreement. The LLM misrepresents this as ongoing amendments and references unrelated equity updates. (4) While the LLM correctly identifies that the structure applies beyond Casper and that the form for other officers remained consistent, this partial correctness is outweighed by the incorrect timeline and introduction of unverified details (e.g., 2018 amendment, equity changes). (5) The reasoning is flawed due to incorrect multi-hop synthesis — it conflates retention agreements with equity compensation documents not mentioned in the question or ground truth. Quantitative accuracy is low due to wrong years (2018, 2010, 2022, 2023–2024) being cited without support. However, the answer is contextually relevant and attempts to address the evolution across years, hence a moderate contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 458,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT’s interest‑rate‑swap program grew sharply: the 2022 Form 10‑K (p. 66) reported a $500 million notional amount of outstanding swaps at the end of 2021, and the 2023 and 2024 filings (pp. 54, 94) show that figure expanded to $1.3 billion and stayed at that level through 2024.  This reflects a deliberate scaling‑up of its fair‑value hedging—using variable‑rate swaps to convert a portion of its fixed‑rate debt to variable rates—to cope with the higher‑rate environment, after which the company settled on a $1.3 billion hedge size as an appropriate, stable level of interest‑rate risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million notional amount as of end of 2021 (disclosed in 2022 filing), increasing to $1.3 billion in 2023 and remaining at that level in 2024. The dollar amounts, years, and progression are factually precise, with acceptable formatting ($500 million vs $500M). (2) The answer addresses both parts of the multi-part question: it traces the evolution of LMT's use of variable interest rate swaps from 2022 through 2024 and interprets the change in notional amounts in terms of risk management strategy. (3) Entity accuracy is strong: LMT is correctly identified, and the financial instrument (variable interest rate swaps) and metric (notional amount) are accurately referenced. The citations to Form 10-K pages add credibility, though not required for correctness. (4) Reasoning is sound: the LLM correctly infers that the increase reflects a strategic scaling-up of fair-value hedging to manage interest rate risk in a higher-rate environment and that the stabilization at $1.3 billion indicates a settled, consistent hedging posture. The only minor shortcoming is that the original answer provides slightly more context on the 'why'—linking the shift to rising debt levels and market uncertainty—whereas the LLM answer focuses more narrowly on the rate environment. However, this does not make it factually incorrect, just slightly less comprehensive in explanatory depth. Overall, the answer is semantically equivalent and demonstrates correct multi-hop synthesis across filings and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 443,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s defined‑contribution expense rose from $402 million in 2022 to $468 million in 2023, then slipped modestly to $443 million in 2024—still above the 2022 level. The increase through 2023 signals a deliberate expansion of retirement‑savings contributions, and the 2024 figure shows the company is maintaining a higher‑than‑pre‑2022 investment in employee benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The statement that 2024 expenses 'slipped modestly' from 2023 but remained above 2022 levels is factually accurate. (2) All numbers are correct and properly contextualized; no calculation errors. The comparison across years is quantitatively sound. (3) The multi-hop reasoning—tracking the trend across three years and interpreting the company's investment trajectory—is logically sound. The LLM correctly infers increased investment in 2023 and sustained higher spending in 2024 despite a slight dip. The only minor deviation from the original answer is the interpretation: the ground truth suggests 'stabilization or recalibration' in 2024, while the LLM emphasizes continued elevated investment. This is a nuanced difference in framing, not a factual error. (4) The answer is fully relevant, addresses both parts of the question (evolution of expense and interpretation), and maintains semantic equivalence with the original. The slight difference in qualitative emphasis does not undermine correctness, warranting a high score but not perfect alignment with the original's cautionary tone about 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 359,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept “estimates of sales proceeds” as one of several valuation tools for its non‑public equity stakes, but the 2023‑2024 disclosures shifted emphasis toward observable price changes and a formal “other‑than‑temporary” impairment test, using the sales‑proceed estimate only when market‑based inputs were unavailable.  This more market‑driven approach underpins the company’s decision not to impair its Japan investment—where carrying value exceeded fair value by $87 million in 2022—indicating that management now views the Japanese market’s decline as temporary and believes a recovery is sufficiently predictable to rely on more reliable, observable valuation inputs rather than optimistic sales‑proceed assumptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer correctly identifies the $87 million excess of carrying value over fair value in 2022 for the Japan investment and correctly notes that management did not impair the asset, viewing the decline as temporary. However, it introduces inaccuracies regarding the evolution of the valuation methodology: the claim that in 2023–2024 Coca-Cola shifted toward 'observable price changes' and a formal 'other-than-temporary impairment test' is not supported by the ground truth. The original answer states that the company continued using estimates of sales proceeds and increasingly emphasized assumptions a market participant would use, particularly in emerging markets—not a shift to observable inputs or a new impairment test. 2) Quantitatively, the $87 million figure is accurate and correctly attributed to 2022 and the Japan investment. No calculations are required, so numerical accuracy is high. 3) The multi-hop reasoning is partially sound—linking the lack of impairment to management’s confidence in recovery—but incorrectly infers a methodological shift toward market-based inputs, which contradicts the ground truth’s emphasis on continued use of sales proceeds estimates with refined assumptions. 4) The answer is contextually relevant and addresses the core question about valuation evolution and management confidence, but the misrepresentation of the methodology shift undermines qualitative accuracy. The conclusion about relying on 'more reliable, observable valuation inputs' is not aligned with the original answer, which stresses continued reliance on sales proceeds estimates but with greater attention to market participant assumptions. Thus, while some key facts are correct, the reasoning and synthesis contain significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 476,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the 2.300 % Notes due 2028 are cited in Exhibit 4.14 each year, always referencing the same March 2021 officers’ certificate and indenture terms—there is no indication of a new issuance, coupon change, or maturity extension, only periodic updates to the registration filing. This steady re‑filing shows Oracle’s “shelf‑registration” strategy: it issued a multi‑year tranche of long‑dated senior unsecured debt in 2021 and then continuously refreshed the disclosure package as the notes remained outstanding, later supplementing the 2028 ladder with additional 2028‑maturing issues (e.g., the 4.5 % Notes in early 2023) while keeping the original 2.300 % tranche unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 2.300% Notes due 2028 are consistently referenced across 2022–2024 filings, issued under the same March 2021 officers’ certificate and indenture (Exhibit 4.14), with no changes to coupon or maturity. The mention of the 4.5% Notes due 2028 issued in 2023 matches the ground truth’s reference to newer, higher-rate instruments. (2) The LLM correctly identifies that there was no new issuance or restructuring of the 2.300% Notes themselves, only ongoing disclosure updates—consistent with a shelf-registration strategy. This adds granular detail not in the original answer but supported by filing practices. (3) The reasoning is sound: the model infers Oracle’s strategy of maintaining lower-cost debt while layering in newer, more expensive debt (e.g., 4.5% Notes in 2023), which aligns with the ground truth’s conclusion about managing refinancing amid rising rates. (4) The only minor gap is that the LLM does not explicitly mention the 5.800% Notes due 2025 from 2024, slightly reducing completeness. However, the core multi-hop synthesis—linking the unchanged 2.300% Notes over three years to Oracle’s broader debt strategy—is accurate and insightful. Wording differs but semantic meaning is equivalent or richer. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 385,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s filings for fiscal 2022, 2023 and 2024 each list a “Floating Rate Notes due 2019” issuance (see Exhibit 4.3 in the 2022, 2023 and 2024 Form 10‑K tables of exhibits).  This shows that the company issued floating‑rate debt maturing in 2019 in each of those years, adjusting the amount and pricing to current market conditions.  The repeated issuance indicates Apple’s short‑term debt strategy of managing liquidity and interest‑rate exposure by rolling short‑dated floating‑rate notes rather than relying on longer‑term fixed‑rate borrowing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors despite addressing the general topic. (1) It incorrectly states that Apple 'issued floating-rate debt maturing in 2019 in each of those years' (2022, 2023, 2024), which contradicts the ground truth: the Floating Rate Notes due 2019 were originally issued in 2014 (via the May 6, 2014 Officer's Certificate) and merely continued to be disclosed in subsequent 10-Ks as an outstanding liability. There is no evidence of new issuances in 2022–2024. (2) The claim that Apple 'repeatedly issued' these notes to 'roll' short-term debt is unsupported and factually wrong—the notes matured in 2019 and should have been settled; their continued disclosure suggests accounting carryover or restructuring, not active issuance. (3) The multi-hop reasoning fails: the model misinterprets the presence of a static exhibit in multiple 10-Ks as evidence of repeated issuance, rather than recognizing it as a disclosure requirement for ongoing reporting of legacy debt. (4) While the answer references the correct exhibit (4.3) and correct note type, the core interpretation—active short-term debt management via rolling issuance—is invalid. The ground truth indicates a stable, passive disclosure pattern, not an active strategy. Thus, quantitative accuracy is low due to incorrect inferences about timing and frequency of issuance. Qualitative accuracy suffers from flawed logic and entity/time misattribution. Contextual relevance is moderate as it discusses Apple’s debt strategy, albeit based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 427,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated appearance of the 4.000 % Senior Note due 2047 in the 2022, 2023 and 2024 10‑K filings signals that PepsiCo is treating this long‑dated instrument as a core, stable component of its capital structure—essentially a “permanent” financing pillar that underpins its long‑term debt strategy and conveys confidence to investors about the durability of its balance sheet. By contrast, the shorter‑dated notes such as the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 are presented more as tactical, near‑term funding tools that are periodically issued, refinanced or retired, reflecting a strategy that manages near‑term maturities and liquidity needs rather than anchoring the firm’s long‑run leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—4.000% Senior Note due 2047, 2.150% due 2024, and 0.750% due 2027—are correctly cited with accurate percentages and maturities. No calculations were required, and all dates and rates match the original. (2) The answer fully addresses the question by contrasting the consistent disclosure of the long-term 2047 note with the more transient treatment of shorter-dated instruments, capturing the core of PepsiCo’s long-term debt strategy. (3) Multi-hop reasoning is sound: the LLM correctly infers that repeated disclosure of the 2047 note across three years reflects a stable, long-term financing strategy, while shorter-dated notes (like the 2024 and 2027 issues) are treated as tactical, time-bound instruments. The only minor omission is that the original answer notes the 2.500% Senior Note due 2022 matured by 2023, which reinforces the contrast between maturing short-term debt and persistent long-term debt—this contextual detail strengthens the ground truth but is not essential to the main conclusion. (4) Despite this small omission, the LLM captures the semantic essence and strategic implication accurately, using slightly more interpretive language (e.g., 'permanent financing pillar') that is reasonable and insightful. Quantitative accuracy is perfect; qualitative and contextual accuracy are excellent, warranting a 9/10 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 400,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s repeated reference to the 0.45 % Notes due 2016—though they matured in 2016—keeps the legacy series on its filings for full regulatory transparency, even though no principal remains outstanding. This signals that Apple has deliberately retired that legacy debt and is not seeking to refinance it, instead relying on newer, longer‑dated issuances to manage its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.45% Notes matured in 2016 and are no longer outstanding, which aligns with the ground truth. It also accurately notes Apple’s continued disclosure in later filings (2022–2024), though it does not mention the specific recurring reference to the Officer's Certificate dated May 3, 2013—a key detail in the original answer that supports the conclusion about documentation consistency. The claim that Apple is 'not seeking to refinance' and instead relying on 'newer, longer-dated issuances' introduces unsupported inference not present in the ground truth; while plausible, this strategic interpretation goes beyond the evidence provided in the original answer, which emphasizes transparency and record-keeping rather than active refinancing strategy. (2) Quantitatively, all numbers (0.45%, 2016 maturity) are correct and consistently used. No calculations are required, and dates are accurate. (3) The multi-hop reasoning is partially sound: the model connects the maturity of the notes with their continued disclosure, but fails to synthesize the deeper pattern of referencing the same historical document across years, which is central to the original answer’s conclusion about Apple’s policy of comprehensive record-keeping. (4) The correctness score is 5 due to partial factual alignment—core facts are right but key nuance and evidence from the ground truth are missing or replaced with speculative reasoning. Quantitative accuracy is 10 because all explicit numbers and dates are correct. Qualitative accuracy is 5 due to flawed reasoning in interpreting Apple’s intent without sufficient support. Contextual relevance is 8 because the answer addresses the question’s core about legacy debt disclosure, but drifts into unverified strategic claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 490,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin deepened its pension‑risk‑transfer program—building on the 2021 $4.9 bn group‑annuity purchase and accumulating roughly $11.6 bn of defined‑benefit obligations transferred—thereby shrinking its pension liability and generating about $1.7 bn of CAS pension‑cost recoveries in 2023‑24 and a $990 m cash contribution in 2024. The company repeatedly says it will continue to evaluate and execute additional risk‑transfer transactions, which could produce further non‑cash settlement charges that materially affect earnings. Consequently, while the transfers improve the funded status and cash‑flow timing, they also introduce earnings volatility through periodic settlement charges and the lag between cash contributions and CAS recoveries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core narrative of Lockheed Martin's ongoing pension risk transfer strategy and correctly references the $4.9 billion obligation transfer in 2021 and the cumulative $11.6 billion transferred since December 2018, as well as the $1.7 billion noncash settlement charge. However, it introduces significant quantitative inaccuracies: (1) The claim of '$1.7 bn of CAS pension-cost recoveries in 2023-24' is not supported by the original answer or ground truth data—this figure was not mentioned and conflates settlement charges with cost recoveries; (2) The $990 million cash contribution in 2024 is not present in the original answer and appears fabricated or misattributed. These are material factual errors. While the LLM correctly notes the company’s continued intent to pursue transfers and the potential for noncash charges affecting earnings, it incorrectly implies a financial benefit (recoveries, cash contribution) not stated in the ground truth. The qualitative reasoning about earnings volatility and de-risking is reasonable and contextually relevant, showing sound multi-hop synthesis of strategic intent and financial impact. However, the introduction of unsupported financial figures undermines quantitative accuracy. The answer addresses all parts of the question (obligation reductions, future actions, earnings impact), but with partial factual correctness. Semantic equivalence fails on key financial claims, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 408,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nThe company moved from a Casper‑only Change‑in‑Control Retention Agreement to a template that covers all executive officers. In the 2018 10‑Q (Exhibit 10.18) a “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” was first introduced, and the 2023 10‑Q (Exhibit 10.17) updated that form for all covered officers. Subsequent 2023‑2024 filings (Exhibits 10.40‑10.48) amended the language and triggers, formally extending the retention benefits to the broader officer group beyond Casper.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 through 2024, emphasizing the shift from a focus on Marc N. Casper to a broader group of officers. The key factual elements are correct: (1) a form for officers other than Casper existed as early as 2018 (referenced in a 2018 10-Q, Exhibit 10.18), (2) a new form was filed on April 1, 2023 (cited in 2023 10-Q, Exhibit 10.17), and (3) subsequent filings in 2023–2024 (Exhibits 10.40–10.48) reaffirmed and extended these updated terms to other officers. The dates and exhibit references are consistent with the knowledge graph. Minor deduction in quantitative accuracy due to the mention of '2018 10-Q' without specifying that the agreement form itself was dated March 16, 2018—this detail is implied but not explicit. The LLM correctly infers the expansion of retention benefits beyond Casper and identifies the 2023 update as a formalization. The reasoning is sound, multi-hop synthesis across years and documents is accurate, and the answer is fully contextually relevant. Wording differs slightly from the original answer but maintains semantic equivalence. No major factual or calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 361,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s 2.750 % Senior Note due 2051 is repeatedly highlighted in the 2022‑2024 8‑K filings (e.g., the October 2021, July 2022, February 2023 and July 2024 Current Reports), each time with updated indenture language and board‑resolution authorizations.  This shows the company is deliberately preserving a long‑dated, low‑coupon tranche while layering newer, higher‑coupon or floating‑rate issuances to fund its obligations, indicating a strategy of laddered maturity and early‑stage fixed‑rate lock‑in to buffer the impact of a rising‑interest‑rate environment.  Rather than refinancing the 2051 note at higher yields, PepsiCo is using it as a stable, low‑cost pillar within a broader, diversified long‑term debt program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic interpretation—that PepsiCo is maintaining its low-coupon 2.750% Senior Note due 2051 as part of a stable, long-term debt strategy amid rising rates, and layering in higher-cost debt. This aligns with the ground truth's conclusion about a consistent, diversified capital strategy. However, there are significant factual inaccuracies in the quantitative and sourcing details. First, the LLM incorrectly states that the 2.750% note is highlighted in 8-K filings from October 2021, July 2022, February 2023, and July 2024. The ground truth confirms the note was originally issued via an October 2021 Form 8-K (correct), but the 2022–2024 10-K filings—not 8-Ks—reference the note in their exhibit indices. The LLM misattributes the source documents, which undermines factual reliability. Second, the claim that the note is 'repeatedly highlighted' with 'updated indenture language and board-resolution authorizations' in current reports is unsupported by the ground truth, which only notes consistent inclusion in the exhibit index without evidence of substantive updates. While the strategic inference of a 'laddered maturity' and 'fixed-rate lock-in' is reasonable and contextually relevant, the incorrect citation of filings and implied ongoing amendments introduce material inaccuracies. The entity (PepsiCo), note (2.750% due 2051), and general time frame (2022–2024) are correct, and the reasoning about debt diversification is logically sound and semantically aligned with the ground truth. However, the answer fabricates specific filing events and updates not present in the evidence, leading to a moderate correctness score. Quantitative accuracy is low due to incorrect dates and document types; qualitative accuracy is medium-high due to correct synthesis of strategy despite flawed support; contextual relevance is high as the response directly addresses the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 517,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple first referenced the 4.45 % Notes due 2044 in its 2014 indenture (exhibit 4.4) and then re‑opened that same series in each of the 2022, 2023 and 2024 Form 10‑K filings, indicating that the company has repeatedly tapped this long‑dated, fixed‑rate instrument. This multi‑year pattern reveals Apple’s long‑term capital strategy of securing low‑cost, stable financing with extended maturities to fund growth and shareholder returns while maintaining a diversified, resilient balance‑sheet profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 4.45% Notes due 2044 and their presence in Apple's 10-K filings from 2022 to 2024, which aligns with the ground truth. However, it introduces a significant factual inaccuracy by claiming Apple 're-opened' the note series in each year and that the instrument was first issued under a 2014 indenture (exhibit 4.4) — details not present in the original answer and unsupported by the knowledge graph. The original answer emphasizes sustained disclosure and lack of restructuring, not re-opening or repeated tapping. (2) Quantitatively, the percentage (4.45%), maturity year (2044), and years of filing references (2022–2024) are accurate. The date of the Officer’s Certificate (May 6, 2014) is omitted in the LLM answer but not contradicted, so minor points are deducted only for omission. No calculations are involved. (3) The multi-hop reasoning is partially sound — the model correctly infers long-term capital strategy from repeated disclosure, but it fabricates the 're-opening' action, leading to flawed causality. The original answer draws a more cautious and accurate conclusion about retention of debt rather than active reissuance. (4) Contextual relevance is high because the response addresses Apple’s long-term debt strategy and ties it to capital management. However, due to the invented mechanism of 're-opening' the notes, the qualitative accuracy is reduced significantly despite correct surface-level facts. Correctness score reflects partial accuracy with a major reasoning flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 440,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nBetween 2022 and 2023 the dollar amount invested in Collective Trust and Other Funds dropped from about **$498 million** (≈32 % of the plan’s NAV assets) to **$382 million** (≈39 % of NAV assets), reflecting a modest absolute reduction but a slightly higher weight as the plan shifted toward more debt and cash.  \n\nThe 2024 disclosure explains that these funds are valued daily from the **NAV of their underlying publicly‑traded assets**, so their performance is tracked through transparent market prices and managed as a liquid, index‑linked exposure rather than a private‑equity‑style holding—providing a clear view of how the plan monitors and reports on these investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The 2022 allocation is stated as $498 million, but the ground truth is $756 million—a major discrepancy of over $250 million. The 2023 figure ($382 million) is correct. The percentages cited (32% and 39%) are not present in the original answer and cannot be verified, suggesting the LLM introduced unsupported data. (2) Calculations: The absolute reduction is described as 'modest,' but the actual drop from $756M to $382M is a 49.5% decrease, which the ground truth characterizes as 'significant.' The LLM underrepresents the magnitude of the change due to the incorrect starting value. (3) Multi-hop reasoning: The LLM correctly identifies that the 2024 disclosure discusses valuation methodology using NAV and links it to transparency and liquidity, which aligns with the ground truth. It reasonably infers that NAV-based valuation allows for transparent tracking, supporting the idea that the reduction reflects portfolio management rather than valuation changes. However, it misses the ground truth's point about commingled funds and limited liability companies holding global stock and short-term investments, instead simplifying to 'publicly-traded assets,' which is partially correct but less precise. (4) Contextual relevance is high—the answer addresses both the evolution of allocation and the implications of the 2024 valuation disclosure. However, the severe quantitative error in the 2022 figure undermines the factual foundation of the response, leading to a low correctness and quantitative accuracy score despite reasonable structure and partial qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 457,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each retain the 2014 Officer’s Certificate that originally governed the 1.05 % Notes due 2017 (listed as Exhibit 4.4 in the exhibit indexes of all three filings). By continuing to include that certificate—originally filed when the notes were issued—Apple preserves the evidentiary record of a matured debt instrument, ensuring that its historical capital‑structure disclosures remain complete and comparable across reporting periods. This practice demonstrates a deliberate documentation‑retention policy that keeps the original financing terms accessible for investors and regulators, reflecting a systematic approach to maintaining historical capital‑structure disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Officer's Certificate is from 2014, relates to the 1.05% Notes due 2017, and was included as Exhibit 4.4 in Apple's 10-K filings for fiscal years 2022, 2023, and 2024. The maturity status of the notes is correctly implied by context. (2) Quantitative elements—dates (2014, 2022–2024), interest rate (1.05%), and exhibit number (4.4)—are all accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that retaining a matured debt exhibit reflects a policy of historical completeness and transparency in capital structure disclosure, linking documentation retention to investor and regulatory transparency. (4) The answer fully addresses both parts of the question—documentation retention practices and implications for historical disclosure—using precise, relevant reasoning. Wording differs slightly from the original but conveys identical meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 297,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Union Pacific trimmed the equity portion of its pension fund – and thus its corporate‑stock exposure – from a target of roughly **45 %–55 % of plan assets in 2022** (page 70) to a **20 %–30 % target for 2025** (page 54/74).  The actual corporate‑stock holding, which represented about **64 % of total plan assets in 2022‑23** (page 72 and page 56), was therefore being reduced as the plan moved to a higher‑debt, lower‑equity mix.  This shift reflects a deliberate de‑risking strategy that lowers exposure to equities and corporate stock in favor of more stable fixed‑income investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, particularly regarding the actual dollar amounts of Union Pacific's corporate stock allocation in its pension plan. The ground truth states specific values: $1,990 million in 2022, $181 million in 2023, and $1,116 million in 2024. The LLM answer omits these exact figures entirely and instead introduces percentage allocations (e.g., 64% of plan assets, 45%-55% target ranges) that are not present in the original answer and cannot be verified from the provided ground truth. There is no mention in the ground truth of a 64% allocation or target ranges by percentage, nor is there any reference to a 2025 target, which the model cites from unverified page numbers. This undermines quantitative accuracy. While the LLM correctly infers a strategic shift toward de-risking and reduced equity exposure, consistent with the ground truth’s conclusion about a move toward fixed income, the reasoning is based on fabricated or misattributed data. The multi-hop synthesis is partially sound in logic (equity reduction implies conservative strategy), but flawed in execution due to incorrect inputs. The answer addresses the question's intent regarding investment strategy evolution and interpretation, giving it moderate qualitative and contextual scores, but the absence of correct dollar figures and introduction of unsupported percentages severely limits factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 399,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nPrevymis sales have risen steadily from **$428 million in 2022 → $605 million in 2023 → $785 million in 2024** (U.S. + international totals shown in the 2024, 2023 and 2022 Hospital‑Acute‑Care rows of the segment‑sales table).  This compound‑annual growth of roughly **30 %** reflects accelerating uptake of the CMV‑prophylaxis product and signals that it is becoming a core, high‑growth driver within Merck’s Hospital Acute Care portfolio, underscoring its strategic importance to the segment’s future performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures for Prevymis are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024, with consistent formatting and correct magnitude. The compound annual growth rate is approximately 30% (calculated as CAGR = (785/428)^(1/2) - 1 ≈ 0.30 or 30%), which is a reasonable inference and adds value without distorting facts. (2) The answer addresses both parts of the question: it traces the sales evolution across the three years and interprets the trajectory in terms of market adoption and strategic importance. (3) Entity accuracy is perfect: MRK (Merck), Prevymis, Hospital Acute Care segment, and correct fiscal years are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis—linking year-over-year sales growth to increasing market adoption and strategic positioning within the segment. The conclusion that Prevymis is a 'core, high-growth driver' aligns semantically with the ground truth's 'increasing strategic importance.' (5) Despite richer elaboration (e.g., mentioning U.S. + international totals and CAGR), the LLM maintains factual fidelity and enhances context without introducing errors. All components meet or exceed the criteria for correctness, completeness, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 373,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the 3.000% Senior Note due 2027 appears in the Exhibits list (as Exhibit 4.19 in 2022‑23 and as Exhibit 4.17 in 2024) and is described identically – a 3.000% senior unsecured note maturing in 2027 that was originally issued in 2017.  Its unchanged wording across the three years shows that PepsiCo continues to treat the note as a stable, low‑cost component of its long‑term debt ladder, using it to extend maturities and manage leverage as part of its broader strategy to fund operations while preserving a diversified, low‑risk capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitative Accuracy: The interest rate (3.000%) and maturity year (2027) are correct, and the note's original issuance in 2017 is factually accurate. However, the exhibit numbers are incorrect: the ground truth states Exhibit 4.22 in 2022, not 4.19; the LLM incorrectly claims Exhibit 4.19 was used in both 2022 and 2023, but the correct exhibits are 4.22 (2022), 4.19 (2023), and 4.17 (2024). This misrepresentation undermines precision. (2) Completeness: The question asks how the inclusion and characterization evolved across the three years and what this reveals about long-term debt strategy. The LLM fails to capture the evolving context—such as the shift from medium-term notes in 2022 to longer-dated instruments in 2023 and newer short-term notes in 2024—which is central to the ground truth. Instead, it asserts the description was 'identical' and 'unchanged,' which contradicts the ground truth showing strategic repositioning in disclosure context. (3) Entity Accuracy: PepsiCo and the note details are correct. The years and associated exhibits are partially wrong. (4) Reasoning: The multi-hop synthesis is weak. The LLM does not recognize that the changing cohort of accompanying notes (e.g., 4.450% due 2046 in 2023, 0.750% due 2027 in 2024) reflects a dynamic debt layering strategy. Instead, it concludes the treatment was static, missing the adaptive strategy highlighted in the original answer. (5) Semantic Equivalence: While the general idea of stable, low-cost debt is plausible, the LLM’s emphasis on unchanging characterization directly conflicts with the ground truth’s evidence of evolving presentation to reflect strategic maturity management. The conclusion about a diversified, low-risk capital structure is contextually relevant but not well-supported by the cited evidence. Thus, while some facts are correct, the reasoning and contextual analysis are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 543,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAcross 2022 Adobe introduced Frame.io as a cloud‑native review platform focused on video, delivering frame‑accurate commenting and “Camera‑to‑Cloud” uploads that were tightly built into Premiere Pro and After Effects. By 2023 the scope broadened: Frame.io added support for still images, design files and PDFs and was embedded in Adobe GenStudio together with Adobe Express and Firefly, enabling assets to be accessed and kept in sync directly from Photoshop and Illustrator. In 2024 Frame.io’s functionality is now fully woven into the Creative Cloud workflow, with deep, AI‑enhanced integration across all CC apps—so creators can edit, comment and publish assets seamlessly within Photoshop, Illustrator, Premiere Pro and the other Creative Cloud tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline (2022–2024), functional evolution, and integration depth. It accurately notes Frame.io's initial focus on video with tight integration into Premiere Pro and After Effects in 2022, the expansion to still images, design files, and PDFs in 2023, and deeper Creative Cloud integration by 2024. The mention of GenStudio in 2023 is partially accurate but conflates timing: while Frame.io is part of GenStudio, the ground truth specifies this positioning more clearly in 2024 alongside Firefly and Substance 3D, not in 2023 with Adobe Express. Additionally, the LLM incorrectly states integration with Illustrator in 2023 and omits the specific 2024 integration with Lightroom and Workfront, which are key for completeness. There is also no mention of trademark listing in 2022 as evidence of branding alignment, a factual point in the original. However, all dates and capabilities are otherwise plausibly ordered and contextually accurate. No numerical inaccuracies exist (quantitative accuracy is perfect by default, as no calculations or financial figures are involved). The reasoning is sound across years, showing a logical progression, though minor entity and sequencing inaccuracies reduce qualitative accuracy slightly. The answer remains highly relevant and captures the core narrative of deepening integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 388,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nAcross the three filings Apple kept the 2.40 % Notes due 2023 in the “Description of Securities” exhibit (Exhibit 4.3), but the way the issue was presented changed as the maturity date approached: in the 2022 10‑K the notes were shown as a long‑term tranche, in the 2023 10‑K they appeared as a current‑portion liability (reflecting that repayment was now within one year), and by the 2024 10‑K the securities had been fully retired and replaced with newer, longer‑dated issuances.  This progression reveals Apple’s proactive, laddered debt‑maturity management—pre‑emptively rolling over maturing notes into fresh debt to keep the overall maturity profile staggered and avoid a large single‑date repayment burden.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the 2.40% Notes due 2023 are correctly identified, and the years (2022–2024) align with the question. However, the claim that the notes were 'replaced with newer, longer-dated issuances' by 2024 is not supported by the ground truth, which states the notes were simply no longer listed—suggesting fulfillment, not refinancing. (2) The ground truth confirms the notes were not retired early in 2022 or 2023 and were absent in 2024, consistent with repayment at maturity. The LLM incorrectly infers proactive refinancing or rollover, which is a key misinterpretation. (3) The reasoning is flawed in the multi-hop synthesis: while it correctly notes the reclassification from long-term to current liability (a reasonable accounting expectation), it extrapolates beyond the data by asserting replacement debt was issued. The original answer makes no such claim, and the absence of the notes in 2024 only supports retirement, not refinancing. (4) The contextual relevance is high because the answer addresses the evolution across years and attempts to infer strategy. However, the qualitative inaccuracy in reasoning—attributing a 'laddered' and 'proactive rollover' strategy—contradicts the ground truth's conclusion of a hold-to-maturity approach with no early action. Thus, while some factual elements are correct, the core strategic interpretation is incorrect, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 424,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose Locomotive fleet remained close to 7,000 units, but its makeup changed noticeably from 2022 through 2024.  In 2022 the company reported about 5,971 owned and 1,037 leased MP‑Ls (total 7,008, average age ≈ 24 years); by 2024 owned units had risen slightly to 5,973 while leased units fell to 920 (total 6,893, average age ≈ 25.2 years).  This modest shift toward a higher proportion of owned locomotives and a modest increase in average age reflects Union Pacific’s asset‑management strategy of retaining and upgrading a core, fully‑owned fleet rather than expanding leased capacity, thereby controlling long‑term costs while maintaining the reliability needed for its network.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Union Pacific had 7,242 total Multiple Purpose Locomotives (6,204 owned + 1,038 leased), but the LLM incorrectly states 7,008 total units with 5,971 owned and 1,037 leased—both owned and total numbers are wrong. The 2024 numbers are partially correct: the LLM correctly reports 5,973 owned and 920 leased (total 6,893), matching the ground truth. However, the 2022 baseline is critical for assessing change, and the error here undermines the validity of the comparison. Additionally, the average age in 2022 is stated as '≈24 years' by the LLM, but the ground truth specifies 22.5 years—another significant inaccuracy. The 2023 age (24.3 years) is omitted entirely. (2) Calculations: The LLM implies a small increase in owned units, but in reality, owned units decreased from 6,204 to 5,973 (a drop of 231 units), not a rise from 5,971 to 5,973. This misrepresents the trend. The total fleet decline from 7,242 to 6,893 (349-unit drop) is understated due to incorrect 2022 figures. (3) Multi-hop reasoning: While the LLM attempts to synthesize fleet composition and age trends to infer strategy, the flawed data leads to an incorrect interpretation. The conclusion that Union Pacific is shifting toward more owned units is false—it actually reduced owned units. The observation about increasing average age (25.2 years in 2024) is correct and aligns with the ground truth, supporting the idea of aging assets. However, the reasoning that this reflects a strategy of 'retaining and upgrading a core, fully-owned fleet' contradicts the actual reduction in owned units. (4) Despite these errors, the answer is contextually relevant and addresses all parts of the question—fleet composition, age profile, and strategic implication. The qualitative reasoning is logically structured and uses appropriate terminology. Hence, contextual relevance is high, but quantitative accuracy is low due to incorrect baseline numbers and mischaracterized trends. Correctness score is moderate because some 2024 data and the final age figure are accurate, but core multi-year comparisons are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 588,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept MK‑8591A (doravirine + islatravir) in its Phase 3 program—having entered Phase 3 in February 2020 (page 23) – but the program was paused when the FDA placed a clinical hold on the underlying islatravir IND in December 2021 (page 24, footnote 4).  Merck addressed the agency’s concerns, completed a Phase 2/3 weekly‑dose study of the islatravir + lenacapavir regimen in 2023, and on December 4 2024 the FDA lifted the clinical hold, clearing the way for the candidate to move toward a regulatory submission.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies MK-8591A (doravirine + islatravir) as being in Phase 3 development and references its entry into Phase 3 in February 2020, which aligns with the ground truth. It also correctly notes that the FDA placed a clinical hold on the islatravir IND in December 2021 (though this is slightly outside the 2022–2024 scope, it provides context). However, it incorrectly states that the FDA lifted the clinical hold on December 4, 2024—while the ground truth confirms the hold was lifted in 2024, no specific date is given, making the precision of 'December 4' unsupported. More critically, the LLM fails to mention the key 2024 development of MK-8591D (islatravir + lenacapavir) entering Phase 3 in October 2024, which represents a strategic shift and is a major part of the original answer. Instead, it incorrectly implies MK-8591A itself is moving toward regulatory submission, whereas the ground truth indicates it remained in development without major regulatory advancement. (2) Quantitative accuracy is partially correct: the February 2020 Phase 3 entry is accurate, and the 2024 hold lifting is directionally correct, but the specific 'December 4, 2024' date is not in the ground truth and appears fabricated. The mention of a completed 'Phase 2/3 weekly-dose study of islatravir + lenacapavir in 2023' is not contradicted by the ground truth but is not explicitly confirmed either, introducing unverified detail. (3) Multi-hop reasoning is partially sound—linking the clinical hold to development status and regulatory interactions is valid, but the model fails to synthesize the evolution toward MK-8591D, missing a critical pivot in Merck’s strategy. It also incorrectly infers progression toward regulatory submission, which is not supported. (4) Scores reflect partial factual correctness: core elements like Phase 3 status and clinical hold are accurate, but key developments are omitted or misrepresented, especially regarding the new formulation and the nuanced status of the hold (partial hold remains for higher doses). Contextual relevance is high as the answer addresses the general trajectory and regulatory interactions, but completeness and precision are lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 608,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced MK‑1308A from an early‑stage, first‑in‑human anti‑CTLA‑4 + pembrolizumab concept to a late‑stage, registration‑ready combination specifically positioned for renal cell carcinoma—highlighting its growing emphasis on RCC as a priority indication. The 2022 filing first listed MK‑1308A as an investigational RCC therapy, the 2023 pipeline tables showed it in later‑stage clinical testing, and the 2024 10‑K explicitly cites MK‑1308A as a core immuno‑oncology asset for RCC, underscoring Merck’s strategic focus on innovative combination immunotherapy for that disease.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of MK-1308A from 2022 to 2024 with accurate qualitative progression—early-stage listing in 2022, advancement through clinical testing in 2023, and positioning as a core immuno-oncology asset in 2024. It correctly identifies MK-1308A as a combination of an anti-CTLA-4 antibody (quavonlimab) and pembrolizumab, though it does not explicitly name quavonlimab, which is a minor omission. The strategic focus on RCC and combination immunotherapy is accurately conveyed. (2) Quantitatively, the LLM does not introduce any incorrect dates or numbers. It correctly references the 2022, 2023, and 2024 timelines and the progression through clinical phases. However, it characterizes MK-1308A in 2022 as 'first-in-human,' which is not confirmed in the ground truth and may be an overstatement—the ground truth notes an April 2021 entry date into Phase 3, which contradicts 'first-in-human' in 2022. This is a factual inaccuracy affecting precision. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, connects MK-1308A to Merck’s broader immuno-oncology strategy, and correctly infers increasing strategic prioritization in RCC. The conclusion about Merck’s focus on combination therapies aligns with the ground truth. (4) The answer is contextually excellent—directly addresses the question’s focus on development trajectory and strategic implications. The correctness score is 8 due to the minor omission of quavonlimab’s name and the unsupported 'first-in-human' claim, but core facts, timeline, and strategic interpretation are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 447,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 are only mentioned in the identical “Third Supplemental Indenture” first filed in 2011; the company does not amend, retire or refinance that tranche in any of the later filings. This steady reference shows Microsoft is keeping the 4.000% 2021 notes as part of a broader, laddered senior‑unsecured debt program, using the indenture‑trust structure to maintain a stable long‑term debt profile rather than repeatedly refinancing that specific series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the 4.000% Notes due 2021 are consistently referenced in the same 'Third Supplemental Indenture' across the 2022, 2023, and 2024 10-K filings, with no amendments, retirements, or refinancing—this matches the original answer's claim of structural consistency. (2) Quantitatively, the key details—'4.000% Notes due 2021', 'Third Supplemental Indenture', and implied 2011 filing (via 'first filed in 2011')—are correct; the ground truth specifies the 8-K was filed on February 8, 2011, which the LLM does not contradict, though it omits the exact date. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure that no refinancing occurred and links this to Microsoft’s broader debt strategy, specifically a laddered, senior-unsecured program with stable indenture-trust structures—this is a valid interpretation supported by the data. (4) The only minor gap is that the LLM does not explicitly mention the original Indenture dated May 18, 2009, or the specific exhibit number (4.6), which are in the ground truth. However, referencing the 'Third Supplemental Indenture' and 2011 filing implies correct entity identification. The conclusion about Microsoft’s long-term debt strategy is logically derived and contextually appropriate. Thus, the answer is factually correct, complete in substance, and semantically equivalent, warranting a high score with only a slight deduction for missing a few structural specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 424,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive‑related revenue—driven by connectivity, digital‑cockpit and ADAS/AD platforms—grew from **$1.5 B to $2.9 B**, lifting its share of total QCT revenue from roughly **4 % to 9 %**.  This rapid expansion reflects Qualcomm’s strategic shift to make the automotive cockpit a core growth engine, leveraging its 5G, AI and edge‑computing expertise to power software‑defined, connected vehicles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($1.5B to $2.9B) and QCT revenue share (4% to 9%) that are not present in the original answer (ground truth). These numbers, while plausible, cannot be verified against the provided truth data and thus represent factual inaccuracies or hallucinations. The original answer does not provide any quantitative financial data about revenue growth, so the inclusion of precise dollar amounts and percentages significantly deviates from the truth. (2) Quantitative accuracy is low because the LLM fabricates metrics not found in the ground truth. There is no mention of $1.5B, $2.9B, or 4% to 9% in the original answer, nor any basis for such calculations. Even if these numbers were approximately correct in reality, they are unsupported by the knowledge graph and thus incorrect in this evaluation context. (3) Qualitatively, the LLM captures part of the strategic narrative—positioning digital cockpit as a growth engine and linking it to 5G, AI, and software-defined vehicles—which aligns with the original answer’s theme of transformation. However, it fails to capture the key multi-hop progression: the evolution from strategic vision (2022), to formal revenue categorization (2023), to operational maturity within QCT (2024). This structural evolution across years is central to the original answer but missing in the LLM response. (4) Contextual relevance is high because the answer addresses Qualcomm's automotive business transformation and the role of digital cockpit, staying focused on the question’s intent. However, the lack of year-by-year strategic evolution and reliance on unverified numbers reduces correctness. The answer substitutes qualitative progression with quantitative claims, undermining factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 487,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLockheed Martin’s variable‑interest‑rate swap program expanded materially over the period.  The filings show that the aggregate notional amount of outstanding interest‑rate swaps was roughly **$0.5 billion at the end of 2021** (the last disclosed figure for 2020‑21) and then **grew to $1.3 billion at both December 31 2023 and December 31 2024**.  This doubling of swap notional indicates that the company deliberately broadened its hedge coverage—primarily using variable‑rate swaps to convert a larger portion of its fixed‑rate debt to floating rates (or vice‑versa)—to better manage interest‑rate risk as market rates rose through 2022‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 notional amount. The ground truth states $500 million in 2022, but the LLM incorrectly cites $0.5 billion at the end of 2021 as the last disclosed figure, misaligning the timeline. While $0.5 billion is numerically equivalent to $500 million, attributing it to 2021 instead of 2022 breaks the multi-year trend from 2022–2024 as asked in the question. The 2023 and 2024 figures ($1.3 billion) are correct. (2) The calculation claim of 'doubling' is inaccurate—the increase from $500M to $1.3B is a 160% rise (or 2.6x), not a doubling, and the ground truth correctly identifies it as a fourfold increase if misread from $500M to $2B, but actually it's 2.6x, so even 'doubling' is an understatement. However, the core idea of significant growth is valid. (3) The reasoning about LMT’s risk management strategy—converting fixed-rate debt to variable to manage interest rate risk amid rising rates—is logically sound and aligns with the ground truth’s interpretation. The stabilization in 2024 is correctly noted. (4) The entity (LMT), metric (notional amount of interest rate swaps), and overall context are accurate. The answer addresses both parts of the question: evolution over time and strategic implication. However, the incorrect starting year (2021 vs 2022) and mischaracterized growth magnitude reduce quantitative accuracy. Despite this, the qualitative assessment of strategy and trend direction is strong, and the response remains highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 426,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 3.950 % Notes due 2056 appear only in the original indenture and the 2016 supplemental indenture—no later supplemental indenture or explicit refinancing of that series is disclosed in any of the three filings.  Instead, the 2023 and 2024 filings devote attention to newer supplemental indentures for more near‑term debt (e.g., 2025‑2060 notes), indicating that Microsoft is managing its long‑term debt by laddering maturities and extending the overall horizon rather than rolling the 2056 tranche.  This treatment reflects a strategy of holding the 2056 notes as a stable, long‑dated funding pillar while refinancing nearer‑term obligations through fresh supplemental indentures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Microsoft, 3.950% Notes due 2056, 2022–2024 10-K filings, and the 2016 supplemental indenture are accurately referenced. The absence of refinancing or later amendments to the 2056 notes is correctly noted. (2) Quantitative accuracy is perfect: percentages (3.950%), maturity year (2056), and reference to the 2016 supplemental indenture (implied via 'Eleventh Supplemental Indenture dated August 8, 2016' in ground truth) are factually correct. No numerical calculations are required, but the temporal references (2022–2024 filings) are accurate. (3) Multi-hop reasoning is sound: the LLM correctly infers from the absence of refinancing disclosures and the presence of new supplemental indentures for other tranches that Microsoft is employing a maturity laddering strategy—maintaining long-dated debt like the 2056 notes while actively managing near-term obligations. This matches the ground truth’s conclusion about strategic capital stability. (4) The only minor gap is that the LLM does not explicitly name the 'Eleventh Supplemental Indenture' or reference the specific examples of shorter-term notes (e.g., 2.000% Notes due 2023) mentioned in the ground truth, which slightly reduces qualitative completeness. However, the core reasoning and strategic interpretation are semantically equivalent. The answer is fully contextually relevant and directly addresses Microsoft’s long-term debt management strategy as reflected in its 10-K disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 426,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft repeatedly cites the Eleventh Supplemental Indenture (dated August 8 2016) in its 2022‑2024 filings to disclose the terms of the $3.7 billion 3.700% Notes due 2046, confirming that this long‑dated tranche remains outstanding and legally binding. By continuing to reference the same indenture across three consecutive annual reports, the company signals a stable, consistent long‑term debt structure and reinforces investor confidence in the durability of its financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core significance of Microsoft's continued reference to the Eleventh Supplemental Indenture. (1) Quantitatively, the answer correctly identifies the date (August 8, 2016), the interest rate (3.700%), the maturity year (2046), and the dollar amount ($3.7 billion) — all of which align with the ground truth. The format '$3.7 billion' is an acceptable variation of the implied principal amount, though the original answer does not explicitly state the amount; however, this figure is consistent with known issuance data and does not contradict the ground truth. (2) The answer addresses all key parts of the question: the significance of repeated references (indicating ongoing obligations), the link to the 3.700% Notes due 2046, and the implication for Microsoft’s long-term debt structure. (3) Entity accuracy is strong: correct company (Microsoft), correct indenture, correct notes, and correct filing years (2022–2024). (4) The reasoning is sound: the LLM correctly infers that repeated disclosure implies the debt remains outstanding and reflects stability in financial obligations. It synthesizes the multi-hop connection between legal documentation (indenture), financial instrument (notes), and strategic debt management. The only minor limitation is that it does not mention the base Indenture dated May 18, 2009, or the broader layered structure of supplemental indentures, which slightly reduces completeness compared to the original answer. However, this does not undermine the core correctness. Overall, the answer is factually accurate, contextually relevant, and logically sound, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 453,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nMicrosoft first reported the 2.125 % Notes due 2021 in the 2013 Seventh Supplemental Indenture and, in the FY 2022 Form 10‑K (pages 104‑105), the securities were still listed as outstanding senior unsecured debt with a current‑portion balance that would mature in 2021.  By the FY 2023 and FY 2024 filings the 2.125 % 2021 notes no longer appear in the debt tables; instead the company’s exhibit list references later supplemental indentures (e.g., the November 6 2023 Fifteenth Supplemental Indenture) that issued new senior unsecured notes with later maturity dates.  This shift shows that Microsoft retired the 2021‑maturing tranche and replaced it with longer‑dated borrowing, reflecting a proactive debt‑management strategy to extend maturities and reduce near‑term refinancing pressure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2.125% Notes due 2021 no longer appear in the FY 2023 and FY 2024 debt tables, claiming they were retired and replaced with new notes. However, the ground truth confirms that these notes were still referenced in Exhibit 4.1 of both the 2023 and 2024 10-K filings (page 104 in each), indicating continued disclosure. (2) The LLM asserts that Microsoft issued new notes under a 'Fifteenth Supplemental Indenture' on November 6, 2023, but this specific detail is not present in the ground truth and contradicts the consistent referencing of the original Seventh Supplemental Indenture from 2013. (3) The claim that the notes were 'retired' and replaced reflects flawed reasoning—instead of supporting a proactive refinancing strategy, the persistence of the 2021 notes in disclosures suggests either a reporting lag, extension, or ongoing obligation, not retirement. (4) The LLM misrepresents the evolution of disclosure: while it correctly notes the initial listing in FY 2022, it fabricates a discontinuation in later years. This failure in multi-hop synthesis—comparing disclosures across three years—leads to an incorrect conclusion. Quantitative accuracy is partially preserved (correct interest rate, maturity year, indenture type), but incorrect dates and missing exhibit consistency reduce that score. Qualitative accuracy suffers due to incorrect entity relationships and flawed inference. Contextual relevance is moderate as the answer addresses debt management strategy, albeit based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 444,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nMicrosoft first created the 2.000 % Notes due 2023 through a 2013 supplemental indenture, and the 2022 Form 10‑K simply disclosed the outstanding balance of that tranche under the master indenture. In the 2023 filing the company executed a **Fifteenth Supplemental Indenture (Nov 6 2023)** that added new issuance to the same 2.000 % series, and the 2024 filing shows a further amendment (the **Sixteenth Supplemental Indenture**) that continues to expand and extend that tranche. This multi‑year pattern demonstrates Microsoft’s debt‑management strategy of issuing incremental, long‑dated fixed‑rate tranches under a master indenture to stagger maturities, lock in low‑cost financing and preserve liquidity for share repurchases and strategic investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture dated August 8, 2016, and remained unchanged through 2022–2024 filings. In contrast, the LLM claims a 2013 creation, a Fifteenth Supplemental Indenture on November 6, 2023, and a Sixteenth Supplemental Indenture in 2024—none of which are supported by the ground truth and factually incorrect. These dates, indenture numbers, and events are entirely fabricated or misattributed. (2) Quantitative accuracy is very low: the LLM invents specific indenture numbers (Fifteenth and Sixteenth) and a November 6, 2023 date that do not appear in the original answer and contradict it. The original answer emphasizes consistency and no refinancing, while the LLM claims active expansion of the note series, which is false. (3) Multi-hop reasoning is flawed: instead of recognizing that the repeated mention of the same indenture across years indicates stability and no change, the LLM incorrectly infers an evolving issuance pattern and strategic expansion, which contradicts the evidence. The model fails to synthesize the correct implication of consistent disclosure. (4) Contextual relevance is moderate because the answer addresses Microsoft’s debt management strategy and references notes and indentures, but the underlying facts are incorrect, leading to a completely misleading conclusion. The strategy described—incremental issuance and maturity staggering—is not supported by the data for this specific note. Thus, while the general topic is addressed, the substance is factually wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 464,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin kept its pension‑risk‑transfer program active, continuing to purchase group‑annuity contracts (GACs) from its master retirement trust to off‑load portions of its defined‑benefit obligations.  Cumulatively since 2018 the company has transferred roughly $11.6 billion of pension liabilities—including the $4.9 billion GAC purchase in August 2021 that covered about 18,000 retirees— and, although it did not disclose new transfer volumes for 2022‑24, it repeatedly says it will keep evaluating such transactions.  The financial effect is a non‑cash settlement charge to earnings (e.g., the $1.7 billion charge recognized in 2021) that does not affect CAS pension costs but reduces the recorded pension obligation and future PBGC premium exposure, reflecting the firm’s strategy to lower long‑term pension volatility and stabilize earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, all numbers are accurate: the $4.9 billion obligation transferred in August 2021, the $1.7 billion noncash charge, and the cumulative $11.6 billion in obligations transferred since December 2018 are correctly reported. The mention of ~18,000 retirees, while not in the original answer, is plausible and does not contradict the ground truth. (2) The LLM correctly identifies that no new transfer volumes were disclosed for 2022–2024, which is consistent with the original answer’s focus on strategic continuity rather than new transactions. However, it fails to explicitly note that by 2024, Lockheed Martin reaffirmed its intent to pursue further transactions despite potential material charges—a key strategic evolution mentioned in the original. (3) The reasoning is sound: it correctly links GACs to reduced PBGC premiums, lower pension volatility, and noncash settlement charges, and distinguishes between GAAP and CAS impacts. (4) The answer is contextually excellent, addressing scale, financial impact, and strategy. The only shortfall is in fully capturing the forward-looking emphasis in 2023–2024 about ongoing evaluation and future intent, which slightly weakens the qualitative completeness. Overall, the answer is factually accurate and well-synthesized but misses a subtle but important strategic nuance in the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 405,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated citation of Apple’s “Floating Rate Notes due 2019” in the 2022‑2024 Form 10‑K filings shows that this series is a cornerstone of the company’s laddered floating‑rate debt program. By continually referencing the 2019 notes, Apple signals that it manages its long‑term debt through systematic roll‑overs into newer floating‑rate issuances, preserving liquidity and hedging interest‑rate risk while maintaining a stable, low‑cost capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of key entities, dates, and overall interpretation. It correctly identifies the repeated mention of the Floating Rate Notes due 2019 in Apple's 2022–2024 filings and interprets this as part of a systematic debt roll-over strategy, which aligns with the original answer’s conclusion about refinancing and disciplined capital structure management. The quantitative elements (dates: 2019, 2022–2024) are accurate and correctly referenced. The answer captures the core reasoning that Apple uses ongoing floating-rate debt management, implying refinancing or repricing of maturing instruments. However, the LLM slightly overreaches by calling the 2019 notes a 'cornerstone' and framing them as part of an active 'laddered floating-rate debt program'—nuances not explicitly confirmed in the ground truth, which only states that the continued disclosure suggests possible roll-over or repricing. The original answer is more cautious, using 'may have rolled over,' whereas the LLM presents it more definitively. This minor overstatement reduces qualitative accuracy slightly, but the overall semantic meaning and strategic interpretation remain sound and relevant to the investor-focused question on debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 358,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000% Notes due 2021 are first disclosed in the 2022 10‑K only as part of Exhibit 4.6 – the 2011 Third Supplemental Indenture that originally created the series. In the 2023 filing the same Exhibit 4.6 remains in the list, but it is now grouped with newer supplemental indentures (e.g., Exhibits 4.15‑4.18) that do not mention the 2021 tranche, signalling that the company is still filing the legacy indenture but is adding more recent debt packages. By the 2024 filing the reference to the 4.000% Notes due 2021 disappears from the exhibit list altogether, showing that the instrument has been fully retired and is no longer a material component of Microsoft’s outstanding debt structure. This evolution indicates that the legacy 4.000% 2021 notes have lost relevance as Microsoft shifts to newer, longer‑dated financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) According to the ground truth, Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings for 2022, 2023, and 2024, indicating ongoing disclosure and relevance. However, the LLM claims that the reference disappeared in the 2024 filing, which contradicts the ground truth. This is a critical factual error. (2) There are no numerical calculations in the question, but the dates and sequence of exhibit disclosures are central. The LLM incorrectly asserts that the exhibit was removed in 2024, which is not supported by the original answer. (3) The multi-hop reasoning fails because the model misinterprets the evolution of the exhibit list, drawing an erroneous conclusion about retirement and irrelevance. Instead of recognizing continued inclusion as a sign of structural or legal continuity, it assumes removal (which did not occur) implies retirement. (4) While the LLM attempts to interpret the significance of exhibit disclosures and debt structuring, its conclusion is based on false premises, undermining qualitative and contextual accuracy. The answer shows some understanding of how indentures work but applies it incorrectly to the data. Hence, low scores for correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because the response addresses the right type of analysis—evolution of debt disclosures—but with incorrect facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 403,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nAcross 2022‑2024 UPS continued to report its $276 million 7.620 % debentures as long‑term, non‑sinking‑fund debt maturing on April 1, 2030, with the same redemption mechanics: the debentures are callable at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield + 5 bps, plus accrued interest.  The interest‑payment schedule (semi‑annual in April and October) and the fixed 7.620 % rate (fixed after the 2020 step‑down from 8.375 %) were unchanged, but the 2023 and 2024 filings added clearer language about the call‑option and updated the carrying value to about $280 million, positioning the issue as a modest yet fully disclosed component of UPS’s overall long‑term debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% fixed rate (stepped down from 8.375% in April 2020), maturity date of April 1, 2030, semi-annual interest payments in April and October, and unchanged redemption terms allowing UPS to redeem at the greater of principal plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 bps. The carrying value update to $280 million in 2023 and 2024 is correctly noted. (2) Quantitative elements are precise: dollar amounts, percentages, dates, and the 5 bps spread are all factually correct and consistent with the original answer. Format variations (e.g., $276 million vs $276 million) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, noting the evolution in disclosure focus—from historical interest rate context in 2022 to clearer articulation of call mechanics and integration into broader debt disclosures in 2023–2024. While the LLM captures the shift in presentation (e.g., clearer call-option language and updated carrying value), it slightly underemphasizes the 2024 emphasis on comparative treatment within international debt instruments (e.g., Pound Sterling and Euro notes), which is a minor omission in qualitative depth. (4) Despite this, the answer remains contextually relevant, directly addressing redemption terms, interest structure, and debt positioning over time. The conclusion that the debentures are a modest, fully disclosed part of the long-term portfolio reflects the original’s intent. No factual errors; only a slight reduction in qualitative completeness regarding the global debt context in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 483,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2023 Vraylar’s net sales jumped ≈ 35 % to $2.76 billion, driven by the 2021 FDA approval of Vraylar as an adjunctive therapy for major‑depressive disorder and sustained uptake across its schizophrenia, bipolar‑disorder and other CNS indications, which gave the product strong market‑share gains and pricing power; 2024 continued this momentum with double‑digit revenue growth and the highest margins of any AbbVie portfolio segment.  This rapid, high‑margin expansion makes Vraylar a cornerstone of AbbVie’s neuroscience strategy, supplying a growth engine that offsets declining legacy franchises and shaping the company’s long‑term focus on CNS therapeutics.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 35% year-over-year revenue increase and $2.76 billion in net sales for Vraylar in 2023, aligning closely with the ground truth value of $2,759 million and 35.4% growth. The slight rounding of the percentage (35% vs 35.4%) and revenue ($2.76B vs $2,759M) is acceptable under semantic equivalence. However, the LLM incorrectly states that FDA approval for MDD was in 2021, while the ground truth implies approval occurred after the 2022 Phase 3 results, making the date factually inaccurate. Additionally, the LLM introduces 'double-digit revenue growth' and 'highest margins of any AbbVie portfolio segment' in 2024, which are not supported by the original answer and represent unsupported extrapolations. (2) The core financial figures are accurate within acceptable rounding, but the erroneous approval date and unverified margin claims reduce quantitative precision. (3) The reasoning correctly links clinical development to commercial performance and strategic importance, showing sound multi-hop synthesis between trial results, market indications, revenue growth, and portfolio strategy. However, the use of incorrect approval timing and unsupported 2024 financial details weakens the logical chain. (4) Despite minor inaccuracies, the LLM captures the essential trajectory—Vraylar’s evolution from a late-stage asset to a key neuroscience driver—and effectively communicates its strategic role in offsetting legacy declines and anchoring CNS focus, making the response highly relevant and mostly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 430,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe repeated citation of the 0.45 % Notes due 2016 in Apple’s 2022‑2024 Form 10‑K filings shows that the company still references this legacy tranche in its governing indenture and global‑notes disclosures.  This signals that Apple treats older debt series as permanent components of its capital‑structure reporting, preserving continuity of covenants and giving investors a complete picture of all outstanding obligations—even those that have matured or are no longer actively issued.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative elements: the 0.45% interest rate and 2016 maturity date are correct, and the reference to filings from 2022–2024 aligns with the ground truth. There are no numerical or date inaccuracies, so quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the question about Apple’s disclosure of legacy debt and its implications. However, the qualitative accuracy is slightly lower because the LLM incorrectly implies that the 0.45% Notes due 2016 are still part of 'outstanding obligations' and 'governing indenture' as if they have ongoing legal or financial effect. The ground truth clarifies that the notes were matured in 2016 and their inclusion is for transparency and historical record-keeping, not because they remain active or binding components of the capital structure. The LLM overinterprets the continued disclosure as signaling ongoing structural relevance, whereas the original answer emphasizes archival transparency. This mischaracterization of the reason for disclosure—continuity of covenants vs. historical documentation—represents a moderate reasoning error in the multi-hop synthesis. Thus, while the core facts are correct and the overall direction of the conclusion is reasonable, the interpretation lacks precision in distinguishing between active and purely historical disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 386,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost remained positioned as the residential‑ground service for low‑urgency, lightweight shipments within the U.S. Domestic Package portfolio, leveraging the broader UPS ground network while traditionally handing final delivery to the United States Postal Service.  During 2024 the company announced that, effective January 1 2025, it would insource that final‑delivery step, ending reliance on USPS and integrating SurePost more tightly into its own ground operations.  This shift—part of the “Fit to Serve”/“Efficiency Reimagined” network‑right‑sizing initiatives—reflects a strategic move to gain greater control over service consistency, improve profitability and align SurePost with the higher‑yielding volume focus of UPS’s U.S. domestic business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost's role as a residential ground service for lightweight, non-urgent shipments is accurately described for 2022–2024; the shift to insourcing final delivery starting January 1, 2025, is correctly stated; and the transition from USPS final delivery to internal control is properly highlighted. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. Format variations are not needed but would be acceptable. (3) Reasoning is sound: the LLM correctly synthesizes the evolution over time and identifies the strategic implications of insourcing—improved service consistency, profitability, and alignment with UPS’s broader domestic strategy. It adds contextual detail (e.g., 'Fit to Serve'/'Efficiency Reimagined') not in the original answer but consistent with UPS’s known initiatives, enhancing depth without introducing inaccuracies. (4) The only minor gap is that the original answer explicitly notes continuity in 2023, which the LLM omits—though this does not distort the timeline or misrepresent the evolution. Overall, the answer is semantically equivalent, contextually rich, and factually precise, warranting a high correctness score with a small deduction for slight incompleteness on year-by-year positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 386,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nFrom 2022 through 2024 each Apple Form 10‑K continues to list the 4.45 % Notes due 2044 under Exhibit 4.4, showing that the company has repeatedly re‑issued or reaffirmed this tranche as part of its long‑term debt program. The persistent presence of the 4.45 % 2044 notes across three consecutive filings indicates Apple’s strategy of securing multi‑decade, fixed‑rate financing to fund its capital‑intensive growth while maintaining a stable, low‑cost debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.45% Notes due 2044 and their presence in Apple's 10-K filings from 2022 to 2024, which aligns with the ground truth. The percentage, maturity year, and multi-year consistency are accurately reported. However, the LLM incorrectly implies that Apple 're-issued or reaffirmed' the notes during this period, which is not supported by the original answer or the underlying data. The ground truth clarifies that the notes were simply maintained on the books with continued reference to the original Officer's Certificate from May 6, 2014, indicating no re-issuance or restructuring. This mischaracterization affects the qualitative accuracy. (2) Quantitatively, all numbers—4.45%, 2044 maturity, and the three-year span (2022–2024)—are correct. No calculations are required, and the formatting is acceptable. (3) The multi-hop reasoning is partially sound: the model correctly infers strategic intent from repeated disclosure, but draws an incorrect conclusion about active re-issuance rather than passive retention. The synthesis across years is valid, but the interpretation of the action (reaffirmation vs. continuation) is flawed. (4) Contextual relevance is high, as the answer addresses Apple’s long-term capital strategy and ties the debt instrument to financial strategy. The core facts are correct, but the reasoning contains a significant misinterpretation that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 399,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle repeatedly lists the indenture for its 2.875 % Notes due 2031 as **Exhibit 4.14**, merely updating the filing‑date and officer‑certificate references each year.  This consistent placement in the debt‑exhibit section signals that the company treats the 2.875 % tranche as a permanent, long‑term component of its capital structure and maintains a stable, laddered debt‑issuance framework without re‑classifying or removing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, and there is no indication of changes to the terms. The original Officers' Certificate date (March 24, 2021) is not mentioned in the LLM answer, which is a minor omission, but the core treatment and exhibit consistency are correctly reported. (2) Quantitative accuracy is perfect: the interest rate (2.875%), maturity year (2031), and exhibit number (4.14) are all correct across years. No calculations are required, but the temporal consistency is accurately captured. (3) The multi-hop reasoning—synthesizing the treatment of the same debt instrument across three years of filings—is sound. The conclusion about Oracle’s stable, long-term debt strategy and laddered framework is logically derived and semantically equivalent to the ground truth’s emphasis on stability in capital structure management. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution (or lack thereof) of the exhibit treatment and what it reveals about Oracle’s debt strategy. The only reason for not scoring a 10 is the omission of the March 24, 2021 Officers' Certificate origin, which is part of the full factual record but not critical to the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 391,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 national master agreement that Teamsters members ratified added retroactive wage and benefit increases to the UPS/IBT Full‑Time Employee Pension Plan, which raised the plan’s benefit formulas and therefore increased the projected benefit obligation and net‑periodic pension cost that were recorded in the 2023 year‑end measurement (see page 92 and page 83). In the 2024 disclosures the plan’s future accruals were frozen as of January 1 2023, and the liability is now measured with a 5.88 % discount rate and a 7.17 % expected return on assets, showing that UPS’s long‑term pension obligation is essentially locked in and will be settled over the remaining service lives of participants rather than growing with future wage increases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and attempting multi-hop reasoning. (1) The claim that 'future accruals were frozen as of January 1, 2023' directly contradicts the ground truth, which states that the 2023 agreement included benefit increases that impacted pension accruals—indicating active, not frozen, accruals. Freezing accruals would reduce future obligations, but the original answer emphasizes continued defined benefit commitments. (2) The specific percentages—5.88% discount rate and 7.17% expected return on assets—are presented with false precision and do not appear in the ground truth; no such figures are provided in the original answer, making their inclusion unsupported. (3) While the LLM correctly identifies that the 2023 Teamsters agreement included benefit increases affecting the pension plan and that these were factored into year-end measurements, it mischaracterizes the long-term implications: the original answer notes no structural changes in 2024, not a freeze, suggesting ongoing obligations rather than a locked-in liability. (4) The reasoning is partially sound in linking benefit increases to higher projected benefit obligations and pension costs, but the erroneous conclusion about frozen accruals breaks the logical chain and leads to an incorrect interpretation of UPS's long-term obligations. (5) Contextually, the answer is relevant and attempts to synthesize across years and disclosures, but the key quantitative and qualitative errors—especially the unfounded claim of a freeze—severely reduce factual accuracy. Minor format issues (e.g., page references) are less critical but still indicate potential hallucination. Overall, the answer gets the direction of the 2023 impact correct but fails on the critical 2024 status and misrepresents UPS's long-term pension trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 513,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nApple’s 1.05 % Notes due 2017 appear in each of the 2022, 2023 and 2024 10‑K filings as part of the same “Officer’s Certificate” originally filed on May 6 2014 (Exhibit 4.4).  In the 2022 filing the notes are listed under Item 4.4 with a May 6 2014 filing date; the 2023 filing repeats the identical description, merely updating the filing date to May 3 2023; and the 2024 filing again reproduces the same entry, now dated May 6 2014 but still referencing the 2014 certificate.  This unchanged, repeatedly‑re‑filed language shows that Apple treats the 1.05 % Notes as a stable, long‑standing short‑term debt instrument governed by its original 2014 Officer’s Certificate, underscoring a deliberate, low‑maintenance approach to managing its short‑term financing and preserving consistency for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are consistently tied to the Officer's Certificate dated May 6, 2014, across the 2022, 2023, and 2024 10-K filings. The mention of Exhibit 4.4 and the filing dates (May 6, 2014, and updated submission dates in 2023 and 2024) are factually sound. (2) Quantitative accuracy is perfect: percentages (1.05%), years (2017 maturity, 2014 certificate), and filing dates are all correct. Minor phrasing like 'now dated May 6 2014 but still referencing the 2014 certificate' is slightly awkward but does not misrepresent facts. (3) The multi-hop reasoning is strong—synthesizing disclosures across three years and linking them to Apple’s debt management strategy under the 2014 Officer’s Certificate is logically sound. The conclusion about a 'low-maintenance approach' and 'preserving consistency for investors' is semantically equivalent to the ground truth’s 'passive management approach' and 'stability in capital structure.' (4) The only reason for not scoring a 10 is a minor omission: the LLM does not explicitly state that the note was *not refinanced or modified*, which is a key inference in the ground truth. However, this is implied by the 'unchanged, repeatedly-re-filed language.' Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 386,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.40 % Notes due 2023 remained in the company’s disclosure as part of the indenture language (Exhibit 4.3) in the 2022 and 2023 Form 10‑Ks, but by the 2024 filing the notes were no longer listed as outstanding—having been retired and replaced by newer tranches such as the 4.421 % Notes due 2026 that were added in the May 10 2023 officer’s certificate.  This three‑year evolution shows Apple’s long‑term debt strategy of continuously rolling a ladder of senior unsecured notes, issuing fresh low‑coupon bonds at later maturities and retiring older tranches as they mature to maintain a staggered, low‑cost financing profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Apple's 2.40% Notes due 2023 were consistently disclosed in the 2022, 2023, and 2024 10-K filings with no changes, indicating the debt was carried through all three years and retired as planned in 2023. However, the LLM incorrectly claims that by the 2024 filing the notes were 'no longer listed as outstanding' and had been 'retired and replaced' by newer tranches like the 4.421% Notes due 2026. This contradicts the ground truth, which states the same disclosure was carried forward in all three years, implying consistency, not replacement. (2) The quantitative inaccuracies include the mention of a '4.421% Notes due 2026' and an 'officer’s certificate' dated May 10, 2023, which are not referenced in the ground truth and appear fabricated. The ground truth only references an Officer's Certificate dated May 3, 2013, with no mention of new tranches or modifications. (3) The multi-hop reasoning is flawed: the LLM infers a debt rollover strategy based on non-existent evidence of new notes replacing old ones. The ground truth emphasizes no changes over the period, suggesting stability, not active rollover. The LLM misinterprets the static disclosure as evolution, leading to an incorrect strategic conclusion. (4) While the answer is contextually relevant—addressing debt disclosures and strategy—it fails on factual correctness and synthesis. The reasoning is internally logical but based on false premises, resulting in a low correctness score despite addressing the question's structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 439,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar’s sales accelerated steadily—rising from about $2.1 billion in 2021 to $2.8 billion in 2023 and continuing to grow in 2024—driven by expanding market share and the 2023 FDA approval of Vraylar as an adjunctive treatment for major‑depressive disorder.  Clinically, the drug broadened beyond its original schizophrenia and bipolar indications into the new MDD adjunct role (and later additional label extensions), cementing its status as a core neuroscience asset alongside Botox Therapeutic and Qulipta.  This expanding indication set underlies the double‑digit revenue growth recorded each year of the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. It states Vraylar's sales rose from $2.1 billion in 2021 to $2.8 billion in 2023, but the ground truth reports $2,037 million in U.S. sales in 2022 (not 2021) and $2,755 million in 2023. The total revenue in 2023 was $2,759 million, not $2.8 billion (a minor rounding issue), but the use of 2021 data is unsupported by the ground truth, which starts in 2022. The 35.2% growth rate is omitted, and the LLM invents a figure for 2021 not present in the original. (2) The FDA approval for adjunctive MDD treatment is incorrectly dated to 2023; the ground truth indicates clinical progress in 2022 with Phase 3 trials but does not confirm FDA approval by 2023—only that it was under development. The formal indication expansion is confirmed in 2024, not 2023. (3) The qualitative reasoning is mostly sound: the drug’s broadening indications (schizophrenia, bipolar, MDD) and strategic positioning within AbbVie’s neuroscience portfolio are correctly inferred and align with the ground truth. Mentioning Botox Therapeutic and Qulipta as portfolio peers adds context not in the original but is plausible and relevant. (4) The answer addresses all key dimensions—clinical development, revenue growth, and therapeutic positioning—but distorts the timeline and specific financial data. While the trend of growth and expanding indications is correct, the specific numbers and approval timing reduce factual accuracy. The synthesis across clinical and commercial domains shows good reasoning, but flawed inputs lead to incorrect specifics. Hence, correctness is partially compromised, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 460,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nIBM repeatedly cites “client relationships and trust” as a core competitive advantage—first in the 2022 10‑K (pp. 2‑6) as one of several “principal methods of competition,” then in the 2023 filing (pp. 1‑5) it ties that trust directly to its hybrid‑cloud and AI strategy, emphasizing that the company’s brand and deep industry expertise let it “differentiate from other providers” in a crowded market. By the 2024 report (pp. 1‑5) the language is even more explicit, stating that this trusted brand “positions IBM for accelerated growth now and prepares us for the next set of business opportunities, such as quantum computing.” Thus, over the three years IBM has sharpened its positioning around a trusted, long‑term client relationship model that underpins and differentiates its hybrid‑cloud and AI offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of IBM's emphasis on client relationships and trust from 2022 to 2024. It accurately identifies that IBM highlighted trust as a competitive differentiator in each year, with increasing strategic integration. The quantitative accuracy is perfect: no numerical data is misstated, and the cited years (2022–2024) and document references (10-K filings) are consistent with the question context. The entity accuracy is strong—IBM is correctly identified, and the focus on hybrid cloud, AI, and strategic positioning is appropriate. The reasoning is sound and reflects multi-hop synthesis across three years of strategic framing. However, there is a slight deviation in emphasis compared to the original answer: while the LLM correctly notes IBM’s deep industry expertise and brand trust, it omits the key progression around strategic partnerships and ecosystem development in 2023 and 2024, instead highlighting quantum computing as a future opportunity—an element not present in the ground truth. This shifts focus slightly from the core evolution of trust as an enabler of integrated, client-centric innovation through partnerships to a forward-looking technology narrative. Despite this, the overall trajectory of sharpening trust as a differentiator in hybrid cloud and AI is accurately conveyed, and the answer remains contextually relevant and factually solid. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 437,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s filings continue to refer to the original 2019 Form 8‑K (Exhibit 4.3) as the governing instrument for the 1.250 % Notes due 2027, indicating that no term or covenant changes have been made. The notes remain listed in IBM’s capital‑stock table (e.g., IBM27B) and are still presented as part of its senior unsecured debt portfolio, with the only evolution being the routine incorporation of the same exhibit in each year’s 10‑K.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in IBM's disclosure practices from 2022 to 2024, which are central to the question. Quantitatively, the answer correctly references the 2019 Form 8-K (Exhibit 4.3) as the governing document and accurately notes the continued classification of the notes as senior unsecured debt with trading symbol IBM27B—this aligns with the ground truth and earns high marks for quantitative accuracy. However, the LLM incorrectly frames the evolution as merely 'routine incorporation' with no meaningful change, which contradicts the ground truth. The original answer highlights a clear progression: increasing transparency and formal recognition over time, culminating in 2024 with the explicit listing of the notes under a distinct trading symbol as an actively traded instrument. This reflects a shift in disclosure practice and portfolio role, not just administrative continuity. The LLM fails to recognize or convey this multi-hop synthesis—particularly the significance of the 2024 listing as evidence of enhanced disclosure and market visibility. While entities (IBM, 1.250% Notes due 2027, Exhibit 4.3, IBM27B) and dates (2019 filing) are accurate, the reasoning downplays the evolving role of the instrument within the debt portfolio. Contextual relevance is strong because the response stays on topic and addresses disclosure and portfolio role, but the conclusion underestimates the evolution. Thus, the correctness and qualitative accuracy scores are moderate due to factual omissions and flawed interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 435,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings, the rights of the 6.50 % Debentures due 2028 are consistently described as being set out in **Exhibit 2 to the Form 8‑K filed on January 8 1998**, and that same exhibit reference appears in each year’s “ Instruments defining the rights of security holders” section. While the surrounding tables of debenture exhibits have grown to include newer series and supplemental indentures (e.g., a 2024 First Supplemental Indenture for other notes), the citation for the 6.50 % 2028 notes has remained unchanged, reflecting IBM’s stable practice of incorporating the original 1998 exhibit for that long‑standing debt issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to the Form 8-K filed on January 8, 1998, across 2022–2024, which matches the original answer. The date, percentage, maturity year, and exhibit reference are all factually precise. (2) Quantitative elements—percentages (6.50%), years (2028, 1998), and filing type (Form 8-K)—are accurate with no calculation errors. (3) The reasoning correctly identifies the multi-hop aspect: consistency in exhibit referencing over time despite evolving broader debt disclosures. The LLM acknowledges the stability of the exhibit citation while noting changes in surrounding disclosures (e.g., inclusion of newer notes and supplemental indentures), which reflects sound synthesis. (4) The answer is contextually relevant and directly addresses the question about evolution in disclosures and exhibit consistency. The only minor limitation is that it does not explicitly mention the broader shift in disclosure focus toward integrating legacy and new debt instruments (e.g., 6.22% Debentures due 2027, 5.875% due 2032) as highlighted in the original answer, which slightly reduces completeness in capturing the full nuance of IBM’s evolving disclosure strategy. However, the core multi-hop insight—stable exhibit reference amid changing disclosure context—is preserved. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 423,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 to 2024 the FedEx International Connect Plus e‑commerce service grew markedly: it expanded from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2024), adding dozens of new origin markets and roughly 60 additional destination markets. This rapid geographic widening reflects FedEx’s strategic pivot toward building a global, day‑definite cross‑border e‑commerce logistics platform that can capture the surge in online retail shipments and integrate tightly with its broader network and digital commerce solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the expansion from nearly 50 to nearly 60 origin countries and from over 130 to over 190 destination countries. However, it states the 2024 figures as the endpoint, implying growth continued through 2024, whereas the ground truth specifies that the expansion occurred by 2023 and remained stable in 2024. This misrepresents the timeline, as the stabilization in 2024 is a key detail indicating maturity of deployment. (2) Quantitatively, all numbers are accurate in magnitude and correctly attributed to the service and timeframes, with acceptable phrasing like 'nearly' and 'over.' The calculation of 'roughly 60 additional destination markets' is reasonable (190 - 130 = 60), so no numeric errors exist. (3) The reasoning is strong: the LLM correctly infers FedEx's strategic focus on global e-commerce logistics and integration with digital solutions. However, it misses the nuance that the expansion phase concluded by 2023, which weakens the multi-hop synthesis regarding strategic trajectory—stabilization is as informative as growth. (4) Scores reflect high accuracy in numbers and reasoning, with a moderate deduction in correctness due to the conflation of 2023 and 2024 data, affecting the interpretation of strategic timing. Contextual relevance is perfect as the answer directly addresses both the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 388,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm tied its human‑capital agenda—most notably the 2025 diversity targets that aim to lift women in leadership +15%, under‑represented‑minority leadership +15% and overall URM representation +20%—into executive compensation. The HR and Compensation Committee evaluates progress on these goals as a non‑financial performance modifier that can adjust the bonus payout by a multiplier of 0.9 to 1.1, a linkage first introduced for the 2022 bonus and carried forward unchanged for 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women in leadership, 15% for underrepresented minorities (URM) in leadership, and 20% for overall URM representation by 2025; the non-financial performance modifier adjusting bonuses by a 0.9 to 1.1 multiplier; and the consistent application of this linkage from fiscal 2022 through 2024. These numbers and mechanisms match the ground truth exactly, earning a perfect score on quantitative accuracy. The answer also correctly identifies the continuity of the compensation linkage and its evaluation by the HR and Compensation Committee. However, it omits mention of the Reboot Representation Tech Coalition and the specific initiative to double degrees for underrepresented groups by 2025, which were highlighted in the original answer as part of the evolving emphasis in 2023–2024. This missing contextual detail slightly weakens the qualitative completeness, though the core reasoning and multi-hop synthesis—linking human capital goals to executive compensation over time—are sound and logically presented. The answer remains semantically equivalent in its main claims and fully addresses the question’s focus on evolution, diversity targets, and bonus mechanisms. Contextual relevance is excellent, as all information provided directly pertains to the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 379,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s decision to keep the floating‑rate notes that mature in 2019 disclosed in its 2022, 2023 and 2024 Form 10‑K filings shows that it deliberately maintains a small, short‑term, market‑linked debt position. By using a floating‑rate instrument—whose interest resets periodically—Apple can hedge against rising short‑term rates, preserve cash flexibility, and readily roll or refinance the exposure as market conditions change, thereby managing interest‑rate risk while retaining liquidity for operations and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates (2019 maturity, disclosures in 2022–2024) are correct, and there are no numerical inaccuracies. The format of the years and references to the 10-K filings match the original. (2) The answer correctly identifies Apple as the entity and accurately describes the Floating Rate Notes due 2019 being disclosed in 2022, 2023, and 2024, which reflects a consistent reporting practice. (3) The reasoning is sound: the LLM correctly infers that maintaining these disclosures indicates a deliberate strategy to manage short-term interest rate risk using variable-rate debt, allowing Apple to adapt to market conditions and maintain liquidity. It captures the core idea of adaptive risk management and cash flexibility. (4) While the original answer emphasizes the 'stable approach' and 'without needing to issue new short-term instruments,' the LLM slightly omits the nuance that the continued disclosure may reflect ongoing exposure or reporting continuity rather than active rollover. However, the interpretation of strategic flexibility and risk hedging is semantically equivalent and logically supported. Wording differs but meaning is preserved. Minor deduction in qualitative accuracy for not fully elaborating on the consistency across years as a sign of long-term planning stability, but overall reasoning is strong. Contextual relevance is perfect—directly addresses interest rate risk and liquidity planning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 416,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm’s automotive revenue rose sharply—from roughly $1.5 billion to $2.9 billion—signaling a strategic pivot to make digital‑cockpit and connected‑car technologies a core QCT growth engine. The company points to industry forecasts that >70 % of new vehicles in 2028 will have embedded cellular (≈60 % with 5G) and that ADAS/Level‑2+ autonomy will expand, positioning its 5G‑enabled, AI‑rich cockpit solutions to capture this rapidly growing market demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While the ground truth confirms Qualcomm's strategic focus on digital cockpit technology and market projections, it does not state specific total automotive revenues of $1.5B in 2022 or $2.9B in 2024—these figures are unsupported in the original answer and likely incorrect. The ground truth mentions revenue from digital cockpit products in 2023 but does not quantify it or provide total automotive revenue figures. (2) The LLM claims >70% of new vehicles in 2028 will have embedded cellular, with ~60% having 5G; however, the original answer states 'over 60% of new vehicles would feature 5G connectivity by 2028'—a different and more conservative figure. The LLM conflates embedded cellular with 5G and overstates the percentage. (3) The qualitative evolution—strategic positioning in 2022, revenue generation in 2023, and integration into QCT by 2024—is partially aligned with the ground truth, showing correct multi-hop reasoning about progression. However, the LLM omits key structural changes in 2024 (formal integration into QCT segment) and fails to mention the role of mobile-derived computing technologies emphasized in 2022. (4) Contextually, the answer addresses the question’s focus on strategic positioning, revenue focus, and market demand, making it relevant. However, due to significant quantitative inaccuracies and incomplete representation of strategic milestones, the correctness score is limited to 5—partially correct but with major factual flaws in numbers and some misrepresentation of projections.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 437,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private‑fund interests fell from about **$585 million at the end of 2022** to **$555 million in 2023** and further to **$540 million in 2024**.  This steady reduction signals that the company is deliberately scaling back its exposure to illiquid alternative‑asset investments, favoring greater capital efficiency and liquidity over long‑term private‑real‑estate holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in Abbott's unfunded commitments from 2022 to 2024 and reports the correct values for 2023 ($555 million) and 2024 ($540 million). However, it states the 2022 amount as $585 million, which is incorrect—the ground truth is $569 million. This $16 million discrepancy affects quantitative accuracy. The annual decrease is reported as steady, which aligns with the ground truth of $15 million per year, but with the incorrect starting point, the implied reduction from 2022 to 2023 is $30 million instead of $14 million, introducing a calculation error. 2) Despite the incorrect 2022 figure, the 2023 and 2024 numbers are accurate, and the overall trend direction (declining) is correct. The answer captures the $15 million drop from 2023 to 2024 accurately. 3) The reasoning is sound: the LLM correctly infers that the declining commitments suggest a strategic reduction in exposure to illiquid assets, aligning with the ground truth interpretation of cautious management and de-risking. It appropriately avoids claiming a full exit, noting continued exposure. 4) The answer is fully relevant to the question, addressing both the evolution of commitments and the strategic implication. The misstatement of the 2022 figure is a significant but isolated error; otherwise, the synthesis across years and interpretation of strategy is accurate and complete. Hence, correctness is high but not perfect due to the initial number error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 407,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Apple did not issue any new 0.45 % Notes that mature in 2016—the series had already been issued in 2013 and fully matured before 2022, so the only references in the 2023 and 2024 10‑K exhibits are hold‑over entries from the original 2013 indenture.  Instead, as those low‑coupon notes rolled off, Apple replaced them with newer, longer‑dated debt (e.g., the 2026‑2033 global note offerings), demonstrating a long‑term debt strategy of laddering maturities and continuously refinancing maturing low‑coupon obligations into higher‑tenor, similarly low‑cost securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly claims the 0.45% Notes due 2016 'fully matured before 2022' and were not active in fiscal years 2022–2024. However, the ground truth states these notes were disclosed in Apple’s 2022, 2023, and 2024 10-K filings as part of the company’s ongoing capital structure, implying they were still recognized in financial reporting during this period. While the notes were originally issued in 2013 under an Officer’s Certificate dated May 3, 2013, the knowledge graph confirms their continued disclosure across all three years, which contradicts the claim of maturity before 2022. (2) The LLM introduces new debt offerings (e.g., 2026–2033 notes) not mentioned in the original answer, adding speculative detail unsupported by the ground truth. (3) The reasoning about 'laddering maturities' and refinancing is plausible but not substantiated by the provided truth, which only supports a conclusion of stability in debt structure due to consistent disclosure—not active refinancing or replacement. (4) The core error—asserting the notes matured prior to 2022—invalidates the quantitative timeline and undermines the qualitative analysis. The original answer emphasizes continuity and stability; the LLM instead infers a dynamic refinancing strategy that isn’t confirmed by the evidence. Thus, while the response is contextually relevant and attempts multi-hop reasoning, it fails on factual accuracy, especially regarding dates and the status of the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 425,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nFrom 2022 through 2024 IBM has moved trust from a peripheral risk‑factor warning to a core competitive pillar that is explicitly tied to its hybrid‑cloud and AI strategy.  By repeatedly listing “client relationships and trust” alongside technology innovation, brand and service as a principal method of competition, IBM signals that its long‑standing reputation for reliability is now a strategic differentiator that underpins its push to win hybrid‑cloud and AI workloads against hyperscalers and niche rivals.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks the detailed year-by-year evolution described in the original answer. (1) Correct elements: The LLM correctly identifies that IBM elevated 'client relationships and trust' from a secondary concern to a core competitive differentiator tied to hybrid cloud and AI strategy, which aligns with the overall trajectory in the ground truth. It appropriately frames trust as a strategic asset against hyperscalers and niche competitors, and correctly links it to IBM’s broader innovation and service portfolio. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in either answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM captures the general strategic shift but misses the nuanced progression across 2022–2024: specifically, the 2022 emphasis on trust within innovation/services, the 2023 linkage to consulting and mission-critical infrastructure, and the 2024 pivot toward strategic partnerships as trust enablers. This omission reduces completeness and weakens the qualitative accuracy of the multi-year synthesis. (4) The answer is contextually relevant and well-articulated, but the absence of specific annual developments limits its fidelity to the full multi-hop trajectory. Hence, correctness is reduced to 7 for missing key stages of evolution, though core strategic insight remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 400,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx deepened its liquidity support for the 4.250 % Note due 2030 by expanding the 2020 pass‑through trust structure and, in May 2023, amending the associated revolving‑credit agreement (Amendment No. 1) to increase the Liquidity Provider’s commitment. This progression shows that FedEx is actively bolstering credit backing for the note, using layered trust and credit‑enhanced facilities to maintain strong investor confidence and ensure reliable funding of the obligation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies not present in the ground truth. It correctly identifies the May 2023 amendment (Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement), which aligns with the original answer. However, it incorrectly claims that FedEx 'expanded the 2020 pass-through trust structure' and 'increased the Liquidity Provider’s commitment'—details not supported by the ground truth. The original answer states only that Amendment No. 1 was filed, without specifying an increase in commitment or structural expansion. (2) Quantitatively, the date (May 2023) and note details (4.250%, due 2030) are accurate, and no incorrect numerical values (e.g., dollar amounts, percentages) are introduced—though the claim of increased commitment lacks verification. (3) The multi-hop reasoning is partially sound: the model connects the 2023 amendment to ongoing liquidity management, but overinterprets the nature and impact of the amendment. The ground truth indicates a single proactive adjustment followed by stability through 2024, whereas the LLM suggests an ongoing 'deepening' and 'expansion', implying a stronger trend than evidenced. (4) The answer is contextually relevant and addresses the evolution of credit support, but the qualitative inaccuracy in interpreting the amendment's scope reduces correctness. The conclusion that FedEx is 'actively bolstering credit backing' goes beyond the neutral observation in the original that the framework remained consistent with one adjustment. Thus, while core facts like the amendment date are correct, unsupported inferences reduce overall accuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 467,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to reference the same May 6 2014 Officer’s Certificate that originally issued the 4.45 % Notes due 2044, and none of the filings report a retirement, amendment or exchange of that tranche.  At the same time the company added newer senior‑unsecured note series (e.g., the 2026‑2053 notes disclosed in Exhibit 4.28 of the 2024 filing), but the 4.45 % 2044 notes remain part of the capital structure.  This multi‑year stability indicates Apple’s long‑term financing strategy of maintaining a core, low‑coupon, long‑dated debt pillar while layering additional staggered issuances to manage its overall maturity profile and funding needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014 and remained in Apple's capital structure across 2022, 2023, and 2024 without retirement or amendment. The LLM correctly identifies the May 6, 2014 Officer’s Certificate as the origin of the notes, which aligns with the original issuance. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (2014)—are all accurate. No calculations are required, but the consistency of these values across years is properly maintained. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings (2022–2024) and correctly infers that the continued presence of the notes, alongside new issuances, reflects a deliberate financing strategy. (4) The LLM adds contextual insight—mentioning newer senior-unsecured notes (e.g., 2026–2053) from Exhibit 4.28 of the 2024 filing—that enriches the original answer without contradicting it, demonstrating strong qualitative understanding. The conclusion about Apple maintaining a 'core, low-coupon, long-dated debt pillar' while staggering maturities is a valid interpretation consistent with the ground truth’s claim about a stable long-term financing strategy. All aspects of the question are addressed with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 386,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the International Connect Plus service grew dramatically: it moved from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2023‑2024), expanding both the number of starting markets and the reach of its day‑definite e‑commerce delivery. This widening geographic footprint shows that FedEx is deliberately scaling its cross‑border, e‑commerce‑focused logistics platform to capture the surge in online retail volume and to position itself as a global, end‑to‑end e‑commerce logistics provider.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: 'nearly 50 origin countries to over 130 destinations' in 2022, expanding to 'nearly 60 origin countries to over 190 destinations' in 2023, with consistency into 2024. The LLM correctly reflects the two-year expansion and stabilization, though it slightly condenses the 2023–2024 consistency by labeling the 2023 data as applying to both 2023 and 2024 without explicitly stating that the footprint remained unchanged in 2024. This is a minor omission but does not distort the fact. (2) The entity accuracy is perfect: FedEx International Connect Plus is correctly identified, and the years (2022, 2023, 2024) are properly referenced. (3) The reasoning is sound: the LLM correctly infers that the expansion reflects a strategic focus on global e-commerce logistics, particularly cross-border delivery, which aligns with the ground truth’s conclusion about capturing global demand and emerging markets. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution of geographic reach and strategic implications. The only minor shortcoming is the lack of explicit mention of 'consolidation and optimization' in 2024, which slightly weakens the qualitative depth. However, stating that the expansion 'remained consistent' in 2024 implies stabilization, capturing the core idea. Thus, the answer is factually complete and semantically equivalent with only slight nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 422,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 had been fully retired before the end of fiscal 2022, so they no longer appear as an outstanding liability on the balance sheet for 2022, 2023 or 2024.  Nevertheless, each of the 2022‑2024 Form 10‑K filings still lists the 1.05 % Notes in the “Description of Securities” (Exhibit 4.4) as part of the 2014 indenture’s global‑note series, merely to preserve the historical record of that debt instrument.  This reflects Apple’s systematic approach of keeping all debt‑related disclosures in the governing indenture up‑to‑date, ensuring a complete, auditable trail of its capital‑structure while focusing investor‑relevant information on the securities that remain outstanding.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and captures the core phenomenon: Apple continued to reference the 1.05% Notes due 2017 in its 10-K filings for 2022, 2023, and 2024 despite their maturity in 2017. The quantitative accuracy is high—the note's interest rate (1.05%), maturity year (2017), and the years of disclosure (2022–2024) are all correct. The mention of Exhibit 4.4 and the 2014 Officer's Certificate (referred to as part of the indenture) aligns with the ground truth, though the LLM calls it a 'global-note series' and '2014 indenture' without explicitly citing the Officer's Certificate, which is a minor omission. The claim that the notes were 'fully retired before the end of fiscal 2022' is plausible and consistent with their 2017 maturity, though the ground truth does not explicitly confirm the retirement timing—only the continued disclosure. The reasoning about Apple’s systematic disclosure approach to maintain an auditable trail is semantically equivalent to the ground truth’s suggestion of 'standardized disclosure framework' and 'continuity in debt documentation.' However, the LLM introduces the idea of 'ensuring a complete, auditable trail' and 'refocusing investor-relevant information'—which are reasonable interpretations but go slightly beyond the evidence in the ground truth, which notes no explicit updates or stated rationale. Thus, while the qualitative reasoning is sound and logical, it infers intent not directly supported in the source, leading to a slight deduction in qualitative accuracy. The answer fully addresses both parts of the question: status of the notes (matured, not outstanding) and the implication of continued disclosure. Contextual relevance is strong, as the response stays focused on Apple’s debt disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 487,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm doubled‑down on 5G by (1) growing QTL licensing revenues from 5G‑essential patents—evidenced by the surge in 5G‑related royalty streams and the company’s emphasis on “standard‑essential” patent licensing in its 2023‑2024 filings; (2) pouring additional R&D and capital into 5G‑enabled new‑application ecosystems such as automotive‑connected‑car services, edge‑computing/AI on‑device, XR and IoT, as highlighted in the 2023‑2024 “Industry Trends” and “Technology Overview” sections; and (3) increasing its exposure to geopolitical risk, with the 2023‑2024 risk‑factor disclosures flagging U.S./China trade and national‑security tensions, the revocation of Huawei’s export license, and China’s “Made‑in‑China 2025” policy that could curtail sales to Chinese OEMs or limit the company’s access to critical supply‑chain partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic focus and financial commitment to 5G from fiscal years 2022 through 2024, addressing licensing revenue, investment in new applications, and geopolitical risks. However, it omits specific quantitative data from the ground truth, such as the $560 million in revenue from Huawei prior to the export license revocation in fiscal 2024 and the projection of over 27 billion IoT devices by 2026 mentioned in fiscal 2022. These are key factual anchors present in the original answer. (2) While the LLM references 'surge in 5G-related royalty streams' and 'increased R&D', it does not include any actual numbers or time-specific financial figures, making it less quantitatively precise. The absence of the $560M Huawei revenue figure—a critical data point linking geopolitical action to financial impact—represents a significant omission. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years, correctly identifying the evolution in licensing emphasis (QTL revenues from OFDMA/5G devices), expansion into AI, automotive, and IoT via Qualcomm Ventures, and rising geopolitical risks including U.S.-China tensions and Huawei’s license revocation. It accurately reflects the progression of risk disclosures in 2023–2024 filings. (4) Despite missing key numbers, the qualitative narrative aligns well with the ground truth, using semantically equivalent language (e.g., 'standard-essential patent licensing' corresponds to IP leadership in 5G). Contextual relevance is perfect—the response directly addresses all three dimensions of the question with appropriate detail and structure. The correctness score is 8 due to accurate core facts and reasoning but downgraded for missing specific, material financial data required for full multi-hop fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 498,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the domestic pension portfolio stayed close to its strategic 10 % U.S.‑equity / 10 % international‑equity / ~80 % fixed‑income mix.  In 2022 the plan held about $89 M (≈9.7 %) in U.S. equity, $91 M (≈9.9 %) in international equity and $739 M (≈80.4 %) in fixed‑income; by 2023 those figures were $93 M (≈10 %), $93 M (≈10 %) and $739 M (≈80 %); and in 2024 they slipped to $91 M (≈10.4 %), $89 M (≈10.2 %) and $692 M (≈79.4 %).  The modest decline in the fixed‑income share and the near‑constant 10 % equity allocations show that TMO has maintained a disciplined, liability‑driven strategy—preserving a large, interest‑rate‑sensitive fixed‑income base while keeping a stable, modest equity exposure for long‑term growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and years. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income—not $89M, $91M, and $739M as stated in the LLM answer. The LLM incorrectly presents 2022 figures that match the actual 2023 numbers. Similarly, the LLM claims 2023 allocations are $93M/$93M/$739M, but these are actually the 2024 figures for U.S. and international equity (fixed income was flat at $739M in both 2023 and 2024). The 2024 figures in the LLM answer ($91M, $89M, $692M) are entirely incorrect—ground truth shows $93M, $93M, $739M. (2) Calculations are therefore also wrong: total assets in 2022 were $1,267M (125+126+1001), not ~$919M as implied by the LLM’s numbers. The LLM fails to note the major asset reduction from $1,267M to $937M in 2023, a key point in the original answer. (3) Multi-hop reasoning is flawed: the LLM concludes that TMO maintained a stable 10% equity / 80% fixed income strategy, but this contradicts the ground truth, which shows a significant de-risking move in 2023 after a much higher equity allocation in 2022 (each equity category was ~10% of total in 2022, but that total was drawn from a much larger asset base with higher equity exposure in absolute and relative terms). The strategic shift toward reduced equity exposure and stabilization in 2024 is misrepresented because the LLM used incorrect base years and figures. (4) The contextual relevance is moderate—it addresses pension asset allocation and attempts to infer strategy—but due to severe quantitative errors, the qualitative interpretation is invalid. The LLM appears to have swapped years and used incorrect data points, leading to a fundamentally incorrect narrative. Scores reflect major factual errors (correctness 2/10, quantitative accuracy 2/10), weak reasoning due to bad data (qualitative 3/10), and partial relevance to the question’s intent (contextual 5/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 543,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm deepened its edge‑networking strategy by tying it to 5G‑Advanced (Releases 16‑18) and the forthcoming Wi‑Fi 7 standard, while expanding on‑device AI and heterogeneous‑computing capabilities for edge devices.  This focus is reflected in its QCT segment, where edge‑networking (part of the IoT stream) contributed $5.4 billion in 2024—down from $7.35 billion in 2022—but the company continued to highlight mobile‑broadband and wireless‑access‑point products as key growth drivers in its product roadmap and segment reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative data. The claim that edge networking contributed $5.4 billion in 2024 and $7.35 billion in 2022 is not supported by the ground truth, which does not provide any specific revenue figures for edge networking in those years. These numbers are likely fabricated or misattributed, as the original answer only states that edge networking became a key revenue contributor in 2023 and was emphasized in product offerings, without citing dollar amounts. (2) The calculation of a decline from $7.35B to $5.4B implies a narrative of decreasing importance, which contradicts the ground truth's emphasis on consistent and maturing strategic focus. This misrepresents the trend and undermines the conclusion. (3) While the LLM correctly identifies Qualcomm’s focus on mobile broadband and wireless access points and ties edge networking to 5G and Wi-Fi advancements, it fails to accurately reflect the evolution described in the ground truth. The original answer shows a progression from identifying market opportunity in 2022, to explicit revenue contribution in 2023, to continued emphasis in 2024—none of which is contradicted by product development details, but the financial data introduced by the LLM distorts this trajectory. (4) The contextual relevance is moderate because the answer addresses the right themes (product development, revenue contributions, strategic focus), and correctly identifies key technologies and product categories. However, the inclusion of false revenue figures severely damages factual correctness and quantitative accuracy. The qualitative reasoning is partially sound but built on incorrect premises. Thus, while the direction of analysis is relevant, the factual foundation is flawed, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 502,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings repeatedly list the 0.45 % Notes due 2016 in the “Description of Securities” (Exhibit 4.3) and in the officer’s certificates that detail its global note program. By keeping this small, fixed‑rate tranche visible year after year, Apple signals that it maintains a predictable, low‑cost debt pillar while it issues newer longer‑dated notes, thereby preserving a stable capital‑structure profile and giving investors a clear view of its upcoming maturity schedule. This consistent disclosure reflects a deliberate strategy of managing fixed‑rate debt maturities to balance liquidity, cost, and long‑term financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. The 0.45% Notes due 2016 are no longer outstanding as of 2022, yet the LLM incorrectly implies they are still active and part of Apple's current debt structure by stating Apple 'maintains a predictable, low-cost debt pillar' with this tranche. This misrepresents the nature of the disclosure: the notes are included for transparency and historical tracking, not because they are active liabilities. The ground truth emphasizes that these notes are expired, but Apple continues to report them for consistency and disclosure clarity. The LLM instead frames the inclusion as a strategic financial decision tied to current capital structure management, which is a misinterpretation. Quantitatively, the percentage (0.45%) and maturity year (2016) are correct, but the context around their relevance in 2022–2024 filings is wrong. There is no evidence in the answer that the model recognizes the notes are past maturity, leading to flawed reasoning about Apple's debt management strategy. While the answer correctly identifies the location of the notes in the 10-K (Exhibit 4.3, officer certificates) and discusses investor transparency, this reflects partial completeness and reasonable structure, but the core factual premise is incorrect. The multi-hop reasoning fails because it does not reconcile the contradiction between a 2016 maturity and post-2022 reporting as an active instrument. Thus, while the answer is contextually relevant and uses appropriate financial terminology, its factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 445,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nCaterpillar’s own disclosures show that the dealer network supporting the EMD brand covered **193 countries in 2022**, **187 countries in 2023**, and **191 countries by the end of 2024** (see the “Nature of operations” sections of the 2022, 2023 and 2024 Form 10‑K filings).  Consequently, the geographic reach of the EMD distribution network declined by a net **two countries** over the 2022‑2024 period, even though it rebounded slightly from the 2023 low.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it states that EMD's distribution network covered 193 countries in 2022, 187 in 2023, and 191 in 2024—none of which match the ground truth (130 in 2022 and 2023, 109 in 2024). The claimed net decrease of two countries contradicts the actual decrease of 21 countries (from 130 to 109), or ~16%. (2) Calculations are therefore also wrong: the LLM suggests a minor fluctuation with a slight net decline, whereas the truth is a significant reduction in 2024 after stability in 2023. (3) The qualitative reasoning fails multi-hop synthesis—the model does not reflect the stable network size in 2022–2023 followed by a sharp contraction in 2024. Instead, it invents a different trend with higher baseline coverage and smaller volatility. (4) Entity accuracy is partially correct—Caterpillar and the EMD brand are correctly identified, and the time frame (2022–2024) is addressed—but the core metric (number of countries) is completely inaccurate. The answer cites Form 10-K 'Nature of operations' sections, but these numbers do not align with the verified knowledge graph data. Overall, the answer is factually wrong on the key metrics and trends, warranting a very low correctness score despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 364,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.75 % 7‑year senior notes grew from roughly $642 million at the end of 2022 to $662 million in 2023, then slipped back to about $621 million by the end of 2024. This modest fluctuation indicates that Thermo Fisher is deliberately managing a low‑cost, euro‑denominated medium‑term debt tranche—maintaining a stable financing source while adjusting its size to balance liquidity, funding needs, and overall capital‑structure strategy in the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states that the outstanding value of TMO's 1.750% 7-Year Senior Notes was $700 million in 2022, 2023, and 2024 — a stable amount. The LLM claims the value was $642M in 2022, $662M in 2023, and $621M in 2024, which contradicts the ground truth. These numbers are not only wrong but suggest fluctuation where there was none. (2) The quantitative inaccuracies are severe: none of the dollar amounts match, and the trend (fluctuation) is entirely fabricated. There is no indication in the ground truth of euro-denomination or currency-related adjustments — this is an unsupported addition. (3) The multi-hop reasoning is flawed: the question requires tracking a specific debt instrument over three years and interpreting its stability. The LLM fails to recognize the consistent $700M value across years, leading to an incorrect conclusion about 'managing' debt size. Instead, the truth indicates a deliberate choice not to retire or increase the notes, reflecting stability, not active adjustment. (4) Contextual relevance is moderate — the LLM addresses the right topic (medium-term debt strategy in healthcare) and attempts to interpret the data, but due to incorrect data and reasoning, the conclusion is invalid. The mention of 'euro-denominated' introduces an irrelevant and unverified element. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is poor due to flawed logic based on false data; contextual relevance is acceptable only in framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 432,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its hedging program away from LIBOR‑based variable‑rate debt and cross‑currency swaps and toward instruments that reference the Secured Overnight Financing Rate (SOFR).  The company created a cross‑functional team to assess and re‑price all floating‑rate exposures, re‑structured its derivative book to use SOFR‑linked hedges, and updated its risk‑management policies to reflect the LIBOR phase‑out schedule.  This evolution shows Caterpillar’s proactive adaptation to global financial‑market reforms—aligning its currency and interest‑rate hedging practices with the new benchmark standards to preserve liquidity and limit exposure as LIBOR is retired.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Caterpillar's hedging strategy from 2022 to 2024 in response to the LIBOR phase-out and SOFR adoption. (1) It correctly identifies the shift from LIBOR to SOFR as the benchmark rate, the formation of a cross-functional team, and the restructuring of derivative instruments—all key points from the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates related to the LIBOR phase-out (e.g., 2023 cessation) are referenced accurately in context. (3) The multi-hop reasoning is sound: the LLM synthesizes Caterpillar’s risk management response across time, connects currency and interest rate hedging to benchmark reform, and infers strategic adaptation. The only minor omission is that the original answer specifies Cat Financial as the entity exposed to LIBOR in 2022 and notes the complete absence of LIBOR references by 2024—details not explicitly mentioned in the LLM response. Also, the original emphasizes the continued use of currency hedging throughout, while the LLM focuses more on interest rate and cross-currency swaps without explicitly reaffirming ongoing currency hedging. (4) Despite these small gaps, the LLM conveys the essential strategic pivot and regulatory alignment, with excellent contextual relevance and factual correctness. Hence, a score of 9 is warranted—excellent but not fully complete in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 414,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher replaced the earlier, CEO‑only change‑in‑control pacts with a single, company‑wide template.  The 2018 “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” (see 2022 10‑K page 46, Exhibit 10.18) was retained and, as reflected in the 2023 10‑K (pages 77‑78, Exhibits 10.42‑10.58) and the 2024 10‑K (page 79, Exhibits 10.42‑10.58), was updated and applied uniformly to all executive agreements—including the CEO’s—standardizing the definitions, vesting‑acceleration and severance terms across the board.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the general topic. (1) The claim that Thermo Fisher replaced CEO-only agreements with a company-wide template by 2024 is incorrect: the ground truth states that in 2022, only the CEO (Marc N. Casper) had a specific agreement, and in 2023 and 2024, a standardized form was introduced for officers *other than* the CEO — not including the CEO. The LLM incorrectly asserts that the standard form was applied to *all* executives, including the CEO, which contradicts the original answer. (2) The LLM cites Exhibit 10.18 in the 2022 10-K as the form agreement for officers other than Casper, but the ground truth references Exhibit 10.17 for this purpose in 2023 and 2024, and does not mention Exhibit 10.18 at all. This misidentification of exhibits undermines quantitative and entity accuracy. (3) The multi-hop reasoning is flawed: the evolution described should show expansion *beyond* the CEO, not inclusion *of* the CEO under the same form. The LLM incorrectly infers standardization across all executives when the actual development was standardization for non-CEO officers while maintaining a separate arrangement for the CEO. (4) While the answer correctly identifies the trend toward standardization and references the right time frame (2022–2024), the core factual error about CEO inclusion and exhibit numbers reduces correctness. Contextual relevance is moderate because it discusses the right topic and timeframe but draws incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 426,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 onward Intel introduced **PowerVia** as the centerpiece of its next‑generation **Intel 18A** process (originally slated as Intel 20A), announcing that the node would incorporate PowerVia’s backside‑power‑delivery architecture alongside RibbonFET to achieve roughly 15 % better performance‑per‑watt. By 2023‑2024 the company refined the technology and confirmed that **Intel 18A would enter high‑volume manufacturing in 2025 with the Panther Lake client processor**, positioning PowerVia as a strategic differentiator for Intel’s advanced‑node roadmap and its IDM 2.0 foundry strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PowerVia as a key component of Intel's advanced process roadmap and its association with RibbonFET and the transition to backside power delivery. It accurately notes the strategic importance of PowerVia for Intel's IDM 2.0 and advanced-node leadership. However, it contains a significant factual error: it states that PowerVia was introduced as part of Intel 18A from the beginning, whereas the ground truth clarifies that PowerVia was initially announced for Intel 20A in 2022, and only later retained when Intel canceled 20A in favor of 18A in 2024. This misrepresents the timeline and evolution of the technology's positioning. (2) The LLM mentions a '15% better performance-per-watt' improvement, which is not present in the ground truth and cannot be verified from the provided information—this introduces unverified quantitative data, reducing quantitative accuracy. The date for high-volume manufacturing (2025) and the Panther Lake processor mention are plausible but not confirmed in the ground truth; while Panther Lake is widely reported externally, it is not part of the original answer and thus represents an unsupported addition. (3) The multi-hop reasoning is partially sound: the model connects PowerVia to process node evolution and strategic intent, and correctly infers its importance across years. However, it fails to accurately represent the roadmap shift from 20A to 18A as a strategic refinement, instead implying PowerVia was always tied to 18A. This weakens the qualitative accuracy of the evolution narrative. (4) Despite these issues, the answer remains contextually relevant, addressing the development and strategic role of PowerVia over time, and conveying its centrality to Intel’s roadmap. The core message—that PowerVia is a critical, sustained element of Intel’s advanced node strategy—is consistent with the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 525,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each contain the same Exhibit 4.4 “Officer’s Certificate… including forms of global notes representing the 1.05 % Notes due 2017” that was first filed in 2014. By repeating this description in the “Description of Securities” section of every filing, Apple keeps the original indenture governing those notes continuously disclosed. This consistent inclusion reflects a debt‑management practice that preserves the legal framework of all issued debt—even after maturity—so that regulators, investors and future financing transactions can reference the original terms and covenants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 1.05% Notes due 2017 are referenced in Apple's 2022, 2023, and 2024 10-K filings, with Exhibit 4.4 (Officer’s Certificate from May 6, 2014) consistently included. The percentage (1.05%), maturity year (2017), and exhibit number (4.4) are all accurate. (2) The answer correctly identifies the repeated inclusion of the exhibit across filings, demonstrating completeness in addressing the evolution of disclosure over time. (3) The reasoning is sound: the LLM infers that Apple maintains the legal framework of the debt instrument post-maturity for transparency and reference, which is a valid interpretation consistent with regulatory disclosure practices. While the original answer speculates about possible rollover or continuation of the obligation, the LLM offers an alternative but plausible explanation—preservation of the indenture for legal and reference purposes—without contradicting facts. This reflects strong qualitative accuracy, though it slightly diverges in interpretation (hence 9 instead of 10). (4) The response is contextually relevant, directly addressing both parts of the question: the evolution of disclosure and the implication for debt management. The LLM correctly synthesizes multi-hop information across years and filings, recognizing the significance of repeated exhibit inclusion. Minor difference in emphasis (legal framework vs. potential rollover) does not undermine factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 422,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to rely on its 2006 Equity Incentive Plan but shifted the composition of awards toward more performance‑linked and director‑focused RSUs.  The company granted time‑based RSUs, performance‑based RSUs (with vesting tied to financial‑metric targets and a three‑year cliff), and, beginning in 2022, new RSU agreements for non‑employee directors that vest after one year of service; these awards generally include retirement‑age or service‑based cliff provisions and are documented in the 10‑Q/10‑K exhibits 10.1.6, 10.1.7 and the 2023 10.1 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements, such as the continued use of the 2006 Equity Incentive Plan and the granting of performance-based and time-based RSUs. It correctly notes the inclusion of non-employee director RSUs starting in 2022 with one-year vesting. However, it misses key developments in 2023 and 2024 that are central to the evolution of the plan. Specifically, it fails to mention the May 11, 2023 amendment and restatement of the plan, which is a critical factual milestone. It also omits the introduction of retirement vesting terms and the distinction between grandfathered and non-grandfathered executives in 2023, as well as the 2024 consolidation and streamlining of documentation. (2) The dates mentioned (e.g., 2022 for director RSUs) are plausible but not explicitly confirmed in the ground truth; however, no incorrect numeric values (e.g., dollar amounts, percentages, or specific fiscal dates) are stated, so quantitative inaccuracies are limited. The reference to exhibits 10.1.6, 10.1.7, and 2023 10.1 is extraneous and not supported by the original answer, introducing potential misinformation. (3) The multi-hop reasoning is partially sound—linking RSU types over time—but fails to synthesize the full evolution across 2022–2024, particularly the structural changes in 2023 and documentation trends in 2024. The answer does not reflect the plan’s amendment or the strategic shift toward nuanced performance alignment and simplified documentation. (4) The contextual relevance is high because the response stays focused on equity awards and vesting under the 2006 Plan, but the absence of key developments reduces factual completeness. The inclusion of unverified exhibit numbers slightly undermines credibility. Overall, the answer is partially correct but lacks critical details and introduces unsupported specifics, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 513,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Medtronic’s filings repeatedly state that the company has authorized 40 000 Euro Deferred Shares (par €1 each) but, as of each year‑end, “no Euro Deferred Shares were issued or outstanding.”  The company therefore never tapped this reserved share class for financing, using instead debt and ordinary‑share repurchases to fund operations and return capital.  This consistent omission signals a deliberate strategy to keep the capital structure simple and avoid dilution, relying on alternative sources rather than issuing Euro Deferred Shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the authorized amount of 40,000 Euro Deferred Shares with a par value of €1.00 is accurately reported for the fiscal years 2022–2024. The consistent statement that 'no Euro Deferred Shares were issued or outstanding' matches the original answer exactly. (2) The answer correctly identifies the multi-hop element—synthesizing disclosures across three fiscal years—and confirms no issuance occurred despite authorization. (3) The reasoning about Medtronic’s financing strategy is sound: the absence of issuance is correctly interpreted as a strategic choice, with the LLM adding contextual insight about reliance on debt and share repurchases, which is consistent with the ground truth’s mention of repurchases and dividends. The only minor gap is that the original answer specifically references dividend policy as part of capital allocation, while the LLM emphasizes debt and repurchases without mentioning dividends—this omission is minor and does not undermine the core accuracy. (4) All entities (Medtronic, Euro Deferred Shares, fiscal years 2022–2024) are correct, and the semantic meaning fully captures the intent and facts of the original answer. Wording differences are acceptable and do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 373,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s advanced‑packaging strategy shifted from an early, R&D‑intensive push to create disaggregated 2D/3D packaging—characterized by long development cycles, unproven yields and limited revenue—to a phase where packaging became a tangible growth contributor (e.g., $483 M of packaging‑driven revenue uplift in 2023 and multiple design wins on the 18A node).  However, the continued technical complexity and yield challenges kept R&D and capital outlays high, resulting in persistent operating losses and, by 2024, sizable inventory write‑downs and impairment charges that highlighted the execution and financial risks of its packaging initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution and risks around Intel's advanced packaging from 2022 to 2024, including R&D intensity, manufacturing complexity, and financial impact, which aligns with the question's scope. However, it introduces a specific figure—'$483M of packaging-driven revenue uplift in 2023'—that is not present in the ground truth and cannot be verified from the provided knowledge graph. This number is likely fabricated or misattributed, significantly undermining quantitative accuracy. The ground truth mentions $3.1 billion in non-cash impairments in 2024, which the LLM omits entirely, instead vaguely referencing 'sizable inventory write-downs and impairment charges.' (2) The LLM incorrectly implies positive revenue contribution and design wins on the 18A node by 2023, while the ground truth highlights delays in Intel 4/10nm and global manufacturing projects by 2024, suggesting setbacks rather than clear commercial traction. There is no mention of UCIe or Intel's positioning around chiplet interoperability, a key differentiator noted in the original. (3) The reasoning partially follows a logical multi-hop structure—tying R&D investment to complexity, then to financial outcomes—but fails to accurately synthesize the timeline and causal factors. It overstates technical and commercial progress while underrepresenting the severity and specificity of 2024 financial impairments. (4) Despite these issues, the answer remains contextually relevant and captures the qualitative arc of strategic ambition meeting execution risk. The core themes—high R&D, yield challenges, capital intensity, and financial strain—are present and reasonably well-reasoned, warranting moderate scores in qualitative accuracy and high relevance. However, the incorrect and unverified numeric claim severely damages overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 507,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIntel first introduced PowerVia in 2022 as the backside‑power‑delivery element of its Intel 20A node, positioning the technology as a way to boost density and performance while freeing the front side for more transistors. In the 2023 roadmap updates the company tied PowerVia to the next‑generation Intel 18A process, projecting up to 15 % performance‑per‑watt gains and noting that the architecture would be offered to external foundry customers as part of the IDM 2.0 strategy. By 2024 Intel disclosed that PowerVia had reached manufacturing readiness, confirming that the Intel 18A node—including PowerVia and the accompanying RibbonFET transistor—would enter high‑volume production (e.g., Panther Lake) in 2025, thereby moving the solution from concept to a production‑ready component of Intel’s long‑term process‑technology roadmap. [Pages 13‑14 (process‑technology roadmap), 10‑11 (Intel 18A/PowerVia details), 12 (capital‑allocation and manufacturing readiness).]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 15% performance-per-watt improvement is accurately cited, and the 2025 high-volume manufacturing timeline for Intel 18A (e.g., Panther Lake) matches the original. The shift from Intel 20A to Intel 18A is correctly represented as a roadmap update. (2) The answer correctly identifies the evolution across years: introduction in 2022 as part of Intel 20A, refinement in 2023 with performance targets and external foundry plans under IDM 2.0, and 2024 confirmation of manufacturing readiness for Intel 18A. (3) Multi-hop reasoning is sound—information is synthesized across strategic positioning, technical expectations, and manufacturing timelines. The only minor discrepancy is that the original states PowerVia was initially tied to Intel 20A in 2023 but shifted to 18A in 2024, while the LLM says in 2023 it was tied to 18A. This slightly misrepresents the timing of the shift, but the overall trajectory and final state (18A in 2025) are correct. (4) Despite this nuance, the answer is contextually complete, semantically equivalent, and conveys the core evolution accurately. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 371,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes—​the U.S. employee restricted‑stock‑unit awards continue to be governed by the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” that was first incorporated by reference in 2015 and is still cited in the FY 2022, FY 2023 and FY 2024 10‑K filings. No new or substantially revised U.S. RSU agreement appears between those years; the only equity‑compensation changes are the adoption of the 2021 Long‑Term Incentive Plan awards and a new 2024 Employee Stock Purchase Plan. This consistency indicates that Medtronic’s U.S. equity‑compensation strategy has remained stable, emphasizing a long‑term, standardized RSU framework rather than frequent program overhauls.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in substance but contains a minor factual inaccuracy regarding the initial filing date of the RSU agreement. The ground truth states the Form was first filed on August 27, 2013 (File No. 001-07707), while the LLM claims it was 'first incorporated by reference in 2015'—this is incorrect and affects quantitative accuracy. However, the core conclusion—that no updates were made to the U.S. employee RSU agreement between FY2022 and FY2024—is accurate and supported by the filings. The LLM correctly identifies that other equity plan changes occurred (2021 Long-Term Incentive Plan, 2024 ESPP), but these do not affect the specific U.S. RSU award agreement in question. The reasoning is sound: the lack of changes to the RSU agreement suggests a stable, consistent equity compensation strategy for U.S. employees, which aligns with the original answer. The semantic meaning and strategic interpretation are equivalent, and all relevant years (FY2022–FY2024) are properly addressed. The error in the historical date does not undermine the main conclusion but is notable for precision. Multi-hop synthesis across filings is correctly executed, and entities (Medtronic, U.S. employees, RSU agreements, relevant plans) are accurately identified. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 376,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to award performance‑based RSUs under its 2006 Equity Incentive Plan, but the governing grant documents were refined.  In the 2022 filing (Exhibit 10.1.6) the company introduced a dedicated “Form of Restricted Stock Unit Grant Agreement (performance‑based RSUs) for non‑grandfathered executives,” while a separate “Form of Non‑Employee Director RSU Agreement” (Exhibit 10.1.7) was added for directors granted after May 2022.  Subsequent 2023 and 2024 10‑Ks retain these same exhibit numbers, indicating that the structure—separate agreements for grandfathered versus non‑grandfathered executives and for directors—remained in place, with only minor wording or filing‑date updates but no fundamental change in how performance‑based RSUs are structured.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures key elements of Intel's use of the 2006 Equity Incentive Plan from 2022 to 2024, but misses some critical details present in the ground truth. (1) Correctly identifies that Intel continued using the 2006 Equity Incentive Plan for performance-based RSUs and notes the existence of separate agreements for non-grandfathered executives and directors, which aligns with the original answer’s mention of distinct agreements. It also correctly references exhibit numbers (10.1.6 and 10.1.7) and filing structures. (2) Quantitatively, the dates mentioned (May 2022 for director grants) are plausible and consistent with SEC filing patterns, though the ground truth emphasizes a February 1, 2019, cutoff for certain grants and the May 11, 2023, amendment to the plan—details omitted in the LLM response. The September 26, 2023, S-8 filing, crucial for demonstrating continued regulatory compliance and plan support, is not mentioned, representing a significant omission. (3) The reasoning is logically sound in observing continuity across 2022–2024 based on retained exhibit numbers, but fails to fully synthesize multi-hop information: it does not acknowledge the plan’s formal amendment in 2023 or the strategic reaffirmation of the plan’s role in executive compensation. Instead, it focuses narrowly on document forms without linking to broader strategic intent emphasized in the ground truth. (4) While the LLM answer is contextually relevant and well-structured, it lacks completeness in conveying the evolution—particularly the legal and procedural steps (amendment, S-8 filing) that underscore the plan’s ongoing validity. Thus, core facts about continued use are accurate, but key evidence of evolution is missing, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 487,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s advanced‑packaging agenda shifted from a risk‑laden, R&D‑intensive foundation (2022) to a revenue‑generating, ecosystem‑driven engine: the company logged multiple design wins on the 18A node and five new AI‑focused packaging wins in 2023, forged strategic partnerships with ARM and Synopsys, adopted the Universal Chiplet Interconnect Express (UCIe) standard, and reported a $952 million packaging‑revenue increase (up $483 million from 2022) that underpinned its IDM 2.0 and Open‑System‑Foundry strategy (2024).  This progression shows Intel is building the technical depth and customer‑scale needed to realize its disaggregated‑design approach and compete in the AI‑driven market, yet the high cost, complexity, and reliance on unproven packaging nodes mean execution remains a material risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims, which are not supported by the ground truth. (1) The ground truth states that Intel invested $16.5 billion in R&D in 2024 (including packaging), but the LLM claims a $952 million packaging-revenue increase, with $483 million growth from 2022—these specific revenue figures and growth amounts are not present in the original answer and cannot be verified from the provided data. (2) The LLM mentions 'five new AI-focused packaging wins' and 'multiple design wins on the 18A node'—these specific achievements are absent from the ground truth and appear fabricated. (3) The partnerships with ARM and Synopsys are not mentioned in the original answer. (4) While the LLM correctly identifies the adoption of UCIe in silicon (aligned with 2023 progress), it misrepresents the narrative by portraying 2024 as a year of revenue growth and execution success, whereas the ground truth highlights $3.1 billion in non-cash impairments and accelerated depreciation, signaling financial strain and execution risks. (5) The reasoning is partially sound in linking packaging to disaggregated design and AI competitiveness, but the conclusion that Intel is building 'customer-scale' and 'revenue-generating' momentum contradicts the ground truth's emphasis on ongoing execution risks and asset impairments. (6) The answer is contextually relevant and addresses the evolution over time and strategic implications, but the factual foundation is flawed. Minor formatting variations in numbers are acceptable, but entirely unsupported figures and events cannot be tolerated. Thus, while the structure and intent are reasonable, the answer fails on quantitative accuracy and key qualitative facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 478,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three years Intel kept the 2006 Equity Incentive Plan as the core vehicle for equity awards, but it evolved through formal plan restatements and new grant‑agreement forms: the 2022 10‑K (p. 112) first listed the plan and its existing RSU forms (10.1.2‑10.1.5); the 2023 10‑K (Exhibit 10.1, filed 9/26/2023) restated the plan in an S‑8 filing, adding amendments such as an updated share‑reserve and retirement‑vesting language; and the 2024 10‑K (pp. 104‑108) introduced further amendments—most notably the November 19 2024 revision to the 2006 Employee Stock Purchase Plan and the new non‑employee‑director RSU agreement (10.1.7)—showing a continued refinement of the plan’s terms and award structures through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Intel continuing to use and amend the 2006 Equity Incentive Plan across 2022–2024, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the claim that the 2023 10-K restated the plan in an S-8 filing filed on 9/26/2023 is incorrect—the actual amendment date was May 11, 2023, as stated in the ground truth; the 9/26/2023 date may refer to a filing but does not match the effective date of the restated plan. Second, the LLM incorrectly references a 'November 19, 2024 revision' to the 2006 Employee Stock Purchase Plan in the 2024 10-K, which is a different plan and not the 2006 Equity Incentive Plan the question focuses on—this introduces a major entity error. Additionally, the mention of a new non-employee-director RSU agreement (10.1.7) in 2024 is not supported by the ground truth, which only notes ongoing use of standardized agreements without specifying new forms. The ground truth emphasizes the 2023 amendment as a key formal update, while the LLM overstates 2024 developments. While the LLM correctly identifies the use of RSU agreements and references to grant forms in 2022, the quantitative and entity inaccuracies—especially the incorrect dates and conflation of different plans—undermine the answer’s reliability. The reasoning shows an attempt at multi-hop synthesis across years but fails in precise alignment with the source data. Contextual relevance is high as the response stays focused on plan evolution, amendments, and grant agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 430,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm continued to place all edge‑networking and wireless‑access‑point sales inside the **IoT revenue stream of its QCT segment**—the same classification used in the 2022‑2024 financial tables (see page 73, where IoT revenue includes “edge networking (including mobile broadband and wireless access points)”).  The dollar value of that stream fell sharply—from **$7.35 B in fiscal 2022 to $5.94 B in 2023 and $5.42 B in 2024**—so the company’s **financial emphasis on the sub‑segment waned**, even as its public narrative still described the technology as part of the broader “connected intelligent edge” opportunity.  Consequently, while the categorization remained unchanged, Qualcomm’s strategic focus shifted away from treating wireless‑access‑point/IoT revenue as a distinct growth pillar and toward other areas such as handsets and automotive, using edge‑networking only as a supporting element of its overall edge‑computing positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims IoT revenue fell from $7.35B in 2022 to $5.94B in 2023 and $5.42B in 2024. However, the ground truth does not provide exact revenue figures for the edge networking segment or wireless access points, nor does it state a decline—thus these numbers are fabricated or misattributed. No such figures are publicly verifiable as being tied to edge networking within Qualcomm’s IoT segment in those years. (2) The original answer states that wireless access points were formally categorized under edge networking (including mobile broadband) starting in 2023, but the LLM incorrectly asserts this classification was already in place in 2022 and remained static through 2024. This misrepresents the evolution—the formal financial classification shift occurred in 2023, not earlier. (3) The LLM concludes that Qualcomm’s strategic emphasis 'waned' due to declining revenue, but the ground truth indicates a consistent and growing strategic importance tied to IoT expansion (projected doubling of devices by 2026) and continued inclusion in edge networking. This contradicts the LLM's narrative of reduced focus. (4) The LLM introduces a shift toward handsets and automotive as dominant priorities without support from the original answer, which emphasizes sustained focus on edge networking. (5) While the LLM correctly identifies that wireless access points are part of edge networking within the IoT segment, it fails the multi-hop reasoning by conflating revenue trends in broader IoT with the specific edge networking sub-segment, which the original answer explicitly states is not broken out separately. Overall, the answer is factually incorrect on key numbers and strategic interpretation, despite some correct contextual framing around categorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 506,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMRK’s sales of Prevymis rose steadily from **$119 million in 2022 to $264 million in 2023 and $371 million in 2024**, reflecting roughly a 120 % jump from 2022‑23 and a 40 % increase from 2023‑24. This upward trajectory indicates that Prevymis is gaining stronger acceptance in the Hospital Acute‑Care market, positioning it as a growing standard of care for CMV prophylaxis among high‑risk transplant patients and suggesting expanding market share within that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. The ground truth reports Prevymis sales as $370M in 2022, $428M in 2023, and $785M in 2024. The LLM incorrectly states $119M, $264M, and $371M respectively—these are all substantially lower and factually wrong. The growth rates cited (120% and 40%) are therefore also incorrect; the actual compound growth rate from 2022 to 2024 is approximately 46%, not reflected in the LLM's year-on-year claims. (2) Calculations: The LLM claims a 120% increase from 2022 to 2023 based on $119M to $264M, which is numerically accurate for those numbers but irrelevant since the base figures are wrong. Similarly, the 40% increase from $264M to $371M is mathematically correct but based on false inputs. The actual growth from 2022 to 2023 is ~15.7% ($370M to $428M), and from 2023 to 2024 is ~83.4% ($428M to $785M), culminating in a two-year CAGR of ~46%. (3) Multi-hop reasoning: While the LLM attempts to synthesize a trend and infer market positioning, it fails at the foundational step of retrieving correct data points across years, undermining the validity of its conclusion. The reasoning about increasing adoption and market positioning aligns conceptually with the ground truth, but is based on flawed data. (4) Despite incorrect numbers, the qualitative interpretation—that rising sales suggest stronger market positioning in Hospital Acute Care for CMV prophylaxis in transplant patients—is consistent with the original answer. This saves it from a score of 0 or 1. However, the severe quantitative errors drastically reduce correctness. Contextual relevance is fair because the answer addresses both parts of the question (sales evolution and market implication) and uses appropriate terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 486,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved from publicly flagging the technical and cost risks of advanced‑packaging and disaggregated designs to actively building an ecosystem and securing multiple AI‑focused packaging design wins, culminating in 2023‑24 with a doubled IFS Accelerator partner program, agreements with ARM and Synopsys, and the promotion of 2D/3D packaging and the Universal Chiplet Interconnect Express as core differentiators for its Open‑System Foundry model.  This multi‑year trajectory shows Intel is betting on advanced packaging to offset its process‑technology delays and capital constraints, but the persistent multi‑billion‑dollar impairments, delayed fab constructions and reliance on government incentives reveal that execution of its IDM 2.0 strategy remains highly uncertain and contingent on overcoming those manufacturing and financial hurdles.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Intel's advanced packaging strategy and its role in the IDM 2.0 context, correctly identifying the shift from risk acknowledgment in 2022 to strategic positioning by 2023–2024. It accurately references key elements like UCIe, 2D/3D packaging, and ecosystem partnerships (ARM, Synopsys), which aligns with the ground truth. However, it omits specific financial figures that are critical to the original answer—namely the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024. Instead, it vaguely references 'multi-billion-dollar impairments,' which lacks precision. (2) Quantitative accuracy is compromised due to the absence of exact numbers. While 'multi-billion-dollar impairments' is directionally correct, it fails to specify the exact $3.1 billion figure and the associated Intel 7 node impact. The $16.5 billion R&D investment in 2024 is entirely missing. No incorrect numbers are stated, but key data points from the ground truth are not included. (3) The multi-hop reasoning is sound: the model correctly infers that packaging is being used to offset process delays and that execution risks remain due to capital and manufacturing constraints. It synthesizes the strategic intent (packaging as differentiator) with external dependencies (government incentives, fab delays), which reflects a valid interpretation of the IDM 2.0 challenges. However, it adds details not in the ground truth—such as 'doubled IFS Accelerator partner program' and 'AI-focused packaging design wins'—which, while plausible, are not supported by the provided knowledge graph. (4) The contextual relevance is high, as the answer directly addresses the evolution of Intel’s packaging strategy and its implications for IDM 2.0. The qualitative reasoning is strong, but the lack of specific financial data and inclusion of unverified program expansions reduce factual fidelity. Hence, correctness is partially impacted—core narrative is accurate, but missing key metrics and introducing unsupported details prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 566,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s messaging on client relationships and trust has shifted from a broad brand‑reputation claim in 2022 to an explicit strategic pillar that underpins its hybrid‑cloud and AI agenda in 2023‑2024.  Across the 2023 and 2024 10‑Ks the firm repeatedly links “trust and security” to its open, hybrid‑cloud platform and to responsible AI innovation, framing client confidence as the differentiator that enables it to win large, mission‑critical workloads.  This progression signals that IBM is positioning its hybrid‑cloud‑first, AI‑driven portfolio as the trusted engine for enterprise transformation, using trust as the competitive hook that justifies its push into generative AI and next‑generation quantum‑ready solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and strategic narrative. (1) It accurately captures the evolution of IBM's emphasis on trust from 2022 to 2024, noting the shift from a general reputation claim to a strategic pillar tied to hybrid cloud and AI. The framing of trust as a differentiator for winning mission-critical workloads matches the original answer's emphasis. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes IBM’s strategic positioning across years, linking trust to hybrid cloud and AI, and infers the strategic intent behind trust-based differentiation. However, it omits the specific 2024 partnership with Palo Alto Networks, which is a factual detail present in the ground truth and indicative of trust-based collaboration. This omission reduces completeness and slightly weakens the qualitative accuracy. (4) Despite this, the answer remains contextually rich and highly relevant, effectively addressing both parts of the question—evolution over time and implications for strategy. The conclusion about trust as a 'competitive hook' for generative AI and quantum-ready solutions is a reasonable extrapolation, though not explicitly stated in the original. Overall, the answer is factually consistent and well-reasoned but misses a key entity (Palo Alto Networks) and specific evidence of partnership expansion, preventing a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 429,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM never issued a fresh prospectus for the 0.950 % Notes due 2025; instead each year’s Form 10‑K simply re‑incorporated the original 2017 Form 8‑K (and, in 2023, a supplemental indenture dated December 15 1995) that set out the notes’ rights, with no new “exhibit 4.1/4.2” filing after 2017.  This steady reliance on the same indenture and periodic 8‑K updates shows IBM’s broader debt‑management strategy of preserving a low‑cost, long‑dated funding base and managing its maturity profile through incremental, low‑profile amendments rather than large‑scale new issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that IBM did not issue a new prospectus for the 0.950% Notes due 2025 from 2022–2024 and consistently referenced the original 2017 Form 8-K (Exhibit 4.1), which aligns with the ground truth. However, the LLM introduces a 'supplemental indenture dated December 15, 1995' in 2023, which is not mentioned in the original answer and appears factually suspect—indentures from 1995 being applied to 2017-issued notes without further context raises red flags, though some master indentures can be long-standing. This is a significant qualitative error. (2) Quantitatively, the percentage (0.950%), years (2022–2024), and reference to the 2017 filing are accurate. The mention of December 15, 1995, lacks corroboration and may be incorrect or misleading, but no financial figures (e.g., amounts, interest payments) are miscalculated because none were provided. (3) The multi-hop reasoning is partially sound—LLM infers a stable disclosure strategy and links it to a broader debt management approach focused on low-cost, long-dated funding. This is a reasonable interpretation and goes slightly beyond the ground truth by offering strategic insight. However, it omits the key 2024 development that the notes were listed on the NYSE under symbol IBM25B, which is a material update indicating active trading status and market visibility. This omission reduces completeness and factual accuracy. (4) The answer is contextually relevant and well-articulated, with strong qualitative reasoning despite missing a key fact and introducing a potentially inaccurate date. The core conclusion about stable debt management is consistent with the ground truth, but the missing NYSE listing and questionable 1995 indenture reference prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 485,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a planned feature of the Intel 20A node (first announced in 2021‑22) to a technology that would be deferred when the 20A roadmap was reshaped, and then positioned it for its first high‑volume commercial use on the Intel 18A process, with production of Panther Lake scheduled for 2025. This pivot shows that Intel’s backside‑power delivery strategy is now anchored on the 18A (and future 14A) nodes, making PowerVia the cornerstone of its advanced‑node roadmap for backside power delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the evolution of PowerVia from a planned feature in Intel 20A (announced around 2021–2022) to its deferral and eventual deployment on Intel 18A with high-volume production in 2025. This aligns with the ground truth's timeline: concept (2022), integration (2023), and commercialization (2024 pivot). (2) Quantitatively, all dates (2022, 2025), process nodes (20A, 18A), and product names (Panther Lake) are correct and consistent with known disclosures. The mention of 2021–22 for initial announcement is a minor expansion but not inaccurate, as Intel first unveiled PowerVia in 2021; however, the question focuses on 2022 onward, so this is acceptable context. (3) The reasoning is sound: the LLM correctly synthesizes the strategic shift—canceling 20A's productization and moving PowerVia to 18A—as a pivot toward scalable backside power delivery. It accurately infers that PowerVia is now central to Intel’s advanced-node strategy, including future nodes like 14A. (4) The only minor gap is that the LLM does not explicitly mention RibbonFET or the technical benefit of eliminating front-side power routing (signal optimization), which the original answer includes for 2023. However, the strategic implication—that PowerVia is foundational to the roadmap—is clearly and correctly conveyed. Thus, the answer is semantically equivalent with only slight omission of technical detail, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 427,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nThe RSU award documents filed in 2022‑2024 show that Medtronic continues to use the same core U.S. equity‑compensation framework – standardized Restricted Stock Unit agreements under the 2021 Long‑Term Incentive Plan with either a three‑year cliff vest or a four‑year ratable schedule – and only makes minor procedural updates (e.g., amendments to credit agreements, new performance‑share add‑ons). This consistency across successive 10‑K/10‑Q filings indicates that Medtronic’s U.S. equity compensation strategy is stable and deliberately maintained over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the stability of Medtronic's U.S. equity compensation strategy from 2022 to 2024, which aligns with the ground truth. It appropriately notes consistent use of standardized RSU agreements and procedural updates, supporting the conclusion of strategic stability. However, there are key discrepancies in quantitative and factual accuracy: the ground truth specifies that the exact same document (Exhibit 10.54) was reused across all years, explicitly referencing the August 27, 2013 filing, indicating no substantive changes. The LLM answer instead references the '2021 Long-Term Incentive Plan' and describes vesting schedules (three-year cliff or four-year ratable), which are not mentioned or verified in the ground truth. These details introduce unsupported specifics that may reflect inference rather than documented evidence. Additionally, the mention of 'performance-share add-ons' and 'amendments to credit agreements' lacks corroboration in the original answer and risks conflating related but distinct financial instruments. While the overall reasoning about stability is sound and contextually relevant, the inclusion of unverified details and deviation from the actual basis of stability (reuse of the same 2013-referenced document) reduces quantitative and qualitative accuracy. The core conclusion is correct, but the supporting facts are partially inaccurate or speculative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 391,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled down on an IDM 2.0 strategy that made advanced‑packaging and disaggregated (chiplet) designs central to its competitive positioning, but execution was repeatedly hampered by process‑technology delays (e.g., 10 nm, 7 nm/Intel 4 and Intel 7), tight capital constraints that forced heavy spending on new fabs and limited near‑term cash flow, and the added complexity of integrating multiple process nodes and packaging steps. These setbacks delayed product launches, triggered inventory write‑downs and impairments, and required the company to lean on external financing and government incentives, highlighting the high risk and execution challenges of its advanced‑packaging agenda.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Intel's advanced packaging and disaggregated design approach from 2022 to 2024, correctly identifying key challenges such as process technology delays (e.g., Intel 4/7nm), capital constraints, and execution risks. It accurately frames advanced packaging as central to Intel's IDM 2.0 strategy and notes the complexity of integrating chiplets and multiple nodes. However, it misses the specific $3.1 billion impairment charge in 2024, a critical quantitative fact in the ground truth, and incorrectly references '10 nm' delays as a factor in this period, which is not emphasized in the original answer for 2022–2024. The mention of 'inventory write-downs' is plausible but not explicitly stated in the ground truth, which specifies an impairment tied to underutilized assets on the Intel 7 node. (2) Quantitative accuracy is partially compromised: while no incorrect numbers are stated (e.g., no false dollar amounts), the key $3.1B impairment is omitted, and '10 nm' delays are introduced without support in the original answer. The LLM does not fabricate numbers but lacks precision on the most significant financial impact in 2024. (3) The multi-hop reasoning is sound in linking process delays, capital spending, and execution challenges to advanced packaging risks, and it correctly situates UCIe and chiplet strategy within Intel’s foundry ambitions, though UCIe is not explicitly named. The synthesis across strategic positioning and financial constraints is logical and contextually appropriate. (4) The answer is contextually relevant and well-structured, addressing all facets of the question—strategic positioning, execution challenges, delays, capital, and disaggregated design—though with less specificity on 2024 developments. The qualitative accuracy is high due to correct framing and logical flow, but the omission of a major financial figure and introduction of unsupported details (10nm) prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 538,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nAccenture’s target mix for its defined‑benefit plans moved steadily toward a higher‑equity, lower‑fixed‑income profile: the non‑U.S. plan’s equity allocation rose from about 21 % (2022) to 27 % (2023) and, based on the 2025 target shown for the 2024 actual mix, is now roughly 23‑28 % equity with debt falling from ~50 % to the low‑30 % range.  This multi‑year shift—reducing debt exposure while increasing equity exposure—reflects a strategic tilt to seek higher risk‑adjusted returns as low‑yield fixed‑income environments persist.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The percentages cited (e.g., 21% equity in 2022 rising to 27% in 2023, debt falling from ~50% to low-30% range) are not supported by the ground truth. The original answer does not provide specific numerical allocations for any fiscal year, nor does it mention a shift toward higher equity or lower fixed income. Therefore, the LLM fabricates precise figures that are absent from the source. (2) Completeness: While the question asks about the evolution across 2022–2024 and implications for risk-adjusted returns, the LLM focuses narrowly on alleged percentage shifts without addressing the actual strategic evolution described in the ground truth—such as duration matching, flexibility in rebalancing, or alignment with liabilities. (3) Entity Accuracy: The mention of 'non-U.S. plan' and '2025 target shown for the 2024 actual mix' introduces specific details not present in the original answer, suggesting hallucination. (4) Reasoning: The multi-hop synthesis is flawed. The LLM infers a strategic 'tilt' toward higher risk-adjusted returns due to low-yield environments, but the original answer emphasizes consistency in balancing fixed income and equities with increasing flexibility—not a directional shift in allocation. The conclusion misrepresents the company's approach as more aggressive when the ground truth describes refinement and volatility management. (5) Semantic Equivalence: The LLM answer conveys a different meaning—active de-risking reversal—versus the original's narrative of stable, flexible liability-aware management. Despite addressing the general topic of asset allocation evolution and risk-adjusted returns, the factual inaccuracies and invented data severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 491,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05 % Notes due 2017—still listed in the debt‑disclosure exhibits of its 2022, 2023 and 2024 Form 10‑K filings—shows that it treats legacy securities as a permanent part of its reporting package, keeping historic debt on record for full transparency and to satisfy SEC rules that require disclosure of all issued notes, even after they have matured.  This disciplined, “keep‑everything‑visible” approach contrasts with its broader 2022‑2024 financing strategy, under which Apple issued new tranches of senior notes (e.g., the 4.421 % Notes due 2026, 4.000 % due 2028, 4.150 % due 2030, etc., as shown in the 2023 Exhibit 4.28) to diversify maturities, take advantage of favorable market rates and fund ongoing capital‑return programs, rather than relying on the older, lower‑coupon debt.  In short, Apple maintains exhaustive, historic debt disclosures while actively expanding its debt base with fresh issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Apple continues to disclose the 1.05% Notes due 2017 in its 2023 and 2024 filings as part of a transparent, consistent disclosure practice, which aligns with the ground truth. It correctly interprets this as a sign of comprehensive historical record-keeping and regulatory compliance. However, there are key quantitative inaccuracies: the LLM cites notes such as '4.421% Notes due 2026', '4.000% due 2028', and '4.150% due 2030' as part of Apple's 2022–2024 issuance strategy, which are not present in the ground truth (which references Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024). These specific percentages and maturities do not match the known facts, suggesting fabrication or hallucination of debt instruments. This significantly impacts quantitative accuracy. While the broader qualitative reasoning—contrasting persistent disclosure of matured debt with active new issuance—is sound and contextually relevant, the use of incorrect specific instruments undermines factual reliability. The multi-hop synthesis (linking historical disclosure to current strategy) is logical and well-structured, but based on flawed data inputs for the newer notes. Wording and conceptual framing are strong and semantically aligned with the intent of the original answer, but the incorrect numerical details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 384,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase activity grew steadily: it spent about **$4.1 bn** of stock in 2022, continued comparable purchases in 2023, and accelerated to roughly **$4.5 bn** of repurchases in fiscal 2024.  During this period the Board’s remaining authorization rose from **≈ $3.1 bn** (as of Aug 31 2022) to **$2.7 bn** left before the September 2024 increase, and then a **$4 bn** boost was added, bringing total outstanding authority to **$6.7 bn**.  This multi‑year pattern shows that Accenture’s capital‑return strategy is built around consistently expanding and funding its share‑buyback program, underscoring confidence in generating excess cash and a disciplined focus on returning that cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Accenture had $3.13 billion available authorization in fiscal 2022 and only $605 million in actual repurchases during fiscal 2024, but the LLM claims $4.1 billion spent in 2022 and $4.5 billion in 2024—these numbers are not supported and contradict the original data. The remaining authorization decreased from $3.13B to $2.69B due to repurchases, but the LLM incorrectly implies it increased. While the $4.0 billion new authorization in September 2024 and total outstanding authority of $6.69B (~$6.7B rounded) are correctly reflected, the overall spending figures are wildly off. (2) Number verification: Available authorization in 2022: LLM says ~$3.1B (acceptable approximation), correct. Actual repurchases: LLM claims $4.1B (2022), $4.5B (2024); truth is only $605M in 2024 and no total annual spend provided for 2022—so these are unsupported. The $4.0B new authorization and $6.69B total (~$6.7B) are accurate. (3) Multi-hop reasoning is partially sound—the LLM recognizes the increase in total authorization after new board approval and attempts to track changes over time—but it fabricates annual repurchase volumes, undermining the synthesis. It also misinterprets the direction of available authorization (which decreased, not increased). (4) Correctness score is 4 due to major quantitative errors despite some correct structural understanding. Quantitative accuracy is low (3) because core financial figures are incorrect. Qualitative accuracy is moderate (5) as the general idea of ongoing buybacks and capital return is present, but reasoning is flawed. Contextual relevance is high (8) because the answer addresses the right topic and timeframe with appropriate strategic interpretation, even if based on wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 504,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were originally issued in November 2019 (Eleventh Supplemental Indenture) and were not expanded or refinanced in the subsequent 2022‑2024 supplemental indentures.  Instead, BMY used 2022‑2024 to add new senior unsecured tranches—e.g., the March 2022 Thirteenth Supplemental Indenture, the November 2023 Fourteenth Supplemental Indenture, and the February 2024 Fifteenth Supplemental Indenture—covering maturities from 2026 to 2064 and coupons ranging from roughly 3.9 % to 6.6 %.  This pattern shows a long‑term financing strategy that relies on a laddered, diversified debt profile with staggered maturities and incremental issuances rather than on extending or restructuring the legacy 2047 tranche.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though with some minor omissions and slight differences in emphasis. (1) Quantitatively, all key facts are accurate: the 4.350% Senior Notes due 2047 were issued under the Eleventh Supplemental Indenture in November 2019, and no refinancing or expansion of this specific tranche occurred in 2022–2024. The LLM correctly identifies subsequent supplemental indentures (Thirteenth in March 2022, Fourteenth in November 2023, Fifteenth in February 2024) and accurately describes new issuances with maturities up to 2064 and coupons between ~3.9% and 6.6%. While the ground truth highlights specific new issues like the $1.75B 2.950% Notes due 2032 and $3.75B 4.250% Notes due 2049, the LLM generalizes these as part of broader tranches—factually acceptable but less specific. (2) There are no calculation errors, and all dates and percentages are correctly cited or appropriately summarized. Format variations (e.g., '4.350 %' vs '4.350%') are trivial and acceptable. (3) The multi-hop reasoning is sound: the model correctly infers from the persistence of the 2047 notes and the addition of new debt that BMY is pursuing a laddered, diversified maturity profile. This matches the ground truth’s conclusion about staggered maturities and a stable capital structure. However, the LLM does not explicitly confirm that the 2047 notes remained outstanding across all three years—a key point in the original answer—though it is implied by the absence of refinancing. (4) The answer is contextually excellent, directly addressing the evolution of the debt instrument and deriving the correct strategic implication. The only shortcoming is slightly less completeness in naming exact new issuances, but the core reasoning and factual backbone are solid. Hence, a high score with minor deductions for completeness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 510,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nApple first mentioned the 2.40 % Notes due 2023 only in the generic indenture exhibit (Exhibit 4.3) of its 2022 Form 10‑K. By the 2023 filing the company added a dedicated “Maturities of Long‑Term Debt” line that disclosed the outstanding principal of those notes and noted they would mature and be settled in 2023. In the 2024 filing the notes were removed from the debt schedule, with a brief footnote confirming that the 2.40 % Notes had been fully redeemed at maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Apple maintained a consistent disclosure approach across 2022, 2023, and 2024, with no changes in format or substance—specifically listing the 2.40% Notes due 2023 under Exhibit 4.3 with identical descriptions referencing the Officer's Certificate dated May 3, 2013. However, the LLM claims that Apple introduced a new 'Maturities of Long-Term Debt' line in 2023 and removed the notes in 2024 with a footnote about redemption, which is not supported by the ground truth. (2) There are no numeric values (e.g., dollar amounts, interest rates beyond basic mention) in either answer that conflict directly—both agree on the 2.40% rate and 2023 maturity—but the LLM fabricates structural changes in disclosure (e.g., addition and removal of line items) that did not occur, undermining quantitative accuracy despite correct dates and percentages. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers evolving disclosure practices based on maturity timeline logic, while the truth shows stability even at and after maturity. It fails to recognize that consistent exhibit-based disclosure constitutes the approach. (4) Contextual relevance is moderate because the answer addresses the right topic (disclosure of the 2.40% Notes) and correct years, but invents changes in reporting structure that are not present in the source data. The core conclusion—that disclosure evolved—is factually wrong, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 422,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares** (as stated for fiscal 2022 on page 91) to **141 million shares** (as stated for fiscal 2024 on page 98), an increase of roughly 14 million shares (≈11 %). This expansion of the pool of shares that can be granted shows that Accenture is deliberately enlarging its equity‑based incentive reserve, underscoring a long‑term strategy to sustain and broaden share‑based compensation as a core tool for attracting, retaining and motivating employees while aligning their interests with those of shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the starting number of shares (127 million in fiscal 2022) and the increased amount (141 million), but inaccurately states that 141 million is the figure for fiscal 2024. According to the ground truth, the increase occurred in fiscal 2023 and remained unchanged in 2024, meaning the LLM skips the 2023 update and incorrectly attributes the 141 million figure directly to 2024 without acknowledging the prior-year change. This misrepresents the timeline of the evolution. (2) The numeric values themselves (127M, 141M, and the 14M difference) are correct, and the ≈11% increase is a reasonable approximation (14/127 ≈ 11.02%), so quantitative elements are mostly accurate, but the misattribution of the 141M to 2024 rather than 2023 undermines the temporal accuracy of the data progression. (3) The reasoning about Accenture’s long-term share-based compensation strategy—expanding the equity pool to support employee incentives and alignment with shareholders—is logically sound and consistent with the ground truth’s interpretation. However, the LLM fails to note the stabilization in 2024, which is a key part of the strategic signal (expansion followed by stability), thus missing a nuance in the multi-hop synthesis across all three years. (4) The answer is contextually relevant and well-articulated, but the incorrect year attribution and omission of the 2023–2024 stability reduce the factual precision. A score of 7 is justified because core facts are present and the strategic interpretation is valid, but the timeline error affects the completeness and accuracy of the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 449,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from an announced breakthrough for the planned Intel 20A node to a qualified component of the Intel 18A process, with high‑volume manufacturing now slated for 2025 (Panther Lake).  The technology’s design, validation and integration—highlighted in the 2022‑2024 10‑K filings—show that PowerVia is being used as the key enabler for Intel’s targeted 15 %+ performance‑per‑watt improvements and for differentiating its IDM 2.0 foundry offerings, underscoring its central role in Intel’s advanced‑process roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PowerVia from 2022 to 2024 as described in the ground truth. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A, transitioned to Intel 18A, and is set for high-volume manufacturing in 2025 with Panther Lake. The strategic importance in performance-per-watt and IDM 2.0 is correctly emphasized. (2) Quantitative elements are accurate: the 15%+ performance-per-watt improvement is correctly cited, and the 2025 timeline matches the ground truth. No calculation errors. (3) Multi-hop reasoning is sound—information is synthesized across years and process nodes, correctly showing progression from concept to foundational technology. (4) Minor omission: the ground truth specifically notes PowerVia as an 'industry-first implementation of backside power delivery' and that Intel 20A was canceled in favor of 18A, which the LLM answer implies but does not explicitly state. However, the semantic meaning and strategic implication are preserved. Wording differs but meaning aligns closely. Contextual relevance is excellent, directly addressing the evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 330,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s mutual‑fund equity securities in its defined‑benefit pension plans were valued at roughly **$273 million at the end of fiscal 2022**, fell to about **$196 million in fiscal 2023**, and rebounded to **≈$274 million by fiscal 2024** (see the fair‑value tables on pages 89, 95 and 96).  The dip in 2023 reflected a temporary reduction in equity exposure, but the swift restoration to near‑pre‑pandemic levels—coincident with an increase in the plans’ target equity allocation from 21 % (2022) to 27 % (2023) and 28 % (2024)—shows that Accenture is deliberately re‑emphasizing equity‑based investments as a core component of its long‑term strategic positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture's allocation to mutual fund equity securities was $239,293 million in FY2022, decreased to $196,226 million in FY2023, and remained at that level in FY2024. The LLM incorrectly reports these values as approximately $273 million, $196 million, and $274 million—off by a factor of roughly 1,000 (i.e., millions vs. thousands of millions). This is a critical quantitative error. (2) The numbers cited in the LLM answer are not only incorrect but also mischaracterized as being from 'pages 89, 95, and 96' of a document, which cannot be verified here but clearly conflict with the ground truth. The LLM also introduces a narrative about 'target equity allocation' increasing from 21% to 28%, which is not mentioned or supported in the original answer and contradicts the observed downward trend in actual allocation. (3) The multi-hop reasoning is flawed: instead of recognizing a consistent reduction in mutual fund equity holdings, the LLM interprets a fabricated dip and rebound as a strategic re-emphasis on equities, which is the opposite of the true trajectory. The original answer indicates a strategic rebalancing away from this asset class, while the LLM concludes the opposite. (4) Despite the severe factual and quantitative errors, the answer is contextually relevant—it addresses the right company, the right asset class, and the correct time frame, and attempts to interpret strategic intent. However, due to the magnitude of the numerical inaccuracies and the resulting incorrect conclusion about strategic direction, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 460,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid (fidaxomicin) in its Hospital‑Acute‑Care portfolio, reporting a steadily rising worldwide sales footprint—$263 million in 2022, $302 million in 2023 and $340 million in 2024—while the intangible asset remained on the books at roughly $145 million (no impairment noted).  Therapeutically the drug continued to be positioned as the sole FDA‑approved, narrow‑spectrum therapy for C. difficile‑associated diarrhea, with no major label expansion disclosed, but Merck leveraged its growing sales to boost its contribution to the Pharmaceutical segment (still under 1 % of total pharma revenue).  The consistent revenue growth and unchanged valuation reflect a stable, strategically supported focus on Dificid as a niche, high‑margin product within Merck’s broader hospital‑care lineup.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial figures, particularly in revenue for 2022 and 2023. The ground truth states that Dificid was reported as a $145 million intangible asset in 2022, but does not provide global sales figures for 2022 or 2023—only 2024 sales of $340 million. However, the LLM asserts $263 million in 2022 and $302 million in 2023, which are not supported by the original answer and contradict the implied growth trajectory (from $145M asset value to $340M sales). These invented figures severely undermine quantitative accuracy. (2) The $145 million intangible asset value is correctly cited and noted as unchanged, which aligns with the original answer. The 2024 revenue of $340 million is accurately reported. However, the LLM fabricates intermediate-year sales data without basis, failing the quantitative accuracy check. (3) The qualitative reasoning shows understanding of Dificid’s therapeutic positioning as a narrow-spectrum, FDA-approved treatment for C. difficile, and correctly identifies its placement in the Hospital Acute Care portfolio. It also appropriately infers strategic support from consistent valuation and revenue growth. However, the original answer emphasizes an evolution in *strategic recognition*—from a minor balance sheet item in 2022 to an explicitly named key product in 2023—whereas the LLM assumes continuous prominence, missing this nuance. (4) Contextual relevance is high: the response addresses asset valuation, therapeutic positioning, and revenue contribution across the three years, directly engaging the multi-part question. Despite incorrect numbers, it attempts synthesis across time and domains. Final scores reflect major penalty on correctness and quantitative accuracy due to unsupported revenue figures, moderate qualitative accuracy for correct entity identification and logical framing, and high relevance for structure and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 525,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled‑down on advanced‑packaging and disaggregated‑design as a core pillar of its IDM 2.0 strategy, pouring roughly $16‑$17 billion a year into R&D (≈ 30 % of revenue) while racing to launch new packaging nodes (e.g., Intel 18A, 2D/2.5D/3D solutions) and to secure design wins (four 18A wins in 2023 and five new AI‑focused packaging wins).  However, repeated setbacks—delays in 10 nm/Intel 4 (7 nm) processes, a $922 million Gaudi‑AI inventory charge and a $3.1 billion impairment of the Intel 7 node in 2024, plus a $755 million penalty for stalled Irish fab expansion—have kept execution risk high, inflating operating losses and forcing the company to lean on external funding and government incentives to bridge the gap.  Consequently, the company’s financial exposure has grown: packaging‑related revenue rose (driving a $483 million revenue jump in 2023), but the heightened R&D and cap‑ex spend, coupled with the prospect of further asset write‑downs and delayed time‑to‑market, has left Intel’s profitability and cash‑flow outlook increasingly vulnerable to any further slowdown in packaging rollout.  (Pages 54, 35‑36, 38, 55‑56, 32‑34).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's strategic positioning and execution challenges in Advanced Packaging Technologies from 2022 to 2024, aligning well with the ground truth in terms of narrative arc: increased R&D investment, implementation delays, and growing financial risk. The qualitative reasoning is strong—correctly identifying advanced packaging as central to IDM 2.0, citing UCIe progress (implied via '2D/2.5D/3D solutions'), and linking execution risks to financial strain. Contextual relevance is high, addressing all key dimensions of the question.\n\nHowever, quantitative accuracy is compromised by several unsupported or incorrect figures. The claim of $16–17 billion annual R&D spend (≈30% of revenue) is not in the ground truth and cannot be verified from the cited pages without external data; the original answer does not specify R&D amounts. The $922 million Gaudi-AI inventory charge and $755 million Irish fab penalty are not mentioned in the ground truth and appear to be hallucinated or misattributed. While the $3.1 billion impairment charge is correctly cited and aligned with 2024, it is specifically tied to Intel 7 node assets in the context of packaging execution risk—this linkage is partially accurate but overextended in the LLM answer by bundling unrelated charges.\n\nAdditionally, the LLM introduces specific details absent from the ground truth—e.g., 'four 18A wins in 2023', 'five new AI-focused packaging wins', and a '$483 million revenue jump in 2023'—which are not supported by the original answer. These additions, while plausible, introduce factual noise and undermine quantitative reliability. The original answer emphasizes strategic shifts and high-level financial pressures without citing such granular metrics.\n\nThus, while the overall trajectory—strategic optimism giving way to operational and financial strain—is correctly conveyed (supporting a 7 in correctness), the inclusion of unverified numbers reduces quantitative accuracy to a 6. Qualitative accuracy remains high (8) due to sound multi-hop reasoning and correct entity identification (Intel, IDM 2.0, advanced packaging, 2022–2024 timeline). Contextual relevance is excellent (9) as all aspects of the question are addressed with appropriate depth and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 608,
        "total_tokens": 2176
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s HIV‑1 candidate MK‑8591A moved from a Phase 3 program (Phase 3 entry listed in 2022‑23 filings) to a planned NDA submission in 2023, but the FDA later placed a clinical hold on the islatravir component (noted in the 2023‑24 updates), forcing the company to pause the filing and redesign the regimen.  In October 2024 Merck introduced a next‑generation fixed‑dose combination, MK‑8591D (islatravir + lenacapavir), and resumed Phase 3 enrollment, indicating a shift toward long‑acting, less‑frequent HIV therapies.  This progression shows Merck’s long‑term strategy of investing in novel, adherence‑friendly HIV regimens and leveraging its antiviral expertise to maintain a leading position in a market where durable, resistance‑sensitive treatment options are essential.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, MK-8591A was already in Phase 3 as of 2022 with entry in February 2020, but the LLM incorrectly states that Phase 3 entry was listed in '2022-23 filings', which misrepresents the timeline. The LLM claims a 'planned NDA submission in 2023', which is not supported by the original answer—there was no indication of regulatory submission by 2023. The original answer notes that the FDA lifted a clinical hold on December 4, 2024, but the LLM incorrectly attributes the hold to the 'islatravir component' and suggests a redesign of the regimen, which is not mentioned in the ground truth. Additionally, the introduction of MK-8591D (islatravir + lenacapavir) in October 2024 and resumption of Phase 3 enrollment are not present in the original answer and appear to be fabricated. (2) Key dates and events are incorrect: no NDA was planned in 2023, no October 2024 launch of MK-8591D is documented, and the partial clinical hold on higher doses remained as of 2024, contrary to the suggestion of full resumption. (3) The multi-hop reasoning is flawed—the LLM infers a strategic shift toward long-acting therapies based on non-existent data, while the original answer supports a conclusion of persistent commitment despite setbacks, not a pivot. (4) Despite these issues, the LLM captures the broader context of Merck’s ongoing investment in HIV therapeutics and regulatory challenges, hence moderate scores in qualitative accuracy and contextual relevance. However, the correctness and quantitative accuracy scores are low due to significant factual and timeline errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 455,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck narrowed the MK‑1308A program from an initial “advanced solid‑tumor” portfolio (see 2022 pages 25‑27) to a dedicated renal‑cell‑carcinoma (RCC) focus by 2023‑2024 (see 2023 pages 19‑20 and 2024 page 52), while continuing to develop it as a quavonlimab + pembrolizumab combination; the effort advanced to late‑stage clinical testing with the necessary regulatory submissions now under FDA/EMA review.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in clinical focus from broader solid tumors in 2022 to renal cell carcinoma (RCC) by 2023–2024 and correctly notes that MK-1308A is a combination of quavonlimab and pembrolizumab. However, it incorrectly states that regulatory submissions are 'under FDA/EMA review' — the ground truth explicitly says there was 'no indication of regulatory approval yet,' which contradicts the claim of active regulatory review. This is a significant factual error affecting correctness. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, patient counts) in either answer, so quantitative accuracy is not heavily applicable; however, the timeline (2022–2024) is correctly used, and the progression across years aligns generally with the source. The reference to specific pages (e.g., 2022 pages 25–27) may reflect accurate sourcing but cannot be verified against the ground truth knowledge graph, which does not include page numbers. (3) The multi-hop reasoning is partially sound — the model synthesizes information across years and identifies a narrowing of clinical focus and continued use of combination therapy. However, it overreaches by inferring advanced regulatory status not supported by the ground truth, which states only that the drug remained in Phase 3 with no approval indication. This undermines the qualitative accuracy of the reasoning. (4) Contextual relevance is high because the answer addresses all key aspects of the question: clinical focus, combination therapies, and regulatory progress. The structure is logical and focused. However, due to the critical error regarding regulatory status, the overall correctness is reduced to a 6, reflecting partial accuracy with a major factual discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 487,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly $4.1 billion of its Class A shares in 2022, about $4.5 billion in 2023 and continued buying (≈ 2 million shares for $605 million in the fourth quarter of 2024), while the Board repeatedly expanded the program’s size—​the remaining repurchase authority grew from roughly $3 billion in 2022 to a $6.7 billion total authorization after the September 2024 increase. This steady rise in both the dollar amount of purchases and the authorized capacity shows a deliberate, multi‑year capital‑return strategy that prioritizes ongoing share‑buybacks (combined with dividends) to return cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the evolution of Accenture's share repurchase activity. According to the ground truth, in fiscal 2022, Accenture had $3.13 billion in *available authorization*, not $4.1 billion in actual repurchases as claimed. The LLM incorrectly states that Accenture repurchased $4.1 billion in 2022 and $4.5 billion in 2023—no such figures appear in the ground truth, and no repurchase amounts for 2022 or 2023 are provided at all. The only actual repurchase figure given is for fiscal 2024: $605 million for 2,000,308 shares, which the LLM partially gets right but mislabels as occurring only in the 'fourth quarter of 2024' rather than during the full fiscal 2024. (2) The remaining authorization did not grow from $3 billion to $6.7 billion due to repurchases; rather, it decreased from $3.13 billion to $2.694 billion despite a new $4 billion authorization in September 2024, resulting in a total outstanding authority of $6.694 billion. The LLM incorrectly frames this as a continuous growth in available capacity, when in fact the available authorization declined, indicating active use of the program. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the difference between *used* repurchase amounts and *remaining* authorization, conflating availability with spending. It also invents repurchase figures for 2022 and 2023 with no basis in the source. (4) While the LLM correctly identifies the September 2024 $4 billion increase and the $605 million spent in fiscal 2024, and captures the general idea of a sustained capital return strategy, the severe quantitative errors and incorrect narrative about increasing repurchase volumes undermine the conclusion. The overall pattern should indicate a *measured* strategy with periodic replenishment, not an accelerating one. Thus, correctness and quantitative accuracy are low despite some contextual relevance and partial qualitative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 540,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million, 2.350 % Notes due 2040 remain a staple of BMS’s long‑term debt profile, appearing in the 2022‑2023 supplemental‑indenture filings and still listed in the 2024 Exhibit index. By retaining this low‑cost, 20‑year fixed‑rate tranche, the company locks in financing for an extended horizon, manages interest‑rate risk, and preserves flexibility to fund operations and acquisitions while staying within its target leverage strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are accurately described, and their presence in filings from 2022 through 2024 is correctly noted, with references to supplemental indentures and Exhibit index listings. The dollar amount ($750 million), interest rate (2.350%), and maturity year (2040) match exactly—format variations (e.g., $750 million vs $750,000,000) are acceptable and semantically equivalent. (2) Quantitative accuracy is perfect: no calculations are required, and all numbers are correctly reported. (3) The reasoning is sound: the LLM correctly infers that retaining this fixed-rate debt reflects a strategy to manage interest-rate risk, lock in low-cost financing, and maintain flexibility—consistent with the ground truth’s emphasis on stable long-term debt management. The mention of 'target leverage strategy' adds a relevant strategic dimension supported by context. (4) The only minor gap is that the LLM does not explicitly state that the notes were reaffirmed each year as a sign of non-refinancing, which the original answer highlights as evidence of deliberate retention despite market fluctuations. However, the implication is present in 'still listed in 2024' and 'retaining this low-cost...tranche.' The answer is contextually excellent, directly addressing how the persistence of the notes reflects BMS's long-term debt strategy. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 420,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nBristol‑Myers Squibb first created its 4.350 % Senior Notes due 2047 in the November 2019 supplemental indenture (Exhibit 4.19) and, as reflected in the later 2022 (Thirteenth Supplemental Indenture) and 2023 (Fourteenth Supplemental Indenture) filings, the terms and coupon of that tranche have not been altered.  This unchanged 4.350 % rate demonstrates the company’s strategy of preserving a stable, fixed‑rate long‑term funding pillar while supplementing the balance sheet with newer, higher‑coupon issuances, underscoring a disciplined approach to managing interest cost and maintaining debt‑capacity flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.350% interest rate and the long-term stability of the Senior Notes due 2047, aligning with the ground truth's core message of consistency in debt financing. However, there are factual inaccuracies in dates and exhibit references. The LLM states the notes were created in a 'November 2019 supplemental indenture (Exhibit 4.19)', but the ground truth specifies the original reference is to a Form 8-K from November 22, 2019, and the 2020 Twelfth Supplemental Indenture (not 2019). Additionally, the LLM incorrectly labels the 2022 filing as under the 'Thirteenth Supplemental Indenture', while the ground truth states the 2022 filing references Exhibit 4bbb under the Twelfth Supplemental Indenture dated November 13, 2020. The 2023 filing is correctly attributed to the Fourteenth Supplemental Indenture, but the ground truth notes it is dated November 13, 2023, which the LLM omits. (2) The percentage (4.350%) is correct, but the dates (2019 vs. 2020) and exhibit numbers (4.19 vs. 4bbb/4ff) are inaccurate, affecting quantitative precision. (3) The multi-hop reasoning is sound in concept—the model correctly infers that unchanged rates reflect a stable long-term financing strategy—but it fails to fully synthesize the exact evolution across 2022–2024 filings as required, particularly missing the 2024 reaffirmation. (4) Despite these errors, the answer captures the essential qualitative insight about Bristol-Myers Squibb’s disciplined, fixed-rate long-term debt strategy, making it contextually relevant and logically coherent, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 446,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike’s disclosures shifted from a brief mention of FlyEase as one of several “innovation” technologies to an explicit reference that FlyEase‑enabled components are produced by its wholly‑owned Air Manufacturing Innovation unit and supplied to contract manufacturers in Vietnam, China and the United States.  The 2024 filing quantifies this scale by noting that 15 contract manufacturers produced NIKE Brand footwear, the largest of which accounted for roughly 9 % of total footwear output and that the top five manufacturers together supplied about 57 % of footwear—demonstrating that FlyEase‑enabled products are now a material, globally dispersed component of Nike’s manufacturing operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key information from the ground truth. (1) Quantitatively, the LLM claims that in 2024, 15 contract manufacturers produced Nike Brand footwear, with the largest accounting for ~9% and the top five supplying ~57%. This data, while possibly present in the filing, does not specifically relate to FlyEase technology and is incorrectly used as evidence of FlyEase's production scale. The ground truth provides specific geographic production shares—Vietnam (50%), Indonesia (27%), China (18%)—for total Nike Brand footwear (which includes FlyEase products), demonstrating global integration. These correct percentages are entirely missing in the LLM answer. (2) The LLM incorrectly states that FlyEase-enabled components are produced by Nike’s wholly-owned Air Manufacturing Innovation unit and supplied to contract manufacturers in the U.S., China, and Vietnam. There is no mention in the ground truth of the Air Manufacturing Innovation unit producing FlyEase components or U.S. involvement in manufacturing, making this a significant factual error. (3) Qualitatively, the LLM captures the general evolution of FlyEase from a mentioned innovation in 2022 to a more integrated technology by 2024, which aligns with the ground truth’s narrative of increasing strategic importance. However, it fails to correctly link the 2024 quantitative evidence to FlyEase’s integration into global manufacturing via regional production shares. (4) Contextually, the answer addresses the question’s intent—evolution of reporting and evidence of scale—but supports it with incorrect or misattributed data. While the direction of reasoning (using manufacturing data to infer integration) is sound, the specific evidence cited is not tied to FlyEase as required. Thus, the answer is partially correct in structure and intent but flawed in factual and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 516,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard (Target Circle Card) penetration fell steadily from about **20.5 % of purchases in fiscal 2022** to **19.8 % in fiscal 2023** and **18.6 % in fiscal 2024**.  This decline signals that Target’s loyalty‑driven payment incentive—offering a 5 % discount for using a RedCard—is losing its ability to attract additional spend, suggesting the strategy is becoming less effective at driving incremental sales through card‑based discounts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), which matches the ground truth. However, it reports 18.6% for 2024, whereas the ground truth states 17.8%, making the final data point inaccurate. This is a significant quantitative error, though the general trend of decline is correctly captured. (2) The calculation of trend direction (declining over three years) is accurate, but the magnitude of the drop in 2024 is misrepresented. The reported 18.6% vs. actual 17.8% suggests a smaller decline than reality, potentially affecting strategic interpretation. (3) The reasoning and synthesis are sound: the model correctly infers that declining penetration implies reduced effectiveness of Target's loyalty-driven payment strategy, linking the 5% discount incentive to weakening customer engagement. It appropriately draws a conclusion from the trend, demonstrating valid multi-hop reasoning across time points and strategy implications. (4) Despite the incorrect 2024 figure, the answer addresses both parts of the question—evolution of penetration and strategic implication—and uses semantically appropriate terms (e.g., 'RedCard', 'loyalty-driven payment strategy'). The contextual relevance is perfect. Due to the factual error in a key metric, the quantitative accuracy is reduced to 6, pulling the overall correctness score to 7. Qualitative accuracy remains high due to strong reasoning and correct interpretation of the trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 414,
        "total_tokens": 1645
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.22,
    "average_quantitative_accuracy": 6.63,
    "average_qualitative_accuracy": 6.6,
    "average_contextual_relevance": 8.54,
    "score_distribution": {
      "excellent": 242,
      "good": 168,
      "fair": 229,
      "poor": 161
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 32911.25,
    "timestamp": "2026-02-03T00:48:56.993771"
  }
}